Citrus Sinensis ID: 002642
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 897 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.297 | 0.325 | 0.380 | 1e-46 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.287 | 0.276 | 0.363 | 8e-46 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.303 | 0.296 | 0.360 | 3e-44 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.294 | 0.198 | 0.348 | 8e-43 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.275 | 0.191 | 0.369 | 1e-42 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.294 | 0.109 | 0.376 | 4e-42 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.304 | 0.168 | 0.361 | 6e-42 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | no | 0.293 | 0.273 | 0.363 | 5e-41 | |
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | no | 0.274 | 0.256 | 0.370 | 1e-40 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.279 | 0.384 | 0.364 | 2e-40 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 189 bits (479), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 111/292 (38%), Positives = 167/292 (57%), Gaps = 25/292 (8%)
Query: 610 NTANTEL------QTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSL 663
N AN EL I DL +++G+G+FGTV +W GSDVA+K E
Sbjct: 531 NRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK-----ILMEQDF 585
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD- 722
+R + +F RE ++ ++ HPN+V F G VT P NL+ VTEY+ GSL ++L +
Sbjct: 586 HAER-VNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGA 642
Query: 723 -RTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+D R+R+ +A D A G+ YLH +N IVH DLKS N LV+ ++ K+ D GLS
Sbjct: 643 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLS 698
Query: 780 KIKQKTLISG-GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS 838
++K T +S GT WMAPE+ + D EK DVYSFGV++WEL T ++P+ +L+
Sbjct: 699 RLKASTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDVYSFGVILWELATLQQPWGNLNP 756
Query: 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+++A + +IP P +++E CW+++P RP+F+ I LR +
Sbjct: 757 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 8e-46, Method: Compositional matrix adjust.
Identities = 100/275 (36%), Positives = 159/275 (57%), Gaps = 17/275 (6%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I +DL + +G G++G V++ W G++VA+K+ F+ +L A+F E +
Sbjct: 664 IPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAAL------AEFRSEVRI 717
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ ++ HPNVV F G VT P NL+ VTE++ GSL ++L R ID R+RI +A+D A
Sbjct: 718 MRRLRHPNVVFFLGAVTRPP--NLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 739 FGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG-GVRGTI 795
G+ LH IVH DLK+ N LV+ K+GD GLS++K T +S GT
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTP 831
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
WMAPE+ +++ + EK DVYSFGV++WEL T P+ ++ +++ + N +IP
Sbjct: 832 EWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIP 889
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+P ++ CW +DP RP+F+++T+ L+ +
Sbjct: 890 KELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPL 924
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 107/297 (36%), Positives = 161/297 (54%), Gaps = 25/297 (8%)
Query: 597 IGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPS 656
+ E S+ YF++ I S+L+ +LG GTFG V+ G W+GS VAIK+IK
Sbjct: 641 VVEPPSQQQQYFSDIE------ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIK-- 692
Query: 657 CFAEGSLEED---RLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGS 713
+ ED +++ +F +E +L ++ HPN+V T P NL +TEY+ GS
Sbjct: 693 ------INEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGS 744
Query: 714 LKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
L L K ++ + +A+ A G+ YLH ++H D+KS N L++ + KI
Sbjct: 745 LYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKI 800
Query: 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
D GLSK+K K+ G+ WM+PEL +D TEKVDVY+FG+++WEL TGE PY
Sbjct: 801 CDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGED--YTEKVDVYAFGIILWELGTGELPY 858
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ L S ++ + +L P IP+ L++ CW DP RP+F+EI L +
Sbjct: 859 SGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 102/293 (34%), Positives = 161/293 (54%), Gaps = 29/293 (9%)
Query: 607 YFTNTA----NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGS 662
+F NT ++ + I SD++ KE+G G F V G WKG DVA+K++ +
Sbjct: 1052 WFVNTVTLPISSSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLN----SNKD 1107
Query: 663 LEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD 722
+ +I +F E +LG + HPN+V YG + + V E++ +G+L +++ K
Sbjct: 1108 KAREEMIQEFKAEVELLGSLQHPNLVTCYGY----SLNPMCIVMEFLPSGNLFELIHSKP 1163
Query: 723 R------TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+D + IA D A G+++LH +NI+H DLKS N L++ + KI DL
Sbjct: 1164 SEQQQSIKLDSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD----KHFNIKIADL 1219
Query: 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL 836
G+++ T + GT+ W APE+ + + +K DVYS+ +V++ELLTGEEPY +
Sbjct: 1220 GIARETSFTQTMTTI-GTVAWTAPEILRHES--YNQKADVYSYAIVLYELLTGEEPYQGI 1276
Query: 837 HSEEIIAGIIKGNLG--PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ AGI+ + G P++P C+P W+ L+ CWS DP RP+F EIT L
Sbjct: 1277 --PPMNAGILVASKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 98/265 (36%), Positives = 153/265 (57%), Gaps = 18/265 (6%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689
+G G +G VF G W+G++VA+K + F + +LI+D +E +L ++ HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKML----FNDNV--NLKLISDLRKEVDLLCKLRHPNIVL 910
Query: 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKN- 748
F G T+ ++ VTEY+ GSL +L + +D R+ + D A G+ YLH +N
Sbjct: 911 FMGACTEP--SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 749 -IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKD 807
I+H DLK+ N LV+ D + K+ D GL+ +K T + + GT W+APE+ +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTF-AKTMCGTTGWVAPEVLAEEG 1023
Query: 808 NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLME 867
TEK DVYS+ +V+WELLT PYA ++ +++ I +G P +P+WC P + +LM
Sbjct: 1024 --YTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSIDRGERLP-MPAWCPPKYAALMN 1080
Query: 868 RCWSSDPKSRPAFSEITKELRAMAA 892
RCW +DP RP+F EI + M +
Sbjct: 1081 RCWETDPTHRPSFPEILPIMEGMIS 1105
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 108/287 (37%), Positives = 157/287 (54%), Gaps = 23/287 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I ++LE+ + +G G FG V G W+ +DVAIK I F S + F E +
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK--RIIIAMD 736
L ++ HPNVV F G T G + VTE+M GSL+Q L +++ R+ +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 737 AAFGIEYLH--EKNIVHFDLKSHNFLVNMR-DPQRPV--------CKIGDLGLSKIK--Q 783
A G+ YLH I+H DL S N L++ DP+ PV CKI D GLS++K Q
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
+ ++ V G IP+MAPE+FK N +EK DVYS+G+V++ELLT +EP D+ ++
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ P IP W+ ++ +CW S+P SRP F +I L+ M
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 106/293 (36%), Positives = 161/293 (54%), Gaps = 20/293 (6%)
Query: 608 FTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDR 667
F +AN I ++ K++G G++G VF GKWKG DVA+K+ F + L E +
Sbjct: 1348 FLTSANMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKK-----FVKQKLSETQ 1402
Query: 668 LIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR 727
L+ +F E L ++ H N+V F G P N+ VTEYM G+L+ VL+ D I
Sbjct: 1403 LL-EFRAEMAFLSELKHSNIVTFIGACIKKP--NICIVTEYMRMGNLRDVLKNPDIKITF 1459
Query: 728 RKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785
++ + AA GI+YLH N IVH D+K N LV+ + KI D G ++IK+
Sbjct: 1460 ANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVD----EHFNVKIADFGFARIKEDN 1515
Query: 786 LISGGVR-GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844
+ R GT W APE+ + + EK DV+SFGVVMWE+LTG+EP+A+ + ++
Sbjct: 1516 --TTMTRCGTPCWTAPEVIRGEK--YCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLD 1571
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
I++G P IPS C + L+++CW + RP +E+ ++L + + K
Sbjct: 1572 ILEGG-RPIIPSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 105/289 (36%), Positives = 156/289 (53%), Gaps = 26/289 (8%)
Query: 606 AYFTNTANTELQT--IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSL 663
AY T+ + +T + ++ ++ LGSG G VF GK++G +VAIK+++
Sbjct: 149 AYSTDYKLQQQETWEVPFEEISELQWLGSGAQGAVFLGKFRGEEVAIKKVR--------- 199
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR 723
E+ + L ++ HPN++AF GV T P L + EY +G L +VLR R
Sbjct: 200 EQKET------DIKHLRKLKHPNIIAFKGVCTQAPCYCL--IMEYCAHGQLYEVLR-AGR 250
Query: 724 TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783
+ R + + A G+ YLH I+H DLKS N LV D KI D G SK
Sbjct: 251 KVSPRLLVDWSNGIASGMNYLHLHKIIHRDLKSPNVLVTHTD----TVKISDFGTSKELS 306
Query: 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
GT+ WMAPE+ +++ V+EKVD++SFGV++WELLTGE PY D+ S II
Sbjct: 307 DKSTKMSFAGTVAWMAPEVIRNEP--VSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIW 364
Query: 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
G+ +L +PS C ++ LM++ W S P++RP+F +I L +A
Sbjct: 365 GVGSNSLHLPVPSTCPDGFKILMKQTWHSKPRNRPSFRQILMHLDIASA 413
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 100/270 (37%), Positives = 146/270 (54%), Gaps = 24/270 (8%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++ ++ LGSG G VF GK++ +VAIK+++ E++ + L ++
Sbjct: 166 EISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNET------DIKHLRKL 210
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN++AF GV T P + EY +G L +VLR R I R + + A G+
Sbjct: 211 KHPNIIAFKGVCTQAPC--YCIIMEYCAHGQLYEVLR-AGRKITPRLLVDWSTGIASGMN 267
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
YLH I+H DLKS N LV D KI D G SK GT+ WMAPE+
Sbjct: 268 YLHLHKIIHRDLKSPNVLVTHTD----AVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV 323
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTW 862
+++ V+EKVD++SFGVV+WELLTGE PY D+ S II G+ +L +PS C +
Sbjct: 324 IRNEP--VSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 381
Query: 863 RSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ LM++ W S P++RP+F + L +A
Sbjct: 382 KILMKQTWQSKPRNRPSFRQTLMHLDIASA 411
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 102/280 (36%), Positives = 160/280 (57%), Gaps = 29/280 (10%)
Query: 619 IKTSDLEYIKE--LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
I +++ Y +E LGSG FG+V+ G +G +VAIK++ + F E ++ E F +E
Sbjct: 167 IDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEENTMNE------FKKEV 220
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT---IDRRKRIII 733
++ ++ +P+++ F G T P +L+ VTE M GS+ +LR K+ T I ++ I+I
Sbjct: 221 SLMAKLRNPHLLLFMGACT-AP-EDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILI 278
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLIS 788
A D G+ +LH NI+H DLK N LV+ Q V K+ D GLSK K K L
Sbjct: 279 ARDTVLGMTWLHASNILHLDLKPANLLVD----QNWVVKVADFGLSKYMKPDSKDKLL-- 332
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE--EIIAGII 846
G G+ +MAPE+ ++ KVDV+SF +++WELLT +EPY L+S +++ G++
Sbjct: 333 -GQAGSPLYMAPEMLVNQP--YDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVV 389
Query: 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
P IP + + L+ RCW P RP+F+EI+K+
Sbjct: 390 NKKNRPIIPDYFPTRLKDLLARCWDHYPSRRPSFAEISKQ 429
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 897 | ||||||
| 359484396 | 1064 | PREDICTED: uncharacterized protein LOC10 | 0.847 | 0.714 | 0.463 | 0.0 | |
| 255566929 | 748 | serine/threonine protein kinase, putativ | 0.577 | 0.692 | 0.527 | 1e-165 | |
| 297738917 | 1021 | unnamed protein product [Vitis vinifera] | 0.759 | 0.666 | 0.437 | 1e-150 | |
| 356564856 | 1073 | PREDICTED: uncharacterized protein LOC10 | 0.381 | 0.318 | 0.613 | 1e-126 | |
| 449525772 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.354 | 0.288 | 0.649 | 1e-126 | |
| 449462731 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.354 | 0.288 | 0.649 | 1e-126 | |
| 413924273 | 1139 | putative protein kinase superfamily prot | 0.303 | 0.238 | 0.719 | 1e-126 | |
| 255570521 | 1090 | serine/threonine protein kinase, putativ | 0.305 | 0.251 | 0.719 | 1e-126 | |
| 356550754 | 1087 | PREDICTED: uncharacterized protein LOC10 | 0.298 | 0.246 | 0.723 | 1e-125 | |
| 222623809 | 1051 | hypothetical protein OsJ_08651 [Oryza sa | 0.328 | 0.280 | 0.686 | 1e-125 |
| >gi|359484396|ref|XP_002281836.2| PREDICTED: uncharacterized protein LOC100267909 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/884 (46%), Positives = 506/884 (57%), Gaps = 124/884 (14%)
Query: 116 GKGVADDSLRKKVMKQQLSAK--------------------QSCDSPLIDLDFGLEEPND 155
G +D SLRK ++KQ+ SAK Q PLIDL P
Sbjct: 203 GGRYSDRSLRKVILKQRFSAKKPAPISSFCSGEREFRRSDEQKYCYPLIDL-----APEA 257
Query: 156 LVVKND---------PFRVNVANGLENGRLRPLNP------RDGNVRNIAVEANASVECL 200
LV K+ P VN+ L P N R+GN R V+ ++ +CL
Sbjct: 258 LVPKSKQTANLNFEHPREVNILICKTEDALSPGNQNFENLVRNGNTR---VDGSSPRQCL 314
Query: 201 VGRSFQGFCYGGGNTTLMGNS----------------------VDCKWDFGNTGQMPFSN 238
+ S C GGG + N+ + K D N M ++N
Sbjct: 315 LRLSG---CNGGGMNQGISNTSSEVVQFPQLSCISSIISLSSGSNAKQDLRNMDPMSWTN 371
Query: 239 FNSENIMPWGATCGSVNNHLGVQSCSNLPVGSGCPVNSSCVGDRVCCA-CQSGLRGNRFA 297
FN +N MP A S L SCSN VGS P+ DR QSG+R +RF
Sbjct: 372 FNRKN-MPCPANYDSGKISLLPLSCSNEMVGSASPMKILSARDRALGGDLQSGIRKHRFG 430
Query: 298 VNDARYQRNYSNYARKN-NNLVEVGNYRGARLDGKIPAGKCYLGIRPKSNISKQGKSMGL 356
+ D R R + R + +NL E+G+ + RLDG+ +G+C G+RP NI+KQG+SM
Sbjct: 431 MCDTRNHRMCLYHIRNHQSNLSEMGSNQNLRLDGRSWSGRCCPGLRPNPNIAKQGQSMRS 490
Query: 357 YNANLSSPWAGFTELASEGVVSVMGSCFNKGISTFDVQYGEKFREHGGPTISQYGLSNLV 416
Y+ N P + +G++ +M S N + D+QY + G S+YG N+
Sbjct: 491 YHPNYLKPLSCTHTHTLQGLMRMMDSSLNSHSCSHDLQYANENIRDQGILASEYGSPNIE 550
Query: 417 ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENF 476
E A H G+ L A+ NP KD LT S HEV Q Y+N
Sbjct: 551 ECKFAYHGAYAGMGNPPLLFRNAVENP--------LKDGFLTDSGSGMHEVPHQNPYQNC 602
Query: 477 HGMPITCKPIHPELENEKLLIDSEESANISGLSNNMNYRNGTASGCNMK----------- 525
H + C+ + + + ++ NIS N Y GT CN K
Sbjct: 603 HRVLTNCESGCYD-SRQPFSLSPQKVDNISAFLNYPGYSQGTELRCNSKLSDREAGIESL 661
Query: 526 ----NGTKNLQGGVASSMDLLYNLSLSSS-KEIEPPQISALQNAATERNDEHKEEIHLDP 580
+G LQGGVAS +DL SS KE+EP +S+ + + HLD
Sbjct: 662 STHRDGAHTLQGGVASPVDLSLGNLSLSSSKEVEPLALSSHVDIDVSEALLKSQSKHLDL 721
Query: 581 LE---------------------------EKVETKKTCECSKVIGEISSRSAAYFTNTAN 613
++ + V K++ + SK+IG +SS AA+++ +
Sbjct: 722 IDGHSSPEAYNSNGMESGSLTGNATKLGNDYVCIKESHKGSKLIGGVSSDLAAFYSLLST 781
Query: 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
ELQTIK +DLEYIKELGSGT+GTV YGKWKGSDVAIKRIKPSCF E +LEEDRL+A+FW
Sbjct: 782 RELQTIKNTDLEYIKELGSGTYGTVSYGKWKGSDVAIKRIKPSCFTEDTLEEDRLVAEFW 841
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
+EAH+LGQ+HHPN+VAFYGVVTDGPVTNLATVTEYMVNGSLKQVL++KDRTID RKR+II
Sbjct: 842 KEAHILGQLHHPNIVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLQKKDRTIDHRKRLII 901
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
AMDAAFG+EYLH KNIVHFDLKSHN +NMRDPQRPVCKIGDLGLSKIKQ+TLISGG+RG
Sbjct: 902 AMDAAFGMEYLHGKNIVHFDLKSHNLFMNMRDPQRPVCKIGDLGLSKIKQRTLISGGLRG 961
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
TIPWMAPELF SK++LVTEKVDVYSFG+ MWELLTGEEPY L SEEIIAGIIKGNL PK
Sbjct: 962 TIPWMAPELFNSKNDLVTEKVDVYSFGIAMWELLTGEEPYGKLSSEEIIAGIIKGNLRPK 1021
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
IP+ C+P WRSLMERCWSSDP SRP FSEI KELR M+AAMNIK
Sbjct: 1022 IPT-CDPAWRSLMERCWSSDPGSRPDFSEIAKELRVMSAAMNIK 1064
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566929|ref|XP_002524447.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223536235|gb|EEF37887.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 327/620 (52%), Positives = 396/620 (63%), Gaps = 102/620 (16%)
Query: 304 QRNYSNYARKNNNLVEVGNYRGARLDGKIPAGKCYLGIRPKSNISKQGKSMGLYNANLSS 363
+RNY + +N + +++ LDG++ GKCY G+R KSNISKQG+ + + + +S
Sbjct: 205 RRNYYHNGIRN----QRDHHQSVGLDGRVSVGKCYYGLRAKSNISKQGQCLRSFYFSKNS 260
Query: 364 PWAGFTELASEGVVSVMGSCFNKGISTFDVQYGEKFREHGGPTISQYGLSNLVESHLACH 423
G T SEG S++ S F RE G +S +G S
Sbjct: 261 ---GCTRNLSEGRKSLLHSSFYVS------------REKSGSAVSLFGNSK--------S 297
Query: 424 STCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITC 483
C+ A V M + D+LTGS + HEV Q++ C
Sbjct: 298 RACDFA----------------HVENMECQQDLLTGSPYKPHEVPYQSV----------C 331
Query: 484 KPIHPELENEKLLIDSEESANISGLSNNMNYRNGTASGCNMKNGTKNLQGGVASSMDLLY 543
NE L +++ NIS + ++ N + C M G +ASS++LL
Sbjct: 332 --------NELLSFSQQKADNISVVYCDLQSSNVPTAECEMDKG-------IASSVELLD 376
Query: 544 NLSLSSSKEIEPPQISALQN----------------------AATERNDEHKEEIHLDPL 581
NLSLSS K +EPP S N E + + +H
Sbjct: 377 NLSLSS-KRVEPPVPSVANNDFATSLLTSKSKHLNLLDGNISTGPEAEKSNADTLHSSAF 435
Query: 582 E----EKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGT 637
EK ET++ +CSK++G IS + A +LQTIK SDLE+IKELGSG +GT
Sbjct: 436 NAIGVEKSETREGIKCSKLMGGISD-------DLATRQLQTIKNSDLEHIKELGSGAYGT 488
Query: 638 VFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697
V+YGKWKGSDVAIKRIKPSCF EGS+ +DRL+ADFW+EAH+LGQ+HHPN+VAFYGVVTDG
Sbjct: 489 VYYGKWKGSDVAIKRIKPSCFTEGSMAKDRLVADFWKEAHILGQLHHPNIVAFYGVVTDG 548
Query: 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSH 757
P NL TVTEYMVNGSLKQVLRRKDRT+DRRKR I+AMDAA G+EYLHEKNIVHFDLKS
Sbjct: 549 PANNLGTVTEYMVNGSLKQVLRRKDRTVDRRKRTILAMDAAIGMEYLHEKNIVHFDLKSP 608
Query: 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVY 817
N LVNMRDP RPVCKIGDLGLSKIK++TL+SGGVRGTIPWMAPEL S + +VTEKVDVY
Sbjct: 609 NLLVNMRDPLRPVCKIGDLGLSKIKKRTLVSGGVRGTIPWMAPELLNSNNKMVTEKVDVY 668
Query: 818 SFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
SFG+VMWELLTGEEPYADL SEEIIAGIIKG L P++PSWC+P WRSLMERCWSSD KSR
Sbjct: 669 SFGIVMWELLTGEEPYADLRSEEIIAGIIKGILRPEVPSWCDPAWRSLMERCWSSDAKSR 728
Query: 878 PAFSEITKELRAMAAAMNIK 897
PAFSEI KELRAM+AAMNIK
Sbjct: 729 PAFSEIAKELRAMSAAMNIK 748
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738917|emb|CBI28162.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1391), Expect = e-150, Method: Compositional matrix adjust.
Identities = 366/836 (43%), Positives = 450/836 (53%), Gaps = 155/836 (18%)
Query: 116 GKGVADDSLRKKVMKQQLSAK--------------------QSCDSPLIDLDFGLEEPND 155
G +D SLRK ++KQ+ SAK Q PLIDL P
Sbjct: 203 GGRYSDRSLRKVILKQRFSAKKPAPISSFCSGEREFRRSDEQKYCYPLIDL-----APEA 257
Query: 156 LVVKND---------PFRVNVANGLENGRLRPLNP------RDGNVRNIAVEANASVECL 200
LV K+ P VN+ L P N R+GN R V+ ++ +CL
Sbjct: 258 LVPKSKQTANLNFEHPREVNILICKTEDALSPGNQNFENLVRNGNTR---VDGSSPRQCL 314
Query: 201 VGRSFQGFCYGGGNTTLMGNS----------------------VDCKWDFGNTGQMPFSN 238
+ S C GGG + N+ + K D N M ++N
Sbjct: 315 LRLSG---CNGGGMNQGISNTSSEVVQFPQLSCISSIISLSSGSNAKQDLRNMDPMSWTN 371
Query: 239 FNSENIMPWGATCGSVNNHLGVQSCSNLPVGSGCPVNSSCVGDRVCCA-CQSGLRGNRFA 297
FN +N MP A S L SCSN VGS P+ DR QSG+R +RF
Sbjct: 372 FNRKN-MPCPANYDSGKISLLPLSCSNEMVGSASPMKILSARDRALGGDLQSGIRKHRFG 430
Query: 298 VNDARYQRNYSNYARKN-NNLVEVGNYRGARLDGKIPAGKCYLGIRPKSNISKQGKSMGL 356
+ D R R + R + +NL E+G+ + RLDG+ +G+C G+RP NI+KQG+SM
Sbjct: 431 MCDTRNHRMCLYHIRNHQSNLSEMGSNQNLRLDGRSWSGRCCPGLRPNPNIAKQGQSMRS 490
Query: 357 YNANLSSPWAGFTELASEGVVSVMGSCFNKGISTFDVQYGEKFREHGGPTISQYGLSNLV 416
Y+ N P + +G++ +M S N + D+QY + G S+YG N+
Sbjct: 491 YHPNYLKPLSCTHTHTLQGLMRMMDSSLNSHSCSHDLQYANENIRDQGILASEYGSPNIE 550
Query: 417 ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENF 476
E A H G+ L A+ NP KD LT S HEV Q Y+N
Sbjct: 551 ECKFAYHGAYAGMGNPPLLFRNAVENP--------LKDGFLTDSGSGMHEVPHQNPYQNC 602
Query: 477 HGMPITCKPIHPELENEKLLIDSEESANISGLSNNMNYRNGTASGCNMK----------- 525
H + C+ + + + ++ NIS N Y GT CN K
Sbjct: 603 HRVLTNCESGCYD-SRQPFSLSPQKVDNISAFLNYPGYSQGTELRCNSKLSDREAGIESL 661
Query: 526 ----NGTKNLQGGVASSMD-LLYNLSLSSSKEIEPPQIS--------------------- 559
+G LQGGVAS +D L NLSLSSSKE+EP +S
Sbjct: 662 STHRDGAHTLQGGVASPVDLSLGNLSLSSSKEVEPLALSSHVDIDVSEALLKSQSKHLDL 721
Query: 560 ------------------ALQNAATERNDE--HKEEIHLDPLEEKVETKKTCECSKVIGE 599
+L AT+ ++ HKEEI LDP + I E
Sbjct: 722 IDGHSSPEAYNSNGMESGSLTGNATKLGNDYVHKEEIQLDPSSD-----------LSIDE 770
Query: 600 ISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFA 659
S YF LQTIK +DLEYIKELGSGT+GTV YGKWKGSDVAIKRIKPSCF
Sbjct: 771 KRDLSFLYF-------LQTIKNTDLEYIKELGSGTYGTVSYGKWKGSDVAIKRIKPSCFT 823
Query: 660 EGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR 719
E +LEEDRL+A+FW+EAH+LGQ+HHPN+VAFYGVVTDGPVTNLATVTEYMVNGSLKQVL+
Sbjct: 824 EDTLEEDRLVAEFWKEAHILGQLHHPNIVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLQ 883
Query: 720 RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+KDRTID RKR+IIAMDAAFG+EYLH KNIVHFDLKSHN +NMRDPQRPVCKIGDLGLS
Sbjct: 884 KKDRTIDHRKRLIIAMDAAFGMEYLHGKNIVHFDLKSHNLFMNMRDPQRPVCKIGDLGLS 943
Query: 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835
KIKQ+TLISGG+RGTIPWMAPELF SK++LVTEKVDVYSFG+ MWELLTGEEPY +
Sbjct: 944 KIKQRTLISGGLRGTIPWMAPELFNSKNDLVTEKVDVYSFGIAMWELLTGEEPYGN 999
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564856|ref|XP_003550663.1| PREDICTED: uncharacterized protein LOC100782903 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1184), Expect = e-126, Method: Compositional matrix adjust.
Identities = 222/362 (61%), Positives = 269/362 (74%), Gaps = 20/362 (5%)
Query: 555 PPQISALQNAATERN-------DEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAY 607
P I++++ AA E DEH + + + + K ET E + G++ S
Sbjct: 713 PELIASVKKAALEDAVQLKAAVDEHADSPNHN-SDTKDETTNEVEPANAHGDLELDSEND 771
Query: 608 FTNTANTE------------LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKP 655
+T E LQTIK DLE I+ELGSGT+G V++GKWKGSDVAIKRIK
Sbjct: 772 HVDTNKIEPTRAEEEAIAKGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKA 831
Query: 656 SCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLK 715
SCFA E RLIADFW+EA ML +HHPNVV+FYG+V DGP +LATVTE+M+NGSLK
Sbjct: 832 SCFAGRPSERARLIADFWKEALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLK 891
Query: 716 QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
Q L +KDRTIDRRKR+IIAMDAAFG+EYLH KNIVHFDLK N LVNMRDPQRP+CKIGD
Sbjct: 892 QFLHKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGD 951
Query: 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835
LGLSK+KQ TL+SGGVRGT+PWMAPEL K N+V+EK+DVYSFG+VMWELLTG EPYAD
Sbjct: 952 LGLSKVKQHTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGNEPYAD 1011
Query: 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895
+H II GI+ L P+IP+WC+P W+SLME CW+SDP RP+FSEI+K+LR+MAA+MN
Sbjct: 1012 MHCASIIGGIVNNTLRPQIPTWCDPEWKSLMESCWASDPVERPSFSEISKKLRSMAASMN 1071
Query: 896 IK 897
+K
Sbjct: 1072 LK 1073
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525772|ref|XP_004169890.1| PREDICTED: uncharacterized protein LOC101228819 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 459 bits (1182), Expect = e-126, Method: Compositional matrix adjust.
Identities = 215/331 (64%), Positives = 260/331 (78%), Gaps = 13/331 (3%)
Query: 569 NDEHKEEIHLDP-LEEKVETKKT-CECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEY 626
N++H H++P LE + E + + E +K E SR LQTIK DLE
Sbjct: 783 NEQHSSNNHVEPELETESENQSSRIEPTKAEEEAISRG-----------LQTIKNDDLEE 831
Query: 627 IKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
I+ELGSGT+G V++GKW+GSDVAIKRIK SCFA E +RLIADFW+EA +L +HHPN
Sbjct: 832 IRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPN 891
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
VV+FYG+V DGP +LATVTE+MVNGSLKQ L +KDRTIDRRKR+IIAMDAAFG+EYLH
Sbjct: 892 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTIDRRKRLIIAMDAAFGMEYLHG 951
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSK 806
KNIVHFDLK N LVNMRDPQRPVCKIGDLGLSK++Q TL+SGGVRGT+PWMAPEL K
Sbjct: 952 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTLVSGGVRGTLPWMAPELLSGK 1011
Query: 807 DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLM 866
N+VTEK+DVYSFG+VMWELLTG+EPY+D+H II GI+ L P+IP+WC+P W++LM
Sbjct: 1012 SNMVTEKIDVYSFGIVMWELLTGDEPYSDMHCASIIGGIVNNCLRPEIPTWCDPEWKALM 1071
Query: 867 ERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
CW SDP RP+FSEI+++LR MAAAMN+K
Sbjct: 1072 SSCWDSDPAKRPSFSEISQKLRNMAAAMNVK 1102
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462731|ref|XP_004149094.1| PREDICTED: uncharacterized protein LOC101215475 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 459 bits (1182), Expect = e-126, Method: Compositional matrix adjust.
Identities = 215/331 (64%), Positives = 260/331 (78%), Gaps = 13/331 (3%)
Query: 569 NDEHKEEIHLDP-LEEKVETKKT-CECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEY 626
N++H H++P LE + E + + E +K E SR LQTIK DLE
Sbjct: 783 NEQHSSNNHVEPELETESENQSSRIEPTKAEEEAISRG-----------LQTIKNDDLEE 831
Query: 627 IKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
I+ELGSGT+G V++GKW+GSDVAIKRIK SCFA E +RLIADFW+EA +L +HHPN
Sbjct: 832 IRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPN 891
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
VV+FYG+V DGP +LATVTE+MVNGSLKQ L +KDRTIDRRKR+IIAMDAAFG+EYLH
Sbjct: 892 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTIDRRKRLIIAMDAAFGMEYLHG 951
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSK 806
KNIVHFDLK N LVNMRDPQRPVCKIGDLGLSK++Q TL+SGGVRGT+PWMAPEL K
Sbjct: 952 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTLVSGGVRGTLPWMAPELLSGK 1011
Query: 807 DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLM 866
N+VTEK+DVYSFG+VMWELLTG+EPY+D+H II GI+ L P+IP+WC+P W++LM
Sbjct: 1012 SNMVTEKIDVYSFGIVMWELLTGDEPYSDMHCASIIGGIVNNCLRPEIPTWCDPEWKALM 1071
Query: 867 ERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
CW SDP RP+FSEI+++LR MAAAMN+K
Sbjct: 1072 SSCWDSDPAKRPSFSEISQKLRNMAAAMNVK 1102
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413924273|gb|AFW64205.1| putative protein kinase superfamily protein isoform 1 [Zea mays] gi|413924274|gb|AFW64206.1| putative protein kinase superfamily protein isoform 2 [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1177), Expect = e-126, Method: Compositional matrix adjust.
Identities = 203/282 (71%), Positives = 241/282 (85%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQTIK DLE I+ELGSGT+G V++GKW+G DVAIKRIK SCFA E +RLI DFW+E
Sbjct: 858 LQTIKNDDLEEIRELGSGTYGAVYHGKWRGCDVAIKRIKASCFAGRPSERERLITDFWKE 917
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
A +L +HHPNVVAFYGVV DGP +LATVTE+MVNGSLKQ LR+KDRTIDRRKR+I+AM
Sbjct: 918 ALILSSLHHPNVVAFYGVVRDGPDGSLATVTEFMVNGSLKQFLRKKDRTIDRRKRVILAM 977
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH KNIVHFDLK N LVNMRDPQRP+CKIGDLGLSK+KQ TL+SGGVRGT+
Sbjct: 978 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLVSGGVRGTL 1037
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL K+N+V+EK+DVYSFG+VMWELLTGEEPY+D+ + EII I+ +L P+IP
Sbjct: 1038 PWMAPELLSGKNNMVSEKIDVYSFGIVMWELLTGEEPYSDMRAAEIIGAIVNDSLRPQIP 1097
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
SWC+P W+ LME CWSSDP RP+F++I++ LR MAAAMN+K
Sbjct: 1098 SWCDPEWKGLMESCWSSDPAERPSFTDISQRLRKMAAAMNVK 1139
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570521|ref|XP_002526218.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223534457|gb|EEF36159.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1177), Expect = e-126, Method: Compositional matrix adjust.
Identities = 203/282 (71%), Positives = 243/282 (86%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQTIK DLE I+ELGSGT+G V++GKWKGSDVAIKRIK SCFA E +RLIADFW+E
Sbjct: 809 LQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERLIADFWKE 868
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
A +L +HHPNVV+FYG+V DGP +LATVTE+MVNGSLKQ L++KDRTIDRRKR+IIAM
Sbjct: 869 ALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 928
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
D AFG+EYLH KNIVHFD+K N LVNMRDPQRPVCKIGDLGLSK+KQ TL+SGGVRGT+
Sbjct: 929 DTAFGMEYLHGKNIVHFDMKCENLLVNMRDPQRPVCKIGDLGLSKVKQHTLVSGGVRGTL 988
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL K ++VTEK+DVYSFG+VMWELLTGEEPYA LH II GI+ +L P+IP
Sbjct: 989 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGEEPYAGLHCASIIGGIVNNSLRPQIP 1048
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
+WC+P W+SLME CW++DP RP+F+EI+++LR+MAAA+N+K
Sbjct: 1049 TWCDPEWKSLMESCWAADPAERPSFTEISRKLRSMAAAVNVK 1090
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550754|ref|XP_003543749.1| PREDICTED: uncharacterized protein LOC100779077 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1174), Expect = e-125, Method: Compositional matrix adjust.
Identities = 204/282 (72%), Positives = 240/282 (85%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQTI DLE I+ELGSGT+G V++GKWKGSDVAIKRIK SCFA E RLI DFW+E
Sbjct: 806 LQTINNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLITDFWKE 865
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
A ML +HHPNVV+FYG+V DGP +LATVTE+M+NGSLKQ L +KDRTIDRRKR+IIAM
Sbjct: 866 ALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDRRKRLIIAM 925
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH KNIVHFDLK N LVNMRDPQRP+CKIGDLGLSK+KQ TL+SGGVRGT+
Sbjct: 926 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLVSGGVRGTL 985
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL K N+V+EK+DVYSFG+VMWELLTG EPYAD+H II GI+ +L P+IP
Sbjct: 986 PWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGNEPYADMHCASIIGGIVNNSLRPQIP 1045
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
+WC+P W+SLME CW+SDP RP+FSEI+K+LR+MAA+MN+K
Sbjct: 1046 TWCDPEWKSLMESCWASDPVERPSFSEISKKLRSMAASMNLK 1087
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222623809|gb|EEE57941.1| hypothetical protein OsJ_08651 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1174), Expect = e-125, Method: Compositional matrix adjust.
Identities = 206/300 (68%), Positives = 248/300 (82%), Gaps = 5/300 (1%)
Query: 603 RSAAYFTNTANTE-----LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSC 657
+S+ TA E LQTIK DLE I+ELGSGT+G V++GKW+G DVAIKRIK SC
Sbjct: 752 KSSGIEATTAEAEALSKGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGCDVAIKRIKASC 811
Query: 658 FAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQV 717
FA E +RLIADFW+EA +L +HHPNVV+FYGVV DGP +LATVTE+M+NGSLKQ
Sbjct: 812 FAGRPSERERLIADFWKEAQILSSLHHPNVVSFYGVVRDGPDGSLATVTEFMINGSLKQF 871
Query: 718 LRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
LR+KDRTIDRRKR+I+AMDAAFG+EYLH KNIVHFDLK N LVNMRDPQRP+CKIGDLG
Sbjct: 872 LRKKDRTIDRRKRVILAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLG 931
Query: 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837
LSK+KQ TL+SGGVRGT+PWMAPEL K N+V+EK+DVYSFG+VMWELLTGEEPY+D+
Sbjct: 932 LSKVKQHTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYSDMR 991
Query: 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
+ II GI+ +L P+IPSWC+P W+SLME CW+S+P RP+F+EI++ LR MAAAMN+K
Sbjct: 992 AAAIIGGIVNNSLRPQIPSWCDPEWKSLMENCWASEPADRPSFTEISQRLRKMAAAMNVK 1051
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 897 | ||||||
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.474 | 0.404 | 0.5 | 6.5e-123 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.309 | 0.222 | 0.618 | 5.7e-115 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.314 | 0.270 | 0.631 | 4.3e-113 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.307 | 0.247 | 0.626 | 1.4e-112 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.309 | 0.242 | 0.625 | 3e-112 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.308 | 0.220 | 0.615 | 7.9e-112 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.315 | 0.241 | 0.621 | 4.3e-111 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.296 | 0.466 | 0.335 | 3.6e-41 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.303 | 0.498 | 0.332 | 8.6e-41 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.290 | 0.341 | 0.371 | 3.8e-40 |
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 220/440 (50%), Positives = 280/440 (63%)
Query: 472 LYENFHGMPITCKPIHPELENEKLLIDSEESANIS-GLSNNMNYRNGTASGCNMKNGTKN 530
L N PI P+ KL E+ ++ G+SN + Y++ K N
Sbjct: 615 LQTNLTAAPIMQTPVMQTSVESKLAQGGEQFNYVNTGISNGVPYQDKPQPLAGGKKDMGN 674
Query: 531 LQGGVASSMDLL-YNLS---LSSSKEI-EPPQISALQNAATERN--DEHKEEIHLDPLXX 583
L S+ L LS LS E+ E + +AL+ AA + +E K+++ + +
Sbjct: 675 LVEVNPSAATLEGAELSVERLSFLPELMESVKRAALEGAAEVKAHPEEAKDQVRPELVEN 734
Query: 584 XXXXXXXXXXXXVIGEISSRSAAYFTNT-ANTE-----LQTIKTSDLEYIKELGSGTFGT 637
+ + + + T A E LQ+I+ DLE I+ELG GT+G+
Sbjct: 735 ESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEAEAKSRGLQSIRNDDLEEIRELGHGTYGS 794
Query: 638 VFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697
V++GKWKGSDVAIKRIK SCFA E +RLI DFW+EA +L +HHPNVV+FYG+V DG
Sbjct: 795 VYHGKWKGSDVAIKRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVSFYGIVRDG 854
Query: 698 PVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAMDAAFGIEYLHEKNIVHFDLKSH 757
P +LATV E+MVNGSLKQ L AMD AFG+EYLH KNIVHFDLK
Sbjct: 855 PDGSLATVAEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDLKCE 914
Query: 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVY 817
N LVNMRDPQRP+CKIGDLGLSK+KQKTL+SGGVRGT+PWMAPEL K N+V+EK+DVY
Sbjct: 915 NLLVNMRDPQRPICKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVY 974
Query: 818 SFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
SFG+VMWELLTGEEPYAD+H II GI+ L PKIP WC+P W+ LME CW+S+P R
Sbjct: 975 SFGIVMWELLTGEEPYADMHCASIIGGIVNNALRPKIPQWCDPEWKGLMESCWTSEPTER 1034
Query: 878 PAFSEITKELRAMAAAMNIK 897
P+F+EI+++LR MAAAMN+K
Sbjct: 1035 PSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 5.7e-115, Sum P(3) = 5.7e-115
Identities = 172/278 (61%), Positives = 212/278 (76%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQ IK DLE ++ELGSGTFGTV++GKW+GSDVAIKRIK SCFA S E++RL +FW E
Sbjct: 956 LQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGE 1015
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAM 735
A +L ++HHPNVVAFYGVV DGP LATVTEYMV+GSL+ VL AM
Sbjct: 1016 AEILSKLHHPNVVAFYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAM 1075
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH KN VHFDLK N LVN++DP RP+CK+GD GLSKIK+ TL+SGGVRGT+
Sbjct: 1076 DAAFGMEYLHSKNTVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 1135
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL + V+EKVDV+SFG+V+WE+LTGEEPYA++H II GI+ L P IP
Sbjct: 1136 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1195
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
+C+ WR+LME CW+ +P +RP+F+EI LR M++A
Sbjct: 1196 GFCDDEWRTLMEECWAPNPMARPSFTEIAGRLRVMSSA 1233
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
Identities = 178/282 (63%), Positives = 212/282 (75%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQ IK +DLE + ELGSGTFGTV+YGKW+G+DVAIKRIK SCF+ GS E+ R DFWRE
Sbjct: 758 LQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGSSEQARQTKDFWRE 817
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAM 735
A +L +HHPNVVAFYGVV DGP +ATVTEYMVNGSL+ VL +
Sbjct: 818 ARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKDRLLDRRKKLMITL 877
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
D+AFG+EYLH KNIVHFDLK N LVN+RDPQRP+CK+GD GLS+IK+ TL+SGGVRGT+
Sbjct: 878 DSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 937
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL N V+EKVDV+SFG+VMWE+LTGEEPYA+LH II GI+ L P +P
Sbjct: 938 PWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCGAIIGGIVNNTLRPPVP 997
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
CE WR LME+CWS DP RP+F+EI + LR+M A+ K
Sbjct: 998 ERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQPK 1039
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
Identities = 173/276 (62%), Positives = 209/276 (75%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQ IK +DLE + ELGSGT+GTV++G W+G+DVAIKRI+ SCFA S E++RL DFWRE
Sbjct: 828 LQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWRE 887
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAM 735
A +L +HHPNVVAFYG+V DG LATVTE+MVNGSL+ L AM
Sbjct: 888 AQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAM 947
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH KNIVHFDLK N LVN+RDPQRP+CK+GDLGLS+IK+ TL+SGGVRGT+
Sbjct: 948 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTL 1007
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL V+EKVDV+S+G+ +WE+LTGEEPYAD+H II GI+K L P IP
Sbjct: 1008 PWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIP 1067
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
C P W+ LME+CWS DP SRP F+EIT LR+M+
Sbjct: 1068 KSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMS 1103
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 953 (340.5 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 174/278 (62%), Positives = 211/278 (75%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQ I DLE +KELGSGTFGTV++GKW+GSDVAIKRIK SCFA S E++RL +FW E
Sbjct: 855 LQIIMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGE 914
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAM 735
A +L ++HHPNVVAFYGVV DGP LATVTEYMV+GSL+ VL AM
Sbjct: 915 AEILSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAM 974
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH KNIVHFDLK N LVN++DP RP+CK+GD GLSKIK+ TL+SGGVRGT+
Sbjct: 975 DAAFGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 1034
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL + V+EKVDV+SFG+V+WE+LTGEEPYA++H II GI+ L P IP
Sbjct: 1035 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1094
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
S+C+ WR LME CW+ +P +RP+F+EI LR M+ A
Sbjct: 1095 SYCDSDWRILMEECWAPNPTARPSFTEIAGRLRVMSTA 1132
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 7.9e-112, Sum P(2) = 7.9e-112
Identities = 171/278 (61%), Positives = 214/278 (76%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
LQ IK DLE +KELGSGTFGTV++GKW+G+DVAIKRIK SCF S E++RL ++FW E
Sbjct: 966 LQVIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQERLTSEFWHE 1025
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAM 735
A +L ++HHPNV+AFYGVV DGP LATVTEYMVNGSL+ VL AM
Sbjct: 1026 AEILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLSNRHLDRRKRLII-AM 1084
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
DAAFG+EYLH K+IVHFDLK N LVN++DP RP+CK+GD GLSKIK+ TL++GGVRGT+
Sbjct: 1085 DAAFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNTLVTGGVRGTL 1144
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
PWMAPEL + V+EKVDV+SFG+V+WE+LTGEEPYA++H II GI+ L P +P
Sbjct: 1145 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTVP 1204
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
++C+P WR LME+CW+ DP RPAF EI + LR M+++
Sbjct: 1205 NYCDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSS 1242
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 953 (340.5 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
Identities = 176/283 (62%), Positives = 212/283 (74%)
Query: 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
+LQ IK SDLE ++ELGSGTFGTV++GKW+G+DVAIKRI CFA E++R+I DFW
Sbjct: 879 QLQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERMIDDFWN 938
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXA 734
EA L +HHPNVVAFYGVV D P ++ATVTEYMVNGSL+ L A
Sbjct: 939 EAQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRCKRQLIA 998
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGT 794
MD AFG+EYLH K IVHFDLKS N LVN+RDP RP+CK+GDLGLSK+K +TLISGGVRGT
Sbjct: 999 MDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGT 1058
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
+PWMAPEL +LV+EKVDV+SFG+V+WEL TGEEPYADLH II GI+ L P+I
Sbjct: 1059 LPWMAPELLNGTSSLVSEKVDVFSFGIVLWELFTGEEPYADLHYGAIIGGIVSNTLRPQI 1118
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
P +C+ W+ LMERCWS++P RP+F+EI ELR MA + K
Sbjct: 1119 PDFCDMDWKLLMERCWSAEPSERPSFTEIVNELRTMATKLPSK 1161
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 3.6e-41, Sum P(2) = 3.6e-41
Identities = 94/280 (33%), Positives = 151/280 (53%)
Query: 611 TANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIA 670
T T+ I L+ K++ G++G +F G + +VAIK +KP + E ++
Sbjct: 279 TDGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPE---RVNAE---MLR 332
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXX 730
+F +E +++ ++ H NVV F G T P NL VTE+M GS+ L
Sbjct: 333 EFSQEVYIMRKVRHKNVVQFIGACTRSP--NLCIVTEFMTRGSIYDFLHKHKGVFKIQSL 390
Query: 731 XXXAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
A+D + G+ YLH+ NI+H DLK+ N L++ + V K+ D G+++++ ++ +
Sbjct: 391 LKVALDVSKGMNYLHQNNIIHRDLKTANLLMD----EHEVVKVADFGVARVQTESGVMTA 446
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
GT WMAPE+ + K + DV+S+ +V+WELLTGE PY+ L + G+++ L
Sbjct: 447 ETGTYRWMAPEVIEHKP--YDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGL 504
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PKIP P L+E+CW DP RP F+EI + L +
Sbjct: 505 RPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQL 544
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 8.6e-41, P = 8.6e-41
Identities = 95/286 (33%), Positives = 154/286 (53%)
Query: 611 TANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIA 670
T T+ I + L+ K++ SG++G + G + +VAIK +KP + ++
Sbjct: 273 TDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRV------NNEMLR 326
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXX 730
+F +E ++ ++ H NVV F G T P L VTE+M GS+ L
Sbjct: 327 EFSQEVFIMRKVRHKNVVQFLGACTRSPT--LCIVTEFMARGSIYDFLHKQKCAFKLQTL 384
Query: 731 XXXAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
A+D A G+ YLH+ NI+H DLK+ N L++ + + K+ D G+++++ ++ +
Sbjct: 385 LKVALDVAKGMSYLHQNNIIHRDLKTANLLMD----EHGLVKVADFGVARVQIESGVMTA 440
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
GT WMAPE+ + K K DV+S+ +V+WELLTG+ PYA L + G+++ L
Sbjct: 441 ETGTYRWMAPEVIEHKP--YNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGL 498
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896
PKIP P + L+ERCW DP+ RP F EI + L+ + +N+
Sbjct: 499 RPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVNV 544
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 3.8e-40, P = 3.8e-40
Identities = 103/277 (37%), Positives = 159/277 (57%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
DL +++G G+ GTV++G W GSDVA+K F++ E+ +I F +E ++ ++
Sbjct: 486 DLTIGEQIGQGSCGTVYHGLWFGSDVAVK-----VFSKQEYSEE-IITSFKQEVSLMKRL 539
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLXXXXXXXXXXXXXXXAMDAAFGIE 742
HPNV+ F G V P L VTE++ GSL ++L A D A G+
Sbjct: 540 RHPNVLLFMGAVAS-P-QRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597
Query: 743 YLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAP 800
YLH + I+H DLKS N LV+ + K+ D GLS+IK +T ++ RGT WMAP
Sbjct: 598 YLHHCSPPIIHRDLKSSNLLVD----RNWTVKVADFGLSRIKHETYLTTNGRGTPQWMAP 653
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E+ +++ EK DVYSFGVV+WEL+T + P+ +L++ ++I + N ++P +P
Sbjct: 654 EVLRNE--AADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDP 711
Query: 861 TWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
W +LME CW S+P+ RP+F E+ +LR + I+
Sbjct: 712 QWIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQ 748
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00016851001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (299 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 897 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-79 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-77 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-76 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-58 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-56 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-52 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-51 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-48 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-47 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-46 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-45 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-44 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-44 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-44 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-42 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-41 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-40 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-40 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-39 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-39 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-39 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-38 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-37 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-37 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-35 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-34 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-34 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-34 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-34 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-34 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-34 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-34 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-34 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-33 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-33 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-33 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-32 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-31 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-31 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-31 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-31 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-31 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-31 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-31 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-30 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-29 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-29 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-29 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-28 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-27 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-27 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-27 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-27 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-25 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-25 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 8e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-24 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-16 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-15 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 3e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 7e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| pfam08706 | 145 | pfam08706, D5_N, D5 N terminal like | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 2e-79
Identities = 101/274 (36%), Positives = 140/274 (51%), Gaps = 26/274 (9%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
LE K+LG G FG V+ G KG VA+K +K + +F EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-------SEEEREEFLEEAS 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HPN+V GV T G L VTEYM G L LR+ + + + +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGT 794
A G+EYL KN VH DL + N LV + V KI D GLS+ + GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I WMAPE KD T K DV+SFGV++WE+ T GE+PY + +EE++ + G
Sbjct: 168 IKWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR-LP 224
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P C LM +CW+ DP+ RP FSE+ ++L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 9e-77
Identities = 99/274 (36%), Positives = 139/274 (50%), Gaps = 26/274 (9%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L K+LG G FG V+ G KG +VA+K +K ++ I +F REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-------SEQQIEEFLREAR 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR-RKDRTIDRRKRIIIAMD 736
++ ++ HPN+V GV T+ L V EYM G L LR + + + + A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEE--PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLI-SGGVRGT 794
A G+EYL KN +H DL + N LV V KI D GLS+ + G +
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I WMAPE K+ T K DV+SFGV++WE+ T GEEPY + + E++ + KG
Sbjct: 168 IRWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR-LP 224
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P C P LM +CW+ DP+ RP FSE+ + L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 1e-76
Identities = 100/273 (36%), Positives = 138/273 (50%), Gaps = 25/273 (9%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L K+LG G FG V+ GK KG +VA+K +K + I +F REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-------QIEEFLREAR 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HPNVV GV T+ L V EYM G L LR+ + + A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEE--PLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTI 795
A G+EYL KN +H DL + N LV + V KI D GLS+ G + I
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
WMAPE K+ T K DV+SFGV++WE+ T GE+PY + +EE++ + G
Sbjct: 168 RWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR-LPQ 224
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P C P LM +CW+ DP+ RP FSE+ + L
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 6e-71
Identities = 104/278 (37%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 628 KELGSGTFGTVFYGKWKGS-----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K+LG G FG V+ GK KG +VA+K +K E + EE+R DF +EA ++ ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-----EDASEEER--KDFLKEARVMKKL 53
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK--------DRTIDRRKRIIIA 734
HPNVV GV T+ L V EYM G L LR+ T+ + + A
Sbjct: 54 GHPNVVRLLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRG 793
+ A G+EYL K VH DL + N LV + V KI D GLS+ + G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+P WMAPE K D + T K DV+SFGV++WE+ T G PY L +EE++ + KG
Sbjct: 168 KLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
P +C LM CW DP+ RP FSE+ + L
Sbjct: 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 6e-58
Identities = 78/261 (29%), Positives = 120/261 (45%), Gaps = 49/261 (18%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG G FGTV+ + K + VAIK IK + L+ + RE +L +++HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK 747
V YGV D L V EY GSLK +L+ + + + + I + G+EYLH
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 748 NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMAPELFKSK 806
I+H DLK N L++ + + K+ D GLSK + + + GT +MAPE+ K
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 807 DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLM 866
+EK D++S GV+++EL P + L+
Sbjct: 169 GY-YSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 867 ERCWSSDPKSRPAFSEITKEL 887
+ DP+ RP+ EI + L
Sbjct: 195 RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 6e-58
Identities = 80/264 (30%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+++LG G+FG V+ + K + VAIK IK + + RE +L ++ H
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-------KIKKDRERILREIKILKKLKH 56
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRII--IAMDAAFGI 741
PN+V Y V D L V EY G L +L+++ R + D + + I +
Sbjct: 57 PNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILS----AL 110
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
EYLH K IVH DLK N L++ + K+ D GL++ GT +MAPE
Sbjct: 111 EYLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY-ADLHSEEIIAGIIKGNLGPKIPSW-CE 859
+ K + VD++S GV+++ELLTG+ P+ D E+ I K P W
Sbjct: 167 VLLGKG--YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 860 PTWRSLMERCWSSDPKSRPAFSEI 883
P + L+ + DP+ R E
Sbjct: 225 PEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 89/269 (33%), Positives = 131/269 (48%), Gaps = 24/269 (8%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E +++LGSG+FGTV+ K KG+ VA+K +K + A RE +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK----RSEKSKKDQTA--RREIRILRR 54
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFG 740
+ HPN+V D L V EY G L L R + D K+I + + G
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYL--VMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI--LRG 110
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL-ISGGVRGTIPWMA 799
+EYLH I+H DLK N L++ + V KI D GL+K K+ GT +MA
Sbjct: 111 LEYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKGNLGPKIPS 856
PE+ N KVDV+S GV+++ELLTG+ P++ + ++I I+ L P
Sbjct: 167 PEVLL-GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225
Query: 857 WCE--PTWRSLMERCWSSDPKSRPAFSEI 883
W + L+++C + DP RP EI
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 96/276 (34%), Positives = 143/276 (51%), Gaps = 28/276 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I S+L ++KELGSG FG V GKW+G DVAIK I+ EG++ ED DF EA
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSED----DFIEEAK 51
Query: 678 MLGQIHHPNVVAFYGVVTD-GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM- 735
++ ++ HPN+V YGV T P + VTEYM NG L LR + + ++ M
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKL--GTEWLLDMC 106
Query: 736 -DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVR 792
D +EYL +H DL + N LV + V K+ D GL++ + + S G +
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTK 162
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851
+ W PE+F + + K DV+SFGV+MWE+ + G+ PY + E++ + G
Sbjct: 163 FPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ P ++M CW P+ RPAF ++ +L
Sbjct: 221 YR-PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 104/273 (38%), Positives = 140/273 (51%), Gaps = 27/273 (9%)
Query: 628 KELGSGTFGTVFYGKWKGS-----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K +G G FG V G+ K DVAIK +K GS ++ RL DF EA ++GQ
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-----GSSDKQRL--DFLTEASIMGQF 62
Query: 683 HHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
HPN++ GVVT PV +TEYM NGSL + LR D + + + A G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVM---IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-GTIP--WM 798
+YL E N VH DL + N LVN VCK+ D GLS+ + + + + G IP W
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT 175
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
APE + T DV+SFG+VMWE+++ GE PY D+ ++++I + G P P
Sbjct: 176 APEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMD 232
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
C LM CW D RP FS+I L M
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 29/271 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L+ ++LG+G FG V+ G W G+ VA+K +KP G++ F +EA
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMS----PEAFLQEAQ 53
Query: 678 MLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAM 735
++ ++ H +V Y V ++ P+ VTEYM GSL L+ + + + + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIY---IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLIS-GGVRG 793
A G+ YL +N +H DL + N LV + VCKI D GL++ I+ + G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 794 TIPWMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
I W APE + T K DV+SFG+++ E++T G PY + + E++ + +G
Sbjct: 167 PIKWTAPEAANY----GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFS 881
P+ P C LM +CW DP+ RP F
Sbjct: 223 MPR-PPNCPEELYDLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 22/271 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I + +L+ +G G FG V G ++G VA+K +K ++ F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---------DDSTAAQAFLAEASV 53
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAMDA 737
+ + HPN+V GVV G L VTEYM GSL LR + R I +++ A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
G+EYL EKN VH DL + N LV+ V K+ D GL+K + SG + + W
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDSG--KLPVKW 165
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856
APE + K + K DV+SFG+++WE+ + G PY + ++++ + KG + P
Sbjct: 166 TAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPE 222
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
C P +M+ CW DP RP F ++ ++L
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 98/285 (34%), Positives = 136/285 (47%), Gaps = 36/285 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIAD 671
+ + I+ELG G+FG V+ G KG + VAIK + + R +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-------ASMRERIE 55
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDR------ 723
F EA ++ + + +VV GVV+ G T V E M G LK LR R +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 724 -TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-I 781
+K I +A + A G+ YL K VH DL + N +V KIGD G+++ I
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTRDI 169
Query: 782 KQKTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHS 838
+ G +G +P WMAPE K D + T K DV+SFGVV+WE+ T E+PY L +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
EE++ +I G P C LM CW +PK RP F EI
Sbjct: 228 EEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 91/277 (32%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
S+L+ I LG G FG VF K KG + A +++ L ++F RE M +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK--------RIII 733
+ H NVV G+ + + + EY G LKQ LR ++ K ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
A G+++L VH DL + N LV+ QR V K+ L LSK +
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVS---SQREV-KVSLLSLSKDVYNSEYYKLRNA 178
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
IP W+APE + ++ + K DV+SFGV+MWE+ T GE P+ L EE++ + G L
Sbjct: 179 LIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+P C LM RCW+ +PK RP+FSE+ L
Sbjct: 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 78/261 (29%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 628 KELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ LG G+FG+V+ K G +A+K ++ + S EE + RE +L + HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALE---REIRILSSLQHP 59
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR----TIDRRKRIIIAMDAAFGI 741
N+V +YG D L EY+ GSL +L++ + I + R I+ G+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----GL 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG---VRGTIPWM 798
YLH IVH D+K N LV+ V K+ D G +K G VRGT WM
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKIPSW 857
APE+ + ++ D++S G + E+ TG+ P+++L + + I P+IP
Sbjct: 171 APEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228
Query: 858 CEPTWRSLMERCWSSDPKSRP 878
+ + +C DPK RP
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 93/271 (34%), Positives = 138/271 (50%), Gaps = 26/271 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I DL ++KELG+G FG V YGKW+G DVAIK IK EGS+ ED +F EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSED----EFIEEAK 51
Query: 678 MLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
++ ++ H +V YGV T P+ VTEYM NG L LR + + + + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIY---IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGT 794
G+ YL K +H DL + N LV+ + K+ D GLS+ + + S G +
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 795 IPWMAPELFK-SKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ W PE+ SK + K DV++FGV+MWE+ + G+ PY ++ E + + +G L
Sbjct: 165 VRWSPPEVLLYSK---FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRL 220
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P ++M CW + RP F ++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I + ++ +++LG+G FG V+ G W + VA+K +KP G+++ DF EA
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-----GTMDPK----DFLAEAQ 53
Query: 678 MLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAM 735
++ ++ HP ++ Y V T P+ VTE M GSL + L+ R + + I +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY---IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRG 793
A G+ YL +N +H DL + N LV + +CK+ D GL+++ ++ + G +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
I W APE N + K DV+SFG+++ E++T G PY + + E++ + +G P
Sbjct: 167 PIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAF 880
P C +M CW DP RP F
Sbjct: 225 C-PPGCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 93/275 (33%), Positives = 144/275 (52%), Gaps = 26/275 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I S+L ++KELGSG FG V GKW+ VAIK I EG++ E+ DF EA
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-----EGAMSEE----DFIEEAK 51
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HP +V YGV T L VTE+M NG L LR++ + + + + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQ--KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV 109
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTI 795
G+EYL + +H DL + N LV+ V K+ D G+++ + + S G + +
Sbjct: 110 CEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN--LGP 852
W PE+F + + K DV+SFGV+MWE+ T G+ P+ + E++ I +G P
Sbjct: 166 KWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
K+ S T +M CW P+ RP F+E+ + +
Sbjct: 224 KLAS---MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 94/287 (32%), Positives = 142/287 (49%), Gaps = 27/287 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLI 669
L+ +K ++LE IK LGSG FGTV+ G W VAIK ++ + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE----- 55
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
EA+++ + HP+VV G+ + + +T+ M G L +R I +
Sbjct: 56 --ILDEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTL 786
+ + A G+ YL EK +VH DL + N LV + PQ KI D GL+K+ +K
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKEY 166
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
+ G + I WMA E + + T K DV+S+GV +WEL+T G +PY + + EI +
Sbjct: 167 HAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
KG P+ P C ++ +CW D +SRP F E+ E MA
Sbjct: 225 EKGERLPQ-PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 96/303 (31%), Positives = 138/303 (45%), Gaps = 54/303 (17%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGK----WKGSD---VAIKRIKPSCFAEGSLEEDRLIA 670
++ + +ELG G FG VF G+ +D VA+K +K E + + R
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-----ETASNDARK-- 53
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
DF REA +L H N+V FYGV T+G V EYM +G L + LR K
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 731 -------------IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
+ IA+ A G+ YL ++ VH DL + N LV V KIGD G
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----YDLVVKIGDFG 167
Query: 778 LS---------KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
+S ++ T++ I WM PE + T + DV+SFGVV+WE+ T
Sbjct: 168 MSRDVYTTDYYRVGGHTMLP------IRWMPPESIMYRK--FTTESDVWSFGVVLWEIFT 219
Query: 829 -GEEPYADLHSEEIIAGIIKGN-LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
G++P+ L +EE+I I +G L P C +M CW DP+ R +I +
Sbjct: 220 YGKQPWYGLSNEEVIECITQGRLLQR--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277
Query: 887 LRA 889
L+
Sbjct: 278 LQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 97/270 (35%), Positives = 133/270 (49%), Gaps = 26/270 (9%)
Query: 628 KELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K +G+G FG VF G K VAIK +KP G E+ R DF EA ++GQ
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-----GYTEKQR--QDFLSEASIMGQF 63
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
H N++ GVVT +TEYM NG+L + LR D + + + A G++
Sbjct: 64 SHHNIIRLEGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISGGVRGTIPWM 798
YL + N VH DL + N LVN CK+ D GLS++ + T + G + I W
Sbjct: 122 YLSDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
APE + T DV+SFG+VMWE+++ GE PY D+ + E++ I G P P
Sbjct: 178 APEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-PMD 234
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
C LM +CW D RP F +I L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 77/260 (29%), Positives = 122/260 (46%), Gaps = 21/260 (8%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
E ++++G G FG V+ + K G +VAIK IK S E+ I E +L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-----SKEKKEKII---NEIQILK 52
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ HPN+V +YG L V E+ GSLK +L+ ++T+ + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAP 800
+EYLH I+H D+K+ N L+ K+ D GLS T + GT WMAP
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSWC 858
E+ K K D++S G+ EL G+ PY++L + + I N P + P
Sbjct: 167 EVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKAL-FKIATNGPPGLRNPEKW 223
Query: 859 EPTWRSLMERCWSSDPKSRP 878
++ +++C +P+ RP
Sbjct: 224 SDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 87/273 (31%), Positives = 141/273 (51%), Gaps = 22/273 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-VAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I S+L ++E+GSG FG V+ G W VAIK I+ EG++ E+ DF EA
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEE----DFIEEAQ 51
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HP +V YGV T+ + + V E+M +G L LR + + + + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTI 795
G+ YL N++H DL + N LV + V K+ D G+++ + S G + +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
W +PE+F + K DV+SFGV+MWE+ + G+ PY + + E++ I G K
Sbjct: 166 KWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK- 222
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P + LM+ CW P+ RP+FS + +L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 99/283 (34%), Positives = 140/283 (49%), Gaps = 28/283 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I S ++ K +G+G FG V G+ K VAIK +K G E+ R DF
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-----GYTEKQR--RDFL 53
Query: 674 REAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
EA ++GQ HPN++ GVVT PV VTEYM NGSL LR+ D + +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVM---IVTEYMENGSLDAFLRKHDGQFTVIQLVG 110
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLIS 788
+ A G++YL + VH DL + N LVN VCK+ D GLS++ + +
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847
G + I W APE + T DV+S+G+VMWE+++ GE PY ++ ++++I I +
Sbjct: 167 RGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
G P P C LM CW D RP F +I L +
Sbjct: 225 GYRLPA-PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 99/284 (34%), Positives = 140/284 (49%), Gaps = 33/284 (11%)
Query: 623 DLEYIK---ELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
D+ +K +G+G FG V G+ K VAIK +K G E+ R DF
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-----SGYTEKQR--RDFLS 54
Query: 675 EAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
EA ++GQ HPN++ GVVT PV +TE+M NG+L LR+ D + + +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVM---IITEFMENGALDSFLRQNDGQFTVIQLVGM 111
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT----LISG 789
A G++YL E N VH DL + N LVN VCK+ D GLS+ + +
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 790 GVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846
+ G IP W APE + T DV+S+G+VMWE+++ GE PY D+ ++++I I
Sbjct: 168 SLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225
Query: 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ P P C LM CW D +RP F +I L M
Sbjct: 226 QDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 86/278 (30%), Positives = 138/278 (49%), Gaps = 24/278 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
++ +D+ +LG G +G V+ G WK VA+K +K E+ + +F +EA
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 53
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAM 735
++ +I HPN+V GV T P +TE+M G+L LR +R ++ + +A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRG 793
+ +EYL +KN +H DL + N LV + + K+ D GLS++ + G +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
I W APE N + K DV++FGV++WE+ T G PY + ++ + KG
Sbjct: 168 PIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ P C P LM CW +P RP+F+EI + M
Sbjct: 226 R-PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 91/269 (33%), Positives = 141/269 (52%), Gaps = 25/269 (9%)
Query: 628 KELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
+++G G FG V+ G KG+ +VA+K + + + L F +EA +L Q HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-------LKRKFLQEAEILKQYDHPN 53
Query: 687 VVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+V GV P+ V E + GSL LR+K + +K + +++DAA G+EYL
Sbjct: 54 IVKLIGVCVQKQPIY---IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL--ISGGVRGTIP--WMAPE 801
KN +H DL + N LV + V KI D G+S+ ++ + +S G IP W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
T + DV+S+G+++WE + G+ PY + +++ I G P P C
Sbjct: 166 ALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPE 222
Query: 861 TWRSLMERCWSSDPKSRPAFSEITKELRA 889
LM +CW+ DP++RP+FSEI EL+
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 84/272 (30%), Positives = 140/272 (51%), Gaps = 22/272 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ +L+ ++ +G G FG V G ++G+ VA+K IK A+ F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----------FLAEASV 52
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMDA 737
+ Q+ H N+V GV+ + L VTEYM GSL LR + R++ ++ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
+EYL N VH DL + N LV+ + V K+ D GL+K T +G + + W
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTGKL--PVKW 165
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856
APE + K + K DV+SFG+++WE+ + G PY + ++++ + KG P
Sbjct: 166 TAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 222
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
C P +M++CW D +RP+F ++ ++L
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 89/267 (33%), Positives = 140/267 (52%), Gaps = 24/267 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ L+ +K+LG+G FG V+ G + G + VAIK +K +GS+ + +A EA+
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLK-----QGSMSPEAFLA----EAN 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMD 736
++ Q+ HP +V Y VVT P+ +TEYM NGSL L+ + + K I +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY---IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGT 794
A G+ ++ KN +H DL++ N LV+ + CKI D GL+++ + + G +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE T K DV+SFG+++ E++T G PY + + E+I + +G P+
Sbjct: 167 IKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR 224
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAF 880
P C LM CW P+ RP F
Sbjct: 225 -PDNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 85/278 (30%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 628 KELGSGTFGTVFYGKWKGS-----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K+LG G+FG V G+W S VA+K C L + ++ DF +EA ++ +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-----CLKSDKLSD--IMDDFLKEAAIMHSL 53
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII-------AM 735
H N++ YGVV P L VTE GSL LR + A+
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLR------KDALGHFLISTLCDYAV 104
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IKQKTLISGGV 791
A G+ YL K +H DL + N L+ D KIGD GL + + ++ +
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK-GN 849
+ W APE +++ + DV+ FGV +WE+ T GEEP+A L +I+ I K G
Sbjct: 161 KVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE 218
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ P C ++M +CW+ +P RP F+ + + L
Sbjct: 219 RLER-PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 89/278 (32%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 628 KELGSGTFGTVFYGKW---KGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
KELG G FG+V G + G +VA+K +K +F REA ++ Q+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-------HIAAGKKEFLREASVMAQL 53
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HP +V GV G L V E G L + L+ K R I +A A G+
Sbjct: 54 DHPCIVRLIGV-CKGEPLML--VMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMGMA 109
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--------IKQKTLISGGVRGT 794
YL K+ VH DL + N L+ R KI D G+S+ + T G R
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRALGAGSDYYRATT---AG-RWP 161
Query: 795 IPWMAPELFKSKDNLVT--EKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851
+ W APE N K DV+S+GV +WE + G +PY ++ E+IA + G
Sbjct: 162 LKWYAPECI----NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
P+ P C S+M CW P+ RP FSE+ R
Sbjct: 218 PR-PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 87/268 (32%), Positives = 138/268 (51%), Gaps = 25/268 (9%)
Query: 628 KELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIA-DFWREAHMLGQIHHP 685
++LGSG FG V+ G WK VAIK +K +D L DF +E L ++ H
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILK---------SDDLLKQQDFQKEVQALKRLRHK 62
Query: 686 NVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEY 743
++++ + V + G PV +TE M GSL LR + + + I +A A G+ Y
Sbjct: 63 HLISLFAVCSVGEPVY---IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMAPEL 802
L E+N +H DL + N LV + VCK+ D GL++ IK+ +S + W APE
Sbjct: 120 LEEQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA 175
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ K DV+SFG++++E+ T G+ PY +++ E+ I G P P+ C
Sbjct: 176 ASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQE 232
Query: 862 WRSLMERCWSSDPKSRPAFSEITKELRA 889
+M CW+++P+ RP+F + +EL
Sbjct: 233 IYKIMLECWAAEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 81/292 (27%), Positives = 140/292 (47%), Gaps = 37/292 (12%)
Query: 624 LEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L++IK+LG G FG V ++ G VA+K + S E++ +DF RE
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFEREIE 58
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+L + H N+V + GV +L + EY+ +GSL+ L+R I+ ++ ++ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTI 795
G++YL + +H DL + N LV + + V KI D GL+K+ + K G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 796 P--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL-- 850
P W APE + + + DV+SFGV ++EL T G+ + + GI +G +
Sbjct: 175 PIFWYAPECLR--TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 851 ---------GPKI--PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
G ++ P C LM+ CW ++P+ RP+F+++ + +
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 83/261 (31%), Positives = 134/261 (51%), Gaps = 26/261 (9%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689
+G G FG V G++ G VA+K IK A+ LEE ++ ++HH N+V
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEE----------TAVMTKLHHKNLVR 63
Query: 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMDAAFGIEYLHEKN 748
GV+ L V E M G+L LR + R + +++ ++D A G+EYL K
Sbjct: 64 LLGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 749 IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDN 808
+VH DL + N LV+ + V K+ D GL+++ + + + + W APE K K
Sbjct: 121 LVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKWTAPEALKHKK- 173
Query: 809 LVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG-NLGPKIPSWCEPTWRSLM 866
+ K DV+S+GV++WE+ + G PY + +E+ + KG + P P C LM
Sbjct: 174 -FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--PEGCPADVYVLM 230
Query: 867 ERCWSSDPKSRPAFSEITKEL 887
CW ++PK RP+F ++ ++L
Sbjct: 231 TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 90/283 (31%), Positives = 139/283 (49%), Gaps = 34/283 (12%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ ++ LG G FG V+ G ++G D VA+K + SC E+D DF EA
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--DFLMEA 60
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR------RKR 730
++ + +H N+V GV + + E M G LK LR +R +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISG 789
+ A D A G +YL E + +H D+ + N L+ + P R V KI D G+++ I + +
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYRASYYRK 177
Query: 790 GVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846
G R +P WM PE F D + T K DV+SFGV++WE+ + G PY ++E++ +
Sbjct: 178 GGRAMLPIKWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235
Query: 847 KG-NLGPKIPSWC-EPTWRSLMERCWSSDPKSRPAFSEITKEL 887
G L P P C P +R +M CW P+ RP F+ I + +
Sbjct: 236 GGGRLDP--PKGCPGPVYR-IMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 91/269 (33%), Positives = 138/269 (51%), Gaps = 28/269 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L+ IK+LG+G FG V+ G W G + VA+K +KP + S F EA
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMD 736
++ ++ H +V Y VV++ P+ VTEYM GSL L+ + R + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGT 794
A G+ Y+ N +H DL+S N LV VCKI D GL+++ + + G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 795 IPWMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851
I W APE L+ T K DV+SFG+++ EL+T G PY +++ E++ + +G
Sbjct: 167 IKWTAPEAALYGR----FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAF 880
P P C + LM +CW DP+ RP F
Sbjct: 223 P-CPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 90/280 (32%), Positives = 139/280 (49%), Gaps = 33/280 (11%)
Query: 630 LGSGTFGTVFYGKWKGSD--------VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
LGSG FG V+ G VA+K ++ +G+ ++++ +F +EAH++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-----KGATDQEK--KEFLKEAHLMSN 55
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRT----IDRRKRIIIAM 735
+HPN+V GV + + E M G L LR R +R + ++ + I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP-VCKIGDLGLSK-IKQKTLISGGVRG 793
D A G YL + + +H DL + N LV+ + V KIGD GL++ I + G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK-GN 849
+P WMAPE D T + DV+SFGV+MWE+LT G++PY L+++E++ + G
Sbjct: 174 LLPVRWMAPESLL--DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
L P C LM CW+ DP RP F I + L+
Sbjct: 232 LQK--PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 56/301 (18%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
S + +++ELG G FG V+ G+ G + VAIK +K + AE ++++ F +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQE-----FRQ 57
Query: 675 EAHMLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK-----------D 722
EA ++ + HPN+V GV T + P L EY+ +G L + L R D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 723 RTI----DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778
T+ D + IA+ A G+EYL + VH DL + N LV V KI D GL
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGL 170
Query: 779 S---------KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT- 828
S +++ K+L+ + WM PE T + D++SFGVV+WE+ +
Sbjct: 171 SRDIYSADYYRVQSKSLLP------VRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSY 222
Query: 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
G +PY ++E+I I L P P C +LM CW+ P RP F +I LR
Sbjct: 223 GLQPYYGFSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
Query: 889 A 889
+
Sbjct: 282 S 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 78/270 (28%), Positives = 134/270 (49%), Gaps = 31/270 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E IK++G G+FG V+ + K G +K I S +E E+ E +L ++
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL------NEVKILKKL 56
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL--RRKDRTIDRRKRII-----IAM 735
+HPN++ +Y + L V EY G L Q + ++K+ ++I+ + +
Sbjct: 57 NHPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 736 DAAFGIEYLHEKNIVHFDLKSHN-FLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG-VRG 793
++YLH + I+H D+K N FL + + K+GD G+SK+ T+ V G
Sbjct: 115 ----ALKYLHSRKILHRDIKPQNIFLTS-----NGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
T +++PEL ++K K D++S G V++EL T + P+ + E+ I+KG P
Sbjct: 166 TPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-PP 222
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
IPS R+L+ DP+ RP+ ++I
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 27/279 (9%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADF 672
I+ D+ + +G G FG V+ G + + VA+K K S+ E F
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREK-----F 54
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+EA+++ Q HP++V GV+T+ PV V E G L+ L+ ++D I+
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENPVW---IVMELAPLGELRSYLQVNKYSLDLASLIL 111
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC-KIGDLGLSKIKQKTLISGGV 791
+ + + YL K VH D+ + N LV+ P C K+GD GLS+ +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 792 RGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
+G +P WMAPE + T DV+ FGV MWE+L G +P+ + + ++I I G
Sbjct: 167 KGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P P C PT SLM +CW+ DP RP F+E+ +L
Sbjct: 225 ERLPM-PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 94/300 (31%), Positives = 137/300 (45%), Gaps = 52/300 (17%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
++EY++++G G FG VF + G + VA+K +K E S + + ADF RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASAD---MQADFQRE 58
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR--------------K 721
A ++ + HPN+V GV G + + EYM G L + LR
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 722 DRTIDRRK-------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774
R ++ IA A G+ YL E+ VH DL + N LV + V KI
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKIA 172
Query: 775 DLGLS-KIKQKTLISGGVRGTIP--WMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLT- 828
D GLS I IP WM PE + N T + DV+++GVV+WE+ +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFSY 228
Query: 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
G +PY + EE+I + GN+ P C +LM CWS P RP+F+ I + L+
Sbjct: 229 GMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 83/275 (30%), Positives = 131/275 (47%), Gaps = 32/275 (11%)
Query: 630 LGSGTFGTVFYGKWKGSD-----VAIK---RIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
+G G FG V++G SD A+K RI LEE + F +E ++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEE---VEQFLKEGIIMKD 52
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
HPNV++ G+ + L V YM +G L+ +R + + I + A G+
Sbjct: 53 FSHPNVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM 111
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLIS----GGVRGTIP 796
EYL K VH DL + N +++ + K+ D GL++ I K S G + +
Sbjct: 112 EYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIP 855
WMA E +++ T K DV+SFGV++WEL+T G PY D+ S +I +++G + P
Sbjct: 168 WMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-P 224
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+C +M CW P+ RP FSE+ + +
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 93/279 (33%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 630 LGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
LG G FG+V + K D VA+K +K F+ +EE F REA + + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE------FLREAACMKEFDH 60
Query: 685 PNVVAFYGVV----TDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIII--AM 735
PNV+ GV G + + +M +G L L R + + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGT 794
D A G+EYL KN +H DL + N M + VC + D GLS KI G
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNC---MLNENMTVC-VADFGLSKKIYSGDYYRQGCASK 176
Query: 795 IP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851
+P W+A E DN+ T DV++FGV MWE++T G+ PYA + + EI +IKGN
Sbjct: 177 LPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR- 233
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
K P C LM +CWS +PK RP+F + +L +
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 85/257 (33%), Positives = 134/257 (52%), Gaps = 24/257 (9%)
Query: 629 ELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
+LG G FG V+ G W G+ VAIK +KP G++ + F +EA ++ ++ H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEA----FLQEAQVMKKLRHEKL 63
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMDAAFGIEYLHE 746
V Y VV++ P+ VTEYM GSL L+ + R +++ +A A G+ Y+
Sbjct: 64 VQLYAVVSEEPIY---IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGTIPWMAPELFK 804
N VH DL++ N LV + VCK+ D GL+++ + + G + I W APE
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE--A 174
Query: 805 SKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863
+ T K DV+SFG+++ EL T G PY + + E++ + +G P P C +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLH 233
Query: 864 SLMERCWSSDPKSRPAF 880
LM +CW +P+ RP F
Sbjct: 234 DLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 86/260 (33%), Positives = 134/260 (51%), Gaps = 24/260 (9%)
Query: 629 ELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
+LG G FG V+ G W G+ VAIK +KP G++ + F +EA ++ ++ H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKP-----GTMMPEA----FLQEAQIMKKLRHDKL 63
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHE 746
V Y VV++ P+ VTE+M GSL L+ D + + + + +A A G+ Y+
Sbjct: 64 VPLYAVVSEEPIY---IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGTIPWMAPELFK 804
N +H DL++ N LV VCKI D GL+++ + + G + I W APE
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE--A 174
Query: 805 SKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863
+ T K DV+SFG+++ EL+T G PY + + E++ + +G P P C +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQGCPESLH 233
Query: 864 SLMERCWSSDPKSRPAFSEI 883
LM+ CW DP RP F I
Sbjct: 234 ELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 22/268 (8%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ +G G FG VF G+ + + VA+K SC +L D L A F +EA +L Q HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC--RETLPPD-LKAKFLQEARILKQYSHP 53
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
N+V GV T + V E + G LR + + ++ I + +AA G+EYL
Sbjct: 54 NIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI--SGGVRGT-IPWMAPEL 802
K+ +H DL + N LV ++ V KI D G+S+ ++ + +GG++ + W APE
Sbjct: 112 SKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ + DV+SFG+++WE + G PYA+L +++ I +G P P C
Sbjct: 168 LNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPELCPDA 224
Query: 862 WRSLMERCWSSDPKSRPAFSEITKELRA 889
LMERCW DP RP+FS + +EL++
Sbjct: 225 VYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 88/283 (31%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 628 KELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K LG G FG+V G+ D VA+K +K +EE F EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE------FLSEAACMKDF 58
Query: 683 HHPNVVAFYGVVTDGPVTNL----ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM--- 735
HPNV+ GV + + +M +G L L R +++ +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLK 117
Query: 736 ---DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--- 789
D A G+EYL +N +H DL + N M VC + D GLSK + SG
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNC---MLREDMTVC-VADFGLSK----KIYSGDYY 169
Query: 790 --GVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAG 844
G +P W+A E D + T K DV++FGV MWE+ T G+ PY + + EI
Sbjct: 170 RQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ GN K P C LM CW +DPK RP F+++ + L
Sbjct: 228 LRHGNR-LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 93/286 (32%), Positives = 145/286 (50%), Gaps = 27/286 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLI 669
L+ +K ++ + IK LGSG FGTV+ G W +G VAIK ++ + S + ++ I
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEI 56
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
D EA+++ + +P+V G+ V +T+ M G L +R I +
Sbjct: 57 LD---EAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQY 110
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTL 786
+ + A G+ YL E+ +VH DL + N LV + PQ KI D GL+K+ +K
Sbjct: 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEY 166
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
+ G + I WMA E + + T + DV+S+GV +WEL+T G +PY + + EI + +
Sbjct: 167 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
KG P+ P C +M +CW D SRP F E+ E MA
Sbjct: 225 EKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 94/282 (33%), Positives = 140/282 (49%), Gaps = 36/282 (12%)
Query: 627 IKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
++ELG G+FG V+ G + + VA+K + S SL E R+ +F EA ++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRE-RI--EFLNEASVM 63
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKD------RTIDRRKRI 731
+VV GVV+ G T V E M +G LK LR R + R + +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 732 I-IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISG 789
I +A + A G+ YL+ K VH DL + N +V KIGD G+++ I +
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 790 GVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846
G +G +P WMAPE K D + T D++SFGVV+WE+ + E+PY L +E+++ ++
Sbjct: 178 GGKGLLPVRWMAPESLK--DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
G + P C LM CW +PK RP F EI L+
Sbjct: 236 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 92/301 (30%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ L K LG G FG V + G D VA+K +K ++ ++D
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSD 61
Query: 672 FWREAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK-------- 721
E M+ I H N++ GV T +GP L V EY +G+L+ LR +
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 722 -------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774
+ T+ ++ + A A G+E+L K +H DL + N LV V KI
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 775 DLGLSK-IKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-G 829
D GL++ I G +P WMAPE LF D + T + DV+SFGV++WE+ T G
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWEIFTLG 231
Query: 830 EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
PY + EE+ + +G K P C LM CW P RP F ++ ++L
Sbjct: 232 GSPYPGIPVEELFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 890 M 890
M
Sbjct: 291 M 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 87/269 (32%), Positives = 125/269 (46%), Gaps = 24/269 (8%)
Query: 630 LGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
LG+G FG + G K VAI ++ C D+ F EA LGQ H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDH 65
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
N+V GV+T G + VTEYM NG+L LR+ + + + + + A G++YL
Sbjct: 66 SNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG-LSKIKQKTLISG-GVRGTIPWMAPEL 802
E VH L +H LVN VCKI L + K + + + + + W APE
Sbjct: 124 SEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ + DV+SFG+VMWE+++ GE PY D+ +++I + G P P C
Sbjct: 180 IQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNL 236
Query: 862 WRSLMERCWSSDPKSRPAFSEITKELRAM 890
LM CW + RP FS+I L M
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 92/281 (32%), Positives = 140/281 (49%), Gaps = 36/281 (12%)
Query: 628 KELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ELG G+FG V+ G KG + VAIK + + +E F EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-------FLNEASVMK 64
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRTIDR-------RKRI 731
+ + +VV GVV+ G T + E M G LK LR R + + +K I
Sbjct: 65 EFNCHHVVRLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGG 790
+A + A G+ YL+ VH DL + N +V + KIGD G+++ I + G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 791 VRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847
+G +P WM+PE K D + T DV+SFGVV+WE+ T E+PY + +E+++ +++
Sbjct: 179 GKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
G L K P C LM CW +PK RP+F EI ++
Sbjct: 237 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 99/298 (33%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKG----SD---VAIKRIKPSCFAEGSLEEDRLIAD 671
IK D+ ELG G FG VF + D VA+K +K + E R D
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS------ESARQ--D 53
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---RTIDRR 728
F REA +L + H ++V FYGV T+G L V EYM +G L + LR + +
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 729 K-----------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
+ + IA A G+ YL + VH DL + N LV Q V KIGD G
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 778 LSK-IKQKTLISGGVRGTIP--WMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
+S+ I G R +P WM PE L++ T + D++SFGVV+WE+ T G++
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK----FTTESDIWSFGVVLWEIFTYGKQ 223
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
P+ L + E I I +G + P C P ++M+ CW +P+ R +I L+A
Sbjct: 224 PWYQLSNTEAIECITQGRELER-PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 73/253 (28%), Positives = 121/253 (47%), Gaps = 19/253 (7%)
Query: 629 ELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
+G G FG V+ G G VAIK+I E +L+ +E +L + HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK------SIMQEIDLLKNLKHPN 60
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
+V + G + +L + EY NGSL+Q++++ + + + G+ YLHE
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY-QVLQGLAYLHE 117
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFKS 805
+ ++H D+K+ N L V K+ D G++ K+ + V GT WMAPE+ +
Sbjct: 118 QGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 806 KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSL 865
+ D++S G + ELLTG PY DL+ + I++ + P +P P +
Sbjct: 174 SG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDF 230
Query: 866 MERCWSSDPKSRP 878
+ +C+ DP RP
Sbjct: 231 LMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 81/275 (29%), Positives = 142/275 (51%), Gaps = 25/275 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I ++ +K+LG+G FG V+ G + S VA+K +KP G++ + F EA+
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMS----VQAFLEEAN 53
Query: 678 MLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAM 735
++ + H +V Y VVT + P+ +TEYM GSL L+ + + K I +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIY---IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRG 793
A G+ Y+ KN +H DL++ N LV+ + +CKI D GL+++ + + G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
I W APE T K DV+SFG++++E++T G+ PY + + ++++ + +G P
Sbjct: 167 PIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
++ + C +M+ CW + RP F + L
Sbjct: 225 RMEN-CPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 92/292 (31%), Positives = 142/292 (48%), Gaps = 39/292 (13%)
Query: 624 LEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L++I++LG G FG+V ++ G VA+K+++ S + E R DF RE
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIE 57
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+L + H N+V + GV NL V EY+ GSL+ L++ +D RK ++ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISGGVRG 793
G+EYL K VH DL + N LV KIGD GL+K+ K+ +
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE----PYA--------DLHSEEI 841
I W APE ++ + DV+SFGVV++EL T + P A D + I
Sbjct: 174 PIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231
Query: 842 I---AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ ++K N P C ++M+ CW++DP RP+FSE+ ++ A+
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 83/269 (30%), Positives = 126/269 (46%), Gaps = 36/269 (13%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDR-LIADFWREAHMLGQIHH 684
+ +G G+FG V+ K ++ VAIK I LEE I D +E L Q
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVI--------DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
P + +YG G + L + EY GS +L+ +D I + G+EYL
Sbjct: 59 PYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYL 114
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVRGTIPWM 798
HE+ +H D+K+ N L++ + V K+ D G+S K+ T + GT WM
Sbjct: 115 HEEGKIHRDIKAANILLS---EEGDV-KLADFGVSGQLTSTMSKRNTFV-----GTPFWM 165
Query: 799 APELFK-SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP-S 856
APE+ K S + EK D++S G+ EL GE P +DLH ++ I K N P + +
Sbjct: 166 APEVIKQSGYD---EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEGN 221
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
++ + C + DPK RP+ E+ K
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 91/310 (29%), Positives = 129/310 (41%), Gaps = 64/310 (20%)
Query: 618 TIKTSDLEYIKELGSGTFGTV----------------FYGKWKGSD--VAIKRIKPSCFA 659
L ++++LG G FG V + VA+K ++P
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--- 57
Query: 660 EGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR 719
D DF +E +L ++ PN+ GV T P L + EYM NG L Q L+
Sbjct: 58 ----ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP--LCMIMEYMENGDLNQFLQ 111
Query: 720 RKD----------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769
+ +++ + +A A G+ YL N VH DL + N LV +
Sbjct: 112 KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG----KNY 167
Query: 770 VCKIGDLGLSKIKQKTLISGG---VRGTIP----WMAPELF-KSKDNLVTEKVDVYSFGV 821
KI D G+S+ L S V+G P WMA E K T K DV++FGV
Sbjct: 168 TIKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGK---FTTKSDVWAFGV 220
Query: 822 VMWELLT--GEEPYADLHSEEII--AGIIKGNLGPKI----PSWCEPTWRSLMERCWSSD 873
+WE+LT E+PY L +++I AG + G +I P C LM CW D
Sbjct: 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRD 280
Query: 874 PKSRPAFSEI 883
+ RP F EI
Sbjct: 281 EEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 76/256 (29%), Positives = 118/256 (46%), Gaps = 29/256 (11%)
Query: 630 LGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG G+FG V + K + A+K +K + + + + E ++L +I+HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-----KIIKRKEVEHTLTERNILSRINHPFI 55
Query: 688 VA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
V Y T+ L V EY G L L ++ R + R R A + +EYLH
Sbjct: 56 VKLHYAFQTE---EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAPE 801
I++ DLK N L++ K+ D GL+K L S G R GT ++APE
Sbjct: 112 LGIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYLAPE 163
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ K + VD +S GV+++E+LTG+ P+ +EI I+K L + P + P
Sbjct: 164 VLLGKGY--GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL--RFPEFLSPE 219
Query: 862 WRSLMERCWSSDPKSR 877
R L+ DP R
Sbjct: 220 ARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 624 LEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
+ ++++G G G V+ + G +VAIK+++ L + E ++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR--------LRKQNKELII-NEILIMKD 71
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
HPN+V +Y G L V EYM GSL ++ + ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLVGDE--LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG----LSKIKQKTLISGGVRGTIPW 797
EYLH +N++H D+KS N L++ K+ D G L+K K K V GT W
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKEKSK---RNSVVGTPYW 182
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP-- 855
MAPE+ K KD KVD++S G++ E+ GE PY + I P +
Sbjct: 183 MAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKNP 239
Query: 856 -SWCEPTWRSLMERCWSSDPKSRPAFSEI 883
W P ++ + +C DP+ RP+ E+
Sbjct: 240 EKW-SPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 96/299 (32%), Positives = 143/299 (47%), Gaps = 54/299 (18%)
Query: 628 KELGSGTFGTVFYG---KWKG----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
K LG G FG V + KG + VA+K +K E + + + D E ++L
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-----ENASSSE--LRDLLSEFNLLK 58
Query: 681 QIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLR--RK---------------- 721
Q++HP+V+ YG + DGP L + EY GSL+ LR RK
Sbjct: 59 QVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 722 -----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+R + I A + G++YL E +VH DL + N LV + KI D
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDF 171
Query: 777 GLSK-IKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
GLS+ + ++ +G IP WMA E LF D++ T + DV+SFGV++WE++T G
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PY + E + ++K + P C +LM CW +P RP F++I+KEL M
Sbjct: 229 PYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 89/265 (33%), Positives = 127/265 (47%), Gaps = 22/265 (8%)
Query: 630 LGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVV 688
LG G FG VF G K + VA+K K E L F EA +L Q HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-------LKIKFLSEARILKQYDHPNIV 55
Query: 689 AFYGVVTD-GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK 747
GV T P+ V E + G LR+K + ++ + A+DAA G+ YL K
Sbjct: 56 KLIGVCTQRQPIY---IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 748 NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP--WMAPELFKS 805
N +H DL + N LV + V KI D G+S+ + + S IP W APE
Sbjct: 113 NCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 806 KDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864
+ + DV+S+G+++WE + G PY + +++ + KG P C
Sbjct: 169 --GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYK 225
Query: 865 LMERCWSSDPKSRPAFSEITKELRA 889
+M+RCW P++RP FSE+ KEL A
Sbjct: 226 VMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 99/305 (32%), Positives = 140/305 (45%), Gaps = 45/305 (14%)
Query: 619 IKTSDLEYIKELGSGTFGTVF----YGKWKGSD---VAIKRIK-PSCFAEGSLEEDRLIA 670
IK D+ +ELG G FG VF Y D VA+K +K P+ A
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---------K 52
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR----------- 719
DF REA +L + H ++V FYGV DG L V EYM +G L + LR
Sbjct: 53 DFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 110
Query: 720 ----RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ + + + IA A G+ YL ++ VH DL + N LV + KIGD
Sbjct: 111 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 166
Query: 776 LGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
G+S+ T + G I WM PE + T + DV+SFGV++WE+ T G++
Sbjct: 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQ 224
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
P+ L + E+I I +G + + P C +M CW +P+ R EI K L A+
Sbjct: 225 PWFQLSNTEVIECITQGRVLER-PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283
Query: 892 AAMNI 896
A I
Sbjct: 284 KATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 82/267 (30%), Positives = 136/267 (50%), Gaps = 24/267 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L+ K+LG+G FG V+ + K + VA+K +KP GS+ + F EA+
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMS----VEAFLAEAN 53
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMD 736
++ + H +V + VVT P+ +TE+M GSL L+ + K I +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY---IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGT 794
A G+ ++ ++N +H DL++ N LV+ VCKI D GL+++ + + G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE T K DV+SFG+++ E++T G PY + + E+I + +G P+
Sbjct: 167 IKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 224
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAF 880
+ C ++M RCW + P+ RP F
Sbjct: 225 PEN-CPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 92/301 (30%), Positives = 139/301 (46%), Gaps = 56/301 (18%)
Query: 622 SDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLIADFWRE 675
S + +++ELG FG ++ G G D VAIK +K + + +F +E
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-------DINNPQQWGEFQQE 57
Query: 676 AHMLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKD------------ 722
A ++ ++HHPN+V GVVT + PV L EY+ G L + L +
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCML---FEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 723 ----RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778
++D + IA+ A G+EYL VH DL + N L+ ++ KI DLGL
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGL 170
Query: 779 SK---------IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT- 828
S+ ++ K+L+ I WM PE + D++SFGVV+WE+ +
Sbjct: 171 SREIYSADYYRVQPKSLLP------IRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSF 222
Query: 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
G +PY ++E+I + K L P C P SLM CW P RP F +I LR
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
Query: 889 A 889
+
Sbjct: 282 S 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 23/261 (8%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689
LGSG+FG+V+ G D +K A+ + +E +L ++ HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGIEYLH 745
+ G + NL E + GSL ++L++ + I R I+ G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKS 805
++N VH D+K N LV D V K+ D G++K + + +G+ WMAPE+
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 806 KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK-GNLG--PKIPSWCEPTW 862
+ D++S G + E+ TG+ P++ L E +A + K G P IP
Sbjct: 176 Q-GGYGLAADIWSLGCTVLEMATGKPPWSQL---EGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 863 RSLMERCWSSDPKSRPAFSEI 883
+ + +C DP RP +E+
Sbjct: 232 KDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 83/283 (29%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 623 DLEYIKELGSGTFGTVF----YGKWKGS---DVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
+L + K LG+G FG V YG K VA+K +KP+ + E + L+++
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS---EREALMSELKIM 92
Query: 676 AHMLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIII 733
+H LG H N+V G T GP+ +TEY G L LRRK + + +
Sbjct: 93 SH-LGN--HENIVNLLGACTIGGPIL---VITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKT--LISGG 790
+ A G+ +L KN +H DL + N L+ + KI D GL++ I + ++ G
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 791 VRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
R + WMAPE +F + + T + DV+S+G+++WE+ + G PY + + +IK
Sbjct: 203 ARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
P +M+ CW +DP RP F +I + +
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 5e-31
Identities = 93/286 (32%), Positives = 142/286 (49%), Gaps = 27/286 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLI 669
L+ +K ++L+ +K LGSG FGTV+ G W +G VAIK + + + ++E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE----- 55
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
F EA ++ + HP++V GV P L VT+ M +G L + I +
Sbjct: 56 --FMDEALIMASMDHPHLVRLLGVCLS-PTIQL--VTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTL 786
+ + A G+ YL E+ +VH DL + N LV + P KI D GL+++ +K
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEY 166
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
+ G + I WMA E + T + DV+S+GV +WEL+T G +PY + + EI +
Sbjct: 167 NADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
KG P+ P C +M +CW D SRP F E+ E MA
Sbjct: 225 EKGERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 8e-31
Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-H 683
+++LG G+FG V+ + VA+K + + + + F RE +L + H
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKK-----LESKSKEVERFLREIQILASLNH 56
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR--TIDRRKRIIIAMDAAFGI 741
PN+V Y D +L V EY+ GSL+ +L++ R + + + I +
Sbjct: 57 PPNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-------GT 794
EYLH K I+H D+K N L+ D V K+ D GL+K+ + + GT
Sbjct: 115 EYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 795 IPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK------ 847
+MAPE+ + D++S G+ ++ELLTG P+ + + +K
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 848 -----GNLGPKIPSWCEPTWRSLMERCWSSDPKSRP 878
L P P L+++ + DPK+R
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLIADF 672
+K ++L +K LGSG FGTV G W +G VAIK I+ + +E I D
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQE---ITD- 58
Query: 673 WREAHML--GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
HML G + H +V G+ P +L VT+ GSL +R+ ++D ++
Sbjct: 59 ----HMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLI 787
+ + A G+ YL E +VH +L + N L ++ + +I D G++ + K
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYF 167
Query: 788 SGGVRGTIPWMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAG 844
+ I WMA E LF T + DV+S+GV +WE+++ G EPYA + E+
Sbjct: 168 YSEHKTPIKWMALESILFGR----YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
+ KG + P C +M +CW D RP F E+ E MA
Sbjct: 224 LEKGERLAQ-PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 37/279 (13%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D E I+ +GSGT+G V+ + + VAIK IK LE +E ML
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQEISML 54
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ HPN+VA++G L V EY GSL+ + + + + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KI-----KQKTLISGGVRG 793
G+ YLHE +H D+K N L+ + K+ D G+S ++ K+K+ I G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----G 163
Query: 794 TIPWMAPELFKSKDNL-VTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
T WMAPE+ + K D+++ G+ EL + P DLH + I K N P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223
Query: 853 KIPS------WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P W P + +++C + DPK RP +++ +
Sbjct: 224 --PKLKDKEKWS-PVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 79/270 (29%), Positives = 120/270 (44%), Gaps = 35/270 (12%)
Query: 622 SDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
SDLE +K LG G+ G V+ K G A+K+I +G E + + RE L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH----VDGDEEFRKQLL---RELKTL 53
Query: 680 GQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
P VV YG +G + + V EYM GSL +L+ K I IA
Sbjct: 54 RSCESPYVVKCYGAFYKEGEI---SIVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQIL 109
Query: 739 FGIEYLH-EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----- 792
G++YLH +++I+H D+K N L+N + KI D G+SK+ L + +
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGISKV----LENTLDQCNTFV 161
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT+ +M+PE + + + D++S G+ + E G+ P+ + GP
Sbjct: 162 GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP 219
Query: 853 KIPSW----CEPTWRSLMERCWSSDPKSRP 878
PS P +R + C DPK RP
Sbjct: 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 97/300 (32%), Positives = 140/300 (46%), Gaps = 51/300 (17%)
Query: 628 KELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
K LG G FG V + G D VA+K +K + D+ +AD E +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMEL 70
Query: 679 LGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK-----DRTIDRRKR- 730
+ I H N++ GV T +GP L + EY G+L++ LR + D T D K
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGP---LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 731 ---------IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK- 780
+ A A G+EYL + +H DL + N LV + V KI D GL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARG 183
Query: 781 ---IKQKTLISGGVRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYAD 835
I S G R + WMAPE LF D + T + DV+SFG++MWE+ T G PY
Sbjct: 184 VHDIDYYKKTSNG-RLPVKWMAPEALF---DRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
Query: 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895
+ EE+ + +G+ K PS C LM CW + P RP F ++ + L + AA++
Sbjct: 240 IPVEELFKLLREGHRMDK-PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 28/270 (10%)
Query: 630 LGSGTFGTVFYG--KWKGSDVAIKRIK-PSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
+GSG+FG+V+ G G +A+K+++ PS A + ++ RE +L ++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGIE 742
+V + G D +L EY+ GS+ +L ++ + R I+ G+
Sbjct: 68 IVQYLGSSLDA--DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK-----GLN 120
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP------ 796
YLH + I+H D+K N LV+ + KI D G+SK + +S G P
Sbjct: 121 YLHNRGIIHRDIKGANILVD----NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 797 -WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
WMAPE+ K T K D++S G ++ E+LTG+ P+ D + I I N P+IP
Sbjct: 177 FWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENASPEIP 233
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
S +E+ + D RP +E+ K
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 95/298 (31%), Positives = 138/298 (46%), Gaps = 40/298 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVF----YGKWKGSD---VAIKRIKPSCFAEGSLEEDRLIAD 671
IK ++ +ELG G FG VF Y D VA+K +K + D D
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKD 53
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR------------ 719
F REA +L + H ++V FYGV +G L V EYM +G L + LR
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 720 RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+ + + + + IA A G+ YL ++ VH DL + N LV + + KIGD G+S
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIGDFGMS 167
Query: 780 KIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYAD 835
+ T + G I WM PE + T + DV+S GVV+WE+ T G++P+
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
Query: 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
L + E+I I +G + + P C LM CW +P R EI L+ +A A
Sbjct: 226 LSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 41/293 (13%)
Query: 624 LEYIKELGSGTFGTVFY------GKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L+ I++LG G FG V G G VA+K +KP S IAD +E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP-----ESGGNH--IADLKKEIE 58
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+L ++H N+V + G+ T+ + + E++ +GSLK+ L R I+ ++++ A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISGGVRG 793
G++YL + VH DL + N LV KIGD GL+K K+ + +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 794 TIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT----GEEPYADL-------HSEEI 841
+ W APE L +SK + + DV+SFGV ++ELLT P H +
Sbjct: 175 PVFWYAPECLIQSKFYIAS---DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT 231
Query: 842 IAGIIK----GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ +++ G P P C LM +CW P R F + + A+
Sbjct: 232 VTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 36/267 (13%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ +++LG G++G+V+ K G VAIK + +EED + + +E +L
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--------PVEED--LQEIIKEISILK 53
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
Q P +V +YG T+L V EY GS+ +++ ++T+ + I G
Sbjct: 54 QCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI------KQKTLISGGVRGT 794
+EYLH +H D+K+ N L+N + K+ D G+S K+ T+I GT
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVI-----GT 162
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP- 852
WMAPE + + N K D++S G+ E+ G+ PY+D+H I +I P
Sbjct: 163 PFWMAPEVIQEIGYN---NKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPT 218
Query: 853 -KIPSWCEPTWRSLMERCWSSDPKSRP 878
P P + +++C DP+ RP
Sbjct: 219 LSDPEKWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 89/286 (31%), Positives = 140/286 (48%), Gaps = 27/286 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLI 669
++ +K ++L+ +K LGSG FGTV+ G W G + VAIK ++ + S + ++ I
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEI 56
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
D EA+++ + P V G+ + + VT+ M G L +R I +
Sbjct: 57 LD---EAYVMAGVGSPYVCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTL 786
+ + A G+ YL E +VH DL + N LV + P KI D GL++ I +
Sbjct: 111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEY 166
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
+ G + I WMA E + T + DV+S+GV +WEL+T G +PY + + EI +
Sbjct: 167 HADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
KG P+ P C +M +CW D + RP F E+ E MA
Sbjct: 225 EKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 82/272 (30%), Positives = 125/272 (45%), Gaps = 30/272 (11%)
Query: 629 ELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
ELGSG FG V G +K DVAIK +K + E + + REA ++ Q+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
P +V GV L V E G L + L K I + + + G++YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 745 HEKNIVHFDLKSHN-FLVNMRDPQRPVCKIGDLGLSKI-----KQKTLISGGVRGTIPWM 798
KN VH DL + N LVN + KI D GLSK S G + + W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
APE + + + DV+S+G+ MWE + G++PY + E+++ I+ P+
Sbjct: 166 APECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLDCPAE 222
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
C P +LM+ CW + RP F+++ + +R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 93/281 (33%), Positives = 128/281 (45%), Gaps = 38/281 (13%)
Query: 628 KELGSGTFGTVFYGKWKGSD----VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
K LG G FG+V G+ D VA+K +K + +E DF EA + +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFD 58
Query: 684 HPNVVAFYGVVTDG--------PVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRII 732
HPNV+ GV PV L +M +G L L R D +++
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILP----FMKHGDLHSFLLYSRLGDCPQYLPTQML 114
Query: 733 IAM--DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISG 789
+ D A G+EYL K+ +H DL + N ++N VC + D GLSK I
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSKKIYNGDYYRQ 170
Query: 790 GVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846
G +P W+A E D + T K DV+SFGV MWE+ T G+ PY + + EI +
Sbjct: 171 GRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
Query: 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+GN K P C SLM CW +PK RP+F + EL
Sbjct: 229 QGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 33/280 (11%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWR-EAHM 678
D E I+ +G G V+ VAIKRI LE+ + D R E
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQA 52
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM--- 735
+ Q +HPNVV +Y G L V Y+ GSL +++ IIA
Sbjct: 53 MSQCNHPNVVKYYTSFVVG--DELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATVLK 109
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVR-- 792
+ G+EYLH +H D+K+ N L+ + KI D G+S + + VR
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 793 --GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
GT WMAPE+ + + K D++SFG+ EL TG PY+ +++ ++ +
Sbjct: 166 FVGTPCWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND- 223
Query: 851 GPKIPS-----WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P + + ++R ++ C DP RP E+ K
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 33/264 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E ++ +G G FG V + + + A+K + K C +GS + + E +L +
Sbjct: 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS------VRNVLNERRILQE 56
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
++HP +V + D N+ V + ++ G L+ L +K + + + + I + +
Sbjct: 57 LNHPFLVNLWYSFQDE--ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLAL 113
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
EYLH K I+H D+K N L++ ++ I D ++ ++ GT +MAPE
Sbjct: 114 EYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ + V VD +S GV +E L G+ PY HS I I + T
Sbjct: 170 VLCRQGYSV--AVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYP--AT 224
Query: 862 W--------RSLMERCWSSDPKSR 877
W L+ER DP+ R
Sbjct: 225 WSTEAIDAINKLLER----DPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 26/271 (9%)
Query: 630 LGSGTFGTVFYG--KWKGSDVAIKRIK-PSCFAEGSLEEDRLIADFWR-EAHMLGQIHHP 685
+G GT+G V+ G +A+K+++ P+ A + + R E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
N+V + G T L+ EY+ GS+ LR R ++ R G+ YLH
Sbjct: 69 NIVQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-TEQVLEGLAYLH 125
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG----GVRGTIPWMAPE 801
K I+H DLK+ N LV+ +CKI D G+SK K + ++G++ WMAPE
Sbjct: 126 SKGILHRDLKADNLLVD----ADGICKISDFGISK-KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK-GNL--GPKIP--- 855
+ S + KVD++S G V+ E+ G P++D EE IA + K GN P IP
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD---EEAIAAMFKLGNKRSAPPIPPDV 237
Query: 856 -SWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P + C++ +P +RP E+ +
Sbjct: 238 SMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 94/300 (31%), Positives = 138/300 (46%), Gaps = 50/300 (16%)
Query: 628 KELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
K LG G FG V + G D VA+K +K + E+D ++D E M
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-----ATEKD--LSDLISEMEM 76
Query: 679 LGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK--------------- 721
+ I H N++ G T DGP L + EY G+L++ LR +
Sbjct: 77 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK- 780
+ + + + A A G+EYL K +H DL + N LV + V KI D GL++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIADFGLARD 189
Query: 781 IKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADL 836
I G +P WMAPE LF D + T + DV+SFGV++WE+ T G PY +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL-RAMAAAMN 895
EE+ + +G+ K PS C +M CW + P RP F ++ ++L R +A N
Sbjct: 247 PVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 93/302 (30%), Positives = 135/302 (44%), Gaps = 52/302 (17%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGS--------DVAIKRIKPSCFAEGSLEED---RLIADF 672
L + ++LG G FG V + +G + + +P A L ED DF
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 673 WREAHMLGQIHHPNVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRKD--------- 722
+E ++ ++ PN++ V +T P L +TEYM NG L Q L R +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 723 -RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
TI I +A A G++YL N VH DL + N LV KI D G+S+
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY----TIKIADFGMSR- 178
Query: 782 KQKTLISGGV-----RGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT--GEE 831
L SG R +P WM+ E + K T DV++FGV +WE+LT E+
Sbjct: 179 ---NLYSGDYYRIQGRAVLPIRWMSWESILLGK---FTTASDVWAFGVTLWEILTLCKEQ 232
Query: 832 PYADLHSEEII--AGIIKGNLGPKI----PSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
PY+ L E++I G + G ++ P+ C + LM CW + K RP+F EI
Sbjct: 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292
Query: 886 EL 887
L
Sbjct: 293 TL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 633 GTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
GTFG +FYG K +V +K +K S + + +E+ +L + H N
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQ---VTLLLQESCLLYGLSHQN 69
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-------KDRTIDRRKRIIIAMDAAF 739
++ V + + YM G+LK L++ + + ++ + +A+ A
Sbjct: 70 ILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IKQKTLISGGVRGTI 795
G+ YLH++ ++H D+ + N ++ D + V KI D LS+ + L R +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVI---DEELQV-KITDNALSRDLFPMDYHCLGDNENR-PV 183
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
WMA E +K + DV+SFGV++WEL+T G+ PY ++ E+ A + G +
Sbjct: 184 KWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ- 240
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
P C ++M CW+ DP+ RP+FS++ + L
Sbjct: 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 23/262 (8%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E + ++G G+FG VF K A+K+I S E + I EA +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAI----DEARVLA 54
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIIIAMDA 737
++ ++ +Y D N+ V EY NG L ++L R + D+ R I
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNI--VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QI 110
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIP 796
G+ +LH K I+H D+KS N ++ D KIGDLG++K+ T + + GT
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856
+++PEL +D EK DV++ GVV++E TG+ P+ + +I II+G P +
Sbjct: 167 YLSPEL--CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQ 223
Query: 857 WCEPTWRSLMERCWSSDPKSRP 878
L+++C + D + RP
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 86/266 (32%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG G FG V+ Y G ++A+K++ F S E + + E +L + H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK---DRTIDRR-KRIIIAMDAAFGI 741
+V +YG + D L+ EYM GS+K L+ T+ R+ R I+ G+
Sbjct: 65 RIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GV 117
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG----VRGTIPW 797
EYLH IVH D+K N L RD V K+GD G SK Q SG V GT W
Sbjct: 118 EYLHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
M+PE+ + K DV+S G + E+LT + P+A+ + I I P++PS
Sbjct: 174 MSPEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEI 883
P R+ + R + + K RP+ E+
Sbjct: 232 VSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-27
Identities = 91/300 (30%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 628 KELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
K LG G FG V + G D VA+K +K + + E+D ++D E M
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-----DDATEKD--LSDLVSEMEM 73
Query: 679 LGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK--------------- 721
+ I H N++ G T DGP L + EY G+L++ LR +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK- 780
D + + + A G+EYL + +H DL + N LV + V KI D GL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFGLARD 186
Query: 781 IKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADL 836
+ G +P WMAPE LF D + T + DV+SFGV+MWE+ T G PY +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243
Query: 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL-RAMAAAMN 895
EE+ + +G+ K P+ C +M CW + P RP F ++ ++L R + N
Sbjct: 244 PVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 628 KELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
ELGSG FGTV G +K VA+K +K +D L+ REA+++ Q+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELL----REANVMQQLD 54
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
+P +V G+ + V E G L + L+ K++ + + + + G++Y
Sbjct: 55 NPYIVRMIGICE---AESWMLVMELAELGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKY 110
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTIP--WMA 799
L E N VH DL + N L+ + KI D GLSK + G P W A
Sbjct: 111 LEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
PE + K DV+SFGV+MWE + G++PY + E+ I G + P C
Sbjct: 167 PECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECPQRC 223
Query: 859 EPTWRSLMERCWSSDPKSRPAFSEITKELR 888
P LM+ CW+ RP F+ + LR
Sbjct: 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 85/276 (30%), Positives = 134/276 (48%), Gaps = 32/276 (11%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
DLEY+ ELG+G G V + G +A+K I+ E + + I RE +L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR----LEINEAIQKQIL---RELDIL 53
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDA 737
+ + P +V FYG + +++ EYM GSL ++L+ I R +I +A+
Sbjct: 54 HKCNSPYIVGFYGAFYNN--GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAV-- 109
Query: 738 AFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
G+ YLHEK I+H D+K N LVN R K+ D G+S +L V GT
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVSGQLVNSLAKTFV-GTSS 164
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-----EIIAGIIKGNLG 851
+MAPE + D V K D++S G+ + EL TG PY + E++ I+
Sbjct: 165 YMAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-P 221
Query: 852 PKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P++PS + ++ + C DP+ RP++ E+ +
Sbjct: 222 PRLPSGKFSPD-FQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 88/285 (30%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 628 KELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEED---RLIADFWREAHMLGQI-H 683
K LG G FG V + G D K KP A L++D + ++D E M+ I
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKD-KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 684 HPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK---------------DRTIDR 727
H N++ G T DGP L + EY G+L++ LR + + +
Sbjct: 77 HKNIINLLGACTQDGP---LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 728 RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTL 786
+ + A A G+EYL + +H DL + N LV + V KI D GL++ +
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDVHNIDY 189
Query: 787 ISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEII 842
G +P WMAPE LF D + T + DV+SFGV++WE+ T G PY + EE+
Sbjct: 190 YKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 843 AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ +G+ K P+ C +M CW + P RP F ++ ++L
Sbjct: 247 KLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 91/299 (30%), Positives = 136/299 (45%), Gaps = 46/299 (15%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
I S + +++ELG FG V+ G G+ VAIK +K AEG L E+
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREE----- 54
Query: 672 FWREAHMLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK--------- 721
F EA M ++ HPN+V GVVT + P L+ + Y + L + L +
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGST 111
Query: 722 --DRTIDRRKR----IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
D+T+ + I A G+E+L ++VH DL + N LV + KI D
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISD 167
Query: 776 LGLSK---IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
LGL + + G I WM+PE + D++S+GVV+WE+ + G +
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS--DIWSYGVVLWEVFSYGLQ 225
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTW-RSLMERCWSSDPKSRPAFSEITKELRA 889
PY ++++I I + P P C P W +LM CW+ P RP F +I LR
Sbjct: 226 PYCGYSNQDVIEMIRNRQVLP-CPDDC-PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 86/292 (29%), Positives = 134/292 (45%), Gaps = 37/292 (12%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
D+++ +G G FG V K + AIK +K E + E D DF E +
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-----EFASENDH--RDFAGELEV 55
Query: 679 LGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------------- 722
L ++ HHPN++ G + +A EY G+L LR+
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 723 RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782
T+ ++ + A D A G++YL EK +H DL + N LV + KI D GLS+ +
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADFGLSRGE 169
Query: 783 QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEI 841
+ + R + WMA E ++ T K DV+SFGV++WE+++ G PY + E+
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
Query: 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
+ +G K P C+ LM +CW P RP F++I+ +L M A
Sbjct: 228 YEKLPQGYRMEK-PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 85/290 (29%), Positives = 135/290 (46%), Gaps = 37/290 (12%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+D+++ +G G FG V + K D AIKR+K E + ++D DF E
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDH--RDFAGELE 59
Query: 678 MLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR---------------RK 721
+L ++ HHPN++ G LA EY +G+L LR
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
T+ ++ + A D A G++YL +K +H DL + N LV + V KI D GLS+
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRG 173
Query: 782 KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840
++ + R + WMA E ++ T DV+S+GV++WE+++ G PY + E
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ + +G K P C+ LM +CW P RP+F++I L M
Sbjct: 232 LYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 19/263 (7%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I+ +G G FG V + K V IK+I E +++RL A E +L +
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP----VEQMTKDERLAAQ--NECQVLKLL 56
Query: 683 HHPNVVAFY-GVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMDAAFG 740
HPN++ +Y + D L V EY G+L + ++++ ++ I+ +
Sbjct: 57 SHPNIIEYYENFLED---KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAP 800
+ ++H K I+H DLK+ N L++ + V KIGD G+SKI + V GT +++P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
EL + K +K D+++ G V++EL + + + + ++ I+ G P I P
Sbjct: 171 ELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSP 227
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
R L+ + DP RP S+I
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 19/268 (7%)
Query: 625 EYIKELGSGTFG--TVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
I+ LG G FG T++ S V K + S +E R + E +L +
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN---LTRLSEKERRDALN---EIVILSLL 56
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQ-VLRRKDRTIDRRKRIIIAMDAAFGI 741
HPN++A+Y D L EY G+L ++R+K + + + +
Sbjct: 57 QHPNIIAYYNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIPWMAP 800
Y+H+ I+H D+K+ N + + K+GD G+SKI + ++ V GT +M+P
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
EL + K D+++ G V++ELLT + + + ++ I++GN P + S
Sbjct: 171 ELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSS 227
Query: 861 TWRSLMERCWSSDPKSRPAFSEITKELR 888
SL+ DP+ RP E+ +
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-25
Identities = 39/93 (41%), Positives = 60/93 (64%), Gaps = 6/93 (6%)
Query: 22 ICSFNGAFHVQPSSNNLRYIGGETRIISVDRTISFPKLRLKISDICSSIPSFTLKYRLPL 81
+CS+ G +P LRY+GGETRI+SVDR+ISF +L K+S++ + TLKY+LP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 82 NPDRKQGDDTPLVLIASDDDVRCMVEEYDKLES 114
D L+ +++D+D++ M+EEYD+L
Sbjct: 61 E------DLDALISVSNDEDLKNMMEEYDRLSG 87
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 93/309 (30%), Positives = 136/309 (44%), Gaps = 65/309 (21%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD----------------VAIKRIKPSCFAEGSLEEDR 667
L ++LG G FG V + +G VA+K ++
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR----- 61
Query: 668 LIADFWREAHMLGQIHHPNVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRKD---- 722
DF +E ++ ++ +PN++ GV V+D P L +TEYM NG L Q L +++
Sbjct: 62 --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIEST 116
Query: 723 -------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
++ + +A+ A G++YL N VH DL + N LV KI D
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG----NHYTIKIAD 172
Query: 776 LGLSKIKQKTLISGGV-----RGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWEL- 826
G+S+ L SG R +P WMA E + K T DV++FGV +WE+
Sbjct: 173 FGMSR----NLYSGDYYRIQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTLWEMF 225
Query: 827 -LTGEEPYADLHSEEII--AGIIKGNLGPKI----PSWCEPTWRSLMERCWSSDPKSRPA 879
L E+PY+ L E++I G N G +I C LM RCWS D K RP
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 880 FSEITKELR 888
F++I LR
Sbjct: 286 FNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 73/270 (27%), Positives = 125/270 (46%), Gaps = 38/270 (14%)
Query: 630 LGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLGQIHH-- 684
+G G +G V+ GK G VA+K I +L+ D ++D RE +L Q+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII--------NLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 685 -PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
PN+ +YG GP L + EY GS++ +++ I + +I + ++Y
Sbjct: 61 PPNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKY 116
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG---DLGLSKIKQKTLISGGVRGTIPWMAP 800
+H+ ++H D+K+ N LV +C G L + K+ T + GT WMAP
Sbjct: 117 IHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFV-----GTPYWMAP 170
Query: 801 ELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP-- 855
E+ K D K D++S G+ ++E+ TG PY+D+ + + I K + P++
Sbjct: 171 EVITEGKYYD----TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDN 225
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ R + C +PK R + E+ K
Sbjct: 226 GY-SKLLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 84/292 (28%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 624 LEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L+ I+ LG G FG V + G VA+K +K C + + + +E +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEIN 58
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+L ++H N+V + G ++ L + EY+ GSL+ L + ++ + ++ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQI 116
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR--GTI 795
G+ YLH ++ +H DL + N L+ D R V KIGD GL+K + VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDRLV-KIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 796 P--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS--EEIIAGIIKG--N 849
P W A E K +N + DV+SFGV ++ELLT + EE+I G +G
Sbjct: 173 PVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMT 229
Query: 850 LGPKI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ I P C LM+ CW ++ K RP F + L+ M
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I ELG G FG V+ + K + + A K I+ +E + + DF E +L +
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--------IESEEELEDFMVEIDILSEC 59
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN+V Y L + E+ G+L ++ +R + + + +
Sbjct: 60 KHPNIVGLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALN 117
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS----KIKQK--TLISGGVRGTIP 796
+LH ++H DLK+ N L+ + K+ D G+S QK T I GT
Sbjct: 118 FLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI-----GTPY 168
Query: 797 WMAPELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
WMAPE+ KDN K D++S G+ + EL E P+ +L+ ++ I+K P
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPT 227
Query: 854 I--PSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ PS ++ ++ C DP RP +E+ K
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 84/282 (29%), Positives = 131/282 (46%), Gaps = 37/282 (13%)
Query: 630 LGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
+G G FG V + K D AIKR+K E + ++D DF E +L ++ HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDH--RDFAGELEVLCKLGHH 55
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRK 729
PN++ G LA EY +G+L LR+ T+ ++
Sbjct: 56 PNIINLLGACEHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG 789
+ A D A G++YL +K +H DL + N LV + V KI D GLS+ ++ +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 169
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
R + WMA E ++ T DV+S+GV++WE+++ G PY + E+ + +G
Sbjct: 170 MGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
K P C+ LM +CW P RP+F++I L M
Sbjct: 228 YRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 25/268 (9%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG G FG V+ Y G ++A+K+++ F S E + + E +L + H
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGI 741
+V +YG + D L+ E+M GS+K L+ + + R I+ G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GV 119
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG----GVRGTIPW 797
YLH IVH D+K N L RD V K+GD G SK Q +SG V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
M+PE+ + K D++S G + E+LT + P+A+ + I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITK 885
R ++R + + K RP+ E+ +
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 36/266 (13%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D E+IK LG+G+FG V + KGS A+K + + + + + + E +L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-----KAKIVKLKQVEHVLNEKRIL 55
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRK----RIIIA 734
I HP +V YG D +NL V EY+ G L LR+ R + ++++A
Sbjct: 56 QSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK---TLISGGV 791
+EYLH +IV+ DLK N L+ D + KI D G +K + TL
Sbjct: 114 ------LEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC---- 159
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT ++APE+ SK + VD ++ G++++E+L G P+ D + +I I++G +
Sbjct: 160 -GTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV- 215
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSR 877
+ PS+ P + L+ D R
Sbjct: 216 -RFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
++G GTFG V+ G +A+K I+ + + + IAD E +L + HP
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIAD---EMKVLELLKHP 59
Query: 686 NVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRK---DRTIDRR--KRIIIAMDAAF 739
N+V +YGV V V EY G+L+++L D + R +++
Sbjct: 60 NLVKYYGVEVHREKVY---IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE------ 110
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGV---RGT 794
G+ YLH IVH D+K N ++ V K+GD G + T + V GT
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 795 IPWMAPELFKSKDNLVTE--KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
+MAPE+ + D++S G V+ E+ TG+ P+++L +E I + P
Sbjct: 167 PAYMAPEVI-TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225
Query: 853 KIPSWCE--PTWRSLMERCWSSDPKSRPAFSEI 883
IP + P + ++RC SDPK RP SE+
Sbjct: 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLI-----------ADFWREAHM 678
LG GTF ++ G R++ G +E ++ F+ A +
Sbjct: 3 LGQGTFTNIYKGVL--------RVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASL 54
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ Q+ H ++V YGV V EY+ G L L R+ + ++ +A A
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI---MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLA 111
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQR---PVCKIGDLGLSKIKQKTLISGGVR-GT 794
+ YL +K +VH ++ N LV P K+ D G+ T++S R
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREERVER 167
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
IPW+APE ++ +T D +SFG + E+ + GEEP + L S E + P
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP- 226
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+P +L+ +CW+ DP RP+F I ++L
Sbjct: 227 MPDC--AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 28/257 (10%)
Query: 630 LGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG G FG V K K + A+K +K E +E + E +L + +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK 747
V Y D + + EY + G L +LR + + R IA EYLH +
Sbjct: 56 VKLYRTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR 112
Query: 748 NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLISGGVRGTIPWMAPEL 802
I++ DLK N L++ K+ D G +K K T GT ++APE+
Sbjct: 113 GIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEI 163
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA--DLHSEEIIAGIIKGNLGPKIPSWCEP 860
+K VD +S G++++ELLTG P+ D EI I+KGN + P++ +
Sbjct: 164 ILNKGY--DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
Query: 861 TWRSLMERCWSSDPKSR 877
+ L+++ +P+ R
Sbjct: 222 AAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 28/272 (10%)
Query: 628 KELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
++LG+G F + + + G+ +A+K++ S E++ ++ +E ++ +++HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVT-YVRNTSS-EQEEVVEALRKEIRLMARLNHP 63
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGI 741
+++ G + NL E+M GS+ +L + K+ I ++ G+
Sbjct: 64 HIIRMLGATCEDSHFNL--FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-----GL 116
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-----SKIKQKTLISGGVRGTIP 796
YLHE I+H D+K N L+ D +I D G +K G + GTI
Sbjct: 117 SYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY-ADLHSE--EIIAGIIKGNLGPK 853
+MAPE+ + + DV+S G V+ E+ T + P+ A+ HS +I I P
Sbjct: 174 FMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
IP P R + RC P+ RP E+ K
Sbjct: 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/249 (28%), Positives = 117/249 (46%), Gaps = 21/249 (8%)
Query: 641 GKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD--GP 698
G + +V I+ K F +G LI E L +I N++ YG + D
Sbjct: 39 GIFNNKEVIIRTFK--KFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSH 757
+ L+ + EY G L++VL K++ + + ++ +A+D G+ L++ N + +L S
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA---PELFKSKDNLVTEKV 814
+FLV + KI GL KI +S + +M ++ + T K
Sbjct: 153 SFLVT----ENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 815 DVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDP 874
D+YS GVV+WE+ TG+ P+ +L ++EI II N K+P C + ++E C S D
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263
Query: 875 KSRPAFSEI 883
RP EI
Sbjct: 264 IKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 82/266 (30%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG G FG V+ Y G ++A K+++ F S E + ++ E +L + H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGI 741
+V +YG + D L EYM GS+K L+ + + R I+ G+
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GM 119
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG-GVR---GTIPW 797
YLH IVH D+K N L RD V K+GD G SK Q +SG G+R GT W
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
M+PE+ + K DV+S G + E+LT + P+A+ + I I P++PS
Sbjct: 176 MSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEI 883
R + C + + RP+ E+
Sbjct: 234 ISEHARDFL-GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 74/275 (26%), Positives = 136/275 (49%), Gaps = 39/275 (14%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD---VAIKRIKPSCFA----EGSLEEDRLIADFWRE 675
D + +K+LG G++G+V+ K + SD A+K + + E ++ E R++A
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILA----- 54
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII--- 732
++HPN++++ DG L V EY G L + + ++ + +++I
Sbjct: 55 -----SVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKK----RKLIPEQ 103
Query: 733 ----IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS 788
I + G++ LHE+ I+H DLKS N L+ D + KIGDLG+SK+ +K +
Sbjct: 104 EIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAK 159
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
+ GT +MAPE++K + + K D++S G +++E+ T P+ +++ + +G
Sbjct: 160 TQI-GTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG 216
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P IP ++ + PK RP +I
Sbjct: 217 KY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 79/248 (31%), Positives = 114/248 (45%), Gaps = 49/248 (19%)
Query: 671 DFWREAHMLGQIHHPNVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRKD------- 722
DF +E +L ++ PN++ GV V + P L +TEYM NG L Q L
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 723 -----------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771
I + +A+ A G++YL N VH DL + N LV +
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG----ENLTI 177
Query: 772 KIGDLGLSKIKQKTLISGGV-----RGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVM 823
KI D G+S+ L +G R +P WMA E + K T DV++FGV +
Sbjct: 178 KIADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGK---FTTASDVWAFGVTL 230
Query: 824 WELLT--GEEPYADLHSEEII--AGIIKGNLGPKI----PSWCEPTWRSLMERCWSSDPK 875
WE+L E+PY +L E++I AG + G ++ P C LM +CWS D +
Sbjct: 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290
Query: 876 SRPAFSEI 883
RP+FS+I
Sbjct: 291 ERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 43/281 (15%)
Query: 628 KELGSGTFGTVFYGK----WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
E+G+G FG V G+ + V +K ++ A + +E L F +E +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR----ASATPDEQLL---FLQEVQPYRELN 53
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRTIDRRKRIIIAM--DAAF 739
HPNV+ G + V E+ G LK LR R +K ++ M + A
Sbjct: 54 HPNVLQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD--LGLSKIKQKTLISGGVRGT-IP 796
G+ +LH+ + +H DL N + KIGD L L + + I+ +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 797 WMAPELFKSK-DNL----VTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII---- 846
W+APEL + + +L T+K +++S GV MWEL T ++PY DL E+++ ++
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227
Query: 847 ----KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
K L K W +M+ CW DP++RP E+
Sbjct: 228 IKLPKPQLDLKYSD----RWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 25/268 (9%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG G FG V+ Y G ++A+K++ F S E + + E +L + H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGI 741
+V +YG + D L+ EYM GS+K L+ + R R I+ G+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GV 119
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG----GVRGTIPW 797
YLH IVH D+K N L RD V K+GD G SK Q +SG V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
M+PE+ + K DV+S + E+LT + P+A+ + I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITK 885
R +++ + + K RP + +
Sbjct: 234 VSDACRDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 78/268 (29%), Positives = 127/268 (47%), Gaps = 33/268 (12%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEE-DRLIADFWREAHMLGQIH 683
++ +G G+FG V+ G + VAIK I LEE + I D +E +L Q
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKII--------DLEEAEDEIEDIQQEITVLSQCD 60
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
P + +YG G T L + EY+ GS +L K ++ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------SKIKQKTLISGGVRGTIPW 797
LH + +H D+K+ N L++ ++ K+ D G+ ++IK+ T + GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
MAPE+ K + K D++S G+ EL GE P +DLH ++ +I N P +
Sbjct: 168 MAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQ 224
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITK 885
++ +E C + DP+ RP E+ K
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E I ++G GT+G V+ + K + VA+K+I+ EG ++ RE +
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----------REIKL 51
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR--TIDRRKRIIIAMD 736
L ++ HPN+V +VT ++ V EYM + L +L + T + K + +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL- 109
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL----SKIKQKTLISGGVR 792
G++YLH I+H D+K N L+N V K+ D GL +K + +
Sbjct: 110 -LEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 793 GTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
T+ + PE L + +VD++S G ++ EL G+
Sbjct: 164 -TLWYRPPELLLGATR--YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 33/268 (12%)
Query: 627 IKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEE-DRLIADFWREAHMLGQIH 683
++ +G G+FG VF G VAIK I LEE + I D +E +L Q
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKII--------DLEEAEDEIEDIQQEITVLSQCD 60
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
P V +YG G T L + EY+ GS +LR D + + + G++Y
Sbjct: 61 SPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDY 116
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------SKIKQKTLISGGVRGTIPW 797
LH + +H D+K+ N L++ ++ K+ D G+ ++IK+ T + GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
MAPE+ + + K D++S G+ EL GE P +D+H ++ I K N P +
Sbjct: 168 MAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGE 224
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITK 885
++ ++ C + DP RP E+ K
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
+ G +G VF K K G AIK I + D+++ E +L Q P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLT----ERDILSQAQSPYV 55
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK 747
V Y NL V EY+ G L +L + RI IA + +EYLH
Sbjct: 56 VKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSN 112
Query: 748 NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISGGVR-----GTIPWM 798
I+H DLK N L++ K+ D GLSK+ +Q L GT ++
Sbjct: 113 GIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
APE+ + + ++ VD +S G +++E L G P+ EEI I+ G + P
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW--PEDV 224
Query: 859 EPT--WRSLMERCWSSDPKSRPAFSEI 883
E + L+ + DP+ R I
Sbjct: 225 EVSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 33/270 (12%)
Query: 630 LGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG GT+G V+ + + V AIK I + R + E + + H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP--------ERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK-------DRTIDRRKRIIIAMDAAFG 740
V + G ++ E + GSL +LR K ++TI + I+ G
Sbjct: 68 VQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-----G 120
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMA 799
++YLH+ IVH D+K N LVN V KI D G SK + + GT+ +MA
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL---HSEEIIAGIIKGNLGPKIPS 856
PE+ D++S G + E+ TG+ P+ +L + G+ K + P+IP
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH--PEIPE 235
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
++ + RC+ DP R + ++ ++
Sbjct: 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 42/285 (14%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKP-SCFAEGSLEEDRLIADFWREAH 677
T E ++ +G GT+G V+ + K G VAIK + E EE ++ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY----- 59
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLAT----VTEYMVNGS---LKQVLRRKDRTIDRRKR 730
+HPN+ FYG V E GS L + LR+K + + ++
Sbjct: 60 ----SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL--KEE 113
Query: 731 II--IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS 788
I I + G+ YLHE ++H D+K N L+ + K+ D G+S TL
Sbjct: 114 WIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAEVKLVDFGVSAQLDSTL-- 167
Query: 789 GGVR----GTIPWMAPELFKSKDNL---VTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
G R GT WMAPE+ + + DV+S G+ EL G+ P D+H
Sbjct: 168 -GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
Query: 842 IAGIIKGNLGPKIPS---WCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ I + N P + S W + + + C + + RP E+
Sbjct: 227 LFKIPR-NPPPTLKSPENWSK-KFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 66/265 (24%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E IK++G G+FG ++ K K IK I + E + +E +L ++
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII-AMDAAFGI 741
HPN+V F+ + L V EY G L + + R+ + +I+ + + G+
Sbjct: 57 KHPNIVTFFASFQEN--GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL-ISGGVRGTIPWMAP 800
+++H++ I+H D+KS N ++ V K+GD G+++ ++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E+ +++ K D++S G V++EL T + P+ + +++ I +G P P++
Sbjct: 172 EICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD 229
Query: 861 TWRSLMERCWSSDPKSRPAFSEITK 885
RSL+ + + P+ RP+ + I K
Sbjct: 230 L-RSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 6e-21
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 41/221 (18%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E +++LG GT+G V+ K G VA+K+I+ EG +L RE +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----------REISL 51
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRI---II 733
L ++ HPN+V V+ L V EY + LK+ L ++ + K I ++
Sbjct: 52 LKELKHPNIVKLLDVIHT--ERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGG 790
G+ Y H I+H DLK N L+N V K+ D GL++ I +T
Sbjct: 109 R-----GLAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 791 VRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
V T+ + APE L SK + VD++S G + E++TG+
Sbjct: 160 V--TLWYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 62/303 (20%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLI-----ADFWR 674
D ++ K +G G+F TV K K ++ AIK L++ +LI
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKI----------LDKRQLIKEKKVKYVKI 50
Query: 675 EAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
E +L ++ HP ++ Y D NL V EY NG L Q +R+ ++ R
Sbjct: 51 EKEVLTRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYA 108
Query: 734 A--MDAAFGIEYLHEKNIVHFDLKSHNFLV--NMRDPQRPVCKIGDLGLSKIKQKTLISG 789
A + A +EYLH K I+H DLK N L+ +M KI D G +K+
Sbjct: 109 AEILLA---LEYLHSKGIIHRDLKPENILLDKDMH------IKITDFGTAKVLDPNSSPE 159
Query: 790 GVR---------------------GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
+ GT +++PEL K + D+++ G +++++LT
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLT 217
Query: 829 GEEPYADLHSEEIIAGIIKGNL--GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
G+ P+ + I+K P P P + L+E+ DP+ R +E E
Sbjct: 218 GKPPFRGSNEYLTFQKILKLEYSFPPNFP----PDAKDLIEKLLVLDPQDRLGVNEGYDE 273
Query: 887 LRA 889
L+A
Sbjct: 274 LKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 73/270 (27%), Positives = 132/270 (48%), Gaps = 28/270 (10%)
Query: 626 YIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+++ +G G++G V + + G IK++ + +R A+ +EA +L Q+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN----LRNASRRERKAAE--QEAQLLSQLK 57
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR-RKDRTIDRRKRIIIAMDAAFGIE 742
HPN+VA Y +G L V + G L L+ +K + + + + + A ++
Sbjct: 58 HPNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK------TLISGGVRGTIP 796
YLHEK+I+H DLK+ N + + + K+GDLG++++ + TLI GT
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLI-----GTPY 167
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856
+M+PELF +K K DV++ G ++E+ T + + ++ II+G L P +P
Sbjct: 168 YMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPK 224
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
P L+ S P+ RP+ I ++
Sbjct: 225 DYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 603 RSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAE 660
++A FT + + K SD E + LG+G+FG V K KG+ AIK C +
Sbjct: 2 KAAYMFTKP---DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-----CLKK 53
Query: 661 GSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR 720
+ + + + +E +L ++ HP +V D + + E++V G L LR+
Sbjct: 54 REILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRK 111
Query: 721 KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
R + + A + EYLH K+I++ DLK N L+ D + V K+ D G +K
Sbjct: 112 AGRFPNDVAKFYHA-ELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFAK 166
Query: 781 -IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE 839
+ +T + GT ++APE+ +SK + + VD ++ GV+++E + G P+ D
Sbjct: 167 KVPDRTFT---LCGTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221
Query: 840 EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
I I+ G L K P+W + R L++ +D R
Sbjct: 222 RIYEKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 627 IKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
++++G G+FG VF KG D +++ + ED I D +E +L Q P
Sbjct: 9 LEKIGKGSFGEVF----KGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
V +YG T L + EY+ GS +L + +D + I + G++YLH
Sbjct: 64 VTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS 119
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFKS 805
+ +H D+K+ N L++ + K+ D G++ ++ + GT WMAPE+ K
Sbjct: 120 EKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 806 KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSL 865
+ K D++S G+ EL GE P+++LH +++ I K N ++ +P +
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL-KEF 232
Query: 866 MERCWSSDPKSRPAFSEITK 885
+E C + +P RP E+ K
Sbjct: 233 VEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 91/336 (27%), Positives = 133/336 (39%), Gaps = 93/336 (27%)
Query: 628 KELGSGTFGTVF----YGKWKGSD---VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
K LG G FG V +G K S VA+K +K A E L++ E +L
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS---EHKALMS----ELKILI 65
Query: 681 QI-HHPNVVAFYGVVT--DGPVTNLATVTEYMVNGSLKQVLRRK--------DRT----- 724
I +H NVV G T +GP L + E+ G+L LR K +++
Sbjct: 66 HIGNHLNVVNLLGACTKPNGP---LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122
Query: 725 ----------IDRRKR--------------------------------------IIIAMD 736
+DRR I +
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRG 793
A G+E+L + +H DL + N L++ + V KI D GL++ K + G R
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 794 TIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851
+ WMAPE +F D + T + DV+SFGV++WE+ + G PY + E +K
Sbjct: 239 PLKWMAPESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ P P +M CW DPK RP FS + + L
Sbjct: 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 29/277 (10%)
Query: 628 KELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K++G G F V+ G VA+K+++ + +D L +E +L Q+ HP
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-----KEIDLLKQLDHP 62
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIIIAMDAAFGIE 742
NV+ + + L V E G L +++ +++ R I R + +E
Sbjct: 63 NVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIPWMAPE 801
++H K I+H D+K N + V K+GDLGL + KT + + GT +M+PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY----ADLHSEEIIAGIIKGNLGPKIPS- 856
+N K D++S G +++E+ + P+ +L+S + I K + P +P+
Sbjct: 177 RI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LCKKIEKCDYPP-LPAD 231
Query: 857 -WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ E R L+ RC + DP+ RP S + + + M A
Sbjct: 232 HYSEEL-RDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ + ++G GT+G V+ + K G VAIK+IK +EG + RE +L ++
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG--IPKTAL----REIKLLKEL 55
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
+HPN++ V +L V E+M + L ++++ + R + G+
Sbjct: 56 NHPNIIKLLDVFRHK--GDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR------GTIP 796
+ H I+H DLK N L+N V K+ D GL++ VR T
Sbjct: 113 FCHSHGILHRDLKPENLLINTEG----VLKLADFGLAR-----SFGSPVRPYTHYVVTRW 163
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ APEL D + VD++S G + ELL+
Sbjct: 164 YRAPELLLG-DKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 79/274 (28%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I+ +G GT+G VF K GS A+K + P + +E E ++L +
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---------EYNILKAL 71
Query: 683 H-HPNVVAFYGVVTDGPVTN---LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM--- 735
HPNVV FYG+ V N L V E GS+ +++ + +R + IIA
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGT 794
+A G+++LH +H D+K +N L+ K+ D G+S ++ L GT
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 795 IPWMAPELFKSKDNLVT---EKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
WMAPE+ + L + + DV+S G+ EL G+ P ADLH + I + N
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR-NPP 246
Query: 852 PKI--PSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P + P + + +C + D + RP S++
Sbjct: 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 22/256 (8%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWRE-AHMLGQIH 683
+K + G FG+V+ K + G AIK +K S + + + E A M+ Q
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS-----DMIAKNQVTNVKAERAIMMIQGE 55
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
P V Y L V EY+ G +++ + + IA + G+E
Sbjct: 56 SPYVAKLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVED 112
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELF 803
LH++ I+H D+K N L++ Q K+ D GLS+ L + GT ++APE
Sbjct: 113 LHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETI 165
Query: 804 KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-PK-IPSWCEPT 861
+ + D +S G V++E L G P+ + + I+ + P+ + +C P
Sbjct: 166 LGVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 862 WRSLMERCWSSDPKSR 877
L+ R DP R
Sbjct: 224 AVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFW-REAHMLGQIHHPN 686
+G G G VF K + + VA+K++ A LE I + RE L HP
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-----ALRRLEGG--IPNQALREIKALQACQHPY 60
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAAFGIEYL 744
VV V G + V EYM L +VLR ++R + K + + G+ Y+
Sbjct: 61 VVKLLDVFPHG--SGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK--GVAYM 115
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR------GTIPWM 798
H I+H DLK N L++ V KI D GL+++ R T +
Sbjct: 116 HANGIMHRDLKPANLLISADG----VLKIADFGLARL----FSEEEPRLYSHQVATRWYR 167
Query: 799 APE-LFKSKDNLVTEKVDVYSFGVVMWELLTG 829
APE L+ ++ VD+++ G + ELL G
Sbjct: 168 APELLYGARK--YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 628 KELGSGTFGTVFYGK----WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
KE+G+G FG V G+ + + V +K ++ S S++E F EA +
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS----ASVQEQM---KFLEEAQPYRSLQ 53
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRTIDRRKRII--IAMDAAF 739
H N++ G T+ VT V E+ G LK LR RK + + +A + A
Sbjct: 54 HSNLLQCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIP 796
G+ +LH+ N +H DL N L+ KIGD GLS K K + + +
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 797 WMAPELFKS-KDNLV----TEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
W+APEL NL+ T++ +V+S GV +WEL G +PY L E+++ ++
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 851 ----GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P++ W +M+ CW P+ RP+ E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 59/236 (25%)
Query: 625 EYIKELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
E +G GT+G V+ K K G + AIK+ K + + RE +L
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLR 57
Query: 681 QIHHPNVVA-----------------------FYGVVTDGPVTNLATVTEYMVNGSLKQV 717
++ H NVV+ + ++ ++ MV L Q+
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 718 LRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
L G+ YLH ++H DLK N LV P+R V KIGDLG
Sbjct: 118 LN--------------------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157
Query: 778 LSKIKQ---KTLISG-GVRGTIPWMAPEL-FKSKDNLVTEKVDVYSFGVVMWELLT 828
L+++ K L V TI + APEL ++ T+ +D+++ G + ELLT
Sbjct: 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LI 787
I + A G+E+L + +H DL + N L++ + V KI D GL++ K +
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVR 237
Query: 788 SGGVRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
G R + WMAPE +F D + T + DV+SFGV++WE+ + G PY + +E
Sbjct: 238 KGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+K + P + P M CW +P RP FSE+ + L
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 31/271 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I ELG G FG V+ + K + V A K I +E LE D+ E +L
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELE------DYMVEIDILASC 59
Query: 683 HHPNVV----AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
HPN+V AFY NL + E+ G++ V+ +R + + ++
Sbjct: 60 DHPNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI-SGGVRGTIPW 797
+ YLHE I+H DLK+ N L + K+ D G+S +T+ GT W
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 798 MAPELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
MAPE+ SKD K DV+S G+ + E+ E P+ +L+ ++ I K P +
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL 228
Query: 855 --PSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
PS ++ +++C + +R +++
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 20/271 (7%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
DLE I+ELG G +G V + + +A+KRI+ + S E+ RL+ D + M
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL--DISMR- 55
Query: 681 QIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ P V FYG + +G V V + ++ K+V K TI IA+
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYD-KGLTIPEDILGKIAVSIVK 114
Query: 740 GIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
+EYLH K +++H D+K N L+N K+ D G+S ++ G P+M
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQ----VKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 799 APELFKSKDNLVTEKV--DVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKIP 855
APE + N V DV+S G+ M EL TG PY + + + +++ P++P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SPQLP 229
Query: 856 S-WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ P ++ + +C + K RP + E+ +
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 29/289 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
++ DLE I +LG+G G+V K K K + I RE +
Sbjct: 2 LRNEDLETISDLGAGNGGSV--SKVKHIPTGTVMAKKVVHIGAKSSVRKQIL---RELQI 56
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDA 737
+ + P +V+FYG + N+ E+M GSL ++ ++ ++ +I +A+
Sbjct: 57 MHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-- 112
Query: 738 AFGIEYLHEKN-IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
G+ YL+ + I+H D+K N LVN R K+ D G+S ++ V GT
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ----IKLCDFGVSGELINSIADTFV-GTST 167
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA----DLHSEEIIAGI------I 846
+M+PE + V K DV+S G+ + EL G+ P+A D ++ GI I
Sbjct: 168 YMSPERIQGGKYTV--KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 847 KGNLGPKIPSWCEPT-WRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
P++PS P R ++ C DP RP ++ + A
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 36/278 (12%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E ++ +G G+FGTV + K G + K I E E+ +L++ E ++L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EKQQLVS----EVNILR 54
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT---IDRRKRIIIAMDA 737
++ HPN+V +Y + D L V EY G L Q++++ + I+ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 738 AFGIEYLH-----EKNIVHFDLKSHN-FLVNMRDPQRPVCKIGDLGLSKIKQ------KT 785
+ H ++H DLK N FL K+GD GL+KI KT
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDA-----NNNVKLGDFGLAKILGHDSSFAKT 169
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
+ GT +M+PE EK D++S G +++EL P+ + ++ + I
Sbjct: 170 YV-----GTPYYMSPEQL--NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+G +IP +++ + DP RP+ E+
Sbjct: 223 KEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 28/275 (10%)
Query: 625 EYIKELGSGTFGTVFYGKWK---GSDVAIKRI---KPSCFAEGSLEEDRLIADFWREAHM 678
++ LGSG FG V+ + K + +A+K I P+ F + E D+ I D E +
Sbjct: 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPA-FGKDKRERDKSIGDIVSEVTI 61
Query: 679 LG-QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQ---VLRRKDRTIDRRKRIIIA 734
+ Q+ HPN+V +Y + L V + + L + L+ K + + I
Sbjct: 62 IKEQLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 735 MDAAFGIEYLH-EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
+ + YLH EK IVH DL +N ++ D I D GL+K KQ V G
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVG 175
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
TI + PE+ K++ EK DV++FG +++++ T + P+ + + I++ P
Sbjct: 176 TILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232
Query: 854 IPSWCEPTW----RSLMERCWSSDPKSRPAFSEIT 884
+P E + ++ C + D ++RP +++
Sbjct: 233 LP---EGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 6e-19
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGT 794
A G+E+L + +H DL + N L++ + V KI D GL++ K + G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ WMAPE +F D + T + DV+SFGV++WE+ + G PY + +E +K
Sbjct: 239 LKWMAPESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
+ P + P S+M CW ++P+ RP FSE+ + L
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 8e-19
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 42/220 (19%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E K+LG GT+ V+ + K + VAIK+IK E +D + RE +L ++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQEL 59
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA---AF 739
HPN++ V N+ V E+M L++V++ K I+ A ++
Sbjct: 60 KHPNIIGLLDVFGHKS--NINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSY 107
Query: 740 ------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
G+EYLH I+H DLK +N L+ V K+ D GL++ S +
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARS----FGSPNRKM 159
Query: 794 T----IPWM-APEL-FKSKDNLVTEKVDVYSFGVVMWELL 827
T W APEL F ++ VD++S G + ELL
Sbjct: 160 THQVVTRWYRAPELLFGAR--HYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I ELG G FG V+ K K G+ A K I E EE+ + D+ E +L
Sbjct: 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEE--LEDYMVEIEILATC 66
Query: 683 HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
+HP +V G DG L + E+ G++ ++ DR + + +I +
Sbjct: 67 NHPYIVKLLGAFYWDG---KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS-GGVRGTIPWMAP 800
+YLH I+H DLK+ N L+ + K+ D G+S KTL GT WMAP
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 801 ELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPS 856
E+ KD K D++S G+ + E+ E P+ +L+ ++ I K PS
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEI 883
+R ++ P++RP+ +++
Sbjct: 240 KWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 628 KELGSGTFGTVFYGKWKGSD----------VAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ LG G+FGTV+ K K + + + + P+ + + E A
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-----------AQ 54
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLK---QVLRRKDRTIDRRKRIIIA 734
+L ++ HP +V F+ + +TEY L + L+ +T+ +
Sbjct: 55 LLSKLDHPAIVKFHASFLER--DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHN-FLVNMRDPQRPVCKIGDLGLSKIKQKTL-ISGGVR 792
+ G+ Y+H++ I+H DLK+ N FL N + KIGD G+S++ + ++
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFLKN------NLLKIGDFGVSRLLMGSCDLATTFT 166
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT +M+PE K + K D++S G +++E+ + + ++ I++G P
Sbjct: 167 GTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-P 223
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+P S+M+ + DP RP+ +EI +
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 49/223 (21%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEE-DRLIADFWREAHMLGQI- 682
IK+LG GTFG+V+ + K G VAIK++K F S EE L RE L ++
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY--SWEECMNL-----REVKSLRKLN 55
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR---TIDRRKRII--IAMDA 737
HPN+V V + L V EYM G+L Q+++ + + + II I
Sbjct: 56 EHPNIVKLKEVFREN--DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ-- 110
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP- 796
G+ ++H+ H DLK N LV+ + V KI D GL++ +R P
Sbjct: 111 --GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR---------EIRSRPPY 155
Query: 797 -------WM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W APE L +S + VD+++ G +M EL T
Sbjct: 156 TDYVSTRWYRAPEILLRSTS--YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 630 LGSGTFGTVF---------YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
LG GTF +F YG+ ++V +K + S F+ A M+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
Q+ H ++V YGV G + + V EY+ GSL L++ I+ ++ +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQR-----PVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ +L +K + H ++ + N L+ +R+ R P K+ D G+S I + I
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGISITVLPKEI---LLERI 168
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG-EEPYADLHSEEIIAGIIKGNLGPKI 854
PW+ PE ++ NL D +SFG +WE+ +G ++P + L S++ + +
Sbjct: 169 PWVPPECIENPQNLSLA-ADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA 226
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P W E +L+ +C +P RP+F I ++L
Sbjct: 227 PKWTELA--NLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 601 SSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF 658
SS S++ + + + S+LE + +GSG GTV+ + + A+K I +
Sbjct: 53 SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-- 110
Query: 659 AEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL 718
ED + RE +L ++HPNVV + + + + E+M GSL+
Sbjct: 111 -----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTH 163
Query: 719 RRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778
++ + R I++ GI YLH ++IVH D+K N L+N + V KI D G+
Sbjct: 164 IADEQFLADVARQILS-----GIAYLHRRHIVHRDIKPSNLLINSA---KNV-KIADFGV 214
Query: 779 SKIKQKTL--ISGGVRGTIPWMAPELFKSKDN---LVTEKVDVYSFGVVMWELLTGEEPY 833
S+I +T+ + V GTI +M+PE + N D++S GV + E G P+
Sbjct: 215 SRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
Query: 834 A-----DLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA 879
D S ++ I P+ P+ +R + C +P R +
Sbjct: 274 GVGRQGDWAS--LMCAICMSQ-PPEAPATASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 33/271 (12%)
Query: 623 DLEYIKELGSGTFGTVFY-----GKWKGSDVAIKRIKPSCFAEGS-----LEEDRLIADF 672
+ E +K LG+G +G VF G G A+K +K + + + +R + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
R++ L +H Y TD T L + +Y+ G L L +++R ++ +I
Sbjct: 61 IRQSPFLVTLH-------YAFQTD---TKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGG 790
+ +E+LH+ I++ D+K N L+ D V + D GLSK + + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY---ADLHSE-EIIAGII 846
GTI +MAP++ + D + VD +S GV+M+ELLTG P+ + +S+ EI I+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
Query: 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
K P P + +++R DPK R
Sbjct: 226 KSE--PPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 8e-18
Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 24/263 (9%)
Query: 628 KELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+++G G GTVF G +VAIK+I +L++ E ++ ++ +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQI--------NLQKQPKKELIINEILVMKELKNP 76
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
N+V F G L V EY+ GSL V+ + +D + + + +E+LH
Sbjct: 77 NIVNFLDSFLVG--DELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH 132
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKIKQKTLISGGVRGTIPWMAPELFK 804
++H D+KS N L+ M K+ D G ++I + + GT WMAPE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSWCEPTW 862
K KVD++S G++ E++ GE PY + + + +I N P++ P P +
Sbjct: 189 RK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSPIF 245
Query: 863 RSLMERCWSSDPKSRPAFSEITK 885
R + RC D + R + E+ +
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 70/268 (26%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIK-PSCFAEGSLEEDRLIADFWREAHML 679
++ +G G+FG + SD A+K I+ P + ++E+ R +EA +L
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSR------KEAVLL 52
Query: 680 GQIHHPNVVAFY-GVVTDGPVTNLATVTEYMVNGSLKQVLR-RKDRTIDRRKRIIIAMDA 737
++ HPN+VAF DG +L V EY G L Q ++ ++ + + +
Sbjct: 53 AKMKHPNIVAFKESFEADG---HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIP 796
G++++HEK ++H D+KS N + Q K+GD G +++ + GT
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTSPGAYACTYVGTPY 165
Query: 797 WMAPELFKSKDNL-VTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++ PE++ +N+ K D++S G +++EL T + P+ + +I + +G+ P +P
Sbjct: 166 YVPPEIW---ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LP 221
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEI 883
S RSL+++ + +P+SRP+ + I
Sbjct: 222 SHYSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWREAHMLG 680
K LG G+FG VF + KG++ AIK +K E ++ E R+++ W
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------- 53
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
HP + Y T NL V EY+ G L ++ + D + A + G
Sbjct: 54 --EHPFLTHLY--CTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICG 108
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTI 795
+++LH K IV+ DLK N L++ KI D G+ K + G + GT
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKEN----MLGDAKTCTFCGTP 160
Query: 796 PWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
++APE L K N VD +SFGV+++E+L G+ P+ EE+ I N P
Sbjct: 161 DYIAPEILLGQKYN---TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCY 215
Query: 855 PSWCEPTWRSLMERCWSSDPKSR 877
P W + ++ + + +P+ R
Sbjct: 216 PRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 67/270 (24%), Positives = 135/270 (50%), Gaps = 31/270 (11%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+K++G G+FG K K G IK I S + EE R +E +L + H
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNMKH 58
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSL-------KQVLRRKDRTIDRRKRIIIAMDA 737
PN+V + + NL V +Y G L + VL +D+ +D +I +A+
Sbjct: 59 PNIVQYQESFEEN--GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL-- 114
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL-ISGGVRGTIP 796
+++H++ I+H D+KS N + +D K+GD G++++ T+ ++ GT
Sbjct: 115 ----KHVHDRKILHRDIKSQNIFL-TKDG---TIKLGDFGIARVLNSTVELARTCIGTPY 166
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856
+++PE+ +++ K D+++ G V++E+ T + + + + ++ II+G+ P + S
Sbjct: 167 YLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSS 223
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
R+L+ + + +P+ RP+ + I ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEG----SLEEDRLIADFWREAH 677
L I+E GT+G V+ + K + VA+K++K EG SL RE +
Sbjct: 10 LNRIEE---GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL----------REIN 56
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR--TIDRRKRIIIAM 735
+L ++ HPN+V VV + + V EY+ + LK ++ + K +++ +
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL 115
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-----SKIKQKTLISGG 790
+ G+ +LH+ I+H DLK+ N L+N R + KI D GL S +K T +
Sbjct: 116 LS--GVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLV-- 167
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
V T+ + APEL + +D++S G + ELLT +
Sbjct: 168 V--TLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 70/273 (25%), Positives = 128/273 (46%), Gaps = 21/273 (7%)
Query: 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K++G G F V+ G VA+K+++ F L + + AD +E +L Q++HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQ--IF---DLMDAKARADCIKEIDLLKQLNHP 62
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR---RKDRTIDRRKRIIIAMDAAFGIE 742
NV+ +Y + N+ V E G L ++++ ++ R I + + +E
Sbjct: 63 NVIKYYASFIEDNELNI--VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMAPE 801
++H + ++H D+K N + V K+GDLGL + KT + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLHSEEIIAGIIKGNLGPKIPS-WCE 859
+ +N K D++S G +++E+ + P Y D + + I+ P +PS
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 860 PTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
R L+ C + DP+ RP + + + M A
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 31/279 (11%)
Query: 621 TSDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
T E I+ +G GT+G V+ K GS A+K + P + +E + I
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP---- 76
Query: 679 LGQIHHPNVVAFYGVV--TDGPVT-NLATVTEYMVNGS----LKQVLRRKDRTIDRRKRI 731
+HPNVV FYG+ D V L V E GS +K +L R +D
Sbjct: 77 ----NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMIS 131
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGG 790
I A G+++LH I+H D+K +N L+ K+ D G+S ++ L
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNT 187
Query: 791 VRGTIPWMAPELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847
GT WMAPE+ + D + DV+S G+ EL G+ P D+H + + I +
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247
Query: 848 GNLGPKI---PSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
N P + WC ++ + +C D ++RP+ + +
Sbjct: 248 -NPPPTLLHPEKWCR-SFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 76/275 (27%), Positives = 118/275 (42%), Gaps = 41/275 (14%)
Query: 623 DLEYIKELGSGTFGTVFY-----GKWKGSDVAIKRIKPSCF------AEGSLEEDRLIAD 671
+ E ++ LG+G +G VF G G A+K +K + AE + E R + +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE-RQVLE 59
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
R L V Y TD T L + +Y+ G L L +++ + R+
Sbjct: 60 AVRRCPFL-------VTLHYAFQTD---TKLHLILDYVNGGELFTHLYQREHFTESEVRV 109
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
IA + +++LH+ I++ D+K N L+ D + V + D GLSK L
Sbjct: 110 YIA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKE---FLAEEEE 161
Query: 792 R-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY----ADLHSEEII 842
R GTI +MAPE+ + + VD +S GV+ +ELLTG P+ EI
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
Query: 843 AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
I+K P P R +++ DPK R
Sbjct: 222 RRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 38/274 (13%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
S L+ ++G G+ G V K G VA+K++ L + + + E ++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--------DLRKQQRRELLFNEVVIM 70
Query: 680 GQIHHPNVVAFYG--VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
HPN+V Y +V D L V E++ G+L ++ ++ + +A+
Sbjct: 71 RDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLK 126
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG----LSK--IKQKTLISGGV 791
A + +LH + ++H D+KS + L+ D + K+ D G +SK ++K+L+
Sbjct: 127 A--LSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLV---- 176
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT WMAPE+ S+ TE VD++S G+++ E++ GE PY + + + I+ NL
Sbjct: 177 -GTPYWMAPEVI-SRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLP 232
Query: 852 PKI--PSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
PK+ P RS ++R DP R +E+
Sbjct: 233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 75/262 (28%), Positives = 132/262 (50%), Gaps = 33/262 (12%)
Query: 627 IKELGSGTFGTVFY-GKWKGSDV----AIKRIKPSCFAEGSLE-EDRLIADFWREAHMLG 680
+K LG G+FG VF K G D A+K +K + +L+ DR+ R+ +L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-----KATLKVRDRVRTKMERD--ILA 53
Query: 681 QIHHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+++HP +V Y T+G L + +++ G L L ++ + + +A + A
Sbjct: 54 EVNHPFIVKLHYAFQTEG---KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 109
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IKQKTLISGGVRGTI 795
+++LH I++ DLK N L++ + K+ D GLSK ++K GT+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKESIDHEKKAY---SFCGTV 162
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
+MAPE+ + + T+ D +SFGV+M+E+LTG P+ +E + I+K LG +P
Sbjct: 163 EYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MP 218
Query: 856 SWCEPTWRSLMERCWSSDPKSR 877
+ P +SL+ + +P +R
Sbjct: 219 QFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-17
Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++E+G G+FG V++ + ++ VAIK++ S G ++ D +E L +I H
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYS----GKQSNEKW-QDIIKEVKFLQRIKH 84
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
PN + + G L V EY + GS +L + + + I A G+ YL
Sbjct: 85 PNSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFK 804
H N++H D+K+ N L + +P + K+ D G + I + GT WMAPE+
Sbjct: 142 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASP---ANSFVGTPYWMAPEVIL 194
Query: 805 SKDNLVTE-KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPT 861
+ D + KVDV+S G+ EL + P ++++ + I + N P + S W +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSD-Y 252
Query: 862 WRSLMERCWSSDPKSRPAFSEITKEL 887
+R+ ++ C P+ RP E+ K +
Sbjct: 253 FRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD---VAIKRIKPSCFAEGSLEEDRLIADFWRE 675
+K D +I+ LG+G+FG V +K D VAIKR F + + + + + + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR-----FEKSKIIKQKQVDHVFSE 81
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
+L I+HP V YG D + L V E+++ G LRR R A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAA 138
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
EYL NIV+ DLK N L++ + K+ D G +K+ + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YAD---LHSEEIIAGIIKGNLG 851
++APE+ + + + D ++ G+ ++E+L G P YA+ L ++I+ GII
Sbjct: 193 EYIAPEILLNVGH--GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----- 245
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSR 877
P + + + LM++ S D R
Sbjct: 246 -YFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 69/257 (26%), Positives = 122/257 (47%), Gaps = 22/257 (8%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++E+G G+FG V++ + + VAIK++ S + + D +E L ++ H
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQKLRH 74
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
PN + + G L V EY + GS +L + + + + A G+ YL
Sbjct: 75 PNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFK 804
H N++H D+K+ N L++ + + K+GD G + I + GT WMAPE+
Sbjct: 132 HSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVIL 184
Query: 805 SKDNLVTE-KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPT 861
+ D + KVDV+S G+ EL + P ++++ + I + N P + S W E
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHWSE-Y 242
Query: 862 WRSLMERCWSSDPKSRP 878
+R+ ++ C P+ RP
Sbjct: 243 FRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 36/227 (15%)
Query: 628 KELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD------FWREAHML 679
LG GT+G V Y G VAIK++K + ++ +L+ RE ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+I H N++ V +G NL V + M LK+V+ RK R + + + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINL--VMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQILN 130
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-----------IKQKT--- 785
G+ LH+ +H DL N +N + +CKI D GL++ K +T
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 786 ---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ S V T+ + APEL + VD++S G + ELLTG
Sbjct: 187 REEMTSKVV--TLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG-QIHH 684
K LG G+FG V + KG++ AIK +K E E ++ E +L H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMV-----ERRVLALAWEH 55
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
P + + T +L V EY+ G L ++ R + R R A + G+++L
Sbjct: 56 PFLTHLF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFL 112
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMA 799
H+K I++ DLK N L++ +D KI D G+ K ++G + GT ++A
Sbjct: 113 HKKGIIYRDLKLDNVLLD-KDGH---IKIADFGMCK----ENMNGEGKASTFCGTPDYIA 164
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PE+ K + E VD +SFGV+++E+L G+ P+ +E+ I+ P P W
Sbjct: 165 PEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PHFPRWIS 220
Query: 860 PTWRSLMERCWSSDPKSR 877
+ + + + DP R
Sbjct: 221 KEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-16
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 40/223 (17%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQ 681
E +K +GSG +G V K G VAIK+I + F +D + A RE +L
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNVF------DDLIDAKRILREIKLLRH 55
Query: 682 IHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGS-LKQVLR-RKDRTIDRRKRIIIAMD 736
+ H N++ ++ + VTE M + L +V++ + T D + + +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQI- 112
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKI-----KQKTLISG 789
G++YLH N++H DLK N LVN + C KI D GL++ +K ++
Sbjct: 113 -LRGLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 790 GV--RGTIPWM-APELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
V R W APEL S T+ +D++S G + ELLT
Sbjct: 166 YVVTR----WYRAPELLLSSSRY-TKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E ++ +G+GT+G V+ G+ G AIK + + G EE+ +E +ML +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEE-----IKQEINMLKK 58
Query: 682 I-HHPNVVAFYGVVTD----GPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAM 735
HH N+ +YG G L V E+ GS+ +++ K T+ I
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR--- 792
+ G+ +LH+ ++H D+K N L+ + K+ D G+S +T+ G R
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTF 171
Query: 793 -GTIPWMAPELFKSKDN---LVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
GT WMAPE+ +N K D++S G+ E+ G P D+H + +I
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPR 230
Query: 849 NLGPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
N P++ S W + ++S +E C + RP ++ K
Sbjct: 231 NPAPRLKSKKWSK-KFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-16
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 623 DLEYIKELGSGTFGTVFY-----GKWKGSDVAIKRIKPSCFAEGS-----LEEDRLIADF 672
+ E +K LG+G +G VF G G A+K ++ + + + +R + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
R++ L +H Y T+ L + +Y+ G + L ++D + R
Sbjct: 61 VRQSPFLVTLH-------YAFQTE---AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGG 790
+ +E+LH+ IV+ D+K N L+ D + V + D GLSK + ++ +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSKEFLSEEKERTYS 165
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-----EIIAGI 845
GTI +MAPE+ + K + VD +S G++++ELLTG P+ L E E+ I
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRI 223
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+K P PS+ P + L+ + DPK R
Sbjct: 224 LK--CDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 12/175 (6%)
Query: 716 QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
++L + +D + + A G+ +L KN +H DL + N L+ + KI D
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICD 257
Query: 776 LGLSK-IKQKT--LISGGVRGTIPWMAPELFKSKDNLV-TEKVDVYSFGVVMWELLT-GE 830
GL++ I+ + ++ G R + WMAPE S N V T + DV+S+G+++WE+ + G
Sbjct: 258 FGLARDIRNDSNYVVKGNARLPVKWMAPE---SIFNCVYTFESDVWSYGILLWEIFSLGS 314
Query: 831 EPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
PY + + +IK P +M+ CW +DP RP F +I +
Sbjct: 315 SPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 28/236 (11%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH---- 677
DLE IK +G+GTFG V + RI +A + +I +E H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVR--------DRISEHYYALKVMAIPEVI-RLKQEQHVHNE 51
Query: 678 --MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
+L ++ HP ++ + D L + EY+ G L LR + A
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYAS 108
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGT 794
+ +EYLH K IV+ DLK N L++ ++ K+ D G +K ++ +T + GT
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWT---LCGT 161
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
++APE+ +SK + + VD ++ G++++E+L G P+ D + I I+ G L
Sbjct: 162 PEYLAPEVIQSKGH--NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 30/270 (11%)
Query: 630 LGSGTFGTVFYG-KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVV 688
LG G +GTV+ G +G +A+K+++ L ++ E +L + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELD--TSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGIEYL 744
+ G D ++ E++ GS+ +L R + + + I+ G+ YL
Sbjct: 66 QYLGTCLDDNTISI--FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPV------C--KIGDLGLSKIKQKTLISGGVRGTIP 796
H +VH D+K +N M P + C ++ +GL L S + GT
Sbjct: 119 HNNCVVHRDIKGNNV---MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPY 173
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG-NLGPKIP 855
WMAPE+ K D++S G ++E+ TG+ P A + + I L P++P
Sbjct: 174 WMAPEVINESGY--GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ C + D RP+ ++ +
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 39/233 (16%)
Query: 645 GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY--GVVTDGPVTNL 702
G +VAIK ++ + EE+ A F RE + +++HPN+VA G G L
Sbjct: 3 GHEVAIKLLR-----TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG---LL 54
Query: 703 ATVTEYMVNGSLKQVLRRK-----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSH 757
V EY+ +L++VL T +++ A+ A H + IVH DLK
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQGIVHRDLKPQ 108
Query: 758 NFLVNMRDPQRPVCKIGDLGLSKI--------KQKTLISGGVRGTIPWMAPELFKSKDNL 809
N +V+ RP K+ D G+ + + V GT + APE + +
Sbjct: 109 NIMVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-- 165
Query: 810 VTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP---KIPSWCE 859
VT D+Y++G++ E LTG+ + +A I+ L P +P W
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR----VVQGASVAEILYQQLSPVDVSLPPWIA 214
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 71/264 (26%), Positives = 125/264 (47%), Gaps = 22/264 (8%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+ E+G G+FG V++ ++ VA+K++ S G ++ D +E L Q+ H
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYS----GKQTNEKW-QDIIKEVKFLQQLKH 80
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
PN + + G L V EY + GS +L + + + I A G+ YL
Sbjct: 81 PNTIEYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFK 804
H N++H D+K+ N L + +P + K+ D G + + GT WMAPE+
Sbjct: 138 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSP---ANSFVGTPYWMAPEVIL 190
Query: 805 SKDNLVTE-KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPT 861
+ D + KVDV+S G+ EL + P ++++ + I + N P + S W + +
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLQSNEWTD-S 248
Query: 862 WRSLMERCWSSDPKSRPAFSEITK 885
+R ++ C P+ RPA +E+ +
Sbjct: 249 FRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 672 FWREAHMLGQIHHPNVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
F+ A M+ Q+ H ++V YGV V D V N+ V E++ G L + RK + +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRD--VENI-MVEEFVEFGPLDLFMHRKSDVLTTPWK 107
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLV---NMRDPQRPVCKIGDLGLSKIKQKTLI 787
+A A + YL +K++VH ++ + N L+ + P K+ D G I L
Sbjct: 108 FKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG---IPITVLS 164
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWEL-LTGEEPYAD--LHSEEIIAG 844
IPW+APE + NL + D +SFG +WE+ GE P D L +E
Sbjct: 165 RQECVERIPWIAPECVEDSKNL-SIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE 223
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
G PS E LM C + DP RP F I +++
Sbjct: 224 ---GQCMLVTPSCKELA--DLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 29/269 (10%)
Query: 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LGSG GTV K G A+K + EG E D+ A E L ++
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVD----MEGMSEADKNRAQ--AEVCCLLNCDFFSI 93
Query: 688 V------AFYGVVTDGPVTNLATVTEYMVNGSLKQVLR---RKDRTIDRRKRIIIAMDAA 738
V A V +A V +Y G L+Q ++ + +RT + ++ +
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----GT 794
+ ++H K+++H D+KS N L+ + K+GD G SK+ T +S V GT
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLC----SNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGT 208
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
++APE+++ K ++K D++S GV+++ELLT + P+ + EE++ + G P +
Sbjct: 209 PYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP-L 265
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P P + ++ SSDPK RP+ S++
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 12/159 (7%)
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKT--LISGGVRGT 794
A G+++L KN +H D+ + N L+ V KI D GL++ I + ++ G R
Sbjct: 222 AQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ WMAPE +F D + T + DV+S+G+++WE+ + G+ PY + ++K
Sbjct: 278 VKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
P + P S+M+ CW+ +P RP FS+I++ ++
Sbjct: 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 45/278 (16%)
Query: 624 LEYIKELGSGTFGTV--FYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
+ + LG G G+V K G A+K I L RE +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-------PNPDLQKQILRELEINKS 55
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRKRII--IAM 735
P +V +YG D +++ EY GSL K+V +R R ++++ IA
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI---GEKVLGKIAE 112
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI---GDLGLSKIKQKTLISGGVR 792
G+ YLH + I+H D+K N L+ R Q +C G+L S ++G
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNS-------LAGTFT 164
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL--------TGEEPYADLHSEEIIAG 844
GT +MAPE + K +T DV+S G+ + E+ GE P + I
Sbjct: 165 GTSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222
Query: 845 I----IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRP 878
+ +K G I W E ++ +++C DP RP
Sbjct: 223 MPNPELKDEPGNGI-KWSEE-FKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 37/280 (13%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
++E + ELG G +G+V+ + G +A+K I+ L+E + E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKF-NQIIMELDIL 53
Query: 680 GQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQV------LRRKDRTIDRRKRII 732
+ P +V FYG +G V EYM GSL ++ + RR
Sbjct: 54 HKAVSPYIVDFYGAFFIEGAVY---MCMEYMDAGSLDKLYAGGVATEGIPEDVLRR---- 106
Query: 733 IAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
I G+++L E+ NI+H D+K N LVN K+ D G+S +L +
Sbjct: 107 ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDFGVSGNLVASLAKTNI 162
Query: 792 RGTIPWMAPELFKS---KDNLV-TEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA---G 844
G +MAPE KS N T + DV+S G+ + E+ G PY I A
Sbjct: 163 -GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT 884
I+ G+ P +PS + + +C + P RP ++++
Sbjct: 222 IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 78/264 (29%), Positives = 128/264 (48%), Gaps = 35/264 (13%)
Query: 627 IKELGSGTFGTVF-YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH------ML 679
+K LG G +G VF K G+D FA L++ ++ + AH +L
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGAD------TGKIFAMKVLKKATIVRNQKDTAHTKAERNIL 54
Query: 680 GQIHHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ HP +V Y T G L + EY+ G L L R+ ++ ++ + +
Sbjct: 55 EAVKHPFIVDLIYAFQTGG---KLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EIS 110
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----GT 794
+E+LH++ I++ DLK N L+ D Q V K+ D GL K +++ G V GT
Sbjct: 111 LALEHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGLCK---ESIHEGTVTHTFCGT 163
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
I +MAPE L +S + VD +S G +M+++LTG P+ + ++ I I+KG L
Sbjct: 164 IEYMAPEILMRSGHG---KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--N 218
Query: 854 IPSWCEPTWRSLMERCWSSDPKSR 877
+P + P R L+++ +P SR
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-15
Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 12/151 (7%)
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLIS-GGVRGT 794
A G+E+L KN VH DL + N L+ + + KI D GL++ ++ IS G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ WMAPE +F +NL T DV+SFG+++WE+ T G PY +L E IK
Sbjct: 305 LKWMAPESIF---NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P+ +M++CW + RP FS++
Sbjct: 362 AKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 36/262 (13%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWREAHMLG 680
K LG G+FG V + KG+D A+K +K E ++ E R++A +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------ 54
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
HP + + L V EY+ G L ++R D + A + G
Sbjct: 55 ---HPFLTQLHSCFQT--KDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLG 108
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTI 795
+++LHE+ I++ DLK N L++ KI D G+ K I GGV GT
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCGTP 160
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ + VD ++ GV+++E+L G+ P+ +E+ I++ + P
Sbjct: 161 DYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYP 216
Query: 856 SWCEPTWRSLMERCWSSDPKSR 877
W +S+++ + +P+ R
Sbjct: 217 RWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-15
Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLIS-GGVRGT 794
A G+E+L KN VH DL + N L+ Q + KI D GL++ + +S G
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ WMAPE +F DNL T DV+S+G+++WE+ + G PY + + IK
Sbjct: 303 VKWMAPESIF---DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAF---SEITKEL 887
P +M +CW+S+P+ RP+F S+I + L
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 22/264 (8%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++E+G G+FG V++ + VAIK++ S + S E+ + D +E L Q+ H
Sbjct: 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQ---DIIKEVRFLQQLRH 74
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
PN + + G L V EY + GS +L + + + I A G+ YL
Sbjct: 75 PNTIEYKGCYLREHTAWL--VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFK 804
H +H D+K+ N L+ + K+ D G + + + GT WMAPE+
Sbjct: 132 HSHERIHRDIKAGNILLT----EPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL 184
Query: 805 SKDN-LVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPT 861
+ D KVDV+S G+ EL + P ++++ + I + N P + S W +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLSSNDWSD-Y 242
Query: 862 WRSLMERCWSSDPKSRPAFSEITK 885
+R+ ++ C P+ RP+ E+ K
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 72/262 (27%), Positives = 117/262 (44%), Gaps = 36/262 (13%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWREAHMLG 680
K LG G+FG V + KG A+K +K E ++ E R++A W E L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLT 59
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
++ T +L V E++ G L ++ K R D + A + G
Sbjct: 60 HLY----------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCG 108
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTI 795
+++LH K I++ DLK N +++ RD KI D G+ K + G R GT
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGMCKEN----VFGDNRASTFCGTP 160
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ + T VD +SFGV+++E+L G+ P+ +E+ I P P
Sbjct: 161 DYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYP 216
Query: 856 SWCEPTWRSLMERCWSSDPKSR 877
W + ++E+ + DP R
Sbjct: 217 RWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
F+ A ++ Q+ H ++ +GV G N+ V E++ +G L LR++ + +I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGS-ENI-MVEEFVEHGPLDVCLRKEKGRVPVAWKI 120
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR---DPQRPVCKIGDLGLSKIKQKTLIS 788
+A A + YL +KN+VH ++ + N L+ + P K+ D G+S T +S
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS----FTALS 176
Query: 789 GGVR-GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWEL-LTGEEPYADLHSEEIIAGII 846
R IPW+APE ++L T D +SFG + E+ GE P + E
Sbjct: 177 REERVERIPWIAPECVPGGNSLST-AADKWSFGTTLLEICFDGEVPLKERTPSE------ 229
Query: 847 KGNLGPKIPSWCEPTWR---SLMERCWSSDPKSRPAFSEITKEL 887
K K EP+ + +L+ +C + +P RP+F I ++L
Sbjct: 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 625 EYIKELGSGTFGTVFYGKWKGS-DVAIKRI--KPSCFAEGSLEEDRLIADFWREAHMLGQ 681
IK L G+ G VF G D + +I K + LI EA +L
Sbjct: 69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT----------LI-----EAMLLQN 113
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
++HP+V+ + G +T + + Y + L L ++ R + + +II G+
Sbjct: 114 VNHPSVIRMKDTLVSGAITCM-VLPHY--SSDLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
YLH + I+H D+K+ N +N D VC IGDLG ++ G+ GT+ APE
Sbjct: 171 RYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGTVETNAPE 226
Query: 802 -LFKSKDNLVTEKVDVYSFGVVMWELL------------TGEEPYADLHSE 839
L + K N K D++S G+V++E+L T EE HS
Sbjct: 227 VLARDKYN---SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 71/283 (25%), Positives = 128/283 (45%), Gaps = 40/283 (14%)
Query: 628 KELGSGTFGTVFYGK-WKGSDVA---IKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+E+G+G FG V + + + VA +K +K + S E++ +F ++ +
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQN----EFLQQGDPYRILQ 53
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR-----RKDRTIDRRKRIIIAMDAA 738
HPN++ G + V EY G LK L R++ + +R+ A + A
Sbjct: 54 HPNILQCLGQCVEA--IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIA 109
Query: 739 FGIEYLHEKNIVHFDLKSHN-FLVNMRDPQRPVCKIGD--LGLSKIKQKTLIS-GGVRGT 794
G+ ++H+ N +H DL N FL + K+GD +G S+ K+ + +
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLT-----VKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 795 IPWMAPELFKS-KDNLV----TEKVDVYSFGVVMWELL-TGEEPYADLHSEEIIAGIIKG 848
+ W+APEL L+ T+ +V++ GV +WEL +PY+ L E++ +IK
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
Query: 849 N----LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P++ W +++ CW S P+ R E+ + L
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 79/263 (30%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG GTFG V + K G A+K +K E + +D +A E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILK----KEVIIAKDE-VAHTLTESRVLQNTRHP 55
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRR-----KDRTIDRRKRIIIAMDAAF 739
+ A Y T L V EY G L L R +DR I+ A+
Sbjct: 56 FLTALKYSFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG--- 109
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GT 794
YLH ++V+ DLK N +++ +D KI D GL K IS G GT
Sbjct: 110 ---YLHSCDVVYRDLKLENLMLD-KDGH---IKITDFGLCKEG----ISDGATMKTFCGT 158
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
++APE+ +DN VD + GVVM+E++ G P+ + E++ I+ + +
Sbjct: 159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RF 214
Query: 855 PSWCEPTWRSLMERCWSSDPKSR 877
P P +SL+ DPK R
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-15
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ I+ +G G G V+ Y VA+K+I+ E E L F REA + +
Sbjct: 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-----EDLSENPLLKKRFLREAKIAADL 59
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--------RKDRTIDRRKRIIIA 734
HP +V Y + +DG + Y+ +LK +L+ K+ K + A
Sbjct: 60 IHPGIVPVYSICSDGDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKELAE---KTSVGA 114
Query: 735 MDAAF-----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ------ 783
+ F IEY+H K ++H DLK N L+ + I D G + K+
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDL 170
Query: 784 -------------KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
I G + GT +MAPE + +E D+Y+ GV+++++LT
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLS 228
Query: 831 EPY 833
PY
Sbjct: 229 FPY 231
|
Length = 932 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 38/271 (14%)
Query: 627 IKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+++G G GTV+ G +VAIK++ + LI + E ++ + H
Sbjct: 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIIN---EILVMRENKH 75
Query: 685 PNVVAFYG--VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
PN+V + +V D L V EY+ GSL V+ + +D + + + +E
Sbjct: 76 PNIVNYLDSYLVGD----ELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 129
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------SKIKQKTLISGGVRGTIP 796
+LH ++H D+KS N L+ M K+ D G + K+ T++ GT
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI-- 854
WMAPE+ K KVD++S G++ E++ GE PY + + + +I N P++
Sbjct: 181 WMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQN 237
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P +R + RC D + R + E+ +
Sbjct: 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 71/269 (26%), Positives = 114/269 (42%), Gaps = 34/269 (12%)
Query: 623 DLEYIKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E I+ +GSGT+G V+ + G AIK IK LE A +E M+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--------LEPGEDFAVVQQEIIMMK 61
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
H N+VA++G L E+ GSL+ + + + ++ + G
Sbjct: 62 DCKHSNIVAYFGSYLRR--DKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQG 118
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK------IKQKTLISGGVRGT 794
+ YLH K +H D+K N L+ K+ D G+S K+K+ I GT
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFI-----GT 169
Query: 795 IPWMAPELFK-SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-P 852
WMAPE+ + + D+++ G+ EL + P DLH + + K N P
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 853 KIP---SWCEPTWRSLMERCWSSDPKSRP 878
K+ W ++ ++ + +PK RP
Sbjct: 230 KLKDKMKWSN-SFHHFVKMALTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
++ E + +G GT+G V+ + S VA+K+++ E D + RE +L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD------NERDGIPISSLREITLL 60
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR--TIDRRKRIIIAMDA 737
+ HPN+V VV + ++ V EY L +L + + K +++ +
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEY-CEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRGT 794
G++YLHE I+H DLK N L+ + KI D GL++ + K + V T
Sbjct: 120 --GLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPAKPMTPKVV--T 171
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ + APEL T +D+++ G ++ ELL +
Sbjct: 172 LWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 24/263 (9%)
Query: 628 KELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+++G G GTV+ G +VAI+++ +L++ E ++ + +P
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEILVMRENKNP 77
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
N+V + G L V EY+ GSL V+ + +D + + + +E+LH
Sbjct: 78 NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 133
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKIKQKTLISGGVRGTIPWMAPELFK 804
++H D+KS N L+ M K+ D G ++I + + GT WMAPE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSWCEPTW 862
K KVD++S G++ E++ GE PY + + + +I N P++ P +
Sbjct: 190 RK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIF 246
Query: 863 RSLMERCWSSDPKSRPAFSEITK 885
R + RC D + R + E+ +
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-14
Identities = 36/83 (43%), Positives = 44/83 (53%), Gaps = 11/83 (13%)
Query: 33 PSSNNLRYIGGETRIISVDRTISFPKLRLKISDICS-SIPSFTLKYRLPLNPDRKQGDDT 91
LRY GGETR +SV R ISF LR K++ SFTLKY Q +D
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKY---------QDEDG 50
Query: 92 PLVLIASDDDVRCMVEEYDKLES 114
LV + SD+D+ +EEYD L S
Sbjct: 51 DLVSLTSDEDLEEAIEEYDSLGS 73
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 79/256 (30%), Positives = 115/256 (44%), Gaps = 24/256 (9%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG GTFG V K K G A+K +K E + +D +A E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILK----KEVIVAKDE-VAHTLTENRVLQNSRHP 55
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
+ A Y T L V EY G L L R +R + + ++YL
Sbjct: 56 FLTALKYSFQTH---DRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYL 111
Query: 745 H-EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPE 801
H EKN+V+ DLK N +++ +D KI D GL K IK + GT ++APE
Sbjct: 112 HSEKNVVYRDLKLENLMLD-KDGH---IKITDFGLCKEGIKDGATMKTFC-GTPEYLAPE 166
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ + DN VD + GVVM+E++ G P+ + E++ I+ + + P P
Sbjct: 167 VLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFPRTLSPE 222
Query: 862 WRSLMERCWSSDPKSR 877
+SL+ DPK R
Sbjct: 223 AKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKR------IKPSCFAEGSLEEDRLIADFWRE 675
D E + ELG+G G V + S + + R IKP+ +++I RE
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAI-------RNQII----RE 49
Query: 676 AHMLGQIHHPNVVAFYGV-VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR-RKRIII 733
+L + + P +V FYG +DG ++ E+M GSL QVL++ R + +I I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEIS---ICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 734 AMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
A+ G+ YL EK I+H D+K N LVN R K+ D G+S ++ + V
Sbjct: 107 AV--LRGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV- 159
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP 832
GT +M+PE + + T + D++S G+ + E+ G P
Sbjct: 160 GTRSYMSPE--RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 76/258 (29%), Positives = 116/258 (44%), Gaps = 29/258 (11%)
Query: 628 KELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG GTFG V + K + A+K ++ E + +D +A E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDE-VAHTVTESRVLQNTRHP 55
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
+ A Y T L V EY G L L R+ + R R A + +EYL
Sbjct: 56 FLTALKYAFQTH---DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYL 111
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMA 799
H +++V+ D+K N +++ +D KI D GL K IS G GT ++A
Sbjct: 112 HSRDVVYRDIKLENLMLD-KDGH---IKITDFGLCK----EGISDGATMKTFCGTPEYLA 163
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PE+ + DN VD + GVVM+E++ G P+ + E + I+ + + P
Sbjct: 164 PEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLS 219
Query: 860 PTWRSLMERCWSSDPKSR 877
P +SL+ DPK R
Sbjct: 220 PEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E ++ +G+GT+G V+ G+ G AIK + E EE +L E +ML +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKL------EINMLKK 68
Query: 682 I-HHPNVVAFYGV-VTDGPVTN---LATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAM 735
HH N+ +YG + P + L V E+ GS+ +++ K + I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR--- 792
+ G+ +LH ++H D+K N L+ + K+ D G+S +T+ G R
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTF 181
Query: 793 -GTIPWMAPELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
GT WMAPE+ ++ D + D++S G+ E+ G P D+H + +I
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPR 240
Query: 849 NLGPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
N PK+ S W + + +E C + SRP+ ++ K
Sbjct: 241 NPPPKLKSKKWSK-KFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 24/263 (9%)
Query: 628 KELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+++G G GTV+ G +VAIK++ +L++ E ++ + +P
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQM--------NLQQQPKKELIINEILVMRENKNP 76
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
N+V + G L V EY+ GSL V+ + +D + + + +++LH
Sbjct: 77 NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH 132
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKIKQKTLISGGVRGTIPWMAPELFK 804
++H D+KS N L+ M K+ D G ++I + + GT WMAPE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSWCEPTW 862
K KVD++S G++ E++ GE PY + + + +I N P++ P +
Sbjct: 189 RK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPERLSAVF 245
Query: 863 RSLMERCWSSDPKSRPAFSEITK 885
R + RC D R + E+ +
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 71/233 (30%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKR------IKPSCFAEGSLEEDRLIADF 672
+K D E I ELG+G G V + K S + + R IKP+ +++I
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI-------RNQII--- 51
Query: 673 WREAHMLGQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
RE +L + + P +V FYG +DG ++ E+M GSL QVL+ R I
Sbjct: 52 -RELQVLHECNSPYIVGFYGAFYSDGEIS---ICMEHMDGGSLDQVLKEAKR-IPEEILG 106
Query: 732 IIAMDAAFGIEYLHEKN-IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
+++ G+ YL EK+ I+H D+K N LVN R K+ D G+S ++ +
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSF 162
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
V GT +M+PE + V + D++S G+ + EL G P ++E+ A
Sbjct: 163 V-GTRSYMSPERLQGTHYSV--QSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/277 (23%), Positives = 124/277 (44%), Gaps = 21/277 (7%)
Query: 622 SDLEYIKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
++ + K++G G F V+ VA+K+++ + +D + +E +L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLL 56
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIIIAMD 736
Q++HPNV+ + + N+ V E G L Q++ +++ R I R +
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNI--VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTI 795
+E++H + ++H D+K N + V K+GDLGL + KT + + GT
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLHSEEIIAGIIKGNLGPKI 854
+M+PE + +N K D++S G +++E+ + P Y D + + I+ P +
Sbjct: 171 YYMSPE--RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228
Query: 855 PS-WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P+ R L+ C DP RP + + + M
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 25/265 (9%)
Query: 626 YIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+IK +G G+ G V K G VA+K++ L + + + E ++
Sbjct: 25 FIK-IGEGSTGIVCIATVKSSGKLVAVKKM--------DLRKQQRRELLFNEVVIMRDYQ 75
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
H NVV Y G L V E++ G+L ++ ++ + +A+ A +
Sbjct: 76 HENVVEMYNSYLVG--DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV-- 131
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKIKQKTLISGGVRGTIPWMAPEL 802
LH + ++H D+KS + L+ D + K+ D G +++ ++ + GT WMAPEL
Sbjct: 132 LHAQGVIHRDIKSDSILLT-HDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--CEP 860
+VD++S G+++ E++ GE PY + + + +I+ NL PK+ + P
Sbjct: 188 ISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSP 244
Query: 861 TWRSLMERCWSSDPKSRPAFSEITK 885
+ + ++R DP R +E+ K
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 37/241 (15%)
Query: 627 IKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++ LG G+ G VF D VA+K+I L + + + RE ++ ++ H
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKI--------VLTDPQSVKHALREIKIIRRLDH 61
Query: 685 PNVVAFYGVVTDG------------PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
N+V Y V+ + ++ V EYM L VL + + + + +
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR--L 118
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLI 787
G++Y+H N++H DLK N +N D V KIGD GL++I K +
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKGYL 175
Query: 788 SGGVRGTIPWM-APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846
S G+ W +P L S +N T+ +D+++ G + E+LTG+ +A H E + I+
Sbjct: 176 SEGL--VTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
Query: 847 K 847
+
Sbjct: 233 E 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 72/265 (27%), Positives = 110/265 (41%), Gaps = 35/265 (13%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWREAHMLGQI 682
LG G FG V ++K + AIK +K E + E R+ E
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE------- 59
Query: 683 HHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
HP +V + T+ ++ V EY G L ++ + + A G+
Sbjct: 60 RHPFLVNLFACFQTE---DHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGL 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IKQKTLISGGVRGTIPW 797
+YLHE IV+ DLK N L+ D + V KI D GL K +T GT +
Sbjct: 115 QYLHENKIVYRDLKLDNLLL---DTEGFV-KIADFGLCKEGMGFGDRT---STFCGTPEF 167
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
+APE+ + T VD + GV+++E+L GE P+ EE+ I+ N + P +
Sbjct: 168 LAPEVL--TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRF 223
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSE 882
S+M R +P+ R E
Sbjct: 224 LSREAISIMRRLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 623 DLEYIKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E I+ +GSGT+G V+ + G A+K IK LE + +E M+
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--------LEPGDDFSLIQQEIFMVK 61
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ H N+VA++G L EY GSL+ + + + + + G
Sbjct: 62 ECKHCNIVAYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQG 118
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKI-----KQKTLISGGVRGT 794
+ YLH K +H D+K N L+ K+ D G+ +KI K+K+ I GT
Sbjct: 119 LAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFI-----GT 169
Query: 795 IPWMAPELFK-SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP- 852
WMAPE+ K+ + D+++ G+ EL + P DLH + + K N P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229
Query: 853 --KIPSWCEPTWRSLMERCWSSDPKSRP 878
K + T+ + ++ + +PK RP
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 71/232 (30%), Positives = 115/232 (49%), Gaps = 32/232 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKR------IKPSCFAEGSLEEDRLIADF 672
+K D E I ELG+G G VF K S + + R IKP+ +++I
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI-------RNQII--- 51
Query: 673 WREAHMLGQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR-RKR 730
RE +L + + P +V FYG +DG ++ E+M GSL QVL++ R ++ +
Sbjct: 52 -RELQVLHECNSPYIVGFYGAFYSDGEIS---ICMEHMDGGSLDQVLKKAGRIPEQILGK 107
Query: 731 IIIAMDAAFGIEYLHEKN-IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG 789
+ IA+ G+ YL EK+ I+H D+K N LVN R K+ D G+S ++ +
Sbjct: 108 VSIAVIK--GLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANS 161
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
V GT +M+PE + V + D++S G+ + E+ G P ++E+
Sbjct: 162 FV-GTRSYMSPERLQGTHYSV--QSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 29/234 (12%)
Query: 663 LEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL-KQVLRRK 721
L ++R A E H L H +V + L + EY G L KQ+ +R
Sbjct: 103 LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIMEYGSGGDLNKQIKQRL 160
Query: 722 DRTIDRRK--------RIIIAMDAAFGIEYLHEKNIVHFDLKSHN-FLVNMRDPQRPVCK 772
+ ++ +I++A+D +H + ++H DLKS N FL+ + K
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLALDE------VHSRKMMHRDLKSANIFLM-----PTGIIK 209
Query: 773 IGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+GD G SK ++ ++ GT ++APEL++ K ++K D++S GV+++ELLT
Sbjct: 210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTL 267
Query: 830 EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P+ EI+ ++ G P P ++L++ S +P RP ++
Sbjct: 268 HRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + +G G +G V + K G VAIK+ K S E + + RE +L Q+
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES---EDDEDVKKTAL---REVKVLRQL 57
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAAFG 740
H N+V L V EY V +L ++L + + I + A
Sbjct: 58 RHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQA-- 112
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR------GT 794
I Y H NI+H D+K N LV+ + V K+ D G + + L + T
Sbjct: 113 IAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA----RALRARPASPLTDYVAT 164
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APEL D + VDV++ G +M ELL GE
Sbjct: 165 RWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
+GSG +G V + VAIK++ +P F S + +RE +L + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQ--SAIHAKRT---YRELRLLKHMDHEN 75
Query: 687 VVAFYGVVTDGPVTNLATVTE-YMVN----GSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
V+ V T P ++L + Y+V L +++ + + D + ++ + G+
Sbjct: 76 VIGLLDVFT--PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI--LRGL 131
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTIPWMA 799
+Y+H I+H DLK N VN D C KI D GL++ + +G V T + A
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLARHTDDEM-TGYV-ATRWYRA 183
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
PE+ + + + VD++S G +M ELLTG+
Sbjct: 184 PEIMLNWMHY-NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 35/274 (12%)
Query: 630 LGSGTFGTVFYGKWK--GSDVAIK-----RIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
LG G FG V + K G A K R+K + +L E + +L ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK----------ILEKV 50
Query: 683 HHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFG 740
+V+ Y T +L V M G LK + + + I A G
Sbjct: 51 SSRFIVSLAYAFETK---DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMA 799
+E+LH++ IV+ DLK N L++ +I DLGL+ ++K I G GT +MA
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMA 162
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG---NLGPKIPS 856
PE+ + + + VD ++ G ++E++ G P+ E++ +K + + P
Sbjct: 163 PEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAVEYPD 219
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEIT-KELRA 889
P + L E DP+ R + E+R
Sbjct: 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 75/290 (25%), Positives = 134/290 (46%), Gaps = 36/290 (12%)
Query: 611 TANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRL 668
T + + +DLE + E+GSGT G V+ ++K G +A+K+++ + E E R+
Sbjct: 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE---ENKRI 60
Query: 669 IADFWREAHMLGQIHHPNVVAFYG-VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR 727
+ D +L P +V YG +TD +++ E M + L ++L+R I
Sbjct: 61 LMDL---DVVLKSHDCPYIVKCYGYFITD---SDVFICMELM-STCLDKLLKRIQGPIPE 113
Query: 728 RKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------SK 780
+ + + YL EK ++H D+K N L++ K+ D G+ SK
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCDFGISGRLVDSK 169
Query: 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKV--DVYSFGVVMWELLTGEEPYADLHS 838
K ++ G +MAPE D + DV+S G+ + EL TG+ PY + +
Sbjct: 170 AKTRS------AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
Query: 839 E-EIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
E E++ I++ P +P P + S ++ C + D + RP + E+ +
Sbjct: 224 EFEVLTKILQEEP-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 26/240 (10%)
Query: 626 YIK--ELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLG 680
YIK +LG GT+ TV+ G+ K +D VA+K I+ LE E+ RE +L
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLK 59
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ H N+V + ++ +L V EY+ + LKQ L +I+ + G
Sbjct: 60 DLKHANIVTLHDIIHTE--KSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTIPW 797
+ Y H + ++H DLK N L+N +R K+ D GL++ K KT + V T+ +
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVV--TLWY 170
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
P++ + T+ +D++ G + +E+ TG + EE + I + P +W
Sbjct: 171 RPPDILLGSTDYSTQ-IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 64/236 (27%), Positives = 97/236 (41%), Gaps = 64/236 (27%)
Query: 623 DLEY--IKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
Y I+ +GSG +G V G VAIK+I P F +L + L RE +
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTL-----RELKI 57
Query: 679 LGQIHHPNVVAF--------------YGVVTDGPVTNL-------ATVTEYMVNGSLKQV 717
L H N++A Y VV D ++L +TE + L Q+
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVY-VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 718 LRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
LR G++Y+H N++H DLK N LVN + +IGD G
Sbjct: 117 LR--------------------GLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152
Query: 778 LSK------IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827
+++ + K ++ V T + APEL S T +D++S G + E+L
Sbjct: 153 MARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 54/271 (19%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+++LG GT+ TV+ G+ + G VA+K I E+ + RE ++ ++ H
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA-------EEGTPSTAIREISLMKELKH 57
Query: 685 PNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF---- 739
N+V + V+ T+ L V EYM + LK+ + D R A+D
Sbjct: 58 ENIVRLHDVIHTE---NKLMLVFEYM-DKDLKKYM---DTHGVRG-----ALDPNTVKSF 105
Query: 740 ------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGG 790
GI + HE ++H DLK N L+N +R K+ D GL++ I T +
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 791 VRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849
V T+ + AP+ L S+ + +D++S G +M E++TG + ++E+ + I +
Sbjct: 162 V--TLWYRAPDVLLGSR--TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR-I 216
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAF 880
+G P+ E TW + S P+ +P F
Sbjct: 217 MG--TPT--ESTWPGI-----SQLPEYKPTF 238
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 39/270 (14%)
Query: 626 YIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
YIK +G G+ G V + K G VA+K + L + + + E ++
Sbjct: 26 YIK-IGEGSTGIVCIAREKHSGRQVAVKMM--------DLRKQQRRELLFNEVVIMRDYQ 76
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
H NVV Y G L + E++ G+L ++ + ++ + ++ A + Y
Sbjct: 77 HQNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA--LCY 132
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG----LSK--IKQKTLISGGVRGTIPW 797
LH + ++H D+KS + L+ + K+ D G +SK K+K+L+ GT W
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLV-----GTPYW 183
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI--IKGNLGPKIP 855
MAPE+ S+ TE VD++S G+++ E++ GE PY S+ + + ++ + PK+
Sbjct: 184 MAPEVI-SRTPYGTE-VDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPPPKLK 238
Query: 856 SW--CEPTWRSLMERCWSSDPKSRPAFSEI 883
+ P R +ER + +P+ R E+
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 625 EYIKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + E+G G +GTV+ + G VA+K+++ L E+ + RE +L Q+
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 683 ---HHPNVVAFYGV---VTDGPVTNLATVTEYMVNGSLKQVLRR------KDRTIDRRKR 730
HPN+V V L V E+ V+ L L + TI K
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETI---KD 111
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLIS 788
++ + G+++LH IVH DLK N LV D Q KI D GL++I + L S
Sbjct: 112 LMRQLLR--GVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEMALTS 165
Query: 789 GGVRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWEL 826
V T+ + APE L +S VD++S G + EL
Sbjct: 166 VVV--TLWYRAPEVLLQSSYA---TPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-12
Identities = 29/78 (37%), Positives = 36/78 (46%), Gaps = 10/78 (12%)
Query: 38 LRYIGGETRIISVDRTISFPKLRLKISDIC-SSIPSFTLKYRLPLNPDRKQGDDTPLVLI 96
LRY GG R +SV ISF +LR K+ F LKY +D LV I
Sbjct: 6 LRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYP---------DEDGDLVSI 56
Query: 97 ASDDDVRCMVEEYDKLES 114
SD+D+ +EE L S
Sbjct: 57 TSDEDLEEAIEEARSLGS 74
|
Length = 84 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 27/232 (11%)
Query: 607 YFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRI-KPSCFAEGSL 663
Y+ N + + + +K++GSG +GTV + G+ VAIK++ +P
Sbjct: 1 YYRQEVNKTIWEVPDRYRD-LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-------F 52
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE-YMV----NGSLKQVL 718
+ + +RE +L + H NV+ V T P +L + Y+V L +++
Sbjct: 53 QSELFAKRAYRELRLLKHMKHENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLM 110
Query: 719 RRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778
+ + + DR + ++ M G++Y+H I+H DLK N VN + KI D GL
Sbjct: 111 KHEKLSEDRIQFLVYQM--LKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGL 164
Query: 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
++ + + ++G V T + APE+ + + T+ VD++S G +M E+LTG+
Sbjct: 165 AR-QTDSEMTGYVV-TRWYRAPEVILNWMHY-TQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 71/265 (26%), Positives = 111/265 (41%), Gaps = 27/265 (10%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D + + ++G G +G VF K K + VA+KR+K S L E R + E +L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF--KLNEVRHVLT---ERDIL 55
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA-MDAA 738
+V D LA EY+ G + +L + R +A M A
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA 113
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
++ LHE +H DLK NFL++ K+ D GLS K + V G+ +M
Sbjct: 114 --VDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS--KGIVTYANSVVGSPDYM 165
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
APE+ + K T VD +S G +++E L G P++ E + + P +
Sbjct: 166 APEVLRGKGYDFT--VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223
Query: 859 EPTWRSLMERCWS------SDPKSR 877
+P +L + W +DP R
Sbjct: 224 DPR-FNLSDEAWDLITKLINDPSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-12
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 39/232 (16%)
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+G++ HPN+V G+ L + EY+ +L +VLR + + +RR++I I + A
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKA 792
Query: 739 FGIEYLH---EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ +LH +V +L +++ +D P ++ GL K IS
Sbjct: 793 --LRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP------------------YADLH 837
++APE ++KD +TEK D+Y FG+++ ELLTG+ P Y+D H
Sbjct: 844 -YVAPETRETKD--ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900
Query: 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
+ I I+G++ E +L C ++DP +RP +++ K L +
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVM--NLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 69/248 (27%), Positives = 114/248 (45%), Gaps = 43/248 (17%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWRE 675
D ++ LG G+FG V + KG+D AIK +K E ++ E R++A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA-LPGK 59
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRKRI 731
L Q+H F + L V EY+ G L +QV + K+ +
Sbjct: 60 PPFLTQLHS----CFQ------TMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----HAV 104
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
A + A G+ +LH K I++ DLK N +++ KI D G+ K I GG
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMCKEN----IFGGK 156
Query: 792 R-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846
GT ++APE+ + + VD ++FGV+++E+L G+ P+ +E+ I+
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 847 KGNLG-PK 853
+ N+ PK
Sbjct: 215 EHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 626 YIK--ELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLG 680
Y+K +LG GT+ TVF G+ K + VA+K I+ LE E+ RE +L
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--------LEHEEGAPCTAIREVSLLK 58
Query: 681 QIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ H N+V + ++ T+ L V EY+ + LKQ L + I
Sbjct: 59 NLKHANIVTLHDIIHTE---RCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTIP 796
G+ Y H++ I+H DLK N L+N ++ K+ D GL++ K KT + V T+
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVV--TLW 168
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ P++ T +D++ G +++E+ TG
Sbjct: 169 YRPPDVLLGSTEYST-PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 76/259 (29%), Positives = 114/259 (44%), Gaps = 31/259 (11%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LG GTFG V + K S A+K +K E + +D +A E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILK----KEVIIAKDE-VAHTLTESRVLKNTRHP 55
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
+ + Y T L V EY+ G L L R+ + R R A + ++YL
Sbjct: 56 FLTSLKYSFQTK---DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYL 111
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK------IKQKTLISGGVRGTIPWM 798
H IV+ DLK N +++ +D KI D GL K KT GT ++
Sbjct: 112 HSGKIVYRDLKLENLMLD-KDGH---IKITDFGLCKEGITDAATMKTFC-----GTPEYL 162
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
APE+ + DN VD + GVVM+E++ G P+ + E++ I+ ++ K P
Sbjct: 163 APEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI--KFPRTL 218
Query: 859 EPTWRSLMERCWSSDPKSR 877
+SL+ DP R
Sbjct: 219 SADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 34/268 (12%)
Query: 623 DLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D++Y + LG G GTV+ Y +A+K I + ++E + I E +L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP----LDITVELQKQIMS---ELEILY 54
Query: 681 QIHHPNVVAFYGVVTDGPVTN-LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ P ++ FYG V N ++ TE+M GSL + + + R IA+
Sbjct: 55 KCDSPYIIGFYGAFF---VENRISICTEFMDGGSLDVYRKIPEHVLGR-----IAVAVVK 106
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
G+ YL I+H D+K N LVN R Q +C D G+S ++ V GT +MA
Sbjct: 107 GLTYLWSLKILHRDVKPSNMLVNTRG-QVKLC---DFGVSTQLVNSIAKTYV-GTNAYMA 161
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-------EIIAGIIKGNLGP 852
PE + + DV+S G+ EL G PY + +++ I+ + P
Sbjct: 162 PERISGEQYGIHS--DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PP 218
Query: 853 KIP-SWCEPTWRSLMERCWSSDPKSRPA 879
+P + + +C PK RPA
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 45/249 (18%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWRE 675
D ++ LG G+FG V + KG+D AIK +K E ++ E R++A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRKRI 731
L Q+H F + L V EY+ G L +QV R K+ +
Sbjct: 60 PPFLTQLHS----CFQ------TMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-----HAV 104
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK------IKQKT 785
A + A G+ +LH K I++ DLK N M D + + KI D G+ K + KT
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNV---MLDSEGHI-KIADFGMCKENMWDGVTTKT 160
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
GT ++APE+ + + VD ++FGV+++E+L G+ P+ +E+ I
Sbjct: 161 FC-----GTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 846 IKGNLG-PK 853
++ N+ PK
Sbjct: 214 MEHNVAYPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E ++++G GT+GTVF K + VA+KR++ EG + + RE +L ++
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKEL 56
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
H N+V Y V+ L V EY + LK+ + ID G+
Sbjct: 57 KHKNIVRLYDVLHSD--KKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRGTIPWMA 799
+ H N++H DLK N L+N + K+ D GL++ I + + V T+ +
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRP 167
Query: 800 PE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEP 832
P+ LF +K L + +D++S G + EL P
Sbjct: 168 PDVLFGAK--LYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDVA-----------IKRIKPSCFAEGSLEEDRLIAD 671
D E +K +G G FG V K K +D +KR + +CF E E D L+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNG 58
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKR 730
+ + +H Y + NL V +Y V G L +L + +DR + R
Sbjct: 59 ---DNQWITTLH-------YAFQDE---NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG--LSKIKQKTLIS 788
+A + I+ +H+ + VH D+K N L++M R + D G L ++ T+ S
Sbjct: 106 FYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQS 160
Query: 789 GGVRGTIPWMAPELFKSKDN---LVTEKVDVYSFGVVMWELLTGEEPY 833
GT +++PE+ ++ ++ + D +S GV M+E+L GE P+
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWREAHMLG 680
K LG G+FG V + KG+D AIK +K + ++ E R++A L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA--------LA 52
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
HP + A + L V EY VNG ++ R D + A +
Sbjct: 53 A-KHPFLTALHCCFQT--KDRLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA 108
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTI 795
+ +LH +++ DLK N L++ CK+ D G+ K I GV GT
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEG----ILNGVTTTTFCGTP 160
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846
++APE+ + + + VD ++ GV+M+E++ G+ P+ + +++ I+
Sbjct: 161 DYIAPEILQELEYGPS--VDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADF-WREAHMLGQ 681
E + ++G G++G VF + + G VAIK+ F E E+D +I RE ML Q
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FVES--EDDPVIKKIALREIRMLKQ 56
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
+ HPN+V V +L V EY + ++ L + R + I +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHL--VFEY-CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGT----IPW 797
+ H+ N +H D+K N L+ + K+ D G ++I L G T W
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFARI----LTGPGDDYTDYVATRW 165
Query: 798 M-APELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
APEL D VDV++ G V ELLTG+
Sbjct: 166 YRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 73/274 (26%), Positives = 112/274 (40%), Gaps = 50/274 (18%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEG----SLEEDRLIADFW 673
K D E + +LG GTFG V+ + G VA+K+I +G +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL---------- 55
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLA------TVTEYMVNGSLKQVLRRKDRTIDR 727
RE +L ++ HPNVV + + P + VT YM + L +L +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTE 114
Query: 728 RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQK 784
+ + GI YLHE +I+H D+K+ N L++ + + KI D GL++
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPP 170
Query: 785 TLISGGVRGT--------IPWM-APELFKSKDNLVTEKVDVYSFGVVMWELLTGE---EP 832
GG GT W PEL + T VD++ G V E+ T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQG 229
Query: 833 YADLHSEEIIAGIIKGNLGPKIP-SWCEPTWRSL 865
+D+ +I + G +W P WRSL
Sbjct: 230 KSDIDQLHLIFKL----CGTPTEETW--PGWRSL 257
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 626 YIK--ELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLG 680
YIK +LG GT+ TVF G+ K ++ VA+K I+ LE E+ RE +L
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--------LEHEEGAPCTAIREVSLLK 59
Query: 681 QIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ H N+V + +V TD +L V EY+ + LKQ + + I
Sbjct: 60 DLKHANIVTLHDIVHTD---KSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTIP 796
G+ Y H + ++H DLK N L+N +R K+ D GL++ K KT + V T+
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVV--TLW 169
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ P++ T+ +D++ G + +E+ +G
Sbjct: 170 YRPPDVLLGSSEYSTQ-IDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 31/233 (13%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE-AHMLGQ------- 681
+G GTFG V+ + K + +RI +A L + ++A +E AH +G+
Sbjct: 1 IGKGTFGQVYQVRKKDT----RRI----YAMKVLSKKEIVAK--KEVAHTIGERNILVRT 50
Query: 682 --IHHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
P +V + TD ++L VT+YM G L L+++ R + R + IA +
Sbjct: 51 LLDESPFIVGLKFSFQTD---SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELV 106
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-QKTLISGGVRGTIPW 797
+E+LH+ +IV+ DLK N L++ +C D GLSK + GT +
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDA-TGHIALC---DFGLSKANLTDNKTTNTFCGTTEY 162
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
+APE+ + T+ VD +S GV+++E+ G P+ ++++ I G +
Sbjct: 163 LAPEVL-LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 62/299 (20%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADF-WREAHMLGQ 681
E + +G G++G V K K G VAIK+ F E E+D+++ RE ML Q
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKK-----FLES--EDDKMVKKIAMREIRMLKQ 56
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID--RRKRIIIAMDAAF 739
+ H N+V V L V E++ + L L + +D R ++ + +
Sbjct: 57 LRHENLVNLIEVFRRK--KRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQI--LR 111
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG-----VRGT 794
GIE+ H NI+H D+K N LV+ Q V K+ D G + +TL + G T
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA----RTLAAPGEVYTDYVAT 163
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIK--GNLG 851
+ APEL D VD+++ G ++ E+LTG EP S+ + + IIK GNL
Sbjct: 164 RWYRAPELL-VGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLI 221
Query: 852 PK---------------IPSWCE--------PTWR----SLMERCWSSDPKSRPAFSEI 883
P+ +P E P L ++C DP RP+ S++
Sbjct: 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ ++++G GT+G V+ + K G VA+K+I+ E E++ + + RE +L ++
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR----LET--EDEGVPSTAIREISLLKEL 55
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRR--KRIIIAMDAAF 739
+HPN+V VV L V E+ ++ LK+ + T +D K + +
Sbjct: 56 NHPNIVRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRGTIP 796
GI Y H ++H DLK N L++ + K+ D GL++ + +T V T+
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARAFGVPVRTYTHEVV--TLW 164
Query: 797 WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT 828
+ APE L S+ + VD++S G + E++
Sbjct: 165 YRAPEILLGSR--QYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 629 ELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
++G G+ G V K G VA+K++ L + + + E ++ HH N
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--------DLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
VV Y G L V E++ G+L ++ ++ + + + + YLH
Sbjct: 81 VVDMYNSYLVG--DELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHN 136
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL-SKIKQKTLISGGVRGTIPWMAPELFKS 805
+ ++H D+KS + L+ D + K+ D G +++ ++ + GT WMAPE+ S
Sbjct: 137 QGVIHRDIKSDSILLT-SDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-S 191
Query: 806 KDNLVTEKVDVYSFGVVMWELLTGEEPY 833
+ TE VD++S G+++ E++ GE PY
Sbjct: 192 RLPYGTE-VDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-11
Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 10/78 (12%)
Query: 38 LRYIGGETRIISVDRTISFPKLRLKISDICS-SIPSFTLKYRLPLNPDRKQGDDTPLVLI 96
++Y G R + V R+ISF LR KI++ SF LKY +D LV I
Sbjct: 5 VKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP---------DEDGDLVTI 55
Query: 97 ASDDDVRCMVEEYDKLES 114
+SD+D+ +EE + S
Sbjct: 56 SSDEDLEEAIEEARRSGS 73
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 56/286 (19%)
Query: 627 IKELGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
++ +G G FG V + G +VAIK+I KP F+ L + +RE +L +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP--FSTPVLAKRT-----YRELKLLKHLR 67
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
H N+++ + P+ ++ VTE + L ++L R ++++ G++Y
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELL-GTDLHRLL--TSRPLEKQFIQYFLYQILRGLKY 123
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
+H +VH DLK N L+N C KI D GL++I Q ++G V T + APE
Sbjct: 124 VHSAGVVHRDLKPSNILINEN------CDLKICDFGLARI-QDPQMTGYV-STRYYRAPE 175
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY------------ADL---HSEEIIAGII 846
+ + +VD++S G + E+L G+ + DL +++I I
Sbjct: 176 IMLTWQKY-DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 847 KGN---------------LGPKIPSWCEPTWRSLMERCWSSDPKSR 877
N K + +P+ L+E+ DP+ R
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKR 279
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD----VAIKRIKPSCF-----AEGSLEEDRLIADFWRE 675
E IKELG G +G V + + VAIK+I + F A+ +L E +L+ F R
Sbjct: 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHF-RG 60
Query: 676 AHMLGQIHHPNVVAFYG--VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
H N+ Y +V G L E M L Q++R D + I
Sbjct: 61 --------HKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI 111
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLI 787
G++Y+H N++H DLK N LVN D + KI D GL+ + +
Sbjct: 112 -YQILCGLKYIHSANVLHRDLKPGNLLVNA-DCE---LKICDFGLARGFSENPGENAGFM 166
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ V T + APE+ S + T+ +DV+S G ++ ELL
Sbjct: 167 TEYV-ATRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 38/277 (13%)
Query: 630 LGSGTFGTVFYGKWKGS-------DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
LG G FG V + + + + KR+K EG++ E R++A ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA----------KV 50
Query: 683 HHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT---IDRRKRIIIAMDAA 738
H +V+ Y T T+L V M G L+ + D +
Sbjct: 51 HSRFIVSLAYAFQTK---TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQII 107
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPW 797
G+E+LH++ I++ DLK N L++ R I DLGL+ ++K + G GT +
Sbjct: 108 SGLEHLHQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGF 163
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY----ADLHSEEIIAGIIKGNLGPK 853
MAPEL + ++ VD ++ GV ++E++ P+ + ++E+ I+ ++
Sbjct: 164 MAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--T 219
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEIT-KELRA 889
P P +S E + DP+ R F + LR
Sbjct: 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 60/296 (20%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
+ IK LG G G VF + KG+ A+K + + +++ E +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----RNKVKRVLT-EQEIL 55
Query: 680 GQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ HP + Y T+ T L V +Y G L ++L+R + + + A
Sbjct: 56 ATLDHPFLPTLYASFQTE---TYLCLVMDYCPGGELFRLLQR------QPGKCLSEEVAR 106
Query: 739 F-------GIEYLHEKNIVHFDLKSHNFLV---------------NMRDPQRPVCKIGDL 776
F +EYLH IV+ DLK N L+ PV K
Sbjct: 107 FYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 777 GLSKIKQKTLI------SGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWE 825
G + ++ R GT ++APE+ + VD ++ G++++E
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYE 224
Query: 826 LLTGEEPYADLHSEEIIAGIIKGNL----GPKIPSWCEPTWRSLMERCWSSDPKSR 877
+L G P+ + +E + I+K + P + S R L+ + DP R
Sbjct: 225 MLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSA----RDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 8e-11
Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 56/251 (22%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRL----IADFWRE 675
D E IK +G G FG V+ K G A+K ++ + D + IA E
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR---------KSDMIKRNQIAHVRAE 51
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA- 734
+L P +V Y D +L V EYM G L +L RKD + R IA
Sbjct: 52 RDILADADSPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE 109
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-------------- 780
+ A ++ +H+ +H D+K N L++ D K+ D GL K
Sbjct: 110 LVLA--LDSVHKLGFIHRDIKPDNILID-ADGH---IKLADFGLCKKMNKAKDREYYLND 163
Query: 781 ----------------IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMW 824
KQ+ + + GT ++APE+ + + D +S GV+++
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILY 221
Query: 825 ELLTGEEPYAD 835
E+L G P+
Sbjct: 222 EMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 33/243 (13%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF-----AEGSLEEDRLIADFWRE 675
D ++ LG G+FG V + KG+D AIK +K E ++ E R++A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LQDK 59
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
L Q+H F V L V EY+ G L +++ + + + A
Sbjct: 60 PPFLTQLHS----CFQ------TVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAA 108
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR--- 792
+ + G+ +LH + I++ DLK N +++ KI D G+ K + ++ G
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMCK---EHMVDGVTTRTF 161
Query: 793 -GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT ++APE+ + + VD +++GV+++E+L G+ P+ +E+ I++ N+
Sbjct: 162 CGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 852 -PK 853
PK
Sbjct: 220 YPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 21/252 (8%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
+G G+FG V + + + A+K I+ + S E +A E +L Q++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-EVTHTLA----ERTVLAQVNCPFI 55
Query: 688 VAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
V + + L V ++ G L L+R+ R R R A + +E LH+
Sbjct: 56 VPLKFSFQSPE---KLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHK 111
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-QKTLISGGVRGTIPWMAPELFKS 805
N+++ DLK N L++ + +C D GL K+ + + GT ++APEL
Sbjct: 112 FNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 806 KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSL 865
T+ VD ++ GV+++E+LTG P+ D + E+ I++ L + P + + L
Sbjct: 168 HG--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL--RFPDGFDRDAKDL 223
Query: 866 MERCWSSDPKSR 877
+ S DP R
Sbjct: 224 LIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
DL+ + E+G G FGTV K S A+KRI+ + E+ RL+ D + M
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDL--DVVMR 58
Query: 680 GQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRKRIIIA 734
P +V FYG + +G + +++ SL K V I IA
Sbjct: 59 SS-DCPYIVKFYGALFREGD----CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 735 MDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
+ + YL E+ I+H D+K N L++ + K+ D G+S ++ G
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 794 TIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGN-- 849
P+MAPE + S + + DV+S G+ ++E+ TG+ PY +S + + ++KG+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229
Query: 850 -LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
L P++ + + C D RP + E+ +
Sbjct: 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 22/253 (8%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPN 686
LG G+FG V + K S A+K +K L++D + E +L HP
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTM-TEKRILSLARNHPF 57
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
+ Y L V E+ VNG +K R D + A + + +LH+
Sbjct: 58 LTQLYCCFQT--PDRLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPELFK 804
K I++ DLK N L++ + CK+ D G+ K I S GT ++APE+
Sbjct: 115 KGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEIL- 168
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864
++ L VD ++ GV+++E+L G P+ + +++ I+ + P+W
Sbjct: 169 -QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAVD 225
Query: 865 LMERCWSSDPKSR 877
+++ + +P R
Sbjct: 226 ILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 622 SDLEYIKELGSGTFGTVF--YGKWKGSDVAIKRIKP---SCFAEGSLEEDRLIADFWREA 676
+L YI G G +G V K G VAIK+I P F + +L E +++ F
Sbjct: 8 QNLSYI---GEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF---- 60
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATV---TEYMVNGSLKQVLRRKDRTIDRRKRIII 733
H N++ ++ + V E M L ++++ + + D + +
Sbjct: 61 ------KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLY 113
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGV 791
+ G++Y+H N++H DLK N L+N C KI D GL++I G
Sbjct: 114 QI--LRGLKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTGF 165
Query: 792 R----GTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
T + APE + SK T+ +D++S G ++ E+L+
Sbjct: 166 LTEYVATRWYRAPEIMLNSK--GYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD-----------VAIKRIKPSCFAEGSLEEDRLIAD 671
D E IK +G G FG V K K ++ +KR + +CF E E + L+
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE---ERNVLVNG 58
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKR 730
+ + +H+ AF L V +Y V G L +L + +DR + R
Sbjct: 59 ---DCQWITTLHY----AFQDE------NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG--LSKIKQKTLIS 788
IA + I +H+ + VH D+K N L++M R + D G L + T+ S
Sbjct: 106 FYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQS 160
Query: 789 GGVRGTIPWMAPELFKSKDNLVTE---KVDVYSFGVVMWELLTGEEPY 833
GT +++PE+ ++ ++ + + + D +S GV M+E+L GE P+
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 31/230 (13%)
Query: 629 ELGSGTFGTVFYGKWK-GSD---VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++G GT+G V+ K K G D A+K+I+ + + + RE +L ++ H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 685 PNVVAFYGVV---TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF-- 739
PNV+A V +D V L E+ + +K R + + ++ +M +
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIK--FHRASKANKKPMQLPRSMVKSLLY 115
Query: 740 ----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS----GGV 791
GI YLH ++H DLK N LV P+R KI D+G +++ L V
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
T + APEL + T+ +D+++ G + ELLT EP E+I
Sbjct: 176 VVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT-SEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLI-----ADFW 673
+K D + +K +G G FG V + K S +A L + +I A FW
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQ--------KVYAMKLLSKFEMIKRSDSAFFW 91
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK---- 729
E ++ + P VV + D L V EYM G L ++ D K
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 149
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG 789
+++A+DA +H ++H D+K N L++ + K+ D G +T G
Sbjct: 150 EVVLALDA------IHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDET---G 196
Query: 790 GVR-----GTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEP-YAD 835
VR GT +++PE+ KS+ D + D +S GV ++E+L G+ P YAD
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 629 ELGSGTFGTVFYGKWKG----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
++G GT+G V+ K K D A+K+I+ + + + RE +L ++ H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 685 PNVVAFYGVV---TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF-- 739
PNV++ V D V L E+ + +K R + + ++ M +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK--FHRASKANKKPVQLPRGMVKSLLY 115
Query: 740 ----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS----GGV 791
GI YLH ++H DLK N LV P+R KI D+G +++ L V
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
T + APEL + T+ +D+++ G + ELLT EP E+I
Sbjct: 176 VVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT-SEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E ++++G GT+G V+ + K G VA+K+ + EG +L E L+ M
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLL-------QM 56
Query: 679 LGQ-IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
L + I+ ++ V +L V EY+ + LK+ + R R
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 738 AF----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGG 790
+ G+ + H+ ++H DLK N LV D Q+ + KI DLGL + I K+
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
V T+ + APE+ + T VD++S G + E+ +
Sbjct: 173 V--TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D I+++G GT+G V+ G+ K G VA+K+I+ EE+ + + RE +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES------EEEGVPSTAIREISLLK 54
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRTIDRRKRIIIAMDAA 738
++ HPN+V V+ L + E++ + LK+ L K + +D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRGTI 795
GI + H + ++H DLK N L++ + V K+ D GL++ I + V T+
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV--TL 165
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
+ APE+ T VD++S G + E+ T
Sbjct: 166 WYRAPEVLLGSPRYST-PVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 50/249 (20%), Positives = 98/249 (39%), Gaps = 41/249 (16%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLE---EDRLIADFWREAH 677
K + K + VA+K+I +L+ ++ L +E
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI--------NLDSCSKEDLKLLQ-QEII 51
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM-- 735
Q+ HPN++ + + L V+ M GS + +L+ + + IA
Sbjct: 52 TSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDLLKT--HFPEGLPELAIAFIL 107
Query: 736 -DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-KTLISGGVRG 793
D ++Y+H K +H +K+ + L+ V LS ++ ++I G R
Sbjct: 108 KDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVV------LSGLRYSVSMIKHGKRQ 158
Query: 794 T------------IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
+PW++PE+ + EK D+YS G+ EL G P+ D+ + ++
Sbjct: 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
Query: 842 IAGIIKGNL 850
+ ++G +
Sbjct: 219 LLEKVRGTV 227
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 630 LGSGTFGTVFYGKWKGS-------DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
LG G FG V + + + + KRIK +L E ++ L ++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI----------LEKV 57
Query: 683 HHPNVVAF-YGVVTDGPVTNLATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFG 740
+ VV+ Y T L V M G LK + + D + + A + G
Sbjct: 58 NSRFVVSLAYAYETKDA---LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMA 799
+E LH + IV+ DLK N L++ R I DLGL+ +I + I G V GT+ +MA
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMA 169
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
PE+ K++ T D + G +++E++ G+ P+
Sbjct: 170 PEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 626 YIK--ELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFW--REAHML 679
Y K +LG G++ TV+ G+ K + VA+K I LE + A F REA +L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEI--------RLEHEEG-APFTAIREASLL 57
Query: 680 GQIHHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ H N+V + ++ T L V EY+ LKQ + + +
Sbjct: 58 KDLKHANIVTLHDIIHTK---KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTI 795
G+ Y H++ ++H DLK N L++ +R K+ D GL++ K KT + V T+
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGLARAKSVPSKTYSNEVV--TL 167
Query: 796 PWMAPE--LFKSKDNLVTEKVDVYSFGVVMWELLTG 829
W P L S + + +D++ G + +E+ TG
Sbjct: 168 -WYRPPDVLLGSTE--YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ I ++G GT+G V+ + K G VA+K+++ EG RE +L Q+
Sbjct: 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQL 63
Query: 683 HHPNVVAFYGVVTDGPVT--------NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
+H N+V +VTD V EYM + L +L
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFM 122
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLISGGV 791
G+ Y H+KN +H D+K N L+N + K+ D GL+++ ++ + V
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
T+ + PEL + +DV+S G ++ EL T
Sbjct: 179 I-TLWYRPPELLLG-EERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 33/235 (14%)
Query: 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLI---- 669
T+L+ +K D + IK +G G FG V + K S +A L + +I
Sbjct: 36 TKLR-MKAEDFDVIKVIGRGAFGEVQLVRHKSSK--------QVYAMKLLSKFEMIKRSD 86
Query: 670 -ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR 728
A FW E ++ + +V + D L V EYM G L ++ D I +
Sbjct: 87 SAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNLMSNYD--IPEK 142
Query: 729 KRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS 788
+ ++ +H +H D+K N L++ K+ D G
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLADFGTCMKMDAN--- 195
Query: 789 GGVR-----GTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEP-YAD 835
G VR GT +++PE+ KS+ D + D +S GV ++E+L G+ P YAD
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686
+G G++ V + K ++ A+K +K + +D I E H+ Q +HP
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKEL-----VNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
+V + + L V EY+ G L ++R+ + + R A + + + YLHE
Sbjct: 58 LVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 114
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----GTIPWMAPEL 802
+ I++ DLK N L++ K+ D G+ K + L G GT ++APE+
Sbjct: 115 RGIIYRDLKLDNVLLDSEGH----IKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEI 167
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPY--------ADLHSEEIIAGIIKGNLGPKI 854
+ +D + VD ++ GV+M+E++ G P+ D ++E+ + +I +I
Sbjct: 168 LRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRI 224
Query: 855 PSWCEPTWRSLMERCWSSDPKSR 877
P S+++ + DPK R
Sbjct: 225 PRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 628 KELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K +G G+FG V + K + A+K ++ + EE ++++ +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSE---RNVLLKNVKHP 56
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+V + + L V +Y+ G L L+R+ ++ R R A + A + YLH
Sbjct: 57 FLVGLH--FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLH 113
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPELF 803
NIV+ DLK N L+ D Q + + D GL K I+ S GT ++APE+
Sbjct: 114 SLNIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVL 168
Query: 804 KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG--NLGPKIPSWCEPT 861
+ VD + G V++E+L G P+ ++ E+ I+ L P I + +
Sbjct: 169 HKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITN----S 222
Query: 862 WRSLMERCWSSDPKSRPAFSEITKELR 888
R L+E D R + E++
Sbjct: 223 ARHLLEGLLQKDRTKRLGAKDDFMEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K +G G+FG V K K GS A+K ++ + E++ ++A+ +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK-EQNHIMAE---RNVLLKNLKHP 56
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
+V Y T L V +Y+ G L L+R+ ++ R R A + A I YL
Sbjct: 57 FLVGLHYSFQT---AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYL 112
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPEL 802
H NI++ DLK N L+ D Q V + D GL K ++ + S GT ++APE+
Sbjct: 113 HSLNIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFC-GTPEYLAPEV 167
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
+ + VD + G V++E+L G P+
Sbjct: 168 LRKEP--YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 625 EYIKELGSGTFGTVFYG---KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E + E+G G +G VF K G VA+KR++ E+ + RE +L
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAVLRH 57
Query: 682 IH---HPNVVAFYGVVTDGPV---TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
+ HPNVV + V T T L V E+ V+ L L + + I M
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 736 DAAF-GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGT 794
G+++LH +VH DLK N LV K+ D GL++I + V T
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLARIYSFQMALTSVVVT 172
Query: 795 IPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELL 827
+ + APE L +S VD++S G + E+
Sbjct: 173 LWYRAPEVLLQSS---YATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 32/230 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLI-----ADFW 673
+K D E +K +G G FG V + K + +A L + +I A FW
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSAFFW 91
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
E ++ + P VV + D L V EYM G L ++ D ++ R
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 148
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR- 792
A + ++ +H +H D+K N L++ + K+ D G K G VR
Sbjct: 149 A-EVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNK---EGMVRC 200
Query: 793 ----GTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEP-YAD 835
GT +++PE+ KS+ D + D +S GV ++E+L G+ P YAD
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLE-EDRLI-ADFWREAHMLG 680
E ++++G GT+G V+ + + ++ +A+K+I+ LE ED + + RE +L
Sbjct: 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIR--------LEQEDEGVPSTAIREISLLK 56
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID--RRKRIIIAM--D 736
++ H N+V VV L V EY+ + LK+ + D + D + R+I
Sbjct: 57 EMQHGNIVRLQDVVHSE--KRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLYQ 110
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRG 793
GI Y H ++H DLK N L++ R K+ D GL++ I +T V
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPVRTFTHEVV-- 165
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
T+ + APE+ + T VD++S G + E++
Sbjct: 166 TLWYRAPEILLGSRHYST-PVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 630 LGSGTFGTV--FYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG G FG V K G A K++ + S E+ L+ E +L +++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 688 VAF-YGVVTDGPVTNLATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
V Y + T+L V M G LK + +R ++ + I + GI +LH
Sbjct: 56 VNLAYAFESK---THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFK 804
+IV+ D+K N L++ + C++ DLGL+ ++K I+ GT +MAPE+ K
Sbjct: 113 SMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILK 167
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
+ + VD ++ G ++E++ G P+ D H E++
Sbjct: 168 EE--PYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEED-RLIADFWREAHMLGQI- 682
+ ++G GTF V + + G AIK +K SLE+ L RE L ++
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNL-----REIQALRRLS 55
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID--RRKRIIIAMDAAFG 740
HPN++ V+ D LA V E M + +L ++++ + R + R K + +
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--LKS 112
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQK----TLISGGVRGTI 795
++++H I H D+K N L+ + K+ D G + I K IS T
Sbjct: 113 LDHMHRNGIFHRDIKPENILIK-----DDILKLADFGSCRGIYSKPPYTEYIS-----TR 162
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
+ APE + D K+D+++ G V +E+L+
Sbjct: 163 WYRAPECLLT-DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDVA-----------IKRIKPSCFAEGSLEEDRLIAD 671
D E +K +G G FG V K K + +KR + +CF E E D L+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE---ERDVLVNG 58
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKR 730
+ + +H+ AF D NL V +Y V G L +L + +DR + R
Sbjct: 59 ---DRRWITNLHY----AF----QDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG--LSKIKQKTLIS 788
+A + I+ +H+ VH D+K N L++ R + D G L + T+ S
Sbjct: 106 FYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTVQS 160
Query: 789 GGVRGTIPWMAPELFKS----KDNLVTEKVDVYSFGVVMWELLTGEEP-YAD 835
GT +++PE+ ++ K E D +S GV M+E+L GE P YA+
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 13/181 (7%)
Query: 702 LATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFL 760
L V M G LK + + + + + A + G+E LH++ IV+ DLK N L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 761 VNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSF 819
++ R I DLGL+ + + I G V GT+ +MAPE+ K++ T D ++
Sbjct: 135 LDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNER--YTFSPDWWAL 187
Query: 820 GVVMWELLTGEEPYADLHSE---EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKS 876
G +++E++ G+ P+ + E + ++K + + P RSL + DPK
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKE 246
Query: 877 R 877
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 9/134 (6%)
Query: 702 LATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFL 760
L V M G LK + + + + + A + G+E LH +N V+ DLK N L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 761 VNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSF 819
++ R I DLGL+ KI + I G V GT+ +MAPE+ ++ T D +
Sbjct: 135 LDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQR--YTLSPDYWGL 187
Query: 820 GVVMWELLTGEEPY 833
G +++E++ G+ P+
Sbjct: 188 GCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 627 IKELGSGTFGTVFYG--KWKGSDVAIKRI----KPSCFAEGSLEEDRLIADFWREAHMLG 680
+K++GSG +G+V K G VAIK++ + FA+ + +RE +L
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA----------YRELTLLK 69
Query: 681 QIHHPNVVAFYGVVTDGPV----TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+ H NV+ V T + V YM L++++ + D+ + ++ M
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP-LSEDKVQYLVYQM- 126
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
G++Y+H I+H DLK N VN D + KI D GL++ + G T
Sbjct: 127 -LCGLKYIHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLARHADAEMT--GYVVTRW 179
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APE+ + + + VD++S G +M E+LTG+
Sbjct: 180 YRAPEVILNWMHY-NQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 33/262 (12%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPN 686
+G G++ V + K +D A+K +K + +D I E H+ Q +P
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-----VHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
+V + + L V EY+ G L ++R+ + + R A + + +LHE
Sbjct: 58 LVGLHSCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY-AAEICIALNFLHE 114
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----GTIPWMAPEL 802
+ I++ DLK N L++ K+ D G+ K + L G GT ++APE+
Sbjct: 115 RGIIYRDLKLDNVLLD----ADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEI 167
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPY------ADLHSEEIIAGIIKGNLGP-KIP 855
+ ++ + VD ++ GV+M+E++ G P+ D+++E+ + +I P +IP
Sbjct: 168 LRGEEYGFS--VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIP 223
Query: 856 SWCEPTWRSLMERCWSSDPKSR 877
+ +++ + DPK R
Sbjct: 224 RFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 630 LGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
+GSG +G+V + G VA+K++ +P + + R +RE +L + H N
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRT----YRELRLLKHMKHEN 77
Query: 687 VVAFYGVVTDGPVTNLATVTE-----YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
V+ V T P +L + +++ L +++ + T D + +I + G+
Sbjct: 78 VIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--LRGL 133
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
+Y+H +I+H DLK N VN D + KI D GL++ + G T + APE
Sbjct: 134 KYIHSADIIHRDLKPSNLAVN-EDCE---LKILDFGLARHTDDEMT--GYVATRWYRAPE 187
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTG 829
+ + + + VD++S G +M ELLTG
Sbjct: 188 IMLNWMHY-NQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 22/255 (8%)
Query: 628 KELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K +G G+FG V K K A+K ++ + E+ ++A+ R +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE--RNV-LLKNVKHP 56
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
+V Y T L V +Y+ G L L+R+ + R R A + A + YL
Sbjct: 57 FLVGLHYSFQT---ADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYL 112
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPEL 802
H NI++ DLK N L+ D Q V + D GL K I+ S GT ++APE+
Sbjct: 113 HSLNIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEV 167
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTW 862
+ + VD + G V++E+L G P+ + E+ I+ L ++ +
Sbjct: 168 LRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSA 223
Query: 863 RSLMERCWSSDPKSR 877
R L+E D R
Sbjct: 224 RHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
EA +L ++ HP V+A V G +T L + +Y L L + R + + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCL-VLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGV 791
I+Y+H + I+H D+K+ N LVN P+ +C +GD G + + T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAACFARGSWSTPFHYGI 322
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWE 825
GT+ APE+ + T VD++S G+V++E
Sbjct: 323 AGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D E IK + +G +G V+ + K + A+K+I + +L I + E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-----KQNLILRNQIQQVFVERDIL 55
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+P VV+ + +L V EY+ G +L+ R+ A +
Sbjct: 56 TFAENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----------------KQ 783
+EYLH IVH DLK N L+ K+ D GLSKI
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
+ + V GT ++APE+ + + VD ++ G++++E L G P+ EE+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 844 GIIKGNL 850
+I ++
Sbjct: 227 QVISDDI 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 33/183 (18%)
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-----KDRTIDRRKRIIIAMDAA 738
HPN++ + V T G + L ++ +M GS +L+ + I A
Sbjct: 58 HPNIMTSWTVFTTG--SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGAL 111
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-KTLISGGVRGTI-- 795
G+ YLH+ +H ++K+ + L++ G + LS + +L+ G + +
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGD---------GLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 796 ----------PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
PW++PEL + K D+YS G+ EL TG P+ D+ +++
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222
Query: 846 IKG 848
+KG
Sbjct: 223 LKG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-08
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
+PN + Y VT ++ + +Y+ +G L +L+++ + + + I +
Sbjct: 67 DNPNFIKLYYSVTT-LKGHV-LIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALN 123
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIPWMAPE 801
LH+ NI+H D+K N L + + +C D GL KI + GT+ + +PE
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCKIIGTPSCY----DGTLDYFSPE 176
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
K K + D ++ GV+ +ELLTG+ P+ + EE+
Sbjct: 177 --KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ ++++G GT+G V+ + K G VA+K+I+ EG + + RE +L ++
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKEL 56
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF--- 739
+HPN+V V+ L V E++ + LK+ + I + + ++
Sbjct: 57 NHPNIVKLLDVIHTE--NKLYLVFEFL-HQDLKKFM-----DASPLSGIPLPLIKSYLFQ 108
Query: 740 ---GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRG 793
G+ + H ++H DLK N L+N K+ D GL++ + +T V
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV-- 162
Query: 794 TIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT 828
T+ + APE L K + VD++S G + E++T
Sbjct: 163 TLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 59/257 (22%), Positives = 111/257 (43%), Gaps = 41/257 (15%)
Query: 627 IKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLGQIH 683
+++LG G++ TV+ G + G VA+K I S++ E+ + REA +L +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVI--------SMKTEEGVPFTAIREASLLKGLK 61
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
H N+V + ++ L V EYM + L Q + + + + G+ Y
Sbjct: 62 HANIVLLHDIIHTK--ETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTIPWMAP 800
+H ++I+H DLK N L++ K+ D GL++ K +T S V T+ + P
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPP 172
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS----------------EEIIAG 844
++ + + +D++ G + E+L G+ + + E+ G
Sbjct: 173 DVLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231
Query: 845 IIK-GNLGPKIPSWCEP 860
+ K N P+ C+P
Sbjct: 232 VSKLPNYKPEWFLPCKP 248
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 702 LATVTEYMVNGSLK-QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFL 760
L V M G LK + + D ++ I A + G+E L + IV+ DLK N L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 761 VNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSF 819
++ R R I DLGL+ +I + + G V GT+ +MAPE+ ++ T D +
Sbjct: 135 LDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEK--YTFSPDWWGL 187
Query: 820 GVVMWELLTGEEPY 833
G +++E++ G+ P+
Sbjct: 188 GCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 77/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K +G G+FG V K K G A+K ++ E+ ++A+ R +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE--RNV-LLKNVKHP 56
Query: 686 NVVAF-YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA-MDAAFGIEY 743
+V Y T L V +++ G L L+R+ + R R A + +A G Y
Sbjct: 57 FLVGLHYSFQT---TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--Y 111
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPE 801
LH NIV+ DLK N L+ D Q V + D GL K I Q + GT ++APE
Sbjct: 112 LHSINIVYRDLKPENILL---DSQGHVV-LTDFGLCKEGIAQSDTTTTFC-GTPEYLAPE 166
Query: 802 LFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
+ + + DN VD + G V++E+L G P+ E+ I+ L + P
Sbjct: 167 VIRKQPYDN----TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR-PGASL 221
Query: 860 PTWRSLMERCWSSDPKSRPAFSEITKELR 888
W S++E D + R E E++
Sbjct: 222 TAW-SILEELLEKDRQRRLGAKEDFLEIQ 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
K E +++LG G++ TV+ GK K G VA+K I+ EE+ REA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-------EEEGTPFTAIREAS 55
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+L + H N+V + ++ L V EY V+ L Q + + + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTK--ETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
G+ Y+H++ I+H DLK N L++ K+ D GL++ K + W
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
P + +D++ G + E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 62/253 (24%), Positives = 102/253 (40%), Gaps = 55/253 (21%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D E IK +G G FG V + K G A+K+++ S LE++++ A E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEKEQV-AHVRAERDIL 55
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ +P VV Y D L + EY+ G + +L +KD + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK------------------- 780
I+ +H+ +H D+K N L++ + K+ D GL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 781 -----IKQKTLISGG---------------VRGTIPWMAPELFKSKDNLVTEKVDVYSFG 820
K + S GT ++APE+F ++ D +S G
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLG 226
Query: 821 VVMWELLTGEEPY 833
V+M+E+L G P+
Sbjct: 227 VIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
IK +G G +G V K VAIK+I + F + ++ R + RE +L + H
Sbjct: 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIA-NAF-DNRIDAKRTL----REIKLLRHLDH 63
Query: 685 PNVVAFYGVVTDGPV-----TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
NV+A ++ P ++ V E M + L Q++R D + +
Sbjct: 64 ENVIAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLR 119
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKT--LISGGVRGTI 795
G++Y+H N++H DLK N L+N C KI D GL++ + ++ V T
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APEL + T +DV+S G + ELL +
Sbjct: 173 WYRAPELLLNCSEY-TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
EAH+L I+HP+++ G T T L + Y + +R D I+A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCL-ILPRYKTDLYCYLAAKRNIAICD-----ILA 186
Query: 735 MDAAF--GIEYLHEKNIVHFDLKSHNFLVNMRDPQRP--VCKIGDLGLS----KIKQKTL 786
++ + I+YLHE I+H D+K+ N +N P VC +GD G + I
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKY 240
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE 831
G GTI APEL ++D VD++S G+V++E+ T +
Sbjct: 241 Y--GWAGTIATNAPELL-ARDPY-GPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 624 LEYIKELGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLG 680
+ + +GSG +G+V Y VA+K++ +P SL R +RE +L
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRT---YRELRLLK 69
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTE-YMVN----GSLKQVLRRKDRTIDRRKRIIIAM 735
+ H NV+ V T P T++ E Y+V L +++ + + + + +I +
Sbjct: 70 HMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
G++Y+H I+H DLK N VN D + +I D GL++ + G T
Sbjct: 128 --LRGLKYIHSAGIIHRDLKPSNVAVN-EDCE---LRILDFGLARQADDEMT--GYVATR 179
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APE+ + + + VD++S G +M ELL G+
Sbjct: 180 WYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 625 EYIKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEG-SLEEDRLIADFWREAHMLGQ 681
E + E+G G +GTV+ + G VA+K ++ +G L R +A R L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR----LEA 58
Query: 682 IHHPNVVAFYGVV----TDGPVTNLATVTEYMVNGSLKQVLRRK-------DRTIDRRKR 730
HPN+V V TD T + V E+ V+ L+ L + + D ++
Sbjct: 59 FDHPNIVRLMDVCATSRTDRE-TKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
+ G+++LH IVH DLK N LV K+ D GL++I +
Sbjct: 117 FLR------GLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALTP 166
Query: 791 VRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELL 827
V T+ + APE L +S VD++S G + E+
Sbjct: 167 VVVTLWYRAPEVLLQST---YATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK------GSDVAIKRIKPSCFAEGSLEEDRLIA--DFWR 674
D+E + +G G FG V W G VA+K++ P+ F L++ +R
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKM-PNVF-------QNLVSCKRVFR 48
Query: 675 EAHMLGQIHHPNVVAFYGVVTD---GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
E ML H NV++ ++ P + VTE M + K ++ + + D K
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK-- 106
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ----KTLI 787
+ G++YLH I+H D+K N LVN V KI D GL+++++ K +
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMT 162
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
V T + APE+ + T VD++S G + ELL
Sbjct: 163 QEVV--TQYYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 630 LGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686
+G G++ V + K + A+K IK + +ED I E H+ +HP
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVND---DED--IDWVQTEKHVFETASNHPF 57
Query: 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE 746
+V + + L V E++ G L ++R+ + + R + + + + +LHE
Sbjct: 58 LVGLHSCFQT--ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY-SAEISLALNFLHE 114
Query: 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPELFK 804
+ I++ DLK N L+ D + + K+ D G+ K I+ S GT ++APE+ +
Sbjct: 115 RGIIYRDLKLDNVLL---DAEGHI-KLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILR 169
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
+D + VD ++ GV+M+E++ G P+
Sbjct: 170 GEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 645 GSDVAIKRIK-PSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV-VTDGPVTNL 702
G V ++RI +C E ++ E H+ +HPN+V + + D L
Sbjct: 25 GEYVTVRRINLEACTNE-------MVTFLQGELHVSKLFNHPNIVPYRATFIAD---NEL 74
Query: 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA---MDAAFGIEYLHEKNIVHFDLKSHNF 759
VT +M GS K ++ +D + IA ++Y+H VH +K+ +
Sbjct: 75 WVVTSFMAYGSAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132
Query: 760 LVNMRDPQRPVCKIGDLGLSKIKQK-TLISGGVRG------------TIPWMAPELFKSK 806
L+++ G + LS ++ ++I+ G R +PW++PE+ +
Sbjct: 133 LISVD---------GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN 183
Query: 807 DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
K D+YS G+ EL G P+ D+ + +++ + G +
Sbjct: 184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 227
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E + ++G GTFG VF + K + VA+K++ EG +L RE +
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----------REIKI 64
Query: 679 LGQIHHPNVVAFYGVV-TDGPVTNLATVTEYMV----NGSLKQVLRRK--DRTIDRRKRI 731
L + H NVV + T N + Y+V L +L K T+ K++
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------SKIKQKT 785
+ + G+ Y+H I+H D+K+ N L+ +D + K+ D GL SK +
Sbjct: 125 MKMLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPN 178
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
+ V T+ + PEL + + +D++ G +M E+ T
Sbjct: 179 RYTNRVV-TLWYRPPELLLGERDYGP-PIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEED--RLIADFWREA 676
E +++LG G +G V WK D VA+K+I F D R +RE
Sbjct: 10 EILQKLGKGAYGIV----WKAIDRRTKEVVALKKI----FDAFRNATDAQRT----FREI 57
Query: 677 HMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII-- 733
L ++ HPN+V V+ ++ V EYM L V+R + D KR I+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIR-ANILEDVHKRYIMYQ 115
Query: 734 ---AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
A ++Y+H N++H DLK N L+N D + K+ D GL+ ++L
Sbjct: 116 LLKA------LKYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLA----RSLSELE 161
Query: 791 VRGTIPWM----------APE-LFKSKDNLVTEKVDVYSFGVVMWELLTG 829
P + APE L S T+ VD++S G ++ E+L G
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 4e-07
Identities = 57/260 (21%), Positives = 114/260 (43%), Gaps = 31/260 (11%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
+ ++ E IK++G+G FG VF K K + S E+ +L+ E +++
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI----EVNVM 66
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT---IDRRKRIIIAMD 736
++ H N+V + + L + E+ G L + +++ + I+ + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 737 AAFGIEYLHE-------KNIVHFDLKSHNFLVNMRDPQ-------------RPVCKIGDL 776
+ Y H + ++H DLK N ++ RP+ KIGD
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL 836
GLSK ++ GT + +PEL + +K D+++ G +++EL +G+ P+
Sbjct: 187 GLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
Query: 837 HS-EEIIAGIIKGNLGPKIP 855
++ ++I+ + + GP +P
Sbjct: 247 NNFSQLISELKR---GPDLP 263
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 66/299 (22%)
Query: 630 LGSGTFGTV--FYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
+G G++G V G VAIK+I F S + R++ RE +L + HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVS-DATRIL----REIKLLRLLRHPDI 61
Query: 688 VAFYGVV---TDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFGIEY 743
V ++ + ++ V E M L QV++ D T + + + + ++Y
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQL--LRALKY 118
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTIPWM--- 798
+H N+ H DLK N L N C KI D GL+++ I W
Sbjct: 119 IHTANVFHRDLKPKNILANAD------CKLKICDFGLARV---AFNDTP--TAIFWTDYV 167
Query: 799 ------APELFKSKDNLVTEKVDVYSFGVVMWELLTGE------------EPYADL---H 837
APEL S + T +D++S G + E+LTG+ + DL
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 838 SEEIIAGIIK-------GNLGPKIP-------SWCEPTWRSLMERCWSSDPKSRPAFSE 882
S E I+ + ++ K P +P L+ER + DPK RP E
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 27/107 (25%), Positives = 45/107 (42%), Gaps = 10/107 (9%)
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKG-- 848
R +MAPE+ + + TEK D+YS G+ ++E L E PY + I+ ++ G
Sbjct: 65 RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122
Query: 849 ----NLGPKIPSWCE-PTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ ++ M C S P+ R A + RA+
Sbjct: 123 ADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+K +GSG G V Y G +VAIK++ +P F + R +RE ++ ++
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--F-QNVTHAKRA----YRELVLMKLVN 73
Query: 684 HPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
H N++ V T P +L V E M + +L QV++ D +R ++ M
Sbjct: 74 HKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQM-DLDHERMSYLLYQM-- 127
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
GI++LH I+H DLK N +V KI D GL++ + + T +
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
APE+ E VD++S G +M E++ G
Sbjct: 184 RAPEVILGMG--YKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 15/149 (10%)
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS--KIKQKTLISGGV 791
A + G+E++H + +V+ DLK N L++ R I DLGL+ K+K S G
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR----ISDLGLACDFSKKKPHASVGT 158
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKG 848
G +MAPE+ + K D +S G ++++LL G P+ ++ EI +
Sbjct: 159 HG---YMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
++P P RSL+E D R
Sbjct: 215 A--VELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 52/256 (20%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E +K +G G FG V + K G A+K ++ + + E + E +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-----KADMLEKEQVGHIRAERDILV 56
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ VV + D NL + E++ G + +L +KD + + IA +
Sbjct: 57 EADSLWVVKMFYSFQDK--LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLA 113
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL---------------------- 778
I+ +H+ +H D+K N L++ + K+ D GL
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGH----VKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 779 --------SKIKQKTL------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMW 824
SK K +T ++ GT ++APE+F + D +S GV+M+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMY 227
Query: 825 ELLTGEEPYADLHSEE 840
E+L G P+ +E
Sbjct: 228 EMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGV 791
A + G+E++H + +V+ DLK N L++ R I DLGL+ K+K S G
Sbjct: 103 ATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR----ISDLGLACDFSKKKPHASVGT 158
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKG 848
G +MAPE+ + K D +S G ++++LL G P+ ++ EI +
Sbjct: 159 HG---YMAPEVLQ-KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
N+ ++P P +SL+E D R
Sbjct: 215 NV--ELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 52/256 (20%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D E +K +G G FG V + K G A+K ++ + + E +A E +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA-----DMLEKEQVAHIRAERDILV 56
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ VV + D NL + E++ G + +L +KD + + IA +
Sbjct: 57 EADGAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLA 113
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL---------------------- 778
I+ +H+ +H D+K N L++ + K+ D GL
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGH----VKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 779 --------SKIKQKTL------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMW 824
SK K +T ++ GT ++APE+F + D +S GV+M+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMY 227
Query: 825 ELLTGEEPYADLHSEE 840
E+L G P+ +E
Sbjct: 228 EMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 625 EYIKELGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQ 681
+ +K +GSG G V + G +VA+K++ +P + +RE +L
Sbjct: 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTHAKRAYRELVLLKC 76
Query: 682 IHHPNVVAFYGVVTDGPV----TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++H N+++ V T ++ V E M + +L QV+ + +D + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQM 132
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
GI++LH I+H DLK N +V KI D GL++ + T +
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTACTNFMMTPYVVTRYY 188
Query: 798 MAPEL---FKSKDNLVTEKVDVYSFGVVMWELLTG 829
APE+ K+N VD++S G +M EL+ G
Sbjct: 189 RAPEVILGMGYKEN-----VDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 627 IKELGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+K +GSG G V Y +VAIK++ +P + +RE ++ ++
Sbjct: 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVN 74
Query: 684 HPNVVAFYGVVTDGPVTNLATVTE-YMV----NGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
H N+++ V T P +L + Y+V + +L QV++ + +D + +
Sbjct: 75 HKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQML 129
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
GI++LH I+H DLK N +V KI D GL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELL 827
APE+ E VD++S G +M E++
Sbjct: 186 APEVILGMG--YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ +K + G FG V+ G+ K + A+K +K + ++ ++ A+ R+A L
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH-QVQAE--RDALALS 61
Query: 681 QIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ P +V +Y + + N+ V EY++ G +K +L + I+ + A
Sbjct: 62 K--SPFIVHLYYSLQS---ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVAL 115
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782
++YLH I+H DLK N L++ K+ D GLSK+
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 627 IKELGSGTFGTV--FYGKWKGSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+K +GSG G V Y +VAIK++ +P + +RE ++ ++
Sbjct: 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVN 81
Query: 684 HPNVVAFYGVVTDGP----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
H N++ V T ++ V E M + +L QV++ + +D + +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLC 137
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
GI++LH I+H DLK N +V KI D GL++ + + T + A
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
PE+ E VD++S G +M E++ G
Sbjct: 194 PEVILGMG--YKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 19/232 (8%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGS-DV-AIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D + +G G FG V + K + D+ A+K +K S L ++ F E +L
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILS 56
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+ P + D NL V EY G L +L R + D +
Sbjct: 57 ISNSPWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWM 798
I +H+ VH D+K N L++ + K+ D G + K + S GT ++
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 799 APELFKSKDNLVTEKVDV----YSFGVVMWELLTGEEPYADLHSEEIIAGII 846
APE+ + + V +S GV+ +E++ G P+ + S + I+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 59/263 (22%), Positives = 95/263 (36%), Gaps = 66/263 (25%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLI-----ADFWREA 676
S IK +G G FG V V + +A +L + ++ A E
Sbjct: 1 SMFVKIKTIGIGAFGEV----CLVRKVDTNAL----YAMKTLRKADVLMRNQAAHVKAER 52
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L + + VV Y D NL V +Y+ G + +L R + R IA +
Sbjct: 53 DILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL------------------ 778
IE +H+ +H D+K N L++ RD K+ D GL
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILID-RDGH---IKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 779 ---------------SKIKQKTLISGGVR-----------GTIPWMAPELFKSKDNLVTE 812
+ + K L R GT ++APE+ T+
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQ 223
Query: 813 KVDVYSFGVVMWELLTGEEPYAD 835
D +S GV+++E+L G+ P+
Sbjct: 224 LCDWWSVGVILYEMLVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 75/320 (23%), Positives = 125/320 (39%), Gaps = 77/320 (24%)
Query: 627 IKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSL-EEDRL----IADFWREAHMLGQ 681
IK LG G FG V +A K + +A +L ++D L +A E +L +
Sbjct: 6 IKTLGIGAFGEVC--------LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
+ VV Y D NL V +Y+ G + +L R + + R IA + I
Sbjct: 58 ADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAI 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNM-------------------------------RDPQRPV 770
E +H+ +H D+K N L+++ +D P
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 771 --------CKIGDLGLSKIKQKT------LISGGVRGTIPWMAPELFKSKDNLVTEKVDV 816
C+ GD L ++Q+ ++ + GT ++APE+ K T+ D
Sbjct: 175 DLWDDVSNCRCGDR-LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQLCDW 231
Query: 817 YSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE--PTWRSLMER-CWSS- 872
+S GV+++E+L G+ P+ E +I IP + P L+ + C S+
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
Query: 873 ---------DPKSRPAFSEI 883
D K+ P FSE+
Sbjct: 292 ERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 627 IKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWR----------- 674
I +L +G FG +F + S + A R + +G + +RLIA +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLEN 212
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRR 728
E LG+++H N++ ++ T + T + +M + + KDR + ++
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW----KDRPLLKQ 268
Query: 729 KRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTL 786
R I+ +EY+H+K ++H D+K N +N +GD G + K++
Sbjct: 269 TRAIMKQLLC-AVEYIHDKKLIHRDIKLENIFLNCDG----KIVLGDFGTAMPFEKEREA 323
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
G GT+ +PE+ + D E D++S G+++ ++L+ +
Sbjct: 324 FDYGWVGTVATNSPEIL-AGDGYC-EITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADF-WREAHMLG 680
E + +G G +G V + K + VAIK+ K S EE+ + + RE ML
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS-------EENEEVKETTLRELKMLR 55
Query: 681 QIHHPNVV----AFYG-----VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
+ N+V AF +V + N+ + E M NG ++ +
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----------EKVRSY 105
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
I + A I + H+ +IVH D+K N L++ D V K+ D G + + L G
Sbjct: 106 IYQLIKA--IHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFA----RNLSEGSN 155
Query: 792 RGTIPWMAPELFKSKDNLV----TEKVDVYSFGVVMWELLTGE 830
++A ++S + L+ + VD++S G ++ EL G+
Sbjct: 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 39/106 (36%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 624 LEYIKELGSGTFGTVF----YGKWKGSD----VAIKRIKPSCFAEGSLEEDRLIADFWRE 675
L + K LG+G FG V YG +K SD VA+K +KPS E + L+++ +
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAH---LTEREALMSEL-KV 91
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK 721
LG +H N+V G T G T +TEY G L LRRK
Sbjct: 92 LSYLG--NHINIVNLLGACTVGGPT--LVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|219981 pfam08706, D5_N, D5 N terminal like | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 17/115 (14%)
Query: 89 DDTPLVLIASDDDVRCMVEEYDKLESCGKGVADDSLRKKVMKQQLS-AKQSCDSPLIDLD 147
D + +D +R ++EE + + K A S K +K L AK D L +LD
Sbjct: 32 DSKKAIRELADKLLRLILEEAEAAKELRK-FAKRSRSKSGVKNVLREAKAMLDVTLDELD 90
Query: 148 FGLEEPNDLVVKNDPFRVNVANG---LENGRLRPLNPRDGNVRNIAVEANASVEC 199
DP+ +N NG L G LRP +P D + V+ + +C
Sbjct: 91 A------------DPYLLNFPNGVLDLRTGELRPHDPEDRLTKITPVDYDPDADC 133
|
This domain is found in D5 proteins of DNA viruses and bacteriophage P4 DNA primases phages. Length = 145 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 17/110 (15%)
Query: 624 LEYIKELGSGTFGTVF----YGKWKGSD---VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
L++ K LG+G FG V +G K + VA+K +K S + E + L+++ +
Sbjct: 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD---EREALMSELKILS 96
Query: 677 HMLGQIHHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRTI 725
H LG H N+V G T GPV +TEY G L LR+K T
Sbjct: 97 H-LG--QHKNIVNLLGACTHGGPVL---VITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM-- 798
+ Y+H K I H DLK N L+ DP K+ D G K L++G + ++ ++
Sbjct: 183 LAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFG----SAKNLLAG--QRSVSYICS 233
Query: 799 ----APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847
APEL N T +D++S G ++ E++ G ++ S + + II+
Sbjct: 234 RFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 897 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.52 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.5 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.49 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.49 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.49 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.48 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.48 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.48 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.48 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.48 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.47 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.47 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.47 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.47 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.47 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.47 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.47 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.46 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.46 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.46 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.45 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.45 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.45 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.45 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.45 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.44 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.44 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.44 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.44 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.44 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.43 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.43 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.42 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.42 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.42 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.42 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.42 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.41 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.41 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.41 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.41 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.4 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.4 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.4 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.4 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.4 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.4 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.4 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.4 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.39 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.39 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.39 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.39 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=413.79 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=224.6
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
..+.|.+.+.||+|+||.|-+|.. +++.||||++.+........ .......+.+|+++|++|+|||||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 356788999999999999999977 57789999997765444332 111223467999999999999999999999987
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...||||||++||+|++.+..+ +.+.+.....++.||+.||.|||++||+||||||+|||+..+ .++..+||+|||
T Consensus 249 --ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~-~e~~llKItDFG 324 (475)
T KOG0615|consen 249 --DSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND-AEDCLLKITDFG 324 (475)
T ss_pred --CceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC-CcceEEEecccc
Confidence 6789999999999999999765 457788888999999999999999999999999999999733 366889999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCC
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLV-TEKVDVYSFGVVMWELLTGEEPYADLHSEE-IIAGIIKGNLGPKIP 855 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~-s~ksDIWSLGvILyELLtGk~PF~~~~~~e-il~~Ii~~~l~~~~p 855 (897)
+|+.........++||||.|.|||++.+....+ ..++|||||||+||-+++|.+||.+..... +.++|.++.+....+
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 999887777777899999999999998765433 348999999999999999999999876655 788888988866555
Q ss_pred C--CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 856 S--WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 856 ~--~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
. .++++..+||.+||..||++||++.|+|++=
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 4 4899999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=403.70 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=223.2
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.+..++|++++.||+|+||+||+++.+ ++.+|+|++++... ......+....|..+|..++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i-----v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI-----VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh-----hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 456789999999999999999999874 66799999977633 23345678889999999999999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+. ..+|+|+||+.||.|+.+|++++ .+++..+..++.+|+.||.|||++|||||||||+|||++ ..++++|+|
T Consensus 96 t~--~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtD 168 (357)
T KOG0598|consen 96 TE--EKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTD 168 (357)
T ss_pred cC--CeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEec
Confidence 88 79999999999999999998764 578887888888999999999999999999999999999 899999999
Q ss_pred cCCccc-cccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 776 LGLSKI-KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 776 FGLAk~-~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
|||++. ......+.+++||+.|||||++.+.+ |+..+||||||+++|||++|.+||...+..++..++.++.. +..
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g--y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~ 245 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG--YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLP 245 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCC--CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCC
Confidence 999994 45556667899999999999999765 89999999999999999999999999999999999988873 456
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRP----AFSEITK 885 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRP----Ta~ELLq 885 (897)
|..++.+.+++|+++|++||++|. ++.+|.+
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 666999999999999999999995 4555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=402.29 Aligned_cols=251 Identities=33% Similarity=0.527 Sum_probs=222.4
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+..++++.++.||+|..|+||+++++ ++.+|+|++... .+....+++.+|+++++..+||+||++|+.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 55678899999999999999999996 667999999543 234567889999999999999999999999998
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+.. .++++||||++|+|.+++... +.+++.....|+.++++||.|||+ ++||||||||+|||++ ..+.|||||
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKicD 222 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKICD 222 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEecc
Confidence 732 699999999999999999876 458999999999999999999996 8999999999999999 889999999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHhcCC
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL-----HSEEIIAGIIKGNL 850 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~-----~~~eil~~Ii~~~l 850 (897)
||.++..... ...++.||..|||||.+.+.. |+.++||||||++++|+.+|++||... ...+++..|+.+.
T Consensus 223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p- 298 (364)
T KOG0581|consen 223 FGVSGILVNS-IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP- 298 (364)
T ss_pred ccccHHhhhh-hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-
Confidence 9999976655 456789999999999999765 899999999999999999999999875 4566777766654
Q ss_pred CCCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 GPKIPSW-CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 ~~~~p~~-ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+|..|.. +|+++++||..||++||.+||+++||++|
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 5778876 99999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=406.34 Aligned_cols=268 Identities=45% Similarity=0.800 Sum_probs=236.9
Q ss_pred cccccCCCceEEEEecccCceEEEEeeecCcc-EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD-VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~-VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
.+++...++.+.+.||+|+||+||++.+.++. ||||++....... ...+.|.+|+.+|.+++|||||++++++
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~------~~~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD------ESRKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh------HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 35566677778888999999999999999998 9999997642221 1178899999999999999999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhh-ccccccHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCeEeccCCCCCC-eE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAMDAAFGIEYLHEKN-IVHFDLKSHNFLVNMRDPQRP-VC 771 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~-~~~~lse~~~l~Ia~QLl~AL~yLHs~G-IVHRDIKPeNILLd~~~~~~g-~V 771 (897)
.+.. ..+.+||||+++|+|.+++.. .+..+++..++.|+.||+.||+|||+++ ||||||||+|||++ ... ++
T Consensus 109 ~~~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~ 183 (362)
T KOG0192|consen 109 TSPP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTL 183 (362)
T ss_pred cCCC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEE
Confidence 9873 278999999999999999988 4678999999999999999999999999 99999999999998 665 99
Q ss_pred EEEecCCccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 002642 772 KIGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 772 KLiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l 850 (897)
||+|||+++..... .......||+.|||||++.+....|+.|+||||||++||||+||+.||...........+.....
T Consensus 184 KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 184 KIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL 263 (362)
T ss_pred EECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999866543 33334789999999999985323489999999999999999999999999999888888888899
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~el 894 (897)
++.+|..+++.+..+|++||..||++||++.+++..|+.+....
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999999999988754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=415.20 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=227.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|+..+.||+|+|+.||.++. .|+.||+|++.+.. ..+......+.+|+++.++|+|||||+++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-----l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-- 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-----LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-- 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-----hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--
Confidence 6899999999999999999987 58899999996642 33445567888999999999999999999999998
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+.|||+|+|..++|..++++ .+.++|.++.+++.||+.||.|||+++|||||||..|||++ ++.+|||+|||||
T Consensus 91 ~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 799999999999999999984 46799999999999999999999999999999999999998 8889999999999
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
.... +.....+.||||.|.|||++.... ++..+||||+|||||-|++|++||....-.+.+..|....+ .+|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--cccccc
Confidence 9766 446667899999999999998655 79999999999999999999999999999999999999887 778899
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++++||.++|+.||.+|||+++++.+
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=410.46 Aligned_cols=330 Identities=32% Similarity=0.558 Sum_probs=263.1
Q ss_pred ccccCCCCC------CCCChhhhhhhhhhcccccccccccCCChhhhhhh---cccccccccccccccccc--ccccccc
Q 002642 543 YNLSLSSSK------EIEPPQISALQNAATERNDEHKEEIHLDPLEEKVE---TKKTCECSKVIGEISSRS--AAYFTNT 611 (897)
Q Consensus 543 ySf~~ss~~------~i~~~~i~~l~naa~~~~~e~~ee~~~~~~eekv~---~~~~~~~s~~i~~iss~s--~~~~~~~ 611 (897)
|+++|.... .+.|+++....+....- ...+...++.+.+.+. ......|.....+..... .+... .
T Consensus 119 yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~--~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~-~ 195 (468)
T KOG0197|consen 119 YSLSVREGDSGGLGAKVKHYRIRQLDGGGLYP--YIDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTP-D 195 (468)
T ss_pred eeEEEEeccccCCccceeeeeeeEcCCCCeec--CCCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCC-c
Confidence 666665544 78899888776643321 1234445555554443 223333333332222211 11111 1
Q ss_pred cccccccccCCCceEEEEecccCceEEEEeeecCc-cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeE
Q 002642 612 ANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 612 ~~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~-~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl 690 (897)
.....|++..+.+.++++||+|-||+||+|.++++ +||+|.++...+. ...|++|+++|++|+|++||++
T Consensus 196 ~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l 266 (468)
T KOG0197|consen 196 LARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKL 266 (468)
T ss_pred cccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEE
Confidence 11456788889999999999999999999999887 8999999865322 2567899999999999999999
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhh-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~-~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
++++..+ ..++||||||+.|+|.++|+. .+..+...+.+.|+.||++||+||+++++|||||..+||||+ ++.
T Consensus 267 ~gV~~~~--~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~ 340 (468)
T KOG0197|consen 267 YGVCTKQ--EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDL 340 (468)
T ss_pred EEEEecC--CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCc
Confidence 9999987 479999999999999999987 566789999999999999999999999999999999999998 888
Q ss_pred eEEEEecCCccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 002642 770 VCKIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii 846 (897)
.+||+|||+|+...+. ..+....-...|+|||.+... .++.|||||||||+||||+| |+.||.+....+++.. +
T Consensus 341 ~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-l 417 (468)
T KOG0197|consen 341 VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-L 417 (468)
T ss_pred eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-H
Confidence 9999999999954433 233444567889999999854 48999999999999999999 9999999999999887 4
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 847 ~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...++.+.|..||+++.++|..||..+|++|||++.+...|+++...
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 55668899999999999999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=400.59 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=225.5
Q ss_pred cCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
...+|.+.+.||.|+|++|++++.+ ++.||||++.+. .+.++...+.+..|-.+|.+| .||.|++||..|++
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~-----~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR-----YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH-----HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 4579999999999999999999874 668999998665 344556678888999999999 89999999999998
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+|+|+||+++|+|.++|++. ..+++.-+..++.||+.||+|||++|||||||||+|||++ .++++||+||
T Consensus 146 ~--~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikITDF 218 (604)
T KOG0592|consen 146 E--ESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKITDF 218 (604)
T ss_pred c--cceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEeec
Confidence 8 6899999999999999999987 4589999999999999999999999999999999999999 8999999999
Q ss_pred CCccccccccc--------------cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002642 777 GLSKIKQKTLI--------------SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEII 842 (897)
Q Consensus 777 GLAk~~~~~~~--------------~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil 842 (897)
|.|+.+.+... ...++||..|.+||++.... .++.+|||+||||||+|+.|.+||.+.+...++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 99985432211 14589999999999998654 789999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 843 AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 843 ~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.|+.-.+ .+|..+++.+++||+++|..||.+|+|++||.+|
T Consensus 297 qkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 99988776 8899999999999999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=387.68 Aligned_cols=253 Identities=30% Similarity=0.538 Sum_probs=220.9
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++.++||+|+|++||+|+++ +..||||.+.+... ..+..+.+..|+.+|+.++|||||.++++++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~- 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD- 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-
Confidence 468999999999999999999984 66899999965422 234456778999999999999999999999988
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCC--CeEEEEec
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR--PVCKIGDL 776 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~--g~VKLiDF 776 (897)
+.+|+|||||+||+|.+|+++.+ .+++..+..++.||+.||++||+++||||||||+|||++.....+ ..+||+||
T Consensus 82 -~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 82 -DFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred -CeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 79999999999999999998864 589999999999999999999999999999999999998542222 78999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPKIP 855 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~~p 855 (897)
|+|+...+.....+.+|+|.|||||++.... |+.|+|+||+|+|||+|++|+.||...+..|.+..+.++.. .+.++
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~--YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQ--YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhcc--ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 9999998888888999999999999997544 89999999999999999999999999999998887666543 44556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEIT 884 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELL 884 (897)
..++....+++...++++|.+|-++.+..
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhh
Confidence 67788888999999999999997766544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.57 Aligned_cols=241 Identities=30% Similarity=0.507 Sum_probs=222.6
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
...++|++++.||.|+||+|.+++.+ +..+|+|++.+. ...+-+..+..++|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~-----~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ-----KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH-----HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 56789999999999999999999984 667999999764 34556678889999999999999999999999998
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ..++|||||++||.|+.++++.+ .+++..+..++.||+.||+|||+++|++||+||+|||++ .+|.+||+||
T Consensus 116 ~--~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 N--SNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred C--CeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 7 79999999999999999998764 589999999999999999999999999999999999999 8999999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
|.|+..... +.+.||||.|+|||+++.++ |+.++|||||||++|||+.|.+||...++..+.++|+.+++ .+|+
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCc
Confidence 999977665 45689999999999999877 89999999999999999999999999999999999999987 8899
Q ss_pred CCcHHHHHHHHHhhccCCCCC
Q 002642 857 WCEPTWRSLMERCWSSDPKSR 877 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeR 877 (897)
.+++++++||+++|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 999999999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=386.22 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=223.8
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVT 695 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~ 695 (897)
.....|++.+.||+|+||+|+++.+ ++..||+|++......... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 4467999999999999999999987 5778999977654221111 123345558999999999 999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCC-CeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR-PVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~-g~VKLi 774 (897)
.. ..+++||||+.||+|++++.. ...+.+..+..++.||+.|++|||++||+||||||+|||++ .+ +.+||+
T Consensus 91 t~--~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~ 163 (370)
T KOG0583|consen 91 TP--TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLS 163 (370)
T ss_pred cC--CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEe
Confidence 88 569999999999999999988 56788899999999999999999999999999999999998 55 899999
Q ss_pred ecCCcccc-ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 775 DLGLSKIK-QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 775 DFGLAk~~-~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
|||++... .........+||+.|+|||++.++..|-+.++||||+|++||.|++|+.||.+.+...+...+..+.+ .
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 99999977 45556678899999999999998654567999999999999999999999999888888888777766 8
Q ss_pred CCCCC-cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWC-EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~l-s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+|.++ ++++++||++||..||.+|+++.+|+++
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 89999 9999999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=377.22 Aligned_cols=256 Identities=25% Similarity=0.461 Sum_probs=220.2
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee-eec
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV-VTD 696 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~-~~e 696 (897)
...+|+++++||+|+||+||+++. ++..+|.|.++-. .......+....|+.+|++|+|||||++|++ |.+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~------~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG------MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh------hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 456899999999999999999987 5778999988633 2234456788999999999999999999994 444
Q ss_pred CCCceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCeEeccCCCCCC
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHE--KN--IVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs--~G--IVHRDIKPeNILLd~~~~~~g 769 (897)
+ ...++|||||+..|+|.+.++. ..+.++++.+++++.||+.||.++|+ .. |+||||||.||+++ .++
T Consensus 91 ~-~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~g 165 (375)
T KOG0591|consen 91 D-NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANG 165 (375)
T ss_pred c-chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCC
Confidence 3 3558999999999999998853 46789999999999999999999999 44 99999999999999 889
Q ss_pred eEEEEecCCcccccc-ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 002642 770 VCKIGDLGLSKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~ 848 (897)
.+||.|||+++.... ......++|||+||+||.+.+.+ |++|+||||+||++|||+.-.+||.+.+-.++..+|-+.
T Consensus 166 vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 999999999996643 34455789999999999998766 899999999999999999999999999888888888888
Q ss_pred CCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 849 NLGPKIP-SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 849 ~l~~~~p-~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
.+ ++.| ..+|..+..+|..|+..||+.||+.-.+++.+..
T Consensus 244 d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 76 4455 7789999999999999999999986666666554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=372.08 Aligned_cols=263 Identities=30% Similarity=0.498 Sum_probs=215.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
|++..++|++.++||+|+||.||++.+. ++.||||+++... .......+.+|+.++..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 5677889999999999999999999742 3469999986431 122346788999999999 899999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------------------------------------------
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------------------------------------- 722 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------------------------------------- 722 (897)
++++++.... ..+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 9999887542 56899999999999999986431
Q ss_pred ---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccc--
Q 002642 723 ---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT-- 785 (897)
Q Consensus 723 ---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~-- 785 (897)
..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc
Confidence 2367778889999999999999999999999999999998 6778999999999754221
Q ss_pred -cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 786 -LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 786 -~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.......+++.|+|||++.+.. ++.++||||||++||||++ |..||......+.+...+.....+..|..+++++.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1122344678899999987544 7899999999999999997 99999886655444444554445566778899999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 864 SLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
++|.+||+.||++||++.|+++.|+++.++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=373.47 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=217.7
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|...+.||+|+||.||++..+ ++..|||.+.... ....+.+.+|+.+|++++|||||++++.....+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--------~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--------SPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--------chhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456888899999999999999985 5789999986431 111667889999999999999999999755442
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC-CCeEEEEecC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ-RPVCKIGDLG 777 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~-~g~VKLiDFG 777 (897)
...+++.|||+++|+|.+++.+.+..+++..+..++.||++||+|||++|||||||||+|||++ . ++.+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCc
Confidence 2479999999999999999998765799999999999999999999999999999999999998 5 6899999999
Q ss_pred Ccccccc----ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCC
Q 002642 778 LSKIKQK----TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD-LHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 778 LAk~~~~----~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~-~~~~eil~~Ii~~~l~~ 852 (897)
+++.... ......+.||+.|||||++.. .....+++|||||||++.||+||+.||.. ....+.+..+......|
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 9986542 222345789999999999985 22233599999999999999999999998 45566666667666778
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
.+|..+|+++++||.+|++++|++|||++++|++.-.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 9999999999999999999999999999999987643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=389.80 Aligned_cols=247 Identities=25% Similarity=0.453 Sum_probs=219.4
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGV 693 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~ 693 (897)
..+..++|.+++.||+|.||+|+++..+ ++.+|||++++... ..++.+.....|.+++...+ ||.++.++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-----l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-----LQRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-----eccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 3567889999999999999999999885 55799999988633 33445677788888888775 9999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
|+++ .++|+||||+.||++..+++. ..+++..+..++.+|+.||+|||++||||||||.+|||++ ..|++||
T Consensus 438 fQT~--~~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~ki 509 (694)
T KOG0694|consen 438 FQTK--EHLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKI 509 (694)
T ss_pred cccC--CeEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEe
Confidence 9998 799999999999995555443 5689999999999999999999999999999999999999 8899999
Q ss_pred EecCCccccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 774 GDLGLSKIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 774 iDFGLAk~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
+|||+++..- ....+++++|||.|||||++.+.. |+..+|||||||+|||||.|..||.+.+.++++..|+....
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-- 585 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-- 585 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Confidence 9999999543 555678999999999999999765 89999999999999999999999999999999999998865
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAF 880 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa 880 (897)
.+|.++|.++.++|+++|.+||++|..+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 8899999999999999999999999643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.01 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=222.4
Q ss_pred ccCCCceEE--EEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYI--KELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeil--k~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+..++++.. ..||+|+++.||+|+.+++.||||.++... .......+.+.+|+.+|++++||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 344444444 679999999999999999999999986531 1223446778899999999999999999999876
Q ss_pred --CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEE
Q 002642 697 --GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 697 --~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+....+++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. +++||||||+|||++ .++.+||
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~kl 164 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKI 164 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEEE
Confidence 4345789999999999999999764 4688899999999999999999985 999999999999998 7789999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
+|||+++...... ....+|..|+|||++.+....++.++|||||||++|||++|+.||......+....+......+.
T Consensus 165 ~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 165 ICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242 (283)
T ss_pred cccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9999998544322 23468899999999975333489999999999999999999999999888888777777766777
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
+|..++++++++|.+||+.||++|||++|+++.|+.+..
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 777889999999999999999999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=377.70 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=220.3
Q ss_pred cccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.+..++|++++.||+|+||.||+++- +|+.+|+|+++++. ......+..+..|-.+|....+|.||++|..|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~-----M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE-----MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH-----HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 46789999999999999999999986 57789999998763 444556788999999999999999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+. .++||||||++||++..+|.+. ..+++..+..++.+++.|++-||+.|||||||||+|+||+ ..|++||+|
T Consensus 212 D~--~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~GHiKLSD 284 (550)
T KOG0605|consen 212 DK--EYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKGHIKLSD 284 (550)
T ss_pred CC--CeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCCCEeecc
Confidence 88 7999999999999999999875 4688888888888999999999999999999999999999 899999999
Q ss_pred cCCcccccc----------------------c-cc-------------------------cCCcccCCcccCccccccCC
Q 002642 776 LGLSKIKQK----------------------T-LI-------------------------SGGVRGTIPWMAPELFKSKD 807 (897)
Q Consensus 776 FGLAk~~~~----------------------~-~~-------------------------~~~~~GT~~Y~APEvl~g~~ 807 (897)
|||++.... . .. ....+|||.|+|||++.+++
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999852100 0 00 01246999999999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhccCCCCCC---CHHH
Q 002642 808 NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRP---AFSE 882 (897)
Q Consensus 808 ~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL~~DPeeRP---Ta~E 882 (897)
|+...||||||||+||||.|.+||...++.+...+|+.-.....+|. .+++++++||.+||. ||++|. .++|
T Consensus 365 --Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 365 --YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred --CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 89999999999999999999999999999999999988775555554 578999999999999 999996 5788
Q ss_pred HHHH
Q 002642 883 ITKE 886 (897)
Q Consensus 883 LLq~ 886 (897)
|.++
T Consensus 442 IK~H 445 (550)
T KOG0605|consen 442 IKKH 445 (550)
T ss_pred HhcC
Confidence 7764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=379.12 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=216.8
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVT 695 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~ 695 (897)
+..++|.++++||.|+||.||+++. +++.||||.++.+... .++. --++|++.|++|+ |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-----~ee~--~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-----WEEC--MNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-----HHHH--HHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 3457899999999999999999987 4778999999876432 1221 2358999999998 999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+.. ..+++||||| ..+|+++++.+++.+++..+..|+.||++||+|+|++|+.|||+||+|||+. ....+||+|
T Consensus 80 d~~-~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaD 153 (538)
T KOG0661|consen 80 DND-RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIAD 153 (538)
T ss_pred ccC-ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEecc
Confidence 874 3999999999 4699999999899999999999999999999999999999999999999997 678999999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC------
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN------ 849 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~------ 849 (897)
||+|+..........++-|.+|.|||++... .+|+.+.|||++|||++|+.+-++-|++.+..+.+.+|..--
T Consensus 154 FGLARev~SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 154 FGLAREVRSKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccccCCCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 9999987766666778899999999999864 579999999999999999999999999988777666553211
Q ss_pred -----------CCCCCC-----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -----------LGPKIP-----------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -----------l~~~~p-----------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+...+| ...+.++.+||.+||++||.+|||++|.+++
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111 1267899999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.15 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=212.9
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++.+ ++.||+|++.... ....+....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE-----VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-- 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-----HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--
Confidence 47899999999999999999985 6789999986431 11223456788999999999999999999988876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 6899999999999999999764 4588889999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
+...... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .+|..++
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~ 222 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--EFPRHLD 222 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--CCCccCC
Confidence 8654322 2456899999999997654 78999999999999999999999999888887777776654 6777889
Q ss_pred HHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
+.++++|++||+.||.+||+ +++++++
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99999999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.84 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=215.1
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
...++|++.+.||+|+||.||+++++ ++.||+|+++... .........+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 44679999999999999999999884 6679999986431 1122345678899999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+++||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 90 ~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~Df 162 (329)
T PTZ00263 90 E--NRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTDF 162 (329)
T ss_pred C--CEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEeec
Confidence 7 6899999999999999999765 4578888889999999999999999999999999999998 7788999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
|+++...... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.... ..+|.
T Consensus 163 g~~~~~~~~~--~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~ 236 (329)
T PTZ00263 163 GFAKKVPDRT--FTLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPN 236 (329)
T ss_pred cCceEcCCCc--ceecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCC
Confidence 9998654332 2457999999999998654 7899999999999999999999999888877777776654 46788
Q ss_pred CCcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
+++..+++||.+||+.||.+||+ +++++++
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 89999999999999999999986 7888765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=376.99 Aligned_cols=247 Identities=27% Similarity=0.487 Sum_probs=219.9
Q ss_pred CCceEEEEecccCceEEEEeeecC--ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKG--SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~kg--~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|.+.+.||+|+||.||+|+.++ +.||+|.+.+.. ..+..++.+.+|+++++.++|||||.++++|+..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-- 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG------RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-- 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--
Confidence 578888999999999999999864 469999996642 2234578899999999999999999999999988
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.++++|+||+.| +|+.++... ..+++..+..|+.|++.||.|||+.+|+|||+||.|||++ ..+.+|+||||+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 799999999987 999999875 4589999999999999999999999999999999999998 8899999999999
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+.+. .........|||.|||||++.+.+ |+..+|+||||||||||++|++||....-.+....|..+.. +.|...
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v--~~p~~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV--KPPSTA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC--CCcccc
Confidence 9654 334455678999999999998655 89999999999999999999999999888888888888765 566789
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..+.+|++.+|.+||.+|.++.+++.+
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 9999999999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.65 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=205.1
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|++.+.||+|+||.||++.. +++.||+|.+..... ........+.+|+.+++.++|++|+++++.+.+. .
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--D 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh-----hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--C
Confidence 378899999999999999987 477899999864321 1122234677899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999999887643 34688999999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--cCCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK--GNLGPKIPSW 857 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~--~~l~~~~p~~ 857 (897)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEK--YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCC--CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 8654333334567999999999997644 78999999999999999999999987654322221111 1222456677
Q ss_pred CcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
++.++.+||++||+.||++||+ +++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 8999999999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=359.07 Aligned_cols=261 Identities=23% Similarity=0.397 Sum_probs=222.6
Q ss_pred ccccccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeE
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 613 ~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl 690 (897)
....+.+..++|++...||.|..++||+++. +++.||||++... .....++.+.+|+..++.++||||+++
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-------kc~~~ld~l~kE~~~msl~~HPNIv~~ 89 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-------KCNNDLDALRKEVQTMSLIDHPNIVTY 89 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-------hhhhhHHHHHHHHHHhhhcCCCCcceE
Confidence 3445677889999999999999999999998 5778999999643 123347889999999999999999999
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
+..|..+ ..+|+||.||.+|++.+++... ...+++..+..|.+++++||.|||++|.||||||+.||||+ .+|
T Consensus 90 ~~sFvv~--~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG 163 (516)
T KOG0582|consen 90 HCSFVVD--SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDG 163 (516)
T ss_pred EEEEEec--ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCC
Confidence 9999987 7899999999999999999753 34589999999999999999999999999999999999999 899
Q ss_pred eEEEEecCCccccccc----ccc-CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002642 770 VCKIGDLGLSKIKQKT----LIS-GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~----~~~-~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~ 844 (897)
.|||.|||.+-...+. ... ..+.||++|||||++...-..|+.|+||||||++..||.+|..||....+.+++..
T Consensus 164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 9999999987533211 111 56789999999999766556699999999999999999999999999999888777
Q ss_pred HHhcCCCCC--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 845 IIKGNLGPK--------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 845 Ii~~~l~~~--------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
-+++..+.. ....++.+++.+|..||++||.+|||+++++++
T Consensus 244 tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 666654311 113467889999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.04 Aligned_cols=256 Identities=33% Similarity=0.595 Sum_probs=213.9
Q ss_pred ccCCCceEEEEecccCceEEEEeeec-----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k-----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
+...+|++.+.||+|+||.||++.++ +..||+|.++... .......+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 44578999999999999999999763 3469999986531 12234678899999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+... ...++||||+++++|.+++......+++..++.++.||+.||+|||++|++||||||+||+++ .++.+||
T Consensus 75 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred EecC--CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 8876 689999999999999999987656789999999999999999999999999999999999998 6788999
Q ss_pred EecCCccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 774 GDLGLSKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 774 iDFGLAk~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
+|||.+........ .....++..|+|||.+.+.. ++.++||||||+++||+++ |..||......+....+.. ..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GF 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCC--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CC
Confidence 99998764322211 11233567899999987544 7899999999999999875 9999998887776665544 34
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.++.|..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 4566778999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.16 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=215.2
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
...|...++||+|+.|.||.++. +++.||||++....... ..-+++|+.+|+..+|+|||.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~- 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVG- 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhccc-
Confidence 35688889999999999999987 46679999997653222 34577999999999999999999988877
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+|+||||++||+|.+.+... .+++.++..|+++++.||+|||.+||+|||||.+|||++ .++.+||+|||+
T Consensus 343 -deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGF 415 (550)
T KOG0578|consen 343 -DELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGF 415 (550)
T ss_pred -ceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeee
Confidence 6899999999999999999764 489999999999999999999999999999999999999 677899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh-cCCCCCCCC
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK-GNLGPKIPS 856 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~-~~l~~~~p~ 856 (897)
+....... ...+.+|||+|||||++..+. |++++||||||++++||+-|++||...++-..+..|.. +....+.+.
T Consensus 416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~ 493 (550)
T KOG0578|consen 416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPE 493 (550)
T ss_pred eeccccccCccccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcc
Confidence 98665443 556788999999999998766 89999999999999999999999998777665554433 334445678
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+|+++++|+.+||+.|+++|+++.|||++
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 899999999999999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=357.48 Aligned_cols=243 Identities=28% Similarity=0.407 Sum_probs=206.7
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|+||.||+++. +++.||||+++... .........+.+|+.+++.++||||+++++++... ..+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV-----IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEE
Confidence 3699999999999987 46789999986531 11233456678999999999999999999999876 689999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-c
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-K 784 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~-~ 784 (897)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 9999999999998764 4688999999999999999999999999999999999998 67889999999987532 2
Q ss_pred ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 785 ~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.... ..+|..+++++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhcCCC--CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 22233567999999999997644 7899999999999999999999999887777766666554 3677889999999
Q ss_pred HHHHhhccCCCCCC-----CHHHHHHH
Q 002642 865 LMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 865 LI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|++||+.||++|| ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=376.38 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=226.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.-|++.+.||+|+-|.|-+|++ +|+..|||++.+... ..+.....+.+|+-+|+.+.|||++++|++|+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-----~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-- 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-----LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-- 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccc-----cccccccchhhhhHHHHHhcCCCeeeeeeeeccC--
Confidence 5689999999999999999998 689999999965421 1223456788999999999999999999999987
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.++|+|+||++||.|++++.+.+ .+++.++.+++.||+.|+.|+|..+|+|||+||+|+|++ ..+.|||+|||.|
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 79999999999999999998764 577888889999999999999999999999999999998 5666999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
..........+.||+|-|.|||++.+.+ |.+.++||||.|||||.|++|+.||.+.+...++.++.++.+ .+|..+|
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~p-YdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRP-YDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCC-CCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCC
Confidence 9877777778899999999999999876 578999999999999999999999999999999999888887 7889999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+++++||.+||..||+.|.|.+||++|-
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCc
Confidence 9999999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.84 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=210.1
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+.|+.+.++|+|+||.||++++ +|+.||||.+..+ .+.....+-.++|+++|++++|||+|.++.+|...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-- 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-- 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--
Confidence 5789999999999999999988 4778999998654 22344455668999999999999999999999987
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++|+||++. ++.+-+++....++...+.+++.|++.|+.|+|++++|||||||+||||+ ..+.+||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 789999999965 66666666666688999999999999999999999999999999999998 8899999999999
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CC------
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG--NL------ 850 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~--~l------ 850 (897)
+... +......++-|.+|.|||.+.+.. .|+..+||||+||++.||++|.+-|++...-+.+..|... .+
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9665 555666788999999999999854 3899999999999999999999999998877665544321 11
Q ss_pred -----------CCCCC----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 -----------GPKIP----------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 -----------~~~~p----------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+-| ..++.-+.+|++.||+.||++|++.+|++.+
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00001 1256678899999999999999999999864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.06 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=210.2
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||++++. ++.||||+++... .........+.+|+.++..++||||+++++++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-- 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-----LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-- 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--
Confidence 37999999999999999999884 6789999986531 11223456788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 6899999999999999999754 4578889999999999999999999999999999999998 7788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--- 856 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--- 856 (897)
+.... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||......+....+.........|.
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGKG--YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCCC--CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 85543 233567999999999998653 78999999999999999999999998887777666554322222222
Q ss_pred ---CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 ---WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ---~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+++++.++|.+||..+|++||++++++++
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 458999999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=341.71 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=227.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecCc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
.....++|++.+.||+|-||.||+++.+.. .||+|++.++. .........+.+|+++...|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-----HHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 345578999999999999999999998644 59999997652 34445567788999999999999999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
.++ ...|+++||...|+|+..++.. ...+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||
T Consensus 92 hd~--~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lki 165 (281)
T KOG0580|consen 92 HDS--KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKI 165 (281)
T ss_pred ecc--ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeec
Confidence 998 7999999999999999999743 34688899999999999999999999999999999999998 7788999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
+|||.+.... .....+.+||..|.|||+..+.. ++..+|+|++|++.||+++|.+||......+....|.+-.+ .
T Consensus 166 AdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~ 240 (281)
T KOG0580|consen 166 ADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--K 240 (281)
T ss_pred cCCCceeecC-CCCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--c
Confidence 9999997654 44455789999999999998766 79999999999999999999999999988888888877765 7
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
+|..++.+++++|.+||.++|.+|.+..|++++-.-
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 789999999999999999999999999999988654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.89 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=204.2
Q ss_pred cCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
+.++|++.++||+|+||.||+++.+ ++.||+|.++..... .....+.+|+.++++++||||+++++++..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3578999999999999999999874 667999998653211 1123567899999999999999999999876
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++||||+++ +|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 76 --~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG 148 (288)
T cd07871 76 --RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFG 148 (288)
T ss_pred --CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCc
Confidence 689999999975 99999877666688899999999999999999999999999999999998 67889999999
Q ss_pred Cccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----
Q 002642 778 LSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP---- 852 (897)
Q Consensus 778 LAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~---- 852 (897)
+++..... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 149 LARAKSVPTKTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred ceeeccCCCccccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 99754322 122345689999999998653 237889999999999999999999998877666554443211000
Q ss_pred -------------CC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 -------------KI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 -------------~~-----------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+ ...+++++.+||++||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 01 12467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.79 Aligned_cols=254 Identities=33% Similarity=0.550 Sum_probs=205.3
Q ss_pred cCCCceEEEEecccCceEEEEeeec------------------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK------------------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k------------------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~ 681 (897)
...+|++.++||+|+||.||++++. +..||+|+++... .......+.+|++++.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4578999999999999999999752 2259999986531 12345678899999999
Q ss_pred CCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc------------------ccccHHHHHHHHHHHHHHHHH
Q 002642 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD------------------RTIDRRKRIIIAMDAAFGIEY 743 (897)
Q Consensus 682 L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~------------------~~lse~~~l~Ia~QLl~AL~y 743 (897)
++||||+++++++.+. ...++||||+.+++|.+++.... ..+++..+..++.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999876 57899999999999999986431 235777889999999999999
Q ss_pred HHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHH
Q 002642 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFG 820 (897)
Q Consensus 744 LHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLG 820 (897)
||+.||+||||||+|||++ .++.+||+|||+++...... ......++..|+|||++.... ++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC--CCchhhhHHHH
Confidence 9999999999999999998 67889999999997543221 222344678899999987544 78999999999
Q ss_pred HHHHHHHc--CCCCCCCCChHHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 821 VVMWELLT--GEEPYADLHSEEIIAGIIK---G---NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 821 vILyELLt--Gk~PF~~~~~~eil~~Ii~---~---~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
+++|||++ +..||......+.+..+.. . ......+..++..+.++|.+||+.||++|||+.||.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999986 6788887766655543322 1 1122345568899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.08 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=215.2
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC---ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG---SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg---~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
..+..++|++.+.||+|+||.||++++++ ..||+|.+.... .........+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK-----IIKQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 34567899999999999999999998643 469999885431 1123345678899999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+.+. ..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 100 ~~~~--~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL 172 (340)
T PTZ00426 100 FKDE--SYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKM 172 (340)
T ss_pred EEeC--CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEE
Confidence 9877 6899999999999999999765 4588999999999999999999999999999999999998 7789999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+..... .
T Consensus 173 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 246 (340)
T PTZ00426 173 TDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--Y 246 (340)
T ss_pred ecCCCCeecCCC--cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 999999865432 23467999999999997644 78899999999999999999999998887777777766543 5
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|..+++.++++|++||+.||++|+ ++++++++
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 6778899999999999999999995 89998876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=338.80 Aligned_cols=254 Identities=33% Similarity=0.620 Sum_probs=212.8
Q ss_pred cCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
...+|++.+.||+|+||.||++...+ ..||+|.++.. ........+.+|+.++..++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-------CCHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 45689999999999999999998743 35899988643 12234567889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSH 757 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPe 757 (897)
++... ...+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+
T Consensus 76 ~~~~~--~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 76 VCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEcCC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 98876 57899999999999999996531 34778889999999999999999999999999999
Q ss_pred CeEeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 002642 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPY 833 (897)
Q Consensus 758 NILLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF 833 (897)
||+++ .++.+||+|||+++..... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||
T Consensus 154 Nil~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 154 NCLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred eEEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 6778999999998754222 1223345688899999987543 7899999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 834 ~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
.+....+....+.... .+..|..+|+++.+|+.+||+.||.+||+++||+++|++
T Consensus 228 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 9888777766655444 455677899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=366.10 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=217.0
Q ss_pred cccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
....+.|+.+++||+|+||.||++++ +++.||+|.++.... ++....-..+||.+|++|+||||+++.+...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 34457899999999999999999998 577799999976522 2334566789999999999999999999998
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+.....+|||+|||+. +|.-++...+-.+++.++..++.||+.||+|||++||+|||||.+||||+ .++.+||+|
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaD 261 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIAD 261 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecc
Confidence 8756799999999964 89999988777899999999999999999999999999999999999999 899999999
Q ss_pred cCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---
Q 002642 776 LGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL--- 850 (897)
Q Consensus 776 FGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l--- 850 (897)
||||+++.... .....+-|.+|.|||++.+.. .|+..+|+||.||||.||+.|++.|.+.+..+.+..|.+---
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 99999665433 234556799999999999865 489999999999999999999999999998887777654211
Q ss_pred ---CC--CCC-------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 851 ---GP--KIP-------------------SWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 851 ---~~--~~p-------------------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
.+ ++| ..++.+..+|+..+|..||.+|.|+.+.|+
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 111 236788889999999999999999998875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=355.55 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=207.3
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||+||+++.+ ++.||||++++.. .........+.+|+.++..++||||+++++.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-- 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-----MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-- 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 47999999999999999999874 6689999986431 12234456788899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 6899999999999999999764 4688999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc------------------------------------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHH
Q 002642 780 KIKQKTL------------------------------------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVM 823 (897)
Q Consensus 780 k~~~~~~------------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvIL 823 (897)
+...... .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHH
Confidence 7432110 012357999999999997654 78999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhccCCC---CCCCHHHHHHH
Q 002642 824 WELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPK---SRPAFSEITKE 886 (897)
Q Consensus 824 yELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL~~DPe---eRPTa~ELLq~ 886 (897)
|||++|+.||......+....+........+|. .++++++++|.+++. +|+ .||+++||+++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 999999999998888888777766433334443 368999999998765 344 46899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=359.03 Aligned_cols=261 Identities=29% Similarity=0.524 Sum_probs=215.9
Q ss_pred cccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCce
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNI 687 (897)
.|.+..++|++.+.||+|+||.||++++. ...||+|.++... .......+.+|+.+++.+ +||||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-------HTDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-------CHHHHHHHHHHHHHHHhhccCCce
Confidence 34566779999999999999999998752 2369999986531 122346788999999999 89999
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------------------------------------
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------------------------------------------- 722 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~--------------------------------------------- 722 (897)
+++++++... ...++||||+++|+|.+++....
T Consensus 105 v~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTHG--GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecCC--CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 9999999877 68899999999999999985421
Q ss_pred ------------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 723 ------------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 723 ------------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++..+..++.||+.||+|||++||+||||||+|||++ .+..+||+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGl 258 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGL 258 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeecee
Confidence 2367788899999999999999999999999999999998 678899999999
Q ss_pred cccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 779 SKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 779 Ak~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
++...... ......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||..................+..
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC
Confidence 97543221 112233567899999987543 8999999999999999997 99999887665555566666666677
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
|..+++++.++|.+||+.||++||++.++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.79 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=211.6
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||+||+++.. ++.||||+++.... ........+.+|++++..++||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-----IKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-- 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-----hhccHHHHHHHHHHHHHhcCCCCccchhhheecC--
Confidence 47999999999999999999985 77899999865311 1223456788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 6899999999999999999765 5688999999999999999999999999999999999998 7788999999999
Q ss_pred ccccccc------------------------------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC
Q 002642 780 KIKQKTL------------------------------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829 (897)
Q Consensus 780 k~~~~~~------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtG 829 (897)
....... ......||+.|+|||++.+.. ++.++|||||||+||+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC--CCCceeeEecchhhhhhccC
Confidence 7543322 223456999999999998654 78999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002642 830 EEPYADLHSEEIIAGIIK--GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA-FSEITKE 886 (897)
Q Consensus 830 k~PF~~~~~~eil~~Ii~--~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPT-a~ELLq~ 886 (897)
+.||......+....+.. .....+....+++++.++|.+||. ||.+||+ +++++++
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999998887777776666 333222233469999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.47 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=223.8
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC--ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG--SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg--~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..+..++|++++.||.|.-|+||++..++ ..+|+|++.+.. ......+.+...|.+||+.+.||.++.+|..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-----l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-----LASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-----HhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 45667899999999999999999999976 569999997653 33455678888999999999999999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+.+ ...++|||||+||+|..+++++ ++.+++..+..++.+++.||+|||-+|||+|||||+||||. ++|+|.|
T Consensus 147 et~--~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIML 220 (459)
T KOG0610|consen 147 ETD--KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIML 220 (459)
T ss_pred ecc--ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEe
Confidence 988 7899999999999999999765 56799999999999999999999999999999999999998 8999999
Q ss_pred EecCCcccc-------c---------------------------c-c----------------------cccCCcccCCc
Q 002642 774 GDLGLSKIK-------Q---------------------------K-T----------------------LISGGVRGTIP 796 (897)
Q Consensus 774 iDFGLAk~~-------~---------------------------~-~----------------------~~~~~~~GT~~ 796 (897)
+||.|+... . . . ..+..++||-+
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999986310 0 0 0 01224679999
Q ss_pred ccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 002642 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKS 876 (897)
Q Consensus 797 Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPee 876 (897)
|+|||++.+.. .+.++|||+|||+||||+.|..||.+.+.++.+.+++.+.+..+-...++..+++||+++|.+||.+
T Consensus 301 YlAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 301 YLAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred cccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999876 7899999999999999999999999999999999999988755544567899999999999999999
Q ss_pred CCC----HHHHHHH
Q 002642 877 RPA----FSEITKE 886 (897)
Q Consensus 877 RPT----a~ELLq~ 886 (897)
|.. ++||.++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 987 8888764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=372.03 Aligned_cols=257 Identities=36% Similarity=0.634 Sum_probs=229.1
Q ss_pred ccccccccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 613 ~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
..++|+|..+...-++-||+|+.|.||+|+.+++.||||.++.- -..+|+-|++|+||||+.|.+
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEee
Confidence 34678888888888899999999999999999999999987521 125788899999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
+|... -.++||||||..|.|+.+|+.. +.+.......+..+|+.||.|||.+.|||||||.-||||. .+..||
T Consensus 180 VCtqs--PcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VK 252 (904)
T KOG4721|consen 180 VCTQS--PCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVK 252 (904)
T ss_pred eecCC--ceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEE
Confidence 99988 5899999999999999999864 5688888899999999999999999999999999999998 667899
Q ss_pred EEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
|+|||-++...+......++||..|||||++...+ .++|+|||||||+||||+||..||.+.+...++..+-...+..
T Consensus 253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L 330 (904)
T KOG4721|consen 253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL 330 (904)
T ss_pred eccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc
Confidence 99999998766666667899999999999998766 8999999999999999999999999988877777666666777
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
+.|..+|.-|+-||++||+..|.+||++++|+.+|+-+..+
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 89999999999999999999999999999999999866543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=358.49 Aligned_cols=259 Identities=29% Similarity=0.518 Sum_probs=213.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeee-------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW-------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~-------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
+.+..++|++.+.||+|+||.||++++ .+..||||+++.... ......+.+|+.++..+ +||||+
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv 102 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIV 102 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCccee
Confidence 456677899999999999999999874 234699999864311 12245678999999999 899999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------------------------------------------
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------------------------------------- 722 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------------------------------------- 722 (897)
++++++... ...++||||+++|+|.+++....
T Consensus 103 ~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 103 NLLGACTVG--GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeccC--CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 999999877 67899999999999999986421
Q ss_pred ----------------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 723 ----------------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 723 ----------------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
..+++..+..++.||+.||+|||++||+||||||+|||++ ....+||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~ 256 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKIC 256 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEe
Confidence 1467788899999999999999999999999999999998 67789999
Q ss_pred ecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 775 DLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 775 DFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
|||+++...... ......++..|+|||++.+.. ++.++||||||+++|||++ |..||........+.+.+....
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~ 334 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc
Confidence 999997543221 112234567799999997544 7899999999999999998 8999988766555555566655
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.+..|...+.++++||.+||+.||++||++.|+++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5666777889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=361.85 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=219.0
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCC------ChhHHHHHHHHHHHHHHHhhCCCCceeeE
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEG------SLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~------~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl 690 (897)
...+.|++++.||+|.||.|-+++. .++.||||++.+...... ....-..++...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4467899999999999999999998 477899999955432111 11111224578899999999999999999
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhhcccc-ccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~-lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
+.+..+.....+|||+||+..|.+...-. .+. +++.++.+|+++++.||+|||.+|||||||||+|+|++ +++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCC
Confidence 99999988889999999999888765432 233 89999999999999999999999999999999999998 789
Q ss_pred eEEEEecCCccccccc------cccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 002642 770 VCKIGDLGLSKIKQKT------LISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~------~~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~ei 841 (897)
++||+|||.+...... .......|||.|+|||...+.. .+.+++.||||+||+||.|+.|+.||.+....++
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998743111 1122367999999999987622 2456889999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 842 l~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
..+|+...+..+....+.+.+++||.+||.+||++|.++.+|..+..
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 99999988754444458899999999999999999999999987654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.86 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||.||++++. ++.||+|.++... .........+.+|+.++++++||||+++++++... ..+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-----IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEc
Confidence 699999999999884 5679999986431 11233456788999999999999999999998876 68999999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-ccc
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-KTL 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~-~~~ 786 (897)
|+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... ...
T Consensus 74 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 99999999999764 4588899999999999999999999999999999999998 77889999999997532 222
Q ss_pred ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 002642 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLM 866 (897)
Q Consensus 787 ~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI 866 (897)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .+|..++++++++|
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL--RFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHcCCC--CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--CCCCcCCHHHHHHH
Confidence 334567999999999997654 78999999999999999999999998888777777766543 67788999999999
Q ss_pred HHhhccCCCCCCC---HHHHHHH
Q 002642 867 ERCWSSDPKSRPA---FSEITKE 886 (897)
Q Consensus 867 ~kcL~~DPeeRPT---a~ELLq~ 886 (897)
.+||+.||++||+ +.|++++
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcC
Confidence 9999999999974 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=356.03 Aligned_cols=252 Identities=23% Similarity=0.427 Sum_probs=227.0
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.-+|++.+.||+|.||+|-+++. .|+.||||.+++.. +..+..+-.+.+|+++|..|+||||+++|.+|+..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-----IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk- 125 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-----IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK- 125 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-----cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-
Confidence 35899999999999999999986 47889999997652 33445567888999999999999999999999987
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+.|||||..+|.|++|+.+. +.+++.++..|++||..|+.|+|+++++|||||.+|||++ .++.+||+|||+
T Consensus 126 -dKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGL 199 (668)
T KOG0611|consen 126 -DKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGL 199 (668)
T ss_pred -ceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccch
Confidence 6899999999999999999876 4599999999999999999999999999999999999999 889999999999
Q ss_pred ccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+-.+.+.....++||+|-|.+||++++.+ |-++.+|-||||++||.|+.|.+||.+.+...++.+|..+.++.+- -
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~P-Y~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~ 275 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTP-YKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---T 275 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCC-CCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---C
Confidence 99888887788999999999999999876 4688999999999999999999999999999999999888874432 2
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
|..+.-||++||-.||++|.|+.+|..+++
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 457888999999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.26 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=209.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||+||+++.+ ++.||||+++... .........+.+|+.++..++||||+++++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-- 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE-----MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-- 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--
Confidence 47999999999999999999884 6789999996431 11233456778899999999999999999999887
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 6899999999999999999764 4589999999999999999999999999999999999998 7789999999998
Q ss_pred ccccccc---------------------------------------ccCCcccCCcccCccccccCCCCCCchhhHHHHH
Q 002642 780 KIKQKTL---------------------------------------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFG 820 (897)
Q Consensus 780 k~~~~~~---------------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLG 820 (897)
+...... .....+||+.|+|||++.... ++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC--CCCeeeeecch
Confidence 6432110 001246999999999987544 78999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002642 821 VVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRPA---FSEITKE 886 (897)
Q Consensus 821 vILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL~~DPeeRPT---a~ELLq~ 886 (897)
|++|||++|..||......+....+........+|. .++++++++|++||. +|.+|++ ++|++++
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999999999998888777777665443334443 468999999999996 9999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=350.40 Aligned_cols=243 Identities=27% Similarity=0.419 Sum_probs=205.8
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|+||.||+++. +++.||+|+++.... ........+.+|+++++.++||||+++++.+... ..+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEE
Confidence 3699999999999987 467899999865311 1223456778899999999999999999999876 689999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-c
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-K 784 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~-~ 784 (897)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 9999999999988754 4688999999999999999999999999999999999998 77889999999987432 2
Q ss_pred ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 785 ~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... .+|..+++++++
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCcccccCCC--CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 22223467999999999997544 78999999999999999999999998887777776665544 567789999999
Q ss_pred HHHHhhccCCCCCC-----CHHHHHHH
Q 002642 865 LMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 865 LI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|.+||..||++|| ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999999998 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=345.37 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=207.1
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+..++|++++.||+|+||.||+++++ +..+|+|.++.. ........+.+|++++++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-------cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45689999999999999999999985 567999998643 122345678899999999999999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+ ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 ~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 D--GEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred C--CEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 6 6899999999999999999764 4588899999999999999999986 699999999999998 678899999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH---------
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII--------- 846 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii--------- 846 (897)
||++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+.
T Consensus 148 fg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Ccccccccccc-cccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 99987553322 23457999999999997644 7899999999999999999999997665544322110
Q ss_pred ------------------------------------hcCCCCCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 847 ------------------------------------KGNLGPKI-PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 847 ------------------------------------~~~l~~~~-p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.....+.. ...+++++++||.+||++||++|||++||+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00111111 1246789999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.46 Aligned_cols=243 Identities=28% Similarity=0.404 Sum_probs=206.0
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|+||.||+++. +++.||+|++.+... ........+.+|+.+++.++||||+++++++... ..+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-----IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEE
Confidence 3689999999999987 467899999865321 1223456788999999999999999999999876 689999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-c
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-K 784 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~-~ 784 (897)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 9999999999988754 4688999999999999999999999999999999999998 67889999999987532 2
Q ss_pred ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 785 ~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.... ..+|..+++++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKS 224 (328)
T ss_pred ccccccccCCcCccChhhhcCCC--CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHH
Confidence 22233467999999999997544 7899999999999999999999998887777666655544 3677889999999
Q ss_pred HHHHhhccCCCCCC-----CHHHHHHH
Q 002642 865 LMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 865 LI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|++||++||++|| ++.|++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.87 Aligned_cols=267 Identities=35% Similarity=0.609 Sum_probs=227.3
Q ss_pred ccccccccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 613 ~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
..+.|++..++..+...||+|+||+||+|.|.| .||||++.... ..++.++.|.+|+.++++-+|.||+-+.|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~------pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDD------PTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCC------CCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 346788999999999999999999999999988 68999997642 22347899999999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++..+ .+.||+.|++|.+|+.+++-.+..++..+...|+.||++||.|||.++|||||||..||++. +++.||
T Consensus 456 ~~~~p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVk 528 (678)
T KOG0193|consen 456 ACMNP---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVK 528 (678)
T ss_pred hhcCC---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEE
Confidence 99987 34899999999999999988777899999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccc---ccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQK---TLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~---~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~ 848 (897)
|+||||+..... ..-.....|...|||||++.. ....|++.+||||||+++|||++|.+||.....+.++..+-++
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 999999974322 222234568899999999864 3446899999999999999999999999966666666655454
Q ss_pred CCCC---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGP---KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~---~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
.+.+ +....++.++++|+..||..++++||.+.+|+..|+.+...
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 3322 23456788999999999999999999999999998888764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.98 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=198.5
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||+++.+ ++.||||+++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 75 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-------GTPFTAIREASLLKGLKHANIVLLHDIIHTK- 75 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-------ccchhHHHHHHHHhhCCCCCcCeEEEEEecC-
Confidence 468999999999999999999984 678999998643211 1123466899999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+. ++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 -~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 76 -ETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred -CeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 68999999995 688888876656688899999999999999999999999999999999998 678899999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCC-----
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLG----- 851 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~Ii~~~l~----- 851 (897)
++..... .......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +.+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 8743322 2223456899999999986533 3788999999999999999999999876442 222222110000
Q ss_pred -----------C-----CCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------P-----KIP---------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------~-----~~p---------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ ..+ ...++++.+||++||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 001 0135678999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.47 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|++++.||+|+||+||+++++ ++.||||++.... .........+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD-----VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--D 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--C
Confidence 6899999999999999999884 5679999986531 12234567788999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 899999999999999999765 4578888889999999999999999999999999999998 67889999999975
Q ss_pred ccccc------------------------------------------------cccCCcccCCcccCccccccCCCCCCc
Q 002642 781 IKQKT------------------------------------------------LISGGVRGTIPWMAPELFKSKDNLVTE 812 (897)
Q Consensus 781 ~~~~~------------------------------------------------~~~~~~~GT~~Y~APEvl~g~~~~~s~ 812 (897)
..... .......||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCC
Confidence 32100 0012357999999999997644 789
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhh--ccCCCCCCCHHHHHHH
Q 002642 813 KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCW--SSDPKSRPAFSEITKE 886 (897)
Q Consensus 813 ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL--~~DPeeRPTa~ELLq~ 886 (897)
++|||||||++|||++|+.||......+....++.......+|. .+++++.++|.+|+ ..++..||++.+++++
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999999999999998877776666654333333443 57899999999955 4455569999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.74 Aligned_cols=246 Identities=26% Similarity=0.465 Sum_probs=205.0
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHH---hhCCCCceeeEeeeeecCC
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML---GQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL---~~L~HPNIVkl~g~~~e~~ 698 (897)
|++++.||+|+||.||++.++ ++.||||++++... ........+.+|++++ +.++||||+++++++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~- 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-----IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE- 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-
Confidence 678999999999999999874 66899999865321 1122334555665554 567899999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++||||+++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 75 -~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 75 -DHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred -CEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 689999999999999988864 4589999999999999999999999999999999999998 778999999999
Q ss_pred ccccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 002642 779 SKIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 779 Ak~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ 857 (897)
++... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .+|..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC
Confidence 87432 222234567999999999997644 78999999999999999999999998888777777766544 56778
Q ss_pred CcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+++++.++|.+||+.||.+|| ++.+++++
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 899999999999999999999 57777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.82 Aligned_cols=258 Identities=32% Similarity=0.566 Sum_probs=213.9
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+...+|++.+.||+|+||.||+|++. ++ .||+|.++.. .......++.+|+.+++.++||||+++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45678999999999999999999863 33 3899988642 11233467889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++... ..++|+||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~k 149 (316)
T cd05108 77 ICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHVK 149 (316)
T ss_pred EEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcEE
Confidence 98764 46789999999999999987666788899999999999999999999999999999999998 677899
Q ss_pred EEecCCccccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||+++....... .....++..|+|||.+.+.. ++.++||||||+++|||++ |..||.+....+.. .++..
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~ 226 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEK 226 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhC
Confidence 999999985432221 11223467899999987544 7899999999999999998 99999887665543 44555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
....+.+..++.++.++|.+||..+|++||++.+++..|.++.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 555566777899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=355.69 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=206.5
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|+++++||+|+||.||+++. +++.||||++.+.. .........+.+|+++++.++||||+++++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-- 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-----MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-- 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--
Confidence 4799999999999999999987 46689999985431 12234467788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 6899999999999999999764 4578888999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc------------------------------------------------ccCCcccCCcccCccccccCCCCCC
Q 002642 780 KIKQKTL------------------------------------------------ISGGVRGTIPWMAPELFKSKDNLVT 811 (897)
Q Consensus 780 k~~~~~~------------------------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s 811 (897)
+...... ......||+.|+|||++.+.. ++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CC
Confidence 6321100 001246999999999997654 78
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 002642 812 EKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSR---PAFSEITKE 886 (897)
Q Consensus 812 ~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL~~DPeeR---PTa~ELLq~ 886 (897)
.++|||||||++|||++|..||......+....+........+|. .++.++++||.+||. +|.+| +++.|++++
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999999999999998887777776665333334443 478999999999997 77765 599999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.36 Aligned_cols=250 Identities=35% Similarity=0.654 Sum_probs=209.9
Q ss_pred cCCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..++|++.+.||+|+||.||+++++. ..+|+|.++.... ....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 71 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ- 71 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------cHHHHHHHHHHHHHCCCCCceeEEEEEccC-
Confidence 34679999999999999999998864 4799998754311 124577899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 72 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~ 146 (256)
T cd05114 72 -KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGM 146 (256)
T ss_pred -CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCC
Confidence 678999999999999999976545688999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 779 SKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 779 Ak~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
++...... ......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||......+....+.... .+..|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~ 223 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRP 223 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcccCc--cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCC
Confidence 87543221 112234567899999987544 7889999999999999999 999998888777777665543 34556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
...+.++.++|.+||+.+|++||+++++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 67789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.51 Aligned_cols=255 Identities=31% Similarity=0.625 Sum_probs=214.7
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
++...+|++.+.||+|+||.||++..+ ++.||+|.+... ......+.+|+++++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---------chHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 456678999999999999999999874 667999988643 112456889999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.+ ..+++||||+++++|.+++... ...+++..++.++.|++.+|+|||++|++||||||+||+++ .++.+||+
T Consensus 73 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~ 146 (263)
T cd05052 73 RE--PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVA 146 (263)
T ss_pred CC--CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeC
Confidence 76 6789999999999999999654 34588889999999999999999999999999999999998 77889999
Q ss_pred ecCCcccccccccc--CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTLIS--GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~--~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||++......... ....++..|+|||.+.+.. ++.++||||||+++|||++ |..||......+....+ .....
T Consensus 147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 223 (263)
T cd05052 147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYR 223 (263)
T ss_pred CCccccccccceeeccCCCCCccccCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCC
Confidence 99999755432211 1223466799999987544 7889999999999999998 99999887766665554 44455
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
+..+..++.++.++|.+||+.+|++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 677888999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.96 Aligned_cols=256 Identities=30% Similarity=0.597 Sum_probs=213.7
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
|++..++|+++++||+|+||.||++..+ ++.||+|.+.... ...+.+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---------MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---------hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567789999999999999999999874 5579999875431 12457889999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.. ...+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+++||||||+||+++ .++.+||+
T Consensus 72 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~ 145 (261)
T cd05072 72 KE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIA 145 (261)
T ss_pred CC--CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEEC
Confidence 76 6789999999999999999753 34678888999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||++........ .....++..|+|||.+.... ++.++||||||+++|+|++ |..||......+....+... ..
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~ 222 (261)
T cd05072 146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YR 222 (261)
T ss_pred CCccceecCCCceeccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CC
Confidence 9999986543221 12334567899999987543 7889999999999999998 99999887776666655443 34
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.+.+..++.++.++|.+||..+|++||+++++.+.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 445566889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.50 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=206.8
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCC-CceeeEeeeeecCCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH-PNVVAFYGVVTDGPV 699 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~H-PNIVkl~g~~~e~~~ 699 (897)
+|++++.||+|+||.||+++.+ ++.||||++++... ........+..|++++..+.| ++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-- 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-- 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--
Confidence 5899999999999999999885 45799999865321 122335667889999999976 4588888888876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 6899999999999999998764 4578889999999999999999999999999999999998 6788999999998
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.... ..+|..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 7432 222223457999999999998654 7899999999999999999999999888887777776554 4677889
Q ss_pred cHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAF-----SEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa-----~ELLq~ 886 (897)
+.++.++|.+||..||.+|++. ++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999975 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.78 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=200.3
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++++ ++.||+|+++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE------NEEVKETTLRELKMLRTLKQENIVELKEAFRRR-- 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc------cccchhhHHHHHHHHHhCCCccccchhhhEecC--
Confidence 37999999999999999999985 56799999865311 122345677899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||++++.+..+.. ....+++..+..++.|++.||+|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 68999999999876665543 345688899999999999999999999999999999999998 7788999999999
Q ss_pred ccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------
Q 002642 780 KIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-------- 849 (897)
Q Consensus 780 k~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-------- 849 (897)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 8643221 222456899999999997644 7899999999999999999999998876544333221100
Q ss_pred -----------CC-C----------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -----------LG-P----------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -----------l~-~----------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. + .....+|.++.+||++||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0 0112367889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.94 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCceEEEEecccCceEEEEeeec---CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC---CCCceeeEeeeee
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI---HHPNVVAFYGVVT 695 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k---g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L---~HPNIVkl~g~~~ 695 (897)
.+|++++.||+|+||.||++++. ++.||+|.++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------chHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 37899999999999999999872 45799999865422111 122344566666554 6999999999875
Q ss_pred c---CCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 696 D---GPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 696 e---~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
. .....+++||||+. ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 22357899999996 5899888653 34588899999999999999999999999999999999998 67889
Q ss_pred EEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 772 KIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 772 KLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
||+|||+++............||+.|+|||++.+.. ++.++|||||||++|||++|++||......+.+..++.....
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999999998654444444567899999999987544 788999999999999999999999988776666655432110
Q ss_pred C-------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 P-------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~-------------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ .....+++.++++|.+||+.||++||++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0112467888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.88 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=226.4
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~ 697 (897)
...|++.+.||+|.||.||+++.+ ++.+|+|++.+..... ......+.+|+.+|+++. |||||++++.|++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-----~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-----KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-----cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 467999999999999999999884 6789999997653322 123467889999999998 99999999999988
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..+++|||++.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.......+.+|++|||
T Consensus 109 --~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 --DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred --CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 6899999999999999999776 389999999999999999999999999999999999998665445689999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS- 856 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~- 856 (897)
++............+||+.|+|||++.... |+..+||||+|+++|.|++|.+||.+....+...++....+....+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~--y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRP--YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCC--CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 999877766667889999999999998544 89999999999999999999999999999999999999887655554
Q ss_pred -CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 857 -WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 857 -~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.++..++++|+.||..||.+|+++.++|++-
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 3789999999999999999999999999973
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=364.52 Aligned_cols=269 Identities=37% Similarity=0.623 Sum_probs=236.7
Q ss_pred cccccccCCCceEEEEecccCceEEEEeeecC-----cc-EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCce
Q 002642 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWKG-----SD-VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687 (897)
Q Consensus 614 ~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-----~~-VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNI 687 (897)
...|++..++-.+.++||+|+||.||+|+.+- .. ||+|..+.. .....+.+.++++|+++|++++||||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-----~~~~~~~~~e~m~EArvMr~l~H~NV 223 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-----SELTKEQIKEFMKEARVMRQLNHPNV 223 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-----ccccHHHHHHHHHHHHHHHhCCCCCE
Confidence 34578888888889999999999999998742 13 899988742 12345678999999999999999999
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~ 767 (897)
|++||+.... ..+++|||+++||+|.++|++.+..++..+...++.+.+.||+|||++++|||||..+|+|++ .
T Consensus 224 Vr~yGVa~~~--~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~ 297 (474)
T KOG0194|consen 224 VRFYGVAVLE--EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----K 297 (474)
T ss_pred EEEEEEEcCC--CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----C
Confidence 9999998887 689999999999999999998877799999999999999999999999999999999999998 6
Q ss_pred CCeEEEEecCCccccccccccC-CcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002642 768 RPVCKIGDLGLSKIKQKTLISG-GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845 (897)
Q Consensus 768 ~g~VKLiDFGLAk~~~~~~~~~-~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~I 845 (897)
...+||+|||+++......... ...-...|+|||.+... .|++++|||||||++||+++ |..||.+....++...+
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred CCeEEeCccccccCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 6778999999998665333332 22356899999999854 69999999999999999999 89999999999999999
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002642 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895 (897)
Q Consensus 846 i~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg 895 (897)
....++.+.|...|.++..++.+||..+|++||++.++.+.|+.+.+...
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 89999999999999999999999999999999999999999999887654
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.40 Aligned_cols=263 Identities=31% Similarity=0.517 Sum_probs=215.7
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
|.+..++|++.+.||+|+||.||++... ++.||+|+++... .....+.+.+|+.++.++ +||||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-------TASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-------CHHHHHHHHHHHHHHHhhccCcchh
Confidence 4566789999999999999999998753 2569999886431 122345677899999999 799999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------------------------------------------
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------------------------------------- 722 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------------------------------------- 722 (897)
++++++.... ..++++|||+++++|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 9999876543 57889999999999999885421
Q ss_pred --------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc--
Q 002642 723 --------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL-- 786 (897)
Q Consensus 723 --------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~-- 786 (897)
..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||+++......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcch
Confidence 2578888999999999999999999999999999999998 67789999999998542211
Q ss_pred -ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 787 -ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 787 -~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
......++..|+|||++.+.. ++.++|||||||+||||++ |..||......+.+...+.....+..+..+++++.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhcCCC--CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 122344667899999987644 8899999999999999998 999998766555555555555556667778899999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 865 LMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 865 LI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
++.+||+.+|++||++.|++++|++++++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=348.87 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=211.6
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||+||+++. +++.||+|+++... .........+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-- 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-----LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-- 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--
Confidence 4799999999999999999987 46789999987531 11233456788899999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 689999999999999999987766789999999999999999999999999999999999998 7789999999999
Q ss_pred ccccccc--ccCCcccCCcccCccccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 780 KIKQKTL--ISGGVRGTIPWMAPELFKSK----DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 780 k~~~~~~--~~~~~~GT~~Y~APEvl~g~----~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||......+.+.++........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 7543222 22234689999999998631 23477899999999999999999999998887777777665443333
Q ss_pred CC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IP--SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p--~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+| ..++.++.+||++||. +|.+||++++++++
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 33 3578999999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.00 Aligned_cols=244 Identities=28% Similarity=0.477 Sum_probs=205.3
Q ss_pred EEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
+.||+|+||.||+++. .++.||+|+++..... ........+.+|+.+++.++||||+++++++..+ ..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeE
Confidence 6799999999999875 3567999998653111 1122345677899999999999999999999876 689
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++||||+++++|.+++... ..+.+..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 9999999999999999765 4577888888999999999999999999999999999998 7789999999998743
Q ss_pred -ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHH
Q 002642 783 -QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861 (897)
Q Consensus 783 -~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~e 861 (897)
..........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+....+..... .+|..++++
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHH
Confidence 2222333467999999999997644 68899999999999999999999998887777777766543 677888999
Q ss_pred HHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 862 WRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 862 l~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+.++|.+||+.+|++|| ++++++++
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 99999999999999999 88888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=327.88 Aligned_cols=255 Identities=38% Similarity=0.660 Sum_probs=213.4
Q ss_pred cCCCceEEEEecccCceEEEEeeec-----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k-----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..++|++.+.||+|+||.||+|+++ ...||||.++... .......+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 3568999999999999999999874 2368999886431 122346788899999999999999999998
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
... ...++||||+++++|.+++......+++..+..++.|++.||+|||+++|+|+||||+||+++ .++.+||+
T Consensus 75 ~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~ 148 (266)
T cd05033 75 TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVS 148 (266)
T ss_pred ecC--CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEEC
Confidence 876 678999999999999999987666789999999999999999999999999999999999998 77889999
Q ss_pred ecCCcccccc--c-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 775 DLGLSKIKQK--T-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 775 DFGLAk~~~~--~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
|||+++.... . .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-Y 225 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCC--CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-C
Confidence 9999986531 1 1111233567899999987544 7899999999999999998 99999887776666655443 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4455677899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=377.09 Aligned_cols=264 Identities=39% Similarity=0.658 Sum_probs=231.5
Q ss_pred cccccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCc
Q 002642 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686 (897)
Q Consensus 614 ~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPN 686 (897)
....+++..+.++.+.||+|+||+||+|+.. ..-||||.++.. ......++|.+|++++..++|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-------a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-------AENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-------ccHHHHHHHHHHHHHHHhccCCC
Confidence 3456788899999999999999999999863 224999999754 23446789999999999999999
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------c----cccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------R----TIDRRKRIIIAMDAAFGIEYLHEKNIVHFD 753 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------~----~lse~~~l~Ia~QLl~AL~yLHs~GIVHRD 753 (897)
||+++|++.++ +.+++|+|||..|||.++|.... . +++..+.+.||.||+.||+||-++.+||||
T Consensus 551 IVrLlGVC~~~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 551 IVRLLGVCREG--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred eEEEEEEEccC--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 99999999988 68999999999999999996531 2 278889999999999999999999999999
Q ss_pred CCCCCeEeccCCCCCCeEEEEecCCccccc--cc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-C
Q 002642 754 LKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ--KT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-G 829 (897)
Q Consensus 754 IKPeNILLd~~~~~~g~VKLiDFGLAk~~~--~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-G 829 (897)
|..+|+||+ +...|||+|||+++..- ++ ...+...-..+|||||.+.... ++++|||||+||+|||+++ |
T Consensus 629 LATRNCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 629 LATRNCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred hhhhhceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccc
Confidence 999999998 88999999999998432 21 2222334578999999998655 8999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 830 EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 830 k~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
+.||.+..+.|+++.+.++++ ...|+.+|.++.+||..||+.+|.+||+++||-..|++..++
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999999999999999988887 889999999999999999999999999999999999998775
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=331.29 Aligned_cols=256 Identities=33% Similarity=0.561 Sum_probs=209.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVk 689 (897)
|++..++|++.+.||+|+||.||++.+++ ..||+|.+.... ......++.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~ 73 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVR 73 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeee
Confidence 34567889999999999999999987642 359999875321 1123456889999999999999999
Q ss_pred EeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 002642 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFL 760 (897)
Q Consensus 690 l~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNIL 760 (897)
+++++.+. ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 74 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil 151 (277)
T cd05062 74 LLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151 (277)
T ss_pred EEEEEcCC--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence 99998776 67899999999999999986532 23567788899999999999999999999999999999
Q ss_pred eccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 002642 761 VNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADL 836 (897)
Q Consensus 761 Ld~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~ 836 (897)
++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++||||||+++|||++ |..||...
T Consensus 152 ~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 152 VA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred Ec----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 98 67889999999987432211 111234577899999987543 7899999999999999999 78999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 837 ~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
...+....+.... .+..+..++.++.++|.+||+.||++||++.|+++.|+
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 226 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 7766666555544 34567778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.03 Aligned_cols=243 Identities=25% Similarity=0.454 Sum_probs=205.3
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++.+ ++.||+|+++.... ........+..|.+++..+ +||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-----LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEE
Confidence 36899999999999885 56799999865311 1223445677888888866 799999999999877 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceeccc
Confidence 99999999999988764 4588889999999999999999999999999999999998 77899999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .+|..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~ 224 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAV 224 (321)
T ss_pred CCccccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 222233567999999999987544 78999999999999999999999999888888887776654 56778899999
Q ss_pred HHHHHhhccCCCCCC-------CHHHHHHH
Q 002642 864 SLMERCWSSDPKSRP-------AFSEITKE 886 (897)
Q Consensus 864 dLI~kcL~~DPeeRP-------Ta~ELLq~ 886 (897)
++|.+||+.||++|| ++++++++
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=343.97 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=207.4
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~ 699 (897)
+|++.+.||+|+||.||+++.+ ++.||||++++... ........+..|..++..+ +||+|+++++++...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-- 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-----IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-- 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--
Confidence 5889999999999999999885 45799999865321 1222345567788888777 589999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 6899999999999999998764 4588899999999999999999999999999999999998 7788999999999
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+... .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+..... .+|..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcC
Confidence 7432 222333567999999999998654 78999999999999999999999999888888777776554 567789
Q ss_pred cHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAF-----SEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa-----~ELLq~ 886 (897)
+.++.++|.+||+.||++|++. .+++++
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999999999974 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.19 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=206.0
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|+++++||+|+||+||+++. .++.||+|++... ..........+.+|+.++++++||||+++++.+.+. .
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-----DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--D 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH-----HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--C
Confidence 689999999999999999987 4567999998643 112234567788999999999999999999999877 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 899999999999999999765 4578888899999999999999999999999999999998 77899999999975
Q ss_pred cccc------------------------------------------------ccccCCcccCCcccCccccccCCCCCCc
Q 002642 781 IKQK------------------------------------------------TLISGGVRGTIPWMAPELFKSKDNLVTE 812 (897)
Q Consensus 781 ~~~~------------------------------------------------~~~~~~~~GT~~Y~APEvl~g~~~~~s~ 812 (897)
.... ........||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCC
Confidence 2110 00012346999999999997654 789
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002642 813 KVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP--SWCEPTWRSLMERCWSSDPKSRPA---FSEITKE 886 (897)
Q Consensus 813 ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p--~~ls~el~dLI~kcL~~DPeeRPT---a~ELLq~ 886 (897)
++|||||||+||||++|+.||...++.+....+........+| ..+++++.++|.+|+ .+|++|++ +.|++++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999999999999999888777776666543333333 457899999999976 59999987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.28 Aligned_cols=243 Identities=24% Similarity=0.450 Sum_probs=204.0
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++.+ ++.||||++++... ........+..|..++..+ +||||+++++++... ..+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEE
Confidence 36999999999999884 56799999865311 1223355677888888876 699999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 99999999999988765 4588999999999999999999999999999999999998 77889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... ..|..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAV 224 (320)
T ss_pred CCCcccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence 222334567999999999997544 78899999999999999999999999888888777766543 56778999999
Q ss_pred HHHHHhhccCCCCCCCH------HHHHHH
Q 002642 864 SLMERCWSSDPKSRPAF------SEITKE 886 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa------~ELLq~ 886 (897)
++|++||+.||++||++ ++++++
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=362.12 Aligned_cols=252 Identities=25% Similarity=0.455 Sum_probs=225.3
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|+.++++|+|+||.+++++++ ++.+++|.+...... +......++|+.++++++|||||.+.+.|.++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC------chhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 468999999999999999998875 557999999654222 223347789999999999999999999999873
Q ss_pred CceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..++|||+|++||+|.+.|.+.+ ..++++.+..++.|++.|+.|||++.|+|||||+.||+++ .+..|||.|||
T Consensus 77 -~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDfG 151 (426)
T KOG0589|consen 77 -QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDFG 151 (426)
T ss_pred -ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecchh
Confidence 34999999999999999997755 6799999999999999999999999999999999999998 77788999999
Q ss_pred Ccccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 778 LSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
+|+...... ...+..||+.|+.||++.+.+ |+.|+|||||||++|||++-+.+|...+....+.++....+ .+.|.
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~ 228 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPS 228 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCc
Confidence 999876665 667789999999999999877 89999999999999999999999999999999998888774 67888
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+.+++.+|+.||..+|+.||++.+||.+
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.18 Aligned_cols=253 Identities=32% Similarity=0.642 Sum_probs=212.9
Q ss_pred cccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
.+...+|++.+.||+|+||.||++..+++.+|+|.++.. ...+.+.+|+.++++++|||++++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 355678999999999999999999999999999988532 1235678999999999999999999976543
Q ss_pred CCceEEEEEeeeeccchHHHHhhccc-cccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~-~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+||
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~df 146 (256)
T cd05082 72 K-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDF 146 (256)
T ss_pred C-CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCC
Confidence 2 578999999999999999976433 478899999999999999999999999999999999998 7788999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
|+++...... .....+..|+|||++.+.. ++.++||||||+++|+|++ |+.||......+....+.. ...+..+
T Consensus 147 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 221 (256)
T cd05082 147 GLTKEASSTQ--DTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAP 221 (256)
T ss_pred ccceeccccC--CCCccceeecCHHHHccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCC
Confidence 9987543322 2334567899999987543 7889999999999999997 9999988777666655443 4455667
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+++.+.++|.+||+.+|++|||+.++++.|+++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 78899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.40 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=205.7
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||+++.+ ++.||||++.... .........+.+|+.+++.++||||+++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-- 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-- 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--
Confidence 47999999999999999999874 6689999986431 11223356678999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 6899999999999999999765 4578888889999999999999999999999999999998 7788999999997
Q ss_pred ccccc--------------------------------------------ccccCCcccCCcccCccccccCCCCCCchhh
Q 002642 780 KIKQK--------------------------------------------TLISGGVRGTIPWMAPELFKSKDNLVTEKVD 815 (897)
Q Consensus 780 k~~~~--------------------------------------------~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksD 815 (897)
..... ........||+.|+|||++.+.. ++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCccee
Confidence 42110 00012357999999999997654 789999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 002642 816 VYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP--SWCEPTWRSLMERCWSSDPKSRP---AFSEITKE 886 (897)
Q Consensus 816 IWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p--~~ls~el~dLI~kcL~~DPeeRP---Ta~ELLq~ 886 (897)
||||||++|||++|+.||......+....+........++ ..+++++.++|.+|+ .+|.+|+ ++.|++++
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999999999999888777666655433322333 357899999999976 5999999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.90 Aligned_cols=243 Identities=29% Similarity=0.418 Sum_probs=204.7
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|+||.||+++. +++.||+|+++.... ........+.+|+++++.++||||+++++++... ..+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEE
Confidence 3699999999999987 466899999865321 1223356678899999999999999999998876 689999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 9999999999988754 468899999999999999999997 7999999999999998 77889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.... ..+|..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHccCC--CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222223457999999999997644 7899999999999999999999998887777666655544 356778999999
Q ss_pred HHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 864 SLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 864 dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
++|++||+.||++|+ ++.+++++
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.61 Aligned_cols=247 Identities=37% Similarity=0.690 Sum_probs=204.4
Q ss_pred eEEEEecccCceEEEEeeec------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 625 EYIKELGSGTFGTVFYGKWK------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 625 eilk~LGkG~fG~Vylg~~k------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
++.+.||.|.||.||+|.+. +..|+||.++.. ...+....+.+|++.+++++||||+++++++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~- 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN- 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-------cccccceeeeeccccccccccccccccccccccc-
Confidence 56789999999999999987 456999999542 1223367888999999999999999999999955
Q ss_pred CceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++||||+++|+|.+++... ...+++..+..|+.|++.||+|||+++++|+||+++||+++ .++.+||+|||
T Consensus 74 -~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 74 -EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp -SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 5699999999999999999876 56789999999999999999999999999999999999998 78899999999
Q ss_pred Ccccccc---ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 778 LSKIKQK---TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 778 LAk~~~~---~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
++..... ............|+|||.+.... ++.++||||||+++|||++ |+.||......+....+ .....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETT
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc-cccccce
Confidence 9985521 12223345678899999997654 7999999999999999999 78999999888877776 4444566
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.+..++..+.++|.+||..||++||++++|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7888999999999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.62 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=213.5
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.+..++|++.+.||+|+||.||+++.+ ++.||+|++.+... ........+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 355679999999999999999999874 66799999864211 11223455778999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
++ ..+++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~~--~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~D 185 (370)
T cd05596 114 DD--KYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (370)
T ss_pred cC--CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEe
Confidence 76 6899999999999999998653 478888889999999999999999999999999999998 778999999
Q ss_pred cCCcccccccc--ccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 776 LGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 776 FGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
||++....... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...........+......
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99997543321 223467999999999986532 24788999999999999999999999988887777777665444
Q ss_pred CCCCC--CCcHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002642 852 PKIPS--WCEPTWRSLMERCWSSDPKS--RPAFSEITKE 886 (897)
Q Consensus 852 ~~~p~--~ls~el~dLI~kcL~~DPee--RPTa~ELLq~ 886 (897)
..+|. .+|.++++||++||+.+|.+ |++++|++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 44454 57899999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=340.39 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=197.5
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC--
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP-- 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~-- 698 (897)
+|++.+.||+|+||.||+++.+ ++.||||.++.... .......+.+|+++++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5899999999999999999874 67899999864311 1122356789999999999999999999875432
Q ss_pred -CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 -VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 -~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...+++||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 235899999995 6899988754 4588999999999999999999999999999999999998 77899999999
Q ss_pred Ccccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH-------
Q 002642 778 LSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII------- 846 (897)
Q Consensus 778 LAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii------- 846 (897)
+++...... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||........+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997432211 113456899999999986533347899999999999999999999998765433221110
Q ss_pred -------------------hcCCCCCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 847 -------------------KGNLGPKI---PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 -------------------~~~l~~~~---p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.......+ ...+++++.++|.+||+.||++||+++|++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000111 12357889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.66 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=209.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++. +++.||||.++.... ........+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-----MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-- 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-----CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--
Confidence 5899999999999999999987 467899998764311 1233456788999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 TNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
...++||||+++++|.+++.. ....+++..+..++.|++.||+|||++|++|+||||+||+++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 688999999999999988853 234578889999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCC
Q 002642 777 GLSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS--EEIIAGIIKGNLGPK 853 (897)
Q Consensus 777 GLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~--~eil~~Ii~~~l~~~ 853 (897)
|++....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+....+.....++.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9987543322 122456889999999987644 78899999999999999999999965432 334444333333333
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.+..++..+.++|.+||..+|++||++.++++.|+.+
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 3456788999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.97 Aligned_cols=255 Identities=31% Similarity=0.613 Sum_probs=212.7
Q ss_pred cccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
++..++|++.+.||+|+||.||++..+ ++.||+|.++.... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 466788999999999999999999874 45799999865311 13457789999999999999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
. ...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 73 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d 146 (261)
T cd05068 73 E--EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVAD 146 (261)
T ss_pred C--CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECC
Confidence 6 67899999999999999997643 4688999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccccccc--CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 002642 776 LGLSKIKQKTLIS--GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 776 FGLAk~~~~~~~~--~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
||+++........ .....+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+.. ....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~ 223 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRM 223 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 9999865432211 1122345799999987543 7899999999999999999 9999988877666665543 3444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 56667889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.53 Aligned_cols=260 Identities=36% Similarity=0.614 Sum_probs=216.7
Q ss_pred ccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
++..+|.+.+.||+|+||+||++... +..+|+|.+... .......+.+|+.+++++.||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34578999999999999999999752 234888887542 123456788999999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhcc------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKD------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNF 759 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNI 759 (897)
+++... ..+++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 74 ~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecC--CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 998876 68899999999999999986432 2488999999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 002642 760 LVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYAD 835 (897)
Q Consensus 760 LLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~ 835 (897)
+++ .++.+||+|||+++...... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998 77889999999997542221 12233457789999998754 37899999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002642 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895 (897)
Q Consensus 836 ~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg 895 (897)
....+....+..... ...+..++.++.+++.+||+.||.+||++.++++.|+++.++-+
T Consensus 226 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 226 LSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 887777776665543 34566788999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.81 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=211.4
Q ss_pred CCceEEEEecccCceEEEEeeecC--c--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKG--S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~kg--~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
++|++.+.||+|+||.||+++.+. . .+++|.++.. ........+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-------ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-------CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 579999999999999999998743 2 3688877532 1122346688999999999 79999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLV 761 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILL 761 (897)
. ..+++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 R--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred C--CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 6 57899999999999999996532 247888999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 002642 762 NMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840 (897)
Q Consensus 762 d~~~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~e 840 (897)
+ .++.+||+|||++..............+..|+|||.+.... ++.++|||||||++|||++ |..||......+
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8 67789999999986433221121222355799999987544 7899999999999999997 999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002642 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 841 il~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~el 894 (897)
....+.. ...+..+..++.++.+||.+||+.+|.+||+++++++.|+.+.+..
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 227 LYEKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 7666544 3445667778999999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.75 Aligned_cols=258 Identities=31% Similarity=0.560 Sum_probs=212.5
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+...+|+++++||+|+||.||+|++. ++ .||+|.++... .......+.+|+.+++.++||||+++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 45679999999999999999999863 33 37999886431 1223467889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++... ..+++|||+++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~k 149 (279)
T cd05109 77 ICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHVK 149 (279)
T ss_pred EEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcEE
Confidence 88754 56789999999999999987656789999999999999999999999999999999999997 667899
Q ss_pred EEecCCccccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|||++ |..||.......... .+..
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEK 226 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHC
Confidence 999999985532211 11223567899999987544 7899999999999999998 999998766655444 3444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...+..+..++.++.++|.+||..||++||++.++++.|+++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 444555667899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.79 Aligned_cols=255 Identities=33% Similarity=0.601 Sum_probs=209.8
Q ss_pred ccCCCceEEEEecccCceEEEEeee------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+..++|++.++||+|+||.||+|+. .+..+|+|.++.. ........+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-------NNPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-------CCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 3457899999999999999999975 2356999988643 11233467889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhc----------------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRK----------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKS 756 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~----------------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKP 756 (897)
++... ...++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||
T Consensus 75 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 152 (283)
T cd05090 75 VVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152 (283)
T ss_pred EEecC--CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhcccc
Confidence 98876 5789999999999999998532 12467888899999999999999999999999999
Q ss_pred CCeEeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 002642 757 HNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEP 832 (897)
Q Consensus 757 eNILLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~P 832 (897)
+|||++ .+..+||+|||+++..... .......++..|+|||.+.+.. ++.++||||||+++|||++ |..|
T Consensus 153 ~nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 153 RNILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred ceEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCC
Confidence 999998 6778999999999754322 1122344577899999987543 7899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 833 F~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
|......+....+.. ...+..+..+++++.++|.+||+.||++||++.+|+++|+.
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 227 YYGFSNQEVIEMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 988776655554444 33455677889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.00 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=214.1
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+.|++.+.||+|++|.||++.. .++.+|+|.+...... .........+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--
Confidence 4688999999999999999986 4678999998643211 12233456788999999999999999999999877
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ .++.++|+|||++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 5899999999999999998764 4578888999999999999999999999999999999998 6778999999998
Q ss_pred ccccccccc----CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 780 KIKQKTLIS----GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 780 k~~~~~~~~----~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
+........ ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||......+...++......+.++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 754322111 2345788999999998654 7899999999999999999999998877766666666666666788
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..++.++.++|.+||..+|++||++.+++++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 8899999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=343.32 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=203.2
Q ss_pred CceEEEEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 623 DLEYIKELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
+|++++.||+|+||.||+++. +++.||+|++++... .........+..|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999875 356799999864311 11223356678899999999 59999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~--~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 E--AKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred C--CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 6 6899999999999999998764 4588899999999999999999999999999999999998 6788999999
Q ss_pred CCccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCC
Q 002642 777 GLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH----SEEIIAGIIKGNL 850 (897)
Q Consensus 777 GLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~----~~eil~~Ii~~~l 850 (897)
|+++..... .......||+.|+|||++.+.. .++.++|||||||++|||++|+.||.... ..+....+.. .
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--C 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCC-CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--C
Confidence 999754222 2223457999999999987532 36789999999999999999999996432 2223333332 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
.+.++..+++.++++|.+||+.||++|| ++++++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 3567778999999999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=327.79 Aligned_cols=254 Identities=31% Similarity=0.586 Sum_probs=214.3
Q ss_pred ccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
....+|++.++||+|+||.||+++.+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 34568999999999999999999985 5679999986431 12245678899999999999999999998876
Q ss_pred CCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
..+++||||+++++|.+++... +..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+||
T Consensus 75 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~ 148 (261)
T cd05148 75 --EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADF 148 (261)
T ss_pred --CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccc
Confidence 6789999999999999999763 34688999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 777 GLSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 777 GLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
|++....... ......++..|+|||.+.... ++.++||||||+++|+|++ |+.||......+.+..+.. ......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 225 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPC 225 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCC
Confidence 9997543321 122334567899999987543 7889999999999999998 8999988877777776554 445566
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
+..+++++.++|.+||+.||++|||+.+|++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 77889999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.26 Aligned_cols=253 Identities=37% Similarity=0.636 Sum_probs=211.7
Q ss_pred cCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
...+|.+.+.||+|+||.||+++.. +..||+|.++.. ...+....+.+|+++++.+.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-------ASNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-------CCHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3567899999999999999999763 246999998643 11223567889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc-------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD-------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNF 759 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNI 759 (897)
++... ...++||||+++++|.+++...+ ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 76 ~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEecC--CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 99877 68999999999999999996542 3467888999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 002642 760 LVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYAD 835 (897)
Q Consensus 760 LLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~ 835 (897)
+++ .++.+||+|||+++..... .......+++.|+|||++.+.. ++.++||||||+++|||++ |..||..
T Consensus 154 li~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 154 LVG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEc----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 998 6789999999998743221 1122334578899999987644 7899999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 836 ~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
....+....+..... ...+..++.+++++|.+||+.||++||++.|+++.|+
T Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 228 LSNEEVIECITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 887777776655443 4456678999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=334.15 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=205.9
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|++.+.||+|+||+||++.. +++.||+|.+..... ........+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-----hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--C
Confidence 488999999999999999987 467899999864311 1222345577899999999999999999998876 5
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++ +++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999999888653 34689999999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--cCCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK--GNLGPKIPSW 857 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~--~~l~~~~p~~ 857 (897)
.............|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCC--CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 8654333333457899999999997543 78899999999999999999999987655433222211 1223455667
Q ss_pred CcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+++.+++||.+||..||++|| ++++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 899999999999999999999 88899775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.31 Aligned_cols=255 Identities=36% Similarity=0.594 Sum_probs=212.3
Q ss_pred cccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeE
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl 690 (897)
++..++|++.+.||+|+||.||++..++ ..||+|.+... ........+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-------ASMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-------cCHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 4667899999999999999999998742 46999997543 112234568899999999999999999
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhhcc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLV 761 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILL 761 (897)
++++... ...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||++
T Consensus 75 ~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill 152 (277)
T cd05032 75 LGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCC--CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence 9998876 67899999999999999986432 236778899999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 002642 762 NMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLH 837 (897)
Q Consensus 762 d~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~ 837 (897)
+ .++.+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||....
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 153 A----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred c----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC--CCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 8 77889999999987543221 122345678899999986543 7889999999999999998 999998887
Q ss_pred hHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 838 ~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
..+....+. ....+..|..++.++.++|.+||+.+|++|||+.++++.|+
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 777766655 33345677778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.18 Aligned_cols=251 Identities=33% Similarity=0.634 Sum_probs=210.1
Q ss_pred cCCCceEEEEecccCceEEEEeeecCc-cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~kg~-~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..++|++.+.||+|+||.||++++++. .+|+|.++.... ....+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 71 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ- 71 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 356899999999999999999988654 599998864311 124578899999999999999999998776
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++||||+.+++|.+++......+++..++.++.|++.||+|||+.|++|+||||+||+++ .++.+||+|||+
T Consensus 72 -~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~ 146 (256)
T cd05113 72 -RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGL 146 (256)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCcc
Confidence 578999999999999999977555789999999999999999999999999999999999998 677899999999
Q ss_pred ccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 779 SKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 779 Ak~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.... .+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRP 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCC
Confidence 875433221 11233567899999987543 7889999999999999998 999998877776666665543 34456
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
...+..+++++.+||+.+|++||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.12 Aligned_cols=242 Identities=28% Similarity=0.484 Sum_probs=199.9
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh-CCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ-IHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~-L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++++ ++.||+|+++.... ........+..|..++.. .+||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-----LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEE
Confidence 36999999999999884 55799999875321 112233445566677765 4899999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 99999999999998764 4588889999999999999999999999999999999998 67889999999997532
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+... .+.+|..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224 (316)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 222334567999999999997644 789999999999999999999999988887777766544 3567888999999
Q ss_pred HHHHHhhccCCCCCCCHH-HHHH
Q 002642 864 SLMERCWSSDPKSRPAFS-EITK 885 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~-ELLq 885 (897)
++|.+||..||++||++. ++++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc
Confidence 999999999999999864 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=360.13 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=216.4
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
.....|..++.||+|+||.||+|.+ +++.||+|++... ..+..+..+.+|+.+|.+++++||.++|+.+..
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-------~~~deIediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-------EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechh-------hcchhhHHHHHHHHHHHhcCcchHHhhhhheee
Confidence 3445788889999999999999998 4667999999754 223346778899999999999999999999988
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..++++|||+.||++.+.++.. ..+++..+..++++++.||.|||.++.+|||||+.|||+. ..+.+||+||
T Consensus 83 g--~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~Df 155 (467)
T KOG0201|consen 83 G--TKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADF 155 (467)
T ss_pred c--ccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEec
Confidence 7 6899999999999999999764 3458888888999999999999999999999999999998 6689999999
Q ss_pred CCccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 777 GLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 777 GLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
|.+...... ....+++|||.|||||++.... |+.|+||||||+++|||++|.+||...++..++..|.+ ..+|.+.
T Consensus 156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~--Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~ 232 (467)
T KOG0201|consen 156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG--YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLD 232 (467)
T ss_pred ceeeeeechhhccccccccccccchhhhcccc--ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccc
Confidence 999865433 3336889999999999998544 89999999999999999999999999998666654444 3456666
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+++.+++||..||.+||+.||++.+|+++
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 7899999999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.36 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=211.8
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|..+++||+|.||.||+|++ +++.||||.++..... +-.-...++|++.|+.++||||+.++++|...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k------dGi~~talREIK~Lqel~h~nIi~LiD~F~~~-- 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK------DGINRTALREIKLLQELKHPNIIELIDVFPHK-- 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc------cCccHHHHHHHHHHHHccCcchhhhhhhccCC--
Confidence 4788899999999999999998 4778999999875222 11234567999999999999999999999987
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+.+|+||++ .+|+..++.....++...+..++.++++||+|||++.|+||||||.|+|++ +++.+||+|||+|
T Consensus 74 ~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 74 SNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred CceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 68999999996 599999998888999999999999999999999999999999999999998 8899999999999
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK----- 853 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~----- 853 (897)
+...... .....+-|.+|.|||.+.+.. .|+..+||||.|||+.||+-|.+-|++.+.-+.+..+...--.|.
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 9654332 222336899999999998854 489999999999999999999999999888777666654322211
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 ---------------------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ---------------------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.-...+.++.+|+.+||..||.+|++++|.+++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011246778999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=357.89 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=199.8
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
....+|++.+.||+|+||.||+++. .++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 3456899999999999999999987 46789999885320 123469999999999999999887643
Q ss_pred C------CCceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC
Q 002642 697 G------PVTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767 (897)
Q Consensus 697 ~------~~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~ 767 (897)
. ....+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++ ..
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~---~~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID---PN 206 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc---CC
Confidence 2 12357799999975 67666643 345688999999999999999999999999999999999997 23
Q ss_pred CCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 002642 768 RPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 768 ~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~ 847 (897)
...+||+|||+++............||+.|+|||++.+.. .++.++|||||||+||||++|.+||.+....+.+..++.
T Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred CCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 3479999999998654443344567899999999986532 378999999999999999999999998876665554433
Q ss_pred cCC---------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 GNL---------------------------GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~~l---------------------------~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
... ...+|...++++.+||.+||++||.+|||+.|++++
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 110 011344578899999999999999999999999965
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.76 Aligned_cols=262 Identities=27% Similarity=0.483 Sum_probs=215.8
Q ss_pred cccccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCce
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNI 687 (897)
.+++..++|.+.++||+|+||.||++++.+ ..||||+++... .......+.+|+++++.+. ||||
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCe
Confidence 456778899999999999999999998632 259999986431 1223467889999999996 9999
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------------------------------------
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------------------------------------------- 722 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~--------------------------------------------- 722 (897)
+++++++.+. ...++||||+++|+|.+++....
T Consensus 104 v~l~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 104 VNLLGACTKS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred eeEEEEEccC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 9999999876 68999999999999999886421
Q ss_pred --------------------------------------------------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 002642 723 --------------------------------------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHF 752 (897)
Q Consensus 723 --------------------------------------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHR 752 (897)
..+++..+..++.|++.||+|||+.+|+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 236677788999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 002642 753 DLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT- 828 (897)
Q Consensus 753 DIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt- 828 (897)
||||+|||++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++||||||+++|||++
T Consensus 262 dikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 262 DLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC--CCchhhHHHHHHHHHHHHHC
Confidence 9999999998 67789999999997542211 122344678899999987543 7899999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 829 Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
|..||........+...+.....+..+..++.++.++|.+||+.+|++||++.+|.+.|+++..
T Consensus 336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999988765555555555555566777889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=356.81 Aligned_cols=249 Identities=22% Similarity=0.391 Sum_probs=210.5
Q ss_pred CCCceEEEEecccCceEEEEeeec---CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k---g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
...|.+.+.||+|+||.||++... ++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 345999999999999999999863 456888876432 122345677899999999999999999999877
Q ss_pred CCceEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
..+++||||+++++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+
T Consensus 138 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~ 211 (478)
T PTZ00267 138 --DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLG 211 (478)
T ss_pred --CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEE
Confidence 6899999999999999988542 34588899999999999999999999999999999999998 77889999
Q ss_pred ecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 212 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~- 288 (478)
T PTZ00267 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY- 288 (478)
T ss_pred eCcCceecCCccccccccccCCCccccCHhHhCCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Confidence 999998653321 234567999999999987644 78999999999999999999999998888777777766654
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...|..++.+++++|.+||..||++||++.+++++
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 34566789999999999999999999999998753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.35 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=203.6
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+..++|++.++||+|+||.||+++++ +..+|+|.++... .......+.+|+++++.++||||+++++++.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45689999999999999999999985 5678999886431 12345678899999999999999999999988
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
. ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 ~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 D--GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred C--CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 6 6899999999999999999764 4578888999999999999999985 799999999999998 677899999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH----------
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI---------- 845 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~I---------- 845 (897)
||++...... ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754332 223457899999999997643 788999999999999999999999765443221110
Q ss_pred ---------------------------------HhcCCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 846 ---------------------------------IKGNLGPKIP-SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 846 ---------------------------------i~~~l~~~~p-~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.....+..+ ..++.++++||.+||++||++||++.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0111111222 2367899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=348.22 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=206.7
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||+++.+ ++.||||+++... .........+.+|+.++..++||+|+++++.+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-----MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-- 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence 47999999999999999999874 6679999986431 12233456788899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 6899999999999999999764 4588999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc------------------------------------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHH
Q 002642 780 KIKQKTL------------------------------------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVM 823 (897)
Q Consensus 780 k~~~~~~------------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvIL 823 (897)
+...... .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC--CCCcceecccccee
Confidence 6432110 011356999999999997654 78999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002642 824 WELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRPA---FSEITKE 886 (897)
Q Consensus 824 yELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~--~ls~el~dLI~kcL~~DPeeRPT---a~ELLq~ 886 (897)
|||++|+.||......+....+........+|. .++++++++|.+++ .||.+|++ ++|++++
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999999999999888777777665333333443 36899999999977 49999984 7787765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.00 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=211.4
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|++|.||+++. +++.|++|.+..... .......+.+|+++++.++||||+++++++.+. .
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM------NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--G 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC------CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--C
Confidence 588999999999999999987 467899998864311 133456788999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999999764 45688999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+...... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||......+....+.... .+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccc
Confidence 8543322 223456889999999987644 7889999999999999999999998887766666655544 34566678
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++.++|.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.19 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=201.5
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
...++|+++++||+|+||.||+++++ ++.||||++... ..+.....+.+|+++++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 44578899999999999999999874 678999998543 123345678899999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ..+++||||+++++|.+.. ..++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 144 ~--~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~Df 212 (353)
T PLN00034 144 N--GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADF 212 (353)
T ss_pred C--CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccc
Confidence 6 6899999999999987542 345677888999999999999999999999999999998 6788999999
Q ss_pred CCcccccccc-ccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHhcC
Q 002642 777 GLSKIKQKTL-ISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE---IIAGIIKGN 849 (897)
Q Consensus 777 GLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e---il~~Ii~~~ 849 (897)
|+++...... ......||..|+|||++... ..+.+.++|||||||++|||++|+.||......+ ....+ ...
T Consensus 213 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~ 291 (353)
T PLN00034 213 GVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMS 291 (353)
T ss_pred ccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hcc
Confidence 9998654322 22345799999999987432 2335678999999999999999999997433222 22222 222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+..+..++.++++||.+||+.||++||++.|++++
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3345667789999999999999999999999999986
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.35 Aligned_cols=242 Identities=28% Similarity=0.447 Sum_probs=203.7
Q ss_pred EEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
+.||+|+||.||+++. .++.+|+|+++.... .......+.+|++++++++||||+++++++..+ ..+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEE
Confidence 5799999999998875 366799999865311 122334567899999999999999999999876 689
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 9999999999999999754 4589999999999999999999999999999999999998 6788999999999754
Q ss_pred ccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHH
Q 002642 783 QKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861 (897)
Q Consensus 783 ~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~e 861 (897)
... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+..... .+|..++++
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHH
Confidence 332 2233467999999999997644 68899999999999999999999998888777777766554 567788999
Q ss_pred HHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 862 WRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 862 l~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
++++|++||+.||++||+ +++++++
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999999999 4555543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.35 Aligned_cols=263 Identities=30% Similarity=0.518 Sum_probs=213.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeee-------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW-------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~-------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
|.+..++|++.+.||+|+||.||++++ .++.||||.++... .......+.+|+.++.++ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-------ChHHHHHHHHHHHHHHhccCCccHh
Confidence 456678999999999999999999974 34579999986431 122346788999999999 689999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------------------------------------------
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------------------------------------- 722 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------------------------------------- 722 (897)
++++++.... ..+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 75 NLLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhcceeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 9999876543 57889999999999999986421
Q ss_pred --------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 723 --------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 723 --------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDI 229 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEeccccccc
Confidence 2356777888999999999999999999999999999998 6778999999998754
Q ss_pred ccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 783 QKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 783 ~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+.+...+........|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCC
Confidence 221 1112234567899999987543 7899999999999999997 999998765544444444444556667778
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
++++.+++..||+.+|++||++.||+++|+.++++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.73 Aligned_cols=251 Identities=34% Similarity=0.661 Sum_probs=214.4
Q ss_pred ccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
+...+|++.+.||.|+||.||++...++.||+|.++... ...+++.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 72 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS---------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG- 72 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccch---------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-
Confidence 456789999999999999999999999999999986431 1356788999999999999999999998875
Q ss_pred CceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g 147 (256)
T cd05039 73 -NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFG 147 (256)
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEcccc
Confidence 68899999999999999997653 3689999999999999999999999999999999999998 77889999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
.++....... ....+..|+|||.+.... ++.++||||||+++|+|++ |..||......+....+ .....+..+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 222 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPE 222 (256)
T ss_pred cccccccccc--cCCCcccccCchhhcCCc--CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hcCCCCCCcc
Confidence 9986533222 233567899999987543 7889999999999999997 99999887766655543 4444556677
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
.+++++.++|.+||..+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=350.07 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=211.2
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+..++|++.+.||+|+||.||+++++ ++.+|+|++.+.. .........+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 44578999999999999999999984 5679999986421 1112234567789999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 115 ~--~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~DF 186 (370)
T cd05621 115 D--KYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADF 186 (370)
T ss_pred C--CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEec
Confidence 6 6899999999999999999653 478888999999999999999999999999999999998 7789999999
Q ss_pred CCcccccccc--ccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 777 GLSKIKQKTL--ISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 777 GLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
|++....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998653322 223567999999999987532 247889999999999999999999999888777777777655444
Q ss_pred CCCC--CCcHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002642 853 KIPS--WCEPTWRSLMERCWSSDPKS--RPAFSEITKE 886 (897)
Q Consensus 853 ~~p~--~ls~el~dLI~kcL~~DPee--RPTa~ELLq~ 886 (897)
.+|. .++..++++|.+||..++.+ |+++.|++++
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 5554 46899999999999865543 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.16 Aligned_cols=263 Identities=31% Similarity=0.545 Sum_probs=215.3
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC---------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCc
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg---------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPN 686 (897)
+++..++|.+.+.||+|+||.||+++..+ ..+|+|.++... .......+..|+.+++.+ +|||
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCC
Confidence 45556889999999999999999997532 359999886431 122345688899999999 7999
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
|+++++++... ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|
T Consensus 86 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 163 (307)
T cd05098 86 IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIH 163 (307)
T ss_pred EeeEEEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999876 57899999999999999997532 24788899999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+||+++ .++.+||+|||+++...... ......+++.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 164 ~dlkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~ 237 (307)
T cd05098 164 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFT 237 (307)
T ss_pred ccccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC--CCcHHHHHHHHHHHHHHHc
Confidence 99999999998 67789999999987543211 111223456899999987543 7899999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002642 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895 (897)
Q Consensus 829 -Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg 895 (897)
|..||......+....+ ........+..++.++.++|.+||..+|++||++.++++.|+++++...
T Consensus 238 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 238 LGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 89999877665555544 4444556777889999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.92 Aligned_cols=259 Identities=31% Similarity=0.561 Sum_probs=210.7
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~ 693 (897)
+..++|++.+.||+|+||.||++.++ +. .+|+|.++.. ........+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45678999999999999999999874 33 3577766432 1123346778899999999 89999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHN 758 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeN 758 (897)
+.++ ..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECCC--CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 9876 67999999999999999996532 247888999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 002642 759 FLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLH 837 (897)
Q Consensus 759 ILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~ 837 (897)
||++ .++.+||+|||++..............+..|+|||.+.+.. ++.++||||||+++|||++ |..||....
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9998 67789999999986432222222223466799999986543 7889999999999999998 999998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 838 ~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
..+....+. .......+..+++++.++|.+||+.+|++||+++++++.|..+..+
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 229 CAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 666655443 3334455666889999999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.98 Aligned_cols=257 Identities=36% Similarity=0.604 Sum_probs=213.9
Q ss_pred cCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+..+|.+.+.||+|+||.||+++.. ...+++|.++.. .....+.+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--------TLAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--------cHHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4568999999999999999999753 234888887532 1223466889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSH 757 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPe 757 (897)
++... ...++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 75 ~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEccC--CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 99876 67899999999999999996532 24788899999999999999999999999999999
Q ss_pred CeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 002642 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPY 833 (897)
Q Consensus 758 NILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF 833 (897)
||+++ .++.+||+|||++....... ......++..|+|||.+.+.. ++.++||||||+++|||++ |+.||
T Consensus 153 Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 153 NCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred eEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99998 67899999999997443221 122345678899999987543 7889999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 834 ~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
......+....+.... .+..+..+|..+.+++.+||+.+|++||+++++++.|+++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 227 FQLSNTEVIECITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCHHHHHHHHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 8887777666554443 3455667889999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=341.22 Aligned_cols=242 Identities=27% Similarity=0.459 Sum_probs=200.2
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++++ ++.||+|.+++.... .+.....+..|..++..+ +||||+++++++.+. ..+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEE
Confidence 46999999999999884 667999998753211 112334566777787654 899999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 99999999999998764 4578889999999999999999999999999999999998 67789999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+... .+.+|.+++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 122233567999999999997654 789999999999999999999999988877776665544 3567788999999
Q ss_pred HHHHHhhccCCCCCCCH-HHHHH
Q 002642 864 SLMERCWSSDPKSRPAF-SEITK 885 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa-~ELLq 885 (897)
++|++||+.||++||++ +++++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999997 46653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=330.94 Aligned_cols=255 Identities=32% Similarity=0.559 Sum_probs=210.6
Q ss_pred ccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
+...+|++.++||+|+||.||++... ++.||||.++... .......+.+|+.++..++||||++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~ 74 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLL 74 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 34567888999999999999999863 3469999986431 123456788999999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRK---------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKS 756 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~---------------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKP 756 (897)
+++.+. ...++++||+.+++|.+++... ...+++..+..++.|++.||+|||++||+||||||
T Consensus 75 ~~~~~~--~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp 152 (283)
T cd05091 75 GVVTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152 (283)
T ss_pred EEEcCC--CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999877 5788999999999999998532 12477888899999999999999999999999999
Q ss_pred CCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 002642 757 HNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEP 832 (897)
Q Consensus 757 eNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~P 832 (897)
+||+++ +++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++||||||+++|||++ |..|
T Consensus 153 ~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 153 RNVLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred hheEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCC
Confidence 999998 67789999999987543221 122344678899999986543 7889999999999999998 8899
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 833 F~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
|......+....+.... ....+..++.++.+++.+||+.+|++||++++|++.|+.
T Consensus 227 ~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 227 YCGYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 98887777766655544 345677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=327.22 Aligned_cols=258 Identities=29% Similarity=0.547 Sum_probs=211.4
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCcc----EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSD----VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~----VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+...+|++++.||+|+||.||++++ .++. +++|.+... .......++..|+.+++.+.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 3456899999999999999999987 3443 666665321 12234567888999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++.. ...++++||+++++|.+++......+++..+..++.||+.||+|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 8764 357789999999999999987667789999999999999999999999999999999999998 778899
Q ss_pred EEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||......+... ++..
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEK 226 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHC
Confidence 99999997543221 122345677899999987543 7899999999999999998 999998876655444 3444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...+..+..++.++.+++.+||..||++||++.|+++.|..+.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 444556667888999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=340.20 Aligned_cols=243 Identities=25% Similarity=0.459 Sum_probs=204.3
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||+||+++++ ++.||||++++... ........+..|+.++..+ +||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-----LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEE
Confidence 36999999999999884 56799999875311 1223355677888998887 699999999998876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 99999999999988764 4588999999999999999999999999999999999998 77889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .+|..++.++.
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHH
Confidence 222233457999999999997644 78999999999999999999999998887777776665543 56778899999
Q ss_pred HHHHHhhccCCCCCCCH-----HHHHHH
Q 002642 864 SLMERCWSSDPKSRPAF-----SEITKE 886 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa-----~ELLq~ 886 (897)
+||++||..||++||++ .+++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.61 Aligned_cols=238 Identities=25% Similarity=0.403 Sum_probs=197.2
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHH-HHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH-MLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~-iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||+||++++ +++.||+|++.+... ........+..|.. +++.++||||+++++.+... ..+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI-----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEE
Confidence 3699999999999998 467899999864311 11222344555554 56789999999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 99999999999998764 4688889999999999999999999999999999999998 77899999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... ..+..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR 224 (323)
T ss_pred CCCccccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 222333567999999999997644 78999999999999999999999998888777777766543 45666899999
Q ss_pred HHHHHhhccCCCCCCCHH
Q 002642 864 SLMERCWSSDPKSRPAFS 881 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ 881 (897)
++|++||+.||.+||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHhhcCHHhCCCCC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.95 Aligned_cols=249 Identities=35% Similarity=0.674 Sum_probs=207.9
Q ss_pred CCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..+|++.+.||+|+||.||++++++ ..+|+|.+..... . ...+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----S----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-- 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----C----HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--
Confidence 4578899999999999999998854 4799998864311 1 23577899999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccc
Confidence 678999999999999999977656789999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccccc--CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 780 KIKQKTLIS--GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 780 k~~~~~~~~--~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
+...+.... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+. .......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPK 224 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCC
Confidence 754332211 1222345799999987543 7889999999999999999 899998877666665544 344556677
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.++.++.+++.+||..+|++||++.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=342.34 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=198.8
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++++ ++.||+|++++... ........+..|..++..+ +||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-----NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEE
Confidence 36899999999999884 66799999975421 1233456778899999888 799999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc-c
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-Q 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~-~ 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 99999999999988654 4689999999999999999999999999999999999998 6788999999998742 2
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------hHHH-HHHHHhcCCCCCC
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH--------SEEI-IAGIIKGNLGPKI 854 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~--------~~ei-l~~Ii~~~l~~~~ 854 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ..+. ...+.... ..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCC
Confidence 222334567999999999998644 7899999999999999999999996321 1122 23333332 467
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPA------FSEITKE 886 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPT------a~ELLq~ 886 (897)
|..++.++.++|++||+.||.+||+ +++++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 7889999999999999999999987 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.65 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=203.1
Q ss_pred ceEEEEecccCceEEEEeee------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 624 LEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
|++++.||+|+||+||++.. .+..||+|.++... .......+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48999999999999988653 35579999986431 112345678899999999999999999988765
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
....+++||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 446789999999999999999763 489999999999999999999999999999999999998 67789999999
Q ss_pred Cccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--------------
Q 002642 778 LSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-------------- 839 (897)
Q Consensus 778 LAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-------------- 839 (897)
+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK--FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccC--CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9975433211 12233567799999987543 789999999999999999999998654321
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 840 EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 840 eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
...............+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111122222334456678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.49 Aligned_cols=259 Identities=32% Similarity=0.572 Sum_probs=214.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
+++..++|++.+.||+|+||.||++...+ ..+|+|.++... .......+.+|+.++..+ +||||+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45667889999999999999999998642 358999886431 122346688999999999 799999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK---------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFD 753 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~---------------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRD 753 (897)
++++++... ..++++|||+++++|.+++... ...+++..++.++.|++.||+|||+++|+|||
T Consensus 80 ~~~~~~~~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 80 NLLGVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eEEEEEcCC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 999998876 6799999999999999998642 34688899999999999999999999999999
Q ss_pred CCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-C
Q 002642 754 LKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-G 829 (897)
Q Consensus 754 IKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-G 829 (897)
|||+||+++ .++.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |
T Consensus 158 lkp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 158 LAARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred cceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC--cCcccceeehhhHHHHHhcCC
Confidence 999999998 67899999999998543321 112233567899999986543 7899999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 830 EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 830 k~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
..||......+....+.. ...+..+..++.++.+|+.+||..||++|||+.|+++.|+++.
T Consensus 232 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 232 GSPYPGIPVEELFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 999988777666655443 4455677788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.84 Aligned_cols=253 Identities=32% Similarity=0.509 Sum_probs=204.8
Q ss_pred eEEEEecccCceEEEEeeecCc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC---
Q 002642 625 EYIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG--- 697 (897)
Q Consensus 625 eilk~LGkG~fG~Vylg~~kg~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~--- 697 (897)
.+.+.||+|+||.||+|+++.. .+|+|.++... ........+.+|+.+++.++||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4678899999999999987432 48999886531 1233457788999999999999999999876432
Q ss_pred -CCceEEEEEeeeeccchHHHHhh-----ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 698 -PVTNLATVTEYMVNGSLKQVLRR-----KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 698 -~~~~l~LVmEy~~GGsL~d~L~~-----~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
.....+++|||+.+++|.+++.. ....+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 12357899999999999988742 223578999999999999999999999999999999999998 67889
Q ss_pred EEEecCCccccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 002642 772 KIGDLGLSKIKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 772 KLiDFGLAk~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~ 847 (897)
||+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCC--cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999986433211 12234567899999987543 7899999999999999999 8999988777666665554
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 848 ~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.. ....+..++..+.++|.+||+.||++|||+.+|++.|+++
T Consensus 230 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 43 3455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=339.89 Aligned_cols=242 Identities=29% Similarity=0.468 Sum_probs=200.3
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh-CCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ-IHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~-L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||+||+++++ ++.||||+++..... .+.....+..|..++.. ++||||+++++++.+. ..+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEE
Confidence 36999999999999984 567999998754211 11223456677778876 4899999999999877 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 99999999999999764 4578888999999999999999999999999999999998 67789999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.... +.+|.+++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 122233457999999999997644 7899999999999999999999999888777776655443 456778999999
Q ss_pred HHHHHhhccCCCCCCCHH-HHHH
Q 002642 864 SLMERCWSSDPKSRPAFS-EITK 885 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~-ELLq 885 (897)
++|.+||+.||++||++. ++++
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHc
Confidence 999999999999999996 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.97 Aligned_cols=242 Identities=23% Similarity=0.394 Sum_probs=203.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPV 699 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~ 699 (897)
+|++.+.||+|+||+||+++.+ ++.||+|++++... ........+..|..++..+. |++|+++++++.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-- 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-----IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-- 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--
Confidence 4788999999999999999874 66899999864311 12233456778888888885 57788899888876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 6899999999999999998764 4588999999999999999999999999999999999998 6788999999998
Q ss_pred cccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
+... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+..... ..|..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence 7432 222233456999999999997644 78999999999999999999999999888777777776554 567788
Q ss_pred cHHHHHHHHHhhccCCCCCCCH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAF 880 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa 880 (897)
+.++.+++.+||+++|.+|++.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.47 Aligned_cols=254 Identities=37% Similarity=0.653 Sum_probs=211.3
Q ss_pred CCCceEEEEecccCceEEEEeeec--C---ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--G---SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g---~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
..+|++.+.||+|+||.||+++++ + ..+|+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 468899999999999999999863 2 258999886431 1223567889999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
.+ ...++||||+++++|.+++......+++..+..++.|++.||+|||+++++||||||+||+++ .++.+||+|
T Consensus 76 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 KS--KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred cC--CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 76 678999999999999999987666789999999999999999999999999999999999998 678899999
Q ss_pred cCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 776 LGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 776 FGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
||++........ .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||......+....+... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-Y 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCc--cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-C
Confidence 999975432211 11122356799999997544 7899999999999999887 99999887776666655443 4
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+.+..+++++.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4555667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.79 Aligned_cols=254 Identities=31% Similarity=0.539 Sum_probs=208.3
Q ss_pred ceEEEEecccCceEEEEeeecC-----ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 624 LEYIKELGSGTFGTVFYGKWKG-----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~kg-----~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
|++.+.||+|+||.||++.... ..||+|.++... ........+.+|+..++.++||||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678899999999999998632 469999986431 12334567889999999999999999999876542
Q ss_pred C----ceEEEEEeeeeccchHHHHhhc-----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 699 V----TNLATVTEYMVNGSLKQVLRRK-----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 699 ~----~~l~LVmEy~~GGsL~d~L~~~-----~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
. ...++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++ +++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 1 3478999999999999988432 23588899999999999999999999999999999999998 678
Q ss_pred eEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002642 770 VCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~I 845 (897)
.+||+|||+++...... .......+..|+|||.+... .++.++||||||+++|||++ |..||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 89999999998543221 11122356789999998654 37899999999999999999 99999888777776665
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 846 i~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.... .+..+..++.++.++|.+||+.||++||++.|+++.|+++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5443 4567778999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.99 Aligned_cols=245 Identities=34% Similarity=0.625 Sum_probs=202.4
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|+||.||++++ +++.+|+|.+... ........+.+|++++++++||||+++++++... ...++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEE
Confidence 3689999999999987 4678999987532 1123346788999999999999999999998876 678999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccc
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~ 785 (897)
|||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCcccccc
Confidence 999999999999976655688999999999999999999999999999999999998 6778999999998754322
Q ss_pred ccc---CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHH
Q 002642 786 LIS---GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861 (897)
Q Consensus 786 ~~~---~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~e 861 (897)
... .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+. .......+..++..
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDA 224 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHH
Confidence 111 1112345699999987544 7889999999999999998 999998776655544443 34445667778999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 862 WRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 862 l~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
+.+++.+||+.+|++||++.++++.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=322.95 Aligned_cols=255 Identities=33% Similarity=0.612 Sum_probs=211.0
Q ss_pred cccCCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
.+...+|++.++||+|+||.||++++++ ..||+|.++.... ....+.+|+++++.++||||+++++.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 4556789999999999999999998754 4699999864311 12457889999999999999999998754
Q ss_pred CCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
...++||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+|+||||||+||+++ .++.+||+|
T Consensus 73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~d 145 (262)
T cd05071 73 ---EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVAD 145 (262)
T ss_pred ---CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEecc
Confidence 3578999999999999999753 34578899999999999999999999999999999999998 678899999
Q ss_pred cCCccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 002642 776 LGLSKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 776 FGLAk~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
||.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+... ...
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~ 222 (262)
T cd05071 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRM 222 (262)
T ss_pred CCceeeccccccccccCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCC
Confidence 999975433221 12334667899999986544 7899999999999999999 89999888777666655433 334
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
..+..++..+.++|.+||+.+|++||++.++++.|++.+
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 456678899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=357.58 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=213.8
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
....+|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.++..++|+||++++..+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 4457999999999999999999987 577899999865421 12345667899999999999999999877653
Q ss_pred CC------CceEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC
Q 002642 697 GP------VTNLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767 (897)
Q Consensus 697 ~~------~~~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~ 767 (897)
.. ...+++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++ .
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~ 178 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----S 178 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----C
Confidence 21 12478999999999999998643 34688999999999999999999999999999999999998 6
Q ss_pred CCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002642 768 RPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844 (897)
Q Consensus 768 ~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~ 844 (897)
++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||......+.+..
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~ 256 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 788999999999754322 2233567999999999997644 78999999999999999999999998888777777
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 845 Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..... ..+|..+++++.++|.+||+.||.+||++.+++++
T Consensus 257 ~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 666554 35677889999999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.11 Aligned_cols=258 Identities=31% Similarity=0.592 Sum_probs=214.2
Q ss_pred ccCCCceEEEEecccCceEEEEeeecC-----ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg-----~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
+...+|.+.+.||+|+||.||+|.+.. ..+|||...... .....+.+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 456789999999999999999998642 258999875431 12345678899999999999999999998
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+.+. ..++||||+++++|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++ ..+.+||
T Consensus 76 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l 148 (270)
T cd05056 76 ITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKL 148 (270)
T ss_pred EcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEE
Confidence 8764 56799999999999999987655689999999999999999999999999999999999998 6778999
Q ss_pred EecCCccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 774 GDLGLSKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 774 iDFGLAk~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
+|||+++....... .....++..|+|||.+.... ++.++||||||+++|+|++ |..||......+....+....
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~- 225 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE- 225 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCC--CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999875433211 11223456899999987543 7899999999999999986 999998887766665554433
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
....+..++.++.++|.+||..+|++|||+.++++.|+++..+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4456778899999999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.67 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
..++|++.+.||+|+||.||++++ .++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF------QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc------cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 357899999999999999999987 46789999986431 1122345677899999999999999999988654
Q ss_pred C----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 698 P----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 698 ~----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
. ...+++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl 164 (359)
T cd07876 93 KSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKI 164 (359)
T ss_pred CCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEE
Confidence 2 1357999999965 56666642 377888889999999999999999999999999999998 7789999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL--- 850 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l--- 850 (897)
+|||+++............+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 165 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ecCCCccccccCccCCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9999998654443344567899999999997654 78899999999999999999999987654433222111000
Q ss_pred -----------------CCC--------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 851 -----------------GPK--------------------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 851 -----------------~~~--------------------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.+. .....++++++||.+||..||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 1112467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.81 Aligned_cols=253 Identities=33% Similarity=0.621 Sum_probs=210.0
Q ss_pred cccCCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
++..++|++.++||+|+||.||++.+++ ..+|+|.+..... ....+.+|+++++.++|||++++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4556789999999999999999998854 4799998754311 12457789999999999999999998754
Q ss_pred CCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
...++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++ +++.++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~d 145 (260)
T cd05069 73 ---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECC
Confidence 3578999999999999999753 34578889999999999999999999999999999999998 778899999
Q ss_pred cCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 002642 776 LGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 776 FGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
||++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.. ...+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~ 222 (260)
T cd05069 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRM 222 (260)
T ss_pred CccceEccCCcccccCCCccchhhCCHHHhccCC--cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 99997543322 112234567899999887543 7899999999999999999 9999998877766665443 4445
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
..+..++..+.++|++||.+||++||+++++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6677789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.45 Aligned_cols=254 Identities=36% Similarity=0.635 Sum_probs=210.5
Q ss_pred CCCceEEEEecccCceEEEEeeec--Cc---cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~---~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
..+|++.+.||+|+||.||+|+.+ ++ .||||.++.. .......++..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 457899999999999999999874 22 4999988643 11334567899999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
++ ...++||||+++++|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++ .+..+||+|
T Consensus 76 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~d 149 (269)
T cd05065 76 KS--RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (269)
T ss_pred CC--CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECC
Confidence 76 678999999999999999987666789999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccccc----CCcc--cCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 776 LGLSKIKQKTLIS----GGVR--GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 776 FGLAk~~~~~~~~----~~~~--GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
||++......... .... .+..|+|||.+.... ++.++||||||+++|||++ |..||......+....+. .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~ 226 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-Q 226 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCc--ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-c
Confidence 9998754322111 1111 245799999987544 7889999999999999887 999998877776666553 3
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
....+.+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 344455667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.32 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=223.1
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
-.+.|++.+.||+|.|+.|++..+ +|+++|+|++....+... ..+++.+|+++-+.|+||||+++.+.+.+.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 346788889999999999998876 578899999865533322 346678999999999999999999998877
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...|+|+|++.|++|..-|-.. ...++..+-.+++||+++|.|+|.+||||||+||+|+|+.+.+ ..--+||+|||
T Consensus 83 --~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FG 158 (355)
T KOG0033|consen 83 --SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFG 158 (355)
T ss_pred --ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccc
Confidence 7899999999999997666544 4578899999999999999999999999999999999997554 44568999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS- 856 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~- 856 (897)
+|....+.....++.|||.|||||++...+ |+..+|||+-|+|||-|+.|.+||.+.+...++++|+++.+..+-|.
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp--y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCC--CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 999887777778899999999999998654 89999999999999999999999999999999999999988666554
Q ss_pred -CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 -WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 -~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++++.++||++||..||.+|.|+.|.|.+
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 489999999999999999999999998865
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.73 Aligned_cols=255 Identities=33% Similarity=0.558 Sum_probs=209.9
Q ss_pred CceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 623 DLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.+.||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47888999999999999998632 358888875431 1223467889999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhc-----------------------cccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRK-----------------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHF 752 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~-----------------------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHR 752 (897)
.. ...++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++|+||
T Consensus 74 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cC--CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 76 5788999999999999998642 1246788899999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 002642 753 DLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT- 828 (897)
Q Consensus 753 DIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt- 828 (897)
||||+|||++ +++.+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhc
Confidence 9999999998 67789999999987432211 122334577899999986543 7899999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 829 Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
|..||....+.+.... .........+..++.++.++|.+||+.+|++||++.|+++.|++++.+
T Consensus 226 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 226 GGNPYPGIAPERLFNL-LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 9999988776665544 444455667788899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.33 Aligned_cols=253 Identities=34% Similarity=0.641 Sum_probs=210.7
Q ss_pred cccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
++..++|++.++||+|+||.||++... +..+|+|.++..... ...+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence 456678999999999999999999874 457999998653211 2457889999999999999999998754
Q ss_pred CCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
...+++|||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++ +++.+||+|
T Consensus 73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~d 145 (260)
T cd05070 73 ---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIAD 145 (260)
T ss_pred ---CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCC
Confidence 3578999999999999999753 34588999999999999999999999999999999999998 678899999
Q ss_pred cCCccccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 002642 776 LGLSKIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 776 FGLAk~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.. ...+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~ 222 (260)
T cd05070 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRM 222 (260)
T ss_pred ceeeeeccCcccccccCCCCCccccChHHHhcCC--CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 999975433221 12233566799999986543 7889999999999999999 9999988777766665543 4455
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
+.+...+.++.++|.+||..+|++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6677789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=321.48 Aligned_cols=245 Identities=31% Similarity=0.555 Sum_probs=203.0
Q ss_pred EecccCceEEEEeee----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 629 ELGSGTFGTVFYGKW----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+||+|+||.||+|.+ ++..+|+|+++... ......+++.+|+.+++.+.||||+++++++.. ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEE
Confidence 589999999999865 34579999886431 123346778899999999999999999998764 36789
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccc
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~ 784 (897)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 99999999999999754 4688999999999999999999999999999999999998 677899999999975432
Q ss_pred ccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 785 TLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 785 ~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
... .....++..|+|||.+... .++.++||||||+++|||++ |..||......+....+.. ...+..|..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCC
Confidence 211 1122345789999998643 37889999999999999998 9999988777666665544 34466778899
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
+++.++|.+||+.||++||++++|.+.|++.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=323.33 Aligned_cols=261 Identities=27% Similarity=0.505 Sum_probs=215.2
Q ss_pred ccCCCceEEEEecccCceEEEEeeecC------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+..++|++.+.||+|+||.||+|.+.. ..|++|.++.. ........+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-------ASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456799999999999999999998753 56899987532 12334577889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc-------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD-------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~ 765 (897)
++.... ...++++||+++++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++
T Consensus 76 ~~~~~~-~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIEDG-EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecCC-CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 876542 57889999999999999986532 3588999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 002642 766 PQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEI 841 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~ei 841 (897)
.++.+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++||+++ |+.||....+.+.
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC--CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 67899999999998543221 112234567899999987543 7899999999999999999 9999988776665
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002642 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 842 l~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~el 894 (897)
... +.....+..+..+++++.++|.+||..||++||++.++++.|+++.+++
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 229 AAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred HHH-HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 544 3344445556678999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.25 Aligned_cols=254 Identities=33% Similarity=0.598 Sum_probs=212.0
Q ss_pred ccccCCCceEEEEecccCceEEEEeee-cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~-kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
|++..++|+++++||+|+||.||++.. +++.+|+|.+..... ....+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 356678999999999999999999987 457899998864311 1246778999999999999999999875
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
. ...++||||+.+++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||+++ .++.++|+
T Consensus 72 ~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~ 144 (260)
T cd05067 72 Q---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIA 144 (260)
T ss_pred c---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEc
Confidence 4 4689999999999999998653 34688899999999999999999999999999999999998 67889999
Q ss_pred ecCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||++....... ......++..|+|||.+.... ++.++||||||+++|+|++ |+.||......+....+. ....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05067 145 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYR 221 (260)
T ss_pred cCcceeecCCCCcccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCC
Confidence 999997544221 112334567899999987543 7889999999999999999 999998887766666543 3445
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
.+.+...+.++.++|.+||..+|++||+++++++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 56677788999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.02 Aligned_cols=259 Identities=28% Similarity=0.518 Sum_probs=214.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCcee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVV 688 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIV 688 (897)
+.+..++|++.+.||+|+||.||+++.. +..+|+|.++... .......+.+|+.+++++ +||||+
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcc
Confidence 3455678999999999999999998752 2358999876431 122346788999999999 799999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~ 767 (897)
++++++... ...++||||+.+++|.+++.... ..+++.++..++.|++.||+|||+++|+|+||||+|||++ .
T Consensus 103 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~ 176 (302)
T cd05055 103 NLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----H 176 (302)
T ss_pred eEEEEEecC--CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----C
Confidence 999998876 57899999999999999997543 3479999999999999999999999999999999999998 6
Q ss_pred CCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 002642 768 RPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIA 843 (897)
Q Consensus 768 ~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~ 843 (897)
+..+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+.+.
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~ 254 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH
Confidence 7789999999987442211 122334678899999987544 7899999999999999998 999998877666665
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 844 ~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
........+..+...++++.++|.+||..+|++||++.|+++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 55655555566677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.49 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=202.0
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.++||+|+||.||+++.+ ++.||+|.++...... ....+.+|+.++++++||||+++++++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHTD- 76 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEeeC-
Confidence 468999999999999999999874 5679999986542111 123466899999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++ +|.+++...+..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 77 -~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 77 -KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred -CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 689999999975 88888876666688899999999999999999999999999999999998 678899999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-------- 849 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-------- 849 (897)
++..... .......+|+.|+|||++.+. ..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9754322 222234678999999998653 247889999999999999999999998876655444332210
Q ss_pred -------------CCC-------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -------------LGP-------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -------------l~~-------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
... .....++++++++|.+||+.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 0112468899999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=361.22 Aligned_cols=439 Identities=21% Similarity=0.252 Sum_probs=288.5
Q ss_pred cccccc-ccccceeccccccCCcceeEeecccCCceeeeeecccc-cccccchhhhHHHHHhhhhhhccCCCCCCCceec
Q 002642 411 GLSNLV-ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKD-DMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 411 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHr 488 (897)
+|.-++ ||.+|.|--+=.....-.|..++..++-++.|+-+--. .-+....++. .-+.+++.||... ||||
T Consensus 49 il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~a---elaLald~lh~l~----iiyr 121 (612)
T KOG0603|consen 49 ILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLA---ELALALDHLHKLG----IAYR 121 (612)
T ss_pred HHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHH---HHHHHHhhcchhH----HHHh
Confidence 445555 88888875544444444588899998888888765411 1122233332 3477899999777 9999
Q ss_pred CCCCCCcccCCCCCeeEcc--cCCC-CCCCCccccccceeeccccccCCccccccccccccCCCC------CC-------
Q 002642 489 ELENEKLLIDSEESANISG--LSNN-MNYRNGTASGCNMKNGTKNLQGGVASSMDLLYNLSLSSS------KE------- 552 (897)
Q Consensus 489 DIK~SNILLD~~~~aKIsD--Lar~-~~~~~~~~~gt~~v~gt~~~~g~~t~ksD~VySf~~ss~------~~------- 552 (897)
|+|++|||||.++..|+.| ++|. ...... -|+..+++++..+| .....| ..+||+..= .+
T Consensus 122 d~k~enilld~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~g-h~~a~D-~ws~gvl~felltg~~pf~~~~~~ 197 (612)
T KOG0603|consen 122 DYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIING-HLSAAD-WWSFGVLAFELLTGTLPFGGDTMK 197 (612)
T ss_pred cccccceeecccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhhc-cCCccc-chhhhhhHHHHhhCCCCCchHHHH
Confidence 9999999999999999999 8872 111111 23335666665553 345578 778776540 00
Q ss_pred ------C-CChhhhhhhh----h--------hccc----cccc-----ccccCCChhhhhhhccc---------------
Q 002642 553 ------I-EPPQISALQN----A--------ATER----NDEH-----KEEIHLDPLEEKVETKK--------------- 589 (897)
Q Consensus 553 ------i-~~~~i~~l~n----a--------a~~~----~~e~-----~ee~~~~~~eekv~~~~--------------- 589 (897)
. .|.++.+... . .... ..+. ...+....++.+.....
T Consensus 198 ~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd 277 (612)
T KOG0603|consen 198 RILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFD 277 (612)
T ss_pred HHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcC
Confidence 0 0111111000 0 0000 0000 01111111111100000
Q ss_pred c---ccc---ccccccccc--cccccccccccccc---cc-ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecC
Q 002642 590 T---CEC---SKVIGEISS--RSAAYFTNTANTEL---QT-IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKP 655 (897)
Q Consensus 590 ~---~~~---s~~i~~iss--~s~~~~~~~~~~~~---~~-i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~ 655 (897)
. .+. ++......+ +-...+...+...+ .. ...+.|++...+|.|+|+.|-.+.+ +++..++|++.+
T Consensus 278 ~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~ 357 (612)
T KOG0603|consen 278 PEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISK 357 (612)
T ss_pred chhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccc
Confidence 0 000 000000000 00000000000011 11 2367899999999999999999887 466799999865
Q ss_pred CcccCCChhHHHHHHHHHHHHHHHhh-CCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHH
Q 002642 656 SCFAEGSLEEDRLIADFWREAHMLGQ-IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734 (897)
Q Consensus 656 ~~~~~~~~~~~~~~~~fl~Ei~iL~~-L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia 734 (897)
... ...+|+.++.. -.||||+++.+.+.+. .+.|+|||.+.|+.|.+.+..... .. ..+..|+
T Consensus 358 ~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~ 421 (612)
T KOG0603|consen 358 RAD------------DNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWA 421 (612)
T ss_pred ccc------------ccccccchhhhhcCCCcceeecceecCC--ceeeeeehhccccHHHHHHHhcch-hH-HHHHHHH
Confidence 411 11245544444 3799999999999987 799999999999988888765432 22 6777899
Q ss_pred HHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchh
Q 002642 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKV 814 (897)
Q Consensus 735 ~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ks 814 (897)
.||+.|+.|||++||||||+||+|||++ .+.++++|+|||.++..... ....+-|..|.|||++...+ |++++
T Consensus 422 ~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~--yt~ac 494 (612)
T KOG0603|consen 422 AELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQE--YTEAC 494 (612)
T ss_pred HHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCC--CCcch
Confidence 9999999999999999999999999994 27788999999999876655 23456799999999998544 89999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 815 DVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 815 DIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
||||||++||+|++|+.||........ +......+++..++|.++++||++||+.||.+||++.+++.+
T Consensus 495 D~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 495 DWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred hhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 999999999999999999987665522 222233445668999999999999999999999999999865
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.63 Aligned_cols=245 Identities=32% Similarity=0.574 Sum_probs=203.3
Q ss_pred EecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 629 ELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
.||+|+||.||+|.+. +..||+|++... ........+.+|+.++++++||||+++++++.. ...++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 4899999999999763 335899988643 112345678899999999999999999998754 36889
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccc
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~ 784 (897)
||||+++++|.+++......+++..++.++.|++.||+|||++|++||||||+||+++ .++.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999976666789999999999999999999999999999999999998 677899999999874322
Q ss_pred cc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 785 TL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 785 ~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
.. ......++..|+|||.+.... ++.++||||||+++|+|++ |..||......+....+.. ...+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCC
Confidence 21 111122357899999987543 7889999999999999996 9999998877766655444 34566778889
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
+++.++|.+||..+|++||++.++++.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=326.15 Aligned_cols=259 Identities=33% Similarity=0.553 Sum_probs=210.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVk 689 (897)
|++..++|++.+.||+|+||.||+|..+ +..||+|.+.... .......+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~ 73 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVR 73 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeee
Confidence 4567789999999999999999998753 2368999875331 1122345778999999999999999
Q ss_pred EeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 002642 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFL 760 (897)
Q Consensus 690 l~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNIL 760 (897)
+++++.+. ...++||||+++++|.+++.... ...++..+..++.|++.||.|||+++|+||||||+||+
T Consensus 74 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 74 LLGVVSKG--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred EEEEEcCC--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 99998876 57899999999999999996532 22456678889999999999999999999999999999
Q ss_pred eccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 002642 761 VNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADL 836 (897)
Q Consensus 761 Ld~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~ 836 (897)
++ .++.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...
T Consensus 152 i~----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 152 VA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred Ec----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98 67889999999987432211 111233567899999987543 7899999999999999998 88999887
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 837 ~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
...+....+..... ...+..++++++++|.+||+.||++||++.++++.|++..
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 226 SNEQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 77776665554433 4556678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.19 Aligned_cols=257 Identities=30% Similarity=0.584 Sum_probs=208.2
Q ss_pred ccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
+..++|.+.+.||+|+||.||++.+.+ ..||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345689999999999999999998854 458888775321 122235688899999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhcc------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKD------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~ 765 (897)
+++.+. ...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||+++..+
T Consensus 76 ~~~~~~--~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 76 GVSFER--LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEEccC--CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence 988876 56789999999999999996542 2578899999999999999999999999999999999997322
Q ss_pred CCCCeEEEEecCCccccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 002642 766 PQRPVCKIGDLGLSKIKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEI 841 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~ei 841 (897)
....+||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|||++ |..||......+.
T Consensus 154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 154 -PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred -CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 245799999999985432211 11223456799999987544 7999999999999999997 9999998777666
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 842 l~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
...+ ........|..++.++.++|.+||+.+|++||++.+++++|+
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5544 333445667788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.78 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=210.6
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.+..++|++.+.||+|+||.||+++++ ++.+|+|++.+.. .........+.+|+.+++.++||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 455689999999999999999999884 5679999985421 112223456778999999999999999999998
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+. ..+++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~~--~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 DD--RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred cC--CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 76 6899999999999999998753 478888899999999999999999999999999999998 678899999
Q ss_pred cCCcccccccc--ccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 776 LGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 776 FGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
||+++...... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...+.......+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99998553321 223567999999999987532 23788999999999999999999999988877777777665433
Q ss_pred CCCC--CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 002642 852 PKIP--SWCEPTWRSLMERCWSSDPKS--RPAFSEITKEL 887 (897)
Q Consensus 852 ~~~p--~~ls~el~dLI~kcL~~DPee--RPTa~ELLq~L 887 (897)
..+| ..++.+++++|.+||..++.+ |+++++++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 3344 358999999999999844433 67999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.97 Aligned_cols=248 Identities=25% Similarity=0.464 Sum_probs=209.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++.++ ++.+|+|.++... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--G 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--C
Confidence 5889999999999999999874 6679999986431 122346677899999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 899999999999999988653 34578899999999999999999999999999999999998 6778999999998
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
...... .......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+..... ...+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCccc
Confidence 754322 2223456889999999987644 78899999999999999999999998777666666555443 4466778
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..+.++|.+||+.||++||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.77 Aligned_cols=249 Identities=34% Similarity=0.512 Sum_probs=201.2
Q ss_pred ceEEEEecccCceEEEEeeecC--ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKWKG--SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~kg--~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++++.||+|+||+||+++..+ +.+|+|++.... ..........+|+.++++++||||+++++++... ..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDD--NY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhcccccccccccccccccccc--cc
Confidence 7899999999999999999854 469999997641 2222233445699999999999999999999886 68
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||+++++|.+++.. ...+++..+..++.|+++||++||++||+|+||||+||+++ .++.++|+|||++..
T Consensus 73 ~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 8999999999999999983 35689999999999999999999999999999999999998 788999999999975
Q ss_pred c-ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCCCCC--
Q 002642 782 K-QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---EEIIAGIIKGNLGPKIP-- 855 (897)
Q Consensus 782 ~-~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~---~eil~~Ii~~~l~~~~p-- 855 (897)
. ..........+|..|+|||++.. ...++.++||||||+++|+|++|..||..... ...+.............
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 2 22333445678999999999871 23378999999999999999999999998732 22333333222211111
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+.++.++|.+||+.||++||++.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234899999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.53 Aligned_cols=245 Identities=40% Similarity=0.681 Sum_probs=209.7
Q ss_pred EEecccCceEEEEeeec-----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k-----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
+.||+|+||.||++... +..+++|.++.... ......+.+|+++++.++|+||+++++++... ..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecCC--Cce
Confidence 36899999999999885 56799999865411 11457788999999999999999999998875 689
Q ss_pred EEEEeeeeccchHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 703 ATVTEYMVNGSLKQVLRRK--------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~--------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999875 46789999999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 002642 775 DLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 775 DFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l 850 (897)
|||.+...... .......++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999855432 222345578899999998754 47899999999999999999 6999999877777776655 34
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
....+..++.++.++|.+||+.+|++||++.|++++|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 55677888999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=337.92 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=207.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||+++.+ ++.||+|++.+. ..........+.+|+.++..++||||+++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-----EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-- 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-----HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--
Confidence 47999999999999999999874 668999998642 112233456678899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 689999999999999999987666789999999999999999999999999999999999998 7788999999998
Q ss_pred ccccccc--ccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 780 KIKQKTL--ISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 780 k~~~~~~--~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||......+....+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 7543221 12234689999999998631 234678999999999999999999999988777776666554322222
Q ss_pred C---CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002642 855 P---SWCEPTWRSLMERCWSSDPKS--RPAFSEITKE 886 (897)
Q Consensus 855 p---~~ls~el~dLI~kcL~~DPee--RPTa~ELLq~ 886 (897)
+ ..++++++++|++||..++++ ||++++++++
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2 347899999999998664433 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=340.15 Aligned_cols=239 Identities=25% Similarity=0.380 Sum_probs=195.8
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHH-HHHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREA-HMLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei-~iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++++ ++.||+|++..... ........+..|. .+++.++||||+++++++... ..+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEE
Confidence 36999999999999884 55699999864311 1112223344444 456788999999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 99999999999999764 4577888888999999999999999999999999999998 67789999999997432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... .++..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR 224 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence 222334567999999999997644 78999999999999999999999998888777777665543 45567899999
Q ss_pred HHHHHhhccCCCCCCCHHH
Q 002642 864 SLMERCWSSDPKSRPAFSE 882 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~E 882 (897)
++|++||+.||.+||++.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHcccCHHHCCCCCC
Confidence 9999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.79 Aligned_cols=256 Identities=37% Similarity=0.647 Sum_probs=211.4
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc---cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~---~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
+...+|+..+.||+|+||.||+++.+ ++ .+|+|.++... .......+.+|+++++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 44568899999999999999999874 32 58999875431 12235678899999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+... ...++||||+++++|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++ .++.+||
T Consensus 75 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl 148 (268)
T cd05063 75 VTKF--KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKV 148 (268)
T ss_pred EccC--CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEE
Confidence 9876 678999999999999999987666789999999999999999999999999999999999998 6778999
Q ss_pred EecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 774 GDLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 774 iDFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
+|||++........ ......+..|+|||++.... ++.++||||||+++|||++ |..||......+....+...
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~ 226 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhhcCC--cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence 99999875432211 11122345799999987543 7899999999999999997 99999887776666665443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
...+.+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 34445566889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.71 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=194.4
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||.||+++.+ ++.||+|.+...... .......+..|++++++++||||+++++++..+ ..+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-----KKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-----cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEe
Confidence 699999999999874 778999998643211 111223455699999999999999999998876 68999999
Q ss_pred eeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc
Q 002642 708 YMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~ 786 (897)
|+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999998886533 3588888999999999999999999999999999999998 67789999999987654433
Q ss_pred ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCcHHH
Q 002642 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE----EIIAGIIKGNLGPKIPSWCEPTW 862 (897)
Q Consensus 787 ~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~----eil~~Ii~~~l~~~~p~~ls~el 862 (897)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... +........... .....+++++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHH
Confidence 333456899999999997654 889999999999999999999999765332 222333332221 1224578999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 863 RSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 863 ~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+++|.+||+.||++||+++|+++++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhh
Confidence 9999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.44 Aligned_cols=256 Identities=34% Similarity=0.583 Sum_probs=205.0
Q ss_pred CCCceEEEEecccCceEEEEeee------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..+|++++.||+|+||.||++.. .+..||+|.++.. .....+.+.+|++++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------TAEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 45899999999999999999874 3567999998643 123356788999999999999999999987
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.......+++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence 65544678999999999999999976555689999999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-----------
Q 002642 775 DLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE----------- 839 (897)
Q Consensus 775 DFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~----------- 839 (897)
|||+++....... .....++..|+|||++.+.. ++.++||||||+++|||++|..|+......
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCC--cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 9999985432211 11122345699999987543 789999999999999999987765433211
Q ss_pred ----HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 840 ----EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 840 ----eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+..++........+..++.++.++|.+||..+|++|||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011223333334455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.69 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=222.9
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..+..++|++++.||+|.||+|.+++.+ ++.+|||++++... .....+...+.|-++|+..+||.+..+-..|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-----iakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-----IAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-----eehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 4567889999999999999999999874 67799999987643 2344567788999999999999999998888
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
+.. .++++||||..||.|+-++.+. +.+++.....+-.+|+.||.|||+++||+||||.+|+|++ .++++||+
T Consensus 238 Qt~--drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKit 310 (516)
T KOG0690|consen 238 QTQ--DRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKIT 310 (516)
T ss_pred ccC--ceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEee
Confidence 876 6999999999999999999764 5688888888899999999999999999999999999999 88999999
Q ss_pred ecCCcccc-ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 775 DLGLSKIK-QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 775 DFGLAk~~-~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
|||+++.. .......+++|||.|+|||++.... |+..+|||.+|+++|||++|+.||...+...++.-|+...+ .
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD--YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--k 386 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND--YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--K 386 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhcccc--ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--c
Confidence 99999843 3444566899999999999998544 89999999999999999999999999998888888888876 8
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|..++++++.|+..+|.+||.+|. ++.||.++
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 8999999999999999999999993 46666553
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.68 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=196.8
Q ss_pred ecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||+||++.+ +++.+|+|.+.... .........+..|+++++.++||||+++++++... ..+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR-----LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH-----HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEe
Confidence 69999999999987 46789999986431 11223345678899999999999999999988876 67999999
Q ss_pred eeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccc
Q 002642 708 YMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784 (897)
Q Consensus 708 y~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~ 784 (897)
|+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999988743 234689999999999999999999999999999999999998 677899999999875432
Q ss_pred c-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCc
Q 002642 785 T-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE----EIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 785 ~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~----eil~~Ii~~~l~~~~p~~ls 859 (897)
. .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... +....+... ...++..++
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 225 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFS 225 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCC
Confidence 2 2233457899999999998654 788999999999999999999999765432 222222222 234567789
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+++.+++.+||+.||++|| ++++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.20 Aligned_cols=254 Identities=33% Similarity=0.564 Sum_probs=208.5
Q ss_pred cCCCceEEEEecccCceEEEEeeecC------------------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWKG------------------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~kg------------------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~ 681 (897)
...+|+++++||+|+||.||+++... ..||+|.+.... .......+.+|++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHh
Confidence 45689999999999999999987632 348999886431 12346778899999999
Q ss_pred CCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD----------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 682 L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~----------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
++||||+++++++..+ ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+|
T Consensus 76 l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 9999999999999876 68899999999999999997643 25889999999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+||+++ .++.++|+|||+++..... .......++..|+|||.+.+.. ++.++||||||+++|||++
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred cccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC--CCccchhhhhHHHHHHHHh
Confidence 99999999998 6689999999998754322 1223445678899999987533 7899999999999999998
Q ss_pred --CCCCCCCCChHHHHHHHHhc------CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 829 --GEEPYADLHSEEIIAGIIKG------NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 829 --Gk~PF~~~~~~eil~~Ii~~------~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
+..||......+.+..+... ......+..+|.++.++|.+||+.||++||++.||++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78899877766665554432 1122345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.46 Aligned_cols=257 Identities=24% Similarity=0.436 Sum_probs=210.3
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++. +++.+|||.+.... .........+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-- 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-----hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--
Confidence 5788899999999999999986 56789999875431 12233456788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 TNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
...+++|||+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 688999999999999998864 234578999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCC
Q 002642 777 GLSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS--EEIIAGIIKGNLGPK 853 (897)
Q Consensus 777 GLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~--~eil~~Ii~~~l~~~ 853 (897)
|++....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .+....+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987543221 223456889999999987544 78899999999999999999999975543 233333333333333
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
.+..++++++++|.+||..||++|||+.+|++.++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 44568899999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.48 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=210.1
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++... ++.||+|.++.... ........+.+|++++++++|+||+++++.+...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-- 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-----MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-- 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-----cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--
Confidence 57999999999999999999884 77899998864321 1122356788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 TNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.||+||||||+||+++ .++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 688999999999999998864 234578999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCC
Q 002642 777 GLSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH--SEEIIAGIIKGNLGPK 853 (897)
Q Consensus 777 GLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~--~~eil~~Ii~~~l~~~ 853 (897)
|++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.... ..+....+..... ++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 227 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-PP 227 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-CC
Confidence 9987543221 222356889999999987544 7889999999999999999999996543 2233344333333 33
Q ss_pred CCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 854 IPS-WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 854 ~p~-~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
.|. .++.++.++|.+||..+|++||++.+|++.|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 443 78889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.43 Aligned_cols=261 Identities=29% Similarity=0.523 Sum_probs=215.0
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec---------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCc
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK---------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k---------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPN 686 (897)
+++...+|++.+.||+|+||.||+++.. +..||+|.++.. ........+.+|+.+++.+ +|||
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-------cchHHHHHHHHHHHHHHhhccCCC
Confidence 4566789999999999999999999742 225899987532 1123356788999999999 7999
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
|+++++++... ...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|
T Consensus 83 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH 160 (304)
T cd05101 83 IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH 160 (304)
T ss_pred chheeEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 99999999876 67899999999999999997531 24677888999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+||+++ .++.+||+|||+++...... ......+++.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 161 ~dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 161 RDLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred cccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC--CCchhhHHHHHHHHHHHHc
Confidence 99999999998 67889999999998543221 122234567899999987543 7899999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 829 -Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
|..||......+....+. .......+..++.++.+||.+||..+|++||++.|+++.|+++..-
T Consensus 235 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 235 LGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 889998877766666544 3344556777899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.43 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=208.6
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.++||+|+||.||+++.+ ++.+|+|++.+.. .........+..|+.++..++||+|+++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-- 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--
Confidence 47999999999999999999885 5569999985421 12223345678899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 689999999999999999987656789999999999999999999999999999999999998 6788999999998
Q ss_pred cccccc--cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 780 KIKQKT--LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 780 k~~~~~--~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
...... .......||+.|+|||++... ...++.++|||||||++|||++|+.||......+....+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 743221 122345799999999998631 224788999999999999999999999988887877777665443333
Q ss_pred C---CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002642 855 P---SWCEPTWRSLMERCWSSDPKS--RPAFSEITKE 886 (897)
Q Consensus 855 p---~~ls~el~dLI~kcL~~DPee--RPTa~ELLq~ 886 (897)
| ..+++++++||++||..++++ |++++|++++
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 3 357899999999999765544 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=374.17 Aligned_cols=263 Identities=34% Similarity=0.670 Sum_probs=228.7
Q ss_pred cccccCCCceEEEEecccCceEEEEeeec---Cc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCcee
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWK---GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVV 688 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~k---g~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIV 688 (897)
+.+++....++.+.||+|.||.||.|... +. .||||.+++. .......+|++|..+|+.++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-------~~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-------SSEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-------CCHHHHHHHHHHHHHHhcCCCccee
Confidence 44577888899999999999999999873 32 3899988654 2234568899999999999999999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhc------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVN 762 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd 762 (897)
+++|++.+. ...++++|||++|+|..+|++. ...++....+.|+.||++|++||+++++|||||..+|+|++
T Consensus 759 ~liGv~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 999999885 6788999999999999999886 67799999999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCccc-ccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 002642 763 MRDPQRPVCKIGDLGLSKI-KQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHS 838 (897)
Q Consensus 763 ~~~~~~g~VKLiDFGLAk~-~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~ 838 (897)
....+||.|||+|+. ++... ......-...|||||.+.. ..++.|+|||||||+|||+++ |..||.+.++
T Consensus 837 ----~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ----ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred ----ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 779999999999993 22211 1112234578999999985 458999999999999999999 9999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002642 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 839 ~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~el 894 (897)
.+++...+.+. +.+.|..||..+.++|.+||+.+|++||++..|++.+.++.+.+
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 99988777766 78899999999999999999999999999999999999988754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.01 Aligned_cols=250 Identities=26% Similarity=0.488 Sum_probs=208.4
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|++|.||+++.+ ++.+|+|.+.... ......+.+.+|++++++++|||++++++.+.... .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-G 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-C
Confidence 5899999999999999999874 5679999985431 11223556788999999999999999998876432 5
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++.++..++.|++.+|++||++||+||||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999999763 34589999999999999999999999999999999999998 7788999999999
Q ss_pred ccccc-ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
..... ........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+..... +..+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCcccc
Confidence 75432 22223456889999999987643 78899999999999999999999988776666665555443 4566778
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++++.++|.+||+.||++||++.+++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.79 Aligned_cols=255 Identities=32% Similarity=0.613 Sum_probs=213.4
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
|++..++|++.++||+|+||.||++..+ +..+|||.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 3567789999999999999999999875 45699998864311 1246788999999999999999999988
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.. ...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ .++.+||+
T Consensus 72 ~~--~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~ 145 (261)
T cd05034 72 EE--EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIA 145 (261)
T ss_pred cC--CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEEC
Confidence 76 57899999999999999997643 4688999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||++....... .......+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...........+.. .+.
T Consensus 146 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~ 222 (261)
T cd05034 146 DFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYR 222 (261)
T ss_pred ccccceeccchhhhhhhccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC
Confidence 999987543221 111223467899999987544 7889999999999999998 9999988777766666544 344
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
...+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 55666778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.52 Aligned_cols=238 Identities=25% Similarity=0.379 Sum_probs=196.1
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHH-HHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH-MLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~-iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++++ ++.||+|++.+... ........+..|.. +++.++||||+++++++.+. ...++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI-----LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEE
Confidence 36999999999999984 66799999864311 12223344555554 57889999999999998876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc-c
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-Q 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~-~ 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 99999999999888654 4578888889999999999999999999999999999998 7789999999998753 2
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+.... ..+|...+.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAAC 224 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222334567999999999987544 7889999999999999999999999888777777666554 356677889999
Q ss_pred HHHHHhhccCCCCCCCHH
Q 002642 864 SLMERCWSSDPKSRPAFS 881 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ 881 (897)
++|.+||+.||.+||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=345.96 Aligned_cols=261 Identities=28% Similarity=0.486 Sum_probs=217.0
Q ss_pred cccccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCce
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNI 687 (897)
.+++..++|.+.++||+|+||.||++++.+ +.||+|+++... .......+.+|+++|.++. ||||
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-------RSSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-------ChhHHHHHHHHHHHHHhcCCCCCe
Confidence 477888899999999999999999998642 469999996431 1122356889999999997 9999
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------------------------------------
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------------------------------------------- 722 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~--------------------------------------------- 722 (897)
+++++++... ...++||||+++|+|.+++++..
T Consensus 104 v~~~~~~~~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 104 VNLLGACTKG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred EEEEEEEccC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 9999999876 57899999999999999986431
Q ss_pred ----------------------------------------------------ccccHHHHHHHHHHHHHHHHHHHHCCce
Q 002642 723 ----------------------------------------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIV 750 (897)
Q Consensus 723 ----------------------------------------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIV 750 (897)
..+++..+..++.||+.||+|||+.+|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 1356667788999999999999999999
Q ss_pred eccCCCCCeEeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 002642 751 HFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827 (897)
Q Consensus 751 HRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELL 827 (897)
||||||+|||++ ..+.+||+|||+++..... .......++..|+|||.+.+.. ++.++||||||+++|||+
T Consensus 262 Hrdlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l 335 (401)
T cd05107 262 HRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIF 335 (401)
T ss_pred cccCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHH
Confidence 999999999998 6788999999999754221 1122345678899999987543 789999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 828 T-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 828 t-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
+ |..||......+.....+....++..|..++.++.++|.+||..+|++||++++|++.|+++.
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8 899998776666666666666666778888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.14 Aligned_cols=243 Identities=26% Similarity=0.430 Sum_probs=196.9
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++.+ ++.+|+|++++... ........+..|+.++.++ +||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-----cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEE
Confidence 36999999999999874 56799999975421 1223456677888888776 799999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 99999999999988654 4688999999999999999999999999999999999998 77889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------ChHHH-HHHHHhcCCCCCC
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL--------HSEEI-IAGIIKGNLGPKI 854 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~--------~~~ei-l~~Ii~~~l~~~~ 854 (897)
.........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||... ...+. ...+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 222234567999999999997654 788999999999999999999999521 11222 2333333 3467
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPA------FSEITKE 886 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPT------a~ELLq~ 886 (897)
|..++.++.++|++||+.||++||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 8889999999999999999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.25 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=195.8
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh---CCCCceeeEeeeeecC
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ---IHHPNVVAFYGVVTDG 697 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~---L~HPNIVkl~g~~~e~ 697 (897)
+|++.+.||+|+||+||+++++ ++.||+|.++....... ....+.+|+.+++. ++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG------LPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC------CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5899999999999999999884 66799999865421111 11223455555554 4799999999987642
Q ss_pred ---CCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 698 ---PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 698 ---~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
....+++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 23568999999974 8888886543 3588999999999999999999999999999999999998 6788999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC----
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN---- 849 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~---- 849 (897)
+|||+++............+|..|+|||++.+.. ++.++|||||||++|+|++|++||......+.+..+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCCC--CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 9999998655443334456899999999987544 7899999999999999999999998876665544443210
Q ss_pred --------------CCC-------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 --------------LGP-------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 --------------l~~-------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.+ .....++.++.++|.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.29 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=214.3
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec---------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCc
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK---------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k---------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPN 686 (897)
+.+..++|.+.+.||+|+||.||+++.. ...+|+|.++... .......+.+|+.+++++ .|||
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCC
Confidence 4556679999999999999999999752 2358999876431 123356788999999999 6999
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
|+++++++... ...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|
T Consensus 80 iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 80 IINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred eeeEEEEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 99999998876 67899999999999999996531 34788889999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 158 ~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 158 RDLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred ccccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC--cCccchhhHHHHHHHHHHh
Confidence 99999999998 67789999999998543221 111223456799999987543 7899999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002642 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 829 -Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~el 894 (897)
|..||......+....+.. ......+..++.++.++|.+||..+|++||++.++++.|+++...+
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 232 LGGSPYPGIPVEELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 8999988777666665444 3345667778899999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=341.42 Aligned_cols=248 Identities=28% Similarity=0.376 Sum_probs=205.5
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
-.|+-.+.+|+|+||.||.|+. .++.||||.+-... +.-.+|+++|+.+.|||||++..+|.....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------------r~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------------RYKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------------CcCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 3678889999999999999987 35689999885431 112379999999999999999887765433
Q ss_pred c---eEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 700 T---NLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 700 ~---~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
. .+.+||||++ .+|.++++. .+..++...+.-++.||++||.|||+.||+||||||.|+|++ ++.+.+||
T Consensus 92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKi 167 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKI 167 (364)
T ss_pred CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEe
Confidence 3 5668999996 489988874 356688888889999999999999999999999999999998 57799999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP- 852 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~- 852 (897)
||||.|+..........+.-|.+|.|||.+.+..+ |+.+.||||.||++.||+-|++-|++.+..+.+..|++---.|
T Consensus 168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~-Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred ccCCcceeeccCCCceeEEEeccccCHHHHcCccc-cCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 99999998877766667888999999999998654 8999999999999999999999999988777665553321110
Q ss_pred --------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 --------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 --------------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
-+...+++++.+|+.++|+.+|.+|.++.|++.+
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0334578999999999999999999999998864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.61 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=211.1
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++++.||.|+||.||++.+ +++.+|+|.+..... .......+..|+++++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999987 466799998864311 123346788999999999999999999988765556
Q ss_pred eEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 701 NLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLH-----EKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLH-----s~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
..+++|||+++++|.+++... ...+++..++.++.||+.||+||| +.+|+|+||||+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999998653 456899999999999999999999 88999999999999998 678999
Q ss_pred EEecCCccccccccc-cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 773 IGDLGLSKIKQKTLI-SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 773 LiDFGLAk~~~~~~~-~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|+|||++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+....+... ..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CC
Confidence 999999986543332 33456899999999987644 788999999999999999999999987765555554443 34
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++..++..+.+++.+||..+|++||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 56777889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.54 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=208.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++.+ ++.||+|++.+.. .........+.+|+.++..++|++|+++++++.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-- 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-----MLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-- 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence 47999999999999999999874 5579999986421 12233345678899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++|+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 689999999999999999987656788999999999999999999999999999999999998 6778999999999
Q ss_pred ccccccc--ccCCcccCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 780 KIKQKTL--ISGGVRGTIPWMAPELFKSKD---NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 780 k~~~~~~--~~~~~~GT~~Y~APEvl~g~~---~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
+...... ......||+.|+|||++.+.. ..++.++||||||++||+|++|+.||......+....+.......++
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 7543322 122356999999999986421 23678999999999999999999999988877777776665443344
Q ss_pred CC---CCcHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002642 855 PS---WCEPTWRSLMERCWSSDPKS--RPAFSEITKE 886 (897)
Q Consensus 855 p~---~ls~el~dLI~kcL~~DPee--RPTa~ELLq~ 886 (897)
|. .++.+++++|.+||...+.+ |+++++++++
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 43 36899999999999876544 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=337.11 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=199.9
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
..++|++.+.||+|+||.||++.+ .++.||||.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc------cChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 357999999999999999999987 46789999986431 1223346677899999999999999999987643
Q ss_pred C----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 698 P----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 698 ~----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
. ....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl 160 (355)
T cd07874 89 KSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKI 160 (355)
T ss_pred ccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEE
Confidence 2 2457999999965 67666643 378888899999999999999999999999999999998 6788999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-- 851 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~-- 851 (897)
+|||+++............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....++.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eeCcccccCCCccccCCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998655444444567999999999997654 789999999999999999999999877654433322211000
Q ss_pred --------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 --------------------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 --------------------------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+...+.++++||.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00112235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.71 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=204.7
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|+..+.||+|+||+||++.+. ++.+|+|.+.... .........+.+|+++++.++|+||+.+++.+..+ .
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR-----IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--D 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh-----hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--C
Confidence 3778899999999999999884 6689999986531 11222345577899999999999999999988876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcc
Confidence 899999999999999888654 34689999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG--NLGPKIPSW 857 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~--~l~~~~p~~ 857 (897)
.............|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+... .....++..
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 7543332223457899999999997543 788999999999999999999999877654433333221 112345667
Q ss_pred CcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
+++++.+|+.+||+.||++||+ +.+++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 8899999999999999999999 7787775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.68 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=204.4
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
...+|++.+.||+|+||.||+++. +++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 356899999999999999999987 46679999986431 11234577899999999999999999998876
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||
T Consensus 79 --~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 79 --EKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred --CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 6889999999999999998754 4578899999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc-ccCCcccCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--
Q 002642 778 LSKIKQKTL-ISGGVRGTIPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK-- 853 (897)
Q Consensus 778 LAk~~~~~~-~~~~~~GT~~Y~APEvl~g~-~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~-- 853 (897)
++....... ......+++.|+|||.+... ...++.++||||||+++|||++|+.||....+.+....+....+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 998543221 22345688999999987532 22367899999999999999999999976655444333323332222
Q ss_pred -CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 854 -IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 854 -~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.+..++.++.++|++||..+|++||++++++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1234688999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=318.06 Aligned_cols=248 Identities=32% Similarity=0.624 Sum_probs=209.4
Q ss_pred cCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
...+|++.+.||+|+||.||++...++.+|+|.++... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-- 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--
Confidence 45689999999999999999999889999999885421 134678899999999999999999998754
Q ss_pred ceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++ .++.+||+|||+
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~ 146 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGL 146 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCcc
Confidence 4689999999999999997643 3578889999999999999999999999999999999998 677899999999
Q ss_pred ccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ 857 (897)
+....... .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||......+....+.. ...+..+..
T Consensus 147 ~~~~~~~~--~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 221 (254)
T cd05083 147 ARVGSMGV--DNSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEG 221 (254)
T ss_pred ceeccccC--CCCCCCceecCHHHhccCC--cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCc
Confidence 87543321 2233467899999987543 7889999999999999998 9999988877666655443 344556677
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
++.++.++|.+||+.+|++||++++|++.|++
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 89999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=346.95 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=227.6
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.-|.+.+.||+|-|..|-++++ +|+.||||++.+..++. -....+.+|++.|+.+.|||||++|.+..+.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~------~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-- 89 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-- 89 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch------hhhhHHHHHHHHHHHhcCcCeeeeeehhccc--
Confidence 4578889999999999999987 79999999997764432 2245678999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+|+|+|.=++|+|++||-+++..+.+..+.+++.||+.|+.|+|+..+|||||||+|+++- ..-+-|||+|||++
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFS 166 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeecccc
Confidence 789999999999999999999888899999999999999999999999999999999999986 36788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
-.+.+.....+.+|+..|.|||++.+.. |-.+++||||||||||.|++|++||...+..|.+..|+.-.+ ..|..++
T Consensus 167 Nkf~PG~kL~TsCGSLAYSAPEILLGDs-YDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS 243 (864)
T KOG4717|consen 167 NKFQPGKKLTTSCGSLAYSAPEILLGDS-YDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVS 243 (864)
T ss_pred ccCCCcchhhcccchhhccCchhhhcCc-cCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhh
Confidence 8888887778899999999999999864 456889999999999999999999999999999999988887 7899999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+.++||..||..||.+|.+.+||...
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 999999999999999999999998754
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.40 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=205.7
Q ss_pred CCceEEEEecccCceEEEEeee------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.-|++++.||+|+||.||+++. .+..||+|.++... .......+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4578899999999999999874 35579999986431 1233567889999999999999999999887
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
.......++||||+++++|.+++.+....+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7644678999999999999999976655689999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------------
Q 002642 776 LGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-------------- 837 (897)
Q Consensus 776 FGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-------------- 837 (897)
||+++...... ......++..|+|||++.+.. ++.++||||||+++|+|++++.|+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK--FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCC--CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99998543221 122345677899999987543 7889999999999999999876653211
Q ss_pred hHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 838 ~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
........+......+.+..++.++.+||.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111122233333445667899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.46 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=196.5
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHH-HHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH-MLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~-iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||+||+++. +++.+|+|++.+... ........+..|.. +++.++||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-----LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEE
Confidence 3689999999999987 467899999864311 11222344555554 46778999999999998876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 99999999999988754 4688999999999999999999999999999999999998 77889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... ..+...+.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 224 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAW 224 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHH
Confidence 222233567999999999997644 78899999999999999999999998888777777766543 44556889999
Q ss_pred HHHHHhhccCCCCCCCHH
Q 002642 864 SLMERCWSSDPKSRPAFS 881 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ 881 (897)
++|++||+.+|.+||+++
T Consensus 225 ~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 225 SILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHhccCHHhcCCCC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=337.28 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=200.5
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++.. .++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc------cCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 57899999999999999999987 46679999986431 11223456778999999999999999999876432
Q ss_pred ----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
....++||||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 2467999999965 77777653 377888899999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||+++............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....++.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998655444444567899999999997654 789999999999999999999999887765554444321100
Q ss_pred -----------------C--------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------------P--------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------------~--------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ ......+.++++||.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0011134678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.93 Aligned_cols=252 Identities=37% Similarity=0.628 Sum_probs=208.9
Q ss_pred cCCCceEEEEecccCceEEEEeee-------cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW-------KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~-------kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+..+|.+.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+++++.+.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------CHHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 456888999999999999999864 2346888887543 1234567889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc--------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHN 758 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~--------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeN 758 (897)
++... ...++||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|
T Consensus 75 ~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~n 152 (280)
T cd05092 75 VCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRN 152 (280)
T ss_pred EEecC--CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhh
Confidence 98876 57899999999999999987542 247888999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 002642 759 FLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYA 834 (897)
Q Consensus 759 ILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~ 834 (897)
||++ +++.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 153 il~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 153 CLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9998 67889999999987442211 122334578899999987544 7899999999999999998 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 835 DLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 835 ~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.....+....+.... ....+..+++.+.++|.+||+.||++||++++|++.|+
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 227 QLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCHHHHHHHHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 877776666655443 34566788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.79 Aligned_cols=255 Identities=33% Similarity=0.551 Sum_probs=204.9
Q ss_pred ccCCCceEEEEecccCceEEEEeeecC----------------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG----------------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg----------------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L 682 (897)
+...+|++.+.||+|+||.||+++..+ ..||+|.++... .......+.+|+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRL 74 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhC
Confidence 345789999999999999999987632 138999886431 122345688999999999
Q ss_pred CCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc-----------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-----------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 683 ~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-----------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
+||||+++++++... ...++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++|
T Consensus 75 ~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 75 KNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred CCCCcCeEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 999999999999876 67899999999999999986432 13678888999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+||+++ .++.+||+|||++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 153 ~dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 153 RDLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred cccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHH
Confidence 99999999998 66789999999987542221 122334577899999987544 7899999999999999988
Q ss_pred --CCCCCCCCChHHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 829 --GEEPYADLHSEEIIAGIIK------GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 829 --Gk~PF~~~~~~eil~~Ii~------~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
+..||......+.+..+.. .......+..+++.+.+||.+||+.||++||++.++++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6789987776665544322 11122345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.45 Aligned_cols=250 Identities=29% Similarity=0.566 Sum_probs=201.9
Q ss_pred EEecccCceEEEEeeec-----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k-----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
+.||+|+||.||++.+. ...+|+|.+... ........+.+|+.+++.++||||+++++++...+ ...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 72 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSP 72 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCc
Confidence 36899999999999863 235899987432 11233567889999999999999999999766432 467
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++||||+.+++|.+++.......++..+..++.|++.||+|||+.+++||||||+|||++ .++.+||+|||+++..
T Consensus 73 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 73 LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDI 148 (262)
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCccccccc
Confidence 899999999999999987655577788889999999999999999999999999999998 6778999999998744
Q ss_pred cccc-----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 783 QKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 783 ~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
.... ......++..|+|||.+.+.. ++.++||||||+++|||++ |.+||......+....+... ..+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPE 225 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCc--cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCC
Confidence 3211 112334677899999987543 7899999999999999999 56778777666655554443 3345566
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
.++..+.+++.+||..+|++||++.++++.|+++..
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.50 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=209.2
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++... ++.+++|.+.... ....+.+.+|+.++++++||||+++++.+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR- 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-
Confidence 468999999999999999999874 5679999986431 11356788999999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..++++|||+.+++|.+++......+++..+..++.|++.||+|||+++|+|+||||+||+++ .++.+||+|||+
T Consensus 73 -~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 147 (262)
T cd06613 73 -DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGV 147 (262)
T ss_pred -CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcccc
Confidence 689999999999999999987656789999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC---
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--- 853 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~-~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~--- 853 (897)
+....... ......++..|+|||.+.+. ...++.++|+||||+++|+|++|+.||......+....+....+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543322 22345688899999998653 11378899999999999999999999988776666555544433222
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+...+.++.++|++||..+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 233467889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.70 Aligned_cols=258 Identities=34% Similarity=0.580 Sum_probs=214.9
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
++..+|++.+.||+|+||.||++.++ ++ .+|+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-------SPKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 45678999999999999999999863 22 48888875431 1334567889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++.. ...++||||+++++|.+++......+++..+..++.|++.||+|||+.||+||||||+||+++ .++.+|
T Consensus 77 ~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~k 149 (279)
T cd05057 77 ICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHVK 149 (279)
T ss_pred EEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeEE
Confidence 8876 478899999999999999987666789999999999999999999999999999999999998 677899
Q ss_pred EEecCCccccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||+++....... .....++..|+|||.+... .++.++||||||+++|||++ |+.||......+....+..
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 226 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK- 226 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-
Confidence 999999985432221 1122245689999998643 37889999999999999998 9999998877766655544
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
......|..++..+.+++.+||..+|.+||++.++++.|++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 334556667889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.68 Aligned_cols=344 Identities=27% Similarity=0.507 Sum_probs=268.7
Q ss_pred cccceeeccccccCCccccccccccccCCCCCCCCChhhhhhhhhhcccccccccccCCChhhhhhhccc---ccccccc
Q 002642 520 SGCNMKNGTKNLQGGVASSMDLLYNLSLSSSKEIEPPQISALQNAATERNDEHKEEIHLDPLEEKVETKK---TCECSKV 596 (897)
Q Consensus 520 ~gt~~v~gt~~~~g~~t~ksD~VySf~~ss~~~i~~~~i~~l~naa~~~~~e~~ee~~~~~~eekv~~~~---~~~~s~~ 596 (897)
+|.|.++-++.+.| .|+.++.....+-||+|--......+. ..+..+..+.+.+.-.. +.....+
T Consensus 173 nGSFLVRESEsSpg--------Q~sISlRyeGRVyHYRINt~~dgK~yv----t~EsrF~TLaELVHHHStvADGLittL 240 (1157)
T KOG4278|consen 173 NGSFLVRESESSPG--------QYSISLRYEGRVYHYRINTDNDGKMYV----TQESRFRTLAELVHHHSTVADGLITTL 240 (1157)
T ss_pred ccceEEeeccCCCc--------ceeEEEEecceEEEEEeeccCCccEEE----eehhhhhHHHHHHhhccccccceeEee
Confidence 45566665555555 677888887888888876544333322 23344555555554221 1111111
Q ss_pred ccccccccc-cccccccccccccccCCCceEEEEecccCceEEEEeeecCc--cEEEEEecCCcccCCChhHHHHHHHHH
Q 002642 597 IGEISSRSA-AYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFW 673 (897)
Q Consensus 597 i~~iss~s~-~~~~~~~~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~--~VAVK~ik~~~~~~~~~~~~~~~~~fl 673 (897)
--+..++.- ..+.-..+.+-|++...+.....+||-|.||.||.|.|+.- .||||.++.. ...+.+|+
T Consensus 241 hYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---------tMeveEFL 311 (1157)
T KOG4278|consen 241 HYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFL 311 (1157)
T ss_pred eccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---------chhHHHHH
Confidence 111111111 12222334567888899999999999999999999999744 5999998754 23478899
Q ss_pred HHHHHHhhCCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccc-cccHHHHHHHHHHHHHHHHHHHHCCceec
Q 002642 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFGIEYLHEKNIVHF 752 (897)
Q Consensus 674 ~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~-~lse~~~l~Ia~QLl~AL~yLHs~GIVHR 752 (897)
.|+.+|+.++|||+|+++++|+.+ -.+|||+|||..|+|.+||++.++ .++....++++.||..||+||..+++|||
T Consensus 312 kEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 312 KEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred HHHHHHHhhcCccHHHHhhhhccC--CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 999999999999999999999987 579999999999999999988755 45666788899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCCeEEEEecCCccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-C
Q 002642 753 DLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-G 829 (897)
Q Consensus 753 DIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-G 829 (897)
||..+|+|+. ++..||++||||++.+... ....+......|+|||-+.- +.++.|+|||+||++|||+.| |
T Consensus 390 DLAARNCLVg----EnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 390 DLAARNCLVG----ENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred hhhhhhcccc----ccceEEeeccchhhhhcCCceecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcC
Confidence 9999999998 8889999999999976433 33345566889999999864 348899999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 830 EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 830 k~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
..||++.+..+++. ++...++++-|..||+...+||+.||+++|..||++.|+-+.|+.++.+
T Consensus 464 MsPYPGidlSqVY~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYG-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCCccHHHHHH-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 99999988766554 6778889999999999999999999999999999999999999998864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.39 Aligned_cols=254 Identities=34% Similarity=0.606 Sum_probs=211.6
Q ss_pred cCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
..++|++++.||+|+||.||+++.+ .+.+++|.+... ........+.+|++++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 4578999999999999999999863 235888877532 12235677889999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc--------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD--------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~--------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~ 764 (897)
++.+. ...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+||+++
T Consensus 76 ~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-- 151 (275)
T cd05046 76 LCREA--EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-- 151 (275)
T ss_pred EECCC--CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe--
Confidence 98876 57899999999999999997543 1588999999999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 002642 765 DPQRPVCKIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEI 841 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~ei 841 (897)
.++.++|+|||+++..... .......++..|+|||.+.+.. .+.++||||||+++|+|++ |..||........
T Consensus 152 --~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 152 --SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred --CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 6778999999998643211 1222345677899999987544 6789999999999999998 8899988777777
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 842 l~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
...+.........+..++..+.++|.+||+.+|++||++.|+++.|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66666555555566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.57 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.4
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|++.+.||+|+||.||++... ++.||+|.+..... ........+.+|+.++++++|++|+.+++.+.+. .
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--D 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-----cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--C
Confidence 4788899999999999999884 66899998864321 1122335567899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 899999999999999988543 23588999999999999999999999999999999999998 6778999999998
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~---eil~~Ii~~~l~~~~p~ 856 (897)
.............||..|+|||++.+.. ++.++||||||+++|+|++|+.||...... +....+.. ......+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 7544333223457899999999997644 789999999999999999999999865432 22222222 22334566
Q ss_pred CCcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
.+++++++||++||+.||++||| ++|++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 78899999999999999999999 8899874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.54 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=212.0
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++++.||.|+||.||.++. +++.+++|.+..... .......+.+|+.++++++|+||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL------SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--N 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--C
Confidence 589999999999999988876 467799998854311 123346678999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
.++++|||+++++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999999764 44688999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+....+. ..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccc
Confidence 7543322 233456899999999987644 678999999999999999999999988887777777666553 345668
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+.++.++|.+||..+|++||++.++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 89999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=334.84 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=198.4
Q ss_pred EEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||+||+++.+ ++.||+|++++.. .........+.+|+.++.++ +||||+++++++... ..+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-----VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEE
Confidence 36999999999999874 5679999997541 12234466788999999888 699999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc-c
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-Q 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~-~ 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 99999999999988654 4589999999999999999999999999999999999998 6788999999998743 2
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------ChHHHHHHHHhcCCCCCCCCC
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL------HSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~------~~~eil~~Ii~~~l~~~~p~~ 857 (897)
.........||+.|+|||++.+.. ++.++||||||++||+|++|+.||... ...+...+.+... ...+|..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~ 225 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRF 225 (327)
T ss_pred CCCceecccCCcccCCHHHHCCCC--CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCC
Confidence 222334567999999999997644 789999999999999999999999532 2223333333322 3457788
Q ss_pred CcHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPA------FSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPT------a~ELLq~ 886 (897)
++..+.++|.+||..||++|++ +++++++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 9999999999999999999997 4566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.56 Aligned_cols=255 Identities=35% Similarity=0.620 Sum_probs=209.8
Q ss_pred ccCCCceEEEEecccCceEEEEeeec-------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k-------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
+..++|++.+.||+|+||.||++... +..+|+|.+.... .......+.+|+.+++.+.||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 34678999999999999999999863 4569999886431 123346788999999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhcc---------------------ccccHHHHHHHHHHHHHHHHHHHHCCce
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------------RTIDRRKRIIIAMDAAFGIEYLHEKNIV 750 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------------~~lse~~~l~Ia~QLl~AL~yLHs~GIV 750 (897)
+++.+. ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++
T Consensus 75 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAVG--KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcCC--CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 998876 57899999999999999996421 2467788899999999999999999999
Q ss_pred eccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 002642 751 HFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827 (897)
Q Consensus 751 HRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELL 827 (897)
||||||+||+++ .++.+||+|||++....... .......+..|+|||.+.+.. ++.++||||||+++|+|+
T Consensus 153 H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 153 HRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIF 226 (288)
T ss_pred cccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHH
Confidence 999999999998 77889999999987432221 112233466799999987544 789999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 828 T-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 828 t-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
+ |..||......+....+..... ...+..++.++.+||.+||+.+|++||++.|+++.|++
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 227 SYGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7 8899988877777666555443 34566788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.43 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=227.6
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGP 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~ 698 (897)
..|+-.+.||+|..+.|-+..+ +++++|+|++...........-.+.+....+|+.+|+++ .||+|+++.++++.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~- 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD- 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-
Confidence 4566678899999999988776 467899999865544444444567788889999999998 699999999999987
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++|+|.|+.|.|+|++... -.++++....|+.||+++++|||.++||||||||+|||++ ++..+||+|||.
T Consensus 96 -sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGF 169 (411)
T KOG0599|consen 96 -AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGF 169 (411)
T ss_pred -chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEeccce
Confidence 6889999999999999999864 5689999999999999999999999999999999999998 888999999999
Q ss_pred ccccccccccCCcccCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKS----KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g----~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
+............||||.|+|||.+.. ....|+..+|+|++|+|||.|+.|.+||.......++..|..+++....
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 998888877778899999999998752 1224788999999999999999999999998888889999999998888
Q ss_pred CCC--CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSW--CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~--ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
|.| ++.+.++||.+||+.||.+|.|++|.|++
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 876 78899999999999999999999999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.01 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=209.7
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCC-ChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEG-SLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~-~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+|.+.+.||+|+||.||+|.. .++.+|+|.+........ ........+.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 467788999999999999987 456899998865432211 223344567888999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~ 153 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGIS 153 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCC
Confidence 6888999999999999999765 4578888999999999999999999999999999999998 7788999999998
Q ss_pred ccccccc-------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 780 KIKQKTL-------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 780 k~~~~~~-------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
+...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........+..+.. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~ 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASP 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCC--CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCC
Confidence 7543211 112345888999999987543 78899999999999999999999988766555554433 3345
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+..++.++.++|++||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 231 EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 6777889999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.03 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=209.5
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|++.+.||+|+||.||+++.. +..||||.+..... ..........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE---SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcC---CcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 57999999999999999999874 66899998854311 11223346788899999999999999999999877544
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.+|+|||+++|+|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 6788999999999999998765 3478888899999999999999999999999999999998 6788999999998
Q ss_pred cccccc----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 780 KIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 780 k~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
...... .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........+..+......+..|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCC--CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 754321 1122345889999999987543 7889999999999999999999998876666665555554456667
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..++..+.++|.+||. +|++||++++++++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 7788899999999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.07 Aligned_cols=254 Identities=31% Similarity=0.571 Sum_probs=211.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
|++..++|++.++||+|+||.||++... +..+|+|.++.. ......+.+|+++++.++|+||+++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---------hhHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 4567889999999999999999999874 557999987643 112456788999999999999999999887
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
. ...+++|||+++++|.+++.+. ...+++..+..++.|++.||.|||+.|++||||||+||+++ ..+.+||+
T Consensus 72 ~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~ 144 (260)
T cd05073 72 K---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIA 144 (260)
T ss_pred C---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEEC
Confidence 6 4678999999999999999763 34578888999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|||++....... ......++..|+|||++.... ++.++|+||||+++|+|++ |+.||...........+. ....
T Consensus 145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05073 145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYR 221 (260)
T ss_pred CCcceeeccCCCcccccCCcccccccCHhHhccCC--cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCC
Confidence 999987543221 112234567799999987543 7889999999999999998 999998877666655443 3444
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
...+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 55567788999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=345.10 Aligned_cols=256 Identities=34% Similarity=0.554 Sum_probs=203.4
Q ss_pred CCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+++|.-...||+|+||.||+|...+ +.||||++..... .. ..+|.+|+.++.+++|||+|+++|||.+...
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~-------~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG-------QG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC-------cc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 4788888999999999999999865 7899998764311 10 3459999999999999999999999998732
Q ss_pred ceEEEEEeeeeccchHHHHhhccc-cccHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFGIEYLHEKN---IVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~-~lse~~~l~Ia~QLl~AL~yLHs~G---IVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
..++|+||+++|+|.+++..... .++|..+++|+.+++.||+|||+.. ||||||||+|||+| ++...||+|
T Consensus 146 -~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsD 220 (361)
T KOG1187|consen 146 -HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSD 220 (361)
T ss_pred -eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccC
Confidence 58999999999999999987655 8999999999999999999999964 99999999999998 889999999
Q ss_pred cCCcccccc-ccccCCc-ccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHHHh
Q 002642 776 LGLSKIKQK-TLISGGV-RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS------EEIIAGIIK 847 (897)
Q Consensus 776 FGLAk~~~~-~~~~~~~-~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~------~eil~~Ii~ 847 (897)
||+|+.... ....... .||..|+|||++... ..+.|+||||||++|.||++|+.|.....+ .+.....+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999976543 2222222 799999999999753 379999999999999999999988775321 111111111
Q ss_pred -----cCCCCCCC-CCCc--HH---HHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 848 -----GNLGPKIP-SWCE--PT---WRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 848 -----~~l~~~~p-~~ls--~e---l~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
..+.+.+. ...+ .+ +..+..+|++.+|.+||++.|++++|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 12223322 2222 23 456778999999999999999999996654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.31 Aligned_cols=246 Identities=33% Similarity=0.559 Sum_probs=203.0
Q ss_pred EEecccCceEEEEeeec--C---ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKWK--G---SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k--g---~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
++||+|+||.||+|++. + ..+|+|.+..... ....+.+.+|+++++.+.||||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 46999999999999763 2 4699998865411 1345678899999999999999999998764 367
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++||||+++++|.+++.... .+++..+..++.|++.+|+|||+++++|+||||+||+++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 89999999999999997654 688999999999999999999999999999999999998 7788999999999754
Q ss_pred ccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 002642 783 QKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 783 ~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ 857 (897)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.. ......+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCC
Confidence 32211 11122346799999987543 7889999999999999998 9999988877666555443 334566778
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
++..++++|.+||..+|++||++.+|++.|+++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.62 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=202.9
Q ss_pred cCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
+.++|++.++||+|+||.||+++.+ ++.||+|.++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 4578999999999999999999874 667999998643211 1123466899999999999999999999876
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++||||+. ++|.+++......+++..+..++.|++.||+|||+.||+|+||||+||+++ .++.+||+|||
T Consensus 77 --~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg 149 (301)
T cd07873 77 --KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFG 149 (301)
T ss_pred --CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCc
Confidence 68999999997 589998877666788999999999999999999999999999999999998 67889999999
Q ss_pred Cccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC------
Q 002642 778 LSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL------ 850 (897)
Q Consensus 778 LAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l------ 850 (897)
++...... .......+++.|+|||++.+.. .++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 98753322 1222345789999999986532 368899999999999999999999988776554433222100
Q ss_pred -----------CCC-----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 -----------GPK-----------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 -----------~~~-----------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
... ....+++++++||.+||+.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 112467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.30 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=208.3
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.+.|+++++||+|+||.||+++.+ ++.+++|.+... .......+.+|+.+++.++||||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD- 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-
Confidence 467999999999999999999884 567999998643 123456788899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++||||+++++|..++.+....+++..+..++.|++.+|+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~dfg~ 156 (292)
T cd06644 82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADFGV 156 (292)
T ss_pred -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccCcc
Confidence 689999999999999998876666789999999999999999999999999999999999997 677899999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCC
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPK 853 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~ 853 (897)
+...... .......+++.|+|||.+.+. ...++.++||||||+++|+|++|..||......+...++..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 8643221 222345688999999998531 22367899999999999999999999988776665555544332 123
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+..++.++.++|.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 355678899999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.56 Aligned_cols=253 Identities=23% Similarity=0.422 Sum_probs=208.7
Q ss_pred CceEEEEecccCceEEEEeee-cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 623 DLEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~-kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
+|++.+.||+|+||+||++.. +++.+|+|.++..... .....+....+.+|+++++.++|+||+++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--Ce
Confidence 477889999999999999987 5667999998654221 122334556788999999999999999999999876 78
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||+++++|.+++.+. ..+++..+..++.|++.+|+|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 99999999999999999764 3578888999999999999999999999999999999998 678899999999874
Q ss_pred ccc-------ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-CCCCC
Q 002642 782 KQK-------TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG-NLGPK 853 (897)
Q Consensus 782 ~~~-------~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~-~l~~~ 853 (897)
... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 321 11122356889999999987544 788999999999999999999999877655544443333 33455
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+..++.++.++|++||..+|++||++.|++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 677789999999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.93 Aligned_cols=244 Identities=34% Similarity=0.611 Sum_probs=202.9
Q ss_pred EecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 629 ELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
.||+|+||.||++... ++.+|+|.++... .......+.+|+++++.++||||+++++++... ...++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEE
Confidence 6899999999999874 5679999876431 122345688999999999999999999998876 57899999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccc
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI 787 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~ 787 (897)
|+++++|.+++......+++..+..++.|++.+|.|||++|++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999976556688999999999999999999999999999999999998 677899999999875432211
Q ss_pred c--CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 788 S--GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 788 ~--~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
. ....++..|+|||++.... ++.++||||||+++|+|++ |..||...........+. .......+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 1 1223456799999987543 7889999999999999998 999998877666655544 34445667778999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHH
Q 002642 865 LMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 865 LI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
++.+||..+|++||++.+++++|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.56 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=210.7
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++.. .++.+|+|.+..... .......+.+|+++++.++||||+++++.+..+ .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM------TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--K 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--C
Confidence 589999999999999999887 466799999864321 122356788999999999999999999988766 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++||||+++++|.+++... ...+++..+..++.|++.+|+|||++||+|+||||+||+++ .....+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD---KHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEccCCCc
Confidence 899999999999999999764 34588999999999999999999999999999999999997 23457899999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
.............++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+..... ..++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcC
Confidence 8665444444566899999999987543 78899999999999999999999988877666666555443 45667789
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++++++|.+||..+|++|||+.|++++
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.28 Aligned_cols=249 Identities=33% Similarity=0.665 Sum_probs=208.1
Q ss_pred CCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..+|++.+.||+|+||.||++.+. +..+|+|.++..... ...+.+|+++++++.||||+++++++...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTER-- 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccC--
Confidence 468999999999999999999875 678999988643211 23577899999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++......+++..+..++.|++.+|+|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 578999999999999999977656688999999999999999999999999999999999998 6778999999998
Q ss_pred cccccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 780 KIKQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 780 k~~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
........ .....++..|+|||.+.+.. ++.++||||||+++|||++ |..||......+....+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCC--cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCC
Confidence 74422211 12233567899999987543 7889999999999999998 99999887776666655433 3344566
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
..+.++.+|+.+||+.+|++||++.+++++|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.38 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=200.4
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC--
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP-- 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~-- 698 (897)
+|++.++||+|+||.||++.. +++.||||.+.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 578899999999999999986 47789999885431 11223457889999999999999999999987652
Q ss_pred -CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 -VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 -~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...+++||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 126899999996 5788877553 4688999999999999999999999999999999999998 77899999999
Q ss_pred Cccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--------
Q 002642 778 LSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK-------- 847 (897)
Q Consensus 778 LAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~-------- 847 (897)
+++..... .......+|+.|+|||++.+.. .++.++|||||||++|||++|+.||...+..+.+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCC-CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99754322 1222346789999999987633 368899999999999999999999988776554443322
Q ss_pred ---------------cCCCC-------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 ---------------GNLGP-------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ---------------~~l~~-------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....+ ......++++.+||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111 1223457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.39 Aligned_cols=261 Identities=30% Similarity=0.544 Sum_probs=214.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecC---------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCc
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg---------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPN 686 (897)
+++...+|++.+.||+|+||.||++++.+ ..+|+|.++.. ........+.+|+.+++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-------ATDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-------cCHHHHHHHHHHHHHHHhhcCCCC
Confidence 56667789999999999999999997521 25899987642 1223456788999999999 7999
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhc---------------cccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK---------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~---------------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
|+++++++... ...+++|||+++++|.+++.+. ...+++..+..++.|++.||.|||++||+|
T Consensus 80 iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999876 6789999999999999998653 124677888999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++||||||+++|||++
T Consensus 158 ~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 158 RDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHh
Confidence 99999999998 67789999999997543221 111223456799999987543 7889999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 829 -Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
|..||......+....+.. ...+..+..++.++.++|.+||+.+|++||++.|+++.|+++...
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred cCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 8999988877666665444 344566777889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.02 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=211.4
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++++.||.|+||.||++.++ ++.+|+|.++.. .......+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE- 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-
Confidence 357999999999999999999874 667999998643 123356788999999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++...+..+++..+..++.|++.+|.|||++||+|+||||+||+++ .++.++|+|||+
T Consensus 75 -~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~ 149 (280)
T cd06611 75 -NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGV 149 (280)
T ss_pred -CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCcc
Confidence 688999999999999999987667799999999999999999999999999999999999998 778899999998
Q ss_pred cccccc-ccccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCC
Q 002642 779 SKIKQK-TLISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPK 853 (897)
Q Consensus 779 Ak~~~~-~~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~ 853 (897)
+..... ........+++.|+|||.+... ...++.++||||||+++|+|++|+.||......+....+..... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 150 SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred chhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 864432 2222345689999999997521 23367899999999999999999999988877666666554432 123
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+..++.++.++|.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 456788999999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.86 Aligned_cols=245 Identities=33% Similarity=0.598 Sum_probs=206.3
Q ss_pred EEecccCceEEEEeeecC---c--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 628 KELGSGTFGTVFYGKWKG---S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg---~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
+.||+|++|.||++.+.. + .||||.+..... ....+.+.+|+.++++++||||+++++++.. ..+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc-------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 368999999999998732 2 589998865421 1456788999999999999999999998876 578
Q ss_pred EEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++ .++.+||+|||+++.
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence 99999999999999997754 5689999999999999999999999999999999999998 668999999999975
Q ss_pred ccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 782 KQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 782 ~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
..... ......++..|+|||.+.... ++.++||||||+++|+|++ |..||......+....+.........+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc
Confidence 43211 112345678899999987544 7889999999999999998 9999988887777666665444455666
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+|..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 78899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.75 Aligned_cols=247 Identities=32% Similarity=0.562 Sum_probs=200.9
Q ss_pred EecccCceEEEEeeecC--c--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEE
Q 002642 629 ELGSGTFGTVFYGKWKG--S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~kg--~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~ 703 (897)
.||+|+||.||+++.++ . .+++|.++.. ........+.+|++++.++ +||||+++++++... ...+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCce
Confidence 58999999999998743 2 3688877532 1122345678899999999 799999999999876 5789
Q ss_pred EEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCC
Q 002642 704 TVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR 768 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~ 768 (897)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999986532 2467889999999999999999999999999999999998 77
Q ss_pred CeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 002642 769 PVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 769 g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~ 847 (897)
+.+||+|||++..............+..|+|||++.... ++.++||||||+++|||++ |..||......+....+..
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 899999999986432221111223456799999986543 7899999999999999997 9999988776666655433
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 848 ~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
......+..++.++.+++.+||..+|.+||++.++++.|++++
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 3344566678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.16 Aligned_cols=255 Identities=33% Similarity=0.546 Sum_probs=203.6
Q ss_pred cCCCceEEEEecccCceEEEEeeec------------------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK------------------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k------------------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~ 681 (897)
..++|++.++||+|+||.||++... ...+|+|.++.. ........+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-------~~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-------ANKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-------CCHHHHHHHHHHHHHHHh
Confidence 3467999999999999999998542 224889988643 122345678899999999
Q ss_pred CCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 002642 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD----------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 682 L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~----------~~lse~~~l~Ia~QLl~AL~yLHs~GIVH 751 (897)
++||||+++++++... ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+|
T Consensus 76 l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999999998876 57899999999999999986532 23667789999999999999999999999
Q ss_pred ccCCCCCeEeccCCCCCCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||...... ++.++||||||+++|||++
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC--ccchhhhhHHHHHHHHHHH
Confidence 99999999998 67889999999987543221 122234467899999876543 7899999999999999998
Q ss_pred --CCCCCCCCChHHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 829 --GEEPYADLHSEEIIAGIIK------GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 829 --Gk~PF~~~~~~eil~~Ii~------~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
|..||......+....... .....+.+..+++.+.++|.+||+.||++||++.+|++.|++
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7899987766555443211 111123455688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.01 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=209.9
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|++.+.||+|+||.||++.. +++.||+|.+...... .........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 4788999999999999999987 4668999988644211 1223345678899999999999999999998876545
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++++|||+++++|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 6889999999999999999764 3478888899999999999999999999999999999998 6778999999998
Q ss_pred cccccc----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 780 KIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 780 k~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
+..... .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......+.+..+......+.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCC--CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 754321 1112345888999999987643 7889999999999999999999998877666666655555556777
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+++.++++| +||..+|++||+++|++++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 88899999999 6788899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=368.15 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=212.6
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
.+....+|+++++||+|+||+||++++. +..+|+|.+..... .......+..|+.++++|+||||++++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL------KEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 3455679999999999999999999984 55699999865421 123356788999999999999999999998
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCeEeccC
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEK-------NIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~-------GIVHRDIKPeNILLd~~ 764 (897)
.......+++||||+++++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 765556899999999999999998652 24689999999999999999999995 49999999999999632
Q ss_pred C-------------CCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 002642 765 D-------------PQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE 831 (897)
Q Consensus 765 ~-------------~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~ 831 (897)
. .....+||+|||++.............||+.|+|||++.+....++.++||||||||||+|++|..
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 1 134569999999998655444444567999999999986544457899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 832 PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
||........+...+......+ ....+.++.+||..||..+|.+||++.|++++
T Consensus 242 PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9987665554444444432222 23468999999999999999999999999964
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.21 Aligned_cols=247 Identities=30% Similarity=0.508 Sum_probs=210.6
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++.+. ++.+|+|.+.... .........+.+|+++++++.||||+++++++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK-----IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-- 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--
Confidence 47899999999999999999884 6789999986431 11233456788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 6899999999999999999765 4688999999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
+..... .....+++.|+|||.+.+.. .+.++||||||+++|+|++|+.||......+....+.... ..+|..++
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK--VRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--ccCCccCC
Confidence 865443 23456899999999987543 6889999999999999999999998877666666665443 46777889
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
..++++|.+||..||.+|+ +++|++++
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 9999999999999999998 77888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.48 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=206.7
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
-|++.+.||+|+||.||++... +..+++|.+... .......+.+|+++++.++||||+++++++... .
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~ 75 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--N 75 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--C
Confidence 3678899999999999999985 456888887543 123356788899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+++++|..++.+....+++..+..++.|++.||.|||+.||+||||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~ 151 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEccccccc
Confidence 88999999999999998876556789999999999999999999999999999999999998 67789999999987
Q ss_pred ccccc-cccCCcccCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCC
Q 002642 781 IKQKT-LISGGVRGTIPWMAPELFKS---KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPKIP 855 (897)
Q Consensus 781 ~~~~~-~~~~~~~GT~~Y~APEvl~g---~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~~p 855 (897)
..... .......+++.|+|||++.. ....++.++|||||||++|+|++|+.||......+....+..... ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd06643 152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231 (282)
T ss_pred cccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCc
Confidence 54322 12234568999999999842 123467899999999999999999999988777666665544332 23345
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..++.+++++|.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6688999999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.89 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=198.1
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC---CCCceeeEeeeeecCCCceEEE
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI---HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L---~HPNIVkl~g~~~e~~~~~l~L 704 (897)
||+|+||+||+++++ ++.||+|++.... .........+..|..++... +||||+++++++.+. ..+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-----IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHH-----HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEE
Confidence 799999999999874 6789999985431 11223344556677777665 699999999999877 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 99999999999998764 4588999999999999999999999999999999999998 67889999999987432
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC-CCCcHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP-SWCEPTW 862 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p-~~ls~el 862 (897)
.........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+....+..... .++ ..+++++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 225 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEK-GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEG 225 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCC-CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHH
Confidence 222234567999999999986532 368899999999999999999999998887777777666554 233 3478999
Q ss_pred HHHHHHhhccCCCCCC----CHHHHHHH
Q 002642 863 RSLMERCWSSDPKSRP----AFSEITKE 886 (897)
Q Consensus 863 ~dLI~kcL~~DPeeRP----Ta~ELLq~ 886 (897)
+++|++||..||++|| ++.+++++
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.18 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=193.6
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+...+|++++.||+|+||.||+++. +++.||+|.... ..+.+|++++++++||||+++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 4567899999999999999999987 466799996431 245689999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ...++|||++. ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 155 ~--~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~DF 226 (391)
T PHA03212 155 N--KFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGDF 226 (391)
T ss_pred C--CeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEEeC
Confidence 6 67899999984 6888888654 4578899999999999999999999999999999999998 6788999999
Q ss_pred CCccccccc--cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHh
Q 002642 777 GLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-------SEEIIAGIIK 847 (897)
Q Consensus 777 GLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-------~~eil~~Ii~ 847 (897)
|+++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....+..++.
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 999743221 1223467999999999997644 7999999999999999999998875321 1111111111
Q ss_pred c--------------------------CC-C-CCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 G--------------------------NL-G-PKIP-----SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~--------------------------~l-~-~~~p-----~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. .. . ...+ ..++.++.+||.+||+.||++|||++|++++
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00 0 0011 1246789999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.00 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=204.7
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~ 697 (897)
...|++.+.||+|+||.||++... ++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 356888899999999999999874 5679999986431 0124567899999988 699999999988653
Q ss_pred C----CceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 698 P----VTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 698 ~----~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
. ...+++||||+.+++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++ .++.+|
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~ 151 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVK 151 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEE
Confidence 2 24689999999999999998764 34688999999999999999999999999999999999998 677899
Q ss_pred EEecCCccccccc-cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||++...... .......|++.|+|||++... ...++.++||||||+++|+|++|+.||...........+...
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 231 (272)
T cd06637 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231 (272)
T ss_pred EccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence 9999999754322 222345789999999998632 224788999999999999999999999876665555444443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......+..++.++.+||.+||..+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 33333445678999999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.56 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=213.3
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|+.+..|++|+||.||+|+++ ++.||+|.++... +++-+.-.-++||.+|.+++|||||.+-.+..-..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 468999999999999999999985 5579999997652 11222334579999999999999999999888777
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
.+.+|+||||++. +|..++.....++...++..++.|++.||+|||...|+||||||+|+|+. ..|.+||+|||+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGL 223 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccch
Confidence 7889999999964 99999988888899999999999999999999999999999999999998 889999999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC------
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG------ 851 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~------ 851 (897)
|+.+..+. .....+-|.+|.|||++.+.. .|+++.|+||+|||+.||+++++-|++....+.+..|.+-.-.
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~-tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAK-TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCc-ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99765543 234566899999999999854 5899999999999999999999999998877776666442111
Q ss_pred -----------------------CCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------------------PKIPSW-CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------------------~~~p~~-ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..|+.. +++...+|+..+|..||.+|.|+.|-|++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 112211 56888999999999999999999998864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.04 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=207.1
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec--
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD-- 696 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e-- 696 (897)
...|..++.||+|+||.|..+.. +++.||||.+... .......++..+|+++|+.++|+||+.+++++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 34566689999999999999887 4778999988532 3345567889999999999999999999999876
Q ss_pred -CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 -GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 -~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
++-+.+|+|+|+| +.+|.+.++.. ..+++..+..+++||+.||+|+|+.+|+|||+||+|+|++ .+..+||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~D 168 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICD 168 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEecc
Confidence 3456789999999 66999999764 4589999999999999999999999999999999999998 788899999
Q ss_pred cCCcccccc---ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---
Q 002642 776 LGLSKIKQK---TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN--- 849 (897)
Q Consensus 776 FGLAk~~~~---~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~--- 849 (897)
||+|+.... ...-+.++-|.+|.|||++.... .|+...||||+||||.||++|++-|.+.+..+.+..++.--
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~-~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS-EYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccc-cccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999997753 22223567899999999986543 48999999999999999999999999877654443332111
Q ss_pred -------------------C--CCCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -------------------L--GPKIP-----SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -------------------l--~~~~p-----~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ .+..| ...++.+.+|+++||..||.+|+|++|.|++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 01111 2568899999999999999999999999876
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.61 Aligned_cols=258 Identities=33% Similarity=0.585 Sum_probs=210.3
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--Cc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+...+|+..+.||+|+||.||++++. +. .+|+|.+.... ......++.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 45678999999999999999999873 43 36888775431 1223346789999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++... ..++++||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+||+++ .++.+|
T Consensus 77 ~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~k 149 (303)
T cd05110 77 VCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHVK 149 (303)
T ss_pred EEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCceE
Confidence 88754 46789999999999999987666788999999999999999999999999999999999997 667899
Q ss_pred EEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||.+....+... ++..
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEK 226 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHC
Confidence 99999998543221 112234567899999987544 7899999999999999997 999998766554443 3444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...+..+..++..+.++|.+||..+|++||++.++++.|+++.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 444555667889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.39 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=197.9
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++++ .++.||+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-- 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--
Confidence 3688999999999999999987 46679999885431 122345688999999999999999999999886
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|..+. .+++..+..++.|++.||+|||+.||+|+||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 6788999999999997653 367788889999999999999999999999999999998 7789999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------HHHHHHHhcCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-------EIIAGIIKGNLGP 852 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-------eil~~Ii~~~l~~ 852 (897)
....... .....+|..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +....+.......
T Consensus 143 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNSI-AKTYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eeccccc-ccCCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 7554332 23467899999999997644 789999999999999999999999653321 2222222222111
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
......+++++++|.+||+.+|++||+++|++++-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 12345788999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.33 Aligned_cols=257 Identities=29% Similarity=0.546 Sum_probs=209.9
Q ss_pred CCCceEEEEecccCceEEEEeeec------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
.++|++.+.||+|+||.||+++++ ++.+|+|.++.... ......+.+|+++++.+.||||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 457888999999999999999864 45799999865411 13456788999999999999999999998
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
........++||||+++++|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 77544688999999999999999987665689999999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-----------
Q 002642 775 DLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE----------- 839 (897)
Q Consensus 775 DFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~----------- 839 (897)
|||++........ .....++..|+|||.+.+.. ++.++||||||+++|||++|..|+......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK--FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCC--CCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999986542211 11223456799999987543 788999999999999999999998654321
Q ss_pred ---HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 840 ---EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 840 ---eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
..+...+........+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 122333344444455667889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.74 Aligned_cols=248 Identities=40% Similarity=0.702 Sum_probs=207.8
Q ss_pred ceEEEEecccCceEEEEeeecC------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 624 LEYIKELGSGTFGTVFYGKWKG------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~kg------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
+++.+.||.|+||.||++++.. ..+|+|.++... .......+..|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3567899999999999998854 679999986541 111456788999999999999999999999887
Q ss_pred CCceEEEEEeeeeccchHHHHhhcccc-ccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~-lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
...+++|||+++++|.+++...... +++..+..++.|++.||+|||+.+++|+||||+||+++ .++.++|+||
T Consensus 74 --~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 74 --EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred --CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 6899999999999999999765444 89999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccccccc--CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 777 GLSKIKQKTLIS--GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 777 GLAk~~~~~~~~--~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
|++......... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.... ...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 224 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLP 224 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence 999754432111 123367899999998543 47899999999999999998 899998877777766655544 455
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6677899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.97 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=210.8
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|+..+.||+|+||.||++..+ ++.|++|.+...... ...++..+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG---QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc---ccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--C
Confidence 4677789999999999999874 678999998643211 11234467788999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 889999999999999999765 3578889999999999999999999999999999999998 67889999999987
Q ss_pred ccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcH
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~ 860 (897)
............++..|+|||.+.... .++.++|+||||+++|+|++|+.||......+....+......+.++..+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 554333334566899999999986533 3788999999999999999999999887765555555543445567778899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 861 TWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 861 el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++.++|.+||+.+|++||++.+++++
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.13 Aligned_cols=245 Identities=35% Similarity=0.639 Sum_probs=203.7
Q ss_pred EEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEE
Q 002642 628 KELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVT 706 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVm 706 (897)
++||+|+||.||++..+ ++.||+|.++.... ......+.+|+++++++.||||+++++++... ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEE
Confidence 36899999999999875 77899998864311 13456788999999999999999999998876 6789999
Q ss_pred eeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc
Q 002642 707 EYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL 786 (897)
Q Consensus 707 Ey~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~ 786 (897)
||+.+++|.+++......+++..+..++.|++.+|+|||+++++||||||+||+++ .++.+||+|||++.......
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCc
Confidence 99999999999976555688899999999999999999999999999999999998 67789999999987543211
Q ss_pred cc---CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHH
Q 002642 787 IS---GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTW 862 (897)
Q Consensus 787 ~~---~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el 862 (897)
.. .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+ ........+..++.++
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEI 224 (251)
T ss_pred ceeccccCcceeccCChHhhccCC--CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHH
Confidence 11 1122356799999987543 7899999999999999999 89999887765555444 3334455677889999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 863 RSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 863 ~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.++|.+||..+|++||++.|+++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.24 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=198.4
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++++.||+|++|.||+++. +++.||+|.++..... +.....+.+|+.+++.++||||+++++++.++ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQE--S 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--C
Confidence 588999999999999999987 4678999998643211 11235667899999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 701 NLATVTEYMVNGSLKQVLRRKD--RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~--~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
.+++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999997 58888886532 5689999999999999999999999999999999999998 778899999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-------
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL------- 850 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l------- 850 (897)
+...... .......+++.|+|||++.+.. .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 8744322 1122345788999999986533 368899999999999999999999987655433322211100
Q ss_pred ---------C-----------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 ---------G-----------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 ---------~-----------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. ......+++++.++|++||..||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00123478899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.40 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=208.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||.|+||.||+++. .++.+|+|.+.... .......+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-- 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--
Confidence 3688899999999999999987 46689999986431 122345678999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++|+||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 6899999999999999999764 688999999999999999999999999999999999998 6788999999999
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC-
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW- 857 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~- 857 (897)
+..... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...++.+....+... ..+..+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccc
Confidence 865433 2233456888999999997654 789999999999999999999999887766665554443 33444545
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++.++.++|.+||..+|++||++++++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 88999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.59 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=189.0
Q ss_pred EEEecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 627 IKELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 627 lk~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
.++||+|+||.||+++++ ++.+|+|.+..... ...+.+|+.+++.++||||+++++++........
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 367999999999999864 35699998864311 1345689999999999999999999876555678
Q ss_pred EEEEeeeeccchHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 703 ATVTEYMVNGSLKQVLRRK--------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~--------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
++||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+...++..+.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99999985 5888877532 12478889999999999999999999999999999999996444467789999
Q ss_pred ecCCcccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HH
Q 002642 775 DLGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---------EI 841 (897)
Q Consensus 775 DFGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~---------ei 841 (897)
|||+++...... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... +.
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999998543221 223457899999999987532 3788999999999999999999999643321 11
Q ss_pred HHHHHhcCCC------------C------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 842 IAGIIKGNLG------------P------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 842 l~~Ii~~~l~------------~------------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
+..+...... + ......+.++.+||.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111110000 0 000123467889999999999999999999987
Q ss_pred H
Q 002642 886 E 886 (897)
Q Consensus 886 ~ 886 (897)
+
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.92 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=203.2
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++++ +++.||+|.++... ......+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~- 78 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR- 78 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-
Confidence 35788899999999999999987 46679999986431 11234577899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++ .++.+||+|||+
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~ 152 (267)
T cd06645 79 -DKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGV 152 (267)
T ss_pred -CEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccee
Confidence 6889999999999999998765 3588999999999999999999999999999999999998 677899999999
Q ss_pred ccccccc-cccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI-- 854 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~-- 854 (897)
+...... .......|+..|+|||++.. ....++.++|||||||++|+|++|..||....+.............+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 8744322 22234578999999999742 1233788999999999999999999999776654444433333332221
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 -PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 -p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...++..+.++|.+||+.+|++||++++|+++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 12467899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.13 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=210.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++... ++.+|+|.+.... .........+..|+++++.+.||||+++++.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-----MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-- 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc-----cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--
Confidence 47899999999999999999884 5789999986542 12233567788999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 6899999999999999998753 35688999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc------------------------------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 002642 779 SKIKQKTL------------------------------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 779 Ak~~~~~~------------------------------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt 828 (897)
+....... ......||..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC--CCchHHHHHHHHHHHHHhh
Confidence 86432110 112346888999999997543 7889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 002642 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA----FSEITKE 886 (897)
Q Consensus 829 Gk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPT----a~ELLq~ 886 (897)
|+.||......+.+..+............++.+++++|.+||..||++||+ ++|++++
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999999888777777766555433333347899999999999999999999 8888774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=313.00 Aligned_cols=246 Identities=28% Similarity=0.531 Sum_probs=194.0
Q ss_pred EecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 629 ELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+||+|+||+||+|... ...+|+|.+.... .......+.+|+.+++.++||||+++++.+.+. ..+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEE
Confidence 5899999999999753 2357777764321 122346688899999999999999999998876 67999
Q ss_pred EEeeeeccchHHHHhhcc----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 705 VTEYMVNGSLKQVLRRKD----RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~----~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
||||+++++|.+++.... ...++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEecccccc
Confidence 999999999999997642 2245677889999999999999999999999999999998 67889999999986
Q ss_pred ccccc---cccCCcccCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC-
Q 002642 781 IKQKT---LISGGVRGTIPWMAPELFKSK-----DNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL- 850 (897)
Q Consensus 781 ~~~~~---~~~~~~~GT~~Y~APEvl~g~-----~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l- 850 (897)
..... .......+++.|+|||++... ...++.++||||||+++|||++ |..||....+.+.+..++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 43221 112233467789999997531 2246789999999999999999 8899988777666655544332
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 851 ---GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 851 ---~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+..+..+++.+.+++..|| .||++||++++|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22344568899999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.21 Aligned_cols=249 Identities=22% Similarity=0.463 Sum_probs=210.2
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||+++. .++.||+|.+..... ......++.+|+.++++++||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM------SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--G 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--C
Confidence 589999999999999999887 467899999864311 122345788999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 899999999999999998754 33578889999999999999999999999999999999998 6778999999999
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
....... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||......+....++.+.. +..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccC
Confidence 7543322 122345888999999987543 78899999999999999999999998887777777666553 4566778
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++.++|.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.17 Aligned_cols=247 Identities=31% Similarity=0.521 Sum_probs=193.0
Q ss_pred EEecccCceEEEEeeecC----ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 628 KELGSGTFGTVFYGKWKG----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg----~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
+.||+|+||.||+|+..+ ..+|+|.++... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 71 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYL 71 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcE
Confidence 358999999999998642 358999876431 112234688899999999999999999998876 5789
Q ss_pred EEEeeeeccchHHHHhhcc----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 704 TVTEYMVNGSLKQVLRRKD----RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~----~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
+||||+++++|.+++.... ...++..+..++.|++.||+|||+++++||||||+||+++ ..+.+||+|||++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~ 147 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLS 147 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCcccc
Confidence 9999999999999996532 2456677888999999999999999999999999999998 6778999999998
Q ss_pred ccccccc---ccCCcccCCcccCccccccCCC-----CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC-
Q 002642 780 KIKQKTL---ISGGVRGTIPWMAPELFKSKDN-----LVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN- 849 (897)
Q Consensus 780 k~~~~~~---~~~~~~GT~~Y~APEvl~g~~~-----~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~- 849 (897)
....... ......++..|+|||++.+... .++.++||||||+++|||++ |+.||......+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 7432221 1223457888999999864221 25789999999999999996 999998776665544333221
Q ss_pred C---CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 850 L---GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 850 l---~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
. .+......++.+.++|+.|| .+|++|||++||++.|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 12233356789999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.50 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=211.9
Q ss_pred CceEEEEecccCceEEEEeeecC---ccEEEEEecCCcccCC--ChhHHHHHHHHHHHHHHHhh-CCCCceeeEeeeeec
Q 002642 623 DLEYIKELGSGTFGTVFYGKWKG---SDVAIKRIKPSCFAEG--SLEEDRLIADFWREAHMLGQ-IHHPNVVAFYGVVTD 696 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~kg---~~VAVK~ik~~~~~~~--~~~~~~~~~~fl~Ei~iL~~-L~HPNIVkl~g~~~e 696 (897)
.|++.+.||+|+||.||++++++ +.+|+|.+........ ....+....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999854 5799998864322111 11234456677889998875 799999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEE
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
. ...++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||||+||+++ .++.+|
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 6 689999999999999988743 34568889999999999999999996 6899999999999998 678899
Q ss_pred EEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
|+|||++.............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC--CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 99999998654443334566899999999997543 7899999999999999999999998877766666666555544
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.....+++++.++|.+||+.||++||++.|+..+++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 344468899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=325.91 Aligned_cols=249 Identities=20% Similarity=0.385 Sum_probs=195.3
Q ss_pred EEEEeccc--CceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 626 YIKELGSG--TFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 626 ilk~LGkG--~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
++++||+| +|++||+++. +++.||+|.++... ........+.+|+.+++.++||||+++++++..+ ..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NE 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CE
Confidence 56789999 6789999987 46789999986431 1223455677899999999999999999999877 68
Q ss_pred EEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 702 LATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++ .++.++++||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999999653 34588999999999999999999999999999999999998 67789999998654
Q ss_pred ccccc--------cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-
Q 002642 781 IKQKT--------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG- 851 (897)
Q Consensus 781 ~~~~~--------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~- 851 (897)
..... .......++..|+|||++.+....++.++|||||||++|||++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 22110 011123467789999998753334789999999999999999999999876554443333222110
Q ss_pred -------------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -------------------------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -------------------------------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......+++++.+||++||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00112356789999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.09 Aligned_cols=248 Identities=28% Similarity=0.513 Sum_probs=207.8
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++++. ++.+++|.+... .....+.+|+++++.++||||+++++++.+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~- 70 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----------EDLQEIIKEISILKQCDSPYIVKYYGSYFKN- 70 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-
Confidence 368999999999999999999985 567999988542 1156788999999999999999999999877
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++++||+.+++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||+
T Consensus 71 -~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~ 145 (256)
T cd06612 71 -TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGV 145 (256)
T ss_pred -CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEccccc
Confidence 689999999999999999987667789999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCCC
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPKIPS 856 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~~p~ 856 (897)
+....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+..... ....+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence 88554332 223345889999999987653 78999999999999999999999987766554443322211 122344
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++.++|.+||+.||++||++.|++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 577899999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.81 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=197.0
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++++ +++.+|+|.++..... +.....+.+|++++++++||||+++++++.+. .
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLYDVLHSD--K 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc------ccCccchhHHHHHHHhcCCCCeeeHHHHhccC--C
Confidence 588999999999999999988 4678999998653211 11234567899999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++|+||+. ++|.+++......+++..+..++.||++||.|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 8999999996 588888876556789999999999999999999999999999999999998 67889999999987
Q ss_pred cccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHhcC---------
Q 002642 781 IKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA-DLHSEEIIAGIIKGN--------- 849 (897)
Q Consensus 781 ~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~-~~~~~eil~~Ii~~~--------- 849 (897)
...... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||. ..+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 543221 12234578899999998653 236889999999999999999988854 333333333222110
Q ss_pred ---------CCCC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 ---------LGPK---------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 ---------l~~~---------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+. ....++++++++|.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 112467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.05 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=205.4
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||+++++ ++.||+|.++... .......+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-- 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--
Confidence 47899999999999999999985 6789999886421 122346788999999999999999999988876
Q ss_pred ceEEEEEeeeeccchHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 TNLATVTEYMVNGSLKQVLRRK--DRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~--~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
..+++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 6899999999999999988753 2368999999999999999999997 5999999999999998 6788999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH--HhcCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKD----NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI--IKGNL 850 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~----~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~I--i~~~l 850 (897)
|++....... .....+++.|+|||.+.+.. ..++.++|||||||++|+|++|+.||...........+ +....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543322 23446888999999985422 13578999999999999999999999766544433221 12223
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+..+..++.++.++|.+||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 345666789999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.57 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=205.2
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~ 697 (897)
.++|++.+.||+|+||.||++..+ ++.+++|++.... .....+.+|+.+++++ .||||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 478999999999999999999984 5679999886431 1235678999999998 799999999998754
Q ss_pred C----CceEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCe
Q 002642 698 P----VTNLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 698 ~----~~~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~ 770 (897)
. ...+++||||+++++|.+++... +..+++..+..++.|++.||+|||+++++|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 2 34689999999999999988653 35689999999999999999999999999999999999998 6788
Q ss_pred EEEEecCCccccccc-cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002642 771 CKIGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 771 VKLiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii 846 (897)
+||+|||++...... .......++..|+|||++... ...++.++||||||++||+|++|+.||..........++.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 999999998754322 222345689999999987532 2246789999999999999999999998776666655555
Q ss_pred hcCCCC-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 847 KGNLGP-KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 ~~~l~~-~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...... ..+..++.+++++|.+||..||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 443211 1223467899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.92 Aligned_cols=257 Identities=26% Similarity=0.487 Sum_probs=207.2
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccC--CChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAE--GSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~--~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
+|.+.+.||.|+||.||+|.. .++.+|+|.++...... .........+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 577889999999999999986 46789999886432111 1112234466788999999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+||+++ .++.++|+|||+
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 6889999999999999999775 4588888999999999999999999999999999999998 678999999999
Q ss_pred cccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 779 SKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 779 Ak~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
++...... ......++..|+|||.+......++.++|+||||+++|+|++|..||......+....+......+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 87543221 122345889999999987544347889999999999999999999997766555444433333333333
Q ss_pred C----CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 S----WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~----~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. .++.+++++|.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3 458899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.07 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=199.0
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++++.||+|+||.||++.. +++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 46899999999999999999987 45679999986431 11223456778999999999999999999876432
Q ss_pred ----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
....+++++++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 24578999987 7899888764 3588999999999999999999999999999999999998 77889999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865433 2345789999999998753 24788999999999999999999999876654443333211000
Q ss_pred ------------------CCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 ------------------PKI--------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ------------------~~~--------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.. ....++.+.+||.+||..||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001 12356778999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.62 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|++.+.||+|+||.||++++ +++.||+|.+..... ..........+.+|++++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD---SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc---cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 5799999999999999999987 467899998743211 11123346788899999999999999999999877655
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 67899999999999999987643 478888999999999999999999999999999999998 6778999999999
Q ss_pred cccccc----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 002642 780 KIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 780 k~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p 855 (897)
+..... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+.+.++......+.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 754321 1112356889999999987643 7889999999999999999999998887777666666655566788
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+++++.++|.+||+ +|..||++.+++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 8899999999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.19 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=201.5
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++++. +..+|+|.++.. ........+.+|++++++++||||+++++.+.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-------IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-- 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--
Confidence 47999999999999999999874 556888987643 1223456788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++ .++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 6899999999999999999765 457888999999999999999998 5999999999999998 677899999999
Q ss_pred ccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH------------
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII------------ 846 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii------------ 846 (897)
+....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDSM-ANSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccccc-cccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 87543322 23567899999999987543 7889999999999999999999997554332221110
Q ss_pred -----------------------hcCCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 847 -----------------------KGNLGPKIP-SWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 847 -----------------------~~~l~~~~p-~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.....+..| ..++.+++++|.+||..+|++||++.|++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 001111222 13678899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.91 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=202.2
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.+.+.....||+|+||.||++++. +..||+|.+.... ......+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN- 77 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-
Confidence 344445578999999999999874 4569999876431 12345788999999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccc--cHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTI--DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~l--se~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
...++|+||+++++|.+++......+ ++..+..++.||+.||+|||++||+||||||+||+++ ...+.+||+||
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~---~~~~~~~l~df 153 (268)
T cd06624 78 -GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN---TYSGVVKISDF 153 (268)
T ss_pred -CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCeEEEecc
Confidence 68999999999999999997653444 7888889999999999999999999999999999997 13568999999
Q ss_pred CCccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCC
Q 002642 777 GLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKI 854 (897)
Q Consensus 777 GLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~Ii~~~l~~~~ 854 (897)
|++...... .......+++.|+|||.+.+....++.++||||||+++|+|++|+.||...... ............+.+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 154 GTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred hhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 998754321 122234588999999998654444788999999999999999999999765432 222222222334567
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
|..+++++.++|.+||..+|++||++.|++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 77889999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=312.76 Aligned_cols=248 Identities=34% Similarity=0.592 Sum_probs=199.6
Q ss_pred EecccCceEEEEeeecC--------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 629 ELGSGTFGTVFYGKWKG--------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~kg--------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.||+|+||.||+++.+. +.+|+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--E 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--C
Confidence 58999999999998742 458999875431 112345688899999999999999999998776 5
Q ss_pred eEEEEEeeeeccchHHHHhhc------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC-CCCCeEEE
Q 002642 701 NLATVTEYMVNGSLKQVLRRK------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD-PQRPVCKI 773 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~-~~~g~VKL 773 (897)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++++|+||||+||+++..+ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999999642 23468888999999999999999999999999999999998321 11237999
Q ss_pred EecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 002642 774 GDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 774 iDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~ 849 (897)
+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.. .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-G 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-C
Confidence 9999987442221 112334578899999987543 7899999999999999998 9999988777666555433 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.....+..+|..+.++|.+||..+|.+||++.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 345566778999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.10 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=204.8
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++.+.||+|+||.||+++. .++.+|+|.+..... .....+.+|+.+++.+.||||+++++.+...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~- 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVG- 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-
Confidence 35899999999999999999986 466899998864311 1235577899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 90 -~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~ 162 (296)
T cd06654 90 -DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (296)
T ss_pred -CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECcccc
Confidence 689999999999999999864 3478889999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPS 856 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-l~~~~p~ 856 (897)
+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....+......+.... .....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred chhccccccccCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 87543222 122346889999999987543 6889999999999999999999998876654443333322 2223456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++..+.++|.+||..+|++||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 688999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.22 Aligned_cols=243 Identities=28% Similarity=0.460 Sum_probs=205.7
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||.|+||.||+++.+ ++.+|+|.+.+... ......+.+.+|+.+++.++||||+++++.+.++ ..+++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-----VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-----hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEe
Confidence 699999999999986 77899999865421 1223456788999999999999999999998876 68999999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccc
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI 787 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~ 787 (897)
|+++++|.+++.+. ..+++..+..++.||+.||+|||+.+++|+||||+||+++ .++.++|+|||+++.......
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 99999999999764 4588899999999999999999999999999999999998 678899999999986544333
Q ss_pred cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 002642 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH--SEEIIAGIIKGNLGPKIPSWCEPTWRSL 865 (897)
Q Consensus 788 ~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~--~~eil~~Ii~~~l~~~~p~~ls~el~dL 865 (897)
.....+++.|+|||.+.... ++.++|+||||+++|+|++|..||.... ..+....+........+|...++++.++
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhcCCC--CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 33456889999999987543 7889999999999999999999998776 5566666665455567777789999999
Q ss_pred HHHhhccCCCCCCC-----HHHHHHH
Q 002642 866 MERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 866 I~kcL~~DPeeRPT-----a~ELLq~ 886 (897)
|.+||..+|++||+ ++|++++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcC
Confidence 99999999999999 8888873
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.44 Aligned_cols=251 Identities=26% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||+++.+ ++.||+|.+...... ....+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-- 72 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--
Confidence 47999999999999999999884 678999988643111 11234567899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|..++... ..+++..+..++.||+.+|+|||++|++||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 6889999999998888876543 4589999999999999999999999999999999999998 6788999999999
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---------
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN--------- 849 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~--------- 849 (897)
....... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCC-CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654332 223456788999999986532 36889999999999999999999998876655443332110
Q ss_pred ----------C-CCC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 ----------L-GPK---------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 ----------l-~~~---------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. .+. .-..++..+.+||.+||+.+|++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000 012457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.79 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=206.3
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++++.||+|+||.||++.+. ++.||+|.+.... .........+.+|+.+++.++||||+++++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-----LILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-- 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--
Confidence 37899999999999999999884 5679999886431 12233456788999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 6899999999999999999765 4588889999999999999999999999999999999998 7788999999998
Q ss_pred cccccc----------------cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 002642 780 KIKQKT----------------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843 (897)
Q Consensus 780 k~~~~~----------------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~ 843 (897)
+..... .......++..|+|||.+.+.. ++.++|+||||+++|||++|..||.+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 632110 0111245788999999987543 7899999999999999999999999888777777
Q ss_pred HHHhcCCC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 844 GIIKGNLG-PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 844 ~Ii~~~l~-~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+...... +..+..++.++.++|.+||+.+|++||+..++++.|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 66655432 2222357899999999999999999998555544444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.53 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=203.8
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~ 697 (897)
...|++.+.||+|+||.||++++. ++.+|+|.+... ......+..|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 468999999999999999999983 567999987532 11235577899999988 799999999988532
Q ss_pred ----CCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 698 ----PVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 698 ----~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
....++++|||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEE
Confidence 235789999999999999998753 34578888899999999999999999999999999999998 677899
Q ss_pred EEecCCccccccc-cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||++...... .......|++.|+|||.+... ...++.++||||||+++|+|++|..||....+.+....+...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 241 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence 9999998754322 222346689999999997532 224678999999999999999999999877665555544443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 ~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......+..++.++.++|.+||+.||.+||++.||+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 33233345688999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=341.54 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=191.0
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC------CCceeeE
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH------HPNVVAF 690 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~------HPNIVkl 690 (897)
+...+|+++++||+|+||+||++.+ .++.||||+++... .....+..|+.+++.++ |++++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 4467899999999999999999987 46679999986421 11223344555555554 4568899
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCC---
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDP--- 766 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~--- 766 (897)
++++.... ..+++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .|||||||||+|||++..+.
T Consensus 197 ~~~~~~~~-~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 197 QRYFQNET-GHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEEEEcCC-ceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccc
Confidence 99887653 5789999988 77899888764 468889999999999999999998 59999999999999973321
Q ss_pred ---------CCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 002642 767 ---------QRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837 (897)
Q Consensus 767 ---------~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~ 837 (897)
+...+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223699999998864322 223567999999999998654 7899999999999999999999998876
Q ss_pred hHHHHHHHHhcCC-------------------------CCCC-C--------------CCCcHHHHHHHHHhhccCCCCC
Q 002642 838 SEEIIAGIIKGNL-------------------------GPKI-P--------------SWCEPTWRSLMERCWSSDPKSR 877 (897)
Q Consensus 838 ~~eil~~Ii~~~l-------------------------~~~~-p--------------~~ls~el~dLI~kcL~~DPeeR 877 (897)
..+.+..+..... .+.. + ...++.+.+||.+||++||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 6554433221100 0000 0 0013567799999999999999
Q ss_pred CCHHHHHHH
Q 002642 878 PAFSEITKE 886 (897)
Q Consensus 878 PTa~ELLq~ 886 (897)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999984
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.72 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=204.4
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++++ .++.||+|++...... +.....+.+|+.++++++||||+++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPHG--S 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEecC--C
Confidence 589999999999999999987 4678999998654211 22346788999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+ +++|.+++......+++..+..++.||+.+|+|||++|++|+||||+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 899999999 9999999977667789999999999999999999999999999999999998 67889999999988
Q ss_pred cccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC------
Q 002642 781 IKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP------ 852 (897)
Q Consensus 781 ~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~------ 852 (897)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|.+||......+.+..+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccc-cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 554322 123456899999999986532 36889999999999999999998887776655444433211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ----------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ----------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......+.++.++|.+||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.25 Aligned_cols=248 Identities=22% Similarity=0.382 Sum_probs=207.4
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|++.+.||.|+||.||+++++ ++.+|+|.+..... ......+.+.+|++++++++||||+++++.+.+. .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-----VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--E 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-----cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--C
Confidence 4889999999999999999885 67899999864311 1223467888999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++|+||+.+++|.+++... ..+++..+..++.||+++|.|||++|++|+||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 899999999999999999765 5688999999999999999999999999999999999998 77889999999987
Q ss_pred ccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCC
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS--EEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~--~eil~~Ii~~~l~~~~p~~l 858 (897)
............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .+.+.+.... ..+..|..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 654433334566889999999987644 78999999999999999999999987763 2333332222 345677788
Q ss_pred cHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAF--SEITK 885 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa--~ELLq 885 (897)
+..+.++|.+||..||.+||++ +|+++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.11 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=207.0
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||.|+||+||++.. ++..+++|++..... ......+.+|+++++.++||||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-- 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc-------chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--
Confidence 4799999999999999999987 456799998864311 11456788999999999999999999988876
Q ss_pred ceEEEEEeeeeccchHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRK--DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~--~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++|||++++++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++ +++.+||+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 6899999999999999999753 24588999999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc-----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 778 LSKIKQKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 778 LAk~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
++....... ......++..|+|||++... ..++.++|+||||+++|+|++|+.||......+.......... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-P 225 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-C
Confidence 987543321 12344688999999998754 2478899999999999999999999988777666555554432 2
Q ss_pred CCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 KIP-----SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ~~p-----~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+ ..+++++.++|.+||..||++||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222 2567899999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.55 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=202.6
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
..++|++.+.||+|+||.||+++. .++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 457899999999999999999987 46679999875421 1124567899999998 69999999998743
Q ss_pred C---CCceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCe
Q 002642 697 G---PVTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 697 ~---~~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~ 770 (897)
. ....+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++ .++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence 2 23578999999999999998753 234678888999999999999999999999999999999998 6677
Q ss_pred EEEEecCCcccccccc-ccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002642 771 CKIGDLGLSKIKQKTL-ISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 771 VKLiDFGLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii 846 (897)
+||+|||+++...... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||......+.+....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 9999999987543221 22344689999999998532 1236889999999999999999999998776655444332
Q ss_pred hcC-CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 847 KGN-LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 847 ~~~-l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
... .....+..++.++.++|.+||+.||++||++.|+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 221 11223455788999999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.81 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=196.5
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHH-HhhCCCCceeeEeeeeecCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM-LGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~i-L~~L~HPNIVkl~g~~~e~~ 698 (897)
++|++.+.||+|+||.||+++++ ++.||+|.++..... +. ...+..|+.+ ++.++||||+++++++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~- 72 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS------QE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE- 72 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc------HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC-
Confidence 47999999999999999999984 678999998654211 11 1234445554 5667899999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 VTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
...++||||++ ++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++ .++.+||+
T Consensus 73 -~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 73 -GDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred -CcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 67999999996 678777654 234689999999999999999999998 999999999999998 67889999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCC
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLH-SEEIIAGIIKGNLG 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~-~~eil~~Ii~~~l~ 851 (897)
|||++.............++..|+|||.+.+.. ..++.++|+||||+++|+|++|+.||.... ..+.+....... .
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-S 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-C
Confidence 999998654333333356889999999886421 236789999999999999999999997532 334444444332 2
Q ss_pred CCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 PKIP-SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~~~p-~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++ ..+|.++.++|.+||..+|++||++++++++
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3333 4578999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.49 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=192.5
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
+...+|++++.||+|+||.||+++.+ ++.||+|+.... ....|+.++++++||||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34568999999999999999999985 457999975432 12458999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ...++|||++. ++|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 129 ~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 G--AITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred C--CeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 6 67899999994 689888877667799999999999999999999999999999999999998 7778999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChH---------HHHHHHH
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLHSE---------EIIAGII 846 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~P-F~~~~~~---------eil~~Ii 846 (897)
|+++............||+.|+|||++.+.. ++.++|||||||++|||+++..| |...... ..+..++
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 9997543333334567999999999997644 78999999999999999985444 4332110 1111111
Q ss_pred hc--CCCCCCC------------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 847 KG--NLGPKIP------------------------------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 ~~--~l~~~~p------------------------------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. ..+..++ ..++.++.+||.+||+.||++|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11 0000111 1346677889999999999999999999875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.63 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=207.8
Q ss_pred ccccccCCCceEEEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEee
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYG 692 (897)
Q Consensus 615 ~~~~i~~~~Yeilk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g 692 (897)
+...++...|+++++||+|+.++||++... .+.+|+|.+... ......+.-|.+|+..|.+|+ |.+||++|+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL------EADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh------hcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 456788899999999999999999999984 456888776432 123456788999999999995 999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
|-..+ ..+||||||= .-+|.++|++....+..-.+..++.|++.++.++|++||||.||||.|+|+- .|.+|
T Consensus 428 YEv~d--~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LK 499 (677)
T KOG0596|consen 428 YEVTD--GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLK 499 (677)
T ss_pred eeccC--ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEE
Confidence 98876 7999999964 5699999988766555457888999999999999999999999999999994 78999
Q ss_pred EEecCCcccccccc---ccCCcccCCcccCccccccCCCC---------CCchhhHHHHHHHHHHHHcCCCCCCCCChH-
Q 002642 773 IGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNL---------VTEKVDVYSFGVVMWELLTGEEPYADLHSE- 839 (897)
Q Consensus 773 LiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~---------~s~ksDIWSLGvILyELLtGk~PF~~~~~~- 839 (897)
|||||+|....... .....+||+.|||||.+...... .++++||||||||||+|+.|+.||....+.
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~ 579 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI 579 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence 99999998654332 34567899999999998643221 568999999999999999999999876532
Q ss_pred HHHHHHHhcCCCCCCCCCCcH-HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 840 EIIAGIIKGNLGPKIPSWCEP-TWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 840 eil~~Ii~~~l~~~~p~~ls~-el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+..|..-.-..++|..-+. ++.++++.||.+||++||++.|||++
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 233333333333345543333 49999999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.44 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=197.9
Q ss_pred ceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCCc
Q 002642 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~~ 700 (897)
|+++++||+|+||.||++.. +++.+|+|.++...... . .....+|+.++.++. ||||+++++++.+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL------E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc------h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67899999999999999987 46679999886532111 1 123347888888885 99999999998876556
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||++ ++|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++ . +.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999996 588888876556789999999999999999999999999999999999998 4 889999999998
Q ss_pred ccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-----------
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN----------- 849 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~----------- 849 (897)
............++..|+|||.+... ..++.++|||||||++|||++|..||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 65443333345688999999986542 346889999999999999999999998877655444332210
Q ss_pred -----CCCCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -----LGPKI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -----l~~~~-----------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....+ ...++.++.++|.+||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00011 12467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.47 Aligned_cols=243 Identities=26% Similarity=0.460 Sum_probs=193.2
Q ss_pred EecccCceEEEEeeec--------------------------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC
Q 002642 629 ELGSGTFGTVFYGKWK--------------------------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k--------------------------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L 682 (897)
.||+|+||.||+|... ...|++|.+... ......++.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5899999999998741 113788877532 223346788899999999
Q ss_pred CCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 002642 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVN 762 (897)
Q Consensus 683 ~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd 762 (897)
+||||+++++++... ...++||||+++++|..++......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 999999999999876 578899999999999999976656788999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCh
Q 002642 763 MRD---PQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL-TGEEPYADLHS 838 (897)
Q Consensus 763 ~~~---~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELL-tGk~PF~~~~~ 838 (897)
..+ .....+||+|||++...... ....++..|+|||.+.+. ..++.++||||||+++|||+ +|..||....+
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 321 12345899999988643221 123578889999988653 34789999999999999995 69999987765
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 839 ~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+.... .... ...|...++.+.++|.+||+.+|++||++.+++++|.
T Consensus 228 ~~~~~~-~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SEKERF-YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH-HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 554332 2222 2344445678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=313.78 Aligned_cols=243 Identities=26% Similarity=0.513 Sum_probs=194.2
Q ss_pred EecccCceEEEEeeecC---------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 629 ELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~kg---------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.||+|+||.||++..+. ..+|+|.+... .......+..|+.+++.+.||||+++++++..+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-- 71 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-- 71 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--
Confidence 58999999999998632 23777776432 223456788899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC----CCCCeEEEEe
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD----PQRPVCKIGD 775 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~----~~~g~VKLiD 775 (897)
...++||||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++..+ ...+.++|+|
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 578899999999999999987666789999999999999999999999999999999999997322 1223489999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG-EEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtG-k~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
||++...... ....++..|+|||.+.+. ..++.++||||||+++|+|++| ..||.......... .... ...+
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998754332 235678899999998753 2468899999999999999998 56766655544332 2232 2355
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
|...+.++.++|.+||+.||++|||+++|++.|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 6667789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.51 Aligned_cols=248 Identities=32% Similarity=0.545 Sum_probs=205.6
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++.++ ++.+|+|.+.... .......+.+|+++++.+.||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-- 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--
Confidence 36788899999999999999985 6679999886541 113456788999999999999999999998877
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++|+||+.+++|.+++......+++..+..++.|++.+|+|||+ .|++|+||||+||+++ .++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeeccc
Confidence 78999999999999999998765678899999999999999999999 9999999999999998 677899999999
Q ss_pred ccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHhcCCCCC
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-----SEEIIAGIIKGNLGPK 853 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-----~~eil~~Ii~~~l~~~ 853 (897)
+......... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... ..+....+... ..+.
T Consensus 148 ~~~~~~~~~~-~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 223 (265)
T cd06605 148 SGQLVNSLAK-TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPR 223 (265)
T ss_pred chhhHHHHhh-cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCC
Confidence 8754332222 26688999999998765 37899999999999999999999997642 22333333333 2344
Q ss_pred CCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSW-CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~-ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+.. ++.++.++|.+||..||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 4444 88999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.06 Aligned_cols=243 Identities=28% Similarity=0.482 Sum_probs=191.2
Q ss_pred EEecccCceEEEEeeecCcc------------EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 628 KELGSGTFGTVFYGKWKGSD------------VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg~~------------VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
+.||+|+||.||++.+.... +++|.+... .. ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD--------HR-DSLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc--------hh-hHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 36899999999999885332 677766432 11 1467889999999999999999999887
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC---CCCCeEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD---PQRPVCK 772 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~---~~~g~VK 772 (897)
. ...++||||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++ .....+|
T Consensus 72 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 72 R---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred c---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 6 356899999999999999987655789999999999999999999999999999999999998322 0112799
Q ss_pred EEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
|+|||++..... .....++..|+|||.+......++.++||||||+++|+|++ |..||......+....... ..
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~- 223 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QH- 223 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CC-
Confidence 999999985433 22345678899999987653357899999999999999999 6888877654433332222 21
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
..+......+.++|.+||..+|.+||++.++++.|+
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 122222378999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.84 Aligned_cols=245 Identities=21% Similarity=0.283 Sum_probs=194.8
Q ss_pred ccCCCceEEEEecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
+...+|++++.||+|+||.||++... +..||+|.+... ....+|++++++++||||+++++++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 44568999999999999999998763 346899987532 1235799999999999999999998
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
... ...++|||++. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+
T Consensus 156 ~~~--~~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~ 227 (392)
T PHA03207 156 RWK--STVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLG 227 (392)
T ss_pred eeC--CEEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEc
Confidence 876 68999999985 688888843 35689999999999999999999999999999999999998 77889999
Q ss_pred ecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHhc
Q 002642 775 DLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKG 848 (897)
Q Consensus 775 DFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~---eil~~Ii~~ 848 (897)
|||++....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||.+.... ..+..++..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 999997543221 122457999999999997644 789999999999999999999999765321 111111110
Q ss_pred -------------------------CCCC--CCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 -------------------------NLGP--KIP-----SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 -------------------------~l~~--~~p-----~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+ ..| ..++.++.++|.+||..||++||++.|++.+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 011 2356788999999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.69 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=203.8
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||+++. +++.||+|.++...... .....+.+|+.++++++||||+++++++....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 57899999999999999999987 46789999986432111 11234567999999999999999999987765
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...+++||||+. ++|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++ ..+.+||+|||+
T Consensus 80 ~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg~ 154 (309)
T cd07845 80 LDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGL 154 (309)
T ss_pred CCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccce
Confidence 567899999996 488888876556789999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP----- 852 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~----- 852 (897)
+....... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||...+..+.+..+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 98554321 11223457889999998653 236889999999999999999999999888776665554321000
Q ss_pred ------------CC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ------------KI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ------------~~-----------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. ....++++.++|.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01257889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.81 Aligned_cols=243 Identities=26% Similarity=0.462 Sum_probs=190.9
Q ss_pred EEecccCceEEEEeeecC--------------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 628 KELGSGTFGTVFYGKWKG--------------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg--------------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
+.||+|+||.||+|+... ..+++|.+... .......+..|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 368999999999998521 13788876532 22345678889999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCC---CCCe
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP---QRPV 770 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~---~~g~ 770 (897)
+... ...++||||+++++|..++......+++..+..++.||+.||+|||+++|+||||||+|||++..+. ....
T Consensus 73 ~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 73 CVRD--VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred EecC--CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 8876 5678999999999999998766667899999999999999999999999999999999999973211 1224
Q ss_pred EEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHhcC
Q 002642 771 CKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL-TGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 771 VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELL-tGk~PF~~~~~~eil~~Ii~~~ 849 (897)
+|++|||++...... ....++..|+|||.+... ..++.++||||||+++|||+ .|..||......+.. ......
T Consensus 151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~ 225 (262)
T cd05077 151 IKLSDPGIPITVLSR---QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ 225 (262)
T ss_pred eEeCCCCCCccccCc---ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC
Confidence 899999998644322 234578899999988632 34788999999999999998 588998766544332 222222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
. ......+.++.+||.+||+.||++||++.+|+++|
T Consensus 226 ~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2 22233467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.50 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=206.9
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..|+.++.||.|+||.||+++++ ++.||+|.+.... .......+.+|+.+++.+.||||+++++.+.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-- 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 46778899999999999999874 6689999886431 123457888999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++ .++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~ 148 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVA 148 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccc
Confidence 689999999999999999865 3578888999999999999999999999999999999998 6778999999999
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....+......+. ....+..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEF 225 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhh
Confidence 7543222 222346788999999987543 7899999999999999999999998877665555432 23345556668
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..+.++|.+||..+|++||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 8999999999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.75 Aligned_cols=254 Identities=25% Similarity=0.475 Sum_probs=206.5
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|+..+.||+|+||.||++.. +++.+|+|.+.... ............+.+|++++++++||||+++++++.+. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR--NTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--S 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeeccc--CCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--C
Confidence 477889999999999999986 56789999986431 11122334567889999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++. ....+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 899999999999999999764 46788999999999999999999999999999999999971 23469999999987
Q ss_pred cccccc-----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCC
Q 002642 781 IKQKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---EEIIAGIIKGNLGP 852 (897)
Q Consensus 781 ~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~---~eil~~Ii~~~l~~ 852 (897)
...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 543221 122346888999999987543 78899999999999999999999975432 23333333344456
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+..+++++.++|.+||..+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 6777889999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=350.98 Aligned_cols=261 Identities=36% Similarity=0.634 Sum_probs=231.3
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--Cc---cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~---~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
.+|..+...+.+.||.|.||+|++|+.+ ++ .||||.+|.. ..++....|+.|+.||.++.||||++|.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-------ytekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-------YTEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-------ccHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 5677888899999999999999999984 33 4999999865 2345678999999999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
++.+.. ....||+|||++|+|+.+|+++...++..+..-+.+.|+.||+||-++++|||||..+|||++ .+..+
T Consensus 697 GVVTks--~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvC 770 (996)
T KOG0196|consen 697 GVVTKS--KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVC 770 (996)
T ss_pred EEEecC--ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEE
Confidence 999987 688999999999999999999888899999999999999999999999999999999999998 88999
Q ss_pred EEEecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 002642 772 KIGDLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGII 846 (897)
Q Consensus 772 KLiDFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii 846 (897)
|++|||+++...+... +.+-.-..+|+|||.+..+. ++.++||||+||+|||.++ |..||.++.+.+++..+
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI- 847 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI- 847 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccchHHHHHHH-
Confidence 9999999997644331 11222357899999998655 8999999999999999888 99999999999998875
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 847 KGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 847 ~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...++.+.|-.||..+.+||..||++|-.+||.+.||+..|+++..+
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 55667788889999999999999999999999999999999999763
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.81 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=205.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|++.+.||.|+||.||++.. .++.|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--------QPKKELIINEILVMKELKNPNIVNFLDSFLVG-- 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--------CchHHHHHHHHHHHHhcCCCceeeeeeeEecC--
Confidence 5799999999999999999986 57789999885431 11235677899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++|+||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++ .++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 6899999999999999998653 578999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPKIPSW 857 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~~p~~ 857 (897)
....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+....+..... ....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 7543221 222346889999999987544 78899999999999999999999988777655544433222 2234567
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+++.+.++|.+||..||++||++.+++++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 88999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.09 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=211.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|.+.+.||+|++|.||++... ++.+++|.+..... .......+.+|+.++++++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD------SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4788899999999999999985 67899999865421 134467888999999999999999999988865446
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++|+||+++++|.+++.... .+++..+..++.|++.+|+|||+.|++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 7899999999999999998754 789999999999999999999999999999999999998 67889999999998
Q ss_pred ccccccc---cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCC
Q 002642 781 IKQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-SEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 781 ~~~~~~~---~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-~~eil~~Ii~~~l~~~~p~ 856 (897)
....... .....++..|+|||.+.... .+.++||||||+++|+|++|..||.... .......+......+.+|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6544432 33456889999999987644 7889999999999999999999998765 3333333333344556777
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++.++|.+||..||++||++.+++++
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 889999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=304.43 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=205.4
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++.. +++.+++|.++.... .....+.+..|+.+++.++|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--E 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--C
Confidence 588999999999999999987 466899999865421 134567889999999999999999999988766 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 899999999999999999764 3478888999999999999999999999999999999998 67889999999987
Q ss_pred ccccccc-----cCCcccCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 781 IKQKTLI-----SGGVRGTIPWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 781 ~~~~~~~-----~~~~~GT~~Y~APEvl~g~~-~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
....... .....++..|+|||++.+.. ..++.++||||||+++|+|++|+.||............+.....+.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5432221 11346788999999987543 23688999999999999999999999766433333322333434455
Q ss_pred CCCC--cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSWC--EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~l--s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
|... ++.+.++|.+||+.+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 5544 8999999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.06 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=187.5
Q ss_pred EEecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 628 KELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
.+||+|+||.||+++.+ +..||+|.+..... ...+.+|+.+++.++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 67999999999999864 34699998864311 23467899999999999999999998765557889
Q ss_pred EEEeeeeccchHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 704 TVTEYMVNGSLKQVLRRK--------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~--------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+...+...+.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9999986 5787776431 124788889999999999999999999999999999999964444677899999
Q ss_pred cCCcccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HHH
Q 002642 776 LGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---------EII 842 (897)
Q Consensus 776 FGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~---------eil 842 (897)
||+++...... ......+|+.|+|||++.+. ..++.++|||||||++|||++|++||...... ..+
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99998543321 12345689999999998753 24788999999999999999999999654321 011
Q ss_pred HHHHhcC-----------------------C-------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 843 AGIIKGN-----------------------L-------------GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 843 ~~Ii~~~-----------------------l-------------~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+.... . ........+..+.+||.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 1110000 0 000111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=303.52 Aligned_cols=248 Identities=31% Similarity=0.522 Sum_probs=209.0
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|++|.||+++.. ++.|++|.+..... ......+.+|+.++..++||||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-- 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--
Confidence 37899999999999999999884 67899999865411 13456788999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++... ..+++..+..++.|++++|+|||+ .+++||||+|+||+++ .++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 6899999999999999999765 568999999999999999999999 9999999999999998 678899999999
Q ss_pred cccccccccc-CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCC
Q 002642 779 SKIKQKTLIS-GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH---SEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 779 Ak~~~~~~~~-~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~---~~eil~~Ii~~~l~~~~ 854 (897)
+......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... ..+....+.. ...+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 223 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSL 223 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCC
Confidence 8855332222 245688999999998764 47889999999999999999999998773 3444444443 333455
Q ss_pred CCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSW-CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~-ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.. ++..+.++|.+||..+|++||++.|++++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 555 88999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.71 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=204.8
Q ss_pred cCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
..++|++++.||+|+||+||++... ++.+|+|++.... .......+.+|+++++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 4578999999999999999999885 7789999875431 123356788999999999999999999999877
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
..+++||||+++++|.+++.+. ..+++..+..++.|++.+|.|||+ .+++||||||+||+++ .++.++|+||
T Consensus 76 --~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 76 --NNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred --CEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 6899999999999999998764 458899999999999999999997 5999999999999998 6788999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHH
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-----------EIIAGI 845 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-----------eil~~I 845 (897)
|++....... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+
T Consensus 149 gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 149 GVSGELINSI-ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred Ccccchhhhc-cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 9986543222 2345789999999998754 3788999999999999999999999865442 222333
Q ss_pred HhcCCCCCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 846 IKGNLGPKIPS-WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 846 i~~~l~~~~p~-~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.... .+.++. .++.++.+||.+||+.||++||++.|++++.
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3322 223333 3788999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.28 Aligned_cols=247 Identities=30% Similarity=0.523 Sum_probs=207.9
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|++|.||++..+ ++.+++|.+..... .....+.+|+++++.++||||+++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--D 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--C
Confidence 5888999999999999999985 67799999865411 2456788999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++++||+++++|.+++......+++..+..++.|++.+|.+||++|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 88999999999999999987656789999999999999999999999999999999999998 67889999999987
Q ss_pred ccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC--C
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--C 858 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~--l 858 (897)
............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+........ ..+..+.. +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCcCccccc
Confidence 654432234566889999999987544 788999999999999999999999887655555444432 22333333 3
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..+.++|.+||+.||++|||+.+++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 8999999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.37 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=203.7
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~ 697 (897)
.++|++.+.||+|+||.||++.. .++.+|+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 57899999999999999999987 36679999885421 1124566788899988 799999999988754
Q ss_pred C---CceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 698 P---VTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 698 ~---~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
+ ...+++||||+++++|.++++. ....+++..+..++.|++.||+|||+.|++||||||+||+++ .++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCE
Confidence 2 2468999999999999998863 345688999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccccc-ccCCcccCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 002642 772 KIGDLGLSKIKQKTL-ISGGVRGTIPWMAPELFKSKD---NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 772 KLiDFGLAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~---~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~ 847 (897)
||+|||++....... ......++..|+|||.+.... ..++.++||||||+++|+|++|+.||......+.+..+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999987543222 223456889999999985432 1257899999999999999999999988776555555443
Q ss_pred cCC-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 GNL-GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~~l-~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
... ....+...+.++.++|.+||+.+|++||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 322 112345567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.37 Aligned_cols=254 Identities=32% Similarity=0.529 Sum_probs=203.3
Q ss_pred ceEEEEecccCceEEEEeeec-----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 624 LEYIKELGSGTFGTVFYGKWK-----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k-----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
|++.+.||+|+||.||++.++ ++.+|||+++... ......+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI------FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc------CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567889999999999999863 4679999986531 12233567889999999999999999999876532
Q ss_pred C----ceEEEEEeeeeccchHHHHhhc-----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 699 V----TNLATVTEYMVNGSLKQVLRRK-----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 699 ~----~~l~LVmEy~~GGsL~d~L~~~-----~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
. ...++++||+.+++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 1 2347889999999998887432 12478888999999999999999999999999999999998 678
Q ss_pred eEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002642 770 VCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~I 845 (897)
.+||+|||+++...... ......+++.|++||.+.... ++.++||||||+++|+|++ |+.||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 89999999988543221 112234567899999987543 7889999999999999999 89999887766655554
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002642 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 846 i~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l 890 (897)
.... ....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4433 3345566889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.79 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=211.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
--++.++|++.++||+|+|+.||+++. ++..+|+|.+... ..+..+..++|++..++++|||+++++++.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--------SQEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--------chHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 346788999999999999999999885 5677999998654 123467788999999999999999999875
Q ss_pred ecC---CCceEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeccCCC
Q 002642 695 TDG---PVTNLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 695 ~e~---~~~~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~G--IVHRDIKPeNILLd~~~~ 766 (897)
..+ .....|++++|...|+|.+.++.. +..+++.+++.|+.+|++||++||+.. ++||||||.|||+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---- 163 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----
Confidence 432 234689999999999999998753 457999999999999999999999998 99999999999998
Q ss_pred CCCeEEEEecCCccccccccc----------cCCcccCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002642 767 QRPVCKIGDLGLSKIKQKTLI----------SGGVRGTIPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYAD 835 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~~~~~~----------~~~~~GT~~Y~APEvl~g~-~~~~s~ksDIWSLGvILyELLtGk~PF~~ 835 (897)
+.+.++|+|||.+....-... ...-.-|..|.|||.+.-+ ....++++|||||||+||+|+.|..||..
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 678899999999874321110 0112368899999998643 23578999999999999999999999964
Q ss_pred CCh--HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 836 LHS--EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 836 ~~~--~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
... ..+...+..+++..+-...+|+.+.++|++||+.||.+||++.+|+..++++.
T Consensus 244 ~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 321 11222334444433334458999999999999999999999999999998864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.00 Aligned_cols=249 Identities=29% Similarity=0.550 Sum_probs=212.9
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++.+. ++.+++|.+..... .......+.+|+++++.++|||++++++.+... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--G 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--C
Confidence 5889999999999999999985 77899999865321 123456788999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 701 NLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..++|+||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999999764 36789999999999999999999999999999999999998 67889999999
Q ss_pred Ccccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 778 LSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
.+....... ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|+.||......+......... ....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 987544332 233456889999999987544 7889999999999999999999998887777766665544 456677
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++.++|.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.33 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=204.2
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||.|+||.||+++++ ++.+|+|.++..... +.....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 57899999999999999999985 667999998654211 2223456789999999999999999998876655
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+. ++|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 78999999997 499998877656789999999999999999999999999999999999998 6788999999998
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---------
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN--------- 849 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~--------- 849 (897)
...... .......+++.|+|||.+.+.. .++.++||||||+++|+|++|..||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 854332 2223345788999999986533 36789999999999999999999998876655544432210
Q ss_pred --------------------CCCCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 --------------------LGPKIPSW-CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 --------------------l~~~~p~~-ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+...++.. +++.+.++|++||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01122333 58889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=344.13 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=217.3
Q ss_pred CCceEEEEecccCceEEEEeeecCcc--EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~kg~~--VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+-|+|+..||.|+||+||++..+... .|-|++.. ..++.+..++.||+||....||+||++++.|+.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--------kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-- 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--------KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-- 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--
Confidence 45788899999999999999886443 56676643 2345678899999999999999999999977766
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
+.++|+.|||.||-...++-.-++.+.+.++..+++|++.||.|||++.|||||||..|||++ .+|.|+|+|||.+
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVS 177 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeeccccc
Confidence 689999999999999999988889999999999999999999999999999999999999998 7889999999976
Q ss_pred c-ccccccccCCcccCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-CCC
Q 002642 780 K-IKQKTLISGGVRGTIPWMAPELFKS---KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-PKI 854 (897)
Q Consensus 780 k-~~~~~~~~~~~~GT~~Y~APEvl~g---~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~-~~~ 854 (897)
. ..........+.|||+|||||++.. +...|+.++||||||++|.||.-+.+|....++..++..+.+...+ ..-
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 5 3344445567999999999999743 3445899999999999999999999999999999888887766543 235
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
|+.++.+|.+|+.+||.+||..||++.+|+++
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 78899999999999999999999999999875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=313.75 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=205.7
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
...|++.+.||+|+||.||+++. .++.||+|.+.... ....+....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~- 87 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE- 87 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-----cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-
Confidence 35689999999999999999987 46789999885431 11233456788999999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+. ++|.+++......+++..+..++.|++.||.|||+.||+||||+|+||+++ .++.+||+|||+
T Consensus 88 -~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~ 161 (307)
T cd06607 88 -HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGS 161 (307)
T ss_pred -CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCc
Confidence 67899999996 577777765556789999999999999999999999999999999999998 678899999999
Q ss_pred ccccccccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ 857 (897)
+...... ....+++.|+|||++.+ ....++.++||||||+++|+|++|+.||...........+.........+..
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 162 ASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred ceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 8754332 23568889999998742 1234788999999999999999999999887766655554443332223445
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++.++.++|.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 78899999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.18 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=204.2
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++++.||+|+||.||++.. .++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVG- 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 36899999999999999999986 477899999864311 1134577899999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~ 161 (297)
T cd06656 89 -DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (297)
T ss_pred -CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 689999999999999999865 3478889999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-CCCCCCCC
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG-NLGPKIPS 856 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~-~l~~~~p~ 856 (897)
+....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcc
Confidence 87543222 122356889999999987644 788999999999999999999999876654433322222 22223456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++..++++|.+||..+|++||++.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 788999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.64 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=201.5
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|+..+.||.|++|.||++.. .++.+|+|.+.... .......+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4789999999999999999998 46679999886431 11334668899999999999999999999877655
Q ss_pred ceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 TNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
..+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++ .++.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 689999999999999988753 334578889999999999999999999999999999999998 6778999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHhcCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL-----HSEEIIAGIIKGNLG 851 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~-----~~~eil~~Ii~~~l~ 851 (897)
|++........ ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||... ...+....+.. ...
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCc
Confidence 99875433221 2345788999999987544 788999999999999999999999765 22333333322 111
Q ss_pred CCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 PKIP------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~~~p------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++ ..+++++.++|.+||..+|++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2222 2346789999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.96 Aligned_cols=246 Identities=29% Similarity=0.482 Sum_probs=204.3
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|+..+.||+|+||.||+|.+. ++.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--T 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--C
Confidence 4666778999999999999873 5679999886431 123456788999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEccccccc
Confidence 89999999999999998864 4578889999999999999999999999999999999998 67789999999987
Q ss_pred cccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 781 IKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 781 ~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
...... ......++..|+|||.+.+.. ++.++|+||||+++|||++|+.||....+......+. ....+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCC--CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccC
Confidence 543322 222346889999999987643 7889999999999999999999998766655544433 233345556678
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++|.+||+.+|++||++.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=353.92 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
.+|++.++||+|+||.||++++. ++.||||+++.... ..+...+++.+|+++++.++||||+++++++.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-- 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-- 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--
Confidence 58999999999999999999874 67899999865321 1234456789999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhc----------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRK----------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~----------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
...++||||++|++|.+++... ....+...++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 6889999999999999988642 12345667888999999999999999999999999999998 678
Q ss_pred eEEEEecCCccccccc-------------------cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 002642 770 VCKIGDLGLSKIKQKT-------------------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~-------------------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk 830 (897)
.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCC
Confidence 8999999999754110 0112356999999999987654 789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHh-cCCCCCCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHH
Q 002642 831 EPYADLHSEEIIAGIIK-GNLGPKIPSWCEPTWRSLMERCWSSDPKSRP-AFSEITKELRAMAA 892 (897)
Q Consensus 831 ~PF~~~~~~eil~~Ii~-~~l~~~~p~~ls~el~dLI~kcL~~DPeeRP-Ta~ELLq~Le~l~~ 892 (897)
.||......+....... ..........+|+.+.+++.+||..||++|| +++++++.|+...+
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99987655443322111 1111111235789999999999999999996 67889898888765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.46 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=207.9
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCc-eeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN-VVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPN-IVkl~g~~~e~ 697 (897)
...|+.+++||+|+||+||+|+. +|+.||+|.++.....+ -.....++|+.+|+.++|+| |+.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E------G~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE------GVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc------CCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 45677788899999999999987 47789999997653221 13345679999999999999 99999998876
Q ss_pred C----CceEEEEEeeeeccchHHHHhhcc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCe
Q 002642 698 P----VTNLATVTEYMVNGSLKQVLRRKD---RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 698 ~----~~~l~LVmEy~~GGsL~d~L~~~~---~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~ 770 (897)
. ...+++|+||++ -+|.+++.... ..++...+..++.||+.||+|||+++|+||||||.||||+ +.+.
T Consensus 84 ~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~ 158 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGV 158 (323)
T ss_pred ccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCc
Confidence 3 238999999994 59999998765 3577788999999999999999999999999999999998 7899
Q ss_pred EEEEecCCccccc-cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 002642 771 CKIGDLGLSKIKQ-KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 771 VKLiDFGLAk~~~-~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~ 849 (897)
+||+|||+|+... +......-++|..|.|||++.+.. .|+...||||+|||++||++++.-|.+....+.+..|..-.
T Consensus 159 lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 9999999998544 222234557899999999999864 48999999999999999999999999998877766664422
Q ss_pred CCC----------------CCCCC------------CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 LGP----------------KIPSW------------CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 l~~----------------~~p~~------------ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
-.| .++.+ .+++..+++.+||+.+|.+|.+++..+++
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 12211 23578899999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=349.14 Aligned_cols=262 Identities=20% Similarity=0.325 Sum_probs=213.7
Q ss_pred cccccCCCceEEEEecccCceEEEEeeec-C-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEee
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWK-G-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYG 692 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~k-g-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g 692 (897)
.-++..-++++.+.|-+|+|+.||+++.. + .++|+|++... .+..++.+.+|+++|++|. |||||.+++
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 34566678899999999999999999984 3 78999998543 3456788899999999996 999999999
Q ss_pred e-eecC---C-CceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeccC
Q 002642 693 V-VTDG---P-VTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMR 764 (897)
Q Consensus 693 ~-~~e~---~-~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~G--IVHRDIKPeNILLd~~ 764 (897)
. .... . .....|+||||.||.|-++++++ ...+++.++++|+.|+++|+.+||... |||||||-|||||.
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-- 180 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-- 180 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc--
Confidence 3 2221 1 24678999999999999999753 334999999999999999999999997 99999999999998
Q ss_pred CCCCCeEEEEecCCcccccccc-ccC---------CcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 002642 765 DPQRPVCKIGDLGLSKIKQKTL-ISG---------GVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPY 833 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~~-~~~---------~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF 833 (897)
.++.+||||||.+....... ... ..--|+.|.|||++.- ....+++|+|||+|||+||-|+....||
T Consensus 181 --~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF 258 (738)
T KOG1989|consen 181 --ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF 258 (738)
T ss_pred --CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence 78899999999986321111 000 0125899999999742 2234899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 834 ~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
...-. ..|+.+.+..+....++..+++||..||+.||++||++.|++.++-.++..
T Consensus 259 e~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 259 EESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred CcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 87632 346777876555567899999999999999999999999999999888753
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.78 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=196.6
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|++|.||+++.+ ++.||||.+....... ....+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHTK- 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEecC-
Confidence 478999999999999999999874 6789999986532111 123456899999999999999999999876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+.+ +|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||+
T Consensus 76 -~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 76 -KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred -CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 689999999975 99999877666788999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCC-----
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-SEEIIAGIIKGNLG----- 851 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-~~eil~~Ii~~~l~----- 851 (897)
++...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||.... ..+.+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 87432211 112234688999999986532 36889999999999999999999997665 22222222110000
Q ss_pred ----------------C-------CCCCCCc--HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 ----------------P-------KIPSWCE--PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ----------------~-------~~p~~ls--~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. .....++ .++.++|.+||+.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0001233 788899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=339.51 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=206.6
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-C-----CceeeEee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-H-----PNVVAFYG 692 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-H-----PNIVkl~g 692 (897)
..+|++++.||+|+||+|.++.+ +++.||||+++.. .....+-..|+.+|..|+ | -|+|++++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 34899999999999999999987 4678999999754 344566678999999997 3 68999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
+|... ++++||+|.+ .-+|+++++.+. ..++...+..|+.||+.||.+||+.||||+||||+||||. ++....|
T Consensus 256 ~F~fr--~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~--~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFR--NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLK--DPKRSRI 330 (586)
T ss_pred ccccc--cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeec--cCCcCce
Confidence 99988 7999999988 579999998754 4589999999999999999999999999999999999997 3456689
Q ss_pred EEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 772 KIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 772 KLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
||||||+|........ .++.+..|.|||++.+-+ |+.+.||||||||++||++|.+.|++.+..+.+..|+.-.-.
T Consensus 331 KVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred eEEecccccccCCcce--eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 9999999987655543 677899999999999876 899999999999999999999999998887766554221000
Q ss_pred --------------------------------------------------CCCC-----------CCCcHHHHHHHHHhh
Q 002642 852 --------------------------------------------------PKIP-----------SWCEPTWRSLMERCW 870 (897)
Q Consensus 852 --------------------------------------------------~~~p-----------~~ls~el~dLI~kcL 870 (897)
...| ..-...+.+||.+||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 0011 012356789999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 002642 871 SSDPKSRPAFSEITKE 886 (897)
Q Consensus 871 ~~DPeeRPTa~ELLq~ 886 (897)
.+||.+|+|..|.+++
T Consensus 487 ~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 487 EWDPAERITPAQALNH 502 (586)
T ss_pred ccCchhcCCHHHHhcC
Confidence 9999999999998875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.23 Aligned_cols=246 Identities=25% Similarity=0.489 Sum_probs=192.8
Q ss_pred EecccCceEEEEeeec-Cc---cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEE
Q 002642 629 ELGSGTFGTVFYGKWK-GS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k-g~---~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+||+|+||.||++... +. .+++|.++.. ........+.+|+.+++.++||||+++++.+... ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-------CChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEE
Confidence 5899999999999753 32 3556655432 1122356788999999999999999999999876 67899
Q ss_pred EEeeeeccchHHHHhhcc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 705 VTEYMVNGSLKQVLRRKD---RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~---~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
||||+++++|.+++.+.. ...++..+..++.||+.||+|||+++++||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999997532 3456667788999999999999999999999999999998 678899999999863
Q ss_pred cccc---cccCCcccCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC---
Q 002642 782 KQKT---LISGGVRGTIPWMAPELFKSKD-----NLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN--- 849 (897)
Q Consensus 782 ~~~~---~~~~~~~GT~~Y~APEvl~g~~-----~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~--- 849 (897)
.... .......++..|+|||++.... ..++.++||||||+++|||++ +..||......+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 2111 1223456789999999975321 125778999999999999997 678998777766666554443
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 850 -LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 850 -l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
..+..+..+++.+.+++..|| .+|++||+++++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 223445567899999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=300.90 Aligned_cols=248 Identities=28% Similarity=0.502 Sum_probs=209.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||+++++ ++.+|+|.+..... .+....++.+|+++++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM------SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--N 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--C
Confidence 5889999999999999999874 56799999865321 123356677899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 701 NLATVTEYMVNGSLKQVLRRK---DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~---~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++ ..+.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999998652 34688899999999999999999999999999999999998 57789999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ 857 (897)
++...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+.... .+..+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchh
Confidence 99865444 223456889999999987644 7889999999999999999999999887766666555444 3455667
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++.+++++|.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 88999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.41 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=213.0
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|.-++.||.|+||.||.+++ +.+.||||.+.-.. -...+....+++|++.|++++|||+|.+-++|-.+ .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG-----KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~ 99 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--H 99 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccc-----cccHHHHHHHHHHHHHHHhccCCCcccccceeecc--c
Confidence 455668899999999999987 45679999885431 12344567899999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..|+|||||- |+-.|++.-..+++-+..+..|..+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.|.
T Consensus 100 TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 100 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSAS 174 (948)
T ss_pred hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchh
Confidence 8899999995 577777776678899999999999999999999999999999999999998 88999999999998
Q ss_pred ccccccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
...+. ..++|||+|||||++.. ....|+-++|||||||+..||.-.++|+..++....+..|.+...+.-....++
T Consensus 175 i~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS 251 (948)
T KOG0577|consen 175 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 251 (948)
T ss_pred hcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH
Confidence 66554 36899999999999753 233488899999999999999999999999999888888777665433445689
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..|++|+..||++-|.+|||.++++++
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 999999999999999999999999876
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.87 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=202.8
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++..+ ++.||||.++...... ........+..|+++++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--C
Confidence 4888999999999999999874 6789999997543221 1122345667899999999999999999999885 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+++||||+ +++|.+++......+++..+..++.||++||.|||++||+|+||||+||+++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 8999999976544689999999999999999999999999999999999998 67889999999997
Q ss_pred ccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 002642 781 IKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-------- 851 (897)
Q Consensus 781 ~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~-------- 851 (897)
..... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|.+||......+.+..+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 54332 122234568889999998543 34688999999999999999998888876665544443321100
Q ss_pred -------------CC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -------------PK-----IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -------------~~-----~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+. .....+.++.++|.+||+.+|++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 112357889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.70 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=194.1
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|.+++.||+|+||.||++.. +++.||+|.+....... ....+.+|+.+++.++|+||+++++++..+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~- 75 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHTK- 75 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEecC-
Confidence 46899999999999999999986 46789999986542111 123456899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+. ++|.+++......+.+..+..++.|++.||+|||+.||+|+||||+||+++ .++.+||+|||+
T Consensus 76 -~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~ 149 (291)
T cd07870 76 -ETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGL 149 (291)
T ss_pred -CeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEecccc
Confidence 68899999995 677777655445577888889999999999999999999999999999998 677899999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcC-------
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGN------- 849 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~Ii~~~------- 849 (897)
++..... .......+++.|+|||++.+.. .++.++||||||+++|+|++|..||...... +.+..+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 8743221 1223345789999999986532 3678999999999999999999999765432 2222221100
Q ss_pred ---------C-----CCCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 ---------L-----GPKIP---------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 ---------l-----~~~~p---------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ ....+ ...+.++.++|.+||..||.+|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00000 0125688999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.69 Aligned_cols=247 Identities=27% Similarity=0.515 Sum_probs=201.8
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC---CCceeeEeeeeecC
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH---HPNVVAFYGVVTDG 697 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~---HPNIVkl~g~~~e~ 697 (897)
.|++.+.||+|+||.||++.+ .++.+|+|.++... .......+.+|+.+++.++ |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 477889999999999999997 46689999986431 1123456778999999986 99999999998776
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++||||+++++|.+++... .+++..+..++.|++.+|.|||+.||+|+||+|+||+++ ..+.++|+|||
T Consensus 75 --~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 75 --PRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred --CEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 6889999999999999998653 688999999999999999999999999999999999998 67889999999
Q ss_pred Ccccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 778 LSKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
++....... ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+... ..+.++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 987543322 22345688999999998642 33688999999999999999999999877655444332222 2233433
Q ss_pred -CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 -WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 -~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++.++|.+||..||++||++.+++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 378899999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=339.90 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=226.2
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
.....|.+.+.||+|.|++|.++++ ++..||||.+.+.... ...+..+.+|+++|+.++|||||+++.+...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 3456899999999999999999988 5788999999876332 2234558899999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+|+||||+.+|.+++|+.++++ +.+..+..++.|++.|++|||+++|+|||||++|||++ .+..+||+||
T Consensus 127 ~--~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDf 199 (596)
T KOG0586|consen 127 E--ATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADF 199 (596)
T ss_pred c--ceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeecc
Confidence 7 799999999999999999998866 44488888899999999999999999999999999998 7788999999
Q ss_pred CCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
|++..+.......+++|++.|.|||++.+.. +.++++|+||+|++||-|+.|.+||.+.+-.+.-...+..++ .+|.
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~ 276 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPF 276 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccc
Confidence 9999888888888999999999999999876 678999999999999999999999999888888777777777 5566
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.++.+.+++|+++|..+|.+|++.+++.++-+
T Consensus 277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred eeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 68899999999999999999999999987643
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.04 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=200.6
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.++||+|+||.||++.++ ++.||+|.+...... ....+.+.+|+++++.++||||+++++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-- 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhcccC--
Confidence 47899999999999999999984 678999987543111 12345677899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|..+.... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++ .++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 6899999999998888876543 3488999999999999999999999999999999999998 6788999999998
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc----------
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG---------- 848 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~---------- 848 (897)
...... .......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhcccc-ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 754322 2222356788999999986532 3678999999999999999999999876654433332210
Q ss_pred ----------CCCCC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 ----------NLGPK---------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 ----------~l~~~---------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+. ....++..+.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 123467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.08 Aligned_cols=250 Identities=25% Similarity=0.494 Sum_probs=206.0
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|+||.||++..+ +..+|+|.+...... ......+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP------VKEKEASKKEVILLAKMKHPNIVTFFASFQEN--G 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc------chhhHHHHHHHHHHHhCCCCChhhhhheeccC--C
Confidence 5889999999999999999884 567999988543111 11235677899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++. ....+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK---NGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC---CCCeEEecccccc
Confidence 8999999999999999987643 35789999999999999999999999999999999999971 2345799999998
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+..... ...+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCC
Confidence 7543322 122345889999999987543 78899999999999999999999988777777666555543 3445567
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.00 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=201.8
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|+||.||++.++ ++.||+|.++.... .......+.+|+++++.++||||+++++++...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 72 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-- 72 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--
Confidence 37999999999999999999884 66899998865321 123346788999999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+++||||++++.+..+... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~ 147 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA 147 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeecc
Confidence 689999999988767665544 34588999999999999999999999999999999999998 6888999999998
Q ss_pred ccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--C------
Q 002642 780 KIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG--N------ 849 (897)
Q Consensus 780 k~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~--~------ 849 (897)
....... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......+.+..+... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 8554332 223456889999999997642 4789999999999999999999999876554433322110 0
Q ss_pred -------------C---------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -------------L---------GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -------------l---------~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+ ...++..++.++.+||++||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 001233458899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=320.11 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=198.8
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++.+.||+|+||.||+++. +++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF------QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc------cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 57899999999999999999987 46789999885431 11223456678999999999999999999876432
Q ss_pred ----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
....++||||+. ++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 235799999995 5888887643 78888999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-- 852 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~-- 852 (897)
|||+++............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998655443334456889999999997654 7899999999999999999999998766544333322110000
Q ss_pred ---------------------------C-----C-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ---------------------------K-----I-------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ---------------------------~-----~-------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. + +...+.+++++|.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 11246678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.80 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=209.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..|+..+.||+|+||.||+++. .++.+|+|.+..... ...+....+.+|+++++.++|||++++++++..+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-----QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-- 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-----CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--
Confidence 4588889999999999999987 466799998854311 1233456788999999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+. ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++ .++.+||+|||++
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 57899999996 478887766566789999999999999999999999999999999999998 6788999999998
Q ss_pred cccccccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
...... ....+++.|+|||++.. ....++.++||||||+++|+|++|+.||...........+.........+..+
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 754322 24568899999999742 12347889999999999999999999998887777666666655444445567
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~Le~ 889 (897)
++.++++|.+||+.+|.+||++.++++++..
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 8899999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.42 Aligned_cols=246 Identities=30% Similarity=0.485 Sum_probs=205.5
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
-|++.+.||+|+||.||++.. .++.+|+|.+... ........+.+|+.++++++||||+++++++..+ .
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--T 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-------cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--C
Confidence 477889999999999999987 3567999987533 1122346788999999999999999999999876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 89999999999999999864 3578899999999999999999999999999999999998 67789999999987
Q ss_pred cccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 781 IKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 781 ~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
...... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+.. ...+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccC
Confidence 543321 122346888999999987543 68899999999999999999999987766555554333 33455667789
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.12 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=199.8
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.++||.|++|.||+++++ ++.||||.++..... .....+.+|+.++++++||||+++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTE--N 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--C
Confidence 5899999999999999999984 678999998654211 1234566899999999999999999999887 6
Q ss_pred eEEEEEeeeeccchHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 701 NLATVTEYMVNGSLKQVLRRKD--RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~--~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++ +++.+||+|||+
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 78999999975 8888886543 4589999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-------- 849 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-------- 849 (897)
+....... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 97543221 122345788999999986532 36889999999999999999999998877665544433211
Q ss_pred --------CCCCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 --------LGPKI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 --------l~~~~-----------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+...+ ...+++.+.++|.+||+.||.+||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111 12357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.99 Aligned_cols=258 Identities=29% Similarity=0.568 Sum_probs=221.7
Q ss_pred ccCCCceEEEEecccCceEEEEeeec----Cc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK----GS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k----g~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
+..+...+.++||.|.||.||.|... |+ .||||.-+..+.. +....|+.|+.+|++++|||||+++|
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------DDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------hhHHHHHHHHHHHHhCCCcchhheee
Confidence 34445556688999999999999873 33 3899988765322 12567999999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++.+. ..|+|||.++-|.|..|++.++..++......++.||+.||.|||++.+|||||..+|||+. +..-||
T Consensus 459 v~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVK 531 (974)
T KOG4257|consen 459 VCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVK 531 (974)
T ss_pred eeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceee
Confidence 99986 68999999999999999999888899999999999999999999999999999999999998 677899
Q ss_pred EEecCCccccccccccC--CcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 002642 773 IGDLGLSKIKQKTLISG--GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~--~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~ 849 (897)
|.|||+++...+..... ...-...|||||.++-+ .++.++|||-||+++||++. |..||.+..+.+++-.+-++
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR--rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG- 608 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR--RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG- 608 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchh--cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-
Confidence 99999999765543322 23345789999998743 48999999999999999988 99999999888887765444
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
-+.+.|..||+.+..|+.+||.++|.+||.+.||...|.+++++
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 46788999999999999999999999999999999999999884
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.41 Aligned_cols=257 Identities=27% Similarity=0.352 Sum_probs=197.2
Q ss_pred CceEEEEecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
+|++.++||+|+||.||++... ++.||+|.+...... .+.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4889999999999999999983 468999998764211 1122355678999999999999999999998775
Q ss_pred CceEEEEEeeeeccchHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRK----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~----~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
...+++||||+++ +|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.+++..+.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 5789999999965 676666432 23688899999999999999999999999999999999998444448899999
Q ss_pred ecCCcccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---------H
Q 002642 775 DLGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE---------I 841 (897)
Q Consensus 775 DFGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e---------i 841 (897)
|||++....... ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999988543221 12344678899999988653 236889999999999999999999997654321 1
Q ss_pred HHHHHh------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 842 IAGIIK------------------------GNLGPKIP-----------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 842 l~~Ii~------------------------~~l~~~~p-----------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..++. ......++ ...+.++.++|.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111100 00001111 1456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.97 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=203.3
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGV 693 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~ 693 (897)
+.+..++|++.+.||+|+||.||+++++ ++.||||.++.... .....++..|+.++..+ .||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-------hHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 4566789999999999999999999986 77899999865311 11234566677766666 49999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCCCCCCeEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
+.+. ...++||||+. ++|.+++......+++..+..++.|++.||+|||+ .||+||||+|+||+++ .++.+|
T Consensus 83 ~~~~--~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~k 155 (296)
T cd06618 83 FITD--SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVK 155 (296)
T ss_pred eecC--CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEE
Confidence 9876 68999999984 57777776655678999999999999999999997 5999999999999998 678899
Q ss_pred EEecCCccccccccccCCcccCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcC
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKD--NLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKGN 849 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~--~~~s~ksDIWSLGvILyELLtGk~PF~~~~~-~eil~~Ii~~~ 849 (897)
|+|||++.............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||..... .+.+..+....
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235 (296)
T ss_pred ECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence 99999987554333333345788999999986542 3367899999999999999999999976433 34444444433
Q ss_pred CCCCCC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 850 LGPKIP--SWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 850 l~~~~p--~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
. +..+ ..++.++.++|.+||..||++||++++++++-
T Consensus 236 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 P-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 2 2222 34789999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.14 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=196.9
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGP 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~ 698 (897)
++|++.+.||+|+||.||++++ +++.||+|.++..... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4789999999999999999987 4678999988653211 112346778999999995 699999999887642
Q ss_pred C---ceEEEEEeeeeccchHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC-CCe
Q 002642 699 V---TNLATVTEYMVNGSLKQVLRRK----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ-RPV 770 (897)
Q Consensus 699 ~---~~l~LVmEy~~GGsL~d~L~~~----~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~-~g~ 770 (897)
. ...++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++ . ++.
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~----~~~~~ 149 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD----KQKGL 149 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe----cCCCe
Confidence 1 237999999985 788887543 23579999999999999999999999999999999999998 4 678
Q ss_pred EEEEecCCccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 002642 771 CKIGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 771 VKLiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~ 849 (897)
+||+|||+++..... .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||......+....+....
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998754322 111223568889999988643 236889999999999999999999998876655444333211
Q ss_pred CCC------------------C--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 LGP------------------K--------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 l~~------------------~--------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+ . ....+++++.++|.+||..||.+||++.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0 012478899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.55 Aligned_cols=244 Identities=28% Similarity=0.438 Sum_probs=201.4
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||.||+++.. ++.+++|.+.... .........+.+|++++++++||||+++++.+... ...++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-----MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-----hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEe
Confidence 689999999999984 7789999986531 12234567788999999999999999999988776 68999999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc-
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL- 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~- 786 (897)
|+++++|.+++.+.. .+++..+..++.||+.||+|||+.|++|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999997654 689999999999999999999999999999999999998 67889999999987432221
Q ss_pred --------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 787 --------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 787 --------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
......++..|+|||.+.... .+.++||||||+++|+|++|..||......+....+.......+....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 223456788999999987544 7889999999999999999999999888877777766644433222234
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+..+.++|.+||+.+|++||++.++.+.|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 89999999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.98 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=198.8
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++++.||.|++|.||+++. +++.||||.++..... ......+.+|++++++++||||+++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTE--N 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc------cccchHHHHHHHHHHhcCCCCCcchhhhcccC--C
Confidence 488999999999999999987 4678999988643211 11235678899999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++||||+. ++|..++... ...+++..+..++.|++.||+|||+++++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999996 5888888653 34688999999999999999999999999999999999998 6778999999998
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC------
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP------ 852 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~------ 852 (897)
...... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||......+...++......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 754322 112233568899999988653 236889999999999999999999998776554443333211000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ---------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ---------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.....++++++++|.+||+.||.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=332.84 Aligned_cols=244 Identities=24% Similarity=0.310 Sum_probs=192.9
Q ss_pred cCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
....|.+.+.||+|+||.||++++. ++.||||.... ..+.+|+++|++++||||+++++++...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999984 56799996421 2345799999999999999999998876
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...++|||++. ++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ ..+.+||+|||
T Consensus 233 --~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFG 305 (461)
T PHA03211 233 --GLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFG 305 (461)
T ss_pred --CEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccC
Confidence 67899999994 689888876656799999999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHHHh
Q 002642 778 LSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-------EEIIAGIIK 847 (897)
Q Consensus 778 LAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~-------~eil~~Ii~ 847 (897)
+++...... ......||+.|+|||++.+.. ++.++|||||||+||||++|..|+..... ...+.+++.
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 997543221 122456999999999997654 78999999999999999998765432210 112222221
Q ss_pred c-CCC-CCCC-------------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 G-NLG-PKIP-------------------------------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~-~l~-~~~p-------------------------------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. ... ..++ ..++.++.+||.+||+.||.+|||+.|+|++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 110 0000 0245688999999999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.33 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=196.3
Q ss_pred ecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||+||++.. +++.+|+|.+.... .........+..|+++++.++||||+++++.+... ..+++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-----LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh-----hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEe
Confidence 68999999999976 46789999986431 11222345567899999999999999999998876 68999999
Q ss_pred eeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc
Q 002642 708 YMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~ 786 (897)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999987643 3589999999999999999999999999999999999998 67789999999987554333
Q ss_pred ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCcHHHHH
Q 002642 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG--NLGPKIPSWCEPTWRS 864 (897)
Q Consensus 787 ~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~--~l~~~~p~~ls~el~d 864 (897)
......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+... ......+..+++++.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 333456788999999987544 788999999999999999999999765432111111111 1233556678999999
Q ss_pred HHHHhhccCCCCCC-----CHHHHHHH
Q 002642 865 LMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 865 LI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|++||+.||++|| ++.+++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhC
Confidence 99999999999999 77777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.51 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=215.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecCc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGV 693 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~ 693 (897)
..+...+|.++..||+|+||+|.++..+|+ .+|||++++...... ..+.-.+.|-++|... +-|.+++++..
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-----DDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-----CcccceehhhhheecCCCCchHHHHHHH
Confidence 367788999999999999999999998765 499999987644322 2233445677777766 46889999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
|++. .++|+||||+.||+|--++++-++ +.+..+..++.+|+-||-+||++|||+||||.+||+++ ..+++||
T Consensus 419 FQTm--DRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi 491 (683)
T KOG0696|consen 419 FQTM--DRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKI 491 (683)
T ss_pred hhhh--hheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEe
Confidence 9987 789999999999999999987654 67778889999999999999999999999999999999 8899999
Q ss_pred EecCCccc-cccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 002642 774 GDLGLSKI-KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 774 iDFGLAk~-~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~ 852 (897)
+|||+++. .-+...+.+++|||.|+|||++..++ |+.++||||+|++||||+.|++||.+.+.+++++.|...+.
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-- 567 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-- 567 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEecc--cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--
Confidence 99999984 33445566899999999999998766 89999999999999999999999999999999999988876
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCC
Q 002642 853 KIPSWCEPTWRSLMERCWSSDPKSRP 878 (897)
Q Consensus 853 ~~p~~ls~el~dLI~kcL~~DPeeRP 878 (897)
.+|..+|.++.++.+..|.+.|.+|.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 78999999999999999999999994
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=294.75 Aligned_cols=248 Identities=29% Similarity=0.543 Sum_probs=209.5
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|++.+.||+|++|.||+++.. ++.+++|.+..... .+.....+.+|++++++++|||++++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI------KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--D 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc------CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--C
Confidence 5889999999999999999874 56799999865421 123457889999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.||+||||||+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999999765 5689999999999999999999999999999999999998 57889999999998
Q ss_pred ccccccc-cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCc
Q 002642 781 IKQKTLI-SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 781 ~~~~~~~-~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls 859 (897)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||............... ..+.++..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCC
Confidence 5443222 23456889999999987544 788999999999999999999999877765555554433 3356677889
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++|.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.86 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=195.3
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGP 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~ 698 (897)
++|+..+.||+|+||.||++++. ++.+|+|.+..... ......+.+|+.++.++. ||||+++++++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~- 75 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE- 75 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-
Confidence 46777889999999999999884 66899999864311 123466788999999996 99999999988775
Q ss_pred CceEEEEEeeeeccchHHH---Hhh-ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEE
Q 002642 699 VTNLATVTEYMVNGSLKQV---LRR-KDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~---L~~-~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
...+++|||+.. +|.++ +.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||
T Consensus 76 -~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 76 -GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred -CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 578899999854 44443 322 235689999999999999999999985 999999999999998 6778999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCC-
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKGNL- 850 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~-~~~s~ksDIWSLGvILyELLtGk~PF~~~~~-~eil~~Ii~~~l- 850 (897)
+|||+++............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||..... .+.+.++.....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999997544333333446889999999987541 2478899999999999999999999976542 122232222211
Q ss_pred --CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 --GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 --~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....+..++.++.+||.+||+.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223478999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.98 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++.++||.|+||.||+++.. ++.+|+|.++... ........+.+|+++++.++|||++++++++.......
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678999999999999999884 5789999997542 11223456778999999999999999999988653468
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||+++ +|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 9999999974 89998876656789999999999999999999999999999999999998 778999999999985
Q ss_pred ccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------
Q 002642 782 KQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP------- 852 (897)
Q Consensus 782 ~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~------- 852 (897)
..... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||........+..+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 54332 122345688899999876532 36889999999999999999999998877655544433211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ----------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ----------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+...+++++.++|++||..+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111237889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.03 Aligned_cols=254 Identities=24% Similarity=0.449 Sum_probs=213.7
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVV 694 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~ 694 (897)
....++++++..||.|+.|.|++.+.+ +...|||.+... ...+..++++..+.++..-+ +|+||+.+++|
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-------~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-------GNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-------CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 345677888999999999999999885 477999999764 23445678888888887765 89999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCCeEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
..+ ...++.||.| ..-+..++.+-..++++..+-++...++.||.||.++ ||+|||+||+|||++ ..+.+||
T Consensus 161 i~n--~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKl 233 (391)
T KOG0983|consen 161 ITN--TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKL 233 (391)
T ss_pred eeC--chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEe
Confidence 987 5677889987 3456667776677899999999999999999999976 899999999999999 8999999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCC
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYADLH-SEEIIAGIIKGNLG 851 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~-~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-~~eil~~Ii~~~l~ 851 (897)
||||++-...+....+...|.+.|||||.+... ...|+.++||||||++|+||.||+.||.+.+ ..+++..+++.. +
T Consensus 234 CDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-P 312 (391)
T KOG0983|consen 234 CDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-P 312 (391)
T ss_pred ecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-C
Confidence 999999877776666677899999999999754 3358899999999999999999999999854 456677766644 4
Q ss_pred CCCCC--CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 PKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ~~~p~--~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
|.+|. .+|+.+.+|+..||++|+.+||.+.+|+++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 55553 379999999999999999999999999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.80 Aligned_cols=249 Identities=29% Similarity=0.510 Sum_probs=207.7
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.+.|++.+.||+|+||.||++.++ ++.+++|++..... ....+.+|+++++.++|+||+++++.+...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVG- 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-
Confidence 456888899999999999999985 67899999865311 345678899999999999999999998877
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++|+||+++++|.+++......+++..+..++.|++.+|.|||+.||+|+||||+||+++ .++.++|+|||+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~~ 162 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGF 162 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccch
Confidence 689999999999999999987654789999999999999999999999999999999999998 677899999998
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-CCCC
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-KIPS 856 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~-~~p~ 856 (897)
+...... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||....+......+....... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchh
Confidence 8644322 1222345788999999987544 7899999999999999999999998877766555544433322 1223
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.+++++|.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 378999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=338.49 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=209.2
Q ss_pred EEecccCceEEEEeeecCc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
-.||+|.||+||.|++..+ .+|||-+..+ ..+..+-++.|+.+.++|+|.|||++++.+.++ +.+-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--------cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEE
Confidence 4699999999999998655 4788877432 234467788999999999999999999998877 688899
Q ss_pred EeeeeccchHHHHhhccccc--cHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc-
Q 002642 706 TEYMVNGSLKQVLRRKDRTI--DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK- 782 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~l--se~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~- 782 (897)
||-++||+|.++++..=.++ .+...-.+..||++||.|||++.|||||||-+|+||+ +-.|.+||+|||-++..
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN---TySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN---TYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe---eccceEEecccccchhhc
Confidence 99999999999998754455 7788889999999999999999999999999999998 46789999999999854
Q ss_pred ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCcHH
Q 002642 783 QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKIPSWCEPT 861 (897)
Q Consensus 783 ~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~Ii~~~l~~~~p~~ls~e 861 (897)
.-...+.++.||..|||||++...+..|+.++|||||||++.||.||++||...... ....++-.-+.-|++|..++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 334456789999999999999877778999999999999999999999999765432 2233332333457899999999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 862 WRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 862 l~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+.||.+|+..+|..||++++||+.
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccC
Confidence 9999999999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.67 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=188.0
Q ss_pred cccccCCCceEEEEecccCceEEEEeeecCc-----cEEEEEecCCcccCCChhHH------HHHHHHHHHHHHHhhCCC
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGS-----DVAIKRIKPSCFAEGSLEED------RLIADFWREAHMLGQIHH 684 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~-----~VAVK~ik~~~~~~~~~~~~------~~~~~fl~Ei~iL~~L~H 684 (897)
+.++...+|++.++||+|+||.||++.+.+. .+|+|....... ....+ ........+...+..+.|
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~---~~~~e~~~~~~~~~~~~~~~~~~~~~~~h 82 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE---TIVMETLVYNNIYDIDKIALWKNIHNIDH 82 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC---chhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence 3445667999999999999999999987543 466665432211 11111 111223345556677889
Q ss_pred CceeeEeeeeecCCC--ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 002642 685 PNVVAFYGVVTDGPV--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVN 762 (897)
Q Consensus 685 PNIVkl~g~~~e~~~--~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd 762 (897)
++|+++++....... ...++++|++. .++.+.+... ...++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 999999987554321 23467777763 3566665543 2356778889999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCccccccc--------cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 002642 763 MRDPQRPVCKIGDLGLSKIKQKT--------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA 834 (897)
Q Consensus 763 ~~~~~~g~VKLiDFGLAk~~~~~--------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~ 834 (897)
.++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.
T Consensus 161 ----~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 161 ----GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred ----CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6678999999999754211 1112346999999999987654 7999999999999999999999998
Q ss_pred CCCh-HHHH--------HHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 835 DLHS-EEII--------AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 835 ~~~~-~eil--------~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
.... .+.+ ..+..... ....++.++.++++.||+.+|++||++++|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 235 GFGHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 7632 2221 22222211 2335689999999999999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.74 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=208.5
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGP 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~ 698 (897)
++|++.+.||+|+||.||+++. +++.||+|++..... ........+.+|+.+++++. ||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~- 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-----IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE- 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-----cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-
Confidence 4799999999999999999987 477899999865321 12223467788999999998 99999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||+
T Consensus 75 -~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 75 -ENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred -ceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 6899999999999999999765 3689999999999999999999999999999999999998 678899999999
Q ss_pred ccccccc---------------------cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 002642 779 SKIKQKT---------------------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837 (897)
Q Consensus 779 Ak~~~~~---------------------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~ 837 (897)
+...... .......++..|+|||++.+.. ++.++|+||||++++++++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 8743221 1122346789999999987543 7889999999999999999999999887
Q ss_pred hHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 002642 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAF----SEITKE 886 (897)
Q Consensus 838 ~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa----~ELLq~ 886 (897)
.......+... ...+|..+++.+.++|.+||+.+|++||++ ++++++
T Consensus 227 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLTFQKILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 66666555533 336677789999999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=303.59 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=198.4
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
++|++.+.||+|.+|.||+++.+ ++.||+|.++..... ......+.+|++++++++||||+++++++...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-- 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEecC--
Confidence 57999999999999999999874 667999988643211 12345677899999999999999999999876
Q ss_pred ceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||+++. ....+||+|||+
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 68999999996 57887775432 34678888899999999999999999999999999999972 345799999999
Q ss_pred ccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC------
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG------ 851 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~------ 851 (897)
+...... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||......+.+.++......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9754222 112234578899999998653 34788999999999999999999999877665554443321000
Q ss_pred -----------------CC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------------PK----IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------------~~----~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. ....+++++.++|.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 113467889999999999999999999999874
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.31 Aligned_cols=247 Identities=25% Similarity=0.462 Sum_probs=214.1
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
+-|.++.+||+|+||.||++.++ |+.+|||.+... ..++++++|+.++++.+.|++|++|+.+...
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-- 100 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-- 100 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccC--
Confidence 34778899999999999999884 778999987432 2468899999999999999999999976654
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..+|+|||||.-|++.+.++-+.+++++.++..+....++||+|||...-||||||..|||++ .++..||+|||.|
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVA 176 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVA 176 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhcccc
Confidence 589999999999999999998889999999999999999999999999999999999999998 7889999999999
Q ss_pred ccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCCCCCCC
Q 002642 780 KIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPSW 857 (897)
Q Consensus 780 k~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-l~~~~p~~ 857 (897)
....+.. ...+..|||.|||||++..-. |+.++||||||++..||..|++||.+.++...+..+-... .....|..
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHh
Confidence 8665543 335678999999999998655 8999999999999999999999999988866655433222 12234667
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+|.++.+||++||.++|++|.|+.+|+++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 89999999999999999999999999876
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.59 Aligned_cols=245 Identities=24% Similarity=0.438 Sum_probs=200.2
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|.....||+|+||.||++.. +++.||||.+... .......+.+|+.+++.++||||+++++.+... .
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~ 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--D 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--C
Confidence 344557799999999999987 4668999987542 122345688999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchh
Confidence 88999999999999998854 3478889999999999999999999999999999999998 67789999999987
Q ss_pred ccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--CCCC
Q 002642 781 IKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--IPSW 857 (897)
Q Consensus 781 ~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~--~p~~ 857 (897)
..... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+.+..+.. ...+. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHK 243 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccc
Confidence 43222 1223356899999999987543 78899999999999999999999988776555444332 22222 2235
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++..+.++|.+||..||.+|||++|++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 78899999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.52 Aligned_cols=245 Identities=24% Similarity=0.452 Sum_probs=201.8
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.|...+.||+|++|.||++.. .++.+++|.++.. .....+.+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--D 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--C
Confidence 455668999999999999986 4567999987532 112245678999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
..++|+||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.++|+|||.+.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 88999999999999999876 4578889999999999999999999999999999999998 67899999999886
Q ss_pred ccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--CCC
Q 002642 781 IKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSW 857 (897)
Q Consensus 781 ~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~--p~~ 857 (897)
..... .......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...++.+....+.... .+.. +..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCccccc
Confidence 43221 1223356899999999987543 7889999999999999999999998877766665554432 2222 333
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++..+.++|.+||..+|++||++.+++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 78999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.13 Aligned_cols=242 Identities=25% Similarity=0.410 Sum_probs=194.5
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHH-hhCCCCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML-GQIHHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL-~~L~HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+||.||+++. .++.||+|.+..... ........+..|..++ ...+||||+++++++... ..+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-----IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-----hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEE
Confidence 5689999999999987 467899999864311 1122233344554443 455899999999999876 68999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccc
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~ 784 (897)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++ .++.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 99999999999999764 4578899999999999999999999999999999999998 677899999999875432
Q ss_pred ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC--CCCCCCCCcHHH
Q 002642 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL--GPKIPSWCEPTW 862 (897)
Q Consensus 785 ~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l--~~~~p~~ls~el 862 (897)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+..... ....+..+++++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 23456889999999987644 78999999999999999999999988887777666555433 223344688999
Q ss_pred HHHHHHhhccCCCCCCCH---HHHHHH
Q 002642 863 RSLMERCWSSDPKSRPAF---SEITKE 886 (897)
Q Consensus 863 ~dLI~kcL~~DPeeRPTa---~ELLq~ 886 (897)
.++|.+||+.+|++||++ +|++.+
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 999999999999999965 455543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.88 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=196.2
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.++||+|+||.||+++.+ ++.||||.+...... +.....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc------CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 357999999999999999999874 678999988543111 111234567999999999999999999876542
Q ss_pred ------CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 699 ------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 699 ------~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
....++||||+. ++|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++ .++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEE
Confidence 235699999996 588888876655789999999999999999999999999999999999998 778999
Q ss_pred EEecCCccccccccc-----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 002642 773 IGDLGLSKIKQKTLI-----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 773 LiDFGLAk~~~~~~~-----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~ 847 (897)
|+|||++........ .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999975432211 1234578889999988653 2367899999999999999999999987665433222111
Q ss_pred --cCCCCC---------------C-------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 --GNLGPK---------------I-------------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 --~~l~~~---------------~-------------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+..++. + +...+..+.++|.+||..||.+||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110000 0 11135678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.51 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=201.6
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
...++|++.+.||+|+||.||+|+++ ++.||+|.++..... +.....+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK------EGFPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc------cCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 34578999999999999999999984 678999998654211 1123456789999999999999999998876
Q ss_pred CC--------CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCC
Q 002642 697 GP--------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR 768 (897)
Q Consensus 697 ~~--------~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~ 768 (897)
.. ...+++|+||+++ +|.+.+......+++..+..++.|++.||+|||+.||+|+||||+||+++ .+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~ 152 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NK 152 (302)
T ss_pred cchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CC
Confidence 42 2478999999976 77777766555689999999999999999999999999999999999998 77
Q ss_pred CeEEEEecCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002642 769 PVCKIGDLGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 769 g~VKLiDFGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii 846 (897)
+.+||+|||++....... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||......+.+..+.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CcEEeCcccccccccCCcccccccceeccCccChHHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 899999999997543322 112234678899999886432 36889999999999999999999998766555444333
Q ss_pred hcCCCC----------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 847 KGNLGP----------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 ~~~l~~----------------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.....+ .....+|..+.++|.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 211000 0112368899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.61 Aligned_cols=243 Identities=22% Similarity=0.340 Sum_probs=190.1
Q ss_pred EecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHH---HHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 629 ELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREA---HMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei---~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
.||+|+||.||++... ++.+|+|.+.+....... . ...+.+|. .++...+||||+.+++++... +..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--G---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--H---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEE
Confidence 3899999999999874 678999998654222111 1 12223333 344445799999999998876 5889
Q ss_pred EEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~ 783 (897)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 999999999999998765 4589999999999999999999999999999999999998 67789999999987543
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCcHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE--EIIAGIIKGNLGPKIPSWCEPT 861 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~--eil~~Ii~~~l~~~~p~~ls~e 861 (897)
... .....||+.|+|||.+... ..++.++||||||+++|+|++|..||...... ..+... .......++..++++
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHH
Confidence 322 2245689999999998632 23788999999999999999999999754321 222222 222344667778999
Q ss_pred HHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 862 WRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 862 l~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+.++|++||..||.+|| +++|++++
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.17 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=201.5
Q ss_pred CceEEEEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 623 DLEYIKELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
+|++.+.||+|+||.||+++. +++.||+|+++.... .........+.+|++++.++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh----hhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478999999999999999886 467799999864311 11122345677899999999 59999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
+ ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++ .++.+||+||
T Consensus 77 ~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 D--TKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 6 6889999999999999999764 4578888899999999999999999999999999999998 6788999999
Q ss_pred CCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCC
Q 002642 777 GLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIAGIIKGNL 850 (897)
Q Consensus 777 GLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~----~eil~~Ii~~~l 850 (897)
|++....... ......|+..|+|||.+.+....++.++||||||+++|+|++|..||..... .+....+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 9987543321 2224568899999999875444467899999999999999999999964322 2233332222
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
.+..|..+++.+.+++++||..||++|| ++++++.+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2456777899999999999999999997 77888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=301.67 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=198.3
Q ss_pred ceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++.+.||.|++|.||++.+ +++.||+|++...... ......+.+|+++++.++||||+++++++.+. ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheeccC--Ce
Confidence 67789999999999999987 4778999998644211 11234577899999999999999999998876 68
Q ss_pred EEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 702 LATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++++||||+|+||+++ .++.++|+|||++.
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 999999995 68999886643 3589999999999999999999999999999999999998 67889999999987
Q ss_pred cccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 002642 781 IKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-------- 851 (897)
Q Consensus 781 ~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~-------- 851 (897)
...... ......+++.|+|||++.+.. .++.++||||||+++|+|++|+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 543221 112335688999999886532 3688999999999999999999999877654443333221100
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......++.++.++|.+||+.+|++||+++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01123467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.04 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=202.7
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++.+.||+|+||.||++.. +++.+|+|.+... .......+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~- 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--------QQPKKELIINEILVMRENKHPNIVNYLDSYLVG- 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--------cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-
Confidence 36899999999999999999976 4667999987532 111235678899999999999999999998876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
...++|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||+
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~ 161 (293)
T cd06647 89 -DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (293)
T ss_pred -CcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcc
Confidence 6789999999999999998753 477888999999999999999999999999999999998 677899999998
Q ss_pred cccccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 002642 779 SKIKQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPS 856 (897)
Q Consensus 779 Ak~~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~-l~~~~p~ 856 (897)
+....... ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||...+..+....+.... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred eecccccccccccccCChhhcCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 87443222 223346889999999987543 7889999999999999999999998766544433322221 1122344
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++..++++|++||..+|++||++.+++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 578899999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.21 Aligned_cols=248 Identities=25% Similarity=0.453 Sum_probs=204.0
Q ss_pred ceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|...++||+|+||.||+++. .++.|++|.+..... ........+.+|+++++.++|||++++++++.+. ..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-----QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-----CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CE
Confidence 66678899999999999987 466899998864311 1223456788899999999999999999999876 68
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||+. ++|.+++......+++..+..++.|++.+|.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 899999995 578888876666789999999999999999999999999999999999998 677899999999864
Q ss_pred cccccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcH
Q 002642 782 KQKTLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860 (897)
Q Consensus 782 ~~~~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~ 860 (897)
... .....++..|+|||++.. ....++.++||||||+++|+|++|..||...+.......+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 224568999999999842 1234788999999999999999999999887776666655554443333445778
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 861 TWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 861 el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+++||.+||+.+|.+||++.+++++
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=350.35 Aligned_cols=250 Identities=30% Similarity=0.512 Sum_probs=194.1
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC-
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG- 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~- 697 (897)
..+|+.++.||+|+||.||+++. +|..||||.+.... .+.....+.+|+..|.+|+|||||++|..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 35788899999999999999998 59999999986541 345567788999999999999999998643220
Q ss_pred --------------------------------------------------------------------------------
Q 002642 698 -------------------------------------------------------------------------------- 697 (897)
Q Consensus 698 -------------------------------------------------------------------------------- 697 (897)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred -----------------------------C-------CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHH
Q 002642 698 -----------------------------P-------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741 (897)
Q Consensus 698 -----------------------------~-------~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL 741 (897)
+ ...+||-||||+..+|.+++.++...-.....+.+++||++||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence 0 0346888999998888888876543224667889999999999
Q ss_pred HHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-------------------cccccCCcccCCcccCccc
Q 002642 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-------------------KTLISGGVRGTIPWMAPEL 802 (897)
Q Consensus 742 ~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~-------------------~~~~~~~~~GT~~Y~APEv 802 (897)
.|+|++|||||||||.||+++ ++..|||+|||+|+... .....++.+||.-|+|||+
T Consensus 711 aYIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999998 78899999999997410 0112345679999999999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCC---CCCCCcHHHHHHHHHhhccCCCCC
Q 002642 803 FKSKDN-LVTEKVDVYSFGVVMWELLTGEEPYAD-LHSEEIIAGIIKGNLGPK---IPSWCEPTWRSLMERCWSSDPKSR 877 (897)
Q Consensus 803 l~g~~~-~~s~ksDIWSLGvILyELLtGk~PF~~-~~~~eil~~Ii~~~l~~~---~p~~ls~el~dLI~kcL~~DPeeR 877 (897)
+.+... .|+.|+|+||||+||+||+. ||.. +....++.++....++.+ +...+ +.-+.+|++|++.||.+|
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccC
Confidence 976442 58999999999999999986 4543 333444555554444333 11223 345679999999999999
Q ss_pred CCHHHHHH
Q 002642 878 PAFSEITK 885 (897)
Q Consensus 878 PTa~ELLq 885 (897)
||+.|||.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999985
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.44 Aligned_cols=247 Identities=23% Similarity=0.404 Sum_probs=201.7
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..|+....||+|+||.||++.. .++.||+|.+.... ......+.+|+.+++.+.||||+++++++..+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-- 90 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-- 90 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--------cchHHHHHHHHHHHHhCCCCchhhhhhheeeC--
Confidence 3455556899999999999987 46789999985431 11234577899999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~ 164 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFC 164 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhH
Confidence 689999999999999998754 3578899999999999999999999999999999999998 7788999999998
Q ss_pred cccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCCCC
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL-GPKIPSW 857 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l-~~~~p~~ 857 (897)
...... .......++..|+|||++.+.. ++.++||||||+++|||++|+.||......+....+..... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06659 165 AQISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242 (297)
T ss_pred hhcccccccccceecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCC
Confidence 743322 1223456899999999997544 78899999999999999999999987776665554433221 1223345
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 858 CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 858 ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
++..+.++|.+||+.+|++||++.+++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 78899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.86 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=196.1
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.++||+|+||.||++++ +++.||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 36899999999999999999987 46789999986421 1223456778999999999999999998866432
Q ss_pred ---CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 699 ---VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 699 ---~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
....++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ ..+.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECc
Confidence 245799999996 488887754 4588899999999999999999999999999999999998 778899999
Q ss_pred cCCcccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh----
Q 002642 776 LGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK---- 847 (897)
Q Consensus 776 FGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~---- 847 (897)
||++....... ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99987543221 11234688999999987542 2378899999999999999999999976654332221110
Q ss_pred -----------cC-------C--CCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 -----------GN-------L--GPK-----IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 -----------~~-------l--~~~-----~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. . ... .....++++.++|.+||+.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 000 012357789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=307.23 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=205.6
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
..|+..+.||+|+||.||+++. .++.+|+|.+..... ........+.+|+++++.++|||++++++++...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-- 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-----cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--
Confidence 4577788999999999999987 456799998854211 1223356678899999999999999999998876
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...++||||+. ++|.+++......+++..+..++.|++.||.|||+++++||||||+||+++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 162 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccc
Confidence 68899999996 588887766556688999999999999999999999999999999999998 6788999999998
Q ss_pred cccccccccCCcccCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKS-KDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g-~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~l 858 (897)
...... ....+++.|+|||.+.. ....++.++||||||+++|+|++|..||......+....+.........+..+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 754332 23568899999999742 12236789999999999999999999998877666665555544433344568
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 859 s~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
+..++++|++||..+|++||++++++++..
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 899999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.05 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=202.3
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|.+.++||+|+||.||++++. +..+++|+++........ ......+..|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLER--D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--C
Confidence 5889999999999999999875 345677776543221111 11233466789999999999999999998876 5
Q ss_pred eEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 701 NLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++ .+.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-----~~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-----cCCEeecccC
Confidence 78999999999999998864 235689999999999999999999999999999999999996 2459999999
Q ss_pred Ccccccc-ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 002642 778 LSKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~ 856 (897)
+++.... ........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+... ..+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCCcc
Confidence 9875432 22233456889999999986543 688999999999999999999999877666655555443 3445667
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.++.++.++|.+||..+|++||++.|++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.43 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred ceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++.+.||.|++|.||++.. +++.+++|.++..... ......+.+|+.++++++||||+++++++..+ ..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------EGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CC
Confidence 56788999999999999987 4667999998654211 12345677899999999999999999998876 68
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 9999999975 88888877656789999999999999999999999999999999999998 678899999999875
Q ss_pred ccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--------
Q 002642 782 KQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-------- 852 (897)
Q Consensus 782 ~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~-------- 852 (897)
..... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..+.+..+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 54332 22234578899999998754 247899999999999999999999998877655544432211000
Q ss_pred --------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 --------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 --------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.....++.++.++|.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0112367899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=303.54 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=197.0
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||+++++ ++.+|+|.+....... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC------CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 579999999999999999999874 6679999885432111 11234568999999999999999999875532
Q ss_pred ------CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 699 ------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 699 ------~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
...+++||||+.+ +|...+......+++..+..++.|+++||+|||++||+|+||||+||+++ .++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 2357999999864 77777766556799999999999999999999999999999999999998 778999
Q ss_pred EEecCCccccccccc------------cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 002642 773 IGDLGLSKIKQKTLI------------SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE 840 (897)
Q Consensus 773 LiDFGLAk~~~~~~~------------~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e 840 (897)
|+|||++........ .....+++.|+|||.+.+. ..++.++||||||+++|+|++|++||.+.....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999874322111 1123568889999988643 236889999999999999999999998776655
Q ss_pred HHHHHHhcCCC---------------------CCCC-------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 841 IIAGIIKGNLG---------------------PKIP-------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 841 il~~Ii~~~l~---------------------~~~p-------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....+...... ...+ ..+++++.++|.+||+.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 44433221100 0000 1244678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=269.69 Aligned_cols=97 Identities=42% Similarity=0.749 Sum_probs=92.7
Q ss_pred EeecCCeeeeCCCCCCeeeecCceEEEEecCCCChHHHHHHHHHHhcCCCcceEEeecCCCCCCCCCCCCceEeecchhh
Q 002642 22 ICSFNGAFHVQPSSNNLRYIGGETRIISVDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDD 101 (897)
Q Consensus 22 ~csygG~i~pr~~d~~l~Y~gg~tri~~v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~Lisv~~ded 101 (897)
||||||+|+|||+||+|+|+||+|||++|+|++||+||++||+++++....++|||||| +||||+||||++|||
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp------~edld~Lisv~~DeD 74 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLP------DEDLDALISVSNDED 74 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcC------CCCcceeEEecCcHH
Confidence 79999999999999999999999999999999999999999999999855589999999 999999999999999
Q ss_pred HHHHHHHhhhhhcCCCCCCCCceEEEEe
Q 002642 102 VRCMVEEYDKLESCGKGVADDSLRKKVM 129 (897)
Q Consensus 102 l~~m~~eyd~~~~~~~~~~~~~~r~f~f 129 (897)
|+|||+||||+ +.+++|+|+|||
T Consensus 75 l~~M~~e~~~~-----~~~~~rirvflf 97 (97)
T cd06410 75 LKNMMEEYDRL-----SGGSARLRVFLF 97 (97)
T ss_pred HHHHHHhhccc-----cCCCceEEEEEC
Confidence 99999999998 447899999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.23 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=201.9
Q ss_pred CceEEEEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 623 DLEYIKELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
+|++.+.||+|+||.||+++. +++.||||.++.... .........+.+|++++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999875 346799999864311 12233456788999999999 59999999999887
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ...++||||+++++|.+++... ..+++..+..++.|++.+|+|||+.+++||||||+||+++ .++.++|+||
T Consensus 77 ~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 D--TKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred C--CEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 6 6789999999999999998754 4578888999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCC
Q 002642 777 GLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH----SEEIIAGIIKGNL 850 (897)
Q Consensus 777 GLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~----~~eil~~Ii~~~l 850 (897)
|+++...... ......++..|+|||.+.+.....+.++||||||+++|+|++|..||.... ..+....+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 9987543221 122346889999999987544346789999999999999999999996432 22333333332
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 851 ~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+..|..++.+++++|.+||+.||++|||+.++.+.|+
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 24567778999999999999999999999776655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.48 Aligned_cols=247 Identities=22% Similarity=0.405 Sum_probs=193.4
Q ss_pred EEeccc--CceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 628 KELGSG--TFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 628 k~LGkG--~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
..||+| +||+||++++ .++.||+|++.... ......+.+.+|+.+++.++||||+++++++..+ ...+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceE
Confidence 456766 8999999988 57889999986431 1123457788999999999999999999999887 6789
Q ss_pred EEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 704 TVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
+||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.||+||||||+||+++ .++.+|++||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhh
Confidence 999999999999998764 23588899999999999999999999999999999999998 6778999999865322
Q ss_pred cccc--------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC----
Q 002642 783 QKTL--------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL---- 850 (897)
Q Consensus 783 ~~~~--------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l---- 850 (897)
.... ......++..|+|||++.+....++.++|||||||++|+|++|+.||......+.....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 1110 0111234667999999876434478999999999999999999999987765554433332211
Q ss_pred -----------------------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 -----------------------------------------GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 -----------------------------------------~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....+..+++.+.+||++||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011122356789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.10 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=196.6
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC---CCCceeeEeeeeecCC
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI---HHPNVVAFYGVVTDGP 698 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L---~HPNIVkl~g~~~e~~ 698 (897)
|++.+.||+|+||.||+++++ ++.+|+|.++.... .+.....+.+|+.+++++ +||||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999984 67899999975421 111223455677666555 6999999999988653
Q ss_pred C---ceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 V---TNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ~---~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
. ..++++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 1 248999999974 8888886643 3589999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||++.............++..|+|||++.+.. ++.++||||||+++|+|++|.+||......+.+..+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 999997654433333445788999999987644 788999999999999999999999887776665555432100
Q ss_pred ---------------CC-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 ---------------PK-------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ---------------~~-------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. ....+++.+.++|.+||+.||.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 011345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.96 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=196.2
Q ss_pred ceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 624 LEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
+.+.+.+|.|+++.|++++.+++.||||+++... ........+.+|+.+++.++||||+++++++.+. ...+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELY 75 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc------cchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEE
Confidence 3445556667777777777788899999986531 1223456789999999999999999999998876 6789
Q ss_pred EEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 704 TVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++|||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++ .++.+||+|||.+...
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSM 151 (314)
T ss_pred EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceee
Confidence 999999999999999753 34578888999999999999999999999999999999998 6788999999988643
Q ss_pred cccc--------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 783 QKTL--------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 783 ~~~~--------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
.... ......++..|+|||++......++.++||||||+++|||++|+.||..................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (314)
T cd08216 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccc
Confidence 2111 11234577889999998754334788999999999999999999999876654443332221110
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+..++.++.+||.+||..||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00112245678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.97 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=191.6
Q ss_pred EecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEE
Q 002642 629 ELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVT 706 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVm 706 (897)
.||+|+||.||+++. .++.||+|.+.+...... ..+........++..++...||+|+++++.+... ..+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEE
Confidence 389999999999987 466899999865422211 1111111222334455566899999999999876 6899999
Q ss_pred eeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccccc
Q 002642 707 EYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL 786 (897)
Q Consensus 707 Ey~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~ 786 (897)
||+.|++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++ .++.+||+|||++.......
T Consensus 77 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCccC
Confidence 999999999988754 4689999999999999999999999999999999999998 67789999999987543222
Q ss_pred ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCcHHHHH
Q 002642 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE--EIIAGIIKGNLGPKIPSWCEPTWRS 864 (897)
Q Consensus 787 ~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~--eil~~Ii~~~l~~~~p~~ls~el~d 864 (897)
.....|+..|+|||.+.+.. .++.++||||+|+++|+|++|+.||...... +...... ....+..|..++.++.+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ 228 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRS 228 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHH
Confidence 23456899999999986432 3788999999999999999999999876321 2222222 22234567778999999
Q ss_pred HHHHhhccCCCCCC-----CHHHHHHH
Q 002642 865 LMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 865 LI~kcL~~DPeeRP-----Ta~ELLq~ 886 (897)
+|.+||..+|.+|| ++.+++++
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=351.75 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=218.5
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~ 695 (897)
.++.++|++++.||+|+||.|.+++++ ++.||+|++.+-. ..+.....-|..|-.+|..-+.+=|+.++..|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-----MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-----MLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH-----HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 356789999999999999999999985 5569999986521 122233467888999998888999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
++ .++|+||||++||+|..++.+.+ .+++.-+.+++.+|+.||.-||+.|+|||||||+|||++ ..|++||+|
T Consensus 146 D~--~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLAD 218 (1317)
T KOG0612|consen 146 DE--RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLAD 218 (1317)
T ss_pred Cc--cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeecc
Confidence 88 79999999999999999999887 789999999999999999999999999999999999999 889999999
Q ss_pred cCCccccc-ccc-ccCCcccCCcccCccccccC--C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 002642 776 LGLSKIKQ-KTL-ISGGVRGTIPWMAPELFKSK--D-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850 (897)
Q Consensus 776 FGLAk~~~-~~~-~~~~~~GT~~Y~APEvl~g~--~-~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l 850 (897)
||.+-.+. +.. .....+|||.|.+||++... . ..|++..||||+||++|||++|..||....-.+.+..|+...-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 99886544 332 34567899999999998642 2 4589999999999999999999999999999999999988755
Q ss_pred CCCCC--CCCcHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002642 851 GPKIP--SWCEPTWRSLMERCWSSDPKSRPA---FSEITKE 886 (897)
Q Consensus 851 ~~~~p--~~ls~el~dLI~kcL~~DPeeRPT---a~ELLq~ 886 (897)
...|| ..+|+++++||++++. +|+.|.. ++++..|
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 55666 5689999999998775 5888876 8888765
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.31 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=199.9
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~ 697 (897)
.++|++.+.||+|+||.||++.+. ++.+|+|.+..... .......+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR------NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC------cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 468999999999999999999874 66799998854211 112234567899999999 999999999998765
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
....+++||||+. ++|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++ .++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeecc
Confidence 5467899999997 5999888654 678888899999999999999999999999999999998 78899999999
Q ss_pred Ccccccccc------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 002642 778 LSKIKQKTL------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 778 LAk~~~~~~------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~ 851 (897)
++....... ......+|..|+|||.+.+. ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 997543221 22245689999999988653 34688999999999999999999999876654433322111100
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 -----------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -----------------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......++.++.++|.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 01112368899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.88 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=200.8
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC-
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP- 698 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~- 698 (897)
.+|.+.+.||+|+||.||+++. +++.||||.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 5799999999999999999987 467899999865311 1112345678999999999999999999876542
Q ss_pred --CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 699 --VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 699 --~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
....++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECcC
Confidence 135899999995 6898888754 4689999999999999999999999999999999999998 6778999999
Q ss_pred CCccccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--------
Q 002642 777 GLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK-------- 847 (897)
Q Consensus 777 GLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~-------- 847 (897)
|++...... .......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999854332 2223456789999999886432 378899999999999999999999987654332221111
Q ss_pred ---------------cCC---CC---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHH
Q 002642 848 ---------------GNL---GP---KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE--LRAM 890 (897)
Q Consensus 848 ---------------~~l---~~---~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~--Le~l 890 (897)
... .+ .....+++++.++|++||+.+|++||++++++++ |+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00 0123578899999999999999999999999988 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.36 Aligned_cols=251 Identities=27% Similarity=0.355 Sum_probs=203.9
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC--
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP-- 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~-- 698 (897)
+|++.+.||+|+||.||+++.. ++.+|||.+.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999974 6789999986531 11233467889999999999999999999887652
Q ss_pred -CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 699 -VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 699 -~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
...+++||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 236899999997 58988887643 789999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 778 LSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 778 LAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
++....... ......+++.|+|||++.+.. .++.++||||||+++|+|++|..||......+....+....-.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654332 223456789999999997652 478999999999999999999999988776655444433111000
Q ss_pred -----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 -----------------------------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 -----------------------------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....++.++.++|.+||+++|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112367889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.62 Aligned_cols=240 Identities=29% Similarity=0.447 Sum_probs=202.0
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|+||.||++..+ ++.+|+|.+..... ........+..|+.+++.++||||+++++.+..+ ...++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-----IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-----cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEe
Confidence 699999999999884 67899999865421 2223456788999999999999999999998876 68999999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccc-c
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT-L 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~-~ 786 (897)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 99999999999765 3588999999999999999999999999999999999998 6778999999998754332 2
Q ss_pred ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 002642 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLM 866 (897)
Q Consensus 787 ~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI 866 (897)
......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......+....+... ...++..++.++.++|
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 233456889999999987543 788999999999999999999999887766666665553 3567788899999999
Q ss_pred HHhhccCCCCCCCH---HHHHH
Q 002642 867 ERCWSSDPKSRPAF---SEITK 885 (897)
Q Consensus 867 ~kcL~~DPeeRPTa---~ELLq 885 (897)
++||..||++||++ .++++
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHh
Confidence 99999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.62 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=197.1
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCCc
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~~ 700 (897)
|++.+.||+|+||+||+|+.. ++.|+||.+...... .......+|+..+.+++ ||||+++++++... .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--D 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--C
Confidence 678899999999999999984 567999988643211 01123456889999998 99999999998875 6
Q ss_pred eEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
..++||||+ +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 789999887653 4689999999999999999999999999999999999998 7889999999999
Q ss_pred cccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC----------
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN---------- 849 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~---------- 849 (897)
.............++..|+|||++.... .++.++|+||||+++++|++|+.||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecCc-CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 8654433333456889999999885432 36889999999999999999999998776554443322100
Q ss_pred -------CCCC-----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 -------LGPK-----------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 -------l~~~-----------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.... .....+..+.++|++||+.+|++||+++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 011236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=322.52 Aligned_cols=265 Identities=31% Similarity=0.543 Sum_probs=224.2
Q ss_pred cccccccccCCCceEEEEecccCceEEEEeeecC-ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeE
Q 002642 612 ANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 612 ~~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~kg-~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl 690 (897)
....++++..+.+.++++||+|.||.|.+....+ ..||+|.++.. .......+|.+|+++|.+++||||+.+
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-------a~~~~r~~F~kEIkiLsqLkhPNIveL 600 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-------ATKNARNDFLKEIKILSRLKHPNIVEL 600 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-------cchhHHHHHHHHHHHHhccCCCCeeEE
Confidence 3445678888999999999999999999999876 78999999865 233446899999999999999999999
Q ss_pred eeeeecCCCceEEEEEeeeeccchHHHHhhccccc-cHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTI-DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 691 ~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~l-se~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
+++|..+ +.+++|+||++.|+|.+++.++..+. +-.....|+.||+.||+||.+.++|||||.+.|+|++ .+.
T Consensus 601 vGVC~~D--ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~ 674 (807)
T KOG1094|consen 601 LGVCVQD--DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEF 674 (807)
T ss_pred EeeeecC--CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----Ccc
Confidence 9999987 68999999999999999998764433 5556677999999999999999999999999999999 899
Q ss_pred eEEEEecCCcccc---ccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHH
Q 002642 770 VCKIGDLGLSKIK---QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT--GEEPYADLHSEEIIAG 844 (897)
Q Consensus 770 ~VKLiDFGLAk~~---~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt--Gk~PF~~~~~~eil~~ 844 (897)
++||+|||.++.. +........+-..+|||||.+.... +++++|+|+||++|||+++ ...||...+.+++..+
T Consensus 675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 9999999999843 2223444566788999999887544 8999999999999999887 8899999888777665
Q ss_pred HHh---cC---CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 845 IIK---GN---LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 845 Ii~---~~---l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
.-. .. .-+..|..||.++.++|..||..+-++||++++|...|++..
T Consensus 753 ~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 753 AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 422 11 123467889999999999999999999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.15 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=230.8
Q ss_pred ccccCCCceEEEEecccCceEEEEeeecCcc--EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~--VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..+...+++++..||-|+||.|-+++.+++. +|+|++++... ...+....+..|-++|...+.|.||++|..|
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-----VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI-----VDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc-----cchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 3466788899999999999999999988776 89999977633 2334456778899999999999999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.++ .+.|++||-|-||.|+..++..+ .+++..+..++..+++|++|||++|||+|||||+|++++ .++.+||.
T Consensus 490 rd~--kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~Gy~KLV 562 (732)
T KOG0614|consen 490 RDS--KYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRGYLKLV 562 (732)
T ss_pred ccc--hhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCCceEEe
Confidence 987 78999999999999999998764 578888888899999999999999999999999999999 88999999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~ 854 (897)
|||+|+.......+.+++|||.|.|||++.++. .+.++|.||||+++|||++|.+||.+.++......|+++.-...+
T Consensus 563 DFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 563 DFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF 640 (732)
T ss_pred ehhhHHHhccCCceeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc
Confidence 999999988888888999999999999999876 789999999999999999999999999999999999998877889
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPA-----FSEITKEL 887 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPT-----a~ELLq~L 887 (897)
|+.++....+||+++...+|.+|.. +.+|.+|-
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 9999999999999999999999964 67777664
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.57 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=199.2
Q ss_pred CCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC--
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG-- 697 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~-- 697 (897)
++|++.+.||+|+||.||+++.+ ++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc------cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 68999999999999999999874 77899999864311 112345677899999999999999999987643
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
....+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 2357899999995 6898888654 4489999999999999999999999999999999999998 77889999999
Q ss_pred Ccccccccc-----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc----
Q 002642 778 LSKIKQKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG---- 848 (897)
Q Consensus 778 LAk~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~---- 848 (897)
++....... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||........+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCc-ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987543221 112356889999999986532 3788999999999999999999999876544332221110
Q ss_pred ------------------CCC--CCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 ------------------NLG--PKI-----PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 ------------------~l~--~~~-----p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
... ... ....+.++.++|++||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 011 13468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.67 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=207.6
Q ss_pred CCCceEE-EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 621 TSDLEYI-KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 621 ~~~Yeil-k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
.++|.+- ++||-|-.|+|....+ +++.+|+|++... ....+|+++.-.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4567664 6799999999998776 4778999998533 1223455544333 69999999998764
Q ss_pred C--CCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 697 G--PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 697 ~--~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
. ....+.+|||.|+||.|+..++.++ ..++++++..|+.||..|+.|||+++|.||||||+|+|..... .+..+||
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKL 205 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKL 205 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEe
Confidence 2 2357889999999999999998764 4699999999999999999999999999999999999997544 6678999
Q ss_pred EecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcC
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIAGIIKGN 849 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~----~eil~~Ii~~~ 849 (897)
+|||+|+.........+.+-||+|.|||++.... |+...|+||+||++|-|++|.+||..... ..+...|..+.
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 9999999766555556788999999999996544 89999999999999999999999986643 45667778888
Q ss_pred CCCCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 LGPKIPSW--CEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 l~~~~p~~--ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.++-|+| +|+..+++|+.+|..+|.+|.|+++++.+
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 87777766 78999999999999999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.41 Aligned_cols=238 Identities=24% Similarity=0.352 Sum_probs=187.9
Q ss_pred CCceEEEEe--cccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 622 SDLEYIKEL--GSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 622 ~~Yeilk~L--GkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
++|++.+.+ |+|+||.||++..+ +..+|+|.+....... .|+.....+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 355665555 99999999999874 6679999986532110 012122212 79999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC-eEEEEe
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP-VCKIGD 775 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g-~VKLiD 775 (897)
. ...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++ .++ .++|+|
T Consensus 81 ~--~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~d 153 (267)
T PHA03390 81 L--KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCD 153 (267)
T ss_pred C--CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEec
Confidence 7 58999999999999999997653 789999999999999999999999999999999999998 455 899999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH----HHHHHhcCCC
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI----IAGIIKGNLG 851 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~ei----l~~Ii~~~l~ 851 (897)
||+++..... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||......+. +.... ...
T Consensus 154 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~ 226 (267)
T PHA03390 154 YGLCKIIGTP---SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKK 226 (267)
T ss_pred CccceecCCC---ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--ccc
Confidence 9998754332 2346899999999997644 78899999999999999999999986543322 11112 222
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002642 852 PKIPSWCEPTWRSLMERCWSSDPKSRPA-FSEITKE 886 (897)
Q Consensus 852 ~~~p~~ls~el~dLI~kcL~~DPeeRPT-a~ELLq~ 886 (897)
...+..+++.+.++|.+||+.+|.+||+ ++|++++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 3455578999999999999999999995 6999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=305.39 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=199.6
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++++.||+|+||.||++.. +++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 56899999999999999999987 46789999985431 12233456789999999999999999999887542
Q ss_pred ----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
...+++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEe
Confidence 13568999998 7799888864 3588999999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||++...... .....+++.|+|||.+.+.. .++.++|+||||+++|+|++|+.||...........+......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999755432 22456789999999986432 3788999999999999999999999876654443333221110
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 --------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 --------------------------~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
......+++++.++|.+||..||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01123567889999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=317.11 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=213.7
Q ss_pred cccccccccccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCC
Q 002642 608 FTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685 (897)
Q Consensus 608 ~~~~~~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HP 685 (897)
|-++..-+.+.+..+.|..-+.||+|+||.||-.+. +|+-+|.|.+.++. +.+..-..-.++|-.||.+++.+
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-----iKkr~ge~maLnEk~iL~kV~s~ 245 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-----IKKRKGETMALNEKQILEKVSSP 245 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-----HHHhhhhHHhhHHHHHHHHhccC
Confidence 334445566788889999999999999999997654 68889999875431 22222334567899999999999
Q ss_pred ceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccC
Q 002642 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 686 NIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~ 764 (897)
.||.+-..|++. ..+++||..|+||+|.-+|-..+ ..+++..+..++.||+.||++||+.+||+||+||+|||+|
T Consensus 246 FiVslaYAfeTk--d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD-- 321 (591)
T KOG0986|consen 246 FIVSLAYAFETK--DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD-- 321 (591)
T ss_pred cEEEEeeeecCC--CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec--
Confidence 999997778776 68999999999999998886654 4689999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----H
Q 002642 765 DPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE----E 840 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~----e 840 (897)
+.++|.|+|.|||..........+.+||..|||||++.+.. |+.+.|||||||+||||+.|+.||...... +
T Consensus 322 --d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE 397 (591)
T KOG0986|consen 322 --DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE 397 (591)
T ss_pred --cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH
Confidence 89999999999998776665555668999999999998654 899999999999999999999999765432 3
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCC
Q 002642 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA 879 (897)
Q Consensus 841 il~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPT 879 (897)
+-..++.. ..+++..+|+++++|.+.+|++||++|..
T Consensus 398 vdrr~~~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 398 VDRRTLED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHHHHhcc--hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 33333333 34788999999999999999999999953
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=326.55 Aligned_cols=257 Identities=19% Similarity=0.271 Sum_probs=185.8
Q ss_pred CCCceEEEEecccCceEEEEeeecC---ccEEEEEecCCc---------ccCCChhHHHHHHHHHHHHHHHhhCCCCcee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKG---SDVAIKRIKPSC---------FAEGSLEEDRLIADFWREAHMLGQIHHPNVV 688 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~kg---~~VAVK~ik~~~---------~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIV 688 (897)
..+|+++++||+|+||+||++..+. ...++|.+.... ..............+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 122222111000 0000011123456688999999999999999
Q ss_pred eEeeeeecCCCceEEEEEeeeeccchHHHHhhcc----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccC
Q 002642 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD----RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 689 kl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~----~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~ 764 (897)
++++++... ...++|+|++. ++|.+++.... .......+..|+.||+.||+|||++|||||||||+|||++
T Consensus 227 ~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-- 301 (501)
T PHA03210 227 KIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-- 301 (501)
T ss_pred cEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 999999877 57889999984 57777764321 2234556778999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCC--ChH
Q 002642 765 DPQRPVCKIGDLGLSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADL--HSE 839 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~P-F~~~--~~~ 839 (897)
.++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||+||||++|..+ |... ...
T Consensus 302 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 --CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred --CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 67889999999998654322 223467999999999998654 78999999999999999998754 4332 222
Q ss_pred HHHHHHHhcC--CCCCC----------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 840 EIIAGIIKGN--LGPKI----------------------------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 840 eil~~Ii~~~--l~~~~----------------------------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+..++... ....+ ...++.++.++|.+||+.||++||++.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2222222110 00000 11256678889999999999999999999975
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=306.11 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=196.9
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
..+|++.+.||.|+||.||+++.+ ++.||+|.+..... ...+.+.+|+++++.++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 368999999999999999999874 66899998854311 23466778999999999999999998766542
Q ss_pred C------------ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCC
Q 002642 699 V------------TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 699 ~------------~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~ 766 (897)
. ...++||||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--- 149 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--- 149 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---
Confidence 1 35789999996 589888864 35788999999999999999999999999999999999972
Q ss_pred CCCeEEEEecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002642 767 QRPVCKIGDLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEII 842 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil 842 (897)
.+..+||+|||+++....... .....++..|+|||.+... ..++.++|||||||++|+|++|+.||......+..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 456789999999975432211 1223578899999987542 34788999999999999999999999877665544
Q ss_pred HHHHhcCC-----------------------CC-----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 843 AGIIKGNL-----------------------GP-----KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 843 ~~Ii~~~l-----------------------~~-----~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..++.... .. .....++.++.+||.+||+.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 43332110 00 0123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=353.66 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=209.0
Q ss_pred CCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~ 699 (897)
-++.....||.|.||.||.+.. +|+..|+|-++..... ....+.+.+|..++..++|||+|++|++-.+.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-- 1306 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-- 1306 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecH--
Confidence 3566678899999999999887 5778999988654211 44567788999999999999999999988776
Q ss_pred ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCc
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLA 779 (897)
...+|.||||++|+|.+.++. ++..++.....+..|++.|+.|||++|||||||||+||+++ .++.+|+.|||.|
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeecccce
Confidence 567889999999999999864 35566776777888999999999999999999999999998 7789999999999
Q ss_pred ccccccc-----ccCCcccCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 780 KIKQKTL-----ISGGVRGTIPWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 780 k~~~~~~-----~~~~~~GT~~Y~APEvl~g~~-~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
....... ......||+.|||||++.+.. .....++|||||||+..||+||+.||...+++=.+--.+...-.|+
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 8543321 123467999999999997643 2345689999999999999999999998766544333345555689
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+|..++++.++||+.||..||++|.++.||+++
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 999999999999999999999999999988875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.06 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=197.7
Q ss_pred CCceE-EEEecccCceEEEEeee--cCccEEEEEecCCcccCCChh------HHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 622 SDLEY-IKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLE------EDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 622 ~~Yei-lk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~------~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
++|.. .+.||.|+||.||++.+ .++.||||.++.......... .......+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 57799999999999986 467899999865422110000 0001235678999999999999999999
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
++... ...++||||+. ++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++ .++.+|
T Consensus 88 ~~~~~--~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVEG--DFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEecC--CcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 98876 68999999996 5899988653 4588899999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccc---------------ccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 002642 773 IGDLGLSKIKQK---------------TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837 (897)
Q Consensus 773 LiDFGLAk~~~~---------------~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~ 837 (897)
|+|||++..... ........+++.|+|||.+.+.. .++.++||||||+++|+|++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999874330 11112234688899999987533 36889999999999999999999998887
Q ss_pred hHHHHHHHHhcCCCC-------------------C-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 838 SEEIIAGIIKGNLGP-------------------K-------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 838 ~~eil~~Ii~~~l~~-------------------~-------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+.+..+....-.+ . .....+.++.++|.+||+.+|++||+++|++.+
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 666554443211000 0 112357889999999999999999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=305.28 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=200.0
Q ss_pred cccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
.|++ ..+|++.+.||+|+||.||++++ +++.||+|.++.... .+.....+.+|+.+++.++||||++++++
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ------SEIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc------cccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 4455 35899999999999999999987 477899999865311 12234567789999999999999999998
Q ss_pred eecCC----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC
Q 002642 694 VTDGP----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 694 ~~e~~----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g 769 (897)
+.... ...+++|+||+. .+|..++. ..+++..+..++.|++.||+|||+++|+||||||+||+++ .++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~ 154 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDC 154 (342)
T ss_pred ecccccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCC
Confidence 86542 235789999996 46766653 3578889999999999999999999999999999999998 678
Q ss_pred eEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 002642 770 VCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~ 849 (897)
.+||+|||+++..... .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........+..++...
T Consensus 155 ~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 231 (342)
T cd07879 155 ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231 (342)
T ss_pred CEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 8999999998754322 2245678899999998652 237889999999999999999999998776544443332210
Q ss_pred C---------------------CCCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHH
Q 002642 850 L---------------------GPKI--------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE--LRAM 890 (897)
Q Consensus 850 l---------------------~~~~--------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~--Le~l 890 (897)
. .+.. ....++++.++|.+||+.||++||++++++++ ++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 0001 12356789999999999999999999999965 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.32 Aligned_cols=242 Identities=25% Similarity=0.435 Sum_probs=197.6
Q ss_pred EEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEE
Q 002642 626 YIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 626 ilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~ 703 (897)
...+||+|+||.||++.. +++.||||.+... .......+.+|+.+++.++||||+++++.+... ...+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 93 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELW 93 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEE
Confidence 346799999999999987 4678999987432 112345688899999999999999999999876 6899
Q ss_pred EEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~ 783 (897)
+||||+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++|+||||+||+++ .++.++|+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 94 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceecc
Confidence 99999999999998754 3478888999999999999999999999999999999998 67789999999887443
Q ss_pred cc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCcH
Q 002642 784 KT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--IPSWCEP 860 (897)
Q Consensus 784 ~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~--~p~~ls~ 860 (897)
.. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+. ...+.. ....+++
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 244 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKLKNLHKVSP 244 (292)
T ss_pred cccccccccccCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCcccCCcccCCH
Confidence 22 1223356889999999986533 6889999999999999999999998776655544432 222222 2345789
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 861 TWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 861 el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+.++|.+||..+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 99999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=292.41 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=200.0
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++.+.||+|.||.||+++.. ++.+|+|.+.... ..+.....+..|+.+++.++||||+++++++... ..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--Cc
Confidence 567889999999999999984 6789999987542 1122345667899999999999999999998876 68
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++||||++ ++|.+++.+....+++..+..++.|++.||+|||++||+||||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999997 589999987645689999999999999999999999999999999999998 678899999999875
Q ss_pred ccccc-ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC----------
Q 002642 782 KQKTL-ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL---------- 850 (897)
Q Consensus 782 ~~~~~-~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l---------- 850 (897)
..... ......++..|+|||.+.+. ..++.++||||||+++|||++|..||......+.+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 22234467889999998754 2478899999999999999999999988765554443322100
Q ss_pred ------CCCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 ------GPKI-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 ------~~~~-----------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...+ ...++..+.++|.+||..||++||++++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 11247789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=325.43 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=208.9
Q ss_pred eEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 625 eilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
++..+||+|+|-+||+|.+. |-.||=-.++... -....+.+.+|..|+.+|+.|+||||+++|++|.+.....+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d----~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD----VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH----hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 45678999999999999884 3344432222111 11234557889999999999999999999999988766789
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK--NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~--GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+|+|.+..|+|..|+++.+ .++.+.+..|++||++||.|||++ -|||||||-+||+|+ ...|.|||.|+|||+
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHH
Confidence 99999999999999998874 588899999999999999999999 599999999999997 477899999999999
Q ss_pred ccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCc
Q 002642 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH-SEEIIAGIIKGNLGPKIPSWCE 859 (897)
Q Consensus 781 ~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~-~~eil~~Ii~~~l~~~~p~~ls 859 (897)
......... ..|||.|||||++.. .|++.+||||||.+|+||+|+..||.... +.+++.++..+..+..+.+.-.
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred Hhhccccce-eccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 887776654 789999999999973 38999999999999999999999998754 5566666666665445555557
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 860 ~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+++++||.+||.. ..+||++.|||++
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 8999999999999 9999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=304.54 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=200.5
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++++. ++.||+|.+.... ........+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 468999999999999999999984 6679999875431 11223456778999999999999999998776542
Q ss_pred C----ceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 V----TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ~----~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
. ...++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEc
Confidence 1 3489999998 6799998875 3588999999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-- 852 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~-- 852 (897)
|||++...... .....++..|+|||.+.+.. .++.++||||||+++|+|++|+.||......+.+..+......+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99999755332 23456788999999986432 47889999999999999999999998776655544433321100
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ---------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ---------------------------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.....+++++.++|.+||..+|++|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0112358899999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.80 Aligned_cols=251 Identities=27% Similarity=0.358 Sum_probs=194.2
Q ss_pred CceEEEEecccCceEEEEeeec----CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec-
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD- 696 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k----g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e- 696 (897)
+|++.+.||+|+||.||+++.. ++.||+|.+.... ......+.+.+|+.+++++ +||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4889999999999999999985 4479999886421 1122345677899999999 59999999986432
Q ss_pred -CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 697 -GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 -~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
......++++||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 22356788999885 6898888653 4688999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc-----ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-
Q 002642 776 LGLSKIKQKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN- 849 (897)
Q Consensus 776 FGLAk~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~- 849 (897)
||+++...... ......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||........+..++...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997543211 12345689999999987642 237889999999999999999999998765443333222110
Q ss_pred ------------------------C-CCC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 850 ------------------------L-GPK---IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 ------------------------l-~~~---~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. ... .....+..+.+||.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000 112357899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=300.65 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=196.8
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|++.+.||+|+||.||++.. +++.||+|.++... ........+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 47899999999999999999986 46789999886431 11122456778999999999999999999876431
Q ss_pred ----CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
....+++++++ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEEe
Confidence 23477888876 78998887643 488899999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||++...... .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........+..+......
T Consensus 163 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ccccccccccc--ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99998754332 2345688999999998652 23788999999999999999999999876654443332221100
Q ss_pred ------------------CCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 ------------------PKI--------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ------------------~~~--------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+.. ....++++.++|.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 11357889999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=302.15 Aligned_cols=246 Identities=23% Similarity=0.377 Sum_probs=203.2
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCCceEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~~~l~L 704 (897)
+.||+|+|+.|--+.. ++..+|||++.+. ....+.++.+|++++.+.. |+||+++++||+++ ..+|+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEE
Confidence 5799999999987665 6889999999654 1223578889999999984 99999999999988 79999
Q ss_pred EEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc-
Q 002642 705 VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~- 783 (897)
|||.|.||+|..+|.++ +.+++.++..+..+|+.||.+||.+||.|||+||+|||....+ .-.-||||||.++....
T Consensus 154 VfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 99999999999999876 5689999999999999999999999999999999999997433 34458999999875321
Q ss_pred --c-----ccccCCcccCCcccCcccc---ccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------------h
Q 002642 784 --K-----TLISGGVRGTIPWMAPELF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH---------------S 838 (897)
Q Consensus 784 --~-----~~~~~~~~GT~~Y~APEvl---~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~---------------~ 838 (897)
+ .....+++|+..|||||++ .++..+|+.+.|.||||+|||-|+.|.+||.+.= .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1112357899999999985 4556679999999999999999999999997542 2
Q ss_pred HHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 839 EEIIAGIIKGNLGPKIPSW--CEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 839 ~eil~~Ii~~~l~~~~p~~--ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
..++..|..+.+..+-..| +|.+.+++|+.+|.+++.+|.++.+++.
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3466777777773333333 8999999999999999999999988877
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=322.35 Aligned_cols=252 Identities=31% Similarity=0.602 Sum_probs=213.8
Q ss_pred ccCCCceEEEEecccCceEEEEeeec---Cc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK---GS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k---g~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
|..++..+.++||+|.||.|++|.|+ |+ .||||.++..... .....|++|+.+|.+|+|||++++|++
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEeee
Confidence 44456677789999999999999995 33 4999999765221 157889999999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhh-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~-~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
+.+. .+.||||.++.|+|.+.|++ ....+-......++.||+.||.||.++++|||||..+|+|+. ....||
T Consensus 180 Vl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVK 252 (1039)
T KOG0199|consen 180 VLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVK 252 (1039)
T ss_pred eccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceee
Confidence 9874 67889999999999999987 444577777888999999999999999999999999999998 667899
Q ss_pred EEecCCccccccc----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 002642 773 IGDLGLSKIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 773 LiDFGLAk~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~ 847 (897)
|+||||.+..... .......-...|+|||.+.... ++.++|||++||++|||++ |..||.+.....+++.+-
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD- 329 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID- 329 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-
Confidence 9999999854222 2222333456799999998655 8999999999999999999 999999999999888876
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 848 ~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+.-+.+.|+.||+++.++++.||..+|++||++..|.+++
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 5556778899999999999999999999999999997544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=327.48 Aligned_cols=148 Identities=27% Similarity=0.473 Sum_probs=129.8
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|.++++||+|+||.||++++. ++.||||+++.... ........+..|+.++..++||||+++++++...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~- 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-----INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA- 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-----cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-
Confidence 468999999999999999999986 77899999865321 2234456788999999999999999999988876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..+++||||+.+++|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 77 -~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGl 150 (669)
T cd05610 77 -NNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGL 150 (669)
T ss_pred -CEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCC
Confidence 6899999999999999999764 3578888999999999999999999999999999999998 678899999998
Q ss_pred cc
Q 002642 779 SK 780 (897)
Q Consensus 779 Ak 780 (897)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=324.74 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=212.9
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC--
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP-- 698 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~-- 698 (897)
-|+.-+.||+|+||.||++++ +|+.||||.+++... .+..+...+|+++|++++|||||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 456668899999999999997 488899999976431 223566789999999999999999999877654
Q ss_pred --CceEEEEEeeeeccchHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 699 --VTNLATVTEYMVNGSLKQVLRRKD--RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 --~~~l~LVmEy~~GGsL~d~L~~~~--~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.....+|||||.||+|+.++++.+ ..+++.+.+.+..++..||.|||++||+||||||.||++-...++.-..||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 456789999999999999998753 4699999999999999999999999999999999999997555566778999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCC
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIAGIIKGNL 850 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~----~eil~~Ii~~~l 850 (897)
|||.|+..++...-..+.||..|++||++.. +.+|+..+|.|||||++|+.+||..||..... .++...++..+.
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999998888877778899999999999975 34589999999999999999999999965432 334444444322
Q ss_pred -------------------CCCCCCCCcHH----HHHHHHHhhccCCCCCC--CHHHHHHHHHHHHHH
Q 002642 851 -------------------GPKIPSWCEPT----WRSLMERCWSSDPKSRP--AFSEITKELRAMAAA 893 (897)
Q Consensus 851 -------------------~~~~p~~ls~e----l~dLI~kcL~~DPeeRP--Ta~ELLq~Le~l~~e 893 (897)
..++|..+++. +...+..+|..+|++|. .+.+...++.+++..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11234444433 44677888999999998 778888887777653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.85 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=196.1
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
..++|++++.||.|+||.||++.. +++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 356899999999999999999986 466799998864311 112345677899999999999999999988653
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
. ...++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+++|+||||||+||+++ .++.+||+|||
T Consensus 82 ~-~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg 153 (328)
T cd07856 82 L-EDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFG 153 (328)
T ss_pred C-CcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCccc
Confidence 2 5788999998 5689888864 3477888889999999999999999999999999999998 67889999999
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh----------
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK---------- 847 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~---------- 847 (897)
++....... ....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+..
T Consensus 154 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 154 LARIQDPQM--TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccccCCCc--CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987543322 234678899999987542 2378999999999999999999999987654322211110
Q ss_pred -------------c-CCCCCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 -------------G-NLGPKI-----PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 -------------~-~l~~~~-----p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
. ...... ...+++++.++|++||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000011 12467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.46 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=211.5
Q ss_pred ccccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEe
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFY 691 (897)
Q Consensus 615 ~~~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~ 691 (897)
..+.+...+|.+++.||+|+|.+|.+++++ .+.+|+|++++..+.. ++.+.....|-.+..+. +||.+|.++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-----dedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-----cccchhHHhhHHHHHhccCCCeEEehh
Confidence 446677899999999999999999999885 4569999998764432 33456667777777665 799999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeE
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~V 771 (897)
..|+++ ..+++|.||++||+|--+++++ +.++++.+..+..+|+.||.|||++|||+||+|.+|+|++ ..+++
T Consensus 318 scfqte--srlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghi 390 (593)
T KOG0695|consen 318 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHI 390 (593)
T ss_pred hhhccc--ceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCce
Confidence 999988 7899999999999999888765 5578888888889999999999999999999999999999 88999
Q ss_pred EEEecCCccc-cccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-------CCChHHHHH
Q 002642 772 KIGDLGLSKI-KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA-------DLHSEEIIA 843 (897)
Q Consensus 772 KLiDFGLAk~-~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~-------~~~~~eil~ 843 (897)
||+|+|.++. ..+...+++++|||.|.|||++.+.. |.+++|||+||++++||+.|+.||. ..+.++.+.
T Consensus 391 kltdygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eecccchhhcCCCCCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 9999999984 45666778999999999999999876 8999999999999999999999995 223445555
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 002642 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRP 878 (897)
Q Consensus 844 ~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRP 878 (897)
+++.+. ...+|..+|..+..+++..|.+||.+|.
T Consensus 469 qvilek-qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHhhh-cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 544433 2478888999999999999999999994
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=323.34 Aligned_cols=261 Identities=32% Similarity=0.549 Sum_probs=220.7
Q ss_pred cccccCCCceEEEEecccCceEEEEeeec---------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCC
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWK---------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHP 685 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~k---------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HP 685 (897)
.+++..+++++.+.||+|.||.|++|..+ ...||||.++... .+...+.+..|+++|+.+ +||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~-------~~~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA-------SSSEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc-------CcHHHHHHHHHHHHHHHhcCCc
Confidence 57777888888889999999999998753 2259999987542 124467888999999998 599
Q ss_pred ceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhcc---------------ccccHHHHHHHHHHHHHHHHHHHHCCce
Q 002642 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIV 750 (897)
Q Consensus 686 NIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~---------------~~lse~~~l~Ia~QLl~AL~yLHs~GIV 750 (897)
||+.+++++... ..+++|+||+..|+|.++++... ..++....+.++.||+.|++||+++.+|
T Consensus 363 niv~llG~~t~~--~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 363 NIVNLLGACTQD--GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred chhhheeeeccC--CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 999999999985 78999999999999999998765 3488889999999999999999999999
Q ss_pred eccCCCCCeEeccCCCCCCeEEEEecCCcccccccccc--CCccc--CCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 002642 751 HFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS--GGVRG--TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWEL 826 (897)
Q Consensus 751 HRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~--~~~~G--T~~Y~APEvl~g~~~~~s~ksDIWSLGvILyEL 826 (897)
||||..+|||++ .+..+||+|||+|+...+.... ..-.+ ...|||||.+.. ..|+.++||||+|++||||
T Consensus 441 HRDLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 441 HRDLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred chhhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHH
Confidence 999999999998 7789999999999843222111 11222 345999999986 4589999999999999999
Q ss_pred Hc-CCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 827 LT-GEEPYADLH-SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 827 Lt-Gk~PF~~~~-~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
++ |..||.+.. ..+. .+.+....+...|..+++++.++|+.||+.+|++||++.++.+.|...++
T Consensus 515 fsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred hhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99 999999976 4455 54777778899999999999999999999999999999999999999654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=282.77 Aligned_cols=223 Identities=22% Similarity=0.270 Sum_probs=179.1
Q ss_pred cCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEeeee
Q 002642 633 GTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMV 710 (897)
Q Consensus 633 G~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmEy~~ 710 (897)
|.|+.||++++ +++.+|+|.++... .+.+|...+....||||+++++++... ...++||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCC
Confidence 89999999988 46679999986531 122344445556799999999998876 68999999999
Q ss_pred ccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCC
Q 002642 711 NGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790 (897)
Q Consensus 711 GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~ 790 (897)
+++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++ .++.++|+|||.+....... ..
T Consensus 69 ~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhcccccc--cc
Confidence 99999998764 3588999999999999999999999999999999999998 67789999999876543321 23
Q ss_pred cccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 002642 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCW 870 (897)
Q Consensus 791 ~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL 870 (897)
..++..|+|||.+.... ++.++|+||+|+++|+|++|+.|+...... ........+|..+++.++++|.+||
T Consensus 142 ~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 44677899999986543 688999999999999999999887643221 1112223567788999999999999
Q ss_pred ccCCCCCCCH-----HHHHH
Q 002642 871 SSDPKSRPAF-----SEITK 885 (897)
Q Consensus 871 ~~DPeeRPTa-----~ELLq 885 (897)
+.||++||++ +++++
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred cCCHHHhcCCCccchHHHHc
Confidence 9999999985 55554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=298.52 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=209.3
Q ss_pred ccccccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceee
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVA 689 (897)
Q Consensus 613 ~~~~~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVk 689 (897)
....+++..++++-+..||.|+||+|++-.++ ++..|||+++... .+...++++.|.+...+- +.||||+
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVk 127 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVK 127 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHH
Confidence 34556777788888899999999999998885 6779999997542 133456677777766554 7999999
Q ss_pred EeeeeecCCCceEEEEEeeeeccchHHHHhh----ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccC
Q 002642 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRR----KDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 690 l~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~----~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~ 764 (897)
+|+....+ +..|+.||.|+ -+|..+... .+..+++...-.|+.-++.||.||.+. .||||||||+|||++
T Consensus 128 fyGa~F~E--GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-- 202 (361)
T KOG1006|consen 128 FYGALFSE--GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-- 202 (361)
T ss_pred HhhhhhcC--CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe--
Confidence 99976654 57899999994 566655432 345688988889999999999999975 899999999999999
Q ss_pred CCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 002642 765 DPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIA 843 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~-~eil~ 843 (897)
..+.+||||||++-...+........|...|||||.+......|+.++|+||||++|||+.||++||..-+. .+.+.
T Consensus 203 --r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 203 --RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred --cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 888999999999987766666666779999999999987665689999999999999999999999987654 34555
Q ss_pred HHHhcCCCCCC-CC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 844 GIIKGNLGPKI-PS---WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 844 ~Ii~~~l~~~~-p~---~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+++.+..+.-. +. ..+..+..+|..||.+|-..||.+.+|+++
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 55555542221 22 368899999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=310.73 Aligned_cols=244 Identities=28% Similarity=0.436 Sum_probs=206.0
Q ss_pred EEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEE
Q 002642 628 KELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LV 705 (897)
+.||+|.||+||-|++ +|+.||||++.+..+..+. ...+.+|+.+|++++||.||.+...|++. ...++|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq------esqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ------ESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch------HHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEE
Confidence 6799999999999887 5889999999776555432 14567899999999999999999989887 689999
Q ss_pred EeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccc
Q 002642 706 TEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785 (897)
Q Consensus 706 mEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~ 785 (897)
||.+.|.-|.-.+......+++.....+..||+.||.|||-++|+|+||||+|||+.+.+ ....+||||||.|+.....
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999976666666666667899999999999999999999999999999999999998553 6778999999999988777
Q ss_pred cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 002642 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--PKIPSWCEPTWR 863 (897)
Q Consensus 786 ~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--~~~p~~ls~el~ 863 (897)
......+|||.|+|||++.++. |+.+.|+||.|+|+|--++|-+||... +++..+|.+..+. +..-+.+++++.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHH
Confidence 7777889999999999999876 899999999999999999999999654 3455555555442 223345899999
Q ss_pred HHHHHhhccCCCCCCCHHHHH
Q 002642 864 SLMERCWSSDPKSRPAFSEIT 884 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ELL 884 (897)
+||..+|+..=.+|-+.+.-+
T Consensus 797 dlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhc
Confidence 999999999999997776544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=280.05 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=204.7
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVT 695 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~ 695 (897)
-..++|++++++|+|.|++||.|.. ++++++||++++. ..+.+.+|+++|+.|. ||||+++++...
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----------kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----------KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----------HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 3678999999999999999999985 6778999999864 2467889999999997 999999999999
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
+.......+|+||+++.+...+... ++...+..++.||+.||.|+|++||+|||+||.|++|+ +....++|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlID 176 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLID 176 (338)
T ss_pred CccccCchhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeee
Confidence 8877889999999999888877643 67778889999999999999999999999999999998 4677899999
Q ss_pred cCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHh-------
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD-LHSEEIIAGIIK------- 847 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~-~~~~eil~~Ii~------- 847 (897)
||+|.++.+.......+-+.+|--||.+..-+ .|+.+.|+|||||+|..|+..+.||.. .++.+.+..|.+
T Consensus 177 WGLAEFYHp~~eYnVRVASRyfKGPELLVdy~-~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 177 WGLAEFYHPGKEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred cchHhhcCCCceeeeeeehhhcCCchheeech-hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 99999887776665566788899999987643 588999999999999999999988753 333333222211
Q ss_pred --------cCCCCC--------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 --------GNLGPK--------------------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 --------~~l~~~--------------------~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
-.+.+. -....++++.+|+.++|..|..+|+|++|.+.+
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001111 112256999999999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=265.12 Aligned_cols=235 Identities=32% Similarity=0.500 Sum_probs=193.0
Q ss_pred CceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEeeeec
Q 002642 634 TFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVN 711 (897)
Q Consensus 634 ~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmEy~~G 711 (897)
+||.||+++.. ++.+|+|++...... ...+.+.+|++.+++++|+||+++++++... ...++++||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK-------KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCC
Confidence 58999999985 578999998654211 1156788999999999999999999998876 688999999999
Q ss_pred cchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCCc
Q 002642 712 GSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791 (897)
Q Consensus 712 GsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~ 791 (897)
++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|+||+++ .++.++|+|||.+............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999876433 78899999999999999999999999999999999998 6689999999999865544333456
Q ss_pred ccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHH
Q 002642 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD-LHSEEIIAGIIKGNLGPKIPSW--CEPTWRSLMER 868 (897)
Q Consensus 792 ~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~-~~~~eil~~Ii~~~l~~~~p~~--ls~el~dLI~k 868 (897)
.++..|+|||.+.... ++.++||||||+++++|++|..||.. .........+..... ...+.. ++.++.+++.+
T Consensus 147 ~~~~~~~~pE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 147 VGTPEYMAPEVLLGKG--YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP-PFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred cCCcCCCCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-CCccccccCCHHHHHHHHH
Confidence 6889999999987443 68899999999999999999999987 444444443333332 222222 88999999999
Q ss_pred hhccCCCCCCCHHHHHH
Q 002642 869 CWSSDPKSRPAFSEITK 885 (897)
Q Consensus 869 cL~~DPeeRPTa~ELLq 885 (897)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=309.61 Aligned_cols=257 Identities=34% Similarity=0.563 Sum_probs=218.1
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCc----cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~----~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~ 693 (897)
+....+..++||+|+||+||+|.+ +++ +||||++.... ......+++.|+.+|..+.|||+++++++
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-------~~~~s~e~LdeAl~masldHpnl~RLLgv 766 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-------SPKASIELLDEALRMASLDHPNLLRLLGV 766 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-------CchhhHHHHHHHHHHhcCCCchHHHHhhh
Confidence 344566678999999999999998 443 58999886432 12234678999999999999999999999
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEE
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKL 773 (897)
+..+ .+.||++|++.|.|.+|++.+...+-.+..+.|..||++||.|||++.+|||||..+|+||. +...+||
T Consensus 767 c~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvki 839 (1177)
T KOG1025|consen 767 CMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKI 839 (1177)
T ss_pred cccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEE
Confidence 9986 47889999999999999999888899999999999999999999999999999999999998 7779999
Q ss_pred EecCCcccccccc---ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 002642 774 GDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 774 iDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~ 849 (897)
+|||+++...... ....-.-.+.|||-|.+.... |+.++|||||||++||++| |..||.+...+++-.- +...
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-le~g 916 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-LEKG 916 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-Hhcc
Confidence 9999999653322 112233467899999987544 8999999999999999999 9999999887776554 4444
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
.+...|..++.++..+|.+||..|+..||+++++...+.+++++
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 45778889999999999999999999999999999999998865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=310.03 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=212.9
Q ss_pred cCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeec
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTD 696 (897)
Q Consensus 620 ~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e 696 (897)
..+.|++.+.||.|.+|+||+++. +++..|+|++..... . -.++..|.++|+.. .|||++.+|++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d------~---deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED------E---EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc------c---cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 456799999999999999998876 577899999865411 1 23556788899887 69999999998753
Q ss_pred ---CCCceEEEEEeeeeccchHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 697 ---GPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 697 ---~~~~~l~LVmEy~~GGsL~d~L~~~-~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
...+.+|+|||||.+|+.-|+++.. +..+.|..+.+|+++++.||.|||...++|||||-.|||++ .++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEE
Confidence 2356899999999999999998753 56789999999999999999999999999999999999999 889999
Q ss_pred EEecCCccccccc-cccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 002642 773 IGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 773 LiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~ 848 (897)
|+|||++...+.. ....+.+|||.|||||++... ...|+.++|+||||++..||.-|.+|+.++.+...+..|...
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 9999998766543 345678899999999998643 234778999999999999999999999999998877766554
Q ss_pred CCCC-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 849 NLGP-KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 849 ~l~~-~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+. ..|..++.++.++|..||.+|.++||+..+++++
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 3221 2366789999999999999999999999998864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=297.51 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=213.5
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
...++|-++.+||+|+|+.||++-+ ..+.||+|+-.... .+.+..++...+...+|.++-+.|.||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK-~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK-NWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc-chhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3457899999999999999999876 45579999865442 23344556778888999999999999999999999987
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK--NIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~--GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
+. ..++.|+||++|.+|.-||+.+ +.++++++..|+.||+.||.||.+. .|||-||||.|||+. .+..-+.+||+
T Consensus 539 Dt-dsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKIT 615 (775)
T KOG1151|consen 539 DT-DSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKIT 615 (775)
T ss_pred cc-ccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEee
Confidence 64 6789999999999999999875 6799999999999999999999987 699999999999996 44577899999
Q ss_pred ecCCcccccccc--------ccCCcccCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002642 775 DLGLSKIKQKTL--------ISGGVRGTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844 (897)
Q Consensus 775 DFGLAk~~~~~~--------~~~~~~GT~~Y~APEvl~g~--~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~ 844 (897)
|||+++.+++.. .++...||.+|++||.+.-. +..++.|+||||+|||+|..+.|+.||........+.+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999999765443 34567899999999987532 33478899999999999999999999987655433221
Q ss_pred ---HHh-cCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 845 ---IIK-GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 845 ---Ii~-~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
|++ ....++....++.++++||++||++--+.|.+..+|..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 122 12222333468899999999999999999998888754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=266.34 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=205.2
Q ss_pred CceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
+|...++||+|.||+||+++.. .+.||+|.++....+ +-.....++|+.+|+.++|.|||++++....+ +
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd------egvpssalreicllkelkhknivrl~dvlhsd--k 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSD--K 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC------CCCcHHHHHHHHHHHHhhhcceeehhhhhccC--c
Confidence 4566688999999999999874 557999999765322 22346678999999999999999999998876 6
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
.+-+|+||+ ..+|..++...+..++.+.+..++.|+++||.++|+++++|||+||.|+||+ .++.+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 899999999 5689999988888899999999999999999999999999999999999998 88999999999998
Q ss_pred ccccc-cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC------
Q 002642 781 IKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP------ 852 (897)
Q Consensus 781 ~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~------ 852 (897)
...-+ .-.+.-+-|..|.+|.++.+. ..|+++.|+||.|||+.|+.. |++.|++.+..+.+..|...--.+
T Consensus 150 afgipvrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 54322 233344679999999999875 468999999999999999998 888899888777766664421111
Q ss_pred ------------CCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 853 ------------KIP---------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ------------~~p---------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+| ..++..-+++++++|.-+|.+|.++++.+++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 1234556899999999999999999988764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=327.82 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=184.6
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCc
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~ 700 (897)
.+...+.||+|+||.||+|+. .+..||||.++.... ....|++++++++|||||++++++.+. .
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~ 756 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSE--K 756 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcC--C
Confidence 456678899999999999986 467899998854210 112357889999999999999999876 5
Q ss_pred eEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH---EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 701 ~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLH---s~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
..++||||+++++|.++++. +++..+..|+.|++.||+||| +.+|+||||||+||+++ .....++. |+
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~ 827 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LS 827 (968)
T ss_pred CCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ec
Confidence 78999999999999999963 788899999999999999999 66999999999999998 44555554 66
Q ss_pred CccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHH-----h
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-----EEIIAGII-----K 847 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~-----~eil~~Ii-----~ 847 (897)
........ ....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+...... .
T Consensus 828 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 828 LPGLLCTD---TKCFISSAYVAPETRETKD--ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred cccccccC---CCccccccccCcccccCCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 55432211 1236889999999987644 89999999999999999999999854321 11111000 0
Q ss_pred cCCCCCC------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 848 GNLGPKI------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 848 ~~l~~~~------p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
....+.. +.....++.+++.+||+.||++||+++|+++.|+++.+
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0011111 11122457789999999999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.72 Aligned_cols=255 Identities=32% Similarity=0.582 Sum_probs=204.3
Q ss_pred CCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh--CCCCceeeEeeeee--c
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ--IHHPNVVAFYGVVT--D 696 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~--L~HPNIVkl~g~~~--e 696 (897)
.....+.+.||+|.||+||+|+|.|+.||||++... + ...+.+|.++.+. |+|+||+.|++.-. .
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-------d----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-------D----ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc-------c----hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 456788999999999999999999999999999643 1 2445677777765 59999999987643 3
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEeccCCCCC
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK--------NIVHFDLKSHNFLVNMRDPQR 768 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~--------GIVHRDIKPeNILLd~~~~~~ 768 (897)
+....+|+|++|.+.|+|+|||.+ ..++-...++++..++.||+|||-. .|.|||||..||||. .+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cC
Confidence 445689999999999999999987 4588889999999999999999963 499999999999998 88
Q ss_pred CeEEEEecCCccccccc-----cccCCcccCCcccCccccccCCC---CCC-chhhHHHHHHHHHHHHcC----------
Q 002642 769 PVCKIGDLGLSKIKQKT-----LISGGVRGTIPWMAPELFKSKDN---LVT-EKVDVYSFGVVMWELLTG---------- 829 (897)
Q Consensus 769 g~VKLiDFGLAk~~~~~-----~~~~~~~GT~~Y~APEvl~g~~~---~~s-~ksDIWSLGvILyELLtG---------- 829 (897)
+.+.|+|+|||...... ......+||.+|||||++.+.-+ +-+ ..+||||||+++||+.-.
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999744322 12345679999999999975321 111 358999999999999862
Q ss_pred CCCCCCCC-----hHHHHHHHHhcCCCCCCCCCCc-----HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 830 EEPYADLH-----SEEIIAGIIKGNLGPKIPSWCE-----PTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 830 k~PF~~~~-----~~eil~~Ii~~~l~~~~p~~ls-----~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
++||.+.. -+++..-+..++++|.+|..+. ..+.++|+.||..||..|.|+-.+.+.|.++.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 57886542 3455555566777888886543 346688999999999999999999999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=298.15 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred ccccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
..+..+-|..++.||-|+||+|.+++.. ...||+|.+++. +......+.....|-.||.....+-||+||..|
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa-----DVl~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA-----DVLMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHH-----HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 3456778999999999999999998763 345999998765 334455677888999999999999999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
++. ..+|+||||++||++-.+|-+.+ -+++..+..++.+|..|+++.|.+|+|||||||+||||| .+++|||+
T Consensus 699 QDk--dnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKLT 771 (1034)
T KOG0608|consen 699 QDK--DNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLT 771 (1034)
T ss_pred ccC--CceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceeee
Confidence 988 79999999999999999887764 477777778888999999999999999999999999999 88999999
Q ss_pred ecCCcccc---------ccc----------------------------------cccCCcccCCcccCccccccCCCCCC
Q 002642 775 DLGLSKIK---------QKT----------------------------------LISGGVRGTIPWMAPELFKSKDNLVT 811 (897)
Q Consensus 775 DFGLAk~~---------~~~----------------------------------~~~~~~~GT~~Y~APEvl~g~~~~~s 811 (897)
||||+.-. ... ......+||+.|+|||++.... |+
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~~ 849 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--YT 849 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--cc
Confidence 99998511 000 0011346999999999998655 78
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 002642 812 EKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK--GNLGPKIPSWCEPTWRSLMERCWSSDPKSRP 878 (897)
Q Consensus 812 ~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~--~~l~~~~p~~ls~el~dLI~kcL~~DPeeRP 878 (897)
...||||.|||||||+.|++||....+-+....++. ..+....-..++.+..+||.++. .+++.|.
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999999999999998877665544433 22223334568999999998755 3466664
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=280.51 Aligned_cols=258 Identities=27% Similarity=0.379 Sum_probs=200.9
Q ss_pred CCCceEEEEecccCceEEEEeeec------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVV 694 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~ 694 (897)
...|+.+..||+|+||.||++..+ ...+|||.++.... ..-......+|+.+++.++|||++.+..+|
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence 457999999999999999999653 22589998865422 112335567899999999999999999988
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCe
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRK----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~----~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~ 770 (897)
... ....++++||.+. +|++.|+-+ .+.++...+..|+.||+.|+.|||+.=|+||||||.|||+.-++++.+.
T Consensus 97 l~~-d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 97 LSH-DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred hcc-CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence 774 2789999999964 888888532 3568888999999999999999999999999999999999877788899
Q ss_pred EEEEecCCccccccccc----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------
Q 002642 771 CKIGDLGLSKIKQKTLI----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE------- 839 (897)
Q Consensus 771 VKLiDFGLAk~~~~~~~----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~------- 839 (897)
|||+|||+++....... ....+-|..|.|||.+.+. ..|+.+.|||++|||+.||++-++-|.+...+
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999997655432 2356789999999999985 46899999999999999999988888654321
Q ss_pred --HHHHHHHhcCCCC---------CCCCC--------------------------CcHHHHHHHHHhhccCCCCCCCHHH
Q 002642 840 --EIIAGIIKGNLGP---------KIPSW--------------------------CEPTWRSLMERCWSSDPKSRPAFSE 882 (897)
Q Consensus 840 --eil~~Ii~~~l~~---------~~p~~--------------------------ls~el~dLI~kcL~~DPeeRPTa~E 882 (897)
+.+..|..---.| ++|.+ -++...+|+.++|+.||.+|.|+++
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 1222221100000 01111 1345779999999999999999999
Q ss_pred HHHHH
Q 002642 883 ITKEL 887 (897)
Q Consensus 883 LLq~L 887 (897)
.+++.
T Consensus 334 Aleh~ 338 (438)
T KOG0666|consen 334 ALEHP 338 (438)
T ss_pred Hhccc
Confidence 88763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=286.17 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=205.6
Q ss_pred CCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhh--CCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ--IHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~--L~HPNIVkl~g~~~e~~ 698 (897)
....++.+.||+|.||.||+|..+++.||||++... ..+.|.+|-++... ++|+||++|++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 456677889999999999999999999999998532 24567777777665 57999999998765432
Q ss_pred --CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCeEeccCCCC
Q 002642 699 --VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK---------NIVHFDLKSHNFLVNMRDPQ 767 (897)
Q Consensus 699 --~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~---------GIVHRDIKPeNILLd~~~~~ 767 (897)
...+++|+||.+.|+|.+||..+ .++|.....|+..+++||+|||+. .|+|||||.+||||. +
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~ 351 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----N 351 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----c
Confidence 35799999999999999999874 589999999999999999999973 599999999999998 8
Q ss_pred CCeEEEEecCCcccccccc---ccCCcccCCcccCccccccCCCCC----CchhhHHHHHHHHHHHHcCCC---------
Q 002642 768 RPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLV----TEKVDVYSFGVVMWELLTGEE--------- 831 (897)
Q Consensus 768 ~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~----s~ksDIWSLGvILyELLtGk~--------- 831 (897)
+.++.|+|||+|..+.... .....+||.+|||||++.+.-+.- -.+.||||+|.+||||+++..
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 8999999999998654332 223468999999999997643322 146899999999999998533
Q ss_pred ---CCC-----CCChHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 832 ---PYA-----DLHSEEIIAGIIKGNLGPKIPSWC-----EPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 832 ---PF~-----~~~~~eil~~Ii~~~l~~~~p~~l-----s~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
||. ...-+++...++..+.+|.+|..+ ..-+++.|+.||..||+.|.|+.=+-+.+.++..
T Consensus 432 Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 432 YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 332 223346667777888888888643 3568899999999999999999988888877653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=298.44 Aligned_cols=251 Identities=17% Similarity=0.200 Sum_probs=167.4
Q ss_pred ccCCCceEEEEecccCceEEEEeeec------CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k------g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g 692 (897)
...++|++.++||+|+||.||++++. +..||+|.+.... ..+. ...| .+....+.++..+..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHHH
Confidence 45679999999999999999999884 4579999875321 0010 1111 111222222222222
Q ss_pred ee----ecCCCceEEEEEeeeeccchHHHHhhcccc-------------------ccHHHHHHHHHHHHHHHHHHHHCCc
Q 002642 693 VV----TDGPVTNLATVTEYMVNGSLKQVLRRKDRT-------------------IDRRKRIIIAMDAAFGIEYLHEKNI 749 (897)
Q Consensus 693 ~~----~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~-------------------lse~~~l~Ia~QLl~AL~yLHs~GI 749 (897)
.+ .......+++||||+.+++|.+++...... ..+..+..++.||+.||+|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 11 112236789999999999999998653211 1233456789999999999999999
Q ss_pred eeccCCCCCeEeccCCCCCCeEEEEecCCcccccc--ccccCCcccCCcccCccccccCCC-------------------
Q 002642 750 VHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK--TLISGGVRGTIPWMAPELFKSKDN------------------- 808 (897)
Q Consensus 750 VHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~--~~~~~~~~GT~~Y~APEvl~g~~~------------------- 808 (897)
+||||||+|||++ ...+.+||+|||+++.... ......+.+|+.|+|||.+.....
T Consensus 277 iHRDLKP~NILl~---~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 277 VHRDVKPQNIIFS---EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred EeCcCCHHHEEEe---CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 9999999999997 2356899999999975432 223345678999999997642211
Q ss_pred -CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-C---------CCCCC----------CCCCcHHHHHHHH
Q 002642 809 -LVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG-N---------LGPKI----------PSWCEPTWRSLME 867 (897)
Q Consensus 809 -~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~-~---------l~~~~----------p~~ls~el~dLI~ 867 (897)
.++.++|||||||+||||+++..|+... ...+..++.. . ..+.. .........+||.
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 1345679999999999999977665432 1111111111 0 00000 0112234558999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 002642 868 RCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 868 kcL~~DPeeRPTa~ELLq~ 886 (897)
+||++||++|||++|++++
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=288.57 Aligned_cols=264 Identities=19% Similarity=0.166 Sum_probs=183.4
Q ss_pred ccCCCceEEEEecccCceEEEEeee------------------cCccEEEEEecCCcccC-CChhH-----HHHHHHHHH
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW------------------KGSDVAIKRIKPSCFAE-GSLEE-----DRLIADFWR 674 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~------------------kg~~VAVK~ik~~~~~~-~~~~~-----~~~~~~fl~ 674 (897)
...++|++.++||+|+||.||+|.. +++.||||.++...... ..... .........
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4578999999999999999999863 23469999986431100 00000 001123445
Q ss_pred HHHHHhhCCCCce-----eeEeeeeecC------CCceEEEEEeeeeccchHHHHhhcc---------------------
Q 002642 675 EAHMLGQIHHPNV-----VAFYGVVTDG------PVTNLATVTEYMVNGSLKQVLRRKD--------------------- 722 (897)
Q Consensus 675 Ei~iL~~L~HPNI-----Vkl~g~~~e~------~~~~l~LVmEy~~GGsL~d~L~~~~--------------------- 722 (897)
|+.++.+++|.++ +++++++... .....++||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888876654 5666665431 1246799999999999999886421
Q ss_pred --ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccC--CcccCCccc
Q 002642 723 --RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG--GVRGTIPWM 798 (897)
Q Consensus 723 --~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~--~~~GT~~Y~ 798 (897)
..+++..+..++.|++.+|.|||+++|+||||||+|||++ .++.+||+|||++.......... ...+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 1235567888999999999999999999999999999998 66789999999997543322211 223478999
Q ss_pred CccccccCCC--------------------CCCchhhHHHHHHHHHHHHcCCC-CCCCCChHHH-----------HHHHH
Q 002642 799 APELFKSKDN--------------------LVTEKVDVYSFGVVMWELLTGEE-PYADLHSEEI-----------IAGII 846 (897)
Q Consensus 799 APEvl~g~~~--------------------~~s~ksDIWSLGvILyELLtGk~-PF~~~~~~ei-----------l~~Ii 846 (897)
|||.+..... ....+.||||+||++|+|+++.. ||........ .....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 9999753221 01234799999999999999875 7754321111 11112
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 002642 847 KGNLGPKIPSWCEPTWRSLMERCWSSDP---KSRPAFSEITKE 886 (897)
Q Consensus 847 ~~~l~~~~p~~ls~el~dLI~kcL~~DP---eeRPTa~ELLq~ 886 (897)
...+........++..++||.+||.++| .+|+|++|+|+|
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 2233233345578999999999999876 689999999976
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=294.87 Aligned_cols=137 Identities=17% Similarity=0.122 Sum_probs=118.6
Q ss_pred hccccccccccceeccccccCC-cceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceec
Q 002642 410 YGLSNLVESHLACHSTCNVAGD-QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHr 488 (897)
-.||+++|||||.|+|||.+++ +++||||||++|++..|++.....+|+|..|++|++++|+||+|||.-+ .++||||
T Consensus 123 ~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHr 201 (361)
T KOG1187|consen 123 EILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHR 201 (361)
T ss_pred HHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecC
Confidence 4799999999999999999999 5999999999999999999985548999999999999999999999544 5579999
Q ss_pred CCCCCCcccCCCCCeeEcc--cCCC-CC-CCCc-cc-cccceeeccc-cccCCccccccccccccCC
Q 002642 489 ELENEKLLIDSEESANISG--LSNN-MN-YRNG-TA-SGCNMKNGTK-NLQGGVASSMDLLYNLSLS 548 (897)
Q Consensus 489 DIK~SNILLD~~~~aKIsD--Lar~-~~-~~~~-~~-~gt~~v~gt~-~~~g~~t~ksD~VySf~~s 548 (897)
||||+|||||++|+|||+| ||+. .. ..+. ++ .||+++..++ ..+|.+|+|+| ||||||-
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsD-VySFGVv 267 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSD-VYSFGVV 267 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccc-cccchHH
Confidence 9999999999999999999 9982 22 3232 22 5677766666 67799999999 9999983
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=272.57 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=196.6
Q ss_pred CCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC-
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG- 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~- 697 (897)
.+.|+...+||+|.||+||+++.+ ++.||+|++.... +++-+....++|+++|..++|+|++.++..+...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 456778889999999999999874 5678888763211 1112233457899999999999999998876532
Q ss_pred -----CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 698 -----PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 698 -----~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
....+|+||++++. +|.-++......++...+.+++.++..||.|+|+..|+|||+||+|+||+ .++.+|
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEE
Confidence 23459999999964 89999987767799999999999999999999999999999999999998 889999
Q ss_pred EEecCCccccccccc-----cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 002642 773 IGDLGLSKIKQKTLI-----SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 773 LiDFGLAk~~~~~~~-----~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~ 847 (897)
|+|||+++....... ....+-|.+|.+||.+.+.. -|+++.|||..|||+.||+++.+-+.+......+..|..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 999999974322211 12234699999999998854 489999999999999999999998888766554433211
Q ss_pred --cCCC------------------CCCCC-------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 --GNLG------------------PKIPS-------------WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 --~~l~------------------~~~p~-------------~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
+... ++.|. .-.++..+|++++|..||.+|+++.+.+.+
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111 00111 123577899999999999999999998865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=278.64 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=199.4
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCC--C----ceee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH--P----NVVA 689 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~H--P----NIVk 689 (897)
.....+|+++..+|+|.||.|-...+. +..||||+++.. ........-|+++|+++.+ | -+++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 344789999999999999999988763 567999998743 3345566779999999942 2 3778
Q ss_pred EeeeeecCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccC----
Q 002642 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR---- 764 (897)
Q Consensus 690 l~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~---- 764 (897)
+.+||.-. ++.++|+|.+ |.++++++..++ .+++...+..|+.||++++++||+.+++|-||||+|||+...
T Consensus 156 m~~wFdyr--ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 156 MRDWFDYR--GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred eehhhhcc--CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 88888876 7999999988 779999998753 468889999999999999999999999999999999998621
Q ss_pred ------------CCCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 002642 765 ------------DPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP 832 (897)
Q Consensus 765 ------------~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~P 832 (897)
......|+|+|||.|+...... ...+.|.-|.|||++.+-+ ++.+.||||+||||+|+.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC--cCCccCceeeeeEEEEeecccee
Confidence 1124579999999998655443 4567899999999999877 89999999999999999999999
Q ss_pred CCCCChHHH---HHHHHhcCCCC----------------------------------CCC--------CCCcHHHHHHHH
Q 002642 833 YADLHSEEI---IAGIIKGNLGP----------------------------------KIP--------SWCEPTWRSLME 867 (897)
Q Consensus 833 F~~~~~~ei---l~~Ii~~~l~~----------------------------------~~p--------~~ls~el~dLI~ 867 (897)
|+..++.|. .+.++. .++. ..| ...-.++.+||+
T Consensus 309 FqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 988776653 333221 1100 000 001235779999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 002642 868 RCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 868 kcL~~DPeeRPTa~ELLq~ 886 (897)
+||..||.+|+|+.|++++
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=268.52 Aligned_cols=262 Identities=24% Similarity=0.448 Sum_probs=218.1
Q ss_pred ccCCCceEEEEecccCceEEEEeeecC-------ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg-------~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~ 691 (897)
+...++++...+-+|.||.||.|++.. +.|-+|.++.. ..+..+..++.|.-++..+.|||+..+.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 345567778889999999999997642 24677776543 2345678899999999999999999999
Q ss_pred eeeecCCCceEEEEEeeeeccchHHHHhhc-------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccC
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRK-------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 692 g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~-------~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~ 764 (897)
++..++ ....+.++.++.-|+|..++... .+.++..+...++.|++.|++|||++||||.||..+|.+|+
T Consensus 354 ~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-- 430 (563)
T KOG1024|consen 354 GVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-- 430 (563)
T ss_pred EEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh--
Confidence 987765 35777889999889999999732 34577778889999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCccccccccc--c-CCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 002642 765 DPQRPVCKIGDLGLSKIKQKTLI--S-GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840 (897)
Q Consensus 765 ~~~~g~VKLiDFGLAk~~~~~~~--~-~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~e 840 (897)
+...+||+|=.+++...+... . ..---...||+||.+.... |+..+|+||||++||||+| |+.||...++.|
T Consensus 431 --d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 431 --DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred --hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 778999999999985432211 1 1112357899999998654 8999999999999999999 999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002642 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895 (897)
Q Consensus 841 il~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg 895 (897)
+... ++..++...|..||+++..+|--||..+|++||+++|+...|.+....++
T Consensus 507 m~~y-lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 507 MEHY-LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHH-HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 8775 45566788899999999999999999999999999999999999887764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=252.66 Aligned_cols=224 Identities=27% Similarity=0.417 Sum_probs=180.1
Q ss_pred ccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGV 693 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~ 693 (897)
.++..+++.-+..||+|++|.|-+-++ .|+..|+|.++.... .+..++.++|+.+..+. .+|.+|.+|+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 355667778889999999999877666 688899999975421 23356777888887665 69999999997
Q ss_pred eecCCCceEEEEEeeeeccchHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeccCCCCCC
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRP 769 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~~GGsL~d~L~~---~~~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd~~~~~~g 769 (897)
+..+ ...++.||.|. -+|..+.++ .+..+++..+-+|+..++.||.|||++ .+||||+||+|||++ ..+
T Consensus 114 ~~re--gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~G 186 (282)
T KOG0984|consen 114 LFRE--GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDG 186 (282)
T ss_pred hhcc--ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCC
Confidence 7665 68999999984 477766543 467799999999999999999999987 899999999999999 889
Q ss_pred eEEEEecCCccccccccccCCcccCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHH
Q 002642 770 VCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADL-HSEEIIAGII 846 (897)
Q Consensus 770 ~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~--~~~~s~ksDIWSLGvILyELLtGk~PF~~~-~~~eil~~Ii 846 (897)
.+|+||||++-...+....+-..|...|||||.+... +..|+.|+||||||+++.||.+++.||..- ++.+.+.+++
T Consensus 187 qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 9999999999877666555556789999999998642 224889999999999999999999999864 5566666665
Q ss_pred hcCCCCCCC
Q 002642 847 KGNLGPKIP 855 (897)
Q Consensus 847 ~~~l~~~~p 855 (897)
.+. .|.+|
T Consensus 267 eep-~P~Lp 274 (282)
T KOG0984|consen 267 EEP-SPQLP 274 (282)
T ss_pred cCC-CCCCc
Confidence 543 34444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=234.07 Aligned_cols=211 Identities=37% Similarity=0.658 Sum_probs=180.5
Q ss_pred ecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 630 LGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 630 LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
||+|.+|.||+++.. ++.+++|++....... ....+.+|++.++.+.|++|+++++++... ...+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEe
Confidence 689999999999986 7889999987542110 346788999999999999999999999876 68899999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCC-CCeEEEEecCCcccccccc
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ-RPVCKIGDLGLSKIKQKTL 786 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~-~g~VKLiDFGLAk~~~~~~ 786 (897)
|+.+++|.+++......+++..+..++.+++.+|++||+.|++|+||+|.||+++ . ...++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999976544688899999999999999999999999999999999998 4 6789999999997554332
Q ss_pred -ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 002642 787 -ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSL 865 (897)
Q Consensus 787 -~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dL 865 (897)
......+...|++||.+... ...+.++|+|++|+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12235578899999998754 2478899999999999999 688999
Q ss_pred HHHhhccCCCCCCCHHHHHHHH
Q 002642 866 MERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 866 I~kcL~~DPeeRPTa~ELLq~L 887 (897)
+.+|+..+|++||++.++++++
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=286.52 Aligned_cols=461 Identities=18% Similarity=0.229 Sum_probs=286.3
Q ss_pred ccchhccccccccccceeccccccCCcceeEeecccCCceeeee-ecccccccccchhhhHHHHHhhhhhhccCCCCCCC
Q 002642 406 TISQYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRV-MNTKDDMLTGSKLERHEVQCQALYENFHGMPITCK 484 (897)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~ 484 (897)
+--|-.+++ |+|++.+++.-...+..++..+|.+.+.++... +.-..++..=.+--- -.|...+|.|+|- ..-
T Consensus 71 ~~~~~~~s~--h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~-~~ql~s~l~~~H~---~~~ 144 (601)
T KOG0590|consen 71 TDIQKKLSK--HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRY-LPQLNSGLSYLHP---ENG 144 (601)
T ss_pred ccccccccc--cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhh-hhhhccCccccCc---ccc
Confidence 334555565 999999999999999999999998888888877 433224433332211 2378899999993 445
Q ss_pred ceecCCCCCCcccCCCC-CeeEcc--cCCC-C--CCCCc---cccc-cceeeccccccC--CccccccccccccCCCCCC
Q 002642 485 PIHPELENEKLLIDSEE-SANISG--LSNN-M--NYRNG---TASG-CNMKNGTKNLQG--GVASSMDLLYNLSLSSSKE 552 (897)
Q Consensus 485 IIHrDIK~SNILLD~~~-~aKIsD--Lar~-~--~~~~~---~~~g-t~~v~gt~~~~g--~~t~ksD~VySf~~ss~~~ 552 (897)
+.||||||+|.|||... ..|++| +|.. . +.... ...| +..+...+...+ ..-+..| +++.|+.....
T Consensus 145 ~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d-~~S~g~~l~~~ 223 (601)
T KOG0590|consen 145 VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVD-VWSLGIVLSAM 223 (601)
T ss_pred cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcc-ccccccccccc
Confidence 99999999999999999 999999 6661 1 11111 1111 111222222233 2345567 99999887543
Q ss_pred CCChhhhh----hhhhhcccccccccc---cCCChhh-------hhhhcccccccccccccccccc-----cccccc---
Q 002642 553 IEPPQISA----LQNAATERNDEHKEE---IHLDPLE-------EKVETKKTCECSKVIGEISSRS-----AAYFTN--- 610 (897)
Q Consensus 553 i~~~~i~~----l~naa~~~~~e~~ee---~~~~~~e-------ekv~~~~~~~~s~~i~~iss~s-----~~~~~~--- 610 (897)
........ ........ .+.... ..+.... .+...... .....+.++.... ...+..
T Consensus 224 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~-~~r~s~~~~~~d~~~~~~~~~~~~~n~ 301 (601)
T KOG0590|consen 224 LTGELPWDFPSRKDGRYSSW-KSNKGRFTQLPWNSISDQAHDLLHKILKENP-SNRLSIEELKLDNWLSSKRNGFSKSNP 301 (601)
T ss_pred ccCCCCccccccccccceee-cccccccccCccccCChhhhhcccccccCCc-hhccccccccccccccccccccccccc
Confidence 33222111 11100000 000000 0000000 00000000 0000000000000 000000
Q ss_pred cccccc----ccccCCCc-eEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC
Q 002642 611 TANTEL----QTIKTSDL-EYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683 (897)
Q Consensus 611 ~~~~~~----~~i~~~~Y-eilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~ 683 (897)
...... .....+.| .....+|.|++|.|+.... ..+..+.|.++.. .. ...........+..|..+-..++
T Consensus 302 ~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~ 379 (601)
T KOG0590|consen 302 CADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLS 379 (601)
T ss_pred cccccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeeccccc
Confidence 000000 00011223 4568899999998877654 2333444444321 10 11222233333888999999999
Q ss_pred CCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecc
Q 002642 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNM 763 (897)
Q Consensus 684 HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~ 763 (897)
|||++.....+.+. ....-+|||++. +|+..+... ..++...+-.++.||+.|++|||++||.|||+||+|+++.
T Consensus 380 h~~~~e~l~~~~~~--~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~- 454 (601)
T KOG0590|consen 380 HPNIIETLDIVQEI--DGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT- 454 (601)
T ss_pred CCchhhhHHHHhhc--ccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-
Confidence 99999888777665 233345999999 999999764 3577788888999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCccccccc-----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 002642 764 RDPQRPVCKIGDLGLSKIKQKT-----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS 838 (897)
Q Consensus 764 ~~~~~g~VKLiDFGLAk~~~~~-----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~ 838 (897)
..+.+||+|||.+...... ......+|+..|+|||.+.+.. +-....||||.|++++.|++|+.||.....
T Consensus 455 ---~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 455 ---ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred ---cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCccccccc
Confidence 7789999999998754322 3445788999999999998754 445679999999999999999999976654
Q ss_pred HHHH--HHHHhcCCC-----CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 839 EEII--AGIIKGNLG-----PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 839 ~eil--~~Ii~~~l~-----~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.+.. ......... ..+-..++.+.+.+|.+||+.||.+|.|+++|++.
T Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 531 SDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 4332 111111100 11223478889999999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=280.55 Aligned_cols=208 Identities=24% Similarity=0.382 Sum_probs=174.5
Q ss_pred ccCCCceEEEEecccCceEEEEeeecCc--cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC---CCceeeEeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH---HPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~kg~--~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~---HPNIVkl~g~ 693 (897)
-+..+|..++.+|.|+||.|++++++.+ .|+||.+++...-...=.+++.+-.+-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 4567899999999999999999999644 6999998765332211122333444557999999998 9999999999
Q ss_pred eecCCCceEEEEEeee-eccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEE
Q 002642 694 VTDGPVTNLATVTEYM-VNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 694 ~~e~~~~~l~LVmEy~-~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VK 772 (897)
|+++ .++|++||-- +|-+|+++|... ..+++.++..|+.|++.|+++||++||||||||-+|+.++ .++.+|
T Consensus 638 FEdd--d~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~k 710 (772)
T KOG1152|consen 638 FEDD--DYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVK 710 (772)
T ss_pred eecC--CeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEE
Confidence 9988 7999999975 345999999865 5699999999999999999999999999999999999999 899999
Q ss_pred EEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~ 835 (897)
|+|||.+....... ...++||..|.|||++.+. .|.+..-|||+||++||.++....||.+
T Consensus 711 lidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCC-cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999987554432 3468999999999999875 4678899999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=273.92 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=205.9
Q ss_pred cccccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC------CCce
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH------HPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~------HPNI 687 (897)
+.++...+|++....|+|-|++|..+.+ .++.||||+++.. +.+.+.-+.|+++|++|+ --++
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---------E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---------EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---------hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 4567778999999999999999999987 4778999999754 334566678999999996 2568
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhccc--cccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR--TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~--~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~ 765 (897)
++++..|... ++++||+|-+ ..+|.+++++.++ .+....+..++.||+.||.+|...||+|.||||+||||+
T Consensus 497 lrl~r~F~hk--nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--- 570 (752)
T KOG0670|consen 497 LRLFRHFKHK--NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--- 570 (752)
T ss_pred HHHHHHhhhc--ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---
Confidence 8888888877 7999999987 5699999988654 467788899999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 002642 766 PQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~I 845 (897)
.....+||||||.|........+ .+.-+..|.|||++.+.+ |+...|+||+||+||||.||+..|++.++..++.-.
T Consensus 571 E~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred cCcceeeeccCcccccccccccc-HHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 36778999999999876665544 344567799999999876 888999999999999999999999998887765432
Q ss_pred H--hcCCCCC-----------------------------------------------------CCCC---CcHHHHHHHH
Q 002642 846 I--KGNLGPK-----------------------------------------------------IPSW---CEPTWRSLME 867 (897)
Q Consensus 846 i--~~~l~~~-----------------------------------------------------~p~~---ls~el~dLI~ 867 (897)
+ ++.++-+ +|.. .-..+++|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 1 1111000 0100 1246789999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 002642 868 RCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 868 kcL~~DPeeRPTa~ELLq~ 886 (897)
+||..||++|.|..|.|++
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999998875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=285.16 Aligned_cols=242 Identities=31% Similarity=0.473 Sum_probs=187.3
Q ss_pred EEEecccCceE-EEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeeeecCCCceEEE
Q 002642 627 IKELGSGTFGT-VFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 627 lk~LGkG~fG~-Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~~e~~~~~l~L 704 (897)
.+.+|.|+.|+ ||+|...++.||||++-.. ......+|+..|+.- .|||||++|+.-.+. ..+||
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----------FFDFAQREIQLLQESDEHPNVIRYYCSEQDR--QFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----------hHHHHHHHHHHHHhccCCCceEEEEeeccCC--ceEEE
Confidence 35689999985 7899999999999987432 234567899999988 599999998877766 78999
Q ss_pred EEeeeeccchHHHHhhc--cccccH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCC-CCCeEEEEecCCcc
Q 002642 705 VTEYMVNGSLKQVLRRK--DRTIDR-RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP-QRPVCKIGDLGLSK 780 (897)
Q Consensus 705 VmEy~~GGsL~d~L~~~--~~~lse-~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~-~~g~VKLiDFGLAk 780 (897)
..|.| ..+|.++++.. ...... .....+..|++.||+|||+.+||||||||.||||...+. ....++|+|||+++
T Consensus 581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99988 56999999873 111111 334667889999999999999999999999999986432 34689999999998
Q ss_pred ccccc----cccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC-
Q 002642 781 IKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI- 854 (897)
Q Consensus 781 ~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~l~~~~- 854 (897)
..... ....+..||..|+|||++.... -+.++|||||||++|+.++ |..||.+.. +...+|+.+......
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHL 735 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeee
Confidence 65332 2234667999999999998654 4668999999999999999 589997653 334455665542211
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
...-..++++||.+|+..+|..||++.+++.|
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111289999999999999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=232.80 Aligned_cols=212 Identities=33% Similarity=0.539 Sum_probs=173.7
Q ss_pred ceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCce
Q 002642 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~ 701 (897)
|++.+.||.|++|.||++... ++.+++|.+...... ...+.+.+|++.++.++|+|++++++++... ..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecC--Cc
Confidence 567899999999999999985 578999998754211 2457788999999999999999999998876 67
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
.++++||+++++|.+++......+++..+..++.|++.+|.+||+.+++|+||+|+||+++ ....++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8899999999999999976543378889999999999999999999999999999999998 568899999999886
Q ss_pred ccccc--ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcC
Q 002642 782 KQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD-LHSEEIIAGIIKGN 849 (897)
Q Consensus 782 ~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~-~~~~eil~~Ii~~~ 849 (897)
..... ......++..|++||.+. ....++.++|+|+||+++++|++|+.||.. ..+.+.+.+.+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 54332 223456788999999984 233467799999999999999999999987 45553444434433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-28 Score=276.31 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=210.8
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCC
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~ 698 (897)
.++|+++..+|.|+||.||++++ +++..|+|+++.... ...+-+.+|+-+++..+|||||.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--------dd~~~iqqei~~~~dc~h~nivay~gsylr~- 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--------DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR- 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--------ccccccccceeeeecCCCcChHHHHhhhhhh-
Confidence 57999999999999999999987 477899999976522 1245566899999999999999999988876
Q ss_pred CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCC
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGL 778 (897)
..++++|||+.||+|.+..+-. .++++.++.++.++.+++|+|||++|=+|||||-.|||++ +.+.+||.|||.
T Consensus 85 -dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfgv 158 (829)
T KOG0576|consen 85 -DKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFGV 158 (829)
T ss_pred -cCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccCc
Confidence 6899999999999999987654 5789999999999999999999999999999999999998 888999999998
Q ss_pred ccccccc-cccCCcccCCcccCccccc-cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC---
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFK-SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--- 853 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~-g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~--- 853 (897)
+..+... .....+.||++|||||+-. ++...|....|||++|+...|+-.-++|..+..+...+.-..+..+.++
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 8654332 2334688999999999853 3334588999999999999999999999888887777666666555443
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
-+..+++.+.+|++.+|.++|++||+++.+|+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 23457899999999999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=251.84 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=195.1
Q ss_pred CCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC-
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG- 697 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~- 697 (897)
..+|.-++.+|.|.- .|..+-+ .++.||+|.+... +.. ..-.++..+|..++..++|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-ccc-----CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457888888999988 5544443 5888999987544 211 12235567899999999999999999998743
Q ss_pred ---CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 698 ---PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 698 ---~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
+....|+|||+| ..+|.+.+.. .++-..+.+|..|++.|++|||+.||+||||||+||++. .+..+||.
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 234678999999 5688888873 367788889999999999999999999999999999998 88899999
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~--- 851 (897)
|||+|+........+.++.|.+|.|||++.+.+ +.+.+||||+||++.||++|..-|.+.+.-+...+++...-.
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999998766664555678999999999999876 889999999999999999999999876544333222111000
Q ss_pred --------------------------CCCC-----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 852 --------------------------PKIP-----------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 --------------------------~~~p-----------~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
..+| ..-+..+++++.+||..||++|.+++++|++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0011 1123567899999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=254.92 Aligned_cols=135 Identities=23% Similarity=0.325 Sum_probs=113.3
Q ss_pred cccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-----C---Cce
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-----H---PNV 687 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-----H---PNI 687 (897)
.+...+|.+.++||+|-|++||++.+. .+.||+|+.+.. +.+....+.||++|++++ | ..|
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 345689999999999999999999884 567999999753 234456678999999884 2 569
Q ss_pred eeEeeeeecCC--CceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEec
Q 002642 688 VAFYGVVTDGP--VTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVN 762 (897)
Q Consensus 688 Vkl~g~~~e~~--~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~-GIVHRDIKPeNILLd 762 (897)
|+|++.|.... ..+.+||+|++ |.+|..+|...+ +-++...+..|++||+.||.|||++ ||||-||||+|||+.
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99999998643 45899999998 778999887643 4588899999999999999999987 999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=253.93 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=190.5
Q ss_pred EEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCC---ce
Q 002642 627 IKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV---TN 701 (897)
Q Consensus 627 lk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~---~~ 701 (897)
-+-||-|+||.||.+++ +++.||+|.+... ...-...+++.+|+++|..++|.|++..+++.+.... ..
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 35699999999999987 5788999987432 1222345788899999999999999998887664421 13
Q ss_pred EEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 702 l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
+|+|+|.|. .+|.+.|... ..++...+.-+.+||++||+|||+.+|+||||||.|+|++ ++..+||||||+++.
T Consensus 132 iYV~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGLARv 205 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEecccccccc
Confidence 567888774 4788877654 4577777888899999999999999999999999999998 899999999999996
Q ss_pred cccccc--cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh------------
Q 002642 782 KQKTLI--SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK------------ 847 (897)
Q Consensus 782 ~~~~~~--~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~------------ 847 (897)
.+.... ...-+-|.+|.|||++.+. ..|+...||||.|||+.||+..+..|....+-+.++-|..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 543322 2233568999999999875 4589999999999999999999999988777655443321
Q ss_pred -----------cCC-CCCCCC--------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002642 848 -----------GNL-GPKIPS--------WCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887 (897)
Q Consensus 848 -----------~~l-~~~~p~--------~ls~el~dLI~kcL~~DPeeRPTa~ELLq~L 887 (897)
+.. .|.++. .-..+...++.+++..||++|.+.++.+.++
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111 111111 1234566888999999999999988877654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=242.68 Aligned_cols=261 Identities=19% Similarity=0.246 Sum_probs=202.0
Q ss_pred CceEEEEecccCceEEEEeeecCc---cEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC----CCceeeEeeeee
Q 002642 623 DLEYIKELGSGTFGTVFYGKWKGS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH----HPNVVAFYGVVT 695 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~kg~---~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~----HPNIVkl~g~~~ 695 (897)
+|.+.++||+|+||.||++..... .+|+|.......... ..+..|..++..+. -+++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998543 589998754311110 13456777777775 268888888884
Q ss_pred -cCCCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC-CCCCeEE
Q 002642 696 -DGPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD-PQRPVCK 772 (897)
Q Consensus 696 -e~~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~-~~~g~VK 772 (897)
.+ ...++||+.+ |.+|.++..... +.++..++..|+.|++.+|++||+.|++||||||+|++++... .....++
T Consensus 91 ~~~--~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 91 STE--DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CCC--ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEE
Confidence 43 5788999977 889999886554 7899999999999999999999999999999999999998432 1225799
Q ss_pred EEecCCcc--ccc-c-------ccc-cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 002642 773 IGDLGLSK--IKQ-K-------TLI-SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841 (897)
Q Consensus 773 LiDFGLAk--~~~-~-------~~~-~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~ei 841 (897)
|+|||+++ ... . ... ...+.||..|+++..+.+.+ .+++.|+||++.++.+|+.|..||........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 99999998 321 1 111 23567999999999998766 78999999999999999999999977654322
Q ss_pred HH---HHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002642 842 IA---GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896 (897)
Q Consensus 842 l~---~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg~ 896 (897)
.. +..............+.++.++...+-..+...+|.+..+...|++...+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 22 22222221213345668899999988899999999999999999999887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=219.58 Aligned_cols=164 Identities=25% Similarity=0.358 Sum_probs=131.0
Q ss_pred cchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCCc
Q 002642 712 GSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791 (897)
Q Consensus 712 GsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~ 791 (897)
|+|.+++...+..+++..+..|+.|++.||+|||+++ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6899999876677999999999999999999999999 99999998 7778888 99987654322 2
Q ss_pred ccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCC-----CCCCCCcH--HHH
Q 002642 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGP-----KIPSWCEP--TWR 863 (897)
Q Consensus 792 ~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~Ii~~~l~~-----~~p~~ls~--el~ 863 (897)
.||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..+....... ..+..++. +++
T Consensus 65 ~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 5899999999997654 789999999999999999999999765432 2233332222111 11222333 699
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 864 SLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 864 dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
++|.+||..+|++||++.|+++++..+..+
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=237.56 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=188.2
Q ss_pred CCceEEEEecccCceEEEEeeecC--ccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeee-eecC
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKG--SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGV-VTDG 697 (897)
Q Consensus 622 ~~Yeilk~LGkG~fG~Vylg~~kg--~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~-~~e~ 697 (897)
+.|.+.+.||+|.||.+-++.+++ +.+++|.+... ....++|.+|...--.| .|.||+.-|+. |+..
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---------hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 578899999999999999999964 46999988543 12356788888765555 59999988875 5555
Q ss_pred CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
+.+++++||++-|+|..-+... .+-+.....++.|++.||.|||++++||||||.+||||-. ++...|||||||
T Consensus 95 --d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~--~df~rvKlcDFG 168 (378)
T KOG1345|consen 95 --DAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD--ADFYRVKLCDFG 168 (378)
T ss_pred --ceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec--CCccEEEeeecc
Confidence 5888999999999999988654 3778888999999999999999999999999999999973 355689999999
Q ss_pred CccccccccccCCcccCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHhcCC
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE----IIAGIIKGNL 850 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e----il~~Ii~~~l 850 (897)
+.+....... ...-+..|.+||..... .....+.+|||.||+++|.+++|++||......+ ...+ ..+..
T Consensus 169 ~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~rk 245 (378)
T KOG1345|consen 169 LTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLKRK 245 (378)
T ss_pred cccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-Hhccc
Confidence 9874433221 12346679999986432 2235678999999999999999999998543221 1222 22233
Q ss_pred CCCCCC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002642 851 GPKIPS---WCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888 (897)
Q Consensus 851 ~~~~p~---~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le 888 (897)
.+..|. .+++.+..+.++-|..+|++|--..+..+.-.
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 344453 46888999999999999999944444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-26 Score=276.69 Aligned_cols=200 Identities=19% Similarity=0.247 Sum_probs=145.2
Q ss_pred hCCC-CceeeEeeeeecC-----CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 002642 681 QIHH-PNVVAFYGVVTDG-----PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDL 754 (897)
Q Consensus 681 ~L~H-PNIVkl~g~~~e~-----~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDI 754 (897)
.+.| +||+.++++|... ....++++|||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777788877321 124577889987 66999999876667999999999999999999999999999999
Q ss_pred CCCCeEeccC---------------CCCCCeEEEEecCCccccccc-----------------cccCCcccCCcccCccc
Q 002642 755 KSHNFLVNMR---------------DPQRPVCKIGDLGLSKIKQKT-----------------LISGGVRGTIPWMAPEL 802 (897)
Q Consensus 755 KPeNILLd~~---------------~~~~g~VKLiDFGLAk~~~~~-----------------~~~~~~~GT~~Y~APEv 802 (897)
||+||||+.. ......+||+|||+++..... .......||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999621 013456777888877632110 00112458999999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHH
Q 002642 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSE 882 (897)
Q Consensus 803 l~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~E 882 (897)
+.+.. ++.++|||||||+||||++|..|+.... ..+..+....+++.... ..+...+++.+||+.+|.+||++.|
T Consensus 187 ~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 187 DNGSS--SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hccCC--CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChHH
Confidence 88654 7999999999999999999988875432 22222222222221111 2356678999999999999999999
Q ss_pred HHHH
Q 002642 883 ITKE 886 (897)
Q Consensus 883 LLq~ 886 (897)
++++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=224.50 Aligned_cols=262 Identities=18% Similarity=0.291 Sum_probs=211.1
Q ss_pred cccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeee
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVV 694 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~ 694 (897)
.+....|.++++||.|+||.+|++.. .|+.||||+-..... -..+.-|.++.+.|. ...|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhhhc
Confidence 35567999999999999999999987 688999998754311 123556888888886 47788877777
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.+. .+-.+|||.+ |.+|.++++-..+.++.++++.++-|++.-++|+|.+++|||||||+|+|++... ....+.||
T Consensus 81 ~e~--~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LI 156 (341)
T KOG1163|consen 81 TEK--DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLI 156 (341)
T ss_pred ccc--ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEE
Confidence 776 5677899988 8899999988888899999999999999999999999999999999999998543 44578999
Q ss_pred ecCCcccccccc--------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHH
Q 002642 775 DLGLSKIKQKTL--------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE---IIA 843 (897)
Q Consensus 775 DFGLAk~~~~~~--------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e---il~ 843 (897)
|||+|+.+.+.. ......||..|.+-..+.+.. -+.+.|+-|+|.+|..+--|..||.+..... ..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 999998553321 223467999999987776544 4789999999999999999999999875532 233
Q ss_pred HHHhcCCCCC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002642 844 GIIKGNLGPK---IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895 (897)
Q Consensus 844 ~Ii~~~l~~~---~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg 895 (897)
.|.......+ +-..+|.++...+.-|-..-.++-|++.-|.+.++.++..++
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 3333333222 235678999999999999999999999999999999988776
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=228.86 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=216.5
Q ss_pred ccCCCceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVT 695 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~ 695 (897)
+..-.|++.++||.|+||.++.|+. ++++||||.-..+.. ...+..|.+..+.|. .++|...|.+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 5567899999999999999999986 789999998643311 234567788888874 799999988888
Q ss_pred cCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCC-CCCeEEEE
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP-QRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~-~~g~VKLi 774 (897)
++ .+-.+|||.+ |.+|.|++.-.++.++.+++..+|.|++.-++|+|++.+|+|||||+|+||+..+. ....|.|+
T Consensus 95 eG--~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EG--KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred cc--chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 77 5677899988 88999999888999999999999999999999999999999999999999985432 34578999
Q ss_pred ecCCccccccccc--------cCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHH
Q 002642 775 DLGLSKIKQKTLI--------SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH---SEEIIA 843 (897)
Q Consensus 775 DFGLAk~~~~~~~--------~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~---~~eil~ 843 (897)
|||+|+.+.++.. .....||.+||+=..+.+++ -+.+.|+.|||-++..++-|.+||.+.. ..+..+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE--QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccch--hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 9999997655432 23567999999988888776 5899999999999999999999998754 344455
Q ss_pred HHHhcCCCCC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002642 844 GIIKGNLGPK---IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896 (897)
Q Consensus 844 ~Ii~~~l~~~---~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~elg~ 896 (897)
+|-..+...+ +-..+|.++...|+-.-..+..+-|+++-+...+.+++..+|-
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 5433322222 2245789999999999999999999999999999999998874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-23 Score=208.63 Aligned_cols=251 Identities=27% Similarity=0.474 Sum_probs=197.8
Q ss_pred ceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCC-ceeeEeeeeecCCCceE
Q 002642 624 LEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP-NVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HP-NIVkl~g~~~e~~~~~l 702 (897)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEE
Confidence 788999999999999999988 778999986542221 13467788999999999988 799999999655 458
Q ss_pred EEEEeeeeccchHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCC-eEEEEecCCc
Q 002642 703 ATVTEYMVNGSLKQVLRRKD--RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP-VCKIGDLGLS 779 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~--~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g-~VKLiDFGLA 779 (897)
+++++++.++++.+++.... ..+.......++.|++.++.|+|+.+++||||||+||+++ ... .++++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776543 2688889999999999999999999999999999999998 445 7999999999
Q ss_pred ccccccc-------ccCCcccCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHh
Q 002642 780 KIKQKTL-------ISGGVRGTIPWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIAGIIK 847 (897)
Q Consensus 780 k~~~~~~-------~~~~~~GT~~Y~APEvl~g~~-~~~s~ksDIWSLGvILyELLtGk~PF~~~~~----~eil~~Ii~ 847 (897)
+...... ......||..|+|||.+.+.. ..++...|+||+|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 7443322 235678999999999997631 3478899999999999999999999877763 333333333
Q ss_pred cCCC---CCCCCCC----cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 848 GNLG---PKIPSWC----EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~~l~---~~~p~~l----s~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.... ....... ...+.+++..++..+|..|.+..+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3321 1112211 2578999999999999999988776654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=238.44 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=188.5
Q ss_pred CCCceEEEEecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-CCCceeeEeeee
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVV 694 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-~HPNIVkl~g~~ 694 (897)
...|..+.+||.|.|++||++.. +.+.||+|.+..... ..++.+|+++|..+ .+.||+++.+.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhh
Confidence 45788999999999999999875 345699999865421 24578999999998 499999999999
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
..+ ....+||||++.....+++.. ++...+..+++.++.||.++|.+|||||||||+|+|.+ ...+.-.|+
T Consensus 105 rnn--d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~Lv 175 (418)
T KOG1167|consen 105 RNN--DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGVLV 175 (418)
T ss_pred ccC--CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCceEE
Confidence 877 688899999999999888864 56778889999999999999999999999999999997 345567899
Q ss_pred ecCCccccccc---------------c------------------------------ccCCcccCCcccCccccccCCCC
Q 002642 775 DLGLSKIKQKT---------------L------------------------------ISGGVRGTIPWMAPELFKSKDNL 809 (897)
Q Consensus 775 DFGLAk~~~~~---------------~------------------------------~~~~~~GT~~Y~APEvl~g~~~~ 809 (897)
|||+|...+.. . ......||++|.|||++..-+ .
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~ 254 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-R 254 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-C
Confidence 99998611000 0 000124999999999997644 3
Q ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHH--------------HhcC---------------------C---
Q 002642 810 VTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGI--------------IKGN---------------------L--- 850 (897)
Q Consensus 810 ~s~ksDIWSLGvILyELLtGk~PF~~~~~~-eil~~I--------------i~~~---------------------l--- 850 (897)
-++++||||.|+|+..+++++.||.....+ ..+..+ .-+. +
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 578999999999999999999999654321 111000 0000 0
Q ss_pred --CC---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 851 --GP---------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 851 --~~---------~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
.. ...+..+..+.+|+.+||..||.+|.|+++.|++
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0112245688999999999999999999998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=214.52 Aligned_cols=167 Identities=18% Similarity=0.141 Sum_probs=125.8
Q ss_pred ccCCCceEEEEecccCceEEEEeeec---CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceee-Eeeee
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA-FYGVV 694 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k---g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVk-l~g~~ 694 (897)
....+|.+.+.||+|+||+||+++++ ++.+|||.+...... .........+.+|+++|++++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW---WSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc---cccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 44678999999999999999999873 456799987532110 012234567889999999999999985 5432
Q ss_pred ecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEeccCCCCCCeEEE
Q 002642 695 TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDL-KSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 695 ~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDI-KPeNILLd~~~~~~g~VKL 773 (897)
...++||||++|++|... ... . ...++.|++++|.|||++||+|||| ||+|||++ .++.+||
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikL 153 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAV 153 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEE
Confidence 347899999999999732 111 1 1357789999999999999999999 99999997 5678999
Q ss_pred EecCCccccccccc---------cCCcccCCcccCccccccC
Q 002642 774 GDLGLSKIKQKTLI---------SGGVRGTIPWMAPELFKSK 806 (897)
Q Consensus 774 iDFGLAk~~~~~~~---------~~~~~GT~~Y~APEvl~g~ 806 (897)
+|||+|+....... -....+++.|+|||.+..+
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999985433211 1245678889999998643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-22 Score=228.40 Aligned_cols=224 Identities=27% Similarity=0.408 Sum_probs=185.5
Q ss_pred ecccCceEEEEeee-----cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCCceEE
Q 002642 630 LGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 630 LGkG~fG~Vylg~~-----kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~~~l~ 703 (897)
+|+|+||.|++++- .+.-+|+|+.++........ .....|..++...+ ||.++++...++.+ ..++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~------~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR------THTKQERIILAFVHNTPFLVKLHYAFQTD--GKLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc------cccccHHHHHhhccCCCceeeeeeeeccc--cchh
Confidence 69999999998653 35569999987664432221 14456777888886 99999999988887 6889
Q ss_pred EEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccc
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~ 783 (897)
+++++..||+|...+..... +++.....+..+++.+++++|+.+|+|||+|++||+++ .+|++|+.|||+++..-
T Consensus 74 l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 99999999999999876544 45555555666999999999999999999999999999 88999999999998654
Q ss_pred cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHH
Q 002642 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWR 863 (897)
Q Consensus 784 ~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~ 863 (897)
+.... +||..|||||++.+ ...++|+||||++++||++|..||.. +....|.+..+ .+|..++..++
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~--~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL--EMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc--CCchhhhHHHH
Confidence 44433 89999999999983 46789999999999999999999987 66666777654 78888999999
Q ss_pred HHHHHhhccCCCCCCC
Q 002642 864 SLMERCWSSDPKSRPA 879 (897)
Q Consensus 864 dLI~kcL~~DPeeRPT 879 (897)
+++..++.++|.+|..
T Consensus 216 ~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLG 231 (612)
T ss_pred HHHHHHHhhCHHHHhc
Confidence 9999999999999954
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=199.10 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=207.6
Q ss_pred cccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecC
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~ 697 (897)
-+...++.++.+|.+.-.|+.|+|++.+..++.|+++.... ..+....|..|.-.|+-+.||||+.+++.+...
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~------t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV------TARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc------chhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 34556677888899999999999999999999998865421 223446788888889889999999999999987
Q ss_pred CCceEEEEEeeeeccchHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeccCCCCCCeEEEE
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 698 ~~~~l~LVmEy~~GGsL~d~L~~~~-~~lse~~~l~Ia~QLl~AL~yLHs~G--IVHRDIKPeNILLd~~~~~~g~VKLi 774 (897)
.++.++..||+-|+|+.++++.. -..+..++.+++.+++.|++|||+.. |.---+....++++ ++.+.+|.
T Consensus 260 --pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltaris 333 (448)
T KOG0195|consen 260 --PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARIS 333 (448)
T ss_pred --CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhhee
Confidence 57889999999999999998753 34677889999999999999999974 33345778888887 44444432
Q ss_pred ecCCccccccccccCCcccCCcccCccccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVT-EKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s-~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~ 853 (897)
.+-+++.... .+..-.|.||+||.++.++...+ .++|+|||.++||||-|...||.+..+.|.--++..+.++..
T Consensus 334 -mad~kfsfqe---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ 409 (448)
T KOG0195|consen 334 -MADTKFSFQE---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH 409 (448)
T ss_pred -cccceeeeec---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc
Confidence 2222211110 12235788999999987654333 568999999999999999999999999998888888889999
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 854 ~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~ 891 (897)
+|..++..+..||+-|+..||.+||.+..++-.|+++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999999999999999988763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-20 Score=201.62 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=150.2
Q ss_pred CCCceeeEeeeeecC-------------------------CCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHH
Q 002642 683 HHPNVVAFYGVVTDG-------------------------PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737 (897)
Q Consensus 683 ~HPNIVkl~g~~~e~-------------------------~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QL 737 (897)
+|||||.+..+|.++ +...+|+||...+ .+|.+++..+. .+-.....|..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999998876542 3456899998774 59999997643 4556666778899
Q ss_pred HHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccccc-------ccccCCcccCCcccCccccccCCCC-
Q 002642 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK-------TLISGGVRGTIPWMAPELFKSKDNL- 809 (897)
Q Consensus 738 l~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~-------~~~~~~~~GT~~Y~APEvl~g~~~~- 809 (897)
++|+.|||++||.|||+|.+|||+..+++.-..+.|.|||++---+. ....-..-|...-||||+....+..
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 99999999999999999999999998888888999999998632111 0111122367778999998754321
Q ss_pred ---CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 810 ---VTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 810 ---~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
.-.|+|.|+.|.+.||++....||...-....-..-.++..-|.+|+.+|+.+++++..+|+.||.+|++..-...
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1248999999999999999999998733221111112333347789999999999999999999999987654433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=193.73 Aligned_cols=178 Identities=13% Similarity=0.129 Sum_probs=134.8
Q ss_pred cccCCCceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHH------HHHHHHHHhhCCCCceeeEe
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD------FWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 618 ~i~~~~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~------fl~Ei~iL~~L~HPNIVkl~ 691 (897)
.+...+|+.++.||.|+||.||+...++..+|||.+++.... .+..... +.+|++.+.++.||+|....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 455789999999999999999997777778999999765321 1222233 67999999999999999999
Q ss_pred eeeecCC------CceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCC
Q 002642 692 GVVTDGP------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 692 g~~~e~~------~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~ 765 (897)
+++.... ....++||||++|.+|.++.. +++ ....+++.+|..||+.|++||||||+||+++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 8866432 135789999999999988742 222 2355999999999999999999999999997
Q ss_pred CCCCeEEEEecCCccccccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 002642 766 PQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELL 827 (897)
.++ ++|+|||..+........ ..++..+. ++.++|+||||+++..+.
T Consensus 170 -~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~--y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 -KNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERH--YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -CCC-EEEEECCCcccccchhhH-----------HHHHHHhH--hcccccccceeEeehHHH
Confidence 455 999999988644222111 01223222 567999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=221.24 Aligned_cols=206 Identities=30% Similarity=0.477 Sum_probs=155.0
Q ss_pred ccCCCceEEEEecccCceEEEEeeec--CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeec
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeilk~LGkG~fG~Vylg~~k--g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e 696 (897)
....+|+.++.|-.|+||.||+++++ .+.+|+|+=+.. .+ ++- ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-----------li---lRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----------LI---LRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccc-----------hh---hhc--cccccCCccee--------
Confidence 34679999999999999999999886 667888543221 00 000 22222233333
Q ss_pred CCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
|+-...++..+ .++. +++.+++|||+.||+|||+||+|.+|+ ..+++|++||
T Consensus 136 ---------------gDc~tllk~~g-~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDf 187 (1205)
T KOG0606|consen 136 ---------------GDCATLLKNIG-PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDF 187 (1205)
T ss_pred ---------------chhhhhcccCC-CCcc--------hhhHHhHhhccCCeecCCCCCCcceee----ecccccccch
Confidence 44444444322 1221 337899999999999999999999998 8899999999
Q ss_pred CCccccc----------------cccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 002642 777 GLSKIKQ----------------KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE 840 (897)
Q Consensus 777 GLAk~~~----------------~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~e 840 (897)
|+++..- ......+.+|||.|.|||++..+. |+..+|||++|+|+||++.|+.||.+..+++
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 9987311 001123568999999999998665 8999999999999999999999999999999
Q ss_pred HHHHHHhcCCC-CCCCCCCcHHHHHHHHHhhccCCCCCC
Q 002642 841 IIAGIIKGNLG-PKIPSWCEPTWRSLMERCWSSDPKSRP 878 (897)
Q Consensus 841 il~~Ii~~~l~-~~~p~~ls~el~dLI~kcL~~DPeeRP 878 (897)
++.+++..... ++-...++++++++|.++|+.+|..|-
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 99888776542 223445789999999999999999994
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=216.70 Aligned_cols=243 Identities=21% Similarity=0.257 Sum_probs=177.0
Q ss_pred CceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 623 DLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
++...+.||++.|=+|.++++....|+||++.+.... ..-.. ..+.+.|++ ...+++||.+.+.-+.... +..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~---~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPT---ISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTD--KAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCC---CCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhh--HHH
Confidence 7888999999999999999987666999998654211 11122 233345555 5567899999987775554 567
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc-
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI- 781 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~- 781 (897)
|||-+|+ .-+|+|.+..+ ..+...+.+.|+.||+.||.-+|..||+|+|||.+||||+ .-+-+.|+||..-+.
T Consensus 97 ylvRqyv-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 7788887 45899988764 4577788888999999999999999999999999999998 666789999987662
Q ss_pred ---cccccccCCcccC----CcccCccccccC--------CC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCh------
Q 002642 782 ---KQKTLISGGVRGT----IPWMAPELFKSK--------DN-LVTEKVDVYSFGVVMWELLT-GEEPYADLHS------ 838 (897)
Q Consensus 782 ---~~~~~~~~~~~GT----~~Y~APEvl~g~--------~~-~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~------ 838 (897)
.+++....-+-.| ..|+|||.+... .. ..+++.||||+||+++||++ |++||.-.+-
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 1222111112222 359999998541 11 26788999999999999999 7888853211
Q ss_pred -HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002642 839 -EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 839 -~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq~ 886 (897)
....++++. +++ +..+++||..|++.||.+|.++++.|+.
T Consensus 251 ~~~~~e~~Le-----~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLE-----KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHH-----hCc---CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000111111 111 2478999999999999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=180.82 Aligned_cols=189 Identities=15% Similarity=0.079 Sum_probs=139.9
Q ss_pred eEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeecCCCceEE
Q 002642 625 EYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 625 eilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e~~~~~l~ 703 (897)
.+...|++|+||+||++...+.+++.+.+...... ........+.+|+++|++|. |++|++++++ ...+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEE
Confidence 35678999999999988887878887776543211 11122335789999999995 5889999885 2368
Q ss_pred EEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDL-KSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDI-KPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++|||+.|.+|.+.+... ...++.|++.+|+++|++||+|||| ||+|||++ .++.++|+|||++...
T Consensus 75 lvmeyI~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPRG--------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRG 142 (218)
T ss_pred EEEeeecCccHHhhhhhh--------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceec
Confidence 999999999997654211 1346789999999999999999999 79999997 6678999999999844
Q ss_pred ccccc--------------cCCcccCCcccCccccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 002642 783 QKTLI--------------SGGVRGTIPWMAPELFKSKDNLVT-EKVDVYSFGVVMWELLTGEEPYADL 836 (897)
Q Consensus 783 ~~~~~--------------~~~~~GT~~Y~APEvl~g~~~~~s-~ksDIWSLGvILyELLtGk~PF~~~ 836 (897)
..... +.....++.|++|+...-... .+ .+.++++.|..+|.++|+..|+...
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~-~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKR-TSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhcc-chhHHHHHHHhcchHHHHHhccCCcccc
Confidence 32221 111236888888886432211 23 5689999999999999999887543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-19 Score=179.54 Aligned_cols=146 Identities=16% Similarity=0.124 Sum_probs=107.7
Q ss_pred EEEecccCceEEEEeee-cCccEEEEEecCCcccCCCh------------------hHHHHHHHHHHHHHHHhhCCCCce
Q 002642 627 IKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSL------------------EEDRLIADFWREAHMLGQIHHPNV 687 (897)
Q Consensus 627 lk~LGkG~fG~Vylg~~-kg~~VAVK~ik~~~~~~~~~------------------~~~~~~~~fl~Ei~iL~~L~HPNI 687 (897)
...||+|+||.||+++. +|+.||||++++........ ...........|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 58899999997642211110 000112233569999999987776
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEeccCCC
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL-HEKNIVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yL-Hs~GIVHRDIKPeNILLd~~~~ 766 (897)
.....+... ..++||||++|+++...+.. ...+++..+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 443332222 23799999998877655332 24688889999999999999999 799999999999999997
Q ss_pred CCCeEEEEecCCcccc
Q 002642 767 QRPVCKIGDLGLSKIK 782 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~ 782 (897)
+ +.++|+|||+|...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 2 56999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=186.84 Aligned_cols=237 Identities=17% Similarity=0.221 Sum_probs=148.6
Q ss_pred CceEEEEecccCceEEEEeee--cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCC----------CceeeE
Q 002642 623 DLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH----------PNVVAF 690 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~--kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~H----------PNIVkl 690 (897)
.+...+.||.|+++.||.+++ +++++|+|++..... ......+.+.+|.-....+.+ -.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 456778999999999999998 468899999854321 122234555555544444322 122222
Q ss_pred eee---------eecCC-Cc-----eEEEEEeeeeccchHHHHhh---cc---ccccHHHHHHHHHHHHHHHHHHHHCCc
Q 002642 691 YGV---------VTDGP-VT-----NLATVTEYMVNGSLKQVLRR---KD---RTIDRRKRIIIAMDAAFGIEYLHEKNI 749 (897)
Q Consensus 691 ~g~---------~~e~~-~~-----~l~LVmEy~~GGsL~d~L~~---~~---~~lse~~~l~Ia~QLl~AL~yLHs~GI 749 (897)
++. +.... .. +.+++|+-+ -++|.+++.. .. ..+....++.+..|+++.+++||++|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 222 11111 11 235677766 4578776542 21 224455667788999999999999999
Q ss_pred eeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCCcccCCcccCccccccC------CCCCCchhhHHHHHHHH
Q 002642 750 VHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSK------DNLVTEKVDVYSFGVVM 823 (897)
Q Consensus 750 VHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~------~~~~s~ksDIWSLGvIL 823 (897)
+|+||||+|++++ .+|.++|.||+........... ...+..|.|||..... .-.++.+.|.|+||+++
T Consensus 167 VHgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999998 8899999999877654433222 3356789999986432 12368899999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 002642 824 WELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877 (897)
Q Consensus 824 yELLtGk~PF~~~~~~eil~~Ii~~~l~~~~p~~ls~el~dLI~kcL~~DPeeR 877 (897)
|.|+++..||........... .+ .... .+|+.+++||..+|++||++|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~----~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW----DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG----GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc----cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999986643211111 11 1223 788999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=206.99 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=186.5
Q ss_pred ccccCCCceEEEEecccCceEEEEeee-cCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC---CCceeeEee
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH---HPNVVAFYG 692 (897)
Q Consensus 617 ~~i~~~~Yeilk~LGkG~fG~Vylg~~-kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~---HPNIVkl~g 692 (897)
.++....|.|.+.||+|+||+||+|.. +++.||+|+-++...++-.+- .+++.+|+ -+-|..+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~-----------~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC-----------LQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh-----------HHHHHhhchhhhcchHHHHH
Confidence 456778899999999999999999987 577899999988765543221 22333333 123344433
Q ss_pred eeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecc---CCCCCC
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNM---RDPQRP 769 (897)
Q Consensus 693 ~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~---~~~~~g 769 (897)
.+.-. +.-++|+||.+-|+|.++++ ..+.+++..++.++.|++..+++||..+|||+||||+|+||.. .++...
T Consensus 762 a~~~~--~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 762 AHVFQ--NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHccC--CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 33322 35678999999999999998 4567999999999999999999999999999999999999963 234566
Q ss_pred eEEEEecCCccc---cccccccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002642 770 VCKIGDLGLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 770 ~VKLiDFGLAk~---~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil~~Ii 846 (897)
.++|||||.+.- ..+.......++|-.+-.+|+..+++ ++.++|.|.|+-+++-|+.|+.- + ..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y~----------q-~~ 905 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKYM----------E-VK 905 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHHH----------H-hc
Confidence 799999999863 33444445677899999999999876 89999999999999999998542 1 11
Q ss_pred hcCC---CCCCCCCCc-HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002642 847 KGNL---GPKIPSWCE-PTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 847 ~~~l---~~~~p~~ls-~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~e 893 (897)
.+.. ...+++.+. +-+.+|+..+|..|-..=|.+.+|...|+..+.+
T Consensus 906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 2111 112233222 3466888999985555558899999988887765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-19 Score=201.70 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=113.7
Q ss_pred hccccccccccceeccccccCC-cceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceec
Q 002642 410 YGLSNLVESHLACHSTCNVAGD-QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHr 488 (897)
-.|++|+|||+|++.|-|.+.. ..-+|.||+++|++.+-+.+.....++|..++.++.|.|+|++|||... + ||||
T Consensus 91 ~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~--~-iIHr 167 (362)
T KOG0192|consen 91 SLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG--P-IIHR 167 (362)
T ss_pred HHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC--C-eeec
Confidence 4788999999999999997655 3559999999999999888866899999999999999999999999766 3 9999
Q ss_pred CCCCCCcccCCCC-CeeEcc--cCCCCC---CCCccccccceeecccc-c--cCCccccccccccccCCCC
Q 002642 489 ELENEKLLIDSEE-SANISG--LSNNMN---YRNGTASGCNMKNGTKN-L--QGGVASSMDLLYNLSLSSS 550 (897)
Q Consensus 489 DIK~SNILLD~~~-~aKIsD--Lar~~~---~~~~~~~gt~~v~gt~~-~--~g~~t~ksD~VySf~~ss~ 550 (897)
||||+|||||.++ +.||+| +|+... .......||.....++. . ...+++|+| ||||||.-.
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~D-vySFgIvlW 237 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSD-VYSFGIVLW 237 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccch-hhhHHHHHH
Confidence 9999999999997 999999 888221 22222445655666663 3 356999999 999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-18 Score=171.16 Aligned_cols=146 Identities=16% Similarity=0.104 Sum_probs=109.2
Q ss_pred EEEecccCceEEEEeeec-CccEEEEEecCCcccCCC------------------hhHHHHHHHHHHHHHHHhhCCCCce
Q 002642 627 IKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGS------------------LEEDRLIADFWREAHMLGQIHHPNV 687 (897)
Q Consensus 627 lk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~------------------~~~~~~~~~fl~Ei~iL~~L~HPNI 687 (897)
.+.||+|+||+||+++.. |+.||||++++....... .........+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999874 889999999765221100 0001112334679999999999987
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHHH-HhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCC
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQV-LRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d~-L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~ 765 (897)
.....+.... .++||||++|+++... +.. ..++......++.|++.+|.+||+ +||+||||||+||+++
T Consensus 82 ~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 82 PVPEPILLKK----NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCceEEEecC----CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 5444433322 3799999998865443 332 346778889999999999999999 9999999999999996
Q ss_pred CCCCeEEEEecCCccccc
Q 002642 766 PQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~ 783 (897)
++.++|+|||+++...
T Consensus 153 --~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 --DGKPYIIDVSQAVELD 168 (190)
T ss_pred --CCCEEEEEcccceecC
Confidence 3579999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=172.32 Aligned_cols=141 Identities=14% Similarity=0.152 Sum_probs=105.6
Q ss_pred EEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhC-----CCCceeeEeeeeecCCC-
Q 002642 626 YIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-----HHPNVVAFYGVVTDGPV- 699 (897)
Q Consensus 626 ilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L-----~HPNIVkl~g~~~e~~~- 699 (897)
-.+.||+|+|+.||....... .+||++..... ...+.+.+|+.+++.+ .||||+++++++.++..
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEecccc--------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 347899999999996322333 47888764311 1235688999999999 57999999999988632
Q ss_pred ce-EEEEEee--eeccchHHHHhhccccccHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCeEeccCCCCCCeEEEEe
Q 002642 700 TN-LATVTEY--MVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI-EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 700 ~~-l~LVmEy--~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL-~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiD 775 (897)
.. +.+|||| ..+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++..+.....++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 23 3478999 5578999999763 35554 24567888777 9999999999999999999985444556899999
Q ss_pred cCCc
Q 002642 776 LGLS 779 (897)
Q Consensus 776 FGLA 779 (897)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.6e-17 Score=166.01 Aligned_cols=142 Identities=21% Similarity=0.309 Sum_probs=114.3
Q ss_pred EEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEe
Q 002642 628 KELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTE 707 (897)
Q Consensus 628 k~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmE 707 (897)
+.||+|++|.||++.+.+..+++|+...................+.+|+.++..+.|++|+....++... ...++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEEE
Confidence 5789999999999999889999998765433222223333345678999999999999887666555544 46789999
Q ss_pred eeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 708 YMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 708 y~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
|++|++|.+++.... . .+..++.+++.+|.+||+.|++|+|++|+|||++ .+.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccC
Confidence 999999999986532 1 6778899999999999999999999999999996 35689999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=162.54 Aligned_cols=139 Identities=24% Similarity=0.304 Sum_probs=108.2
Q ss_pred EecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceEEEEEee
Q 002642 629 ELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEY 708 (897)
Q Consensus 629 ~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l~LVmEy 708 (897)
.||+|+||.||++.+.+..+++|...................++.+|++++..+.|+++.....++... ...++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEEE
Confidence 379999999999999999999999765433222222333456788999999999887655433333333 356899999
Q ss_pred eeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCcccc
Q 002642 709 MVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 709 ~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~ 782 (897)
++|++|.+++..... .++.|++.+|.+||+.|++|+|++|+||+++ .+.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcCC
Confidence 999999998754321 6788999999999999999999999999996 467999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=182.97 Aligned_cols=208 Identities=34% Similarity=0.558 Sum_probs=165.2
Q ss_pred HhhCCCCceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 002642 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNI-VHFDLKSH 757 (897)
Q Consensus 679 L~~L~HPNIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GI-VHRDIKPe 757 (897)
|+.+.|.|+.++++....+ ...++|.+|+.-|+|.+.+......+++.-...+.++|+.||+|||...| .|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 3567899999999999887 68899999999999999998877788999899999999999999998865 99999999
Q ss_pred CeEeccCCCCCCeEEEEecCCccccccc---cccCCcccCCcccCccccccCC--C---CCCchhhHHHHHHHHHHHHcC
Q 002642 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKD--N---LVTEKVDVYSFGVVMWELLTG 829 (897)
Q Consensus 758 NILLd~~~~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~--~---~~s~ksDIWSLGvILyELLtG 829 (897)
|.+++ ....+||+|||+....... .......-..-|.|||.+.... . ..+.+.||||||++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 8999999999998755321 1111122345699999987631 1 146789999999999999999
Q ss_pred CCCCCCC----ChHHHHHHHHhcCC---CCCCCC--CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002642 830 EEPYADL----HSEEIIAGIIKGNL---GPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 830 k~PF~~~----~~~eil~~Ii~~~l---~~~~p~--~ls~el~dLI~kcL~~DPeeRPTa~ELLq~Le~l~~ 892 (897)
+.||... .+.+++..+..... +|.... .+++++..++..||..+|++||+++++...++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999763 23455555444222 222221 345678999999999999999999999998887765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=185.05 Aligned_cols=143 Identities=25% Similarity=0.269 Sum_probs=113.8
Q ss_pred CceEEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCceeeEeeeeecCCCceE
Q 002642 623 DLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPNIVkl~g~~~e~~~~~l 702 (897)
.|...+.||+|+||+||++.+.+..+++|...................++.+|+++++.++|++++..+.+.... ...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--EEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--CCC
Confidence 445678999999999999999877777776533322222222233456788999999999999998876666554 456
Q ss_pred EEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccc
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 703 ~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~ 781 (897)
++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||++ ++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCccccc
Confidence 89999999999999885 2456889999999999999999999999999994 45789999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=192.29 Aligned_cols=350 Identities=16% Similarity=0.176 Sum_probs=238.8
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
++---||||+|-++|-=...+.-...+|||..|++-..-+-| |+|.=..--+-++.+-.||+|||++. =|||||
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g----k~hRdi 138 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG----KIHRDI 138 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC----cccccc
Confidence 566779999999999988888888999999999998766654 77777777777888999999999888 689999
Q ss_pred CCCCcccCCCCCeeEcc--cCCCCCCCCc-cccccceeeccc----------cccCCccccccccccccCCCC--CCCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNNMNYRNG-TASGCNMKNGTK----------NLQGGVASSMDLLYNLSLSSS--KEIEP 555 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~~~~~~~-~~~gt~~v~gt~----------~~~g~~t~ksD~VySf~~ss~--~~i~~ 555 (897)
|=.||||.++...|++| .+-...++-. .. .+.||. ...|.+.++|| +++.|+++. .+.++
T Consensus 139 KGanilltd~gDvklaDfgvsaqitati~Krk----sfiGtpywmapEvaaverkggynqlcd-iwa~gitAiel~eLqp 213 (829)
T KOG0576|consen 139 KGANILLTDEGDVKLADFGVSAQITATIAKRK----SFIGTPYWMAPEVAAVERKGGYNQLCD-IWALGITAIELGELQP 213 (829)
T ss_pred cccceeecccCceeecccCchhhhhhhhhhhh----cccCCccccchhHHHHHhccccccccc-ccccccchhhhhhcCC
Confidence 99999999999999999 3321111000 01 133443 56789999999 999998774 33333
Q ss_pred hhhhhhhhhhcccccccccccCCChhhhhhhccccccccccccccccccccccccccccccccccCCCceEEEEecccCc
Q 002642 556 PQISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTF 635 (897)
Q Consensus 556 ~~i~~l~naa~~~~~e~~ee~~~~~~eekv~~~~~~~~s~~i~~iss~s~~~~~~~~~~~~~~i~~~~Yeilk~LGkG~f 635 (897)
|--. +-+.....-..+....+... .+ +...++....++++++
T Consensus 214 plfd------------------lhpmr~l~LmTkS~~qpp~l--------------kD------k~kws~~fh~fvK~al 255 (829)
T KOG0576|consen 214 PLFD------------------LHPMRALFLMTKSGFQPPTL--------------KD------KTKWSEFFHNFVKGAL 255 (829)
T ss_pred cccc------------------cchHHHHHHhhccCCCCCcc--------------cC------CccchHHHHHHHHHHh
Confidence 3211 11111000000000000000 00 1122334455789999
Q ss_pred eEEEEeeecCcc-EEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCCCc-eeeEeeeeecCCCceEEEEEeeeecc-
Q 002642 636 GTVFYGKWKGSD-VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN-VVAFYGVVTDGPVTNLATVTEYMVNG- 712 (897)
Q Consensus 636 G~Vylg~~kg~~-VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~HPN-IVkl~g~~~e~~~~~l~LVmEy~~GG- 712 (897)
+++++.+-..+. ...+++... ....-++++|.+.+||| .+..++-++.+ ...+++++++.++
T Consensus 256 tknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E--~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 256 TKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGE--DYLWIPMRICSTGR 320 (829)
T ss_pred cCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCcc--cccchhhhhhcCCc
Confidence 999988764332 334444211 23345788999999999 44444444443 6888999999877
Q ss_pred chHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecCCccccccccccCCcc
Q 002642 713 SLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792 (897)
Q Consensus 713 sL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk~~~~~~~~~~~~ 792 (897)
+-.......+..+.+-+...+.+.-+++|+++|+.-=+||| ||+.. ....|+.||+....+..........
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCcccCcccccccCC
Confidence 33222222222344445556677778899999998778999 88875 4678999999988776665666788
Q ss_pred cCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002642 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835 (897)
Q Consensus 793 GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~ 835 (897)
+|+.++|||+..+.. +....|.|+++.-..+|.-|.+|-..
T Consensus 392 ~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCCCC
Confidence 999999999887543 78899999999877778777777544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=164.79 Aligned_cols=148 Identities=16% Similarity=0.062 Sum_probs=110.1
Q ss_pred CceEEEEecccCceEEEEee-e--cCccEEEEEecCCcccCCC----------------hhHHHHHHHHHHHHHHHhhCC
Q 002642 623 DLEYIKELGSGTFGTVFYGK-W--KGSDVAIKRIKPSCFAEGS----------------LEEDRLIADFWREAHMLGQIH 683 (897)
Q Consensus 623 ~Yeilk~LGkG~fG~Vylg~-~--kg~~VAVK~ik~~~~~~~~----------------~~~~~~~~~fl~Ei~iL~~L~ 683 (897)
.|++.+.||+|+||.||++. + +++.||||+++........ ...+.....+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 3 6789999999754321100 011122345678999999997
Q ss_pred CC--ceeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCeE
Q 002642 684 HP--NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKN-IVHFDLKSHNFL 760 (897)
Q Consensus 684 HP--NIVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~G-IVHRDIKPeNIL 760 (897)
+. .+++++++ . ..++||||++|.+|....... ...+...+..++.|++.+|++||++| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 23344432 2 347999999998887665332 34566667789999999999999999 999999999999
Q ss_pred eccCCCCCCeEEEEecCCcccc
Q 002642 761 VNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 761 Ld~~~~~~g~VKLiDFGLAk~~ 782 (897)
++ .+.++|+|||.+...
T Consensus 182 i~-----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-----CCCEEEEEChhhhcc
Confidence 96 357999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=154.58 Aligned_cols=142 Identities=18% Similarity=0.063 Sum_probs=106.0
Q ss_pred ceEEEEecccCceEEEEeee-cCccEEEEEecCCcccCCChhH--------------HHHHHHHHHHHHHHhhCCCCc--
Q 002642 624 LEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEE--------------DRLIADFWREAHMLGQIHHPN-- 686 (897)
Q Consensus 624 Yeilk~LGkG~fG~Vylg~~-kg~~VAVK~ik~~~~~~~~~~~--------------~~~~~~fl~Ei~iL~~L~HPN-- 686 (897)
|.+.+.||+|+||.||++.. +++.||||++............ .........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67778999999999999988 5789999997653211100000 111234678899999887774
Q ss_pred eeeEeeeeecCCCceEEEEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCC
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 687 IVkl~g~~~e~~~~~l~LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~ 766 (897)
++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.||+||||||+||+++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4444432 245899999999998775431 23456788999999999999999999999999998
Q ss_pred CCCeEEEEecCCcccc
Q 002642 767 QRPVCKIGDLGLSKIK 782 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~ 782 (897)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 6789999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-16 Score=178.81 Aligned_cols=168 Identities=26% Similarity=0.394 Sum_probs=130.4
Q ss_pred ceEEEEEeeeeccchHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEecC
Q 002642 700 TNLATVTEYMVNGSLKQVLRR--KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 700 ~~l~LVmEy~~GGsL~d~L~~--~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDFG 777 (897)
.++||.|+++...+|.+||.. .....++...+.++.|++.+++| +|.+|||+||.||+.. .+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhh
Confidence 468999999999999999964 33456777888999999999999 9999999999999997 56689999999
Q ss_pred Ccccccccc-------ccCCcccCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 002642 778 LSKIKQKTL-------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 778 LAk~~~~~~-------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLt-Gk~PF~~~~~~eil~~Ii~~~ 849 (897)
+........ ......||..||+||.+.++. |+.|+||||||++|+|++. =..+|... ..+..+-.+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCC
Confidence 987544333 334667999999999999766 8999999999999999988 22333221 2233344444
Q ss_pred CCCCCCCCCcHHHHHHHHHhhccCCCCCCCH
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAF 880 (897)
Q Consensus 850 l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa 880 (897)
+++.+-...|. -..|+.++|...|.+||++
T Consensus 477 ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 477 IPPEFLQDYPE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred CChHHhhcCcH-HHHHHHHhcCCCcccCchH
Confidence 44344444443 4579999999999999943
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-15 Score=168.09 Aligned_cols=133 Identities=14% Similarity=0.096 Sum_probs=107.8
Q ss_pred ccccccccccceeccccccCC-cceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 411 GLSNLVESHLACHSTCNVAGD-QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
+|-+..||++|.--|+.+-.. +-.+.+|||++|++-.-+-+. |.++-.-.=+++++..+||.||| ...+|||||
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh---~~~~IIHRD 204 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLH---EERKIIHRD 204 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hccCeeecc
Confidence 677889999999999999888 488999999999997765543 55666666778899999999999 446799999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||||||+++.++.||+| .|+. .+....+-.||..++.++ ...+.++.++| |+|||++-
T Consensus 205 IKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sD-IWSLGLsl 267 (364)
T KOG0581|consen 205 IKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSD-IWSLGLSL 267 (364)
T ss_pred CCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccc-eecccHHH
Confidence 999999999999999999 6662 222222344666677666 56669999999 99999876
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-14 Score=150.27 Aligned_cols=144 Identities=14% Similarity=0.151 Sum_probs=105.1
Q ss_pred EEec-ccCceEEEEeeecCccEEEEEecCCcccCCC-----hhHHHHHHHHHHHHHHHhhCCCCce--eeEeeeeecCCC
Q 002642 628 KELG-SGTFGTVFYGKWKGSDVAIKRIKPSCFAEGS-----LEEDRLIADFWREAHMLGQIHHPNV--VAFYGVVTDGPV 699 (897)
Q Consensus 628 k~LG-kG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~-----~~~~~~~~~fl~Ei~iL~~L~HPNI--Vkl~g~~~e~~~ 699 (897)
..|| .|+.|+||.+...+..++||.+.......+- .........+.+|+.++..+.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 8888889888888889999988543211000 0111234667889999999998775 666665443221
Q ss_pred c--eEEEEEeeeec-cchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeccCCCCCCeEEEEec
Q 002642 700 T--NLATVTEYMVN-GSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 700 ~--~l~LVmEy~~G-GsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~GIVHRDIKPeNILLd~~~~~~g~VKLiDF 776 (897)
. ..++|||+++| .+|.+++... .+++. .+.||+.+|.+||+.||+||||||+|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 6899888643 34443 356899999999999999999999999998 4568999999
Q ss_pred CCccc
Q 002642 777 GLSKI 781 (897)
Q Consensus 777 GLAk~ 781 (897)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.2e-16 Score=185.31 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=191.1
Q ss_pred CCCceEEEEecccCceEEEEeeec---CccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCC-CCceeeEeeeeec
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTD 696 (897)
Q Consensus 621 ~~~Yeilk~LGkG~fG~Vylg~~k---g~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~-HPNIVkl~g~~~e 696 (897)
...|.+.+.||+|+|+.|-+.... ...+|+|.+.... ........+..|..+-+.+. |+|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCC
Confidence 457888888999999999877653 2236666654332 11223445556788877776 9999999998887
Q ss_pred CCCceEEEEEeeeeccchHHHH-hhccccccHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEeccCCCCCC-eEEE
Q 002642 697 GPVTNLATVTEYMVNGSLKQVL-RRKDRTIDRRKRIIIAMDAAFGIEYLH-EKNIVHFDLKSHNFLVNMRDPQRP-VCKI 773 (897)
Q Consensus 697 ~~~~~l~LVmEy~~GGsL~d~L-~~~~~~lse~~~l~Ia~QLl~AL~yLH-s~GIVHRDIKPeNILLd~~~~~~g-~VKL 773 (897)
. ...+++++|..|+++++-+ .......+...+..++.|+..++.|+| ..++.||||||+|.+++ ..+ .+|+
T Consensus 93 ~--~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~ 166 (601)
T KOG0590|consen 93 P--RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKI 166 (601)
T ss_pred C--cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccC
Confidence 6 6788899999999999988 443325666677788999999999999 99999999999999998 555 8999
Q ss_pred EecCCcccccc-c---cccCCccc-CCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHh
Q 002642 774 GDLGLSKIKQK-T---LISGGVRG-TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEII-AGIIK 847 (897)
Q Consensus 774 iDFGLAk~~~~-~---~~~~~~~G-T~~Y~APEvl~g~~~~~s~ksDIWSLGvILyELLtGk~PF~~~~~~eil-~~Ii~ 847 (897)
.|||+|..... . ......+| ++.|+|||.+.+. .+..+..|+||.|+++.-+++|..||......... .....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 99999985443 1 22234567 9999999999864 35678999999999999999999999776543321 11111
Q ss_pred c--CCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002642 848 G--NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885 (897)
Q Consensus 848 ~--~l~~~~p~~ls~el~dLI~kcL~~DPeeRPTa~ELLq 885 (897)
. .........++....+++.+++..+|..|.+.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 1122344567888999999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.9e-14 Score=132.38 Aligned_cols=132 Identities=23% Similarity=0.146 Sum_probs=108.2
Q ss_pred EEEEecccCceEEEEeeecCccEEEEEecCCcccCCChhHHHHHHHHHHHHHHHhhCCC--CceeeEeeeeecCCCceEE
Q 002642 626 YIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH--PNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 626 ilk~LGkG~fG~Vylg~~kg~~VAVK~ik~~~~~~~~~~~~~~~~~fl~Ei~iL~~L~H--PNIVkl~g~~~e~~~~~l~ 703 (897)
+++.||+|.++.||+++..+..+++|....... ...+.+|+.+++.+.| +++++++.+.... ...+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccE
Confidence 457899999999999999888899998864311 3467788999998876 5888888877765 6789
Q ss_pred EEEeeeeccchHHHHhhccccccHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCeEeccCCCCCCeEEEEecCCcc
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK---NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 704 LVmEy~~GGsL~d~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs~---GIVHRDIKPeNILLd~~~~~~g~VKLiDFGLAk 780 (897)
++|||+++..+..+ +......++.+++.+|++||.. +++|+|++|+||+++ ..+.++++|||.+.
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999998877654 3345566788999999999985 799999999999998 56789999999886
Q ss_pred c
Q 002642 781 I 781 (897)
Q Consensus 781 ~ 781 (897)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.3e-15 Score=169.12 Aligned_cols=135 Identities=13% Similarity=0.132 Sum_probs=108.9
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
++-+|+|+|||+|.|+|...+--++|.|||+.|++-.=+-+.....+.-...|..+.|.|+|.+||+.+. +||||+
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~----~IHRDL 329 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN----YIHRDL 329 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC----ccchhh
Confidence 6789999999999999988775679999999999877666644667778889999999999999999665 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCCC--CCCCccccccceee--ccc-cccCCccccccccccccCCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNNM--NYRNGTASGCNMKN--GTK-NLQGGVASSMDLLYNLSLSSS 550 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~~--~~~~~~~~gt~~v~--gt~-~~~g~~t~ksD~VySf~~ss~ 550 (897)
-+.|||+|++..+|||| |||.. +.-.....+-+-+. .++ +..+++|.||| |+||||.-.
T Consensus 330 AARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSD-VWSFGVlL~ 395 (468)
T KOG0197|consen 330 AARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSD-VWSFGVLLW 395 (468)
T ss_pred hhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccc-eeehhhhHH
Confidence 99999999999999999 99932 22112222222222 122 68899999999 999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.2e-15 Score=159.06 Aligned_cols=136 Identities=13% Similarity=0.063 Sum_probs=109.2
Q ss_pred hhccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceec
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHr 488 (897)
...|.+++|||++.+.+++...+..++++||++++++..++.......+++.....+..|.++||+|||... ||||
T Consensus 51 ~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----iiH~ 126 (285)
T cd05631 51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER----IVYR 126 (285)
T ss_pred HHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EEeC
Confidence 457889999999999999998888889999999999877665544556888888999999999999999654 9999
Q ss_pred CCCCCCcccCCCCCeeEcc--cCCCC-C-CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 489 ELENEKLLIDSEESANISG--LSNNM-N-YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DIK~SNILLD~~~~aKIsD--Lar~~-~-~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||||+|||||++..+||+| +++.. . .......|+..+..++ ...+.++.++| |||+|+.-
T Consensus 127 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-vwslGvil 191 (285)
T cd05631 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPD-WWGLGCLI 191 (285)
T ss_pred CCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccC-chhHHHHH
Confidence 9999999999999999999 66621 1 1111222444555555 45668899999 99999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.9e-14 Score=140.61 Aligned_cols=143 Identities=16% Similarity=0.053 Sum_probs=95.2
Q ss_pred EEEecccCceEEEEeeec-CccEEEEEecCCcccCCChhHH----------------HHHHHHHHHHHHHhhCCCCc--e
Q 002642 627 IKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEED----------------RLIADFWREAHMLGQIHHPN--V 687 (897)
Q Consensus 627 lk~LGkG~fG~Vylg~~k-g~~VAVK~ik~~~~~~~~~~~~----------------~~~~~fl~Ei~iL~~L~HPN--I 687 (897)
.+.||+|+||+||++... ++.||||+++............ ........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 7889999987542211110000 00011135566666654332 3
Q ss_pred eeEeeeeecCCCceEEEEEeeeeccchHH-HHhhccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeccCC
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQ-VLRRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMRD 765 (897)
Q Consensus 688 Vkl~g~~~e~~~~~l~LVmEy~~GGsL~d-~L~~~~~~lse~~~l~Ia~QLl~AL~yLHs-~GIVHRDIKPeNILLd~~~ 765 (897)
.+.++. ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|+ .||+||||||+||+++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 344332 13589999999854322 121111 11 5567889999999999999 9999999999999996
Q ss_pred CCCCeEEEEecCCccccc
Q 002642 766 PQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 766 ~~~g~VKLiDFGLAk~~~ 783 (897)
++.++|+|||.+....
T Consensus 150 --~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 --DGKVYIIDVPQAVEID 165 (187)
T ss_pred --CCcEEEEECccccccc
Confidence 4679999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.8e-15 Score=157.66 Aligned_cols=134 Identities=10% Similarity=-0.022 Sum_probs=103.6
Q ss_pred hccccccccccceecccccc----CCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCc
Q 002642 410 YGLSNLVESHLACHSTCNVA----GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKP 485 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~I 485 (897)
..|.+++|||+|++.|++.. .....+++||++++++...+-+ ...++|...+.+.+|++.||+|||.. ..+
T Consensus 70 ~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~ 144 (283)
T PHA02988 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY---TNK 144 (283)
T ss_pred HHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc---CCC
Confidence 58899999999999999866 2345699999999998877654 35789999999999999999999943 237
Q ss_pred eecCCCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccccc---cCCccccccccccccCCC
Q 002642 486 IHPELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTKNL---QGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 486 IHrDIK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~~~---~g~~t~ksD~VySf~~ss 549 (897)
+||||||+|||+|+++.+||+| +++..........|+..+..++.. .+.++.|+| |||||+.-
T Consensus 145 ~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~D-i~SlGvil 212 (283)
T PHA02988 145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD-IYSLGVVL 212 (283)
T ss_pred CCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhh-hhHHHHHH
Confidence 7999999999999999999999 776221111112233334444422 257899999 99999765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=159.54 Aligned_cols=133 Identities=13% Similarity=0.162 Sum_probs=106.1
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++...+..++++||+++++++..+.+ ...+++.....+..|.+.||+|||... |||||
T Consensus 47 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrD 120 (328)
T cd05593 47 RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK----IVYRD 120 (328)
T ss_pred HHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecc
Confidence 468899999999999999988999999999999998766544 356888888889999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCCCC--ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||||++..+||+| +++. ..... ....|+..+..++ ......+.++| ||++|+.-
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslGvil 185 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD-WWGLGVVM 185 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCC-ccccchHH
Confidence 999999999999999999 7762 11111 1122344445555 44567889999 99999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=159.17 Aligned_cols=135 Identities=11% Similarity=0.025 Sum_probs=99.3
Q ss_pred hccccc-cccccceeccccccCCc-ceeEeecccCCceeeeeeccc----------------------------------
Q 002642 410 YGLSNL-VESHLACHSTCNVAGDQ-FFLSHTAINNPSTFVRVMNTK---------------------------------- 453 (897)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---------------------------------- 453 (897)
..|.++ +|||+|.+.|.|...+. .++++||++++++...+-...
T Consensus 62 ~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (338)
T cd05102 62 KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQ 141 (338)
T ss_pred HHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccccc
Confidence 356777 89999999999976554 568999999998754332210
Q ss_pred --------------------------ccccccchhhhHHHHHhhhhhhccCCCCCCCceecCCCCCCcccCCCCCeeEcc
Q 002642 454 --------------------------DDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPELENEKLLIDSEESANISG 507 (897)
Q Consensus 454 --------------------------~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDIK~SNILLD~~~~aKIsD 507 (897)
...+++...+.+.+|.++||+|||.. .||||||||+|||+|++..+||+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~D 217 (338)
T cd05102 142 ASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICD 217 (338)
T ss_pred CCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEee
Confidence 23577888888999999999999954 499999999999999999999999
Q ss_pred --cCCCC--CCCCc---cccccceeeccc-cccCCccccccccccccCCC
Q 002642 508 --LSNNM--NYRNG---TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 508 --Lar~~--~~~~~---~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
+|+.. ..... +..++..+..++ .....++.|+| |||||+.-
T Consensus 218 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD-iwslG~il 266 (338)
T cd05102 218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSD-VWSFGVLL 266 (338)
T ss_pred cccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccC-HHHHHHHH
Confidence 77621 11111 111122344444 45667899999 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-14 Score=158.61 Aligned_cols=133 Identities=13% Similarity=0.153 Sum_probs=106.3
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++...+..++++||+.++.++.++.+ .+.+++.....+..|.+.||+|||... |||||
T Consensus 47 ~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~----ivHrD 120 (323)
T cd05571 47 RVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD----VVYRD 120 (323)
T ss_pred HHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeCC
Confidence 367899999999999999999989999999999998776654 457888888888899999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCCCC--ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||||++..+||+| +|+. ..... ....|+..+..++ .....++.++| ||++|+.-
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlG~il 185 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD-WWGLGVVM 185 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCcccc-Ccccchhh
Confidence 999999999999999999 7762 11111 1122344445554 44566889999 99999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=157.70 Aligned_cols=133 Identities=17% Similarity=0.178 Sum_probs=106.0
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||+|.+.+++...+..++++||++.+.+...+.. .+.+++.....+..|.++||+|||... |+|||
T Consensus 45 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~HrD 118 (312)
T cd05585 45 TVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFN----VIYRD 118 (312)
T ss_pred HHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeCC
Confidence 468899999999999999998999999999999998876654 456888888889999999999999644 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCCCCc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~~~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|+++.+||+| +++. ...... ...|+..+..++ .....++.++| ||++|+..
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwslGvil 183 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD-WWTLGVLL 183 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccc-eechhHHH
Confidence 999999999999999999 7762 111111 112344444444 44566889999 99999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-14 Score=156.97 Aligned_cols=133 Identities=13% Similarity=0.166 Sum_probs=104.8
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+.+++|||++++.+++...+..++++||+.++.+...+.+ ...+++.....+..|.+.||+|||. ...||||||
T Consensus 48 ~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDi 122 (325)
T cd05594 48 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS---EKNVVYRDL 122 (325)
T ss_pred HHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCC
Confidence 57789999999999999888888999999999988765543 3568888888899999999999994 235999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-C-CCCC-ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-M-NYRN-GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~-~~~~-~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||+|++..+||+| +++. . .... ....|+..+..++ ...+.++.++| ||++|+.-
T Consensus 123 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 186 (325)
T cd05594 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD-WWGLGVVM 186 (325)
T ss_pred CCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccc-ccccccee
Confidence 99999999999999999 6662 1 1111 1122444455554 44567889999 99999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=158.76 Aligned_cols=133 Identities=14% Similarity=0.159 Sum_probs=106.1
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++...+..++++||+.+++++.++.+ .+.+++.....+..|.+.||+|||... |||||
T Consensus 47 ~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~D 120 (323)
T cd05595 47 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD----VVYRD 120 (323)
T ss_pred HHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecC
Confidence 478899999999999999988889999999999998765543 357888888899999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCC--CCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNY--RNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~--~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||||++..+||+| +++. ... ......|+..+..++ ...+.++.++| ||++|+.-
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlGvil 185 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD-WWGLGVVM 185 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhc-hhhhHHHH
Confidence 999999999999999999 6662 111 111122444455555 45667899999 99999765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-14 Score=153.08 Aligned_cols=134 Identities=13% Similarity=0.117 Sum_probs=103.8
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.|++..++..++++||+..+++...+.. ..+.++|...++...|.++||+|||.. .|||||
T Consensus 58 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~d 132 (266)
T cd05064 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM----GYVHKG 132 (266)
T ss_pred HHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecc
Confidence 467889999999999999999999999999999987654433 346789999999999999999999954 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCC-Cc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYR-NG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~-~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+||||+++..+|++| ++... ... .. ...++.....++ ...+.++.++| |||+|+.-
T Consensus 133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-i~slG~~l 198 (266)
T cd05064 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD-VWSFGIVM 198 (266)
T ss_pred ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhH-HHHHHHHH
Confidence 999999999999999999 33311 110 00 111122233444 45678899999 99999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.5e-15 Score=162.32 Aligned_cols=132 Identities=14% Similarity=0.154 Sum_probs=102.5
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
.+|..++|||+|+|+-|+-.++.-+||+|||+.|-+...+.+. +.+.=..--+--.|.|.||++||.-. |||||
T Consensus 61 ~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~----IiHRD 134 (429)
T KOG0595|consen 61 KILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN----IIHRD 134 (429)
T ss_pred HHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eeecc
Confidence 4799999999999999998888888999999999887766655 23333333444569999999999444 99999
Q ss_pred CCCCCcccCCC------CCeeEcc--cCCCCCCCC--ccccccceeeccc-cccCCccccccccccccCC
Q 002642 490 LENEKLLIDSE------ESANISG--LSNNMNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLS 548 (897)
Q Consensus 490 IK~SNILLD~~------~~aKIsD--Lar~~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~s 548 (897)
|||.||||+.. -..||+| +||...... .+.-|+..++.++ .+.++++.|.| .+|.|.-
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKAD-LWSiG~I 203 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKAD-LWSIGTI 203 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhh-HHHHHHH
Confidence 99999999886 4689999 999322212 2333555666666 56899999999 9999853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-14 Score=155.96 Aligned_cols=135 Identities=14% Similarity=0.085 Sum_probs=102.4
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecc-----------------cccccccchhhhHHHHHhhh
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT-----------------KDDMLTGSKLERHEVQCQAL 472 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~ 472 (897)
-.|.+++|||+++++|++...+..++++||+.++++...+... ....++|...+++..|.++|
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 150 (304)
T cd05096 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150 (304)
T ss_pred HHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 3578899999999999999999999999999998876543221 12356788889999999999
Q ss_pred hhhccCCCCCCCceecCCCCCCcccCCCCCeeEcc--cCCCCCCCC---c--cccccceeeccc-cccCCcccccccccc
Q 002642 473 YENFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNMNYRN---G--TASGCNMKNGTK-NLQGGVASSMDLLYN 544 (897)
Q Consensus 473 ~~~~h~~~~~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~~~~~---~--~~~gt~~v~gt~-~~~g~~t~ksD~VyS 544 (897)
|+|||... ||||||||+||||+++..+||+| +++...... . ...++..+..++ ...+.++.++| |||
T Consensus 151 l~~lH~~~----ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-v~s 225 (304)
T cd05096 151 MKYLSSLN----FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD-VWA 225 (304)
T ss_pred HHHHHHCC----ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhh-hHH
Confidence 99999554 99999999999999999999999 776211110 0 011122233333 35577899999 999
Q ss_pred ccCCC
Q 002642 545 LSLSS 549 (897)
Q Consensus 545 f~~ss 549 (897)
||+.-
T Consensus 226 lG~~l 230 (304)
T cd05096 226 FGVTL 230 (304)
T ss_pred HHHHH
Confidence 99764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-15 Score=157.39 Aligned_cols=135 Identities=15% Similarity=0.122 Sum_probs=104.0
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
-.|.+++|||++++.|+|...+..++++||++.+++...+.......+++..++.+..|+|+||+|||.. .|||+|
T Consensus 53 ~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~ 128 (259)
T PF07714_consen 53 QILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGN 128 (259)
T ss_dssp HHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccc
Confidence 4678999999999999999888889999999999998888887788899999999999999999999954 399999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCCCc----cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNG----TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~~~----~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|+++|||||+++.+||+| +++.. ..... ..........++ ...+..|.|+| ||+||+.-
T Consensus 129 l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksD-VysfG~~l 195 (259)
T PF07714_consen 129 LSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSD-VYSFGMLL 195 (259)
T ss_dssp -SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHH-HHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 999999999999999999 55522 11000 110111222232 34567899999 99999765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.4e-14 Score=152.63 Aligned_cols=132 Identities=14% Similarity=0.071 Sum_probs=101.7
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+++++|||+|++.|+|. ++..++++||++++++...+.. ..+.++|...+.+..|.++||+|||... ||||||
T Consensus 62 ~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~----iiH~dl 135 (279)
T cd05111 62 AMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR----MVHRNL 135 (279)
T ss_pred HHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC----Eecccc
Confidence 468999999999999985 4566789999999988766543 3568999999999999999999999544 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC--CCCC-Ccc--ccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN--MNYR-NGT--ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~--~~~~-~~~--~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||+|++..+||+| +++. .... ... ..++..+..++ ...+.++.++| ||+||+.-
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D-v~slG~il 201 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD-VWSYGVTV 201 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhh-HHHHHHHH
Confidence 99999999999999999 6651 1111 111 11222233333 45678899999 99999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=167.68 Aligned_cols=135 Identities=10% Similarity=0.053 Sum_probs=105.5
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeec--ccccccccchhhhHHHHHhhhhhhccCCCCCCCcee
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMN--TKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIH 487 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIH 487 (897)
..|.+++|||+|++.+++...+..+|++||++++++...+.. .....+++.....+..|.++||+|||.. .|||
T Consensus 117 ~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH 192 (478)
T PTZ00267 117 HCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMH 192 (478)
T ss_pred HHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEE
Confidence 478899999999999999999999999999999998765432 2245677777777888999999999954 4999
Q ss_pred cCCCCCCcccCCCCCeeEcc--cCCCCCCC-----Cccccccceeeccc-cccCCccccccccccccCCC
Q 002642 488 PELENEKLLIDSEESANISG--LSNNMNYR-----NGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 488 rDIK~SNILLD~~~~aKIsD--Lar~~~~~-----~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||||+|||||++..+||+| +|+..... ..+..||..+..++ .....++.++| ||++|+.-
T Consensus 193 rDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-v~slG~~l 261 (478)
T PTZ00267 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD-MWSLGVIL 261 (478)
T ss_pred CCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHh-HHHHHHHH
Confidence 99999999999999999999 77721111 11112444455554 44567899999 99999764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=160.17 Aligned_cols=133 Identities=13% Similarity=0.111 Sum_probs=105.6
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||+|++.|++...+..++++||+..+++...+.. .+.+++.....+..|.+.||+|||... |||||
T Consensus 83 ~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrD 156 (340)
T PTZ00426 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLN----IVYRD 156 (340)
T ss_pred HHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEccC
Confidence 468899999999999999999989999999999988766543 345777777888899999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||||++..+||+| +++.......+..|+..+..++ ......+.++| |||+|+.-
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlGvil 218 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAAD-WWTLGIFI 218 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCcccc-ccchhhHH
Confidence 999999999999999999 7763222222223444455555 34456789999 99999775
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-14 Score=158.96 Aligned_cols=133 Identities=12% Similarity=0.147 Sum_probs=104.9
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++...+..++++||++.+.+...+.+. +.++......+..|.+.||+|||... |+|||
T Consensus 70 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~d 143 (329)
T PTZ00263 70 SILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD----IIYRD 143 (329)
T ss_pred HHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eeecC
Confidence 4688999999999999999999999999999999887766543 56677777777889999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||||+++.+||+| +++.......+..|+..+..++ ......+.++| ||++|+.-
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 205 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVD-WWTMGVLL 205 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcce-eechHHHH
Confidence 999999999999999999 7762222112222444445555 44556789999 99999764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.2e-14 Score=155.82 Aligned_cols=133 Identities=11% Similarity=0.095 Sum_probs=102.9
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..+.++.|||++.++|+|.. +...++++|++.+++...+... ...+++...+...+|.+.||+|||.. .|||||
T Consensus 61 ~~l~~l~h~niv~~~g~~~~-~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~d 134 (316)
T cd05108 61 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRD 134 (316)
T ss_pred HHHHhCCCCCCCeEEEEEcC-CCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc----Ceeccc
Confidence 46889999999999999976 4567999999999987765544 45688888999999999999999954 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC--CCCCcc---ccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--NYRNGT---ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~--~~~~~~---~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+||||+++..+||+| +++.. ...... ..++..+..++ ...+.++.++| ||+||+.-
T Consensus 135 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D-i~slGv~l 201 (316)
T cd05108 135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD-VWSYGVTV 201 (316)
T ss_pred cchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh-hHHHHHHH
Confidence 999999999999999999 77621 111111 11122334444 45677899999 99999654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-14 Score=155.97 Aligned_cols=132 Identities=14% Similarity=0.177 Sum_probs=104.0
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+.+++|||++++.+++...+..++++||+.++.+...+.+ .+.+.+.....+..|.+.||+|||... |+||||
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g----ivH~di 122 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN----IIYRDL 122 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCC
Confidence 46789999999999999999999999999999988665543 356777777788899999999999654 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-CCCCC--ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-MNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||||++..+||+| +++. ..... ....|+..+..++ ......+.++| ||++|+.-
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwslG~il 186 (323)
T cd05575 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVD-WWCLGAVL 186 (323)
T ss_pred CHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcccc-ccccchhh
Confidence 99999999999999999 7762 11111 1112344455555 45567889999 99999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-14 Score=152.66 Aligned_cols=132 Identities=11% Similarity=0.116 Sum_probs=97.9
Q ss_pred cccccccccceecccccc-----CCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCce
Q 002642 412 LSNLVESHLACHSTCNVA-----GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPI 486 (897)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~II 486 (897)
|.++.|||++++.++|.. ....++++||++. .+...+.......+++.....+..|.++||+|||... ||
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~----ii 132 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VV 132 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----ee
Confidence 456689999999999852 3446799999974 4444444444556888999999999999999999654 99
Q ss_pred ecCCCCCCcccCCCCCeeEcc--cCCCCC--CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 487 HPELENEKLLIDSEESANISG--LSNNMN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 487 HrDIK~SNILLD~~~~aKIsD--Lar~~~--~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||||||+|||++++..+||+| +|+... .......|+..+..++ ......+.++| |||+|+.-
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-iwslG~il 199 (290)
T cd07862 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVD-LWSVGCIF 199 (290)
T ss_pred eCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccc-hHHHHHHH
Confidence 999999999999999999999 666211 1111122333444444 34567889999 99999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.9e-14 Score=155.82 Aligned_cols=132 Identities=12% Similarity=0.166 Sum_probs=104.5
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+.+++|||++++.+++...+..++++||+.++++..++.+ .+.+++........|.++||+|||... ||||||
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g----ivH~Dl 122 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN----IVYRDL 122 (325)
T ss_pred HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCC
Confidence 57789999999999999999999999999999988765543 457788888888999999999999654 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-CCCCC--ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-MNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||||++..+||+| +++. ..... ....|+..+..++ ...+.++.++| ||++|+.-
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwslG~il 186 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD-WWCLGAVL 186 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCc-ccccccee
Confidence 99999999999999999 7662 11111 1112333344444 45567889999 99999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.5e-14 Score=164.46 Aligned_cols=134 Identities=14% Similarity=0.044 Sum_probs=108.2
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
+..++.|||+|+++|-|....-.++++|+|++|++-.++-+. .+.++...++.-+.|||+||+|||.+. +|||||
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~----~IHRDI 288 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKN----CIHRDI 288 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCC----CcchhH
Confidence 456799999999999998777777999999999999888776 458999999999999999999999776 899999
Q ss_pred CCCCcccCCCCCeeEcc--cCCCCC-CCCccccc--cceeeccc-cccCCccccccccccccCCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNNMN-YRNGTASG--CNMKNGTK-NLQGGVASSMDLLYNLSLSSS 550 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~~~-~~~~~~~g--t~~v~gt~-~~~g~~t~ksD~VySf~~ss~ 550 (897)
=+.|+|++.+..+|||| ||+..+ .......- -..-..++ ..++.+|.|+| ||+|||...
T Consensus 289 AARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTD-V~sfGV~~~ 353 (474)
T KOG0194|consen 289 AARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTD-VWSFGVLLW 353 (474)
T ss_pred hHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccc-hhheeeeEE
Confidence 99999999999999999 988332 11111000 00122233 67889999999 999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.9e-14 Score=155.23 Aligned_cols=133 Identities=14% Similarity=0.165 Sum_probs=104.7
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++...+..++++||+.++.+..++.+ ...+++.....+..|.++||+|||... |+|||
T Consensus 50 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~d 123 (318)
T cd05582 50 DILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG----IIYRD 123 (318)
T ss_pred HHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCC
Confidence 478999999999999999998999999999999988766533 457888888999999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCC---Cccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYR---NGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~---~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++..... .....|+..+..++ ......+.++| ||++|+.-
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-iwslG~il 188 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD-WWSFGVLM 188 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccc-eeccceEe
Confidence 999999999999999999 66621111 11112333344444 33456788999 99999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.4e-14 Score=151.44 Aligned_cols=135 Identities=13% Similarity=0.125 Sum_probs=106.8
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++.+.+++..+++.++++||++++++..++.+.....+.+........|.+.||+|||... |+|||
T Consensus 45 ~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~d 120 (277)
T cd05607 45 EILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD----IVYRD 120 (277)
T ss_pred HHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC----EEEcc
Confidence 36889999999999999988888899999999998877665554556888888889999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCC--CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~--~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| ++.... .......|+..+..++ ...+.++.++| |||+|+.-
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwslGv~l 184 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD-WFAMGCSI 184 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchh-HHHHHHHH
Confidence 999999999999999999 555211 1111122333444454 44566899999 99999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-14 Score=154.55 Aligned_cols=131 Identities=13% Similarity=0.122 Sum_probs=103.5
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+++++|||++++.+++..++..++++||+..+.+..... .+.+++........|.++||+|||... ||||||
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~----ivHrdl 127 (324)
T cd05589 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENK----IVYRDL 127 (324)
T ss_pred hccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecCC
Confidence 3578999999999999999999999999999988765442 357899999999999999999999654 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCCC---CCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNNM---NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~~---~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||||++..+||+| +++.. .....+..|+..+..++ .....++.++| ||++|+.-
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-iwslG~il 191 (324)
T cd05589 128 KLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVD-WWGLGVLI 191 (324)
T ss_pred CHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccc-hhhHHHHH
Confidence 99999999999999999 66621 11111122344445554 44567789999 99999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-14 Score=154.17 Aligned_cols=132 Identities=14% Similarity=0.163 Sum_probs=101.5
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.+.+++|||+|++.+++...+..++++||+.++.+..++.+. ..++......+..|.++||+|||... ||||||
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~----ivH~Dl 122 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN----IIYRDL 122 (321)
T ss_pred HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccC
Confidence 578899999999999998889999999999999987666443 34555556667889999999999654 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-CCCCCc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-MNYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~~~~~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||||++..+||+| +++. ...... ...|+..+..++ .....++.++| ||++|+.-
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 186 (321)
T cd05603 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD-WWCLGAVL 186 (321)
T ss_pred CHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCc-ccccchhh
Confidence 99999999999999999 6662 111111 112333444444 44567889999 99999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.9e-14 Score=154.96 Aligned_cols=133 Identities=13% Similarity=0.170 Sum_probs=102.9
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++.+.+++...+..++++||+.++.++..+.+ .+.+..........|.++||+|||... |||||
T Consensus 52 ~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~d 125 (323)
T cd05584 52 NILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG----IIYRD 125 (323)
T ss_pred HHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCC
Confidence 468899999999999999988889999999999988766543 355666666677889999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CC-CC-Cccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MN-YR-NGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~-~~-~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++. .. .. .....|+..+..++ ......+.++| ||++|+.-
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 190 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVD-WWSLGALM 190 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcce-ecccHHHH
Confidence 999999999999999999 6662 11 11 11112444455555 34456788999 99999765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.8e-14 Score=150.28 Aligned_cols=132 Identities=11% Similarity=0.037 Sum_probs=99.6
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.++++.|||+|++.|+|...+..++++||++++++...+- ...+.+++..++.+.+|.++||+|||.. .||||||
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dl 143 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWKITVAQQLASALSYLEDK----NLVHGNV 143 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCC
Confidence 5789999999999999999999999999999998755443 3367788888999999999999999955 4999999
Q ss_pred CCCCcccCCCCC-------eeEcc--cCCCCCCCCccccccceeeccc-c-ccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEES-------ANISG--LSNNMNYRNGTASGCNMKNGTK-N-LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~-------aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~-~~g~~t~ksD~VySf~~ss 549 (897)
||+||||+++.. .|++| +++...... ...++..+..++ . ....++.++| ||+||+.-
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~aPe~~~~~~~~~~~~D-v~slG~~l 211 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-ERVERIPWIAPECVPGGNSLSTAAD-KWSFGTTL 211 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCcccccccccc-ccccCCcccCchhhcCCCCCCcHHH-HHHHHHHH
Confidence 999999987543 68999 544111000 111222344444 2 2356789999 99999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.4e-14 Score=154.76 Aligned_cols=133 Identities=14% Similarity=0.114 Sum_probs=106.2
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++..++..++++||++.+++...+-+ .+.+++.....+..|.+.||+|||... |||||
T Consensus 53 ~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----ivH~d 126 (333)
T cd05600 53 DILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG----YIHRD 126 (333)
T ss_pred HHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccC
Confidence 468899999999999999999999999999999988776533 456777777888899999999999554 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +|+..........|+..++.++ .....++.++| ||++|+.-
T Consensus 127 lkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwslG~il 188 (333)
T cd05600 127 LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVD-YWSLGCML 188 (333)
T ss_pred CCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccc-eecchHHH
Confidence 999999999999999999 7762221112223444555555 44557899999 99999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.7e-14 Score=157.73 Aligned_cols=133 Identities=13% Similarity=0.096 Sum_probs=104.0
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||+|++++++..++..+++++++.. .+...+.+ ....++|...+.+..|.++||+|||... |||||
T Consensus 109 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrD 182 (357)
T PHA03209 109 MLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR----IIHRD 182 (357)
T ss_pred HHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCC
Confidence 468899999999999999999999999999954 44444433 3567899999999999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CC-CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MN-YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~-~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+||||+++..+||+| +++. .. .......|+..+..++ .....++.++| ||++|+.-
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlGvvl 246 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKAD-IWSAGIVL 246 (357)
T ss_pred CCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhh-HHHHHHHH
Confidence 999999999999999999 6652 11 1111222444455555 44567899999 99999765
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.1e-14 Score=164.97 Aligned_cols=133 Identities=14% Similarity=0.130 Sum_probs=102.5
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
-+|.+|+|||+|++++++..++..+|+++++. +.+...+ ......++|...+.+.+|.++||+|||... |||||
T Consensus 212 ~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g----IvHrD 285 (461)
T PHA03211 212 RLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGEG----IIHRD 285 (461)
T ss_pred HHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----EEECc
Confidence 47889999999999999999999999999995 4443333 333457999999999999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC--C-CCCc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--N-YRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~--~-~~~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+||||+++..+||+| +|+.. . .... ...||..+..++ .....++.++| |||||+.-
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sD-vwSlGviL 352 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVD-IWSAGLVI 352 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHH-HHHHHHHH
Confidence 999999999999999999 77621 1 1111 112333444444 44567899999 99999864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-14 Score=146.96 Aligned_cols=134 Identities=11% Similarity=0.050 Sum_probs=104.1
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++.+.++|...+..++++||++++++...+... .+.++|........|.+.||+|||... |+|||
T Consensus 51 ~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~d 125 (256)
T cd05114 51 KVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS----FIHRD 125 (256)
T ss_pred HHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccc
Confidence 5788999999999999999999999999999999887654433 467899999999999999999999554 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCCCcc---ccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGT---ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~~~~---~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+||++++++.+||+| +++.. ...... ..++..+..++ ......+.++| ||+||+.-
T Consensus 126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-i~s~G~~l 191 (256)
T cd05114 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD-VWSFGVLM 191 (256)
T ss_pred cCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhh-hHHHHHHH
Confidence 999999999999999999 66521 111111 11112233344 34456789999 99999654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.9e-14 Score=158.98 Aligned_cols=135 Identities=13% Similarity=0.044 Sum_probs=102.1
Q ss_pred hccccc-cccccceeccccccCCcceeEeecccCCceeeeeeccc-----------------------------------
Q 002642 410 YGLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK----------------------------------- 453 (897)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------- 453 (897)
-.|.++ +|||+|+++|+|...+..++++||++.++++..+....
T Consensus 93 ~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (374)
T cd05106 93 KILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSG 172 (374)
T ss_pred HHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccc
Confidence 356677 89999999999999999999999999998876543221
Q ss_pred ---------------------------------ccccccchhhhHHHHHhhhhhhccCCCCCCCceecCCCCCCcccCCC
Q 002642 454 ---------------------------------DDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPELENEKLLIDSE 500 (897)
Q Consensus 454 ---------------------------------~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDIK~SNILLD~~ 500 (897)
...+++...+.+..|.++||+|||.. .||||||||+|||+|++
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~ 248 (374)
T cd05106 173 FSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDG 248 (374)
T ss_pred ccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCC
Confidence 12467777788999999999999954 49999999999999999
Q ss_pred CCeeEcc--cCCCC-CCCCccc----cccceeeccc-cccCCccccccccccccCCC
Q 002642 501 ESANISG--LSNNM-NYRNGTA----SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 501 ~~aKIsD--Lar~~-~~~~~~~----~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
..+||+| +++.. ....... .++..+..++ ...+.++.++| |||+|+.-
T Consensus 249 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwSlGvil 304 (374)
T cd05106 249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSD-VWSYGILL 304 (374)
T ss_pred CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCcccc-HHHHHHHH
Confidence 9999999 77621 1111111 1112244444 45677899999 99999664
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.42 E-value=6e-14 Score=153.98 Aligned_cols=134 Identities=8% Similarity=0.085 Sum_probs=104.6
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++..++..++++||++.+++...+.+. ..+++.....+..|.+.||+|||. ...|||||
T Consensus 55 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~d 129 (331)
T cd06649 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE---KHQIMHRD 129 (331)
T ss_pred HHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCC
Confidence 3678999999999999999999999999999999887665433 457777888899999999999994 33599999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| +++.. ........|+..+..++ .....++.++| ||++|+.-
T Consensus 130 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-iwslG~il 192 (331)
T cd06649 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD-IWSMGLSL 192 (331)
T ss_pred CChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHh-HHHHHHHH
Confidence 999999999999999999 66621 11111122344455555 34567899999 99999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.6e-14 Score=173.60 Aligned_cols=132 Identities=11% Similarity=0.095 Sum_probs=106.3
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..+.+++|||+|+++|+|...+..++++||++++++...+. .++|..+.++.+|.|+||+|||+.. .+.|||||
T Consensus 735 ~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~d 808 (968)
T PLN00113 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGN 808 (968)
T ss_pred HHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCC-CCCeecCC
Confidence 46789999999999999999999999999999999876653 3899999999999999999999653 45699999
Q ss_pred CCCCCcccCCCCCeeEcc-cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG-LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD-Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|+++.+++.. +++.... .....++..+..++ ...+.++.|+| ||+||+.-
T Consensus 809 lkp~Nil~~~~~~~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sD-v~S~Gvvl 868 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLRLSLPGLLCT-DTKCFISSAYVAPETRETKDITEKSD-IYGFGLIL 868 (968)
T ss_pred CCHHhEEECCCCceEEEecccccccc-CCCccccccccCcccccCCCCCcccc-hhhHHHHH
Confidence 999999999999999876 4441111 11112334566666 45677999999 99999875
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.7e-14 Score=152.55 Aligned_cols=132 Identities=14% Similarity=0.163 Sum_probs=101.7
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
.|.+++|||++++.+++...+..++++||+.++.+...+.+. +.+.......+..|.++||+|||... ||||||
T Consensus 49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g----iiHrDl 122 (325)
T cd05602 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN----IVYRDL 122 (325)
T ss_pred HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCC
Confidence 567899999999999999999999999999999887766543 34444555567889999999999654 999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-CCCCC--ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-MNYRN--GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~~~~~--~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||+|++..+||+| +|+. ..... ....|+..+..++ .....++.++| ||++|+.-
T Consensus 123 kp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 186 (325)
T cd05602 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVD-WWCLGAVL 186 (325)
T ss_pred CHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccc-cccccHHH
Confidence 99999999999999999 7762 11111 1112344444444 44567889999 99999775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=4e-14 Score=152.23 Aligned_cols=133 Identities=13% Similarity=0.124 Sum_probs=104.3
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++..++..++++||++.+++...+.+ .+.+++.....+..|.+.||+|||... |+|||
T Consensus 53 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~d 126 (291)
T cd05612 53 RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE----IVYRD 126 (291)
T ss_pred HHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecC
Confidence 368899999999999999888888899999999987665533 356788888889999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++.......+..|+..+..++ ......+.++| |||+|+.-
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlG~il 188 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVD-WWALGILI 188 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhh-HHHHHHHH
Confidence 999999999999999999 7763221111222344455555 34455788999 99999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.6e-14 Score=157.03 Aligned_cols=135 Identities=13% Similarity=0.033 Sum_probs=102.2
Q ss_pred hccccc-cccccceeccccccCCcceeEeecccCCceeeeeecc------------------------------------
Q 002642 410 YGLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT------------------------------------ 452 (897)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 452 (897)
..|.++ +|||+|++.|+|..++..++++||+++|.+...+-..
T Consensus 90 ~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (375)
T cd05104 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYM 169 (375)
T ss_pred HHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhh
Confidence 356777 8999999999999999999999999998775443221
Q ss_pred -------------------------------------cccccccchhhhHHHHHhhhhhhccCCCCCCCceecCCCCCCc
Q 002642 453 -------------------------------------KDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPELENEKL 495 (897)
Q Consensus 453 -------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDIK~SNI 495 (897)
....++|...+.+..|.++||+|||.. .||||||||+||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Ni 245 (375)
T cd05104 170 DMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNI 245 (375)
T ss_pred hcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhE
Confidence 123578888899999999999999954 499999999999
Q ss_pred ccCCCCCeeEcc--cCCCC-CCCCcc----ccccceeeccc-cccCCccccccccccccCCC
Q 002642 496 LIDSEESANISG--LSNNM-NYRNGT----ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 496 LLD~~~~aKIsD--Lar~~-~~~~~~----~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|++++..+||+| +++.. ...... ..++..+..++ ...+.++.++| ||+||+.-
T Consensus 246 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD-i~slG~~l 306 (375)
T cd05104 246 LLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD-VWSYGILL 306 (375)
T ss_pred EEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCC-HHHHHHHH
Confidence 999999999999 77621 111111 11112244444 45567899999 99999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.9e-14 Score=149.30 Aligned_cols=135 Identities=14% Similarity=0.070 Sum_probs=108.3
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++.+.+++..++..++++||+..+++..++.......+++.....+..|.++||+|||... |||||
T Consensus 52 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~d 127 (285)
T cd05605 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER----IVYRD 127 (285)
T ss_pred HHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC----cEecC
Confidence 47789999999999999998888999999999999987776665667899999999999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCC--CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~--~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++... .......|+..+..++ ......+.++| ||++|+.-
T Consensus 128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-iws~G~~l 191 (285)
T cd05605 128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD-WWGLGCLI 191 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCcccc-chhHHHHH
Confidence 999999999999999999 666211 1111112333444444 44567889999 99999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.4e-14 Score=155.81 Aligned_cols=95 Identities=16% Similarity=0.145 Sum_probs=84.9
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.++.|||++++.+++...+..++++||++++.+...+.+ .+.++......+..|.++||+|||... |||||
T Consensus 53 ~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g----ivHrD 126 (363)
T cd05628 53 DILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG----FIHRD 126 (363)
T ss_pred HHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecC
Confidence 467889999999999999888888999999999988877765 357888888888999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCC
Q 002642 490 LENEKLLIDSEESANISG--LSN 510 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar 510 (897)
|||+|||||++..+||+| +|+
T Consensus 127 lKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 127 IKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred CCHHHeEECCCCCEEEeeccCcc
Confidence 999999999999999999 776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.1e-14 Score=146.19 Aligned_cols=135 Identities=10% Similarity=0.050 Sum_probs=104.2
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.++|...+..++++||++.+++...+-......++|...+.+..|.++||+|||.. .|+|||
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~d 129 (263)
T cd05052 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRD 129 (263)
T ss_pred HHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecc
Confidence 4677899999999999999999999999999998887655444456789999999999999999999954 399999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCCCc---cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNG---TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~~~---~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| +++.. ..... ...++..+..++ .....++.++| ||++|+.-
T Consensus 130 lkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-v~slG~il 195 (263)
T cd05052 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD-VWAFGVLL 195 (263)
T ss_pred cCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhH-HHHHHHHH
Confidence 999999999999999999 66521 11110 111111233444 45567889999 99999654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.9e-14 Score=152.95 Aligned_cols=133 Identities=11% Similarity=0.129 Sum_probs=104.8
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.+++..++..++++||+..+++...+.+. +.++......+..|.++||+|||.. .|||||
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~D 126 (350)
T cd05573 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL----GFIHRD 126 (350)
T ss_pred HHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccC
Confidence 4688899999999999999999999999999999887766554 6788888888899999999999964 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCCCC--------------------------------ccccccceeeccc-cccCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRN--------------------------------GTASGCNMKNGTK-NLQGG 534 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~~~--------------------------------~~~~gt~~v~gt~-~~~g~ 534 (897)
|||+|||||++..+||+| +++...... ....|+..+..++ .....
T Consensus 127 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (350)
T cd05573 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206 (350)
T ss_pred CCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 999999999999999999 666211111 1112333333333 34557
Q ss_pred ccccccccccccCCC
Q 002642 535 VASSMDLLYNLSLSS 549 (897)
Q Consensus 535 ~t~ksD~VySf~~ss 549 (897)
++.++| ||++|+..
T Consensus 207 ~~~~~D-iwSlG~il 220 (350)
T cd05573 207 YGLECD-WWSLGVIL 220 (350)
T ss_pred CCCcee-eEecchhh
Confidence 899999 99999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.3e-14 Score=145.48 Aligned_cols=135 Identities=11% Similarity=0.060 Sum_probs=105.7
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..+.+++|||++++.+++..++..++++||+.++++...+.......+++...+....|.+++|+|||.. .|+|||
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~d 128 (261)
T cd05072 53 NLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRD 128 (261)
T ss_pred HHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----Ceeccc
Confidence 3567899999999999999999999999999999887766555566788999999999999999999964 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCCCC-CCc---cccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNY-RNG---TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~~~-~~~---~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++.... ... ...++..+..++ ...+..+.++| ||++|+.-
T Consensus 129 l~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-i~slG~~l 194 (261)
T cd05072 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD-VWSFGILL 194 (261)
T ss_pred cchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhh-hhhhHHHH
Confidence 999999999999999999 6662111 111 111122234444 34567889999 99999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.1e-14 Score=147.69 Aligned_cols=135 Identities=7% Similarity=0.018 Sum_probs=102.8
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeeccc--------ccccccchhhhHHHHHhhhhhhccCCCC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK--------DDMLTGSKLERHEVQCQALYENFHGMPI 481 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~h~~~~ 481 (897)
..+.+++|||++++.++|.++...++++||++.+++...+.+.. ...++|...+.+..|.++||+|||..
T Consensus 61 ~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-- 138 (277)
T cd05062 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-- 138 (277)
T ss_pred HHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45778999999999999999999999999999998876543321 23467788888899999999999954
Q ss_pred CCCceecCCCCCCcccCCCCCeeEcc--cCCCCCCC---Cc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 482 TCKPIHPELENEKLLIDSEESANISG--LSNNMNYR---NG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 482 ~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~~~~---~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
.|+||||||+|||++++..+||+| +++..... .. ...++..+..++ ...+..+.++| |||+|+.-
T Consensus 139 --~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-i~slG~~l 211 (277)
T cd05062 139 --KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD-VWSFGVVL 211 (277)
T ss_pred --CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhH-HHHHHHHH
Confidence 499999999999999999999999 66621110 00 011122344444 34567899999 99999764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.6e-14 Score=148.70 Aligned_cols=134 Identities=13% Similarity=0.067 Sum_probs=101.5
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeec----------------------ccccccccchhhhHHHH
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMN----------------------TKDDMLTGSKLERHEVQ 468 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~ 468 (897)
.|.+++|||+++++++|...+..++++||+.++++...+-. .....++|...+.+..|
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred HHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence 56789999999999999999999999999998887654221 12346889999999999
Q ss_pred HhhhhhhccCCCCCCCceecCCCCCCcccCCCCCeeEcc--cCCCC--CCCC---ccccccceeeccc-cccCCcccccc
Q 002642 469 CQALYENFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNM--NYRN---GTASGCNMKNGTK-NLQGGVASSMD 540 (897)
Q Consensus 469 ~~~~~~~~h~~~~~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~--~~~~---~~~~gt~~v~gt~-~~~g~~t~ksD 540 (897)
.+.||+|||.. .||||||||+||||+++..+||+| +++.. .... ....++..+..++ .....++.++|
T Consensus 136 i~~~l~~LH~~----~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D 211 (290)
T cd05045 136 ISRGMQYLAEM----KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211 (290)
T ss_pred HHHHHHHHHHC----CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhH
Confidence 99999999954 499999999999999999999999 66621 1110 0011111233333 34566899999
Q ss_pred ccccccCCC
Q 002642 541 LLYNLSLSS 549 (897)
Q Consensus 541 ~VySf~~ss 549 (897)
||+||+..
T Consensus 212 -i~slG~~l 219 (290)
T cd05045 212 -VWSFGVLL 219 (290)
T ss_pred -HHHHHHHH
Confidence 99999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-13 Score=147.69 Aligned_cols=134 Identities=14% Similarity=0.092 Sum_probs=103.8
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeeccc---------ccccccchhhhHHHHHhhhhhhccCCCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK---------DDMLTGSKLERHEVQCQALYENFHGMPI 481 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~h~~~~ 481 (897)
.|.+++|||++++.++|..++..++++|+++.+++...+.+.. ...+++...+.+.+|.++||+|||..
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-- 149 (296)
T cd05051 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-- 149 (296)
T ss_pred HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence 6789999999999999999999999999999888776654432 12688999999999999999999954
Q ss_pred CCCceecCCCCCCcccCCCCCeeEcc--cCCCCCCC---Cc--cccccceeeccc-cccCCccccccccccccCCC
Q 002642 482 TCKPIHPELENEKLLIDSEESANISG--LSNNMNYR---NG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 482 ~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~~~~---~~--~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
.|+||||||+|||++++..+||+| +++..... .. ...++..+..++ ...+..+.++| ||+||+.-
T Consensus 150 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-v~slG~~l 222 (296)
T cd05051 150 --NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD-VWAFGVTL 222 (296)
T ss_pred --CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccch-hhhhHHHH
Confidence 399999999999999999999999 66621110 11 111122344444 44568899999 99999653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-13 Score=148.37 Aligned_cols=134 Identities=13% Similarity=0.076 Sum_probs=102.6
Q ss_pred ccccccccccceeccccccCCcceeEeecccCCceeeeeecc----------cccccccchhhhHHHHHhhhhhhccCCC
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT----------KDDMLTGSKLERHEVQCQALYENFHGMP 480 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~h~~~ 480 (897)
.|.+++|||++.+.+++...+..++++||++++++...+... ....++|...+.+..|.++||+|||...
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 688999999999999999999999999999999876654322 1234788889999999999999999654
Q ss_pred CCCCceecCCCCCCcccCCCCCeeEcc--cCCCC-CCCCccc----cccceeeccc-cccCCccccccccccccCCC
Q 002642 481 ITCKPIHPELENEKLLIDSEESANISG--LSNNM-NYRNGTA----SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 481 ~~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~-~~~~~~~----~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|+||||||+||||++++.+||+| +++.. ....... .++..+..++ ...+.++.++| |||||+.-
T Consensus 150 ----i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwSlG~~l 221 (295)
T cd05097 150 ----FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASD-VWAFGVTL 221 (295)
T ss_pred ----eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhh-HHHHHHHH
Confidence 99999999999999999999999 66521 1111111 1111233333 45577899999 99999664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=8e-14 Score=154.34 Aligned_cols=95 Identities=14% Similarity=0.160 Sum_probs=84.6
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
-+|.+++|||++++.+++...+..++++||+.++.+...+.+. +.++......+..|.+.||+|||... |||||
T Consensus 53 ~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~----ivH~D 126 (364)
T cd05599 53 DILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG----YIHRD 126 (364)
T ss_pred HHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eEecc
Confidence 4678899999999999999999999999999999888776653 56888888888999999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCC
Q 002642 490 LENEKLLIDSEESANISG--LSN 510 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar 510 (897)
|||+|||+|++..+||+| +++
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred CCHHHeEECCCCCEEEeecccce
Confidence 999999999999999999 665
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-13 Score=144.45 Aligned_cols=136 Identities=13% Similarity=0.144 Sum_probs=104.3
Q ss_pred hhccccccccccceeccccccC-CcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCcee
Q 002642 409 QYGLSNLVESHLACHSTCNVAG-DQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIH 487 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIH 487 (897)
...|.+++|||++++.|++... +..++++||++++++.....+.....++|...+...+|.+.||+|||.. .|+|
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H 125 (256)
T cd05082 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVH 125 (256)
T ss_pred HHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEec
Confidence 3578899999999999987654 4567999999998887766555555689999999999999999999954 4999
Q ss_pred cCCCCCCcccCCCCCeeEcc--cCCCCCCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 488 PELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 488 rDIK~SNILLD~~~~aKIsD--Lar~~~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||||+|||+|++..+|++| +++.......+..++..+..++ .....++.++| ||++|+.-
T Consensus 126 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-v~slG~i~ 189 (256)
T cd05082 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD-VWSFGILL 189 (256)
T ss_pred cccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhh-hHHHHHHH
Confidence 99999999999999999999 6662111111111122344454 45567889999 99999653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-13 Score=145.76 Aligned_cols=134 Identities=12% Similarity=0.082 Sum_probs=103.1
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..+.+++|||++++.|+|...+..++++||+..+++...+-.. .+.++|...+.+.+|.+.||+|||.. .|+|+|
T Consensus 51 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~d 125 (256)
T cd05113 51 KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRD 125 (256)
T ss_pred HHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----Ceeccc
Confidence 3578899999999999999888889999999998877654433 44789999999999999999999954 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CCCCCcc---ccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MNYRNGT---ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~~~~~~---~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| +++. ....... ..++..+..++ ...+.++.++| ||++|+.-
T Consensus 126 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D-i~slG~~l 191 (256)
T cd05113 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD-VWAFGVLM 191 (256)
T ss_pred cCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhH-HHHHHHHH
Confidence 999999999999999999 5551 1111111 11122233343 34467889999 99999654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.4e-14 Score=152.63 Aligned_cols=131 Identities=13% Similarity=0.162 Sum_probs=101.3
Q ss_pred cccc-cccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecCC
Q 002642 412 LSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 412 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrDI 490 (897)
+.++ +|||+|++.+++...+..++++||++++.+..++-+ .+.+++.....+..|.+.||+|||.. .||||||
T Consensus 49 l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Di 122 (329)
T cd05618 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDL 122 (329)
T ss_pred HHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCC
Confidence 4444 899999999999999999999999999887655432 35678888888899999999999955 4999999
Q ss_pred CCCCcccCCCCCeeEcc--cCCC-CC--CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 491 ENEKLLIDSEESANISG--LSNN-MN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 491 K~SNILLD~~~~aKIsD--Lar~-~~--~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||+|||+|++..+||+| +++. .. .......|+..+..++ .....++.++| |||+|+.-
T Consensus 123 kp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il 186 (329)
T cd05618 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD-WWALGVLM 186 (329)
T ss_pred CHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccc-eecccHHH
Confidence 99999999999999999 7762 11 1111122344455555 44567788999 99999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-13 Score=147.84 Aligned_cols=136 Identities=15% Similarity=0.126 Sum_probs=105.9
Q ss_pred hhccccccccccceeccccccCCcceeEeecccCCceeeeeec--ccccccccchhhhHHHHHhhhhhhccCCCCCCCce
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMN--TKDDMLTGSKLERHEVQCQALYENFHGMPITCKPI 486 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~II 486 (897)
...|.++.|||++.+.+++...+..++++||++.+++...+.+ .....+++...+.+..|.+.||+|||... ||
T Consensus 44 ~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~ 119 (280)
T cd05608 44 KRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR----II 119 (280)
T ss_pred HHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cc
Confidence 3478899999999999999888888899999999998755433 33567899999999999999999999654 99
Q ss_pred ecCCCCCCcccCCCCCeeEcc--cCCCCC--CCC-ccccccceeeccc-cccCCccccccccccccCCC
Q 002642 487 HPELENEKLLIDSEESANISG--LSNNMN--YRN-GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 487 HrDIK~SNILLD~~~~aKIsD--Lar~~~--~~~-~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||||||+|||+|++..+||+| +++... ... ....|+..+..++ ...+..+.++| ||++|+.-
T Consensus 120 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D-vwslG~il 187 (280)
T cd05608 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD-YFALGVTL 187 (280)
T ss_pred cCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCcccc-HHHHHHHH
Confidence 999999999999999999999 665211 111 1112333444444 45667889999 99999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-13 Score=145.43 Aligned_cols=133 Identities=10% Similarity=0.040 Sum_probs=100.8
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
-.|.+++|||++++.|+|......++++||++.+++-..+ ....+.+++...+.+..|.++||+|||.. .|||||
T Consensus 56 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~d 130 (262)
T cd05077 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM-HRKSDVLTTPWKFKVAKQLASALSYLEDK----DLVHGN 130 (262)
T ss_pred HHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCC
Confidence 3678999999999999999999999999999988764332 23356788989999999999999999954 499999
Q ss_pred CCCCCcccCCCCC-------eeEcc--cCCCCCCCCccccccceeecccc--ccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEES-------ANISG--LSNNMNYRNGTASGCNMKNGTKN--LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~-------aKIsD--Lar~~~~~~~~~~gt~~v~gt~~--~~g~~t~ksD~VySf~~ss 549 (897)
|||+||||+.+.. .|++| +++..... ....++..+..++. ....++.++| ||+||+.-
T Consensus 131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~D-iwslG~~l 199 (262)
T cd05077 131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAAD-KWSFGTTL 199 (262)
T ss_pred CCcccEEEecCCccCCCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhH-HHHHHHHH
Confidence 9999999987664 78999 55421111 11112223455552 2456889999 99999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-13 Score=144.08 Aligned_cols=132 Identities=11% Similarity=0.032 Sum_probs=101.9
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.++.|||++.++|+|.. +..++++||++.+++...+... ...+++...+.+.+|.+.||+|||.. .|+|||
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~d 126 (259)
T cd05037 53 SLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK----KLVHGN 126 (259)
T ss_pred HHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC----Ceeccc
Confidence 36889999999999999988 7789999999999887655443 33788999999999999999999953 499999
Q ss_pred CCCCCcccCCCC-------CeeEcc--cCCCCCCCCccccccceeeccccc-c--CCccccccccccccCCC
Q 002642 490 LENEKLLIDSEE-------SANISG--LSNNMNYRNGTASGCNMKNGTKNL-Q--GGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~-------~aKIsD--Lar~~~~~~~~~~gt~~v~gt~~~-~--g~~t~ksD~VySf~~ss 549 (897)
|||+||||+.+. .+||+| +++....... ..++..+.+++.. . ...+.++| ||++|+..
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~~D-i~slG~~~ 196 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-RVERIPWIAPECIRNGQASLTIAAD-KWSFGTTL 196 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCcccccccccc-cccCCCccChhhhcCCCCCcchhhH-HHHHHHHH
Confidence 999999999988 799999 6662211111 1122234455532 2 36899999 99999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-13 Score=146.76 Aligned_cols=135 Identities=13% Similarity=0.109 Sum_probs=102.7
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecc---------------cccccccchhhhHHHHHhhhhh
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT---------------KDDMLTGSKLERHEVQCQALYE 474 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~ 474 (897)
..|.+++|||+++++|++..++..++++||++.+.+...+... ....+++...+.+.+|.+++|+
T Consensus 59 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 138 (283)
T cd05090 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138 (283)
T ss_pred HHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 4688999999999999998888889999999988775544211 1235788888999999999999
Q ss_pred hccCCCCCCCceecCCCCCCcccCCCCCeeEcc--cCCCC--CC---CCccccccceeeccc-cccCCcccccccccccc
Q 002642 475 NFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNM--NY---RNGTASGCNMKNGTK-NLQGGVASSMDLLYNLS 546 (897)
Q Consensus 475 ~~h~~~~~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~--~~---~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~ 546 (897)
|||... |+||||||+|||+|++..+||+| +++.. .. ......++..+..++ ...+.++.++| ||++|
T Consensus 139 ~lH~~~----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-v~slG 213 (283)
T cd05090 139 YLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD-IWSFG 213 (283)
T ss_pred HHHhcC----eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhh-hHHHH
Confidence 999654 99999999999999999999999 66621 11 011111222344444 34567899999 99999
Q ss_pred CCC
Q 002642 547 LSS 549 (897)
Q Consensus 547 ~ss 549 (897)
+.-
T Consensus 214 ~il 216 (283)
T cd05090 214 VVL 216 (283)
T ss_pred HHH
Confidence 763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-13 Score=153.80 Aligned_cols=95 Identities=15% Similarity=0.174 Sum_probs=81.5
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||+|++.+++...+..++++||++++.+...+.+ .+.++......+..|.+.||+|||... |||||
T Consensus 53 ~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g----ivHrD 126 (377)
T cd05629 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG----FIHRD 126 (377)
T ss_pred HHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccC
Confidence 467889999999999999999999999999999988766543 345565555567889999999999654 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCC
Q 002642 490 LENEKLLIDSEESANISG--LSN 510 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar 510 (897)
|||+||||+.+..+||+| +|+
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred CCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999999 774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-13 Score=148.12 Aligned_cols=134 Identities=10% Similarity=0.060 Sum_probs=101.9
Q ss_pred ccccc-cccccceeccccccCCcceeEeecccCCceeeeeeccc--------------ccccccchhhhHHHHHhhhhhh
Q 002642 411 GLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK--------------DDMLTGSKLERHEVQCQALYEN 475 (897)
Q Consensus 411 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~ 475 (897)
.++++ +|||++.+.+++...+..++++||++.++++..+.+.. .+.+++.....+..|.++||+|
T Consensus 55 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 134 (297)
T cd05089 55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY 134 (297)
T ss_pred HHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHH
Confidence 45677 69999999999999888999999999998876654421 2468888889999999999999
Q ss_pred ccCCCCCCCceecCCCCCCcccCCCCCeeEcc--cCCCCCC--CCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 476 FHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNMNY--RNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 476 ~h~~~~~~~IIHrDIK~SNILLD~~~~aKIsD--Lar~~~~--~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
||. ..||||||||+||||+++..+||+| +++.... .......+..+..++ .....++.++| |||||+.-
T Consensus 135 lH~----~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwSlG~il 208 (297)
T cd05089 135 LSE----KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD-VWSFGVLL 208 (297)
T ss_pred HHH----CCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh-HHHHHHHH
Confidence 995 3499999999999999999999999 6652111 111010111244444 34556789999 99999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.8e-14 Score=148.77 Aligned_cols=133 Identities=11% Similarity=0.082 Sum_probs=99.2
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..|.+++|||++++.++....+..++++||+++ .+... +......+++.....+..|.++||+|||.. .|||||
T Consensus 55 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~-l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~d 128 (288)
T cd07871 55 SLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQY-LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRD 128 (288)
T ss_pred HHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCC
Confidence 468899999999999999877778899999975 44333 333344577778888899999999999964 499999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC---CCCCccccccceeecccc--ccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM---NYRNGTASGCNMKNGTKN--LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~---~~~~~~~~gt~~v~gt~~--~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++.. ........++..++.++. .....+.++| |||+|+.-
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D-iwslG~~l 194 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID-MWGVGCIL 194 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHH-HHHHHHHH
Confidence 999999999999999999 66621 111112223334455552 2346789999 99999765
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-13 Score=151.73 Aligned_cols=132 Identities=11% Similarity=0.135 Sum_probs=102.8
Q ss_pred ccccc-cccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 411 GLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 411 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
.+.++ +|||++.+.+++...+..++++||++.+.+..++.+ .+.+++.....+..|.+.||+|||... |+|||
T Consensus 48 il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----ivH~d 121 (329)
T cd05588 48 VFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG----IIYRD 121 (329)
T ss_pred HHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecC
Confidence 45566 699999999999988889999999999988655433 467888888899999999999999554 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCC-CC--CCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNN-MN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~-~~--~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| +++. .. ....+..|+..+..++ .....++.++| ||++|+.-
T Consensus 122 lkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~~l 186 (329)
T cd05588 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD-WWALGVLM 186 (329)
T ss_pred CCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccc-eechHHHH
Confidence 999999999999999999 6662 11 1111122344444444 44567789999 99999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.9e-14 Score=152.71 Aligned_cols=134 Identities=9% Similarity=0.086 Sum_probs=103.6
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
-.|.+++|||+|++.|+|...+..++++||+..+++...+-+ .+.+++........|.++||+|||. ...|||||
T Consensus 55 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~d 129 (333)
T cd06650 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRD 129 (333)
T ss_pred HHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCEEecC
Confidence 357789999999999999999999999999999988765533 4567788888889999999999994 33599999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-CCCCccccccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~~~~~~~~gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||+|++..+||+| +++.. ........|+..+..++ ......+.++| ||++|+.-
T Consensus 130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwslG~il 192 (333)
T cd06650 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD-IWSMGLSL 192 (333)
T ss_pred CChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHH-HHHHHHHH
Confidence 999999999999999999 66521 11111112333445555 34456889999 99999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-13 Score=144.42 Aligned_cols=134 Identities=12% Similarity=0.063 Sum_probs=104.7
Q ss_pred hccccccccccceeccccccCCcceeEeecccCCceeeeeecccccccccchhhhHHHHHhhhhhhccCCCCCCCceecC
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~IIHrD 489 (897)
..+.+++|||++++.|++...+..++++||+.++++...+ ..+.+.++|.....+.+|.+.||+|||... |+|||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~d 132 (268)
T cd05063 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYLSDMN----YVHRD 132 (268)
T ss_pred HHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccc
Confidence 4688999999999999999999999999999988876654 344678999999999999999999999554 99999
Q ss_pred CCCCCcccCCCCCeeEcc--cCCCC-C--CCCcccc---ccceeeccc-cccCCccccccccccccCCC
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-N--YRNGTAS---GCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 IK~SNILLD~~~~aKIsD--Lar~~-~--~~~~~~~---gt~~v~gt~-~~~g~~t~ksD~VySf~~ss 549 (897)
|||+|||++++..+||+| +++.. . ....+.. .+..+..++ ...+..+.++| ||++|+.-
T Consensus 133 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D-v~slG~il 200 (268)
T cd05063 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASD-VWSFGIVM 200 (268)
T ss_pred cchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhH-HHHHHHHH
Confidence 999999999999999999 55511 1 1111110 111233344 44567899999 99999664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 897 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-44 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-43 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-39 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-39 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-39 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-33 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-33 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-32 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-32 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-32 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-32 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-32 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-32 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-32 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-31 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-31 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-31 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-31 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-31 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-31 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-31 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-31 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-30 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-30 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-30 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-30 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-30 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-30 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-29 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-29 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-29 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-29 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-29 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-29 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-29 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-29 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-29 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-29 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-29 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-29 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-29 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-29 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-29 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-29 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-29 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-29 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-29 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-29 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-29 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-28 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-28 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-28 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-28 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-27 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-27 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-27 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-27 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-27 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-27 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-27 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-27 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-27 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-27 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-27 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-27 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-27 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-27 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-27 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-26 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-26 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-26 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-26 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-26 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-26 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-26 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-26 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-26 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-26 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-26 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-26 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-26 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-26 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-26 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-26 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-26 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-26 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-26 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-26 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-26 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-26 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-26 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-26 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-26 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-26 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-26 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-26 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-26 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-26 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-26 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-26 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-26 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-26 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-26 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-26 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-26 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-26 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-25 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-25 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-25 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-25 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-25 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-25 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-25 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-25 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-25 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-25 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-25 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-25 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-25 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-25 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-25 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-25 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-25 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-25 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-25 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-25 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-25 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-25 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-25 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-25 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-25 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-25 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-25 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-25 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-25 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-24 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-24 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-24 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-24 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-23 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-23 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-23 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-23 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-23 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-21 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-21 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-21 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-21 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-21 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-21 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-21 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-21 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-21 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-21 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-21 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-19 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-18 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-18 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-16 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-15 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-15 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-120
Identities = 107/301 (35%), Positives = 169/301 (56%), Gaps = 19/301 (6%)
Query: 599 EISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCF 658
+I + YF + + I DL +++G+G+FGTV +W GSDVA+K + F
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF 73
Query: 659 AEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL 718
+ E F RE ++ ++ HPN+V F G VT P NL+ VTEY+ GSL ++L
Sbjct: 74 HAERVNE------FLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLL 125
Query: 719 RRKD--RTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIG 774
+ +D R+R+ +A D A G+ YLH +N IVH +LKS N LV+ ++ K+
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVC 181
Query: 775 DLGLSKIKQKTLISG-GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
D GLS++K T +S GT WMAPE+ + + EK DVYSFGV++WEL T ++P+
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFGVILWELATLQQPW 239
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
+L+ +++A + +IP P +++E CW+++P RP+F+ I LR + +
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
Query: 894 M 894
Sbjct: 300 A 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 362 bits (930), Expect = e-119
Identities = 103/285 (36%), Positives = 151/285 (52%), Gaps = 14/285 (4%)
Query: 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIA 670
+ L T+ +++EY K++G G FG V G+ S VAIK + EG E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS-EGETEMIEKFQ 68
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
+F RE ++ ++HPN+V YG++ + P V E++ G L L K I +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 731 IIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVC-KIGDLGLSKIKQKTLI 787
+ + +D A GIEY+ +N IVH DL+S N + D PVC K+ D GLS+ +
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI--IAGI 845
G+ G WMAPE +++ TEK D YSF ++++ +LTGE P+ + +I I I
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ L P IP C P R+++E CWS DPK RP FS I KEL +
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-118
Identities = 92/279 (32%), Positives = 142/279 (50%), Gaps = 18/279 (6%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I ++L + +G G FG V+ W G +VA+K + + S + I + +EA +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDIS----QTIENVRQEAKL 59
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ HPN++A GV P NL V E+ G L +VL K I + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 739 FGIEYLHEKN---IVHFDLKSHNFLVNMR----DPQRPVCKIGDLGLSKIKQKTLISGGV 791
G+ YLH++ I+H DLKS N L+ + D + KI D GL++ +T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
G WMAPE+ ++ + ++ DV+S+GV++WELLTGE P+ + + G+ L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
IPS C + LME CW+ DP SRP+F+ I +L +
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-117
Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 18/276 (6%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I L ++ +L G ++ G+W+G+D+ +K +K ++ R DF E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST------RKSRDFNEECPR 60
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDRTIDRRKRIIIAMDA 737
L HPNV+ G P + +T +M GSL VL + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 738 AFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
A G+ +LH I L S + +++ +I + Q G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDM----TARISMADVKFSFQSP----GRMYAP 172
Query: 796 PWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
W+APE + K + D++SF V++WEL+T E P+ADL + EI + L P I
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P P LM+ C + DP RP F I L M
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-112
Identities = 94/281 (33%), Positives = 150/281 (53%), Gaps = 22/281 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I + + +GSG+FGTV+ GKW G DVA+K + + L+ F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA------FKNEVGV 73
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
L + H N++ F G T LA VT++ SL L + + +K I IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS---GGVRGTI 795
G++YLH K+I+H DLKS+N ++ + KIGD GL+ K + S + G+I
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 796 PWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKGNL--- 850
WMAPE+ + +D N + + DVY+FG+V++EL+TG+ PY+++++ ++II + +G+L
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
K+ S C + LM C RP+F I E+ +A
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-111
Identities = 76/287 (26%), Positives = 115/287 (40%), Gaps = 27/287 (9%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I LE + +G G FG V++G+W G +VAI+ I E L+ F RE
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKA------FKREVM 81
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
Q H NVV F G P +LA +T +L V+R +D K IA +
Sbjct: 82 AYRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG------GV 791
G+ YLH K I+H DLKS N + I D GL I
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYDNG-----KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 792 RGTIPWMAPELFKSKDNLV-------TEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844
G + +APE+ + ++ DV++ G + +EL E P+ +E II
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
+ G ++ CW+ + + RP F+++ L +
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-108
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 27/285 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
L I ++E + +G G FG V KW+ DVAIK+I+ + F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIVE 51
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT--IDRRKRIII 733
L +++HPN+V YG + + V EY GSL VL + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 734 AMDAAFGIEYLHE---KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
+ + G+ YLH K ++H DLK N L+ V KI D G + Q + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT---VLKICDFGTACDIQTHMTNN- 163
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI-IAGIIKGN 849
+G+ WMAPE+F+ + +EK DV+S+G+++WE++T +P+ ++ I +
Sbjct: 164 -KGSAAWMAPEVFEGSN--YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
P + SLM RCWS DP RP+ EI K + +
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 297 bits (761), Expect = 2e-93
Identities = 84/323 (26%), Positives = 132/323 (40%), Gaps = 58/323 (17%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
+Q ++ +K++G G +G V+ GKW+G VA+K + A ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEAS-----------WFRE 79
Query: 676 A--HMLGQIHHPNVVAFYGVVTDGPV--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
+ + H N++ F G T L +T+Y NGSL L+ T+D + +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSML 137
Query: 732 IIAMDAAFGIEYLHEKN--------IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783
+A + G+ +LH + I H DLKS N LV + C I DLGL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFI 193
Query: 784 KT-----LISGGVRGTIPWMAPELFKSKDNLV----TEKVDVYSFGVVMWELLTGEE--- 831
+ GT +M PE+ N D+YSFG+++WE+
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 832 -------PYADL-----HSEEIIAGIIKGNLGPKIPSW-----CEPTWRSLMERCWSSDP 874
PY DL E++ + L P P+ C LM CW+ +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 875 KSRPAFSEITKELRAMAAAMNIK 897
SR + K L M+ + +IK
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 6e-93
Identities = 78/295 (26%), Positives = 130/295 (44%), Gaps = 34/295 (11%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ SDL + + LG G FG + + + +K + ++ F +E
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--------FDEETQRTFLKEV 58
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
++ + HPNV+ F GV+ L +TEY+ G+L+ +++ D +R+ A D
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG------ 790
A G+ YLH NI+H DL SHN LV + + D GL+++
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 791 ---------VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
V G WMAPE+ + EKVDV+SFG+V+ E++ D +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 842 IAGI-IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895
G+ ++G L P C P++ + RC DP+ RP+F ++ L + +
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 2e-84
Identities = 84/322 (26%), Positives = 129/322 (40%), Gaps = 58/322 (18%)
Query: 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
Q + + +G G FG V+ GKW+G +VA+K R ++REA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS-----------SREERSWFREA 85
Query: 677 --HMLGQIHHPNVVAFYGVVT--DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+ + H N++ F +G T L V++Y +GSL L R T+ I
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIK 143
Query: 733 IAMDAAFGIEYLHEK--------NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ- 783
+A+ A G+ +LH + I H DLKS N LV + C I DLGL+
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDS 199
Query: 784 ----KTLISGGVRGTIPWMAPELFKSKDNL----VTEKVDVYSFGVVMWELLTGEE---- 831
+ GT +MAPE+ N+ ++ D+Y+ G+V WE+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 832 ------PYADL-----HSEEIIAGIIKGNLGPKIPS-----WCEPTWRSLMERCWSSDPK 875
PY DL EE+ + + L P IP+ +M CW ++
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 876 SRPAFSEITKELRAMAAAMNIK 897
+R I K L ++ IK
Sbjct: 320 ARLTALRIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-80
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 58/316 (18%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
+Q D+ ++ +G G +G V+ G W+G +VA+K R ++RE
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS-----------RDEKSWFRE 50
Query: 676 A--HMLGQIHHPNVVAFYGVVTDGPV--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
+ + H N++ F T L +T Y GSL L+ T+D +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCL 108
Query: 732 IIAMDAAFGIEYLHEK--------NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783
I + A G+ +LH + I H DLKS N LV C I DLGL+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMHS 164
Query: 784 KT-----LISGGVRGTIPWMAPELFKSKDNLV----TEKVDVYSFGVVMWELLTGEE--- 831
++ + + GT +MAPE+ + ++VD+++FG+V+WE+
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 832 -------PYADLHS-----EEIIAGIIKGNLGPKIPSW-----CEPTWRSLMERCWSSDP 874
P+ D+ E++ + P IP+ + LM+ CW +P
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 875 KSRPAFSEITKELRAM 890
+R I K L +
Sbjct: 285 SARLTALRIKKTLTKI 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 8e-74
Identities = 86/278 (30%), Positives = 135/278 (48%), Gaps = 22/278 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ DL +++G G FG VF G+ + VA+K + E + + A F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLK--AKFLQEA 163
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L Q HPN+V GV T + V E + G LR + + + + + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYI--VMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTI 795
AA G+EYL K +H DL + N LV ++ V KI D G+S+ + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 796 P--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
P W APE + + DV+SFG+++WE + G PY +L +++ + KG P
Sbjct: 278 PVKWTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP 335
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P C LME+CW+ +P RP+FS I +EL+++
Sbjct: 336 C-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-72
Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 29/292 (9%)
Query: 610 NTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSL 663
N A + +K ++ + IK LGSG FGTV+ G W VAIK ++ E +
Sbjct: 5 NQALLRI--LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATS 57
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR 723
+ + EA+++ + +P+V G+ + +T+ M G L +R
Sbjct: 58 PKAN--KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKD 112
Query: 724 TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-- 781
I + + + A G+ YL ++ +VH DL + N LV KI D GL+K+
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLG 168
Query: 782 -KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSE 839
++K + G + I WMA E + T + DV+S+GV +WEL+T G +PY + +
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 840 EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
EI + + KG P+ P C +M +CW D SRP F E+ E MA
Sbjct: 227 EISSILEKGERLPQ-PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-71
Identities = 88/283 (31%), Positives = 134/283 (47%), Gaps = 25/283 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I+ +E + +G G FG V G + + VAIK K + + R F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVR--EKFL 64
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
+EA + Q HP++V GV+T+ PV + E G L+ L+ + ++D I+
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
A + + YL K VH D+ + N LV+ D K+GD GLS+ + + +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+P WMAPE T DV+ FGV MWE+L G +P+ + + ++I I G
Sbjct: 178 KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
P P C PT SLM +CW+ DP RP F+E+ +L +
Sbjct: 236 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-70
Identities = 70/325 (21%), Positives = 119/325 (36%), Gaps = 58/325 (17%)
Query: 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADF 672
TE ++ L+ ++ G FG V+ + VA+K E
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNE-------- 66
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGP--VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
E + L + H N++ F G G +L +T + GSL L+ + +
Sbjct: 67 -YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNEL 123
Query: 731 IIIAMDAAFGIEYLHEK----------NIVHFDLKSHNFLV--NMRDPQRPVCKIGDLGL 778
IA A G+ YLHE I H D+KS N L+ N+ I D GL
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL------TACIADFGL 177
Query: 779 SKIKQKTLISG---GVRGTIPWMAPELFKSKDNL---VTEKVDVYSFGVVMWELLTGEEP 832
+ + +G G GT +MAPE+ + N ++D+Y+ G+V+WEL +
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 833 YADLHS----------------EEIIAGIIKGNLGPKIPSWCEP-----TWRSLMERCWS 871
E++ ++ P + + + +E CW
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 872 SDPKSRPAFSEITKELRAMAAAMNI 896
D ++R + + + + M NI
Sbjct: 298 HDAEARLSAGCVGERITQMQRLTNI 322
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-70
Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 25/280 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I D+ + LG G FG V+ G + VA+K K + +++ F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-----KDCTLDNK--EKFM 61
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
EA ++ + HP++V G++ + P + E G L L R ++ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
++ + YL N VH D+ N LV + K+GD GLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+P WM+PE T DV+ F V MWE+L+ G++P+ L ++++I + KG+
Sbjct: 175 RLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PK P C P +LM RCW DP RP F+E+ L +
Sbjct: 233 LPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-70
Identities = 69/286 (24%), Positives = 127/286 (44%), Gaps = 31/286 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLI 669
I+ DL + + LG GTF +F G + V +K + +
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSE-- 57
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
F+ A M+ ++ H ++V YGV G L V E++ GSL L++ I+
Sbjct: 58 -SFFEAASMMSKLSHKHLVLNYGVCVCGDENIL--VQEFVKFGSLDTYLKKNKNCINILW 114
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR----PVCKIGDLGLSKIKQKT 785
++ +A A + +L E ++H ++ + N L+ + ++ P K+ D G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAG 844
++ IPW+ PE ++ NL D +SFG +WE+ + G++P + L S+ +
Sbjct: 174 --KDILQERIPWVPPECIENPKNL-NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ P P E +L+ C +P RP+F I ++L ++
Sbjct: 231 YEDRHQLPA-PKAAE--LANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-69
Identities = 87/279 (31%), Positives = 139/279 (49%), Gaps = 22/279 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I S+L +++E+GSG FG V G W VAIK I+ EG++ E+ DF EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEE----DFIEEAE 55
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HP +V YGV + + VTE+M +G L LR + + + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP- 796
G+ YL E ++H DL + N LV + V K+ D G+++ + P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 797 -WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
W +PE+F + + K DV+SFGV+MWE+ + G+ PY + + E++ I G K
Sbjct: 170 KWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK- 226
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
P +M CW P+ RPAFS + ++L +A +
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-69
Identities = 91/277 (32%), Positives = 132/277 (47%), Gaps = 24/277 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I DL ++KELG+G FG V YGKW+G DVAIK IK EGS+ ED +F EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSED----EFIEEAK 71
Query: 678 MLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
++ + H +V YGV T P+ +TEYM NG L LR ++ + + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
+EYL K +H DL + N LVN + V K+ D GLS+ + V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 797 --WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
W PE+ + + K D+++FGV+MWE+ + G+ PY + E I +G +
Sbjct: 185 VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P ++M CW RP F + + +
Sbjct: 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-69
Identities = 73/303 (24%), Positives = 138/303 (45%), Gaps = 27/303 (8%)
Query: 599 EISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRI 653
++S+ + + + + + + + +G G FG V++G +D A+K +
Sbjct: 3 DLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 61
Query: 654 KPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGS 713
+ + + F E ++ HPNV++ G+ + L V YM +G
Sbjct: 62 N-----RITDIGEV--SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV-VLPYMKHGD 113
Query: 714 LKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
L+ +R + + I + A G++YL K VH DL + N +++ ++ K+
Sbjct: 114 LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKV 169
Query: 774 GDLGLSKIKQKT---LISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
D GL++ + +P WMA E + T K DV+SFGV++WEL+T
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMT 227
Query: 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
G PY D+++ +I +++G + P +C +M +CW + RP+FSE+ +
Sbjct: 228 RGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
Query: 888 RAM 890
A+
Sbjct: 287 SAI 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-69
Identities = 86/276 (31%), Positives = 139/276 (50%), Gaps = 22/276 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+K ++ +KELGSG FG V GKWKG DVA+K IK EGS+ ED +F++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSED----EFFQEAQ 55
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
+ ++ HP +V FYGV + + VTEY+ NG L LR + ++ + + + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYI--VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP- 796
G+ +L +H DL + N LV+ K+ D G+++ V P
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 797 -WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
W APE+F + K DV++FG++MWE+ + G+ PY + E++ + +G+ +
Sbjct: 170 KWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR- 226
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P T +M CW P+ RP F ++ + +
Sbjct: 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 9e-69
Identities = 83/291 (28%), Positives = 133/291 (45%), Gaps = 32/291 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ ++ I+ LG G FG V+ G+ G VA+K + E E+D D
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDE--LD 79
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRR------KDRT 724
F EA ++ + +H N+V GV P + E M G LK LR + +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQ 783
+ + +A D A G +YL E + +H D+ + N L+ P R V KIGD G+++ I +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 195
Query: 784 KTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840
+ G +P WM PE F + + T K D +SFGV++WE+ + G PY ++E
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
++ + G P C +M +CW P+ RP F+ I + +
Sbjct: 254 VLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-68
Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 29/292 (9%)
Query: 610 NTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSL 663
N A + +K ++ + IK LGSG FGTV+ G W VAIK ++ E +
Sbjct: 5 NQALLRI--LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATS 57
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR 723
+ + EA+++ + +P+V G+ + +T+ M G L +R
Sbjct: 58 PKAN--KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKD 112
Query: 724 TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-- 781
I + + + A G+ YL ++ +VH DL + N LV KI D GL+K+
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLG 168
Query: 782 -KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSE 839
++K + G + I WMA E + T + DV+S+GV +WEL+T G +PY + +
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 840 EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
EI + + KG P+ P C +M +CW D SRP F E+ E MA
Sbjct: 227 EISSILEKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-68
Identities = 99/286 (34%), Positives = 139/286 (48%), Gaps = 27/286 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLIADF 672
I S + K +G+G FG V+ G K S VAIK +K G E+ R DF
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQR--VDF 93
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
EA ++GQ H N++ GV++ + +TEYM NG+L + LR KD + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
+ A G++YL N VH DL + N LVN VCK+ D GLS++ + +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 793 --GTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847
G IP W APE T DV+SFG+VMWE++T GE PY +L + E++ I
Sbjct: 208 SGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
G P P C LM +CW + RP F++I L + A
Sbjct: 266 GFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 99/285 (34%), Positives = 138/285 (48%), Gaps = 26/285 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-----DVAIKRIKPSCFAEGSLEEDRLIADFW 673
I+ S + K +GSG G V YG+ + VAIK +K G E R DF
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-----AGYTERQR--RDFL 98
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
EA ++GQ HPN++ GVVT G + + VTEYM NGSL LR D + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMI--VTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----TLISG 789
G+ YL + VH DL + N LV+ VCK+ D GLS++ + +
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
G + I W APE + DV+SFGVVMWE+L GE PY ++ + ++I+ + +G
Sbjct: 213 GGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
P P C LM CW D RP FS+I L A+ +
Sbjct: 271 YRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-68
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ +G G FG V++G++ AIK + E + + F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREG 73
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
++ ++HPNV+A G++ + YM +G L Q +R R + I +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQK--TLISGGVRG 793
A G+EYL E+ VH DL + N +++ + K+ D GL++ I + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+P W A E + T K DV+SFGV++WELLT G PY + ++ + +G
Sbjct: 189 RLPVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
P+ P +C + +M++CW +DP RP F + E+ + +A+
Sbjct: 247 LPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 6e-68
Identities = 85/284 (29%), Positives = 127/284 (44%), Gaps = 26/284 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I DL +++LG G+FG V G+W VA+K +K L + + DF
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-----PDVLSQPEAMDDFI 69
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
RE + + + H N++ YGVV P+ VTE GSL LR+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISG 789
A+ A G+ YL K +H DL + N L+ RD + KIGD GL + ++
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 182
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK- 847
+ W APE K + D + FGV +WE+ T G+EP+ L+ +I+ I K
Sbjct: 183 HRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
G P+ P C ++M +CW+ P+ RP F + L
Sbjct: 241 GERLPR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-68
Identities = 87/282 (30%), Positives = 127/282 (45%), Gaps = 27/282 (9%)
Query: 619 IKTSDLEYIK-ELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFW 673
+K +L ELG G FG+V G ++ DVAIK +K G+ + D +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-----GTEKADT--EEMM 58
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
REA ++ Q+ +P +V GV + V E G L + L K I +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEALM---LVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGV 791
+ G++YL EKN VH DL + N L+ R KI D GLSK + +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 792 RGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
G P W APE + + DV+S+GV MWE L+ G++PY + E++A I +G
Sbjct: 172 AGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P C P +LM CW + RP F + + +RA
Sbjct: 230 KRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-68
Identities = 83/291 (28%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ ++ I+ LG G FG V+ G+ G VA+K + E E+D D
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDE--LD 120
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRR------KDRT 724
F EA ++ + +H N+V GV P + E M G LK LR + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQ 783
+ + +A D A G +YL E + +H D+ + N L+ P R V KIGD G+++ I +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 236
Query: 784 KTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840
G +P WM PE F + + T K D +SFGV++WE+ + G PY ++E
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
++ + G P C +M +CW P+ RP F+ I + +
Sbjct: 295 VLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 1e-67
Identities = 81/274 (29%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ +L+ ++ +G G FG V G ++G+ VA+K IK + + F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQ-----AFLAEASV 67
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMDA 737
+ Q+ H N+V GV+ + L VTEYM GSL LR + R++ ++ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
+EYL N VH DL + N LV+ + V K+ D GL+K T + + W
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST--QDTGKLPVKW 180
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856
APE ++ + K DV+SFG+++WE+ + G PY + ++++ + KG P
Sbjct: 181 TAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PD 237
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
C P +M+ CW D RP+F ++ ++L +
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 1e-67
Identities = 85/284 (29%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
++ +D+ +LG G +G V+ G WK VA+K +K E ++E + +F +EA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVE----EFLKEA 60
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAM 735
++ +I HPN+V GV T P + +TE+M G+L LR +R ++ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYI--ITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ +EYL +KN +H DL + N LV + K+ D GLS++ +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 796 P--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
P W APE N + K DV++FGV++WE+ T G PY + ++ + K
Sbjct: 175 PIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896
+ P C LM CW +P RP+F+EI + M +I
Sbjct: 233 R-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 92/284 (32%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
+ +++ K +G+G FG V G+ K VAIK +K G E+ R DF
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQR--RDFL 94
Query: 674 REAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
EA ++GQ HPN++ GVVT PV VTEYM NGSL LR+ D + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVM---IVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLIS 788
+ A G++YL + VH DL + N L+N VCK+ D GL ++ + +
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCKVSDFGLGRVLEDDPEAAYTT 207
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847
G + I W +PE T DV+S+G+V+WE+++ GE PY ++ ++++I + +
Sbjct: 208 RGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
G P P C LM CW D +RP F +I L +
Sbjct: 266 GYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-67
Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 26/283 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
+ + + + +G G FG V++G +D A+K + + + + F
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITDIGEV--SQFL 138
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
E ++ HPNV++ G+ + V YM +G L+ +R + + I
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGG 790
+ A G+++L K VH DL + N +++ ++ K+ D GL++ +
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 791 VRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847
+P WMA E + T K DV+SFGV++WEL+T G PY D+++ +I +++
Sbjct: 254 TGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
G + P +C +M +CW + RP+FSE+ + A+
Sbjct: 312 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-67
Identities = 88/296 (29%), Positives = 133/296 (44%), Gaps = 31/296 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I + LG G FG+V + K D VA+K +K A +E +F
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE------EFL 73
Query: 674 REAHMLGQIHHPNVVAFYGVVTD-GPVTNLAT---VTEYMVNGSLKQVLR-----RKDRT 724
REA + + HP+V GV L + +M +G L L
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQ 783
+ + + +D A G+EYL +N +H DL + N ++ + + D GLS KI
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYS 189
Query: 784 KTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEE 840
G +P W+A E DNL T DV++FGV MWE++T G+ PYA + + E
Sbjct: 190 GDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896
I +I GN + P C LM +CWS+DPK RP+F+ + EL + +++
Sbjct: 248 IYNYLIGGNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-67
Identities = 78/303 (25%), Positives = 130/303 (42%), Gaps = 41/303 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
+ L+++++LG G FG+V ++ VA+K+++ S + DF
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--------LRDF 58
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
RE +L + H N+V + GV NL + EY+ GSL+ L++ ID K +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLIS 788
G+EYL K +H DL + N LV + KIGD GL+K+ K+ +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKVK 174
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT----------------GEEP 832
I W APE ++ + DV+SFGVV++EL T G +
Sbjct: 175 EPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ +I + P+ P C +M CW+++ RP+F ++ + +
Sbjct: 233 QGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
Query: 893 AMN 895
M
Sbjct: 292 NMA 294
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-67
Identities = 81/283 (28%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
K ++L +K LGSG FGTV G W V IK I+ + S +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-----DKSGRQSF--QAV 62
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+G + H ++V G+ L VT+Y+ GSL +R+ + + +
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLISG 789
+ A G+ YL E +VH +L + N L+ ++ D G++ + K L+
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLYS 175
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
+ I WMA E T + DV+S+GV +WEL+T G EPYA L E+ + KG
Sbjct: 176 EAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
+ P C +M +CW D RP F E+ E MA
Sbjct: 234 ERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-67
Identities = 82/293 (27%), Positives = 127/293 (43%), Gaps = 30/293 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I + L K LG G FG+V G K D VA+K +K + S + + +F
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREI--EEFL 84
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGSLKQVLRR-----KDRTI 725
EA + HPNV+ GV + + + +M G L L + I
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 726 DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQK 784
+ + +D A G+EYL +N +H DL + N ++ + D GLSK I
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSG 200
Query: 785 TLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEI 841
G +P W+A E D + T K DV++FGV MWE+ T G PY + + E+
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 842 IAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
++ G+ + P C +M CW +DP RP FS + +L + ++
Sbjct: 259 YDYLLHGHRLKQ-PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-67
Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 41/302 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
+ L+++++LG G FG+V ++ VA+K+++ S + DF
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--------LRDF 89
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
RE +L + H N+V + GV NL + EY+ GSL+ L++ ID K +
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLIS 788
G+EYL K +H DL + N LV + KIGD GL+K+ K+ +
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKVK 205
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT----------------GEEP 832
I W APE ++ + DV+SFGVV++EL T G +
Sbjct: 206 EPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ +I + P+ P C +M CW+++ RP+F ++ + +
Sbjct: 264 QGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
Query: 893 AM 894
M
Sbjct: 323 QM 324
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-67
Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ L+ ++ LG+G FG V+ G + G VA+K +K +GS+ D F EA+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPD----AFLAEAN 60
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMD 736
++ Q+ H +V Y VVT P+ +TEYM NGSL L+ +++ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI---YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
A G+ ++ E+N +H DL++ N LV+ CKI D GL+++ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 797 --WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
W APE T K DV+SFG+++ E++T G PY + + E+I + +G +
Sbjct: 174 IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P C LM CW P+ RP F + L
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 8e-67
Identities = 88/280 (31%), Positives = 134/280 (47%), Gaps = 25/280 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I+ +E + +G G FG V G + + VAIK K + + R F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVR--EKFL 439
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
+EA + Q HP++V GV+T+ PV + E G L+ L+ + ++D I+
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPV---WIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
A + + YL K VH D+ + N LV+ D K+GD GLS+ + + +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 552
Query: 794 TIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+P WMAPE T DV+ FGV MWE+L G +P+ + + ++I I G
Sbjct: 553 KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P P C PT SLM +CW+ DP RP F+E+ +L +
Sbjct: 611 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 9e-67
Identities = 95/302 (31%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
IK D+ +ELG G FG VF + VA+K +K + +L D
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAA---RKD 63
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRR---------- 720
F REA +L + H ++V FYGV DG P L V EYM +G L + LR
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 721 -----KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ + + IA A G+ YL ++ VH DL + N LV + KIGD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 176
Query: 776 LGLSK-IKQKTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
G+S+ + G +P WM PE T + DV+SFGV++WE+ T G++
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
P+ L + E+I I +G + + P C +M CW +P+ R EI K L A+
Sbjct: 235 PWFQLSNTEVIECITQGRVLER-PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293
Query: 892 AA 893
A
Sbjct: 294 KA 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-66
Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 44/303 (14%)
Query: 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDR 667
+L+ I S + +++ELG FG V+ G G VAIK +K + + R
Sbjct: 2 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLR 56
Query: 668 LIADFWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRK----- 721
+F EA + ++ HPNVV GVVT P L+ + Y +G L + L +
Sbjct: 57 --EEFRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSD 111
Query: 722 ----------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771
++ + + A G+EYL ++VH DL + N LV +
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNV 167
Query: 772 KIGDLGLS-KIKQKTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828
KI DLGL ++ +P WMAPE + D++S+GVV+WE+ +
Sbjct: 168 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFS 225
Query: 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
G +PY +++++ I + P P C +LM CW+ P RP F +I L
Sbjct: 226 YGLQPYCGYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 888 RAM 890
RA
Sbjct: 285 RAW 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-66
Identities = 67/327 (20%), Positives = 111/327 (33%), Gaps = 73/327 (22%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREA- 676
++ +L+ ++ +G G +G V+ G VA+K + F E
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN-----------FINEKN 57
Query: 677 -HMLGQIHHPNVVAFYGVVTDGPV---TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+ + + H N+ F V EY NGSL + L T D
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCR 115
Query: 733 IAMDAAFGIEYLHE---------KNIVHFDLKSHNFLV--NMRDPQRPVCKIGDLGLSKI 781
+A G+ YLH I H DL S N LV + C I D GLS
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT------CVISDFGLSMR 169
Query: 782 KQKTLISG---------GVRGTIPWMAPELFKSKDNL-----VTEKVDVYSFGVVMWELL 827
+ GTI +MAPE+ + NL ++VD+Y+ G++ WE+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 828 TGEE-------------PYADLHS-----EEIIAGIIKGNLGPKIPSWCEP------TWR 863
+ E++ + + PK P + + +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 864 SLMERCWSSDPKSRPAFSEITKELRAM 890
+E CW D ++R + + +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-66
Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 22/274 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ +L+ ++ +G G FG V G ++G+ VA+K IK + + F EA +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQ-----AFLAEASV 239
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDA 737
+ Q+ H N+V GV+ + L VTEYM GSL LR + R + + ++D
Sbjct: 240 MTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
+EYL N VH DL + N LV+ + V K+ D GL+K T + + W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST--QDTGKLPVKW 352
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856
APE ++ + K DV+SFG+++WE+ + G PY + ++++ + KG P
Sbjct: 353 TAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PD 409
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
C P +M+ CW D +RP F ++ ++L +
Sbjct: 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-65
Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 39/297 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
+ L+ I++LG G FG V ++ VA+K +K S AD
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHI--ADL 70
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+E +L ++H N+V + G+ T+ + + E++ +GSLK+ L + I+ ++++
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGG 790
A+ G++YL + VH DL + N LV KIGD GL+K K +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVK 186
Query: 791 VRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT---------------GEEPY 833
P W APE + DV+SFGV + ELLT +
Sbjct: 187 DDRDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ ++ + +G P P C LM +CW P +R +F + + A+
Sbjct: 245 GQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 98/301 (32%), Positives = 137/301 (45%), Gaps = 44/301 (14%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
IK D+ ELG G FG VF + VA+K +K E S D
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESA---RQD 89
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR 730
F REA +L + H ++V F+GV T+G P L V EYM +G L + LR
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 731 --------------IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+ +A A G+ YL + VH DL + N LV Q V KIGD
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDF 202
Query: 777 GLSK-IKQKTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEP 832
G+S+ I G R +P WM PE T + DV+SFGVV+WE+ T G++P
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ L + E I I +G + P C P ++M CW +P+ R + ++ L+A+A
Sbjct: 261 WYQLSNTEAIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
Query: 893 A 893
A
Sbjct: 320 A 320
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-65
Identities = 93/293 (31%), Positives = 138/293 (47%), Gaps = 38/293 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ + +ELG G+FG V+ G KG VAIK + E + +R +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRER--IE 74
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRK--------- 721
F EA ++ + + +VV GVV+ G P + E M G LK LR
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-K 780
K I +A + A G+ YL+ VH DL + N +V + KIGD G++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRD 187
Query: 781 IKQKTLISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLH 837
I + G +G +P WM+PE K D + T DV+SFGVV+WE+ T E+PY L
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+E+++ +++G L K P C LM CW +PK RP+F EI ++
Sbjct: 246 NEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-64
Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L +LG G FG V+ G W G+ VAIK +K G++ + F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPE----AFLQEAQ 231
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMD 736
++ ++ H +V Y VV++ P+ VTEYM GSL L+ + R +++ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPI---YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGT 794
A G+ Y+ N VH DL++ N LV VCK+ D GL+++ + G +
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE T K DV+SFG+++ EL T G PY + + E++ + +G P
Sbjct: 345 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P C + LM +CW +P+ RP F + L
Sbjct: 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-64
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 619 IKTSDLE-YIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLIADFW 673
+ L KELGSG FGTV G ++ VA+K +K + + +
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-----EANDPAL-KDELL 66
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
EA+++ Q+ +P +V G+ V E G L + L+ ++R + + I +
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAESWM---LVMEMAELGPLNKYLQ-QNRHVKDKNIIEL 122
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGV 791
+ G++YL E N VH DL + N L+ + KI D GLSK +
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQT 178
Query: 792 RGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
G P W APE + K DV+SFGV+MWE + G++PY + E+ A + KG
Sbjct: 179 HGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P+ C LM CW+ D ++RP F+ + LR
Sbjct: 237 ERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-64
Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD----VAIKRIKPSCFAEGSLEEDRLIADFWR 674
+ +D+++ +G G FG V + K AIKR+K E + ++D DF
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDH--RDFAG 74
Query: 675 EAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK----------- 721
E +L ++ HHPN++ G G L EY +G+L LR+
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 722 ----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
T+ ++ + A D A G++YL +K +H DL + N LV + V KI D G
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFG 187
Query: 778 LSKIKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPY 833
LS+ ++ + G +P WMA E L ++ T DV+S+GV++WE+++ G PY
Sbjct: 188 LSRGQEVYVKKTM--GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ E+ + +G K P C+ LM +CW P RP+F++I L M
Sbjct: 243 CGMTCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 8e-64
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 40/300 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
+ L+YI +LG G FG+V ++ VA+K+++ ++ R DF
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQR---DF 71
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
RE +L +H +V + GV +L V EY+ +G L+ L+R +D + ++
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT----LIS 788
+ G+EYL + VH DL + N LV KI D GL+K+ ++
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVVR 187
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYA------------- 834
+ I W APE DN+ + + DV+SFGVV++EL T ++ +
Sbjct: 188 EPGQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 835 -DLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
++ + +G P P C LM+ CW+ P+ RP+FS + +L + +
Sbjct: 246 DVPALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-63
Identities = 85/284 (29%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS--DVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
++ +D+ +LG G +G V+ G WK VA+K +K E ++E + +F +EA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVE----EFLKEA 267
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAM 735
++ +I HPN+V GV T P +TE+M G+L LR +R ++ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ--KTLISGGVRG 793
+ +EYL +KN +H +L + N LV + K+ D GLS++ G +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
I W APE N + K DV++FGV++WE+ T G PY + ++ + K
Sbjct: 382 PIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896
+ P C LM CW +P RP+F+EI + M +I
Sbjct: 440 R-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-63
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 24/282 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L+ K+LG+G FG V+ + VA+K +K GS+ + F EA+
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVE----AFLAEAN 235
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMD 736
++ + H +V + VVT P+ +TE+M GSL L+ + + ++I +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPI---YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGT 794
A G+ ++ ++N +H DL++ N LV+ VCKI D GL+++ + G +
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE T K DV+SFG+++ E++T G PY + + E+I + +G P+
Sbjct: 349 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMN 895
P C ++M RCW + P+ RP F I L A
Sbjct: 407 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 3e-63
Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGS-DVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L +LG G FG V+ G W G+ VAIK +K G++ + F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPE----AFLQEAQ 314
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMD 736
++ ++ H +V Y VV++ P+ VTEYM GSL L+ + R +++ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPI---YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGT 794
A G+ Y+ N VH DL++ N LV VCK+ D GL+++ + G +
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE T K DV+SFG+++ EL T G PY + + E++ + +G P
Sbjct: 428 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P C + LM +CW +P+ RP F + L
Sbjct: 486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-63
Identities = 94/309 (30%), Positives = 140/309 (45%), Gaps = 54/309 (17%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWR 674
+++EY++++G G FG VF + G VA+K +K E + + + ADF R
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQ--ADFQR 99
Query: 675 EAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRR------------- 720
EA ++ + +PN+V GV G P + + EYM G L + LR
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 721 ----------KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770
+ +++ IA A G+ YL E+ VH DL + N LV + V
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMV 212
Query: 771 CKIGDLGLS-KIKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWEL 826
KI D GLS I IP WM PE +F N T + DV+++GVV+WE+
Sbjct: 213 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEI 269
Query: 827 LT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ G +PY + EE+I + GN+ P C +LM CWS P RP+F I +
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 886 ELRAMAAAM 894
L+ M
Sbjct: 329 ILQRMCERA 337
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-63
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
L+ I++LG G FG V + ++ VA+K +K + + +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGW 80
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+E +L ++H +++ + G D +L V EY+ GSL+ L R +I + ++
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLL 138
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL----IS 788
A G+ YLH ++ +H DL + N L++ + KIGD GL+K + +
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVR 194
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT---------------GEEPY 833
+ W APE K+ DV+SFGV ++ELLT
Sbjct: 195 EDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
+ + + +G P+ P C LM+ CW ++ RP F + L+ +
Sbjct: 253 GQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
Query: 894 M 894
Sbjct: 312 Y 312
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 9e-63
Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 26/292 (8%)
Query: 612 ANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDR 667
+ +L + + L ELG G FG+V G ++ DVAIK +K G+ + D
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-----GTEKADT 380
Query: 668 LIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR 727
+ REA ++ Q+ +P +V GV + V E G L + L K I
Sbjct: 381 --EEMMREAQIMHQLDNPYIVRLIGVCQAEALM---LVMEMAGGGPLHKFLVGKREEIPV 435
Query: 728 RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKT 785
+ + G++YL EKN VH +L + N L+ R KI D GLSK +
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGLSKALGADDS 491
Query: 786 LISGGVRGTIP--WMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEII 842
+ G P W APE + + DV+S+GV MWE L+ G++PY + E++
Sbjct: 492 YYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 843 AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
A I +G P C P +LM CW + RP F + + +RA ++
Sbjct: 550 AFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-62
Identities = 89/300 (29%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLIADF 672
L K LG G FG V + G D VA+K +K + + E+D +D
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDL--SDL 87
Query: 673 WREAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK--------- 721
E M+ I H N++ G T DGP L + EY G+L++ LR +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 722 ------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ + + + A G+EYL + +H DL + N LV + V KI D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 200
Query: 776 LGLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GE 830
GL++ G +P WMAPE LF D + T + DV+SFGV+MWE+ T G
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 831 EPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PY + EE+ + +G+ K P+ C +M CW + P RP F ++ ++L +
Sbjct: 258 SPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-61
Identities = 90/305 (29%), Positives = 134/305 (43%), Gaps = 54/305 (17%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWR 674
+L K LG G FG V VA+K +K E + + D
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-----ENASPSEL--RDLLS 75
Query: 675 EAHMLGQIHHPNVVAFYGVVTDG-PVTNLATVTEYMVNGSLKQVLRRK------------ 721
E ++L Q++HP+V+ YG + P L + EY GSL+ LR
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 722 -----------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770
+R + I A + G++YL E +VH DL + N LV +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 771 CKIGDLGLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWEL 826
KI D GLS+ + +G IP WMA E LF D++ T + DV+SFGV++WE+
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEI 245
Query: 827 LT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+T G PY + E + + G+ + P C LM +CW +P RP F++I+K
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 886 ELRAM 890
+L M
Sbjct: 305 DLEKM 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-61
Identities = 89/300 (29%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLIADF 672
L K LG G FG V + G D VA+K +K + + E+D +D
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDL--SDL 133
Query: 673 WREAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK--------- 721
E M+ I H N++ G T DGP L + EY G+L++ LR +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 722 ------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ + + + A G+EYL + +H DL + N LV + V KI D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 776 LGLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GE 830
GL++ G +P WMAPE LF D + T + DV+SFGV+MWE+ T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 831 EPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PY + EE+ + +G+ K P+ C +M CW + P RP F ++ ++L +
Sbjct: 304 SPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 4e-60
Identities = 89/303 (29%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLI 669
+ L K LG G FG V + G + VA+K +K + E+D
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDL-- 118
Query: 670 ADFWREAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK------ 721
+D E M+ I H N++ G T DGP L + EY G+L++ L+ +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 722 ---------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772
+ + + + A A G+EYL K +H DL + N LV + V K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMK 231
Query: 773 IGDLGLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT 828
I D GL++ G +P WMAPE LF D + T + DV+SFGV++WE+ T
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFT 288
Query: 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
G PY + EE+ + +G+ K PS C +M CW + P RP F ++ ++L
Sbjct: 289 LGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
Query: 888 RAM 890
+
Sbjct: 348 DRI 350
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-59
Identities = 87/300 (29%), Positives = 126/300 (42%), Gaps = 49/300 (16%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWR 674
L+ K LG G FG V G D VA+K +K EG+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSEH--RALMS 79
Query: 675 EAHMLGQI-HHPNVVAFYGVVT--DGPVTNLATVTEYMVNGSLKQVLRRK---------- 721
E +L I HH NVV G T GP L + E+ G+L LR K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 722 -----DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+ I + A G+E+L + +H DL + N L++ ++ V KI D
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 192
Query: 777 GLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEE 831
GL++ K +P WMAPE +F D + T + DV+SFGV++WE+ + G
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 832 PYADLHS-EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
PY + EE + +G P + P M CW +P RP FSE+ + L +
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-59
Identities = 78/301 (25%), Positives = 122/301 (40%), Gaps = 50/301 (16%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
+ L + K LG+G FG V G VA+K +K + +R
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTER--EALMS 75
Query: 675 EAHMLGQI-HHPNVVAFYGVVTD-GPVTNLATVTEYMVNGSLKQVLRRK----------- 721
E +L + +H N+V G T GP +TEY G L LRRK
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 722 ------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ +D + + A G+ +L KN +H DL + N L+ + KI D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 776 LGLSKIKQKTLI-SGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GE 830
GL++ + +P WMAPE +F + + T + DV+S+G+ +WEL + G
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGS 245
Query: 831 EPYADLHS-EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889
PY + + I +G P +M+ CW +DP RP F +I + +
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 890 M 890
Sbjct: 305 Q 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 8e-59
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 46/297 (15%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
++L++ K LG+G FG V G VA+K +K + +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-----STAHADEK--EALMS 98
Query: 675 EAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR-- 730
E ++ + H N+V G T GP + +TEY G L LRRK R ++
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 731 -----------IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+ + A G+ +L KN +H D+ + N L+ V KIGD GL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 780 KIKQKT---LISGGVRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYA 834
+ ++ G R + WMAPE +F D + T + DV+S+G+++WE+ + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 835 DLHS-EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+ + + G + P++ S+M+ CW+ +P RP F +I L+
Sbjct: 269 GILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 85/306 (27%), Positives = 123/306 (40%), Gaps = 55/306 (17%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
+LE+ K LGSG FG V G VA+K +K E + +R
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-----EKADSSER--EALMS 97
Query: 675 EAHMLGQI-HHPNVVAFYGVVT-DGPVTNLATVTEYMVNGSLKQVLRRK----------- 721
E M+ Q+ H N+V G T GP + + EY G L LR K
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 722 -----------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770
+ + A A G+E+L K+ VH DL + N LV V
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKV 210
Query: 771 CKIGDLGLS-KIKQKTLISGGVRGTIP--WMAPE-LFKSKDNLVTEKVDVYSFGVVMWEL 826
KI D GL+ I + +P WMAPE LF + + T K DV+S+G+++WE+
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLWEI 267
Query: 827 LT-GEEPYADLHS-EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT 884
+ G PY + I G + P + +M+ CW+ D + RP+F +T
Sbjct: 268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326
Query: 885 KELRAM 890
L
Sbjct: 327 SFLGCQ 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 72/264 (27%), Positives = 118/264 (44%), Gaps = 21/264 (7%)
Query: 626 YIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
+ E+G G+F TV+ G +VA ++ + + F EA ML +
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKGLQ 83
Query: 684 HPNVVAFYGVVTDGPVTN--LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
HPN+V FY + VTE M +G+LK L+ + + + + G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGL 142
Query: 742 EYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
++LH + I+H DLK N + KIGDLGL+ +K+ + V GT +MA
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMA 198
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII-KGNLGPKIPSWC 858
PE+++ K E VDVY+FG+ M E+ T E PY++ + I + G
Sbjct: 199 PEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 859 EPTWRSLMERCWSSDPKSRPAFSE 882
P + ++E C + R + +
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKD 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 65/321 (20%), Positives = 110/321 (34%), Gaps = 22/321 (6%)
Query: 568 RNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYI 627
+ H + L ++ + +V + + ++ + +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL 62
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
LG G++G VF + K G A+KR G + R + E ++ H
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARKL----AEVGSHEKVGQH 116
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYL 744
P V +G L TE SL+Q ++ + D + +L
Sbjct: 117 PCCVRLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFK 804
H + +VH D+K N + R CK+GD GL G +MAPEL +
Sbjct: 174 HSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS 864
DV+S G+ + E+ E H E + +G L P+ + RS
Sbjct: 230 GSYG---TAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGLSSELRS 283
Query: 865 LMERCWSSDPKSRPAFSEITK 885
++ DPK R +
Sbjct: 284 VLVMMLEPDPKLRATAEALLA 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-47
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 609 TNTANTELQTIKTSDLEYI--KELGSGTFGTVFY-GKWKGSDVAIKRIKPSCFAEGSLEE 665
+ + E + + + LG G GT+ Y G + DVA+KRI P CF+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------ 62
Query: 666 DRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT 724
RE +L + HPNV+ ++ D E +L++ + +KD
Sbjct: 63 -----FADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL-CAATLQEYVEQKDFA 114
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC-KIGDLGLSKI-- 781
+ I + G+ +LH NIVH DLK HN L++M + + I D GL K
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 782 --KQKTLISGGVRGTIPWMAPELFKSKDNL-VTEKVDVYSFGVVMWELLT-GEEPYADLH 837
+ GV GT W+APE+ T VD++S G V + +++ G P+
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 838 SEEIIAGIIKGNLGPKIPSW-CEPTWRSLMERCWSSDPKSRPAFSEI 883
+ + +L P + R L+E+ + DP+ RP+ +
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 85/297 (28%), Positives = 139/297 (46%), Gaps = 43/297 (14%)
Query: 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
+L+ T++ ++ +G G FG V+ G + G+ VA+KR P +G E F
Sbjct: 33 DLEEA-TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEE-------FE 83
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR---RKR 730
E L HP++V+ G + + + +YM NG+LK+ L D +R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLI 787
+ I + AA G+ YLH + I+H D+KS N L++ + V KI D G+SK +T +
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTHL 197
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY-------------- 833
S V+GT+ ++ PE F +TEK DVYSFGVV++E+L
Sbjct: 198 STVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 834 -ADLHSEEIIAGIIKGNLGPKIPSWCEPTWR--SLMERCWSSDPKSRPAFSEITKEL 887
+ H+ + I+ NL KI E + +C + + RP+ ++ +L
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-47
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 19/255 (7%)
Query: 630 LGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687
LG GT+G V+ G +AIK I + R E + + H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP--------ERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII--IAMDAAFGIEYLH 745
V + G ++ + E + GSL +LR K + ++ I G++YLH
Sbjct: 82 VQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMAPELFK 804
+ IVH D+K N L+N V KI D G SK + + GT+ +MAPE+
Sbjct: 140 DNQIVHRDIKGDNVLINTYSG---VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKIPSWCEPTWR 863
+ D++S G + E+ TG+ P+ +L + + + P+IP +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 864 SLMERCWSSDPKSRP 878
+ + +C+ DP R
Sbjct: 257 AFILKCFEPDPDKRA 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 64/290 (22%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 603 RSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAE 660
S+ T N Q+++ ++++G G+FG K G IK I S +
Sbjct: 7 HSSGVDLGTENLYFQSME--KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 661 GSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL-R 719
EE R RE +L + HPN+V + + +L V +Y G L + +
Sbjct: 65 KEREESR------REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINA 116
Query: 720 RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+K + + + ++++H++ I+H D+KS N + ++GD G++
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIA 172
Query: 780 KIKQ------KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
++ + I GT +++PE+ ++K K D+++ G V++EL T + +
Sbjct: 173 RVLNSTVELARACI-----GTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAF 225
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ ++ II G+ P + RSL+ + + +P+ RP+ + I
Sbjct: 226 EAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-44
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 35/301 (11%)
Query: 602 SRSAAYFTNTANTELQTIKTSDLEY--IKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCF 658
S+ T N Q++ Y +K++GSG VF + AIK +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 659 AEGSLEEDRLIADFWREAHMLGQIHHPN--VVAFYGVVTDGPVTNLATVTEYMVNGSLKQ 716
+L+ + E L ++ + ++ Y + V E N L
Sbjct: 66 DNQTLDS------YRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNS 116
Query: 717 VLRRKDR-TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
L++K RK M + +H+ IVH DLK NFL+ + K+ D
Sbjct: 117 WLKKKKSIDPWERKSYWKNM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLID 169
Query: 776 LGLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNL---------VTEKVDVYSFGVVM 823
G++ +++ GT+ +M PE K + ++ K DV+S G ++
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 824 WELLTGEEPYADLHSE-EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSE 882
+ + G+ P+ + ++ + II N + P E + +++ C DPK R + E
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 883 I 883
+
Sbjct: 290 L 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 41/279 (14%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D + I+ +GSG FG VF K + G IKR+K ++ RE L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAE----REVKAL 58
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLAT--------------VTEYMVNGSLKQVL-RRKDRT 724
++ H N+V + G + E+ G+L+Q + +R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784
+D+ + + G++Y+H K +++ DLK N + KIGD GL +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844
+GT+ +M+PE S+D ++VD+Y+ G+++ ELL + + +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS--KFFTD 230
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ G I + ++L+++ S P+ RP SEI
Sbjct: 231 LRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 64/333 (19%), Positives = 123/333 (36%), Gaps = 35/333 (10%)
Query: 570 DEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEY--I 627
H L P ++ + + + +++ + I Y +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 628 KELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPN 686
K++GSG VF + AIK + +L+ + E L ++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIAYLNKLQQHS 115
Query: 687 --VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAMDAAFGIEY 743
++ Y + V E N L L++K RK M +
Sbjct: 116 DKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHT 170
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ---KTLISGGVRGTIPWMAP 800
+H+ IVH DLK NFL+ + K+ D G++ Q +++ G + +M P
Sbjct: 171 IHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 801 ELFKSKDNL---------VTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNL 850
E K + ++ K DV+S G +++ + G+ P+ + ++ + II N
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ P E + +++ C DPK R + E+
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 63/298 (21%)
Query: 630 LGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGS--LEEDRLIADFWREAHMLGQIHHPNV 687
+G G FG V+ G + VA+K++ ++ F +E ++ + H N+
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ------FDQEIKVMAKCQHENL 92
Query: 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT--IDRRKRIIIAMDAAFGIEYLH 745
V G +DG +L V YM NGSL L D T + R IA AA GI +LH
Sbjct: 93 VELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 746 EKNIVHFDLKSHNFLV--NMRDPQRPVCKIGDLGLSKI---KQKTLISGGVRGTIPWMAP 800
E + +H D+KS N L+ KI D GL++ +T+++ + GT +MAP
Sbjct: 151 ENHHIHRDIKSANILLDEAFT-A-----KISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E + + +T K D+YSFGVV+ E++TG D H E L E
Sbjct: 205 EALRGE---ITPKSDIYSFGVVLLEIITGLPAV-DEHREP-------QLL----LDIKEE 249
Query: 861 TW---RSLME----------------------RCWSSDPKSRPAFSEITKELRAMAAA 893
+++ + +C RP ++ + L+ M A+
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-42
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 33/283 (11%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
++K +K++GSG VF + AIK + +L+ + E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEI 58
Query: 677 HMLGQIHHPN--VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIII 733
L ++ + ++ Y + V E N L L++K RK
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLISGG 790
M + +H+ IVH DLK NFL+ + K+ D G++ +++
Sbjct: 116 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 791 VRGTIPWMAPELFKSKDNL---------VTEKVDVYSFGVVMWELLTGEEPYADLHSE-E 840
GT+ +M PE K + ++ K DV+S G +++ + G+ P+ + ++
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ II N + P E + +++ C DPK R + E+
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 64/260 (24%), Positives = 104/260 (40%), Gaps = 30/260 (11%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+G G+FG V K K G A+K+++ LE R+ E + P
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRV-----EELVACAGLSSP 110
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+V YG V +GP N+ E + GSL Q++++ + + + A G+EYLH
Sbjct: 111 RIVPLYGAVREGPWVNI--FMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH 167
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG------VRGTIPWMA 799
+ I+H D+K+ N L+ + D G + Q + + GT MA
Sbjct: 168 TRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPSWC 858
PE+ K KVD++S +M +L G P+ + I +IP C
Sbjct: 225 PEVVMGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 859 EPTWRSLMERCWSSDPKSRP 878
P ++ +P R
Sbjct: 283 APLTAQAIQEGLRKEPVHRA 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 69/289 (23%), Positives = 114/289 (39%), Gaps = 43/289 (14%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
+D E I+ LG G FG VF K K + AIKRI+ L ++++ RE L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVM----REVKAL 57
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLAT----------VTEYMVNGSLKQVLRRKDRTIDRRK 729
++ HP +V ++ + T + +LK + + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 730 RII--IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI------ 781
+ I + A +E+LH K ++H DLK N M D V K+GD GL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 782 KQKTLISGGVR-------GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA 834
+Q L GT +M+PE + KVD++S G++++ELL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLYP--FST 229
Query: 835 DLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ + + P + + P +++ S P RP I
Sbjct: 230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 60/286 (20%), Positives = 113/286 (39%), Gaps = 37/286 (12%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
T++ ++++GSG FG+VF + G AIKR K GS++E + RE +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNAL----REVYA 63
Query: 679 LGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR---RKDRTIDRRKRIIIA 734
+ H +VV ++ + ++ EY GSL + R + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMR---------------DPQRPVCKIGDLGLS 779
+ G+ Y+H ++VH D+K N ++ + + KIGDLG
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE 839
+ G ++A E+ + ++ K D+++ + + E +
Sbjct: 182 TRISSPQV---EEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236
Query: 840 EIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
I +G L P+IP + L++ DP+ RP+ + K
Sbjct: 237 --WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + +G+G++G + K G + K + E E+ L+ E ++L ++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLV----SEVNLLREL 62
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIIIAMDAAF 739
HPN+V +Y + D T L V EY G L V+ ++ + +D + +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 740 GIEYLHEKN-----IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ------KTLIS 788
++ H ++ ++H DLK N ++ + K+GD GL++I KT +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKTFV- 177
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
GT +M+PE EK D++S G +++EL P+ +E+ I +G
Sbjct: 178 ----GTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+IP ++ R + RP+ EI
Sbjct: 232 KF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 65/268 (24%), Positives = 121/268 (45%), Gaps = 23/268 (8%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K++G G F V+ G VA+K+++ + + R AD +E +L Q+
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKAR--ADCIKEIDLLKQL 89
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL---RRKDRTIDRRKRIIIAMDAAF 739
+HPNV+ +Y + L V E G L +++ +++ R I R +
Sbjct: 90 NHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-KQKTLISGGVRGTIPWM 798
+E++H + ++H D+K N + V K+GDLGL + KT + + GT +M
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYA--DLHSEEIIAGIIKGNLGPKIPS 856
+PE K D++S G +++E+ + P+ ++ + I + + P +PS
Sbjct: 204 SPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PPLPS 260
Query: 857 WC-EPTWRSLMERCWSSDPKSRPAFSEI 883
R L+ C + DP+ RP + +
Sbjct: 261 DHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/293 (21%), Positives = 110/293 (37%), Gaps = 46/293 (15%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
SD E I LG G FG V + AIK+I+ + + ++ E +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVML 55
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLAT-----------VTEYMVNGSLKQVLRRKDRTIDR 727
L ++H VV +Y + EY NG+L ++ ++ R
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 728 RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI 787
+ + + Y+H + I+H DLK N + D R V KIGD GL+K ++L
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLD 171
Query: 788 SGGVR---------------GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP 832
+ GT ++A E+ + EK+D+YS G++ +E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-NEKIDMYSLGIIFFEMIYP--F 228
Query: 833 YADLHSEEIIAGIIKGNLG--PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ I+ + ++ P + ++ DP RP +
Sbjct: 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-40
Identities = 72/289 (24%), Positives = 110/289 (38%), Gaps = 49/289 (16%)
Query: 628 KELGSGTFGTVFY-GKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHP 685
K LG G+ GTV + G ++G VA+KR+ E +L + HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----------IALMEIKLLTESDDHP 69
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII------IAMDAAF 739
NV+ +Y T L E N +L+ ++ K+ + + K + A
Sbjct: 70 NVIRYYCSETTD--RFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC---------KIGDLGLSKIKQKTLISGG 790
G+ +LH I+H DLK N LV+ I D GL K S
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 791 VR-----GTIPWMAPELFKSKDNLV-----TEKVDVYSFGVVMWELLT-GEEPYADLHSE 839
GT W APEL + +NL T +D++S G V + +L+ G+ P+ D
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KY 244
Query: 840 EIIAGIIKGNL---GPKIPSWCE--PTWRSLMERCWSSDPKSRPAFSEI 883
+ II+G K L+ + DP RP ++
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 67/295 (22%), Positives = 110/295 (37%), Gaps = 31/295 (10%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
I +I++LG G F V + G A+KRI C + EE + RE
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQ------RE 76
Query: 676 AHMLGQIHHPNVVAFYGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDR--RKRI 731
A M +HPN++ G + + G+L + R + +I
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 732 I-IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS-- 788
+ + + G+E +H K H DLK N L+ + DLG +
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSR 192
Query: 789 --------GGVRGTIPWMAPELFKSKDNL-VTEKVDVYSFGVVMWELLTGEEPY-ADLHS 838
R TI + APELF + + + E+ DV+S G V++ ++ GE PY
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
+ +A ++ L L+ + DP RP + +L A+
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 630 LGSGTFGTVFYGK-WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVV 688
LG G FG V+ G+ G+ VA+KR+K G L+ F E M+ H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-------FQTEVEMISMAVHRNLL 90
Query: 689 AFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR---TIDRRKRIIIAMDAAFGIEYLH 745
G T V YM NGS+ LR + +D KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTP--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 746 EK---NIVHFDLKSHNFLVNMR-DPQRPVCKIGDLGLSKI--KQKTLISGGVRGTIPWMA 799
+ I+H D+K+ N L++ + +GD GL+K+ + T ++ VRGTI +A
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
PE + +EK DV+ +GV++ EL+TG+ +
Sbjct: 204 PEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 27/276 (9%)
Query: 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIAD 671
++ + D E + LG G FG V+ + K S +A+K + + LE+ +
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQ 55
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
RE + + HPN++ YG D T + + EY G++ + L++ + ++R
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IKQKTLI 787
I A + Y H K ++H D+K N L+ KI D G S ++ L
Sbjct: 114 YITELAN-ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSRRTDLC 168
Query: 788 SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847
GT+ ++ PE+ + + + EKVD++S GV+ +E L G+ P+ +E I +
Sbjct: 169 -----GTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P + R L+ R +P RP E+
Sbjct: 222 VEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 66/281 (23%), Positives = 121/281 (43%), Gaps = 27/281 (9%)
Query: 609 TNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEED 666
T A + D + + LG G FG V+ + K + +A+K + S LE++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-----QLEKE 55
Query: 667 RLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID 726
+ RE + + HPN++ Y D + + E+ G L + L++ R +
Sbjct: 56 GVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDE 113
Query: 727 RRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK----IK 782
+R + A + Y HE+ ++H D+K N L+ + KI D G S ++
Sbjct: 114 QRSATFMEELAD-ALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSLR 168
Query: 783 QKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEII 842
++T+ GT+ ++ PE+ + K + EKVD++ GV+ +E L G P+ E
Sbjct: 169 RRTMC-----GTLDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 843 AGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
I+ +L K P + + L+ + P R +
Sbjct: 222 RRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 25/289 (8%)
Query: 620 KTSDLEYI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
TS+ ++ LG G VF G+ K G AIK F D + RE
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQM----RE 57
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT--IDRRKRIII 733
+L +++H N+V + + + + + E+ GSL VL + + +I+
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
D G+ +L E IVH ++K N + + + + V K+ D G ++ + + G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 794 TIPWMAPELFKSKDNLV------TEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIA 843
T ++ P++++ VD++S GV + TG P+ +E++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPK--SRPAFSEITKELRAM 890
II G I + + SR +T L +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 38/308 (12%)
Query: 599 EIS---SRSAAYFTNTANTELQTIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVA 649
EI+ SR+ + + Q++ L YI K LGSG G V + VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 650 IKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYM 709
I+ I FA GS E + E +L +++HP ++ + V E M
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELM 221
Query: 710 VNGSLKQVLRRKDRTIDRRK----------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNF 759
G L D+ + ++ ++ ++YLHE I+H DLK N
Sbjct: 222 EGGEL------FDKVVGNKRLKEATCKLYFYQMLL-----AVQYLHENGIIHRDLKPENV 270
Query: 760 LVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE-LFKSKDNLVTEKVDVYS 818
L++ ++ + KI D G SKI +T + + GT ++APE L VD +S
Sbjct: 271 LLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 819 FGVVMWELLTGEEP-YADLHSEEIIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPK 875
GV+++ L+G P + I G W E L+++ DPK
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 876 SRPAFSEI 883
+R E
Sbjct: 390 ARFTTEEA 397
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 33/267 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + ELG G FG V+ K K G+ A K I + + + D+ E +L
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVI--------ETKSEEELEDYIVEIEILATC 73
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HP +V G L + E+ G++ ++ DR + + ++ +
Sbjct: 74 DHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVRGTIP 796
+LH K I+H DLK+ N L+ + ++ D G+S K+ + I GT
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 797 WMAPEL---FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
WMAPE+ KD K D++S G+ + E+ E P+ +L+ ++ I K + P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SDPPT 241
Query: 854 I--PSWCEPTWRSLMERCWSSDPKSRP 878
+ PS +R ++ +P++RP
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRP 268
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 62/284 (21%), Positives = 107/284 (37%), Gaps = 33/284 (11%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
LG G VF G+ K G AIK F D + RE +L +++H
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQM----REFEVLKKLNHK 67
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT--IDRRKRIIIAMDAAFGIEY 743
N+V + + + + + E+ GSL VL + + +I+ D G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLISGGVRGTIPWM 798
L E IVH ++K N + + + + V K+ D G ++ + +L GT ++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYL 182
Query: 799 APELFKSKDNLV------TEKVDVYSFGVVMWELLTGEEPYADLHS----EEIIAGIIKG 848
P++++ VD++S GV + TG P+ +E++ II G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 849 NLGPKIPSW--CEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
I E S SR +T L +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-36
Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 625 EYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + LG+G FG V + G VAIK+ + + +R E ++ ++
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWC----LEIQIMKKL 69
Query: 683 HHPNVVAFYGVVTDGPVTNLAT----VTEYMVNGSLKQVLRRKDRTIDRRKRII--IAMD 736
+HPNVV+ V EY G L++ L + + ++ I + D
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLISGGV 791
+ + YLHE I+H DLK N ++ + KI DLG +K +
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFV---- 184
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT+ ++APEL + K T VD +SFG + +E +TG P+ G ++
Sbjct: 185 -GTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 852 PKIPSWCEPTWR-SLMERCWSSDPKSRPAFSEITKELRAM 890
I + + T + + S ++ + L+ M
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 4e-36
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 30/287 (10%)
Query: 621 TSDLEYIKELGSG--TFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE--EDRLIADFWR 674
E + +G G TV ++K G V ++RI +LE + ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--------NLEACSNEMVTFLQG 75
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR-RKDRTIDRRKRIII 733
E H+ +HPN+V + L VT +M GS K ++ ++ I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLI 787
++Y+H VH +K+ + L+++ + L + +Q+ +
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDG----KVYLSGLRSNLSMISHGQRQRVVH 189
Query: 788 SGGVR--GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
+PW++PE+ + K D+YS G+ EL G P+ D+ + +++
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
+ G + P + L S S + S T R
Sbjct: 250 LNGTV-PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 33/263 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRL-IADFWREAHMLGQ 681
++++G G+FG VF G VAIK I LEE I D +E +L Q
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--------LEEAEDEIEDIQQEITVLSQ 76
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
P V +YG T L + EY+ GS +L + +D + I + G+
Sbjct: 77 CDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGL 132
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVRGTI 795
+YLH + +H D+K+ N L++ K+ D G++ +IK+ T + GT
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEH----GEVKLADFGVAGQLTDTQIKRNTFV-----GTP 183
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
WMAPE+ K K D++S G+ EL GE P+++LH +++ I K N P +
Sbjct: 184 FWMAPEVIKQSA--YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLE 240
Query: 856 SWCEPTWRSLMERCWSSDPKSRP 878
+ +E C + +P RP
Sbjct: 241 GNYSKPLKEFVEACLNKEPSFRP 263
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 58/320 (18%), Positives = 106/320 (33%), Gaps = 42/320 (13%)
Query: 599 EISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIK---- 654
+I S + + + +D I+ L G F + + A+K+ +
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLL 67
Query: 655 -----PSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYM 709
+ + DF E ++ I + + G++T+ + + EYM
Sbjct: 68 EKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYM 125
Query: 710 VNGSLKQVLRRKDRTIDRRKRIIIAMDAAF-------GIEYLH-EKNIVHFDLKSHNFLV 761
N S+ + I Y+H EKNI H D+K N L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 762 NMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGV 821
D V K+ D G S+ I G RGT +M PE F ++ + KVD++S G+
Sbjct: 186 ---DKNGRV-KLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 822 VMWELLTGEEP-YADLHSEEIIAGIIKGNL-----------------GPKIPSWCEPTWR 863
++ + P + E+ I N+ ++
Sbjct: 241 CLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 864 SLMERCWSSDPKSRPAFSEI 883
++ +P R +
Sbjct: 301 DFLKLFLRKNPAERITSEDA 320
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 31/266 (11%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K LGSG G V + VAIK I FA GS E + E +L +++HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK----------RIIIAM 735
++ + V E M G L D+ + ++ ++
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGEL------FDKVVGNKRLKEATCKLYFYQMLL- 125
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
++YLHE I+H DLK N L++ ++ + KI D G SKI +T + + GT
Sbjct: 126 ----AVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTP 180
Query: 796 PWMAPELFKSKDNLV-TEKVDVYSFGVVMWELLTGEEP-YADLHSEEIIAGIIKGNLGPK 853
++APE+ S VD +S GV+++ L+G P + I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 854 IPSWCE--PTWRSLMERCWSSDPKSR 877
W E L+++ DPK+R
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKAR 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 51/291 (17%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRL-IADFWR 674
+I D E + +GSG V K VAIKRI LE+ + + + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--------LEKCQTSMDELLK 62
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI--- 731
E + Q HHPN+V++Y L V + + GS+ +++ + + +
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 732 ----IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-------- 779
I + G+EYLH+ +H D+K+ N L+ +I D G+S
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG----SVQIADFGVSAFLATGGD 176
Query: 780 ---KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL 836
+KT + GT WMAPE+ + K D++SFG+ EL TG PY
Sbjct: 177 ITRNKVRKTFV-----GTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKY 230
Query: 837 HSEEIIAGIIKGNLGPKIPSWCE---------PTWRSLMERCWSSDPKSRP 878
+++ ++ N P + + + ++R ++ C DP+ RP
Sbjct: 231 PPMKVLMLTLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 34/268 (12%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+++G G GTV+ G +VAI+++ L++ E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILV 70
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ + +PN+V + G L V EY+ GSL V+ +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECL 126
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVR 792
+E+LH ++H D+KS N L+ M K+ D G + K+ T++
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMV----- 177
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT WMAPE+ K KVD++S G++ E++ GE PY + + + +I N P
Sbjct: 178 GTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP 234
Query: 853 KI--PSWCEPTWRSLMERCWSSDPKSRP 878
++ P +R + RC D + R
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRG 262
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-35
Identities = 75/265 (28%), Positives = 116/265 (43%), Gaps = 31/265 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +K+LGSG +G V + K + AIK I+ + + S E +L +
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS------KLLEEVAVLKLL 93
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK-------RIIIAM 735
HPN++ Y D N V E G L D I R K II +
Sbjct: 94 DHPNIMKLYDFFEDK--RNYYLVMECYKGGELF------DEIIHRMKFNEVDAAVIIKQV 145
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ + YLH+ NIVH DLK N L+ ++ + KI D GLS + + GT
Sbjct: 146 LSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERLGTA 202
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ + K EK DV+S GV+++ LL G P+ +EI+ + KG P
Sbjct: 203 YYIAPEVLRKK---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259
Query: 856 SWCEPTW--RSLMERCWSSDPKSRP 878
W + + L+++ D + R
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRRI 284
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 39/280 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E ++ +G+GT+G V+ G+ G AIK + + D + +E +ML +
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--------VTGD-EEEEIKQEINMLKKY 77
Query: 683 -HHPNVVAFYG----VVTDGPVTNLATVTEYMVNGSLKQVLR-RKDRTIDRRKRIIIAMD 736
HH N+ +YG G L V E+ GS+ +++ K T+ I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGG 790
G+ +LH+ ++H D+K N L+ K+ D G+S ++ T I
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 791 VRGTIPWMAPELFKSKDNLVT---EKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847
GT WMAPE+ +N K D++S G+ E+ G P D+H + I +
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 848 GNLGPKI--PSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
N P++ W ++S +E C + RPA ++ K
Sbjct: 249 -NPAPRLKSKKWS-KKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 34/264 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +++LG G++G+V+ K G VAIK++ +E D + + +E ++ Q
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--------VESD--LQEIIKEISIMQQC 81
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
P+VV +YG T+L V EY GS+ ++R +++T+ + I G+E
Sbjct: 82 DSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVRGTIP 796
YLH +H D+K+ N L+N K+ D G++ K+ T+I GT
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVI-----GTPF 190
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI-- 854
WMAPE+ + D++S G+ E+ G+ PYAD+H I I N P
Sbjct: 191 WMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPTFRK 247
Query: 855 PSWCEPTWRSLMERCWSSDPKSRP 878
P + +++C P+ R
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRA 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 26/261 (9%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++E+G G+FG V++ + VAIK++ ++ E D +E L ++
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRFLQKL 111
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN + + G V EY GS +L + + + + A G+
Sbjct: 112 RHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTIPWMAP 800
YLH N++H D+K+ N L++ + K+GD G + I + + GT WMAP
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPANSFV-----GTPYWMAP 219
Query: 801 EL-FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PSW 857
E+ + KVDV+S G+ EL + P ++++ + I + N P + W
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHW 278
Query: 858 CEPTWRSLMERCWSSDPKSRP 878
+R+ ++ C P+ RP
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRP 298
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 30/265 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ + LG G+FG V K K G + A+K I +++ RE +L Q+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKR-----QVKQKTDKESLLREVQLLKQL 83
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK-------RIIIAM 735
HPN++ Y D V E G L D I R++ RII +
Sbjct: 84 DHPNIMKLYEFFEDK--GYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQV 135
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ I Y+H+ IVH DLK N L+ + + +I D GLS + + GT
Sbjct: 136 LSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTA 192
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ EK DV+S GV+++ LL+G P+ + +I+ + KG ++P
Sbjct: 193 YYIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249
Query: 856 SWCEPTW--RSLMERCWSSDPKSRP 878
W + + + L+ + + P R
Sbjct: 250 QWKKVSESAKDLIRKMLTYVPSMRI 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 34/268 (12%)
Query: 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
L+ ++G G+ G V + K G VA+K + L + + + E +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVI 95
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ H NVV Y G L + E++ G+L ++ ++ + +
Sbjct: 96 MRDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVL 151
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS------KIKQKTLISGGVR 792
+ YLH + ++H D+KS + L+ + K+ D G K+K+L+
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLV----- 202
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT WMAPE+ +VD++S G+++ E++ GE PY + + ++ + P
Sbjct: 203 GTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPP 259
Query: 853 KI--PSWCEPTWRSLMERCWSSDPKSRP 878
K+ P R +ER DP+ R
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERA 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 617 QTIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIA 670
+ K +E Y +ELGSG F V + K G + A K IK R
Sbjct: 3 EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR--E 60
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR--- 727
+ RE +L Q+ H NV+ + V + T++ + E + G L D +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELF------DFLAQKESL 112
Query: 728 --RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785
+ G+ YLH K I HFDLK N ++ ++ P K+ D GL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
+ + GT ++APE+ + + + D++S GV+ + LL+G P+ +E +A I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 846 IKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSR 877
+ + E + + + + + R
Sbjct: 231 TSVSY-----DFDEEFFSHTSELAKDFIRKLLVKETRKR 264
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 55/285 (19%)
Query: 618 TIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRI-KPSCFAEGSLEEDRLIA 670
+++T+++ +I + LGSG F VF K + G A+K I K F + SLE
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE------ 54
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK- 729
E +L +I H N+V + T+ V + + G L DR ++R
Sbjct: 55 ---NEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGELF------DRILERGVY 103
Query: 730 --RIIIAMDAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
+ DA+ ++YLHE IVH DLK N L + + I D GLSK
Sbjct: 104 TEK-----DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSK 157
Query: 781 IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE 840
++Q ++S GT ++APE+ K ++ VD +S GV+ + LL G P+ + +
Sbjct: 158 MEQNGIMSTAC-GTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPPFYEETESK 214
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSRP 878
+ I +G + P W + DP R
Sbjct: 215 LFEKIKEGYY-----EFESPFWDDISESAKDFICHLLEKDPNERY 254
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 65/280 (23%), Positives = 117/280 (41%), Gaps = 30/280 (10%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
DL+ + E+G G +G+V K G +A+KRI+ + +E + + +
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLL---MD 70
Query: 676 -AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRKR 730
++ P +V FYG + + E M + S K V D I
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFRE--GDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 731 IIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG 789
I + + +L E I+H D+K N L++ + K+ D G+S ++
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKT 183
Query: 790 GVRGTIPWMAPELFKSKDNLV--TEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGII 846
G P+MAPE + + DV+S G+ ++EL TG PY +S + + ++
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 847 KGNLGPKIPSWCEPTW----RSLMERCWSSDPKSRPAFSE 882
KG+ P++ + E + + + C + D RP + E
Sbjct: 244 KGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 36/318 (11%), Positives = 79/318 (24%), Gaps = 60/318 (18%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
L+ ++ L G VF + D A+K + +
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG-----AENSRSELERLHEATF 114
Query: 678 MLGQIHHPN------------------------VVAFYGVVTDGPVTNLATVTEYMVNGS 713
++ + D V N +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VD 173
Query: 714 LKQVLRRKDRTIDRRK------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767
L+ + D R I+ L K +VH N + P
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPD 230
Query: 768 RPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827
+ +GD+ + + + E + T ++ + G+ ++ +
Sbjct: 231 GRL-MLGDVSALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 828 TGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTW-------RSLMERCWSSDPKSR--- 877
P+ + + P S + ++L+ R + D + R
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347
Query: 878 ------PAFSEITKELRA 889
P F ++ E+ +
Sbjct: 348 LEAMETPEFLQLQNEISS 365
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-33
Identities = 78/279 (27%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 620 KTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIK-----PSCFAEGSLEEDRL 668
K + Y ++LGSG +G V K K S+ AIK IK +++ + ++
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 669 IADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR 728
+ + E +L + HPN++ + V D VTE+ G L ++ I+R
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDK--KYFYLVTEFYEGGELF------EQIINRH 141
Query: 729 K-------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
K I+ + + I YLH+ NIVH D+K N L+ ++ + KI D GLS
Sbjct: 142 KFDECDAANIMKQILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSF 198
Query: 782 KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI 841
K GT ++APE+ K K EK DV+S GV+M+ LL G P+ + ++I
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKK---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 842 IAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRP 878
I + KG W + L++ + D R
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 20/268 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+K D E I ELG+G G VF K G +A K I E I RE
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQII---REL 82
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L + + P +V FYG ++ E+M GSL QVL++ I + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIA 139
Query: 737 AAFGIEYLH-EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
G+ YL + I+H D+K N LVN R K+ D G+S ++ + V GT
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 194
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
+M+PE + + + D++S G+ + E+ G P ++E+ G
Sbjct: 195 SYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ P + D + A E+
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ LG G F F A K + S L + E + + H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+VV F+G D + V E SL ++ +R+ + R + G +YLH
Sbjct: 76 HVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 132
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAP 800
++H DLK N +N KIGD GL+ + G R GT ++AP
Sbjct: 133 RNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIAP 184
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E+ K + +VDV+S G +M+ LL G+ P+ +E I K IP P
Sbjct: 185 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINP 240
Query: 861 TWRSLMERCWSSDPKSRPAFSEITK 885
SL+++ +DP +RP +E+
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLN 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 41/272 (15%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ + +LG G TV + D VAIK I E ++ + F RE H
Sbjct: 14 KIVDKLGGGGMSTV----YLAEDTILNIKVAIKAIFIP-PRE----KEETLKRFEREVHN 64
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNG-SLKQVLRRKDRTIDRRKRIIIAMDA 737
Q+ H N+V+ V + L V EY + G +L + + + I
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYL--VMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQI 120
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI--SGGVRGTI 795
GI++ H+ IVH D+K N L+ D + + KI D G++K +T + + V GT+
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILI---DSNKTL-KIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY--------ADLHSEEIIAGIIK 847
+ +PE K + E D+YS G+V++E+L GE P+ A H ++ + +
Sbjct: 177 QYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234
Query: 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA 879
++ IP + +++ R D +R
Sbjct: 235 -DVRKDIP----QSLSNVILRATEKDKANRYK 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 35/280 (12%)
Query: 616 LQTIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLI 669
++T K +E Y +ELGSG F V + K G + A K IK R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-- 59
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR-- 727
+ RE +L Q+ HPN++ + V + T++ + E + G L D +
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENR--TDVVLILELVSGGELF------DFLAQKES 111
Query: 728 ---RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784
+ G+ YLH K I HFDLK N ++ ++ P K+ D GL+ +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844
+ + GT ++APE+ + + + D++S GV+ + LL+G P+ +E +A
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
Query: 845 IIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSR 877
I + + E + + + + + R
Sbjct: 230 ITAVSY-----DFDEEFFSQTSELAKDFIRKLLVKETRKR 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 69/265 (26%), Positives = 108/265 (40%), Gaps = 27/265 (10%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ LG G F F A K + S L + E + + H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+VV F+G D + V E SL ++ +R+ + R + G +YLH
Sbjct: 102 HVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 158
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAP 800
++H DLK N +N KIGD GL+ + G R GT ++AP
Sbjct: 159 RNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIAP 210
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E+ K + + +VDV+S G +M+ LL G+ P+ +E I K IP P
Sbjct: 211 EVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINP 266
Query: 861 TWRSLMERCWSSDPKSRPAFSEITK 885
SL+++ +DP +RP +E+
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLN 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 56/265 (21%), Positives = 106/265 (40%), Gaps = 26/265 (9%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
LG G+F V+ + G +VAIK I ++ + ++ E + Q+ HP
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID-RRKRIIIAMDAAFGIEYL 744
+++ Y D + V E NG + + L+ + + R + G+ YL
Sbjct: 72 SILELYNYFEDS--NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-GMLYL 128
Query: 745 HEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR----GTIPWMAP 800
H I+H DL N L+ KI D GL+ + GT +++P
Sbjct: 129 HSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKM---PHEKHYTLCGTPNYISP 181
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEP 860
E+ + + DV+S G + + LL G P+ + + ++ + ++PS+
Sbjct: 182 EIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSI 237
Query: 861 TWRSLMERCWSSDPKSRPAFSEITK 885
+ L+ + +P R + S +
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 58/304 (19%), Positives = 107/304 (35%), Gaps = 55/304 (18%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+G G++G V + AIK + + + + ++ + E ++ ++HHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTEVRLMKKLHHP 88
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM---------- 735
N+ Y V D + V E G L L + + +
Sbjct: 89 NIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 736 ----------------------DAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDP 766
+ + YLH + I H D+K NFL + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 767 QRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGV 821
+ K+ D GLSK K GT ++APE+ + + K D +S GV
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 822 VMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRPA 879
++ LL G P+ ++ + I+ ++ L + P++ P R L+ + + R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 880 FSEI 883
Sbjct: 325 AMRA 328
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 65/286 (22%), Positives = 126/286 (44%), Gaps = 29/286 (10%)
Query: 609 TNTANTELQTIKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEED 666
T + + +DLE + E+GSGT G V+ + G +A+K+++ G+ EE+
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 667 RLIADFWREAHML-GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTI 725
+ I + ++ P +V +G T++ E M +++ +R I
Sbjct: 68 KRIL---MDLDVVLKSHDCPYIVQCFGTFITN--TDVFIAMELM-GTCAEKLKKRMQGPI 121
Query: 726 DRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784
R + + + YL EK ++H D+K N L++ +R K+ D G+S
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVD 177
Query: 785 TLISGGVRGTIPWMAPELFKSKDNLV---TEKVDVYSFGVVMWELLTGEEPYADLHSE-E 840
G +MAPE D + DV+S G+ + EL TG+ PY + ++ E
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
Query: 841 IIAGIIKGNLGPKIPSWCEPTW----RSLMERCWSSDPKSRPAFSE 882
++ +++ P +P + +S ++ C + D + RP +++
Sbjct: 238 VLTKVLQEEP-PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 34/279 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWRE- 675
+K DLE I ELG G +G V G +A+KRI+ A + +E + + +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLL---MDL 56
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI---- 731
+ + P V FYG + ++ E M + SL + + + ID+ + I
Sbjct: 57 DISMRTVDCPFTVTFYGALFRE--GDVWICMELM-DTSLDKFYK---QVIDKGQTIPEDI 110
Query: 732 --IIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS 788
IA+ +E+LH K +++H D+K N L+N K+ D G+S +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAK 166
Query: 789 GGVRGTIPWMAPELFKSKDNLV--TEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGI 845
G P+MAPE + N + K D++S G+ M EL PY + + + +
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 846 IKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSE 882
++ P++P+ + +C + K RP + E
Sbjct: 227 VEEP-SPQLPADKFSAEF-VDFTSQCLKKNSKERPTYPE 263
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 37/279 (13%)
Query: 618 TIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIAD 671
+ +++ Y +ELGSG F V + K G A K IK R D
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR--ED 60
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR---- 727
RE +L +I HPNV+ + V + T++ + E + G L D ++
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELF------DFLAEKESLT 112
Query: 728 -RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKT 785
+ G+ YLH I HFDLK N ++ R+ +P KI D GL+ KI
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI 845
GT ++APE+ + + + D++S GV+ + LL+G P+ +E +A +
Sbjct: 173 EFKNIF-GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229
Query: 846 IKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSR 877
N + + + + + R DPK R
Sbjct: 230 SAVNY-----EFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 31/265 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ LG G+FG V K + + A+K I + RE +L ++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS------TILREVELLKKL 78
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK-------RIIIAM 735
HPN++ + ++ D ++ V E G L D I R++ RII +
Sbjct: 79 DHPNIMKLFEILEDS--SSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQV 130
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
+ I Y+H+ NIVH DLK N L+ ++ + KI D GLS Q+ GT
Sbjct: 131 FSG--ITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ + EK DV+S GV+++ LL+G P+ + +I+ + G +P
Sbjct: 188 YYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244
Query: 856 SWCE--PTWRSLMERCWSSDPKSRP 878
W + L+ + + P R
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 74/269 (27%), Positives = 110/269 (40%), Gaps = 47/269 (17%)
Query: 628 KELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
ELG G V+ K KG+ A+K +K + E +L ++ HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKT----------VDKKIVRTEIGVLLRLSHP 108
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM------DAAF 739
N++ + T ++ V E + G L DR I+ DAA
Sbjct: 109 NIIKLKEIFETP--TEISLVLELVTGGEL----------FDR----IVEKGYYSERDAAD 152
Query: 740 -------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
+ YLHE IVH DLK N L P P+ KI D GLSKI + ++ V
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVC 211
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLHSEEIIAGIIKGNLG 851
GT + APE+ + +VD++S G++ + LL G EP Y + + + I+
Sbjct: 212 GTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269
Query: 852 PKIPSWCE--PTWRSLMERCWSSDPKSRP 878
P W E + L+ + DPK R
Sbjct: 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRL 298
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 35/275 (12%)
Query: 620 KTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
++ +I ++LGSG FG V + + G + IK I + +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-----RSQVP--MEQIE 68
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
E +L + HPN++ + V D N+ V E G L +R + + R
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGELL------ERIVSAQARGKA 120
Query: 734 A--MDAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK 784
A + Y H +++VH DLK N L P P+ KI D GL+++ +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKS 179
Query: 785 TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG 844
S GT +MAPE+FK VT K D++S GVVM+ LLTG P+ EE+
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 845 IIKGNLG-PKIPSWCEPTWRSLMERCWSSDPKSRP 878
P L+++ + DP+ RP
Sbjct: 237 ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 43/277 (15%)
Query: 620 KTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
D+ Y +G G++G V K A K+I +E+ + F
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-----FVED---VDRFK 54
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK---- 729
+E ++ + HPN++ Y D T++ V E G L +R + +R
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGELF------ERVVHKRVFRES 106
Query: 730 ------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783
+ +++ + Y H+ N+ H DLK NFL P P+ K+ D GL+ +
Sbjct: 107 DAARIMKDVLS-----AVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFK 160
Query: 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
+ GT +++P++ + + D +S GV+M+ LL G P++ E++
Sbjct: 161 PGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML 217
Query: 844 GIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRP 878
I +G W P SL+ R + PK R
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ELG G F V K G + A K I + + REA + ++ HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM------DAAF 739
N+V + + + + V + + G L + I+A DA+
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 109
Query: 740 -------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
I Y H IVH +LK N L+ + V K+ D GL+ + G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT +++PE+ K ++ VD+++ GV+++ LL G P+ D + A I G
Sbjct: 169 GTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 853 KIPSWCE--PTWRSLMERCWSSDPKSR 877
P W P +SL++ + +PK R
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKR 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 33/265 (12%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ELGSG F V + K G + A K IK + R + RE ++L +I HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR--EEIEREVNILREIRHP 68
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR-----RKRIIIAMDAAFG 740
N++ + + + T++ + E + G L D ++ + G
Sbjct: 69 NIITLHDIFENK--TDVVLILELVSGGELF------DFLAEKESLTEDEATQFLKQILDG 120
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMA 799
+ YLH K I HFDLK N ++ ++ P K+ D G++ I+ GT ++A
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVA 179
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PE+ + + + D++S GV+ + LL+G P+ +E + I N + E
Sbjct: 180 PEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-----DFDE 232
Query: 860 PTWRS-------LMERCWSSDPKSR 877
+ + + R DPK R
Sbjct: 233 EYFSNTSELAKDFIRRLLVKDPKRR 257
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 59/285 (20%), Positives = 110/285 (38%), Gaps = 47/285 (16%)
Query: 616 LQTIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLI 669
+ TI + Y +ELG G F V G + A I + +
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ----- 55
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
REA + + HPN+V + +++ + + + + G L +
Sbjct: 56 -KLEREARICRLLKHPNIVRLHDSISEE--GHHYLIFDLVTGGEL----------FED-- 100
Query: 730 RIIIAM------DAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
I+A DA+ + + H+ +VH +LK N L+ + V K+ D
Sbjct: 101 --IVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADF 157
Query: 777 GLSK-IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835
GL+ ++ + G GT +++PE+ + + VD+++ GV+++ LL G P+ D
Sbjct: 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPPFWD 215
Query: 836 LHSEEIIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRP 878
+ I G P W P + L+ + + +P R
Sbjct: 216 EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 44/292 (15%), Positives = 88/292 (30%), Gaps = 41/292 (14%)
Query: 618 TIKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIA 670
+ + + LG G F V+ + +K KP+ E +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT----- 115
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK----DRTID 726
+ L + FY V E G+L + ++ +
Sbjct: 116 ---QLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 727 RRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC-------KIGDLGLS 779
+ I AM + IE +H+ I+H D+K NF++ ++ + DLG S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 780 ---KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YAD 835
K+ K I T + E+ +K ++D + ++ +L G +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 836 LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
E G+ + W + ++ ++
Sbjct: 289 EGGECKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
+ I + A G+E+L + +H DL + N L++ ++ V KI D GL++
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARD 242
Query: 782 KQKTLI---SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLH 837
K G R + WMAPE D + T + DV+SFGV++WE+ + G PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 838 S-EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
EE + +G P + P M CW +P RP FSE+ + L +
Sbjct: 301 IDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 37/168 (22%), Positives = 53/168 (31%), Gaps = 21/168 (12%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWR 674
L+ K LG G FG V G D VA+K +K
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMS 74
Query: 675 EAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
E +L I HH NVV G T + + E+ G+L LR K R + +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMV-IVEFCKFGNLSTYLRSK-----RNEFVPY 128
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
A + + DLK + + + LS +
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 44/276 (15%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
E + LG G V D VA+K ++ A + F REA
Sbjct: 15 ELGEILGFGGMSEV----HLARDLRDHRDVAVKVLRAD-LAR----DPSFYLRFRREAQN 65
Query: 679 LGQIHHPNVVAFYGV-VTDGPVTNLA-TVTEYMVNG-SLKQVLRRKDRTIDRRKRIIIAM 735
++HP +VA Y + P L V EY V+G +L+ ++ + + ++ I +
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIA 123
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS----GGV 791
DA + + H+ I+H D+K N ++ V K+ D G+++ + S V
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAV 179
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY--------ADLHSEEIIA 843
GT +++PE + V + DVYS G V++E+LTGE P+ A H E
Sbjct: 180 IGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
Query: 844 GIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPA 879
+ + +++ + + +P++R
Sbjct: 238 PPSARH--EGLS----ADLDAVVLKALAKNPENRYQ 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-31
Identities = 68/270 (25%), Positives = 108/270 (40%), Gaps = 41/270 (15%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ +G G F V + G A+K + + F D REA + + HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS---SPGLSTEDLKREASICHMLKHP 86
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA---MDAAF--- 739
++V + L V E+M L I +R A+
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADLC------FE-IVKRADAGFVYSEAVASHYMR 137
Query: 740 ----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT-LISGGVRGT 794
+ Y H+ NI+H D+K H L+ ++ PV K+G G++ ++ L++GG GT
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGT 196
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
+MAPE+ K + + VDV+ GV+++ LL+G P+ E + GIIKG
Sbjct: 197 PHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKY---- 249
Query: 855 PSWCEPTWRS-------LMERCWSSDPKSR 877
W L+ R DP R
Sbjct: 250 -KMNPRQWSHISESAKDLVRRMLMLDPAER 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 40/308 (12%), Positives = 89/308 (28%), Gaps = 56/308 (18%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRI----KPSCFAEGSLEEDRLIADFWREAHMLGQ 681
LG + G + +P A ++E+ L R Q
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 682 I----------------HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR------ 719
++ D V + + M +L+
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS 197
Query: 720 RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779
+++ R+ + + + LH +VH L+ + ++ D + V +
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGFEHL 253
Query: 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNL---------VTEKVDVYSFGVVMWELLTGE 830
++S + + PEL + + +T D ++ G+V++ + +
Sbjct: 254 VRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 831 EPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT-----K 885
P + I + IP R+L+E + R + +
Sbjct: 311 LPITKDAALGGSEWIFRSC--KNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYE 364
Query: 886 ELRAMAAA 893
+LR +A
Sbjct: 365 QLRTELSA 372
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 58/269 (21%), Positives = 101/269 (37%), Gaps = 41/269 (15%)
Query: 627 IKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ +G G G V ++ D VA+K + + + + REA G
Sbjct: 39 RRLVGRGGMGDV----YEAEDTVRERIVALKLMSET-LSS----DPVFRTRMQREARTAG 89
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNG-SLKQVLRRKDRTIDRRKRIIIAMDAAF 739
++ P+VV + + +NG L +LRR+ + + + I
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYV--DMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGS 145
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLI--SGGVRGTIPW 797
++ H H D+K N LV+ D + D G++ + G GT+ +
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY-------ADLHSEEIIAGIIKGNL 850
MAPE F T + D+Y+ V++E LTG PY H + I
Sbjct: 202 MAPERFSESH--ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR- 258
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPA 879
P IP + +++ R + +P+ R
Sbjct: 259 -PGIP----VAFDAVIARGMAKNPEDRYV 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 48/310 (15%)
Query: 617 QTIKTSDLEY--IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADF 672
QT++ +L + L G F V+ + G + A+KR+ E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAII----- 73
Query: 673 WREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMV-----NGSLKQVL--RRKDRT 724
+E + ++ HPN+V F + G + E+++ G L + L
Sbjct: 74 -QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782
+ + I ++++H + I+H DLK N L++ + K+ D G +
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTI 188
Query: 783 QKTLISGG-------------VRGTIPWMAPELFKSKDNL-VTEKVDVYSFGVVMWELLT 828
T + PE+ N + EK D+++ G +++ L
Sbjct: 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 829 GEEPYADLHSEEIIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRPAFSEITKE 886
+ P+ D I+ G IP + SL+ +P+ R + +E+ +
Sbjct: 249 RQHPFED----GAKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302
Query: 887 LRAMAAAMNI 896
L+ +AAA N+
Sbjct: 303 LQEIAAARNV 312
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 41/269 (15%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
KELG G F V K G + A K +K + + R A+ E +L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ----DCR--AEILHEIAVLELAKSC 88
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF----- 739
P V+ + V + + + + EY G + + ++ D
Sbjct: 89 PRVINLHEVYENT--SEIILILEYAAGGEIF------SLCLPELAEMVSENDVIRLIKQI 140
Query: 740 --GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIP 796
G+ YLH+ NIVH DLK N L++ P + KI D G+S+ I + + GT
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFGMSRKIGHACELREIM-GTPE 198
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856
++APE+ +T D+++ G++ + LLT P+ ++E I + N+
Sbjct: 199 YLAPEILNYDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV-----D 251
Query: 857 WCEPTWRS-------LMERCWSSDPKSRP 878
+ E T+ S ++ +P+ RP
Sbjct: 252 YSEETFSSVSQLATDFIQSLLVKNPEKRP 280
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
LG G+FG V K + + A+K I K S + + RE +L ++ H
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDH 80
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA------MDAA 738
PN++ + ++ D ++ V E G L D II DAA
Sbjct: 81 PNIMKLFEILEDS--SSFYIVGELYTGGEL----------FDE----IIKRKRFSEHDAA 124
Query: 739 F-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
GI Y+H+ NIVH DLK N L+ ++ + KI D GLS Q+
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDR 183
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT ++APE+ + EK DV+S GV+++ LL+G P+ + +I+ + G
Sbjct: 184 IGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 852 PKIPSWCE--PTWRSLMERCWSSDPKSRP 878
+P W + L+ + + P R
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+ELG G F V K G + A K I + + REA + ++ HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM------DAAF 739
N+V + + + + V + + G L + I+A DA+
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 132
Query: 740 -------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
I Y H IVH +LK N L+ + V K+ D GL+ + G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 191
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
GT +++PE+ K ++ VD+++ GV+++ LL G P+ D + A I G
Sbjct: 192 GTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 853 KIPSWCE--PTWRSLMERCWSSDPKSR 877
P W P +SL++ + +PK R
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKR 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-30
Identities = 55/270 (20%), Positives = 95/270 (35%), Gaps = 53/270 (19%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
E + G G + + D V +K + S + A E
Sbjct: 83 EVKGCIAHGGLGWI----YLALDRNVNGRPVVLKGLVHS-------GDAEAQAMAMAERQ 131
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNG-SLKQVLRRK---DRTIDRRKR 730
L ++ HP++V + V V EY V G SLK+ +K I
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQKLPVAEAIA---- 186
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISG 789
++ + YLH +V+ DLK N ++ ++ K+ DLG I G
Sbjct: 187 --YLLEILPALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINS----FG 235
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849
+ GT + APE+ ++ T D+Y+ G + L + + G+ + +
Sbjct: 236 YLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRY----VDGLPEDD 288
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPA 879
K ++ L+ R DP+ R
Sbjct: 289 PVLKTY----DSYGRLLRRAIDPDPRQRFT 314
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 66/340 (19%), Positives = 124/340 (36%), Gaps = 45/340 (13%)
Query: 554 EPPQISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTAN 613
+P + +A DE K D E+ + S +
Sbjct: 92 KPCEPTAP---VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY---- 144
Query: 614 TELQTIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDR 667
+ IK + Y +ELG+G FG V + G++ A K + +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--------HES 196
Query: 668 LIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDR 727
+E + + HP +V + D + + E+M G L ++ D
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELF------EKVADE 248
Query: 728 RKRIIIAMDAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS- 779
++ +A G+ ++HE N VH DLK N + + K+ D GL+
Sbjct: 249 HNKMS-EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTA 305
Query: 780 KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE 839
+ K + GT + APE+ + K V D++S GV+ + LL+G P+ + +
Sbjct: 306 HLDPKQSVKVTT-GTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362
Query: 840 EIIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSR 877
E + + + ++ + + + +DP +R
Sbjct: 363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 402
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 36/307 (11%), Positives = 82/307 (26%), Gaps = 47/307 (15%)
Query: 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEED--------------- 666
L LG + G + + + +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 667 --RLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYM--VNGSLKQVLR--- 719
+ R + P V D + + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 720 ---RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+++ R+ + + + LH +VH L+ + ++ D + V +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGF 255
Query: 777 GLSKIKQKTLIS--GGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEE 831
+ +S G A + L+T D ++ G+ ++ + +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT-----KE 886
P D + I + IP R+L+E + R + ++
Sbjct: 316 PNTDDAALGGSEWIFRSC--KNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
Query: 887 LRAMAAA 893
LR +A
Sbjct: 370 LRTELSA 376
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 39/291 (13%)
Query: 601 SSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF 658
+ + + + + D ++ K LG G+F TV + + AIK ++
Sbjct: 9 RPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-- 66
Query: 659 AEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVL 718
+ ++ + RE ++ ++ HP V Y D L Y NG L + +
Sbjct: 67 ---HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYI 121
Query: 719 RRKDRTIDRRKR-----IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLV--NMRDPQRPVC 771
R+ + R I+ A +EYLH K I+H DLK N L+ +M
Sbjct: 122 RKIGSFDETCTRFYTAEIVSA------LEYLHGKGIIHRDLKPENILLNEDMH------I 169
Query: 772 KIGDLGLSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWEL 826
+I D G +K+ S R GT +++PEL K + D+++ G ++++L
Sbjct: 170 QITDFGTAKVLSP--ESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQL 225
Query: 827 LTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ G P+ + I IIK P P R L+E+ D R
Sbjct: 226 VAGLPPFRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKR 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 48/282 (17%)
Query: 618 TIKTSDLE--YI--KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIAD 671
+K + Y +ELGSG FG V K G K I D+
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN------TPYPLDK--YT 94
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
E ++ Q+HHP ++ + D + + E++ G L DR
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELF------DRIAAE-DYK 145
Query: 732 IIAMDAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQ 783
+ + G++++HE +IVH D+K N + + KI D GL+ K+
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNP 203
Query: 784 KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIA 843
++ T + APE+ + V D+++ GV+ + LL+G P+A E +
Sbjct: 204 DEIVKVTT-ATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 260
Query: 844 GIIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSRP 878
+ + + + E + S ++ +P+ R
Sbjct: 261 NVKRCDW-----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 66/270 (24%), Positives = 104/270 (38%), Gaps = 37/270 (13%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQI-H 683
+ LG G V K + A+K I + + E L +E +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK----------RIII 733
HPN++ T V + M G L D ++ R ++
Sbjct: 83 HPNIIQLKDTYETN--TFFFLVFDLMKKGELF------DYLTEKVTLSEKETRKIMRALL 134
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRG 793
I LH+ NIVH DLK N L+ D + K+ D G S V G
Sbjct: 135 E-----VICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLREVCG 185
Query: 794 TIPWMAPELFKSKDNLV----TEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849
T ++APE+ + N ++VD++S GV+M+ LL G P+ ++ I+ GN
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 850 LGPKIPSWCE--PTWRSLMERCWSSDPKSR 877
P W + T + L+ R P+ R
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 65/361 (18%), Positives = 126/361 (34%), Gaps = 58/361 (16%)
Query: 550 SKEIEPP--QISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAY 607
+KE +I L N E+ + DP + + + + + +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 608 FTNTANTELQTIKTSDLE--YI--KELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEG 661
+ + Y +G G V + G + A+K ++ +
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 662 SLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR 720
+ + + RE H+L Q+ HP+++ + + V + M G L
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS--SFMFLVFDLMRKGEL------ 187
Query: 721 KDRTIDRRKRIIIAM------DAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767
D + + + +LH NIVH DLK N L+ D
Sbjct: 188 ----FDY----LTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236
Query: 768 RPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLV----TEKVDVYSFGVVM 823
+ ++ D G S + + GT ++APE+ K + ++VD+++ GV++
Sbjct: 237 MQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 824 WELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKS 876
+ LL G P+ ++ I++G + P W L+ R DP++
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQY-----QFSSPEWDDRSSTVKDLISRLLQVDPEA 350
Query: 877 R 877
R
Sbjct: 351 R 351
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 25/268 (9%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
LG G++G V A+K +K E + +E +L ++ H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSL----KQVLRRKDRTIDRRK-RIIIAMDAAFG 740
NV+ V+ + + V EY V G +R +I G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----G 121
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR---GTIPW 797
+EYLH + IVH D+K N L+ + KI LG+++ R G+ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
PE+ D KVD++S GV ++ + TG P+ + ++ I KG+ IP
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--AIPGD 235
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEITK 885
C P L++ +P R + +I +
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 67/347 (19%), Positives = 130/347 (37%), Gaps = 43/347 (12%)
Query: 548 SSSKEIEPPQISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAY 607
++ + + + + +E+ + + K+ S + +I + A +
Sbjct: 14 LGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPF 73
Query: 608 FTNTANTELQTIKTS-DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE 664
+ + + + + LG G FG V + G +A K IK
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK------TRGM 127
Query: 665 EDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT 724
+D+ + E ++ Q+ H N++ Y ++ V EY+ G L DR
Sbjct: 128 KDK--EEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEYVDGGELF------DRI 177
Query: 725 IDR------RKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778
ID I+ GI ++H+ I+H DLK N L RD ++ KI D GL
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ--IKIIDFGL 235
Query: 779 SK-IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837
++ K + + GT ++APE+ V+ D++S GV+ + LL+G P+ +
Sbjct: 236 ARRYKPREKLKVNF-GTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 838 SEEIIAGIIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSR 877
E + I+ + ++ + + + R
Sbjct: 293 DAETLNNILACRW-----DLEDEEFQDISEEAKEFISKLLIKEKSWR 334
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
K +G G F V + G +VAIK I + SL++ RE ++ ++HP
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF------REVRIMKILNHP 74
Query: 686 NVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTID---RRK-RIIIAMDAAFG 740
N+V + V+ T+ L + EY G + L R + R K R I++
Sbjct: 75 NIVKLFEVIETE---KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----A 126
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPWMA 799
++Y H+K IVH DLK+ N L+ D + KI D G S + + G P+ A
Sbjct: 127 VQYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPPYAA 181
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PELF+ K +VDV+S GV+++ L++G P+ + +E+ +++G +IP +
Sbjct: 182 PELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMS 238
Query: 860 PTWRSLMERCWSSDPKSRPAFSEITK 885
+L++R +P R +I K
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 35/289 (12%)
Query: 611 TANTELQTIKTSDLEYI------KELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGS 662
EL+ + + EY LGSG FG V+ K K +V +K IK E
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 663 LEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGS-LKQVLRRK 721
ED + E +L ++ H N++ + + V E +G L + R
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRH 124
Query: 722 DRTID---RRK-RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
R + R +++ + YL K+I+H D+K N ++ + K+ D G
Sbjct: 125 PRLDEPLASYIFRQLVS-----AVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFG 175
Query: 778 LS-KIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADL 836
+ +++ L GTI + APE+ +++++S GV ++ L+ E P+ +L
Sbjct: 176 SAAYLERGKLFYTFC-GTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCEL 233
Query: 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
EE + I P SL+ P+ R ++
Sbjct: 234 --EETVEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 61/315 (19%), Positives = 108/315 (34%), Gaps = 30/315 (9%)
Query: 584 KVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKW 643
+ + K +C+ I I + E++ + + I + T
Sbjct: 24 EAKNKVD-DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP---E 79
Query: 644 KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703
K + + + L + + + N V P L
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL--QPSSPKVYLY 137
Query: 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRII--IAMDAAFGIEYLHEKNIVHFDLKSHNFLV 761
+ +LK + R+ DR + I + A +E+LH K ++H DLK N
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 762 NMRDPQRPVCKIGDLGLSKI------KQKTLISGGVR-------GTIPWMAPELFKSKDN 808
M D V K+GD GL +Q L GT +M+PE +
Sbjct: 198 TMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 809 LVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMER 868
+ KVD++S G++++ELL + II + P + + P +++
Sbjct: 254 --SHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKF-PLLFTQKYPQEHMMVQD 308
Query: 869 CWSSDPKSRPAFSEI 883
S P RP ++I
Sbjct: 309 MLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 9/73 (12%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
+D E I+ +G G FG VF K K + AIKRI+ L +++ RE L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKV----MREVKAL 58
Query: 680 GQIHHPNVVAFYG 692
++ HP +V ++
Sbjct: 59 AKLEHPGIVRYFN 71
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 47/268 (17%), Positives = 97/268 (36%), Gaps = 45/268 (16%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
++LG G FG V K +K D+ +E +L H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-------GTDQ--VLVKKEISILNIARHR 61
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF------ 739
N++ + L + E++ + +R + +
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIF------ERINTSAFELN-EREIVSYVHQVC 112
Query: 740 -GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS-KIKQKTLISGGVRGTIPW 797
+++LH NI HFD++ N + + + KI + G + ++K +
Sbjct: 113 EALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEY 169
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857
APE+ + V+ D++S G +++ LL+G P+ +++II I+ ++
Sbjct: 170 YAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-----TF 222
Query: 858 CEPTWRS-------LMERCWSSDPKSRP 878
E ++ ++R + KSR
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRM 250
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 26/297 (8%)
Query: 586 ETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKG 645
KK E V ++ + T + + IK LG+G+FG V K K
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 646 SD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703
S A+K + + + + I E +L ++ P +V D +NL
Sbjct: 65 SGNHYAMKILDKQ-----KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLY 117
Query: 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNM 763
V EY+ G + LRR R + R A EYLH ++++ DLK N L++
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLDLIYRDLKPENLLID- 175
Query: 764 RDPQRPVCKIGDLGLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFG 820
Q+ ++ D G +K + TL GT +APE+ SK + VD ++ G
Sbjct: 176 ---QQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILSKGY--NKAVDWWALG 225
Query: 821 VVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
V+++E+ G P+ +I I+ G + + PS + L+ D R
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/270 (22%), Positives = 100/270 (37%), Gaps = 39/270 (14%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH- 683
LG G FGTVF G VAIK I + L + E +L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP---LEVALLWKVGA 93
Query: 684 ---HPNVVAFYGVVTDGPVTNLATVTEYMVNGS-LKQVLRRKDR---TIDRRK-RIIIAM 735
HP V+ V E + L + K R ++A
Sbjct: 94 GGGHPGVIRLLDWFETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
I++ H + +VH D+K N L+ D +R K+ D G + + GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 796 PWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
+ PE V+S G+++++++ G+ P+ +EI+ +
Sbjct: 203 VYSPPEWISRHQYHA---LPATVWSLGILLYDMVCGDIPFER--DQEILEAEL------H 251
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P+ P +L+ RC + P SRP+ EI
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 32/279 (11%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRI-KPSCFAEGSLEEDRLIADFWREAHM 678
E ++ +G G+FG V + + A+K + K C + +E +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF------KELQI 68
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ + HP +V + D ++ V + ++ G L+ L++ + ++ I +
Sbjct: 69 MQGLEHPFLVNLWYSFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELV 125
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
++YL + I+H D+K N L+ D V I D ++ + + + GT P+M
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 799 APELFKSKDNLV-TEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGIIKGNLGPKI 854
APE+F S+ + VD +S GV +ELL G PY S EI+ +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TY 239
Query: 855 PSWCEPTWRSLMERCWSSDPKSR----------PAFSEI 883
PS SL+++ +P R P ++I
Sbjct: 240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 40/285 (14%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRI------------------KPSCFAEGSLEED 666
E+G G++G V + A+K + G ++
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 667 RLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID 726
I ++E +L ++ HPNVV V+ D +L V E + G + +V K + D
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 727 --RRK-RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783
R + +I GIEYLH + I+H D+K N LV KI D G+S +
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEFK 188
Query: 784 K--TLISGGVRGTIPWMAPELFKSKDNLVT-EKVDVYSFGVVMWELLTGEEPYADLHSEE 840
L+S V GT +MAPE + + + +DV++ GV ++ + G+ P+ D
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 841 IIAGIIKGNLGPKIPSWCE--PTWRSLMERCWSSDPKSRPAFSEI 883
+ + I L + P + + L+ R +P+SR EI
Sbjct: 248 LHSKIKSQAL--EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 619 IKTSDLE-------YIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLI 669
+K S K LG G+F K A+K I R+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----------KRME 49
Query: 670 ADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR 728
A+ +E L HPN+V + V D + V E + G L +R ++
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGELF------ERIKKKK 101
Query: 729 K-------RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
I+ + +A + ++H+ +VH DLK N L + + KI D G +++
Sbjct: 102 HFSETEASYIMRKLVSA--VSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGFARL 158
Query: 782 KQ------KTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYAD 835
K KT T+ + APEL E D++S GV+++ +L+G+ P+
Sbjct: 159 KPPDNQPLKTPC-----FTLHYAAPELLNQNG--YDESCDLWSLGVILYTMLSGQVPFQS 211
Query: 836 -------LHSEEIIAGIIKGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSRP 878
+ EI+ I KG+ S+ W++ L++ + DP R
Sbjct: 212 HDRSLTCTSAVEIMKKIKKGDF-----SFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 33/267 (12%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRI-KPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
LGSG FG+V+ G VAIK + K G L + E +L ++
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEVVLLKKVS 104
Query: 684 H--PNVVAFYGVVTDGPVTNLATVTEYMVN-GSLKQVLRRKDR---TIDRRK-RIIIAMD 736
V+ + + E L + + + R ++
Sbjct: 105 SGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE-- 160
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP 796
+ + H ++H D+K N L+ D R K+ D G + + T+ + GT
Sbjct: 161 ---AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRV 213
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856
+ PE + V+S G+++++++ G+ P+ EEII G +
Sbjct: 214 YSPPEWIRYHRYHGRS-AAVWSLGILLYDMVCGDIPFEH--DEEIIRGQV------FFRQ 264
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ L+ C + P RP F EI
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 42/281 (14%), Positives = 74/281 (26%), Gaps = 66/281 (23%)
Query: 629 ELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
G W+ D VA+ + P + D ++ + L +I
Sbjct: 38 FHGGVPPLQF----WQALDTALDRQVALTFVDP-----QGVLPDDVLQETLSRTLRLSRI 88
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
P V VV + V E++ GSL++V + I A +
Sbjct: 89 DKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAAD 143
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
H + V+ I G V P P+
Sbjct: 144 AAHRAGVALSIDHPSRVRVS------------------------IDGDVVLAYPATMPD- 178
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK---------GNLGPK 853
+ D+ G ++ LL P + +A + ++
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
IP ++ R D R A S + ++ A
Sbjct: 232 IP----FQISAVAARSVQGDGGIRSA-STLLNLMQQATAVA 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 59/273 (21%), Positives = 96/273 (35%), Gaps = 51/273 (18%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWRE-AHMLGQIHH 684
+ LG G G V + G A+K + D +E H
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY-----------DS--PKARQEVDHHWQASGG 81
Query: 685 PNVVAFYGVVTDGPVTNLAT--VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF--- 739
P++V V + + E M G L R +R + +AA
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELF------SRIQERGDQAFTEREAAEIMR 135
Query: 740 ----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
I++LH NI H D+K N L ++ + K+ D G +K + + T
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTP 193
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLH---SEEIIAGIIKGNLG 851
++APE+ + + D++S GV+M+ LL G P Y++ S + I G
Sbjct: 194 YYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY- 250
Query: 852 PKIPSWCEPTWRS-------LMERCWSSDPKSR 877
+ P W L+ +DP R
Sbjct: 251 ----GFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 65/279 (23%), Positives = 103/279 (36%), Gaps = 64/279 (22%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHP 685
+++G G++ K + A+K I S EE +L HP
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKS--KRDPTEE---------IEILLRYGQHP 76
Query: 686 NVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK----------RIIIAM 735
N++ V DG + VTE M G L D+ + ++ I
Sbjct: 77 NIITLKDVYDDGKYVYV--VTELMKGGELL------DKILRQKFFSEREASAVLFTITK- 127
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ------KTLISG 789
+EYLH + +VH DLK N L +I D G +K + T
Sbjct: 128 ----TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-- 181
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE---EIIAGII 846
T ++APE+ + + D++S GV+++ +LTG P+A+ + EI+A I
Sbjct: 182 ---YTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236
Query: 847 KGNLGPKIPSWCEPTWRS-------LMERCWSSDPKSRP 878
G S W S L+ + DP R
Sbjct: 237 SGKF-----SLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 64/269 (23%), Positives = 120/269 (44%), Gaps = 36/269 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
D + ++ LG+G+FG V + + + A+K +K + + E
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTND----ER 57
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR-----I 731
ML + HP ++ +G D + + +Y+ G L +LR+ R + + +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLIS 788
+A +EYLH K+I++ DLK N L++ + KI D G +K TL
Sbjct: 116 CLA------LEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYTLC- 164
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
GT ++APE+ +K + +D +SFG++++E+L G P+ D ++ + I+
Sbjct: 165 ----GTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
L + P + + L+ R + D R
Sbjct: 219 EL--RFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 37/273 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
LG GTFG V G+ + G VA+K + + ++ RE L
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG-KIK----REIQNLKLF 68
Query: 683 HHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTID---RRK-RIIIAMDA 737
HP+++ Y V+ T T+ V EY+ G L + + R + RR + I++
Sbjct: 69 RHPHIIKLYQVISTP---TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--- 122
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-----KTLISGGVR 792
++Y H +VH DLK N L+ D KI D GLS + +T
Sbjct: 123 --AVDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSDGEFLRTSC----- 171
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
G+ + APE+ + +VD++S GV+++ LL G P+ D H + I G
Sbjct: 172 GSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-- 228
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
IP + + +L+ DP R +I +
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 67/331 (20%), Positives = 122/331 (36%), Gaps = 44/331 (13%)
Query: 557 QISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECS----KVIGEISSRSAAYFTNTA 612
+ + N + E + LD L+ V + + I + + Y
Sbjct: 5 RFEKMDNLLRDPKSEVNSDCLLDGLDALVY-----DLDFPALRKNKNIDNFLSRYKDTIN 59
Query: 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIA 670
+K D E +K +G G FG V + K + A+K + + + A
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSDSA 114
Query: 671 DFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK- 729
FW E ++ + P VV + D L V EYM G L ++ D +
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 172
Query: 730 ---RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL 786
+++A ++ +H +H D+K N L++ + K+ D G K
Sbjct: 173 YTAEVVLA------LDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCM---KMN 219
Query: 787 ISGGVR-----GTIPWMAPELFKSKDNLV--TEKVDVYSFGVVMWELLTGEEPYADLHSE 839
G VR GT +++PE+ KS+ + D +S GV ++E+L G+ P+
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279
Query: 840 EIIAGIIKGNLGPKIPSWCE--PTWRSLMER 868
+ I+ P + ++L+
Sbjct: 280 GTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 27/299 (9%)
Query: 592 ECS----KVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD 647
EC+ + I T+ + + D E +K +G G FG V K K +D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 648 --VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATV 705
A+K + + + A F E +L + + D NL V
Sbjct: 100 KVFAMKILNKW-----EMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--NNLYLV 152
Query: 706 TEYMVNGSLKQVLRRKDRTID-RRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMR 764
+Y V G L +L + + + R +A + I+ +H+ + VH D+K N L+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILM--- 208
Query: 765 DPQRPVCKIGDLGLSK--IKQKTLISGGVRGTIPWMAPELFKSKDNLV---TEKVDVYSF 819
D + ++ D G ++ T+ S GT +++PE+ ++ + + D +S
Sbjct: 209 DMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 820 GVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE---PTWRSLMERCWSSDPK 875
GV M+E+L GE P+ E I+ + P+ + L+ R S
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH 326
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 75/267 (28%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ +D +Y+K LG GTFG V + K + A+K ++ E + E+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVT----ES 56
Query: 677 HMLGQIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAM 735
+L HP + A Y T L V EY G L L R+ + R R A
Sbjct: 57 RVLQNTRHPFLTALKYAFQTH---DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA- 112
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR--- 792
+ +EYLH +++V+ D+K N ++ D + KI D GL K IS G
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLCKEG----ISDGATMKT 164
Query: 793 --GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
GT ++APE+ + D VD + GVVM+E++ G P+ + E + I+ +
Sbjct: 165 FCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ P P +SL+ DPK R
Sbjct: 223 --RFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 66/329 (20%), Positives = 107/329 (32%), Gaps = 57/329 (17%)
Query: 547 LSSSKEIEPPQISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAA 606
LS+S+ PP + P + + + +S
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPT---------PALPHPPAQPPPPPPQQFPQFHVKSGL 52
Query: 607 YFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE 664
A + + + + LG G G V K A+K +
Sbjct: 53 QIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKML----------- 95
Query: 665 EDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLAT--VTEYMVNGSLKQVLRRK 721
+D RE + + P++V V + V E + G L
Sbjct: 96 QDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF------ 147
Query: 722 DRTIDRRKRIIIAMDAAF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774
R DR + +A+ I+YLH NI H D+K N L + P + K+
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLT 206
Query: 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEP 832
D G +K T ++APE+ + D + D++S GV+M+ LL G P
Sbjct: 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD----KSCDMWSLGVIMYILLCGYPP 262
Query: 833 -YAD---LHSEEIIAGIIKGNLGPKIPSW 857
Y++ S + I G P W
Sbjct: 263 FYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 5e-25
Identities = 85/474 (17%), Positives = 176/474 (37%), Gaps = 37/474 (7%)
Query: 417 ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENF 476
+ H C + + +++ ++ ++ + ++ V N
Sbjct: 135 TCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPM---DPNG 191
Query: 477 HGMPITCKPIHPELENEKLLIDSEESANISGLSNNMNYRNGTASGCNMKNGTKNLQGGVA 536
P + P+ ++E ++++ N S + + + +
Sbjct: 192 LSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLT 251
Query: 537 SSMDLLYNLSLSSSKEIEPPQISALQNAATERNDEHKEEIHLDPLEEKVETKKTCECSKV 596
S D + +LS S+ + + + E + + + E E ++ E +K+
Sbjct: 252 SRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKI 311
Query: 597 ----IGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAI 650
+ N +K +D ++ LG G+FG V + KG+D A+
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371
Query: 651 KRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVA-FYGVVTDGPVTNLATVTEY 708
K +K + + +D + E +L P + T L V EY
Sbjct: 372 KILK-----KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM---DRLYFVMEY 423
Query: 709 MVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR 768
+ G L +++ R + A + A G+ +L K I++ DLK N ++ D +
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYRDLKLDNVML---DSEG 479
Query: 769 PVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVM 823
+ KI D G+ K I GV GT ++APE+ + + VD ++FGV++
Sbjct: 480 HI-KIADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLL 532
Query: 824 WELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+E+L G+ P+ +E+ I++ N+ P ++ + + P R
Sbjct: 533 YEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 38/273 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ LG G+FG V VA+K I L++ + RE L +
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ-----LLKKSDMHMRVEREISYLKLL 66
Query: 683 HHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSL--KQVLRRKDRTIDRRK--RIIIAMDA 737
HP+++ Y V+ T T++ V EY G L V +++ + R+ + II
Sbjct: 67 RHPHIIKLYDVITTP---TDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--- 119
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-----KTLISGGVR 792
IEY H IVH DLK N L+ D V KI D GLS I KT
Sbjct: 120 --AIEYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLSNIMTDGNFLKTSC----- 168
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
G+ + APE+ K +VDV+S G+V++ +L G P+ D + +
Sbjct: 169 GSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY-- 225
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+P + P +SL+ R +DP R EI +
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 37/275 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ ++ LG G +G V + VA+K + + + + +E + +
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD---CPENIK----KEICINKML 62
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL--KQVLRRKDRTIDRRK--RIIIAMDAA 738
+H NVV FYG +G EY G L + D ++ ++A
Sbjct: 63 NHENVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---- 116
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR---GTI 795
G+ YLH I H D+K N L+ D + + KI D GL+ + + + GT+
Sbjct: 117 -GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 796 PWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGP 852
P++APEL K + E VDV+S G+V+ +L GE P+ + + +
Sbjct: 172 PYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KT 226
Query: 853 KIPSWCE--PTWRSLMERCWSSDPKSRPAFSEITK 885
+ W + +L+ + +P +R +I K
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 64/340 (18%), Positives = 116/340 (34%), Gaps = 46/340 (13%)
Query: 560 ALQNAATERNDEHKEEIHLDPLEEKVETKKTCECS----KVIGEISSRSAAYFTNTANTE 615
++Q + E + LD L + E ++ +
Sbjct: 1 SMQQLVLDPGFLGLEPL-LDLLLGVHQ-----ELGASELAQDKYVADFLQWAEPIVVRLK 54
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFW 673
++ D E +K +G G F V K K + A+K + + + ++ F
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-----DMLKRGEVSCFR 109
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTID-RRKRII 732
E +L + + D L V EY V G L +L + I R
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR 792
+A + I+ +H VH D+K N L++ ++ D G K G VR
Sbjct: 168 LA-EIVMAIDSVHRLGYVHRDIKPDNILLDRCGH----IRLADFGSCL---KLRADGTVR 219
Query: 793 -----GTIPWMAPELFKSKDNLVTEK-----VDVYSFGVVMWELLTGEEPYADLHSEEII 842
GT +++PE+ ++ D ++ GV +E+ G+ P+ + E
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279
Query: 843 AGIIKGNL---GPKIPSWCEPTWRSLMER--CWSSDPKSR 877
I+ P + R ++R C P++R
Sbjct: 280 GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC---PPETR 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 26/287 (9%)
Query: 600 ISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSC 657
+ S F E Q + + + LG G FG V + + + A K+++
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE--- 218
Query: 658 FAEGSLEEDRLIADFWREAHMLGQIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQ 716
+ +++ + A E +L +++ VV+ Y T L V M G LK
Sbjct: 219 --KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---DALCLVLTLMNGGDLKF 273
Query: 717 VLRRKDRTIDRRKRIII-AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775
+ + R + A + G+E LH + IV+ DLK N L+ +I D
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISD 329
Query: 776 LGLSK-IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-Y 833
LGL+ + + I G V GT+ +MAPE+ K++ T D ++ G +++E++ G+ P
Sbjct: 330 LGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERY--TFSPDWWALGCLLYEMIAGQSPFQ 386
Query: 834 AD---LHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ EE+ + + + P RSL + DP R
Sbjct: 387 QRKKKIKREEVERLVKEVPE--EYSERFSPQARSLCSQLLCKDPAER 431
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 51/282 (18%)
Query: 625 EYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+++K++GSG FG K VA+K I+ + +++ RE +
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---------REIINHRSL 73
Query: 683 HHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKR-----IIIAMD 736
HPN+V F V+ T T+LA + EY G L + + R + R ++
Sbjct: 74 RHPNIVRFKEVILTP---THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG-- 128
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-----KTLISGGV 791
+ Y H I H DLK N L++ P KI D G SK K+ +
Sbjct: 129 ----VSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV---- 178
Query: 792 RGTIPWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE----IIAGI 845
GT ++APE+ + D DV+S GV ++ +L G P+ D I I
Sbjct: 179 -GTPAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 846 IKGNLGPKIPS--WCEPTWRSLMERCWSSDPKSRPAFSEITK 885
+ IP P L+ R + +DP +R + EI
Sbjct: 235 LSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 30/268 (11%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+K D K LG G+FG VF ++K ++ AIK +K + + D + E
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----KDVVLMDDDVECTMVEK 68
Query: 677 HMLGQ-IHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
+L HP + F T NL V EY+ G L ++ + R A
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTK---ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-- 792
+ G+++LH K IV+ DLK N L+ D + KI D G+ K + G +
Sbjct: 126 -EIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGMCKEN----MLGDAKTN 176
Query: 793 ---GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849
GT ++APE+ + VD +SFGV+++E+L G+ P+ EE+ I N
Sbjct: 177 TFCGTPDYIAPEILLGQKY--NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
Query: 850 LGPKIPSWCEPTWRSLMERCWSSDPKSR 877
P W E + L+ + + +P+ R
Sbjct: 235 P--FYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 609 TNTANTELQTIKTSDLEYIKELGSGTFGTVF---YGKWKGSDV--AIKRIKPSCFAEGSL 663
+ N + I+ E ++ LG G +G VF + A+K +K + +
Sbjct: 4 ETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK 63
Query: 664 EEDRLIADFWREAHMLGQIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD 722
+ A E ++L ++ HP +V Y T G L + EY+ G L L R+
Sbjct: 64 DTAHTKA----ERNILEEVKHPFIVDLIYAFQTGG---KLYLILEYLSGGELFMQLEREG 116
Query: 723 RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782
++ +A + + + +LH+K I++ DLK N ++ + Q V K+ D GL K
Sbjct: 117 IFMEDTACFYLA-EISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLCKES 171
Query: 783 QKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH 837
I G GTI +MAPE+ + VD +S G +M+++LTG P+ +
Sbjct: 172 ----IHDGTVTHTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPPFTGEN 225
Query: 838 SEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
++ I I+K L +P + R L+++ + SR
Sbjct: 226 RKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 82/324 (25%), Positives = 127/324 (39%), Gaps = 30/324 (9%)
Query: 563 NAATERNDEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTS 622
+ T E + + + + A + + +
Sbjct: 89 HVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN 148
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ EY+K LG GTFG V K K + A+K +K + + +A E +L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTENRVLQ 203
Query: 681 QIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
HP + A Y T L V EY G L L R+ + R R A +
Sbjct: 204 NSRHPFLTALKYSFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVS 259
Query: 740 GIEYLH-EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----G 793
++YLH EKN+V+ DLK N ++ D + KI D GL K I G G
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLML---DKDGHI-KITDFGLCKEG----IKDGATMKTFCG 311
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
T ++APE+ + D VD + GVVM+E++ G P+ + E++ I+ + +
Sbjct: 312 TPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--R 367
Query: 854 IPSWCEPTWRSLMERCWSSDPKSR 877
P P +SL+ DPK R
Sbjct: 368 FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-24
Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 31/291 (10%)
Query: 600 ISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSC 657
+ S F E Q + + LG G FG VF + K + A K++
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN--- 219
Query: 658 FAEGSLEEDRLIADFWREAHMLGQIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLK- 715
+ L++ + E +L ++H +V+ Y T T+L V M G ++
Sbjct: 220 --KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK---TDLCLVMTIMNGGDIRY 274
Query: 716 ---QVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772
V + R A G+E+LH++NI++ DLK N L++ +
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVR 329
Query: 773 IGDLGLSK--IKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
I DLGL+ +T G GT +MAPEL ++ VD ++ GV ++E++
Sbjct: 330 ISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY--DFSVDYFALGVTLYEMIAAR 386
Query: 831 EPY----ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
P+ + ++E+ +++ + P P + E DP+ R
Sbjct: 387 GPFRARGEKVENKELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 45/286 (15%)
Query: 609 TNTANTELQTIKTSDLEYIKELGSGTFGTVF-----YGKWKGSDVAIKRIKPSCFAEGSL 663
T+ + S E +K LG G+FG VF G A+K +K
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------- 61
Query: 664 EEDRLIADFWREAHM------LGQIHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQ 716
+ L L +++HP +V Y T+G L + +++ G L
Sbjct: 62 -KATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEG---KLYLILDFLRGGDLFT 115
Query: 717 VLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
L ++ + + +A + A +++LH I++ DLK N L+ D + + K+ D
Sbjct: 116 RLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILL---DEEGHI-KLTDF 170
Query: 777 GLSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE 831
GLSK I + GT+ +MAPE+ + + T+ D +SFGV+M+E+LTG
Sbjct: 171 GLSKES----IDHEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTL 224
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
P+ +E + I+K L +P + P +SL+ + +P +R
Sbjct: 225 PFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 37/275 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ ++ LG G +G V + VA+K + + + + +E + +
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD---CPENIK----KEICINKML 62
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSL--KQVLRRKDRTIDRRK--RIIIAMDAA 738
+H NVV FYG +G EY G L + D ++ ++A
Sbjct: 63 NHENVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---- 116
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR---GTI 795
G+ YLH I H D+K N L+ D + + KI D GL+ + + + GT+
Sbjct: 117 -GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 796 PWMAPELFKSK--DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGP 852
P++APEL K + E VDV+S G+V+ +L GE P+ + + +
Sbjct: 172 PYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KT 226
Query: 853 KIPSWCE--PTWRSLMERCWSSDPKSRPAFSEITK 885
+ W + +L+ + +P +R +I K
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 53/229 (23%), Positives = 83/229 (36%), Gaps = 46/229 (20%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
LG G V + A+K I E R + +RE ML Q H
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKII------EKQPGHIR--SRVFREVEMLYQCQGH 70
Query: 685 PNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK----------RIIIA 734
NV+ + V E M GS+ RR + + +
Sbjct: 71 RNVLELIEFFEEE--DRFYLVFEKMRGGSIL------SHIHKRRHFNELEASVVVQDVAS 122
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-- 792
+++LH K I H DLK N L + PV KI D L + +
Sbjct: 123 -----ALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTP 176
Query: 793 ------GTIPWMAPELFKSKDNLVT---EKVDVYSFGVVMWELLTGEEP 832
G+ +MAPE+ ++ + ++ D++S GV+++ LL+G P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
LG GTFG V GK + G VA+K + + ++ RE L
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ-----KIRSLDVVGKIRREIQNLKLF 73
Query: 683 HHPNVVAFYGVV-TDGPVTNLATVTEYMVNGSLKQVLRRKDRTID---RRK-RIIIAMDA 737
HP+++ Y V+ T +++ V EY+ G L + + R + RR + I++
Sbjct: 74 RHPHIIKLYQVISTP---SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--- 127
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ-----KTLISGGVR 792
G++Y H +VH DLK N L+ D KI D GLS + +T
Sbjct: 128 --GVDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSDGEFLRTSC----- 176
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852
G+ + APE+ + +VD++S GV+++ LL G P+ D H + I G
Sbjct: 177 GSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-- 233
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITK 885
P + P+ SL++ DP R +I +
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 60/269 (22%), Positives = 91/269 (33%), Gaps = 61/269 (22%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
+ LG G G V K A+K + +D RE + +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKML-----------QDC--PKARREVELHWRASQC 70
Query: 685 PNVVAFYGVVTDGPV--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF--- 739
P++V V + L V E + G L R DR + +A+
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELF------SRIQDRGDQAFTEREASEIMK 124
Query: 740 ----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
I+YLH NI H D+K N L + P + K+ D G
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGF----------------- 166
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLH---SEEIIAGIIKGNLG 851
A E K + + D++S GV+M+ LL G P Y++ S + I G
Sbjct: 167 ---AKETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220
Query: 852 PKIPSWCE--PTWRSLMERCWSSDPKSRP 878
P W E + L+ ++P R
Sbjct: 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 33/285 (11%)
Query: 609 TNTANTELQTIKTSDLEYIKELGSGTFGTVF-----YGKWKGSDVAIKRIKPSCFAEGSL 663
T + + + E +K LG+G +G VF G G A+K +K + +
Sbjct: 41 TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI----V 96
Query: 664 EEDRLIADFWREAHMLGQI-HHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK 721
++ + E +L I P +V Y T+ L + +Y+ G L L ++
Sbjct: 97 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET---KLHLILDYINGGELFTHLSQR 153
Query: 722 DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781
+R + +I + + +E+LH+ I++ D+K N L+ D V + D GLSK
Sbjct: 154 ERFTEHEVQIYVG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHV-VLTDFGLSK- 207
Query: 782 KQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY--- 833
+ + R GTI +MAP++ + D+ + VD +S GV+M+ELLTG P+
Sbjct: 208 --EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
Query: 834 -ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
EI I+K P + L++R DPK R
Sbjct: 266 GEKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 625 EYIKE-LGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
EY +G GT+G V+ K K D A+K+I+ + + + RE +L
Sbjct: 23 EYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----------REIALL 72
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--RKDRTIDRRKRIIIAMDA 737
++ HPNV++ V + + +Y L +++ R + + ++ M
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 738 AF------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-----IKQKTL 786
+ GI YLH ++H DLK N LV P+R KI D+G ++ +K
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 787 ISGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ V T W APE L ++ T+ +D+++ G + ELLT E
Sbjct: 192 LDPVVV-TF-WYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 602 SRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFA 659
S+ + + E+I+ LG G+FG V + K + A+K +K
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK----- 57
Query: 660 EGSLEEDRLIADFWREAHMLGQI-HHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQV 717
+ + +D + E +L +HP + F T L V E++ G L
Sbjct: 58 KDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---DRLFFVMEFVNGGDLMFH 114
Query: 718 LRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777
+++ R + R R A + + +LH+K I++ DLK N L+ D + K+ D G
Sbjct: 115 IQKSRRFDEARARFYAA-EIISALMFLHDKGIIYRDLKLDNVLL---DHEGHC-KLADFG 169
Query: 778 LSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP 832
+ K I GV GT ++APE+ + VD ++ GV+++E+L G P
Sbjct: 170 MCKEG----ICNGVTTATFCGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ + +++ I+ + P+W +++ + +P R
Sbjct: 224 FEAENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-22
Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 32/286 (11%)
Query: 601 SSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCF 658
++ + + F N N + +K +D ++ LG G+FG V + KG+D A+K +K
Sbjct: 1 TTNTVSKFDNNGNRD--RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---- 54
Query: 659 AEGSLEEDRLIADFWREAHMLGQI-HHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQ 716
+ + +D + E +L P + T L V EY+ G L
Sbjct: 55 -KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---RLYFVMEYVNGGDLMY 110
Query: 717 VLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+++ R + A + A G+ +L K I++ DLK N ++ D + + KI D
Sbjct: 111 HIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADF 165
Query: 777 GLSKIKQKTLISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE 831
G+ K I GV GT ++APE+ + + VD ++FGV+++E+L G+
Sbjct: 166 GMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQA 219
Query: 832 PYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
P+ +E+ I++ N+ P ++ + + P R
Sbjct: 220 PFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 30/277 (10%)
Query: 610 NTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDR 667
N + K SD ++K +G G+FG V + K +V A+K ++ + ++ + +
Sbjct: 26 NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-----KKAILKKK 80
Query: 668 LIADFWREAHMLGQ-IHHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTI 725
E ++L + + HP +V + T L V +Y+ G L L+R+ +
Sbjct: 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---DKLYFVLDYINGGELFYHLQRERCFL 137
Query: 726 DRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785
+ R R A + A + YLH NIV+ DLK N L+ D Q + + D GL K
Sbjct: 138 EPRARFYAA-EIASALGYLHSLNIVYRDLKPENILL---DSQGHI-VLTDFGLCKEN--- 189
Query: 786 LISGGVR-----GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE 840
I GT ++APE+ + VD + G V++E+L G P+ ++ E
Sbjct: 190 -IEHNSTTSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ I+ L ++ + R L+E D R
Sbjct: 247 MYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 71/317 (22%), Positives = 124/317 (39%), Gaps = 28/317 (8%)
Query: 572 HKEEIHLDPLEEKVETKKTCECSKVIGE-ISSRSAAYFTNTANTELQT-IKTSDLEYIKE 629
K+++ D + +E V + I S F N EL + +D +
Sbjct: 137 VKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRI 196
Query: 630 LGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH---H 684
+G G FG V+ + + A+K + + ++ + E ML +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 685 PNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
P +V Y T L+ + + M G L L + + R A + G+E+
Sbjct: 252 PFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELF 803
+H + +V+ DLK N L++ + +I DLGL+ K V GT +MAPE+
Sbjct: 308 MHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 362
Query: 804 KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---EEIIAGIIKGNLGPKIPSWCEP 860
+ D +S G ++++LL G P+ + EI + + ++P P
Sbjct: 363 QKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSP 419
Query: 861 TWRSLMERCWSSDPKSR 877
RSL+E D R
Sbjct: 420 ELRSLLEGLLQRDVNRR 436
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 74/309 (23%)
Query: 617 QTIKTSDLEY--IKELGSGTFGTVFYGKWKGSD-VAIKRIKPSCFAEGSLEEDRLIADFW 673
+T + ++ Y K +G+G+FG VF K SD VAIK++ ++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL--------QDKRFKN---- 80
Query: 674 REAHMLGQIHHPNVVA----FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
RE ++ + HPNVV FY L V EY+ ++ + R + ++
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAK---LKQ 136
Query: 730 RIIIAMDAAF------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--I 781
+ + + + + Y+H I H D+K N L++ P V K+ D G +K I
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILI 193
Query: 782 KQKTLISGGV----RGTIPWMAPEL-FKSKDNLVTEKVDVYSFGVVMWELLTGE-----E 831
+ +S R APEL F + + T +D++S G VM EL+ G+ E
Sbjct: 194 AGEPNVSYICSRYYR------APELIFGATN--YTTNIDIWSTGCVMAELMQGQPLFPGE 245
Query: 832 PYAD-LH---------SEEIIAGIIKGNLGPKIPSWCEPTWRS------------LMERC 869
D L S E I + + K P + L+ R
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305
Query: 870 WSSDPKSRP 878
P +R
Sbjct: 306 LEYTPSARL 314
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 66/277 (23%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ D + ++ +G G++ V + K +D A+K +K + + +D I E
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-----KELVNDDEDIDWVQTEK 60
Query: 677 HMLGQI-HHPNVVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
H+ Q +HP +V T+ + L V EY+ G L ++R+ + + R A
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTE---SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 117
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-- 792
+ + + YLHE+ I++ DLK N L+ D + + K+ D G+ K + G
Sbjct: 118 -EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG----LRPGDTTS 168
Query: 793 ---GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---------EE 840
GT ++APE+ + +D VD ++ GV+M+E++ G P+ + S +
Sbjct: 169 TFCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 841 IIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSR 877
+ I++ + +IP S+++ + DPK R
Sbjct: 227 LFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 71/326 (21%), Positives = 137/326 (42%), Gaps = 44/326 (13%)
Query: 570 DEHKEEIHLDPLEEKVETKKTCECSKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKE 629
H + P E + + I A T + ++ D + ++
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMG-----SGIEEEKEAMNTRESGKASSSLGLQDFDLLRV 59
Query: 630 LGSGTFGTVFYGKWKGSDV--AIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686
+G G++ V + K +D A++ +K + + +D I E H+ Q +HP
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK-----KELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 687 VVA-FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH 745
+V T+ + L V EY+ G L ++R+ + + R A + + + YLH
Sbjct: 115 LVGLHSCFQTE---SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 170
Query: 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVR-----GTIPWMAP 800
E+ I++ DLK N L+ D + + K+ D G+ K + G GT ++AP
Sbjct: 171 ERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG----LRPGDTTSTFCGTPNYIAP 222
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---------EEIIAGIIKGNLG 851
E+ + +D VD ++ GV+M+E++ G P+ + S + + I++ +
Sbjct: 223 EILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSR 877
+IP S+++ + DPK R
Sbjct: 280 -RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-21
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 51/229 (22%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E ++++G GT+GTVF K + VA+KR++ EG +L RE +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----------REICL 54
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMD 736
L ++ H N+V + V+ L V E+ + LK+ + +D K + +
Sbjct: 55 LKELKHKNIVRLHDVLHSD--KKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TL 786
G+ + H +N++H DLK N L+N + K+ + GL++ TL
Sbjct: 112 K--GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 787 ISGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
W P+ LF +K + +D++S G + EL P
Sbjct: 166 ----------WYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPL 202
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 71/311 (22%), Positives = 114/311 (36%), Gaps = 83/311 (26%)
Query: 620 KTSDLEY--IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWRE 675
+ ++ Y K +G+G+FG V+ K G VAIK++ L++ R RE
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKN---RE 97
Query: 676 AHMLGQIHHPNVVA----FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
++ ++ H N+V FY L V +Y+ ++ +V R R ++ +
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSR---AKQTL 153
Query: 732 IIAMDAAF------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT 785
+ + + Y+H I H D+K N L++ P V K+ D G + K
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSA----KQ 206
Query: 786 LISGGVRGTIPWM----------APEL-FKSKDNLVTEKVDVYSFGVVMWELLTGE---- 830
L+ G APEL F + D T +DV+S G V+ ELL G+
Sbjct: 207 LVRG------EPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQPIFP 258
Query: 831 -EPYAD-LH---------SEEIIAGIIKGNLGPKIPSWCEPTWRS------------LME 867
+ D L + E I + K P W L
Sbjct: 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 318
Query: 868 RCWSSDPKSRP 878
R P +R
Sbjct: 319 RLLEYTPTARL 329
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 625 EYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHML 679
++++G GT+G V+ + G A+K+I+ EG ++ RE +L
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----------REISIL 54
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDA 737
++ H N+V Y V+ L V E++ + LK++L + ++ K ++ +
Sbjct: 55 KELKHSNIVKLYDVIHTK--KRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TLI 787
GI Y H++ ++H DLK N L+N + KI D GL++ TL
Sbjct: 112 --GIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIVTL- 164
Query: 788 SGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W AP+ L SK + +D++S G + E++ G
Sbjct: 165 ---------WYRAPDVLMGSK--KYSTTIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 45/223 (20%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I ++G G++G VF + + G VAIK+ S + IA RE ML Q+
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIA--LREIRMLKQL 59
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAAFG 740
HPN+V V L V EY + ++ L R R + K I
Sbjct: 60 KHPNLVNLLEVFRRK--RRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQT--LQA 114
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIP---- 796
+ + H+ N +H D+K N L+ V K+ D G +++ T P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFARLL-----------TGPSDYY 159
Query: 797 -------WM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W +PE L VDV++ G V ELL+G
Sbjct: 160 DDEVATRWYRSPELLVGDTQ--YGPPVDVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 625 EYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHML 679
+ ++++G GT+G V+ K G VA+KRI+ EG ++ RE +L
Sbjct: 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----------REISLL 73
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDA 737
++HHPN+V+ V+ L V E+M LK+VL + K + +
Sbjct: 74 KELHHPNIVSLIDVIHSE--RCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TLI 787
G+ + H+ I+H DLK N L+N K+ D GL++ TL
Sbjct: 131 --GVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVVTL- 183
Query: 788 SGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W AP+ L SK + VD++S G + E++TG+
Sbjct: 184 ---------WYRAPDVLMGSKK--YSTSVDIWSIGCIFAEMITGK 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 57/231 (24%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
I +LG GT+G V+ VAIKRI+ EG ++ RE +
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----------REVSL 86
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
L ++ H N++ V+ L + EY LK+ +D+ + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHN--HRLHLIFEYA-ENDLKKY-------MDKNPDVSMRVIKS 136
Query: 739 F------GIEYLHEKNIVHFDLKSHNFLVNMRD-PQRPVCKIGDLGLSKIKQK------- 784
F G+ + H + +H DLK N L+++ D + PV KIGD GL++
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 785 ---TLISGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
TL W PE L S+ + VD++S + E+L
Sbjct: 197 EIITL----------WYRPPEILLGSRH--YSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 51/226 (22%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + +G G++G V + K G VAIK+ S + + IA RE +L Q+
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIA--MREIKLLKQL 81
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAAFG 740
H N+V V V E++ + ++ L +D + ++ + + G
Sbjct: 82 RHENLVNLLEVCKKK--KRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN--G 136
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TLISGG 790
I + H NI+H D+K N LV+ V K+ D G ++ T
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEVYDDEVATR---- 188
Query: 791 VRGTIPWM-APELFKSKDNLVTEK-----VDVYSFGVVMWELLTGE 830
W APEL LV + VDV++ G ++ E+ GE
Sbjct: 189 ------WYRAPEL------LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADF--WREAHMLG 680
E + LG G F TV+ + K VAIK+IK G E + + RE +L
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-----GHRSEAKDGINRTALREIKLLQ 67
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAA 738
++ HPN++ +N++ V ++M L+ +++ + K ++
Sbjct: 68 ELSHPNIIGLLDAFGHK--SNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ- 123
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK---IKQKTLISGGVRGTI 795
G+EYLH+ I+H DLK +N L++ + V K+ D GL+K + V T
Sbjct: 124 -GLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVV--TR 176
Query: 796 PWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W APE LF ++ VD+++ G ++ ELL
Sbjct: 177 -WYRAPELLFGARM--YGVGVDMWAVGCILAELLLRV 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 47/239 (19%), Positives = 89/239 (37%), Gaps = 70/239 (29%)
Query: 621 TSDLEYIKELGSGTFGTVFYG--KWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
D + +++LG G + VF V +K +KP +++ ++ RE +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIK----REIKI 83
Query: 679 LGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
L + PN++ +V D A V E++ N KQ+ + + D
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDI 132
Query: 738 AF-------GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
F ++Y H I+H D+K HN +++ + ++ D GL+
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLA----------- 178
Query: 791 VRGTIPWM------------APELFKSKDNLVTEK-----VDVYSFGVVMWELLTGEEP 832
P PEL LV + +D++S G ++ ++ +EP
Sbjct: 179 -EFYHPGQEYNVRVASRYFKGPEL------LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 73/329 (22%), Positives = 115/329 (34%), Gaps = 76/329 (23%)
Query: 602 SRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFA 659
+ A E + + + G GTFGTV GK K G VAIK++
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------ 56
Query: 660 EGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTN-----LATVTEYMVNGSL 714
+++ R + L +HHPN+V + L V EY+ +L
Sbjct: 57 ---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTL 112
Query: 715 KQVLRRKDRTIDRRKRIIIAMDAAF------GIEYLHEK--NIVHFDLKSHNFLVNMRDP 766
+ R R I+I + F I LH N+ H D+K HN LVN
Sbjct: 113 HRCCRNYYRRQVAPPPILIKV---FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---E 166
Query: 767 QRPVCKIGDLGLSKI--KQKTLISGGV----RGTIPWMAPEL-FKSKDNLVTEKVDVYSF 819
K+ D G +K + ++ R APEL F ++ T VD++S
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR------APELIFGNQH--YTTAVDIWSV 218
Query: 820 GVVMWELLTGE-----EPYAD-LH---------SEEIIAGIIKGNLGPKIPSWCEPTWRS 864
G + E++ GE + A LH S E++ + + + + W +
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN 278
Query: 865 ---------------LMERCWSSDPKSRP 878
L+ P+ R
Sbjct: 279 VFSDHSLKDAKEAYDLLSALLQYLPEERM 307
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/231 (22%), Positives = 85/231 (36%), Gaps = 49/231 (21%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAHM 678
E + ++G GTFG VF + + G VA+K++ EG +L RE +
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----------REIKI 69
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRR--KR 730
L + H NVV + V ++ + L +L KR
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 731 IIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGG 790
++ + G+ Y+H I+H D+K+ N L+ + V K+ D GL+ S
Sbjct: 129 VMQMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLA-----RAFSLA 177
Query: 791 VRGTIPWM----------APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
PE L +D +D++ G +M E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 46/223 (20%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLGQ 681
+ +LG GT+ TV+ GK K + VA+K I+ LE E+ RE +L
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKD 56
Query: 682 IHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRR--KRIIIAMDAAF 739
+ H N+V + ++ +L V EY+ + LKQ L I+ K + +
Sbjct: 57 LKHANIVTLHDIIHTE--KSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL--LR 111
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TLISG 789
G+ Y H + ++H DLK N L+N +R K+ D GL++ K TL
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVVTL--- 164
Query: 790 GVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W P+ L S D + ++D++ G + +E+ TG
Sbjct: 165 -------WYRPPDILLGSTD--YSTQIDMWGVGCIFYEMATGR 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 49/231 (21%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKP---SCFAEGSLEEDRLIADFWRE 675
+ LG G +G V + VAIK+I+P FA +L RE
Sbjct: 14 QLKSLLGEGAYGVV----CSATHKPTGEIVAIKKIEPFDKPLFALRTL----------RE 59
Query: 676 AHMLGQIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+L H N++ + + N + E M L +V+ + + D + I
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFI 118
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLS-KIKQKTLISG 789
++ LH N++H DLK N L+N C K+ D GL+ I + +
Sbjct: 119 YQT--LRAVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNS 170
Query: 790 GVRGTIPWM----------APELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
G M APE+ + + +DV+S G ++ EL
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAK-YSRAMDVWSCGCILAELFLRR 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 49/225 (21%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHMLGQIH 683
+++LG+GT+ TV+ G K G VA+K +K L+ E+ + RE ++ ++
Sbjct: 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELK 61
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF---- 739
H N+V Y V+ L V E+M + LK+ + + + + + + + F
Sbjct: 62 HENIVRLYDVIHTE--NKLTLVFEFM-DNDLKKYMDSR-TVGNTPRGLELNLVKYFQWQL 117
Query: 740 --GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK----------TLI 787
G+ + HE I+H DLK N L+N +R K+GD GL++ TL
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSSEVVTL- 172
Query: 788 SGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
W AP+ L S+ + +D++S G ++ E++TG+
Sbjct: 173 ---------WYRAPDVLMGSRT--YSTSIDIWSCGCILAEMITGK 206
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 27/220 (12%)
Query: 625 EYIKELGSGTFGTVFYGK-WKGSDVAIKRIKPSCFAEGSLE--EDRLIAD-FWREAHMLG 680
+ + SG++G V G +G VAIKR+ + ++ D + RE +L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 681 QIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGSLKQVLRRKDRTI-DRRKRIIIAMD 736
HHPN++ + + VTE M L QV+ + I + + +
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM--- 140
Query: 737 AAF----GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGG 790
+ G+ LHE +VH DL N L+ I D L++
Sbjct: 141 --YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANKTH 192
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APEL T+ VD++S G VM E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKG-FTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQIH 683
+K +GSG G V Y +VAIK++ F +++ A +RE ++ ++
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPF------QNQTHAKRAYRELVLMKCVN 82
Query: 684 HPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
H N++ V T P +L V E M + +L QV++ + +R ++ M
Sbjct: 83 HKNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQM-- 136
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTI 795
GI++LH I+H DLK N +V C KI D GL++ + + T
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
+ APE+ E VD++S G +M E++ G
Sbjct: 191 YYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGG 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 51/232 (21%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRI--KPSCFAEGSLEEDRLIADFWREA 676
+K LG G G V + D VAIK+I + +L RE
Sbjct: 14 MDLKPLGCGGNGLV----FSAVDNDCDKRVAIKKIVLTDPQSVKHAL----------REI 59
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLAT------------VTEYMVNGSLKQVLRRKDRT 724
++ ++ H N+V + ++ V EYM L VL +
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLL 118
Query: 725 IDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKI- 781
+ + + + G++Y+H N++H DLK N +N D KIGD GL++I
Sbjct: 119 EEHARLFMYQL--LRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARIM 171
Query: 782 ----KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG 829
K +S G+ T + +P L S +N T+ +D+++ G + E+LTG
Sbjct: 172 DPHYSHKGHLSEGL-VTKWYRSPRLLLSPNN-YTKAIDMWAAGCIFAEMLTG 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 55/233 (23%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFW-----REAH 677
E + E+G G +GTV+ + S VA+K ++ + RE
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--------VPNGGGGGGGLPISTVREVA 63
Query: 678 MLGQIH---HPNVVAFYGVVTD---GPVTNLATVTEYMVNGSLKQVLRRKDR---TIDRR 728
+L ++ HPNVV V + V E++ + L+ L + +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 729 KRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK---- 784
K ++ G+++LH IVH DLK N LV K+ D GL++I
Sbjct: 123 KDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARIYSYQMAL 176
Query: 785 -----TLISGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
TL W APE L +S VD++S G + E+ +
Sbjct: 177 TPVVVTL----------WYRAPEVLLQST---YATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 57/233 (24%)
Query: 625 EYIKELGSGTFGTVFYG---KWKGSDVAIKRIKPSCFAEG----SLEEDRLIADFWREAH 677
E + E+G G +G VF K G VA+KR++ EG ++ RE
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----------REVA 63
Query: 678 MLGQIH---HPNVVAFYGVVTDGPV---TNLATVTEYMVNGSLKQVLRRKDR---TIDRR 728
+L + HPNVV + V T T L V E++ + L L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 729 KRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK---- 784
K ++ + G+++LH +VH DLK N LV K+ D GL++I
Sbjct: 123 KDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMAL 176
Query: 785 -----TLISGGVRGTIPWM-APE-LFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
TL W APE L +S VD++S G + E+ +
Sbjct: 177 TSVVVTL----------WYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 52/225 (23%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQIH 683
+ +GSG +G+V + G VA+K++ F + + A +RE +L +
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPF------QSIIHAKRTYRELRLLKHMK 86
Query: 684 HPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
H NV+ V T P +L VT M L +++ + T D + +I +
Sbjct: 87 HENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI-- 141
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTI 795
G++Y+H +I+H DLK N VN C KI D GL+ R T
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLA------------RHTA 183
Query: 796 PWM----------APELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
M APE+ + + + VD++S G +M ELLTG
Sbjct: 184 DEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKP---SCFAEGSLEEDRLIADFWREAHMLGQ 681
+ +G G +G V Y VAIK+I P + + +L RE +L +
Sbjct: 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----------REIKILLR 81
Query: 682 IHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
H N++ ++ + + V + M L ++L+ + + D + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--L 138
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKI-----KQKTLISGGV 791
G++Y+H N++H DLK N L+N C KI D GL+++ ++ V
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
T + APE+ + T+ +D++S G ++ E+L+
Sbjct: 193 -ATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 62/336 (18%), Positives = 110/336 (32%), Gaps = 113/336 (33%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
K LG+G+FG V G A+K++ L++ R RE ++ +
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKN---RELDIMKVL 57
Query: 683 HHPNVVA----FYGVVTDGPVTNLAT--------------------------------VT 706
H N++ FY + P +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 707 EYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF------GIEYLHEKNIVHFDLKSHNFL 760
EY+ +L +VL+ R+ + I + + + + + ++H I H D+K N L
Sbjct: 118 EYV-PDTLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 761 VNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM----------APEL-FKSKDNL 809
VN + K+ D G +K + APEL + +
Sbjct: 174 VN---SKDNTLKLCDFGSAKKLIPS----------EPSVAYICSRFYRAPELMLGATE-- 218
Query: 810 VTEKVDVYSFGVVMWELLTGE-----EPYAD-LH---------SEEIIAGIIKGNLGPKI 854
T +D++S G V EL+ G+ E D L ++E + + +
Sbjct: 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF 278
Query: 855 PSWCEPTWRS------------LMERCWSSDPKSRP 878
P+ WR L+E+ +P R
Sbjct: 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQIH 683
++ +GSG +G V G+ VAIK++ F + L A +RE +L +
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPF------QSELFAKRAYRELRLLKHMR 82
Query: 684 HPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
H NV+ V T P L V +M L ++++ + DR + ++ M
Sbjct: 83 HENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM-- 137
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTI 795
G+ Y+H I+H DLK N VN C KI D GL+ R
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLA------------RQAD 179
Query: 796 PWM----------APELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
M APE+ + T+ VD++S G +M E++TG+
Sbjct: 180 SEMTGYVVTRWYRAPEVILNWMR-YTQTVDIWSVGCIMAEMITGK 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQIH 683
+K +GSG G V Y +VAIK++ F +++ A +RE ++ ++
Sbjct: 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPF------QNQTHAKRAYRELVLMKCVN 119
Query: 684 HPNVVAFYGVVTDGPVTN----LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
H N+++ V T + V E M + +L QV++ + +R ++ M
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLC-- 175
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTIPW 797
GI++LH I+H DLK N +V C KI D GL++ + + T +
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
APE+ E VD++S G +M E++ +
Sbjct: 230 RAPEVILGMG--YKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 53/225 (23%)
Query: 627 IKELGSGTFGTVF--YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIAD-FWREAHMLGQIH 683
+GSG +G+V K G VAIK++ F + + A +RE +L +
Sbjct: 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPF------QSEIFAKRAYRELLLLKHMQ 81
Query: 684 HPNVVAFYGVVTDGPVTNLAT------VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
H NV+ V T P ++L V +M L++++ + ++ + ++ M
Sbjct: 82 HENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIMG-LKFSEEKIQYLVYQM-- 135
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGTI 795
G++Y+H +VH DLK N VN C KI D GL+ R
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLA------------RHAD 177
Query: 796 PWM----------APELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
M APE+ S + + VD++S G +M E+LTG+
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 55/276 (19%), Positives = 106/276 (38%), Gaps = 65/276 (23%)
Query: 601 SSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIK 654
S R YF N + + +G G++G V + D VAIK++
Sbjct: 9 SGRENLYFQGIKNVHV----PDNYIIKHLIGRGSYGYV----YLAYDKNTEKNVAIKKV- 59
Query: 655 PSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVN 711
F E ++ R++ RE +L ++ ++ Y ++ + V E +
Sbjct: 60 NRMF-EDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-D 113
Query: 712 GSLKQVLRRKDRTIDRRKRIIIAMDAAF----GIEYLHEKNIVHFDLKSHNFLVNMRDPQ 767
LK++ + + + I+ + G ++HE I+H DLK N L+N +D
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTIL-----YNLLLGENFIHESGIIHRDLKPANCLLN-QD-- 165
Query: 768 RPVC--KIGDLGLS-------------KIKQKTLISGGVRGTIPWM----------APEL 802
C K+ D GL+ +++ + + APEL
Sbjct: 166 ---CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS 838
++N T+ +D++S G + ELL + + + +
Sbjct: 223 ILLQEN-YTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 60/255 (23%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
E +G+G++G V + D VAIK+I F E ++ R++ RE +
Sbjct: 56 EIRHLIGTGSYGHV----CEAYDKLEKRVVAIKKI-LRVF-EDLIDCKRIL----REIAI 105
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLAT---VTEYMVNGSLKQVLRRKDR-TIDRRKRIIIA 734
L +++H +VV +V V V E + K++ R T K ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLS------------- 779
+ G++Y+H I+H DLK N LVN C K+ D GL+
Sbjct: 165 L--LVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQL 216
Query: 780 -----KIKQKTLISGGVRGTIPWM----------APELFKSKDNLVTEKVDVYSFGVVMW 824
+ + + + APEL ++N TE +DV+S G +
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN-YTEAIDVWSIGCIFA 275
Query: 825 ELLTGEEPYADLHSE 839
ELL + H++
Sbjct: 276 ELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 51/236 (21%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIAD-FWREAH 677
E +K+LG G +G V WK D VA+K+I F ++ A +RE
Sbjct: 12 ELVKKLGKGAYGIV----WKSIDRRTGEVVAVKKI-FDAF------QNSTDAQRTFREIM 60
Query: 678 MLGQIH-HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L ++ H N+V V+ ++ V +YM L V+R ++ ++ +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC--KIGDLGLSKIKQKTLISGGVRGT 794
I+YLH ++H D+K N L+N + C K+ D GLS+
Sbjct: 120 K--VIKYLHSGGLLHRDMKPSNILLN-AE-----CHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 795 IPWMAPELFKSKDNLVTEKV--------------DVYSFGVVMW-------ELLTG 829
E F ++T+ V Y+ G+ MW E+L G
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 8e-11
Identities = 28/195 (14%), Positives = 52/195 (26%), Gaps = 40/195 (20%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ T L+ +++G G FG VF + VAIK I + + + E +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 679 LGQIH---------HPNVVAFYGVV----------------------------TDGPVTN 701
++ + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 702 LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFL 760
L V E+ G + +R K ++ K I+ + H DL N L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSIL--HQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 761 VNMRDPQRPVCKIGD 775
+ ++ +
Sbjct: 195 LKKTSLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 26/180 (14%), Positives = 55/180 (30%), Gaps = 43/180 (23%)
Query: 627 IKELGSGTFGTVFYG----------KWKGSDVAIK--RIKPSCFAEGSLEE---DRLIAD 671
G ++ + ++K F E + + L +
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 672 FWREAHMLGQIHHPNVVAF-------YGVVTD--GPVTNLATVTEYMVNG--SLKQVLRR 720
W++ + + P + F +V G +L + + S + VL+
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQSALDVSPKHVLSERSVLQV 164
Query: 721 KDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
R +D +E+LHE VH ++ + N V+ D + + G +
Sbjct: 165 ACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 38/177 (21%), Positives = 61/177 (34%), Gaps = 40/177 (22%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLE-EDRL--------IADFWRE 675
K++GSG FG ++ K A +K G L E + W E
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 676 AHMLGQIHHPNVVAF----------YGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDR 723
L + P +V + G +L ++ VL+ R
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKISGQNGTFKKSTVLQLGIR 159
Query: 724 TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
+D +EY+HE VH D+K+ N L+ ++P + + D GLS
Sbjct: 160 MLDV-------------LEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 34/184 (18%), Positives = 55/184 (29%), Gaps = 51/184 (27%)
Query: 627 IKELGSGTFGTVFYGKWK-------GSDVAIKRIK---PSCFAEGSLEE---DRLIADFW 673
+G G FG ++ + +K F E + W
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMV--------------NG---SLKQ 716
L + P G +M+ N S K
Sbjct: 100 IRTRKLKYLGVPKYWGS------GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 717 VLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
VL+ R +D +EY+HE VH D+K+ N L+N ++P + + D
Sbjct: 154 VLQLSLRILDI-------------LEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDY 198
Query: 777 GLSK 780
GL+
Sbjct: 199 GLAY 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 31/165 (18%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH 684
+ +G G+FG +F G VAIK A +E R + G
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK------LLAGCTGI 68
Query: 685 PNVVAF------YGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
PNV F +V D GP SL+ +L R + + A
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP--------------SLEDLLDLCGRKFSVKTVAMAAKQ 114
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRP-VCKIGDLGLSK 780
++ +HEK++V+ D+K NFL+ + + + + D G+ K
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 45/172 (26%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLE-EDRLIADFWREAHML---- 679
K++G G FG + GK + VAIK LE E
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIK-----------LEPMKSRAPQLHLEYRFYKQLG 62
Query: 680 GQIHHPNVVAF------YGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
P V F +V + GP SL+ + DRT + +
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELLGP--------------SLEDLFDLCDRTFSLKTVL 108
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG---DLGLSK 780
+IA+ +EY+H KN+++ D+K NFL + P ++ D L+K
Sbjct: 109 MIAIQLISRMEYVHSKNLIYRDVKPENFL--IGRPGNKTQQVIHIIDFALAK 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 57/258 (22%), Positives = 113/258 (43%), Gaps = 45/258 (17%)
Query: 627 IKELGSGTFGTVFYGKWK------GSDVAIKRIKPSC-FAEGSLEEDRLI-----ADFWR 674
+++LG G F TV W + VA+K ++ + E + +E +L+ AD +
Sbjct: 24 VRKLGWGHFSTV----WLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 675 EAHMLGQIHHPNVVAFYG--VVTDGPVTNLATVTEYMVNGSLKQVLRR-KDR--TIDRRK 729
E M +++ ++ V E + +L ++++ + R + K
Sbjct: 80 EDSM----GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 730 RIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQ--RPVCKIGDLGLSKIKQKTL 786
+I + G++Y+H + I+H D+K N L+ + D KI DLG + +
Sbjct: 135 QISKQL--LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 787 ISGGVRGTIPWMAPE-LFKSKDNLVTEKVDVYSFGVVMWELLTG------EEPYADLHSE 839
+ T + +PE L + D++S +++EL+TG +E ++ +
Sbjct: 193 TNSIQ--TREYRSPEVLLGAP---WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 840 EIIAGIIKGNLGPKIPSW 857
+ IA II+ LG +PS+
Sbjct: 248 DHIAQIIE-LLGE-LPSY 263
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 39/168 (23%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML----G 680
+++GSG+FG ++ G G +VAIK E + + E+ + G
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLH---IESKIYKMMQG 63
Query: 681 QIHHPNVVAF------YGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
+ P + +V + GP SL+ + R + ++
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGP--------------SLEDLFNFCSRKFSLKTVLL 109
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
+A IEY+H KN +H D+K NFL+ + V I D GL+K
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 39/168 (23%)
Query: 627 IKELGSGTFGTVFYGK--WKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML----G 680
+++GSG+FG ++ G +VAIK L E+ + G
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLL---------YESKIYRILQG 61
Query: 681 QIHHPNVVAF------YGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
PNV F +V D GP SL+ + R + + ++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGP--------------SLEDLFNFCSRKLSLKTVLM 107
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
+A +E++H K+ +H D+K NFL+ + V I D GL+K
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAK 154
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 55/255 (21%), Positives = 101/255 (39%), Gaps = 55/255 (21%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIK-PSCFAEGSLEEDRLIADFWREA----- 676
E +K +G G+FG V Y VA+K ++ F + EE R++ + R+
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL-EHLRKQDKDNT 158
Query: 677 ----HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRR-KDR--TIDRRK 729
HML N ++ E + + +L +++++ K + ++ +
Sbjct: 159 MNVIHMLENFTFRN--------------HICMTFELL-SMNLYELIKKNKFQGFSLPLVR 203
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISG 789
+ A ++ LH+ I+H DLK N L+ R K+ D G S + + + +
Sbjct: 204 KF--AHSILQCLDALHKNRIIHCDLKPENILLK--QQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 790 GV----RGTIPWMAPELFKSKDNL---VTEKVDVYSFGVVMWELLTGEEPYADLHSEEII 842
R APE+ L +D++S G ++ ELLTG + +
Sbjct: 260 IQSRFYR------APEVI-----LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308
Query: 843 AGIIKGNLGPKIPSW 857
A +I+ LG
Sbjct: 309 ACMIE-LLGM-PSQK 321
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 61/301 (20%), Positives = 102/301 (33%), Gaps = 82/301 (27%)
Query: 625 EYIKELGSGTFGTVF--YGKWKGSDVAIKRIKPSC-FAEGSLEEDRL---IADFWREAHM 678
I++LG G F TV+ + VA+K +K + + E +L+E RL + +
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN------- 92
Query: 679 LGQIHHPN---VVAFYGVVT-DGPV-TNLATVTEYMVNG-SLKQVLRR-KDRTIDRRKRI 731
+ PN VV G T++ V E + G L + + + + +
Sbjct: 93 -SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVK 149
Query: 732 IIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDP------------------------ 766
I G++YLH K I+H D+K N L+++ +
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 767 ---------------------QRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE-LFK 804
++ KI DLG + K T + + E L
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIG 267
Query: 805 SKDNLVTEKVDVYSFGVVMWELLTGEEPY------ADLHSEEIIAGIIKGNLGPKIPSWC 858
S D++S + +EL TG+ + E+ IA II LG
Sbjct: 268 SG---YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII-ELLGKVPRKLI 323
Query: 859 E 859
Sbjct: 324 V 324
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 74/535 (13%), Positives = 142/535 (26%), Gaps = 190/535 (35%)
Query: 12 CKKS--ASKV----KLICSF-NGAFHVQPSSNNLRYIGGETRIISVDRTISFPKLRLKIS 64
K+ A V K+ C F + NL+ ++ KL +I
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWL-----NLKNCNSPETVL-----EMLQKLLYQID 210
Query: 65 DICSSIPSFTLKYRLPLNPDR---------KQGDDTPLVLIASDDDVRCMVEEYDKLE-S 114
+S + +L ++ + K ++ LVL +V + ++ S
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL----LNV-QNAKAWNAFNLS 265
Query: 115 C-------GKGVADDSLRKKVMKQQLSAKQSCDSPLIDLDFGLEE--------------P 153
C K V D LSA + L L P
Sbjct: 266 CKILLTTRFKQVTDF----------LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 154 NDL---VVKNDPFRVN-VANGLENGRLRPLNPRDGNVRNIAVEANASVECLVGRSFQGFC 209
DL V+ +P R++ +A + +G N + N + +S+ L ++
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK-M 374
Query: 210 YGGGNTTLMGNSVDCKWDFGNTGQMPFSNFN-SENIMP------WGA----TCGSVNNHL 258
+ S F S +I W V N L
Sbjct: 375 F---------------DR--------LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 259 GVQSCSNLPVGSGCPVNSSCVGDRVCCACQSGLRGNRFAVND--ARYQRNYSNYARKNNN 316
S V + + + ++ + N + +
Sbjct: 412 ---------------HKYSLV--------EKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 317 LVEVGNYRGAR---LDGKIPAGK-----CYLGIRPKSNISKQGKSMGLYNANLSSPWAGF 368
+V+ +Y + D IP ++G L N F
Sbjct: 449 IVD--HYNIPKTFDSDDLIPPYLDQYFYSHIGHH-------------LKNIEHPERMTLF 493
Query: 369 TELASEGVVSVMGSCFNKGISTFDVQY-GEKFREHGGPTISQYGLSNLVESHLACHSTCN 427
+ F D ++ +K R + + N +
Sbjct: 494 RMV------------F------LDFRFLEQKIRHDSTAWNASGSILNTL----------- 524
Query: 428 VAGD-QFFLSHTAINNPSTFVRVMNTKDDML--TGSKLERHE----VQCQALYEN 475
+F+ + N+P + R++N D L L + ++ + E+
Sbjct: 525 --QQLKFYKPYICDNDP-KYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 897 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 2e-75
Identities = 89/284 (31%), Positives = 146/284 (51%), Gaps = 22/284 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
I + + +GSG+FGTV+ GKW G DVA+K + + L+ F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA------FKNEVGV 57
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
L + H N++ F G T LA VT++ SL L + + K I IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK---TLISGGVRGTI 795
G++YLH K+I+H DLKS+N ++ + KIGD GL+ +K + + + G+I
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 796 PWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL---- 850
WMAPE+ + +D N + + DVY+FG+V++EL+TG+ PY+++++ + I ++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
K+ S C + LM C RP F +I + +A ++
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-68
Identities = 84/274 (30%), Positives = 138/274 (50%), Gaps = 22/274 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ +L+ ++ +G G FG V G ++G+ VA+K IK A+ F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----------AFLAEASV 53
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAMDA 737
+ Q+ H N+V GV+ + L VTEYM GSL LR + R+ + + ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
+EYL N VH DL + N LV+ + V K+ D GL+K T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPS 856
APE + K + K DV+SFG+++WE+ + G PY + ++++ + KG P
Sbjct: 167 TAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAPD 223
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
C P +M+ CW D RP+F ++ ++L +
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-65
Identities = 90/274 (32%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I DL ++KELG+G FG V YGKW+ DVAIK IK EGS+ ED F EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDE----FIEEAK 51
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ + H +V YGV T + +TEYM NG L LR ++ + + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTI 795
+EYL K +H DL + N LVN + V K+ D GLS+ + S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854
W PE+ + K D+++FGV+MWE+ + G+ PY + E I +G L
Sbjct: 166 RWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
P ++M CW RP F + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-65
Identities = 80/276 (28%), Positives = 128/276 (46%), Gaps = 20/276 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I S+L +++E+GSG FG V G W VAIK I+ +E DF EA
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---------EDFIEEAE 52
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDA 737
++ ++ HP +V YGV + + V E+M +G L LR + + + +D
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 738 AFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGTI 795
G+ YL E ++H DL + N LV + V K+ D G+++ + S G + +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
W +PE+F + K DV+SFGV+MWE+ + + + S + I P
Sbjct: 167 KWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
+M CW P+ RPAFS + ++L +A
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (554), Expect = 1e-64
Identities = 61/262 (23%), Positives = 111/262 (42%), Gaps = 18/262 (6%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++E+G G+FG V++ + VAIK++ S + + D +E L ++
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQKL 72
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN + + G L V EY + + + K + + + + A G+
Sbjct: 73 RHPNTIQYRGCYLREHTAWL--VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE- 801
YLH N++H D+K+ N L++ + K+GD G + I GT WMAPE
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPT 861
+ + KVDV+S G+ EL + P ++++ + I +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 862 WRSLMERCWSSDPKSRPAFSEI 883
+R+ ++ C P+ RP +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-64
Identities = 85/286 (29%), Positives = 126/286 (44%), Gaps = 27/286 (9%)
Query: 619 IKTSDLEYIK-ELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
+K +L ELG G FG+V G ++ DVAIK +K E +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMM 57
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
REA ++ Q+ +P +V GV L V E G L + L K I +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISG 789
+ G++YL EKN VH DL + N L+ R KI D GLSK
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARS 170
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
+ + W APE + + + DV+S+GV MWE L+ G++PY + E++A I +G
Sbjct: 171 AGKWPLKWYAPECINFRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894
+ P C P +LM CW + RP F + + +RA ++
Sbjct: 229 KR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-64
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 22/273 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ L+ ++ LG+G FG V+ G + + VA+K +K +GS+ D F EA+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDA----FLAEAN 60
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRT-IDRRKRIIIAMD 736
++ Q+ H +V Y VVT P + +TEYM NGSL L+ + K + +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGT 794
A G+ ++ E+N +H DL++ N LV+ CKI D GL+++ + G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
I W APE T K DV+SFG+++ E++T + + ++
Sbjct: 174 IKWTAPEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P C LM CW P+ RP F + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-63
Identities = 74/267 (27%), Positives = 121/267 (45%), Gaps = 21/267 (7%)
Query: 624 LEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
L++ E+G G+F TV+ G +VA ++ + + F EA ML
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKG 64
Query: 682 IHHPNVVAFYGVVTDGPVTN--LATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ HPN+V FY + VTE M +G+LK L+R + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILK 123
Query: 740 GIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW 797
G+++LH + I+H DLK N + KIGDLGL+ +K+ + + V GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEF 179
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII-KGNLGPKIPS 856
MAPE+++ K E VDVY+FG+ M E+ T E PY++ + I + G
Sbjct: 180 MAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEI 883
P + ++E C + R + ++
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-63
Identities = 84/280 (30%), Positives = 127/280 (45%), Gaps = 24/280 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I DL +++LG G+FG V G+W VA+K +KP L + + DF
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD-----VLSQPEAMDDFI 59
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
RE + + + H N++ YGVV P + VTE GSL LR+
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISG 789
A+ A G+ YL K +H DL + N L+ RD + KIGD GL + ++
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 172
Query: 790 GVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848
+ W APE K++ + D + FGV +WE+ T G+EP+ L+ +I+ I K
Sbjct: 173 HRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
P C ++M +CW+ P+ RP F + L
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-63
Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 21/266 (7%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E I ELG G FG V+ + K + A K I + + + D+ E +L
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--------KSEEELEDYMVEIDILASC 66
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN+V NL + E+ G++ V+ +R + + ++ +
Sbjct: 67 DHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL-ISGGVRGTIPWMAPE 801
YLH+ I+H DLK+ N L K+ D G+S +T+ GT WMAPE
Sbjct: 125 YLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 802 LF---KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-KIPSW 857
+ SKD K DV+S G+ + E+ E P+ +L+ ++ I K PS
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 858 CEPTWRSLMERCWSSDPKSRPAFSEI 883
++ +++C + +R S++
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-62
Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 24/275 (8%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ D E + +G+G++G + K G + K + E + E +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM------LVSEVN 55
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR---TIDRRKRIIIA 734
+L ++ HPN+V +Y + D T L V EY G L V+ + + +D + +
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 735 MDAAFGIEYLHEKN-----IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLIS 788
++ H ++ ++H DLK N ++ + K+GD GL++ + T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFA 171
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
GT +M+PE EK D++S G +++EL P+ +E+ I +G
Sbjct: 172 KAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
+IP ++ R + RP+ EI
Sbjct: 230 KF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 9e-62
Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 27/286 (9%)
Query: 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLI 669
L+ +K ++ + IK LGSG FGTV+ G W VAIK ++ + +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKAN 55
Query: 670 ADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRK 729
+ EA+++ + +P+V G+ + +T+ M G L +R I +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 730 RIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTL 786
+ + A G+ YL ++ +VH DL + N LV KI D GL+K+ ++K
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 787 ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845
+ G + I WMA E + T + DV+S+GV +WEL+T G +PY + + EI + I
Sbjct: 169 HAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-I 225
Query: 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891
++ P C +M +CW D SRP F E+ E MA
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-61
Identities = 84/280 (30%), Positives = 130/280 (46%), Gaps = 25/280 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFW 673
I+ +E + +G G FG V G + + VAIK K D + F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 674 REAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
+EA + Q HP++V GV+T+ + + E G L+ L+ + ++D I+
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGV 791
A + + YL K VH D+ + N LV+ D K+GD GLS+ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNL 850
+ I WMAPE + T DV+ FGV MWE+L G +P+ + + ++I I G
Sbjct: 170 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227
Query: 851 GPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
+P C PT SLM +CW+ DP RP F+E+ +L +
Sbjct: 228 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 4e-61
Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 19/264 (7%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D E + LG G FG V+ + K S +A+K + + LE+ + RE +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ HPN++ YG D T + + EY G++ + L++ + D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 117
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
+ Y H K ++H D+K N L+ KI D G S + + GT+ ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PE+ + + + EKVD++S GV+ +E L G+ P+ +E I + P +
Sbjct: 173 PEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVT 228
Query: 860 PTWRSLMERCWSSDPKSRPAFSEI 883
R L+ R +P RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 6e-61
Identities = 78/306 (25%), Positives = 117/306 (38%), Gaps = 49/306 (16%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+LE+ K LGSG FG V G VA+K +K +
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-------ADSSEREA 86
Query: 672 FWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR------- 723
E M+ Q+ H N+V G T + + EY G L LR K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 724 ---------------TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR 768
+ + A A G+E+L K+ VH DL + N LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 769 PVCKIGDLGLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWE 825
V KI D GL++ ++ G R + WMAPE T K DV+S+G+++WE
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWE 258
Query: 826 LLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT 884
+ + G PY + + +I+ P + +M+ CW+ D + RP+F +T
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 885 KELRAM 890
L
Sbjct: 319 SFLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-61
Identities = 80/270 (29%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 628 KELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
KELGSG FGTV G ++ VA+K +K + L + EA+++ Q+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVMQQLD 66
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
+P +V G+ + V E G L + L++ R + + I + + G++Y
Sbjct: 67 NPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKY 122
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLISGGVRGTIPWMA 799
L E N VH DL + N L+ + KI D GLSK + + + W A
Sbjct: 123 LEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
PE + K DV+SFGV+MWE + G++PY + E+ A + KG P+ C
Sbjct: 179 PECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGC 235
Query: 859 EPTWRSLMERCWSSDPKSRPAFSEITKELR 888
LM CW+ D ++RP F+ + LR
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 2e-60
Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 22/284 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
++ +D+ +LG G +G V+ G WK VA+K +K E+ + +F +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 64
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-TIDRRKRIIIAM 735
++ +I HPN+V GV T P +TE+M G+L LR +R + + +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 736 DAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ--KTLISGGVRG 793
+ +EYL +KN +H DL + N LV + K+ D GLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK 853
I W APE + K DV++FGV++WE+ T + +++ + +
Sbjct: 179 PIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
P C LM CW +P RP+F+EI + M +I
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-60
Identities = 81/273 (29%), Positives = 124/273 (45%), Gaps = 22/273 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-VAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
I L +LG G FG V+ G W G+ VAIK +KP + F +EA
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---------EAFLQEAQ 64
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII-IAMD 736
++ ++ H +V Y VV++ P + VTEYM GSL L+ + R +++ +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--KQKTLISGGVRGT 794
A G+ Y+ N VH DL++ N LV + VCK+ D GL+++ + G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
I W APE T K DV+SFG+++ EL T + ++
Sbjct: 178 IKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKEL 887
P C + LM +CW +P+ RP F + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-60
Identities = 90/285 (31%), Positives = 130/285 (45%), Gaps = 25/285 (8%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD------VAIKRIKPSCFAEGSLEEDRLIADF 672
I S + K +G+G FG V+ G K S VAIK +K ++ DF
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-------YTEKQRVDF 56
Query: 673 WREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
EA ++GQ H N++ GV++ + +TEYM NG+L + LR KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI----KQKTLIS 788
+ A G++YL N VH DL + N LVN VCK+ D GLS++ + T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
G + I W APE + T DV+SFG+VMWE++T E S + I
Sbjct: 171 SGGKIPIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893
P C LM +CW + RP F++I L + A
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 8e-60
Identities = 89/306 (29%), Positives = 133/306 (43%), Gaps = 50/306 (16%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+++EY++++G G FG VF + G VA+K +K + AD
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQAD 62
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-------- 723
F REA ++ + +PN+V GV G + + EYM G L + LR
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 724 ---------------TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR 768
+ +++ IA A G+ YL E+ VH DL + N LV +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----EN 176
Query: 769 PVCKIGDLGLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWE 825
V KI D GLS+ G I WM PE T + DV+++GVV+WE
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWE 234
Query: 826 LLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT 884
+ + G +PY + EE+I + GN+ P C +LM CWS P RP+F I
Sbjct: 235 IFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 885 KELRAM 890
+ L+ M
Sbjct: 294 RILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 3e-59
Identities = 94/286 (32%), Positives = 136/286 (47%), Gaps = 28/286 (9%)
Query: 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIAD 671
+ I S ++ + +G+G FG V G K VAIK +K ++ D
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-------YTEKQRRD 73
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRI 731
F EA ++GQ HPNV+ GVVT T + +TE+M NGSL LR+ D + +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 131
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI------KQKT 785
+ A G++YL + N VH DL + N LVN VCK+ D GLS+
Sbjct: 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 786 LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAG 844
+ G + I W APE + + T DV+S+G+VMWE+++ GE PY D+ ++++I
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 845 IIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
I + P C LM CW D RP F +I L M
Sbjct: 246 IEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-59
Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 624 LEYIKELGSGTFGTVFYGKWKGSD-----VAIKRIKPSCFAEGSLEEDRLIADFWREAHM 678
+ + + +G G FG V++G +D A+K + + ++ F E +
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGII 81
Query: 679 LGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+ HPNV++ G+ + V YM +G L+ +R + + I + A
Sbjct: 82 MKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK-----QKTLISGGVRG 793
G+++L K VH DL + N +++ ++ K+ D GL++ G +
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 794 TIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGP 852
+ WMA E +++ T K DV+SFGV++WEL+T G PY D+++ +I +++G
Sbjct: 197 PVKWMALESLQTQKF--TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-L 253
Query: 853 KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
P +C +M +CW + RP+FSE+ + A+
Sbjct: 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 82/298 (27%), Positives = 131/298 (43%), Gaps = 37/298 (12%)
Query: 614 TELQTIKTSDLEYIKELGSGTFGTVFYGKWKGS----DVAIKRIKPSCFAEGSLEEDRLI 669
T + +D+++ +G G FG V + K D AIKR+K +
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------H 54
Query: 670 ADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD------ 722
DF E +L ++ HHPN++ G L EY +G+L LR+
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 723 ---------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
T+ ++ + A D A G++YL +K +H DL + N LV + V KI
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKI 168
Query: 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEP 832
D GLS+ ++ + R + WMA E T DV+S+GV++WE+++ G P
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTP 226
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
Y + E+ + +G + P C+ LM +CW P RP+F++I L M
Sbjct: 227 YCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-58
Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 22/263 (8%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+++G G GTV+ G +VAI+++ L++ E ++ +
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMREN 74
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
+PN+V + G L V EY+ GSL V+ + + + +E
Sbjct: 75 KNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR--ECLQALE 130
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWMAPE 801
+LH ++H D+KS N L+ M K+ D G I + + GT WMAPE
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-KIPSWCEP 860
+ K KVD++S G++ E++ GE PY + + + I + P
Sbjct: 187 VVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
+R + RC D + R + E+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 8e-58
Identities = 77/314 (24%), Positives = 121/314 (38%), Gaps = 54/314 (17%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ + +G G FG V+ GKW+G +VA+K E E + +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---------AEIYQTVML 54
Query: 683 HHPNVVAFYGVVT--DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
H N++ F +G T L V++Y +GSL L R T++ + +A+ A G
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTASG 112
Query: 741 IEYLHE--------KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI-----KQKTLI 787
+ +LH I H DLKS N LV C I DLGL+ +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDIA 168
Query: 788 SGGVRGTIPWMAPELFKSKDNL----VTEKVDVYSFGVVMWELLTGEEPY---------- 833
GT +MAPE+ N+ ++ D+Y+ G+V WE+
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 834 -----ADLHSEEIIAGIIKGNLGPKIPSW-----CEPTWRSLMERCWSSDPKSRPAFSEI 883
+D EE+ + + L P IP+ +M CW ++ +R I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 884 TKELRAMAAAMNIK 897
K L ++ IK
Sbjct: 289 KKTLSQLSQQEGIK 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 200 bits (509), Expect = 8e-58
Identities = 57/263 (21%), Positives = 106/263 (40%), Gaps = 18/263 (6%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ ++ELGSG FG V K G K I D+ E ++ Q+
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP------YPLDK--YTVKNEISIMNQL 83
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HHP ++ + D + + E++ G L + +D + + I A G++
Sbjct: 84 HHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
++HE +IVH D+K N + + KI D GL+ I T + APE+
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--CEP 860
+ V D+++ GV+ + LL+G P+A E + + + + ++ P
Sbjct: 200 VDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
+ ++ +P+ R +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-57
Identities = 75/298 (25%), Positives = 115/298 (38%), Gaps = 38/298 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ L + K LG+G FG V G VA+K +KPS
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-------AHLTEREA 72
Query: 672 FWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRK--------- 721
E +L + +H N+V G T G T + +TEY G L LRRK
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 722 --------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
+ +D + + A G+ +L KN +H DL + N L+ +C
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDF 189
Query: 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP- 832
G K ++ G R + WMAPE + T + DV+S+G+ +WEL +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
Y + + +IK P +M+ CW +DP RP F +I + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 197 bits (502), Expect = 6e-57
Identities = 52/263 (19%), Positives = 103/263 (39%), Gaps = 18/263 (6%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +ELG+G FG V + G++ A K + + +E + +
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--------PHESDKETVRKEIQTMSVL 80
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HP +V + D + + E+M G L + + + + + + G+
Sbjct: 81 RHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
++HE N VH DLK N + + K+ D GL+ GT + APE+
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--CEP 860
+ K V D++S GV+ + LL+G P+ + +E + + + ++
Sbjct: 197 AEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
+ + + +DP +R +
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-57
Identities = 67/272 (24%), Positives = 115/272 (42%), Gaps = 21/272 (7%)
Query: 617 QTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWR 674
+ + D ++ K LG G+F TV + + AIK ++ + ++ + R
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-----HIIKENKVPYVTR 57
Query: 675 EAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIA 734
E ++ ++ HP V Y D L Y NG L + +R+ + R A
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 735 MDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLISGGV 791
+ +EYLH K I+H DLK N L+N + +I D G +K+ + K +
Sbjct: 116 -EIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
GT +++PEL K + D+++ G ++++L+ G P+ + I IIK
Sbjct: 171 VGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-- 226
Query: 852 PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
P P R L+E+ D R E+
Sbjct: 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-56
Identities = 70/310 (22%), Positives = 117/310 (37%), Gaps = 62/310 (20%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+K D E I ELG+G G VF K S +A K I + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L + + P +V FYG ++ E+M GSL QVL++ R I + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 737 AAFGIEYLHEKN-IVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI 795
G+ YL EK+ I+H D+K N LVN R K+ D G+S ++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
+M+PE + + + D++S G+ + E+ G P ++E+ G
Sbjct: 168 SYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 856 SWCEPTW------------------------------------------RSLMERCWSSD 873
+ P + + +C +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 874 PKSRPAFSEI 883
P R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 2e-55
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 17/263 (6%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++ LG+G F V + K VAIK I + E +L +I
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-------ALEGKEGSMENEIAVLHKI 64
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN+VA + G +L + + + G L + K R + ++
Sbjct: 65 KHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVK 121
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
YLH+ IVH DLK N L D + I D GLSK++ + GT ++APE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--CEP 860
K ++ VD +S GV+ + LL G P+ D + ++ I+K P W
Sbjct: 181 LAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
+ + + DP+ R +
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 21/267 (7%)
Query: 623 DLEYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D + ++ LG G +G V + ++ VA+K + + +E +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------RAVDCPENIKKEICINK 58
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
++H NVV FYG +G + L EY G L + + G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYL--FLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAG 115
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI---KQKTLISGGVRGTIPW 797
+ YLH I H D+K N L++ RD KI D GL+ + + + + GT+P+
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 798 MAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE-EPYADLHSEEIIAGIIKGNLGPKIPS 856
+APEL K ++ E VDV+S G+V+ +L GE S + + +
Sbjct: 172 VAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 857 WCEPTWRSLMERCWSSDPKSRPAFSEI 883
+ +L+ + +P +R +I
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 189 bits (482), Expect = 5e-55
Identities = 70/271 (25%), Positives = 108/271 (39%), Gaps = 17/271 (6%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDR-LIADFWREAHML 679
+ E + LG G V K + A+K I + S EE + L +E +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 680 GQIH-HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
++ HPN++ V + M G L L K T+ ++ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALL 120
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
I LH+ NIVH DLK N L++ K+ D G S V GT ++
Sbjct: 121 EVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 799 APELFKSKDNL----VTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854
APE+ + N ++VD++S GV+M+ LL G P+ ++ I+ GN
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 855 PSWCE--PTWRSLMERCWSSDPKSRPAFSEI 883
P W + T + L+ R P+ R E
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-55
Identities = 48/263 (18%), Positives = 98/263 (37%), Gaps = 19/263 (7%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++LG G FG V S K +K + +E +L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---------VLVKKEISILNIA 58
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
H N++ + L + E++ + + + ++ R+ + ++
Sbjct: 59 RHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
+LH NI HFD++ N + R KI + G ++ + + + APE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--CEP 860
+ V+ D++S G +++ LL+G P+ +++II I+ ++
Sbjct: 175 HQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
++R + KSR SE
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-54
Identities = 72/299 (24%), Positives = 116/299 (38%), Gaps = 37/299 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD---------VAIKRIKPSCFAEGSLEEDRLI 669
+ L K LG G FG V + G D VA+K +K ++ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-------ATEKDL 62
Query: 670 ADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLR--------- 719
+D E M+ I H N++ G T L + EY G+L++ L+
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 720 ------RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
+ + + + A A G+EYL K +H DL + N LV + + +
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK-IADF 179
Query: 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
G + R + WMAPE + T + DV+SFGV++WE+ T
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892
E + ++K PS C +M CW + P RP F ++ ++L + A
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-54
Identities = 69/263 (26%), Positives = 110/263 (41%), Gaps = 11/263 (4%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +ELGSG F V + K G A K IK D RE +L +I
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS--RRGVSREDIEREVSILKEI 70
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPNV+ + V + T++ + E + G L L K+ + + G+
Sbjct: 71 QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-ILNGVY 127
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
YLH I HFDLK N ++ R+ +P KI D GL+ + GT ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--PKIPSWCEP 860
+ + + D++S GV+ + LL+G P+ +E +A + N + S
Sbjct: 188 VNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 861 TWRSLMERCWSSDPKSRPAFSEI 883
+ + R DPK R +
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-54
Identities = 87/290 (30%), Positives = 129/290 (44%), Gaps = 36/290 (12%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
+ + +ELG G+FG V+ G KG VAIK + + R +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-------ASMRERIE 69
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-------- 723
F EA ++ + + +VV GVV+ G + E M G LK LR
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 724 -TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI- 781
K I +A + A G+ YL+ VH DL + N +V + KIGD G+++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 782 --KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE-PYADLHS 838
G + WM+PE K D + T DV+SFGVV+WE+ T E PY L +
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 839 EEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELR 888
E+++ +++G L P C LM CW +PK RP+F EI ++
Sbjct: 242 EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (466), Expect = 7e-53
Identities = 54/273 (19%), Positives = 112/273 (41%), Gaps = 15/273 (5%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + LG G V + DVA+K ++ + F REA +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQNAAAL 64
Query: 683 HHPNVVAFYGVVTD--GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+HP +VA Y V EY+ +L+ ++ + + ++ I + DA
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 123
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAP 800
+ + H+ I+H D+K N +++ + + + ++ + V GT +++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW--C 858
E + V + DVYS G V++E+LTGE P+ + ++ + P
Sbjct: 184 EQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 859 EPTWRSLMERCWSSDPKSRP-AFSEITKELRAM 890
+++ + + +P++R +E+ +L +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 20/260 (7%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D K LG G+FG VF ++K AIK +K + D + E +L
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-----VVLMDDDVECTMVEKRVLS 57
Query: 681 -QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
HP + + NL V EY+ G L ++ + D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL 114
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTIPWM 798
G+++LH K IV+ DLK N L++ KI D G+ K + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
APE+ + VD +SFGV+++E+L G+ P+ EE+ I N P P W
Sbjct: 171 APEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWL 226
Query: 859 EPTWRSLMERCWSSDPKSRP 878
E + L+ + + +P+ R
Sbjct: 227 EKEAKDLLVKLFVREPEKRL 246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-51
Identities = 78/298 (26%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWKGSD-------VAIKRIKPSCFAEGSLEEDRLIAD 671
L+ K LG G FG V G D VA+K +K A
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRAL 63
Query: 672 FWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDR-------- 723
++ HH NVV G T P L + E+ G+L LR K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 724 -------TIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776
+ I + A G+E+L + +H DL + N L++ ++ V KI D
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 777 GLSKI---KQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEE-P 832
GL++ + G R + WMAPE + T + DV+SFGV++WE+ + P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASP 236
Query: 833 YADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890
Y + +E +K + P + P M CW +P RP FSE+ + L +
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 177 bits (450), Expect = 3e-50
Identities = 63/267 (23%), Positives = 121/267 (45%), Gaps = 20/267 (7%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
D + ++ LG+G+FG V + + G A+K +K + + + E ML
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE-----IVVRLKQVEHTNDERLML 58
Query: 680 GQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
+ HP ++ +G D + + +Y+ G L +LR+ R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
+EYLH K+I++ DLK N L++ + KI D G +K + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE 859
PE+ +K + +D +SFG++++E+L G P+ D ++ + I+ + P +
Sbjct: 170 PEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFN 225
Query: 860 PTWRSLMERCWSSDPKSRPAFSEITKE 886
+ L+ R + D R + E
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (440), Expect = 2e-48
Identities = 59/260 (22%), Positives = 99/260 (38%), Gaps = 16/260 (6%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
D + +G G FG V+ + G A+K + E L + ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL--NERIMLSLVS 62
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
P +V L+ + + M G L L + + R A G
Sbjct: 63 TGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IILG 119
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAP 800
+E++H + +V+ DLK N L++ + +I DLGL+ K GT +MAP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAP 174
Query: 801 ELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--PKIPSWC 858
E+ + D +S G ++++LL G P+ H + I + L ++P
Sbjct: 175 EVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 859 EPTWRSLMERCWSSDPKSRP 878
P RSL+E D R
Sbjct: 233 SPELRSLLEGLLQRDVNRRL 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 51/261 (19%), Positives = 93/261 (35%), Gaps = 21/261 (8%)
Query: 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH- 683
LGSG FG+V+ G VAIK ++ ++ + E +L ++
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSS 66
Query: 684 -HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
V+ + + E + + +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
+ H ++H D+K N L+ D R K+ D G + + T+ + GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTW 862
+ V+S G+++++++ G+ P+ H EEII G +
Sbjct: 181 IRYH-RYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQV------FFRQRVSSEC 231
Query: 863 RSLMERCWSSDPKSRPAFSEI 883
+ L+ C + P RP F EI
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-47
Identities = 61/268 (22%), Positives = 98/268 (36%), Gaps = 28/268 (10%)
Query: 628 KELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HH 684
+ LG G G V K A+K ++ RE + +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQC 64
Query: 685 PNVVAFYGVVTDGPVTN--LATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGI 741
P++V V + L V E + G L ++ + D+ R+ I I
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPE 801
+YLH NI H D+K N L + P + K+ D G +K T ++APE
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 802 LFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLH----SEEIIAGIIKGNLGPKIPSW 857
+ + + D++S GV+M+ LL G P+ H S + I G P W
Sbjct: 184 VLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 858 CE--PTWRSLMERCWSSDPKSRPAFSEI 883
E + L+ ++P R +E
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 7e-47
Identities = 51/289 (17%), Positives = 98/289 (33%), Gaps = 31/289 (10%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+++GSG+FG ++ G G +VAIK E+ + +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----------KTKHPQLHIESKIYKMM 59
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
+ N+ V E + SL+ + R + +++A IE
Sbjct: 60 QGGVGIPTIRWCGAEGDYNV-MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI--------KQKTLISGGVRGT 794
Y+H KN +H D+K NFL+ + V I D GL+K + + GT
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 795 IPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG--- 851
+ + + + + D+ S G V+ G P+ L + + +
Sbjct: 177 ARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 852 ---PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
+ + + + C S +P +S + + R +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-46
Identities = 70/271 (25%), Positives = 112/271 (41%), Gaps = 19/271 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREA 676
+ +D +Y+K LG GTFG V + K G A+K ++ + +A E+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE-----VIIAKDEVAHTVTES 56
Query: 677 HMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMD 736
+L HP + A L V EY G L L R+ + R R A +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 113
Query: 737 AAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK-IKQKTLISGGVRGTI 795
+EYLH +++V+ D+K N +++ + KI D GL K GT
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 796 PWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855
++APE+ + D VD + GVVM+E++ G P+ + E + I+ + P
Sbjct: 170 EYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFP 225
Query: 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
P +SL+ DPK R +
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (411), Expect = 3e-45
Identities = 43/291 (14%), Positives = 94/291 (32%), Gaps = 33/291 (11%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ + +G G+FG +F G VAIK E +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----------RRSDAPQLRDEYRTYKLL 57
Query: 683 -HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGI 741
+ Y +G + ++ SL+ +L R + + A +
Sbjct: 58 AGCTGIPNVYYFGQEG---LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 742 EYLHEKNIVHFDLKSHNFLVNMRDPQRPVC-KIGDLGLSKIKQKTLIS--------GGVR 792
+ +HEK++V+ D+K NFL+ + + + D G+ K + + +
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 793 GTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG- 851
GT +M+ ++ + + D+ + G V L G P+ L + +
Sbjct: 175 GTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232
Query: 852 -----PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897
++ + + M + + P + + + +N
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 5e-44
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 21/278 (7%)
Query: 619 IKTSDLEYIKELGSGTFGTVF-----YGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFW 673
+ + E +K LG+G +G VF G G A+K +K + + + +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ----KAKTTEHTR 76
Query: 674 REAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRII 732
E +L I P +V + T L + +Y+ G L L +++R + +I
Sbjct: 77 TERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 733 IAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK--IKQKTLISGG 790
+ + +E+LH+ I++ D+K N L++ + D GLSK + +T +
Sbjct: 135 VG-EIVLALEHLHKLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYD 189
Query: 791 VRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL 850
GTI +MAP++ + D+ + VD +S GV+M+ELLTG P+ + A I + L
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 851 G--PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886
P P + L++R DPK R +
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-44
Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 40/290 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ 681
E + E+G G +G VF + G VA+KR++ EG L
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRHLET 66
Query: 682 IHHPNVVAFYGVVTDGPV---TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
HPNVV + V T T L V E++ + + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
G+++LH +VH DLK N LV K+ D GL++I + V T+ +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW- 857
APE+ VD++S G + E+ + + + + I+ P W
Sbjct: 183 APEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 858 ------------------------CEPTWRSLMERCWSSDPKSRPAFSEI 883
+ + L+ +C + +P R +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 38/287 (13%)
Query: 625 EYIKELGSGTFGTVFYGKWKGSD--VAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E + LG G F TV+ + K ++ VAIK+IK +E +D + RE +L ++
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQEL 57
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
HPN++ +N++ V ++M + + + M G+E
Sbjct: 58 SHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
YLH+ I+H DLK +N L++ + V K+ D GL+K + + W
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWCE--- 859
+ VD+++ G ++ ELL + + I + P W +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 860 -----------------------PTWRSLMERCWSSDPKSRPAFSEI 883
L++ + +P +R ++
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 43/291 (14%)
Query: 623 DLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG 680
+ + ++++G GT+G V+ + K G VA+K+I+ E + + + RE +L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLLK 56
Query: 681 QIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
+++HPN+V V+ L V E++ K + I G
Sbjct: 57 ELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPW-MA 799
+ + H ++H DLK N L+N K+ D GL++ + + W A
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG----------- 848
PE+ + VD++S G + E++T + + + I +
Sbjct: 171 PEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 849 -----NLGPKIPSWCEPTW-----------RSLMERCWSSDPKSRPAFSEI 883
+ P P W + RSL+ + DP R +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-43
Identities = 53/296 (17%), Positives = 108/296 (36%), Gaps = 51/296 (17%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +G G +G V VAIK+I P E RE +L +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 683 HHPNVVAFYGVVTDGPVTNLAT--VTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFG 740
H N++ ++ + + + +++ L ++L+ + + D + + G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQI--LRG 121
Query: 741 IEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTI----P 796
++Y+H N++H DLK N L+N KI D GL+++ G
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 797 WMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP---- 852
+ APE+ + T+ +D++S G ++ E+L+ + H + + I+ P
Sbjct: 178 YRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 853 --------------KIPSWCEPTW-----------RSLMERCWSSDPKSRPAFSEI 883
+P + W L+++ + +P R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (399), Expect = 4e-43
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 21/291 (7%)
Query: 597 IGEISSRSAAYFTNTANTELQTIKT-SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRI 653
+ E +++ F T Q + IK LG+G+FG V K K G+ A+K +
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 654 KPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLATVTEYMVNGS 713
+ + + I E +L ++ P +V D NL V EY+ G
Sbjct: 75 DKQ-----KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGE 127
Query: 714 LKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773
+ LRR R A EYLH ++++ DLK N L++ + ++
Sbjct: 128 MFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQV 182
Query: 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
D G +K + + + GT +APE+ SK + VD ++ GV+++E+ G P+
Sbjct: 183 TDFGFAKRVKGRTWT--LCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPF 238
Query: 834 ADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEIT 884
+I I+ G + PS + L+ D R +
Sbjct: 239 FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 6e-43
Identities = 52/287 (18%), Positives = 101/287 (35%), Gaps = 41/287 (14%)
Query: 625 EYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH 683
++++G GT+G V+ + G A+K+I+ EG RE +L ++
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST------TIREISILKELK 58
Query: 684 HPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEY 743
H N+V Y V+ L ++ LK++L + ++ + GI Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 744 LHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELF 803
H++ ++H DLK N L+N KI D GL++ + W
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 804 KSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW------ 857
+ +D++S G + E++ G + + + + I + P +W
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 858 ---------------------CEPTWRSLMERCWSSDPKSRPAFSEI 883
+ + L+ + DP R +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-41
Identities = 61/299 (20%), Positives = 99/299 (33%), Gaps = 51/299 (17%)
Query: 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAH 677
+ K +G+G+FG V+ K G VAIK++ RE
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQ 65
Query: 678 MLGQIHHPNVVAFYGVVTDGPVTN----LATVTEYMVNGSLKQVLR--RKDRTIDRRKRI 731
++ ++ H N+V L V +Y+ + R +T+
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 732 IIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGV 791
+ + Y+H I H D+K N + DP V K+ D G +K + +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNL---LLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 792 RGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851
+ + APEL + T +DV+S G V+ ELL G+ + + + IIK
Sbjct: 183 ICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 852 PKIPSWCE---------------------------PTWRSLMERCWSSDPKSRPAFSEI 883
P E P +L R P +R E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 55/305 (18%), Positives = 103/305 (33%), Gaps = 55/305 (18%)
Query: 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHML 679
S E + ++G GTFG VF + + G VA+K++ E++ RE +L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 680 GQIHHPNVVAFYGVVTDGPVT------NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIII 733
+ H NVV + ++ V ++ + + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 734 AMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS----- 788
M G+ Y+H I+H D+K+ N L+ + V K+ D GL++ S
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG 848
T+ + PEL + +D++ G +M E+ T + +A I +
Sbjct: 179 TNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 849 NLGPKIPSWCE------------------------------PTWRSLMERCWSSDPKSRP 878
W P L+++ DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 879 AFSEI 883
+
Sbjct: 298 DSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 57/289 (19%), Positives = 99/289 (34%), Gaps = 43/289 (14%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
E ++++G GT+GTVF K + VA+KR++ EG RE +L ++
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS------ALREICLLKEL 58
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
H N+V + V+ L V E+ K + + G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLG 115
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPEL 802
+ H +N++H DLK N L+N K+ + GL++ + W P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 803 FKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKIPSW---- 857
L + +D++S G + EL P + + + I + P W
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 858 -----------------------CEPTWRSLMERCWSSDPKSRPAFSEI 883
T R L++ +P R + E
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 142 bits (359), Expect = 7e-38
Identities = 52/329 (15%), Positives = 112/329 (34%), Gaps = 58/329 (17%)
Query: 594 SKVIGEISSRSAAYFTNTANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIK 651
++V ++++ + + + ++ D + +++LG G + VF V +K
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66
Query: 652 RIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYGVVTDGPVTNLATVTEYMV 710
+KP RE +L + PN++ +V D A V E++
Sbjct: 67 ILKPV-----------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115
Query: 711 NGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770
N KQ+ + + + ++Y H I+H D+K HN ++ D +
Sbjct: 116 NTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRK 168
Query: 771 CKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE 830
++ D GL++ + + PEL +D++S G ++ ++ +
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRK 227
Query: 831 EPYADLHSE-EIIAGIIKGNLGPKIPSWCE------------------------------ 859
EP+ H + + I K + + +
Sbjct: 228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287
Query: 860 -----PTWRSLMERCWSSDPKSRPAFSEI 883
P +++ D +SR E
Sbjct: 288 QHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 7e-38
Identities = 64/294 (21%), Positives = 113/294 (38%), Gaps = 51/294 (17%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
++ +GSG +G V G+ VAIK++ + + +RE +L +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 683 HHPNVVAFYGVVTDGP----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
H NV+ V T T+ V +M L ++++ + DR + ++ M
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 131
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
G+ Y+H I+H DLK N VN + KI D GL++ + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP------ 852
APE+ + T+ VD++S G +M E++TG+ + + + I+K P
Sbjct: 186 APEVILNWMRY-TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 853 -----------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEI 883
I + P +L+E+ D + R E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 52/268 (19%), Positives = 103/268 (38%), Gaps = 23/268 (8%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ +K +GSG G V +VAIK++ + +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCV 73
Query: 683 HHPNVVAFYGVVTDGP----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAA 738
+H N+++ V T ++ V E M + + +D + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129
Query: 739 FGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWM 798
GI++LH I+H DLK N +V KI D GL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 799 APELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858
APE+ E VD++S G +M E++ + + + +I+ LG P +
Sbjct: 186 APEVILGMGY--KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ-LGTPCPEFM 242
Query: 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886
+ ++ + + F ++ +
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPD 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 49/293 (16%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+ + +GSG +G+V G VA+K++ + +RE +L +
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHM 74
Query: 683 HHPNVVAFYGVVTDGPVT---NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAF 739
H NV+ V T N + +++ L +++ + T D + +I +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--LR 132
Query: 740 GIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMA 799
G++Y+H +I+H DLK N VN KI D GL++ + T + A
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTDDEMTG--YVATRWYRA 186
Query: 800 PELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW-- 857
PE+ + + + VD++S G +M ELLTG + + + I++ P
Sbjct: 187 PEIMLNWMH-YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 858 ---------------------------CEPTWRSLMERCWSSDPKSRPAFSEI 883
P L+E+ D R ++
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-26
Identities = 40/225 (17%), Positives = 82/225 (36%), Gaps = 27/225 (12%)
Query: 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI 682
+++LG G F TV+ K + VA+K ++ + E +L ++
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---------DKVYTEAAEDEIKLLQRV 66
Query: 683 HHPNVVAFYGVVTDGPVTNLATVTEYMVNGS-------------LKQVLRRKDRTIDRRK 729
+ + + + + L NG L + + + R I
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 730 RIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTLIS 788
I+ G++Y+H + I+H D+K N L+ + D + +I L
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 789 GGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPY 833
T + +PE+ D++S +++EL+TG+ +
Sbjct: 187 TNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 5e-15
Identities = 28/158 (17%), Positives = 45/158 (28%), Gaps = 18/158 (11%)
Query: 628 KELGSGTFGTVFYGKWK-GSDVAIKRIKPS--CFAEGSLEEDRLIADFWREAHMLGQIHH 684
K +G G VF + + +K K F + + D F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 685 PNVVAFYG--VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIE 742
+ G V A + E + L +V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV--------LDMILEEVA 117
Query: 743 YLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780
+ + IVH DL +N LV+ I D S
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 897 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.83 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.82 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.8 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.8 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.79 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.79 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.77 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.76 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.76 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.76 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.75 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.74 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.73 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.73 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.73 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.73 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.72 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.72 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.72 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.72 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.71 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.7 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.7 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.7 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.69 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.69 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.69 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.69 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.68 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.67 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.67 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.67 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.67 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.67 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.65 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.65 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.64 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.64 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.64 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.62 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.61 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.6 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.59 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.57 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.56 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.56 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.54 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.54 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.53 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.52 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.51 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.47 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.46 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.43 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.43 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.41 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.39 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.38 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.38 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.37 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.33 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.22 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 97.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.45 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 96.23 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 96.03 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 95.82 | |
| d1oeyj_ | 105 | Neutrophil cytosol factor 4 (p40phox component of | 85.71 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 84.98 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 82.54 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.64 Aligned_cols=265 Identities=34% Similarity=0.590 Sum_probs=224.7
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
Q ss_conf 33234889159999522695499985655940799985478656787247899999999999996179996326832210
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 616 ~~~i~~~~Yeiik~LG~G~fG~VYla~~kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~ 695 (897)
-|++..++|++.+.||+|+||+||++++++ .||||+++...... ...+.+.+|+.++++++||||+++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 713154518998898307885899999999-89999997346998------99999999999998479987864567971
Q ss_pred CCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 48975079999542236267887202666338899999999999999999899631268999758513799999099982
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 696 e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiD 775 (897)
+. .+++||||+++|+|.+++...+..+++..+..|+.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 75 ~~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~D 147 (276)
T d1uwha_ 75 AP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGD 147 (276)
T ss_dssp SS---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECC
T ss_pred CC---EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEEC----CCCCEEECC
T ss_conf 55---89999965899888999852357899999999999999998887509995161478997981----899788750
Q ss_pred CCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-
Q ss_conf 5995023344---3358864688645731113588-8789234699999999999909999999995999999992478-
Q 002642 776 LGLSKIKQKT---LISGGVRGTIPWMAPELFKSKD-NLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNL- 850 (897)
Q Consensus 776 FGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~-~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~- 850 (897)
||+|+..... .......||+.|+|||++.+.. ..++.++||||||+++|||++|+.||........+...+....
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 02213335567763125665574317999995056899995315163599999999788998998969999999965888
Q ss_pred CC---CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 99---999988299999999930039999978999999999999972
Q 002642 851 GP---KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 851 ~~---~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
.+ ..+..+|+++.+||.+||..||.+|||+++++++|+.+.+.+
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 98600036555499999999975889768929999999999999709
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.15 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=218.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||+||+++++ ++.||+|++.+... ........+.+|+.+++.++||||+++++++.+.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 78 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA- 78 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-
T ss_conf 5376998898517785899999989994999999816885-----6768999999999999856888888599999989-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 79 -~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG~ 152 (263)
T d2j4za1 79 -TRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGW 152 (263)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCCS
T ss_pred -CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEEC----CCCCEEECCCCE
T ss_conf -9989998504798589887504-8999999999999999999999988946522023441466----899871155563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 50233443358864688645731113588878923469999999999990999999999599999999247899999988
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p~~i 858 (897)
|+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..+....+ .+|..+
T Consensus 153 a~~~~~~~~-~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 227 (263)
T d2j4za1 153 SVHAPSSRR-TTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 227 (263)
T ss_dssp CSCCCCCCC-EETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--CCCTTS
T ss_pred EEECCCCCC-CCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCC
T ss_conf 354488852-3557887634999975899--89314404675999998329999888999999999971899--998668
Q ss_pred CHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 2999999999300399999789999999
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
++++.+||.+||+.||.+|||+++++++
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9999999999764797689099999719
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.09 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=221.2
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 34889159999522695499985655--9407999854786567872478999999999999961799963268322104
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 619 i~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e 696 (897)
++.++|++++.||+|+||+||+++++ ++.||+|++++... .......++.+|+.+|+.++||||+++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 844742898898317684999999989998999999815654-----497999999999999986799988778764035
Q ss_pred CCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 89750799995422362678872026663388999999999999999998996312689997585137999990999825
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDF 776 (897)
. ..+|+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~--~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DF 149 (337)
T d1o6la_ 77 H--DRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred C--CCCCCCEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEEEEC
T ss_conf 6--4211100035798605555325-6775999999999996521134315962246477784765----8998888205
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 99502334-43358864688645731113588878923469999999999990999999999599999999247899999
Q 002642 777 GLSKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 777 GLAk~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p 855 (897)
|+|+.... .......+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||...+..+....+....+ .+|
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--~~p 225 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCCCC--CCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCC
T ss_conf 65200356786205510088996666504898--88333102230678899878999999699999999852899--898
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHH
Q ss_conf 988299999999930039999978-----9999999
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 856 ~~is~eL~dLI~kcL~~DP~eRPS-----aeELL~~ 886 (897)
..+++++++||.+||++||.+|++ +++++++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 668999999998666389344225652349999729
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.01 Aligned_cols=260 Identities=37% Similarity=0.633 Sum_probs=222.9
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEEC--CC---CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 234889159999522695499985655--94---0799985478656787247899999999999996179996326832
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GS---DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 618 ~i~~~~Yeiik~LG~G~fG~VYla~~k--g~---~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d 692 (897)
++..++|++.+.||+|+||+||+++++ ++ .||||.+.... .....+++.+|+.+|++++||||+++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEE
T ss_conf 208004278569802788299999995799788999999978445-------9899999999999998579988861899
Q ss_pred EEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEE
Q ss_conf 21048975079999542236267887202666338899999999999999999899631268999758513799999099
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VK 772 (897)
++.+. ..+++||||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+|
T Consensus 95 ~~~~~--~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~K 168 (299)
T d1jpaa_ 95 VVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCK 168 (299)
T ss_dssp EECSS--SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEEEC--CEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEE
T ss_conf 99628--877999972279853002104567999999999999999988988527983576150448988----999199
Q ss_pred EEECCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHH
Q ss_conf 982599502334433------58864688645731113588878923469999999999990-99999999959999999
Q 002642 773 IGDLGLSKIKQKTLI------SGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGI 845 (897)
Q Consensus 773 LiDFGLAk~~~~~~~------~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~i 845 (897)
|+|||+++....... .....||+.|+|||.+.+.. ++.++||||||+++|||++ |+.||......+....+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 88844315756777765365025666883003878883699--7861214453578999986799999999999999999
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 924789999998829999999993003999997899999999999997
Q 002642 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 846 i~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
.. ...+..+..++..+.+||.+||+.||.+||++.++++.|+++.+.
T Consensus 247 ~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 247 EQ-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HC-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 73-788999742269999999997587976892999999999998418
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.22 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=223.3
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECCC-------CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCE
Q ss_conf 3323488915999952269549998565594-------079998547865678724789999999999999617-99963
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWKGS-------DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeiik~LG~G~fG~VYla~~kg~-------~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L-~HPNI 687 (897)
.|++..++|++.+.||+|+||+||++++.+. .||+|.+.... .......+.+|+.++.++ +||||
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnI 103 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENI 103 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 4657789939701983078819999998578855420499999966335-------878999999999999971589968
Q ss_pred EEEEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 26832210489750799995422362678872026----------------------66338899999999999999999
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD----------------------RTIDRRKRIIIAMDAAFGIEYLH 745 (897)
Q Consensus 688 VkL~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~----------------------~~lse~~il~Ia~QIl~aL~yLH 745 (897)
+++++++.+. ..+++||||+++|+|.++++... ..+++..++.++.|++.||.|||
T Consensus 104 v~l~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 104 VNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp CCEEEEECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEEEC--CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 6877888629--95899997279995999998625777510221000012220012577899999999999999999997
Q ss_pred HCCCEECCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89963126899975851379999909998259950233443---358864688645731113588878923469999999
Q 002642 746 EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVV 822 (897)
Q Consensus 746 s~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiL 822 (897)
+++|+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+.. ++.++||||||++
T Consensus 182 ~~~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 182 FKSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGIL 255 (325)
T ss_dssp HTTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHH
T ss_pred HCCEEECCCCHHCCCCC----CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC--CCCCEECCCHHHH
T ss_conf 39905052703214434----59828985142222045778615623435787657838872799--9963303000399
Q ss_pred HHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 999990-9999999995999999992478999999882999999999300399999789999999999
Q 002642 823 MWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRA 889 (897)
Q Consensus 823 LyELLt-Gk~PF~~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~ 889 (897)
+|||++ |+.||......+.+..++.....+..|..+|+++.+||.+||+.||++|||+++|+++|..
T Consensus 256 l~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 99998389999999898999999985699899887678999999999758896689399999999748
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=375.04 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=220.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||.||+++++ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD- 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 657589889840768199999988999899999984524--------31699999999999867997999299999989-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+++|+|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+
T Consensus 96 -~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 -NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGL 172 (350)
T ss_dssp -TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTT
T ss_pred -CEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCC--CCCEEEEEECCH
T ss_conf -99999998579988999997623789999999999999999999975697600015467364168--898699954521
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC--CC
Q ss_conf 5023344335886468864573111358887892346999999999999099999999959999999924789999--99
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PS 856 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~--p~ 856 (897)
++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..+....+.... ..
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 250 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG
T ss_pred HEECCCCCCCCEECCCCCCCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 04425654320006862421889975899--8726765546599999985989989979999999998478898942235
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++.++++||.+||+.||.+|||+++++++
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 899999999999756896679089998629
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=372.79 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=218.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 89159999522695499985655--9407999854786567872478999999999999961799963268322104897
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~ 699 (897)
..|+.+++||+|+||+||+++++ ++.||||+++... .......+.+.+|+.++++++||||+++++++.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-- 87 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-- 87 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-----SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--
T ss_conf 85676279701888099999998999399999984444-----35889999999999999977899982389999989--
Q ss_pred CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 50799995422362678872026663388999999999999999998996312689997585137999990999825995
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLA 779 (897)
..+|+||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEEC----CCCCEEEEECCCC
T ss_conf 9889999806999457899737-9999999999999999999999868976667884217987----9997898443653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 023344335886468864573111358-8878923469999999999990999999999599999999247899999988
Q 002642 780 KIKQKTLISGGVRGTIPWMAPELFKSK-DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 780 k~~~~~~~~~~~~GT~~Y~APEvl~g~-~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p~~i 858 (897)
+..... ....||+.|+|||++.+. ...|+.++|||||||++|+|++|..||......+.+..+.....+...+..+
T Consensus 163 ~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (309)
T d1u5ra_ 163 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (309)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 346778---73134766368899834678886721454558999999987889999979999999998289998887888
Q ss_pred CHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 2999999999300399999789999999
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 859 s~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
++.+.+||.+||+.||.+|||+++++++
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 9999999999773796579189999719
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.88 Aligned_cols=263 Identities=29% Similarity=0.537 Sum_probs=224.3
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 333234889159999522695499985655--940799985478656787247899999999999996179996326832
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 615 ~~~~i~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d 692 (897)
+.|++..++|++.++||+|+||+||+++++ +..||||+++.... ..+++.+|+.+++.++||||+++++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC---------HHHHHHHHHHHHHHCCCCCEECCCC
T ss_conf 6517457993986598208880899999999996999999777610---------3999999999998679998826775
Q ss_pred EEECCCCCEEEEEEEEEECCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEE
Q ss_conf 21048975079999542236267887202-66633889999999999999999989963126899975851379999909
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 693 ~~~e~~~~~l~IVmEyl~GGSL~~~L~~~-~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~V 771 (897)
++.+. ..++++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 81 ~~~~~--~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~ 154 (287)
T d1opja_ 81 VCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLV 154 (287)
T ss_dssp EECSS--SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCE
T ss_pred CEEEC--CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCE
T ss_conf 27457--8547876314676067775303554157999999999999978889878930576045768998----99928
Q ss_pred EEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 99825995023344--3358864688645731113588878923469999999999990999999999599999999247
Q 002642 772 KIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 772 KLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~ 849 (897)
||+|||+|+..... .......|++.|+|||++.+.. ++.++||||||+++|||+++..||........+...+...
T Consensus 155 Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp EECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC
T ss_conf 98324454653788722103556654666927872799--9810430217899999986799887742599999998558
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 899999988299999999930039999978999999999999972
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 850 ~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
..+..+..++.++.+||.+||+.||.+|||++++++.|+.+.++-
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 888887433099999999975779768939999999999998757
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=373.26 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=220.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||.||+++++ ++.||+|+++... ......+.+|+.++++++||||+++++++.++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~- 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK- 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 403599899931778299999998999799999988726--------46799999999999867997989199999989-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||++||+|.+++...+..+++..++.|+.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+
T Consensus 99 -~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGl 175 (352)
T d1koba_ 99 -YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGL 175 (352)
T ss_dssp -SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTT
T ss_pred -CEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCC--CCCEEEEEECCC
T ss_conf -99999998289980888898638998999999999999999999997792651314455311346--788489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--CCCC
Q ss_conf 50233443358864688645731113588878923469999999999990999999999599999999247899--9999
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP--KIPS 856 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~--~~p~ 856 (897)
|+............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+.+..+....... ....
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 253 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 03437887201004764534899974799--8976333898999999996889989979999999998478898930024
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++.++.+||.+||+.||.+|||+++++++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 799999999999756996689189999609
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.95 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=214.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
..+|+++++||+|+||+||+++++ ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 89 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVG- 89 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--------HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-
T ss_conf 10538878981285829999999899989999998430172--------799999999999867999880585779889-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+++|+|.+++.+ ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 90 -~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~ 162 (293)
T d1yhwa1 90 -DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (293)
T ss_dssp -TEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred -CEEEEEEEECCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf -998999970379808988641--5999999999999999999999987972267768886887----899686425156
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-CCCCCCC
Q ss_conf 502334-43358864688645731113588878923469999999999990999999999599999999247-8999999
Q 002642 779 SKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN-LGPKIPS 856 (897)
Q Consensus 779 Ak~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~-~~~~~p~ 856 (897)
++.... ........||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||......+.+..+.... .....+.
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGG
T ss_pred HEEECCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 413213666444444477736826644799--880120313729999980488998997999999999857999888855
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++.++++||.+||..||.+|||+++++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 379999999999866996689099999649
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.60 Aligned_cols=257 Identities=32% Similarity=0.638 Sum_probs=221.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 34889159999522695499985655-94079998547865678724789999999999999617999632683221048
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 619 i~~~~Yeiik~LG~G~fG~VYla~~k-g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~ 697 (897)
+..++|+++++||+|+||+||++++. ++.||||+++..... .+++.+|+.+++.++||||+++++++...
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCCCCCCCEECCC
T ss_conf 896995888898208882999999889999999998788676---------89999999999966899756535243159
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
..+++||||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 73 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 73 --APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp --SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred --CCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEEC----CCCCEEECCCC
T ss_conf --933799983699918997520134788999999999999987765316431044315326666----88776865532
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 950233443--358864688645731113588878923469999999999990-99999999959999999924789999
Q 002642 778 LSKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 778 LAk~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~~~~~~~ 854 (897)
+++...... ......||+.|+|||++.+.. ++.++||||||+++|||++ |.+||......+....+.. ...+..
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCC
T ss_pred HHEECCCCCCEEECCEECCCCCCCHHHHCCCC--CCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCC
T ss_conf 10023688733504300176667857860799--984033210599999998789888778999999999980-688899
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 998829999999993003999997899999999999997
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 855 p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
|..+++++.+||.+||+.||.+||++++++++|+++++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 543679999999997657976891999999999999857
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=374.88 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=221.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.+.|++++.||+|+||+||+++++ ++.||||++...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 79 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-------GKEGSMENEIAVLHKIKHPNIVALDDIYESG- 79 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH-------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 66669988994065839999999999989999998157731-------2899999999999867998999198999989-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+...+ .++.+||+|||+
T Consensus 80 -~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 80 -GHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp -SEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred -CEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCC-CCCEEEEECCCE
T ss_conf -9888988526898488865303-6788789999999999998752413055687046300110468-882499831543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 502334433588646886457311135888789234699999999999909999999995999999992478999--999
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--IPS 856 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~--~p~ 856 (897)
++............||+.|+|||++.+.. ++.++||||+||++|+|++|+.||......+....+........ .+.
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred EEECCCCCEEEEEEECCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 58725897044003284225918873799--9807873451599999985979999989999999986168777876666
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.+|+++.+||.+||..||.+|||++|++++
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 789999999999760897579189998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.22 Aligned_cols=253 Identities=24% Similarity=0.444 Sum_probs=219.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||+||+++++ ++.||+|.++.... .+...+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 3337996798308891999999999997999999874657------9799999999999999778999824899999178
Q ss_pred CCEEEEEEEEEECCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEECCCCCCCCE
Q ss_conf 7507999954223626788720---2666338899999999999999999899-----6312689997585137999990
Q 002642 699 VTNLATVTEYMVNGSLKQVLRR---KDRTIDRRKRIIIAMDAAFGIEYLHEKN-----IVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~---~~~~lse~~il~Ia~QIl~aL~yLHs~G-----IIHRDIKPeNILLd~~d~~~g~ 770 (897)
...+|+||||+++|+|.+++.+ ....+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCC----CCCC
T ss_conf 998999995689993899998515457899999999999999999999997167788788586765425747----8885
Q ss_pred EEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 999825995023344-3358864688645731113588878923469999999999990999999999599999999247
Q 002642 771 CKIGDLGLSKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 771 VKLiDFGLAk~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~ 849 (897)
+||+|||+++..... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC
T ss_conf 79800100032245777556677882327999983999--9938988752789999801889989989999999997189
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 8999999882999999999300399999789999999
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 850 ~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
. +.++..+++++.+||.+||+.||.+|||+++++++
T Consensus 231 ~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 9-88974359999999999767995579189999729
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.23 Aligned_cols=261 Identities=31% Similarity=0.564 Sum_probs=221.5
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 333234889159999522695499985655-9407999854786567872478999999999999961799963268322
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 615 ~~~~i~~~~Yeiik~LG~G~fG~VYla~~k-g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~ 693 (897)
+.|++..++|++.+.||+|+||+||+++++ ++.||||+++..... .+.+.+|+.++++++||||++++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 7700388993886798107982899999999999999998647688---------8999999999986799988578731
Q ss_pred EECCCCCEEEEEEEEEECCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEE
Q ss_conf 1048975079999542236267887202-666338899999999999999999899631268999758513799999099
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 694 ~~e~~~~~l~IVmEyl~GGSL~~~L~~~-~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VK 772 (897)
+.++ .+++||||+++|+|.+++... ...+++..++.|+.|++.||.|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~K 149 (272)
T d1qpca_ 77 VTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCK 149 (272)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEE
T ss_pred ECCC---CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEE----CCCCEE
T ss_conf 0459---769999957898288887514789887889999999999999999748954675642251562----024404
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCC
Q ss_conf 9825995023344--33588646886457311135888789234699999999999909-99999999599999999247
Q 002642 773 IGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG-EEPYADLHSEEIIAGIIKGN 849 (897)
Q Consensus 773 LiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtG-k~PF~~~~~~e~l~~ii~~~ 849 (897)
|+|||+|+..... .......||+.|+|||++.+.. ++.++||||||+++|||+++ .+|+......+....+. ..
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~ 226 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RG 226 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-HC
T ss_conf 2341014773588644203567744445828983799--98245645257999999968988888889999999997-06
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 899999988299999999930039999978999999999999972
Q 002642 850 LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 850 ~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
..+..|..++.++.+||.+||+.||.+|||++++++.|++++.+-
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 888896557199999999975889768939999999861132137
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.99 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=209.9
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
Q ss_conf 234889159999522695499985655--940799985478656787247899999999999996179996326832210
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVT 695 (897)
Q Consensus 618 ~i~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~ 695 (897)
++..++|+++++||+|+||+||+++++ ++.||+|+++.... ......+.+|+.+++.++||||+++++++.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 7875688897897127780999999989996999999875409-------789999999999998679999994999999
Q ss_pred CCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCCEEECCCCCCCCEEEEE
Q ss_conf 4897507999954223626788720266633889999999999999999989-963126899975851379999909998
Q 002642 696 DGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEK-NIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 696 e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~-GIIHRDIKPeNILLd~~d~~~g~VKLi 774 (897)
+. ..+++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+
T Consensus 75 ~~--~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~ 147 (322)
T d1s9ja_ 75 SD--GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLC 147 (322)
T ss_dssp CS--SEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred EC--CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEEEE
T ss_conf 89--9999999767998689987424-99999999999999999999999859997144577994687----89989995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------------
Q ss_conf 2599502334433588646886457311135888789234699999999999909999999995999-------------
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI------------- 841 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~------------- 841 (897)
|||+|+...... ....+||+.|+|||++.+.. |+.++||||+||++|||++|+.||......+.
T Consensus 148 DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 148 DFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCCHHHHHHT-C---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred ECCCCCCCCCCC-CCCCCCCCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 487762567886-21113771411946875899--894888998999999999888998998878999999887517754
Q ss_pred -----------------------------HHHHHHCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHH
Q ss_conf -----------------------------99999247899999-9882999999999300399999789999999--999
Q 002642 842 -----------------------------IAGIIKGNLGPKIP-SWCEPTWRSLMERCWSSDPKSRPAFSEITKE--LRA 889 (897)
Q Consensus 842 -----------------------------l~~ii~~~~~~~~p-~~is~eL~dLI~kcL~~DP~eRPSaeELL~~--Le~ 889 (897)
...+.. ..++..+ ..++.++.+||.+||+.||.+|||++|++++ |+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHT-SCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 57742123332211112223541347788766502-68766764448999999999986899467908999960986476
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.37 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=216.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 89159999522695499985655--9407999854786567872478999999999999961799963268322104897
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~ 699 (897)
+.|++++.||+|+||+||+++++ +..||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-- 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYYE-- 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--
T ss_conf 3759847993077819999999999939999998728999--------999999999999867999988498898009--
Q ss_pred CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 50799995422362678872026663388999999999999999998996312689997585137999990999825995
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLA 779 (897)
..+++||||+++|+|.+++.+....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a 157 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVS 157 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEEC----CCCCEEEEECHHH
T ss_conf 958999962799818899986289999999999999999999999988988714070031487----8999899716123
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCC
Q ss_conf 023344-335886468864573111358---887892346999999999999099999999959999999924789-999
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSK---DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG-PKI 854 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~---~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~-~~~ 854 (897)
+..... .......||+.|+|||++... ...++.++||||+||++|+|++|+.||......+.+..+.....+ ...
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred HCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 03577864100102562647999983202578888806657878999999820889999989999999997079987776
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 99882999999999300399999789999999
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
+..+++++.+||.+||+.||.+|||+++++++
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 56699999999999766996689199999629
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.16 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=218.6
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 4889159999522695499985655--94079998547865678724789999999999999617999632683221048
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~ 697 (897)
..++|++++.||+|+||+||+++++ ++.||||++.+... ........+.+|+.++++++||||+++++++.+.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 99877898898508790999999989997999999865775-----5777899999999999876888861799999989
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 81 --~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DFG 153 (288)
T d1uu3a_ 81 --EKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFG 153 (288)
T ss_dssp --SEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred --CEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCC----CCCEEEECCCC
T ss_conf --9889999704898777765315-9999999999999999999762165088476774123668----88538860321
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 9502334---4335886468864573111358887892346999999999999099999999959999999924789999
Q 002642 778 LSKIKQK---TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 778 LAk~~~~---~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~ 854 (897)
+|+.... ........||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...+..+...++....+ .+
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~ 229 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--DF 229 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--CC
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCC--CCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CC
T ss_conf 024225677643335556775525844002689--89666230456999998038899899599999999971899--99
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 99882999999999300399999789999999
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
|..+++++++||.+||+.||.+|||++|++++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 85479999999999855797689197897377
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.59 Aligned_cols=261 Identities=35% Similarity=0.597 Sum_probs=220.2
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCC------CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 323488915999952269549998565594------07999854786567872478999999999999961799963268
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGS------DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 617 ~~i~~~~Yeiik~LG~G~fG~VYla~~kg~------~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL 690 (897)
.++.++.|++.+.||+|+||+||++.++.. .||||.++... ......++.+|+.+++.++||||+++
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 85788996861598117790999999968998787999999988445-------96899999999999985689878323
Q ss_pred EEEEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCE
Q ss_conf 32210489750799995422362678872026663388999999999999999998996312689997585137999990
Q 002642 691 YGVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 691 ~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~ 770 (897)
++++.+. ..++++|||+.++++.+++......+++..+..++.|++.||.|||+++|+||||||+|||++ .++.
T Consensus 75 ~g~~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~ 148 (283)
T d1mqba_ 75 EGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLV 148 (283)
T ss_dssp EEEECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCC
T ss_pred EEEEECC--CCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC----CCCE
T ss_conf 6778338--803899972135740222102345420899999999999854121212342576564427888----9984
Q ss_pred EEEEECCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHH
Q ss_conf 9998259950233443----3588646886457311135888789234699999999999909999-9999959999999
Q 002642 771 CKIGDLGLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEP-YADLHSEEIIAGI 845 (897)
Q Consensus 771 VKLiDFGLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~P-F~~~~~~e~l~~i 845 (897)
+||+|||+++...... ......||+.|+|||++.+.. ++.++||||||+++|||+++..| +......+....
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~- 225 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA- 225 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred EEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH-
T ss_conf 99845510300357876526742677773434888870499--997355634489899999679886556899999999-
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 924789999998829999999993003999997899999999999997
Q 002642 846 IKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 846 i~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
+.....++.+..++..+.+||.+||+.||++||++.++++.|+.+.+.
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 863578998504579999999997767976893999999999998669
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.97 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=210.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||+||+++++ ++.||+|++..... ....+++.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~- 75 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREG- 75 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEET-
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-------CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC-
T ss_conf 7460899897217480999999999997999999845664-------12799999999999857998884696540467-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 -~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~ 149 (271)
T d1nvra_ 76 -NIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 149 (271)
T ss_dssp -TEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred -CEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf -4367988645898089997537-9999999999999999999999975983575468997887----899879832314
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHHCCCCCCC
Q ss_conf 502334---4335886468864573111358887892346999999999999099999999959-999999924789999
Q 002642 779 SKIKQK---TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE-EIIAGIIKGNLGPKI 854 (897)
Q Consensus 779 Ak~~~~---~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~-e~l~~ii~~~~~~~~ 854 (897)
|+.... .......+||+.|+|||++.+.. +++.++||||+|+++|+|++|+.||...... ...............
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCC-CCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 22404688653111325574742872861899-99971016173799999982997888898599999998638887886
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 99882999999999300399999789999999
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 855 p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
...+++++.+||.+||+.||.+|||+++++++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44699999999999767996689099999619
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.30 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=221.0
Q ss_pred CCCCCCEEEE-EECCCCCEEEEEEEEC----CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 3488915999-9522695499985655----9407999854786567872478999999999999961799963268322
Q 002642 619 IKTSDLEYIK-ELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeiik-~LG~G~fG~VYla~~k----g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~ 693 (897)
+..++|.+.. +||+|+||+||++.++ +..||||+++... .....+++.+|+.++++++||||++++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 54447188784873060809999999608976899999988203-------97899999999999986799888068656
Q ss_pred EECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEE
Q ss_conf 10489750799995422362678872026663388999999999999999998996312689997585137999990999
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKL 773 (897)
+..+ .+++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||
T Consensus 78 ~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl 150 (285)
T d1u59a_ 78 CQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 150 (285)
T ss_dssp EESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred ECCC---EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEEE
T ss_conf 0368---07999980789968997521256999999999999999987899868810576764660454----6885420
Q ss_pred EECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 825995023344----3358864688645731113588878923469999999999990-99999999959999999924
Q 002642 774 GDLGLSKIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 774 iDFGLAk~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~ 848 (897)
+|||+++..... .......||+.|+|||++.+.. ++.++||||||+++|||++ |+.||......+....+..
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~- 227 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 227 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-
T ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-
T ss_conf 33134211554343211356211374335868872799--995412322017899999389999999799999999981-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 7899999988299999999930039999978999999999999972
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 849 ~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
...+..|..+|+++.+||.+||+.||++||++.++++.|+.....+
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 8999999767899999999975779768909999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.45 Aligned_cols=259 Identities=27% Similarity=0.359 Sum_probs=222.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||+||+++++ ++.||||++++....... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENK- 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHH--HHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 56779827981178959999999999989999998756632134--068999999999999867998999388999979-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.....+||+|||+
T Consensus 86 -~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 -TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred -CEEEEEEECCCCCCCCCHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf -9899999867786431001035-64215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 502334433588646886457311135888789234699999999999909999999995999999992478999--999
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK--IPS 856 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~--~p~ 856 (897)
++............||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||...+..+.+..+........ .+.
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCC
T ss_conf 21057776312247777430999981899--9976652214099999970889988999999999998168888701047
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++..+++||.+||+.||.+|||+++++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 889999999999863896689199999619
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=366.54 Aligned_cols=249 Identities=25% Similarity=0.474 Sum_probs=218.5
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 4889159999522695499985655--94079998547865678724789999999999999617999632683221048
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~ 697 (897)
+.++|++++.||+|+||+||+++++ ++.||||++++... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEEC
T ss_conf 65470888897207680899999989997999999845775-----4889999999999999863696753303568528
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
..+|+||||++||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 77 --~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG 149 (316)
T d1fota_ 77 --QQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFG 149 (316)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCS
T ss_pred --CEEEEEEEECCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEEC----CCCCEEEECCC
T ss_conf --8005676503786322343222-2111007999999998765541247677055681050386----89988983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 95023344335886468864573111358887892346999999999999099999999959999999924789999998
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSW 857 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p~~ 857 (897)
+|+...... ....||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||...+..+....+..... .+|..
T Consensus 150 ~a~~~~~~~--~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (316)
T d1fota_ 150 FAKYVPDVT--YTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPF 223 (316)
T ss_dssp SCEECSSCB--CCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTT
T ss_pred CCEEECCCC--CCCCCCCCCCCHHHHCCCC--CCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCC
T ss_conf 216712456--4345763435999983899--98043046533368999759899999699999999970898--89977
Q ss_pred CCHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 829999999993003999997-----89999999
Q 002642 858 CEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 858 is~eL~dLI~kcL~~DP~eRP-----SaeELL~~ 886 (897)
+++++.++|.+||.+||.+|+ ++++++++
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 8999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=366.24 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=218.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||.||+++++ ++.||||++.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN- 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCC-
T ss_conf 2370898896117680899999989998999999826774-----5889999999999999974877274034444322-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+++||||+.+|+|..++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 114 -~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 -SNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGF 187 (350)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred -CCCCCCCCCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCC----CCCCEEEEECEE
T ss_conf -2223222233466226667515-8989999999999999989999859986176799993607----789788610103
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 50233443358864688645731113588878923469999999999990999999999599999999247899999988
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p~~i 858 (897)
|+...... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+..... .++..+
T Consensus 188 a~~~~~~~--~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 261 (350)
T d1rdqe_ 188 AKRVKGRT--WTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp CEECSSCB--CCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTC
T ss_pred EEECCCCC--CCCCCCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCCC
T ss_conf 33225666--4336763567889971799--88533114500789999758899899599999999861798--897668
Q ss_pred CHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 29999999993003999997-----89999999
Q 002642 859 EPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 859 s~eL~dLI~kcL~~DP~eRP-----SaeELL~~ 886 (897)
++++.+||.+||..||.+|+ ++++++++
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 999999999983409986065534549999719
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.48 Aligned_cols=261 Identities=32% Similarity=0.590 Sum_probs=225.0
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC-----CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 32348891599995226954999856559-----4079998547865678724789999999999999617999632683
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG-----SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 617 ~~i~~~~Yeiik~LG~G~fG~VYla~~kg-----~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~ 691 (897)
|++..++|++.+.||+|+||.||++++.. ..||+|.++.. ........+.+|+.+++.++||||++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-------TSHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-------CCHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 976889969877993078829999999369964499999993656-------6879999999999999868999985698
Q ss_pred EEEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEE
Q ss_conf 22104897507999954223626788720266633889999999999999999989963126899975851379999909
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 692 d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~V 771 (897)
+++.+ ..+++||||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEEC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEEC----CCCCE
T ss_conf 89953---747999984069807765422478999999999999998775230226744141026553206----78967
Q ss_pred EEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 99825995023344--3358864688645731113588878923469999999999990-99999999959999999924
Q 002642 772 KIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 772 KLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~ 848 (897)
||+|||+++..... .......||+.|+|||++.+.. ++.++||||||+++|||++ |.+||......+....+...
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
T ss_conf 87650342133677623305400583103266751699--8874524442478999982699998889999999999818
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 7899999988299999999930039999978999999999999972
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 849 ~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
. .++++..+|+.+.+||.+||..||.+|||+.+++++|+.+.++.
T Consensus 226 ~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 E-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 9-99898777999999999976879768929999999999997786
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.41 Aligned_cols=266 Identities=30% Similarity=0.496 Sum_probs=222.2
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEECC-------CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 3332348891599995226954999856559-------4079998547865678724789999999999999617-9996
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 615 ~~~~i~~~~Yeiik~LG~G~fG~VYla~~kg-------~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L-~HPN 686 (897)
..|++..++|++.++||+|+||.||++++.+ +.||+|.++... .....+.+.+|...+.++ +|+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-------CCHHHHHHHHHHHHHHHHCCCCE
T ss_conf 25261679979844984167839999998677755578399999986001-------71789999999999886149984
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEE
Q ss_conf 326832210489750799995422362678872026---------------66338899999999999999999899631
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkL~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~---------------~~lse~~il~Ia~QIl~aL~yLHs~GIIH 751 (897)
|+.+++++.+.. ..+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+|
T Consensus 79 iv~~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 79 VVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp BCCEEEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEECCCC-CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 997411540479-7579999845899299999853666665322202332146899999999999999999887379717
Q ss_pred CCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 2689997585137999990999825995023344---3358864688645731113588878923469999999999990
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt 828 (897)
|||||+|||++ .++.+||+|||+|+..... .......||+.|+|||++.+.. ++.++||||+|+++|||++
T Consensus 158 rDlKp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 158 RDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp SCCCGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCEEEC----CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC--CCCCCCEEEHHHHHHHHHH
T ss_conf 86773106577----99828984575200113566522247516672102036864688--9966322136789999986
Q ss_pred C-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 9-99999999599999999247899999988299999999930039999978999999999999972
Q 002642 829 G-EEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 829 G-k~PF~~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
+ .+||......+.+...+.....+..+..+++++.++|.+||+.||.+|||+++++++|+.+.++.
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 8899998999899999999638988888657899999999976779667919999999997998677
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=361.43 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=208.6
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 4889159999522695499985655--94079998547865678724789999999999999617999632683221048
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~ 697 (897)
+.++|++++.||+|+||.||+++++ ++.||||++.+..... ........+...++.+++.++||||+++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCH--HHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 7776851018842889099999999999799999984587542--66799999999999998508998588999999989
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
..+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||
T Consensus 80 --~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFG 152 (364)
T d1omwa3 80 --DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLG 152 (364)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCT
T ss_pred --CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEEC----CCCCEEEEEEC
T ss_conf --9889999914898389998732-5532789999999999999999977962204442216785----88967982201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHHCCCCCCCCC
Q ss_conf 9502334433588646886457311135888789234699999999999909999999995999999-992478999999
Q 002642 778 LSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAG-IIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~-ii~~~~~~~~p~ 856 (897)
+|+...... .....||+.|+|||++.... .++.++|||||||++|+|++|+.||......+.... .........++.
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred EEEECCCCC-CCCCCCCCCCCHHHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 023337886-43311345542168760389-9984410467789999998599988889989999999860468887887
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHH
Q ss_conf 88299999999930039999978-----9999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPA-----FSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPS-----aeELL~~ 886 (897)
.+++++++||.+||..||.+||+ +++++++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 78999999999985669888088743579999749
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.82 Aligned_cols=251 Identities=28% Similarity=0.475 Sum_probs=208.4
Q ss_pred CCC-EEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-
Q ss_conf 891-59999522695499985655--94079998547865678724789999999999999617999632683221048-
Q 002642 622 SDL-EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG- 697 (897)
Q Consensus 622 ~~Y-eiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~- 697 (897)
.+| ++.++||+|+||+||+++++ +..||+|.+..... .....+.+.+|++++++++||||+++++++...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 8778851697008284999999999995999999851227------9899999999999998579998506999984033
Q ss_pred -CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCEEEEE
Q ss_conf -975079999542236267887202666338899999999999999999899--63126899975851379999909998
Q 002642 698 -PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKN--IVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 698 -~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~G--IIHRDIKPeNILLd~~d~~~g~VKLi 774 (897)
....+|+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ ..++.+||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~---~~~~~~Kl~ 157 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIG 157 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEEC
T ss_pred CCCCEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEE---CCCCCEEEE
T ss_conf 4588899999578989489997513-554699999999999999999997899799687674351166---799988980
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHCCCCCC
Q ss_conf 2599502334433588646886457311135888789234699999999999909999999995999-999992478999
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEI-IAGIIKGNLGPK 853 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~-l~~ii~~~~~~~ 853 (897)
|||+++....... ....||+.|+|||++.+ . ++.++||||+||++|+|++|+.||........ ...+.....++.
T Consensus 158 DFGla~~~~~~~~-~~~~GT~~Y~aPE~~~~-~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 158 DLGLATLKRASFA-KAVIGTPEFMAPEMYEE-K--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233 (270)
T ss_dssp CTTGGGGCCTTSB-EESCSSCCCCCGGGGGT-C--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred ECCCCEECCCCCC-CCCCCCCCCCCHHHHCC-C--CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 0576542368766-77553813008988478-9--998671100799999998788999876559999999973899865
Q ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 999882999999999300399999789999999
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
++..+++++.+||.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 675578999999999763797589299999677
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.17 Aligned_cols=253 Identities=33% Similarity=0.608 Sum_probs=221.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 4889159999522695499985655-940799985478656787247899999999999996179996326832210489
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k-g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
..++|+++++||+|+||+||+++++ +..||||.++..... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~- 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ- 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCS-
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEEEC-
T ss_conf 96997996898207883999999889989999998747577---------89999999999966898601588998507-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+++||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++ ..+.+||+|||+
T Consensus 72 -~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 72 -RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp -SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred -CCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEC----CCCCEEECCCHH
T ss_conf -816999970489938886410246776899999999999999987546843466541358876----998479886144
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 50233443--358864688645731113588878923469999999999990-999999999599999999247899999
Q 002642 779 SKIKQKTL--ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 779 Ak~~~~~~--~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~~~~~~~p 855 (897)
++...... ......+|+.|+|||.+.+.. ++.++||||||+++|||++ |+.||......+....+.. ...+..|
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred HEECCCCCCEEECCCCCCCCCCCCHHHCCCC--CCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCC
T ss_conf 2023578722524657887757807863799--885210336432467397559999889999999999980-7978996
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 98829999999993003999997899999999999
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 856 ~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l 890 (897)
..++.++.+||.+||+.||++|||+++++++|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 54659999999997668976893999999874188
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.02 Aligned_cols=249 Identities=32% Similarity=0.549 Sum_probs=212.5
Q ss_pred EEECCCCCEEEEEEEEC----CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEEE
Q ss_conf 99522695499985655----94079998547865678724789999999999999617999632683221048975079
Q 002642 628 KELGSGTFGTVFYGKWK----GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNLA 703 (897)
Q Consensus 628 k~LG~G~fG~VYla~~k----g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~~~l~ 703 (897)
++||+|+||+||++.+. ++.||||+++... ......+++.+|+.++++++||||+++++++..+ ..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH------CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC---CEE
T ss_conf 7834587829999998169738599999988010------8989999999999999867998985277775059---779
Q ss_pred EEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 99954223626788720266633889999999999999999989963126899975851379999909998259950233
Q 002642 704 TVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQ 783 (897)
Q Consensus 704 IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~ 783 (897)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||+++...
T Consensus 84 lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCC----CCCCCCCCCHHHHHHCC
T ss_conf 999747889689997522-5789999999999999997668747955677761131023----56751234134533134
Q ss_pred CC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 44----3358864688645731113588878923469999999999990-999999999599999999247899999988
Q 002642 784 KT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKIPSWC 858 (897)
Q Consensus 784 ~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~~~~~~~p~~i 858 (897)
.. .......||+.|+|||++.+.. ++.++||||||+++|||++ |+.||......+....+.. ...+..|..+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~ 235 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGC 235 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTC
T ss_pred CCCCCCCCCCCCCCCCEECCCHHHCCCC--CCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCC
T ss_conf 3234432244567784203916653799--984344303403132896589999999899999999982-8999998656
Q ss_pred CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 29999999993003999997899999999999997
Q 002642 859 EPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 859 s~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
|.++.+||.+||+.||.+||+++++++.|+....+
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 79999999997588976890989999985288750
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.06 Aligned_cols=259 Identities=32% Similarity=0.552 Sum_probs=219.3
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEEC--CC----CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 234889159999522695499985655--94----079998547865678724789999999999999617999632683
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWK--GS----DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 618 ~i~~~~Yeiik~LG~G~fG~VYla~~k--g~----~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~ 691 (897)
.+...+|++++.||+|+||+||++++. ++ .||+|.++... .....+++.+|+.++++++||||++++
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 77 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 77 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 3888999783198208992999999958998898999999965134-------979999999999999867998881589
Q ss_pred EEEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEE
Q ss_conf 22104897507999954223626788720266633889999999999999999989963126899975851379999909
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 692 d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~V 771 (897)
+++.++ ..++++|++.+++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 78 g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~~~ 150 (317)
T d1xkka_ 78 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHV 150 (317)
T ss_dssp EEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTEE
T ss_pred EEEECC---CEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEEC----CCCCE
T ss_conf 999619---83699984268740101113345799999999999999999999876950476212031167----99875
Q ss_pred EEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHH
Q ss_conf 998259950233443---358864688645731113588878923469999999999990-9999999995999999992
Q 002642 772 KIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 772 KLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~ 847 (897)
||+|||+++...... ......||+.|+|||++.+.. ++.++||||||+++|||++ |.+||......+....+..
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~ 228 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH
T ss_pred EEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
T ss_conf 860255222335444532236510586446708874699--983565440799999999779999999998999999975
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 4789999998829999999993003999997899999999999997
Q 002642 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 848 ~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
...+..|..++..+.+||.+||+.||.+|||+.+++++|..+.++
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -998999855689999999984789934691999999999998758
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=355.77 Aligned_cols=259 Identities=25% Similarity=0.276 Sum_probs=224.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEECCCCCCCCCH-HHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 88915999952269549998565--59407999854786567872-47899999999999996179-9963268322104
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSL-EEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTD 696 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~--kg~~VAIK~ik~~~~~~~~~-~~~~~~~~i~rEi~iLk~L~-HPNIVkL~d~~~e 696 (897)
.++|++++.||+|+||+||++++ +++.||||++++........ ......+.+.+|+.+++.+. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 89750799995422362678872026663388999999999999999998996312689997585137999990999825
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDF 776 (897)
. ..+|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred C--CCEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf 7--6059999768986689999865-9999999999999999999999875994323462548986----8998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 995023344335886468864573111358----8878923469999999999990999999999599999999247899
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSK----DNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~----~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~ 852 (897)
|+++............||+.|+|||.+.+. ...++.++||||+|+++|+|++|+.||......+....+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 03167268872134524678889888605344567889923318565602310322888988999999999998189888
Q ss_pred CC--CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 99--99882999999999300399999789999999
Q 002642 853 KI--PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ~~--p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.. ...+|+++++||.+||+.||.+||++++++++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 985434689999999999765896689199999739
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.66 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=218.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++++.||+|+||+||+++++ ++.||+|+++.... ....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~- 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---------DQVLVKKEISILNIARHRNILHLHESFESM- 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---------HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC---------CHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-
T ss_conf 0105887898317783999999989996999999757866---------599999999999857997989098999889-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||++|++|.+++...+..+++..+..|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||+
T Consensus 74 -~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 -EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp -TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred -CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEEECCCCH
T ss_conf -98899995389980889987538999999999999999999999987699751355444344378--851899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC--CC
Q ss_conf 5023344335886468864573111358887892346999999999999099999999959999999924789999--99
Q 002642 779 SKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKI--PS 856 (897)
Q Consensus 779 Ak~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~--p~ 856 (897)
++............+++.|+|||.+.+.. ++.++||||+||++|+|++|..||......+.+..+....+.... ..
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCC
T ss_conf 10034677532122332223402104877--7840113027999999982899999989999999998389998802236
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 882999999999300399999789999999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++.++.+||.+||..||.+|||+++++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 789999999999866996689099999639
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=353.47 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=221.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|++.+.||+|+||+||++++. ++.||||+++.... .......++.+|+.+++.++||||+++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-----TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 6206986899608992999999999998999999855664-----69899999999999998569998873114354326
Q ss_pred C--CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 7--50799995422362678872026663388999999999999999998996312689997585137999990999825
Q 002642 699 V--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 699 ~--~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDF 776 (897)
. ..+|+||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ ..+..+|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCC
T ss_pred CCCCEEEEEEECCCCCEEHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCCEEEHH
T ss_conf 8876699999778898710112035-8999999999999999999999857952763467556657----5432010034
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 995023344----3358864688645731113588878923469999999999990999999999599999999247899
Q 002642 777 GLSKIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 777 GLAk~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~ 852 (897)
|.+...... .......||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||......+...+++.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 44322123544333346425762436999983999--9966320265289999976979989969999999998469999
Q ss_pred --CCCCCCCHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf --99998829999999993003999997-8999999999999
Q 002642 853 --KIPSWCEPTWRSLMERCWSSDPKSRP-AFSEITKELRAMA 891 (897)
Q Consensus 853 --~~p~~is~eL~dLI~kcL~~DP~eRP-SaeELL~~Le~l~ 891 (897)
.....+|+++.++|.+||+.||.+|| +++++++.|.++.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 710034789999999999866797677739999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=355.86 Aligned_cols=259 Identities=34% Similarity=0.604 Sum_probs=221.7
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC-------CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 32348891599995226954999856559-------40799985478656787247899999999999996179996326
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG-------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689 (897)
Q Consensus 617 ~~i~~~~Yeiik~LG~G~fG~VYla~~kg-------~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVk 689 (897)
.+++.++|++++.||+|+||+||+|++++ +.||||+++... .....+++.+|+.+++.++||||++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 138988938867982078839999998887657788299999988210-------8579999999999999668997655
Q ss_pred EEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 832210489750799995422362678872026-----------------------663388999999999999999998
Q 002642 690 FYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-----------------------RTIDRRKRIIIAMDAAFGIEYLHE 746 (897)
Q Consensus 690 L~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~-----------------------~~lse~~il~Ia~QIl~aL~yLHs 746 (897)
+++++... ...+++|||+++|+|.+++.... ..+++..++.|+.|++.||+|||+
T Consensus 81 ~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 81 LLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp EEEEECSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEECCC--CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 24666059--8038999815899299999852755421000011100121034678898999999999999998554135
Q ss_pred CCCEECCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 996312689997585137999990999825995023344---33588646886457311135888789234699999999
Q 002642 747 KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVM 823 (897)
Q Consensus 747 ~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLL 823 (897)
++++||||||+|||++ .++.+||+|||+++..... .......|++.|+|||.+.+.. ++.++||||||+++
T Consensus 159 ~~ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVL 232 (301)
T ss_dssp TTCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHH
T ss_pred CCEEEEEECCCCEEEC----CCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHCCCHHHH
T ss_conf 7868548840116898----99928983314421136776411157777676767989972688--98056302523629
Q ss_pred HHHHCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999099-9999999599999999247899999988299999999930039999978999999999999
Q 002642 824 WELLTGE-EPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMA 891 (897)
Q Consensus 824 yELLtGk-~PF~~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~ 891 (897)
|||+++. +||......+....+..+. .+..|..++.++.+||.+||+.||.+|||+.++++.|+++.
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHCCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 999806899999989999999997399-78887325299999999974889657939999999999842
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.89 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=212.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECC
Q ss_conf 88915999952269549998565--5940799985478656787247899999999999996-17999632683221048
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLG-QIHHPNVVAFYGVVTDG 697 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~--kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk-~L~HPNIVkL~d~~~e~ 697 (897)
.++|++++.||+|+||+||++++ +++.||||++++... ........+.+|..++. .++||||+++++++.++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 9971886589408782899999999998999999805553-----38489999999999999847999687898897049
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
..+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||
T Consensus 76 --~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG 148 (320)
T d1xjda_ 76 --ENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFG 148 (320)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCT
T ss_pred --CCEEEEEEECCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC----CCCCEECCCCC
T ss_conf --8316777503798089986404-7899999999999999999999868934034765404444----89963015553
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 9502334-433588646886457311135888789234699999999999909999999995999999992478999999
Q 002642 778 LSKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIPS 856 (897)
Q Consensus 778 LAk~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p~ 856 (897)
+++.... ........||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+.... +.+|.
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~ 224 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPR 224 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCC
T ss_conf 0232356653345457877768999982799--8832320112278989873889999989999999997189--98975
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHH-HHHH
Q ss_conf 8829999999993003999997899-9999
Q 002642 857 WCEPTWRSLMERCWSSDPKSRPAFS-EITK 885 (897)
Q Consensus 857 ~is~eL~dLI~kcL~~DP~eRPSae-ELL~ 885 (897)
.+++++.+||.+||..||.+||++. ++++
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 679999999999654489878388999980
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.55 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=205.9
Q ss_pred CCCCEEEE-EECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEC
Q ss_conf 88915999-9522695499985655--9407999854786567872478999999999999961-799963268322104
Q 002642 621 TSDLEYIK-ELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ-IHHPNVVAFYGVVTD 696 (897)
Q Consensus 621 ~~~Yeiik-~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~-L~HPNIVkL~d~~~e 696 (897)
.++|+++. .||+|+||+||++++. ++.||||+++.. ..+.+|+.++.+ ++||||+++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 148798107965454869999998899989999998974-------------7799999999986699997829899950
Q ss_pred --CCCCEEEEEEEEEECCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEE
Q ss_conf --89750799995422362678872026-663388999999999999999998996312689997585137999990999
Q 002642 697 --GPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 697 --~~~~~l~IVmEyl~GGSL~~~L~~~~-~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKL 773 (897)
.....+|+||||++||+|.+++.+.+ ..+++..+..|+.|++.||.|||++||+||||||+|||++..+ ..+.+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 346897899999778998499999862787757999999999999999999976986444100220113555-5663113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-
Q ss_conf 8259950233443358864688645731113588878923469999999999990999999999599999999247899-
Q 002642 774 GDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP- 852 (897)
Q Consensus 774 iDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~- 852 (897)
+|||+++............||+.|+|||++.+.. |+.++|||||||++|+|++|+.||......+....+.......
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 5455123336888643226775637927774898--88888887645167788658899889887788999999985388
Q ss_pred -CCC----CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -999----9882999999999300399999789999999
Q 002642 853 -KIP----SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 -~~p----~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.++ ..+++++.+||.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 888985434699999999999756996579099999709
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.93 Aligned_cols=258 Identities=31% Similarity=0.586 Sum_probs=223.7
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC---C--CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 348891599995226954999856559---4--07999854786567872478999999999999961799963268322
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKWKG---S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGV 693 (897)
Q Consensus 619 i~~~~Yeiik~LG~G~fG~VYla~~kg---~--~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~ 693 (897)
+..++|++++.||+|+||.||++++.. + .||||++++... ......+++.+|+.+++.++||||++++++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-----~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 864891997898038883999999988999079999999983555-----798999999999999986899998789877
Q ss_pred EECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEE
Q ss_conf 10489750799995422362678872026663388999999999999999998996312689997585137999990999
Q 002642 694 VTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKI 773 (897)
Q Consensus 694 ~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKL 773 (897)
+.+. .+++||||++++++.+++......+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||
T Consensus 80 ~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vkl 152 (273)
T d1u46a_ 80 VLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVKI 152 (273)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEEE
T ss_pred EEEC---CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCC----CCCCEEE
T ss_conf 7401---00114654238612544421268999999999999999999875217875205668881565----5654332
Q ss_pred EECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 825995023344----3358864688645731113588878923469999999999990-99999999959999999924
Q 002642 774 GDLGLSKIKQKT----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKG 848 (897)
Q Consensus 774 iDFGLAk~~~~~----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~ 848 (897)
+|||+++..... .......|+..|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+...
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred CCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 56115553035887526547632573107999983799--9942156614899999996899999996999999999847
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 789999998829999999993003999997899999999999
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAM 890 (897)
Q Consensus 849 ~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l 890 (897)
...++.+..+|..+.+||.+||..||++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 999998544539999999997688966792999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.19 Aligned_cols=260 Identities=30% Similarity=0.548 Sum_probs=223.9
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC---------CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 32348891599995226954999856559---------4079998547865678724789999999999999617-9996
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPN 686 (897)
Q Consensus 617 ~~i~~~~Yeiik~LG~G~fG~VYla~~kg---------~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L-~HPN 686 (897)
|++..++|++++.||+|+||.||+++..+ ..||||+++... ......++.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 72258996970098516782899999857875556675499999988112-------86889999999999998139996
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEE
Q ss_conf 326832210489750799995422362678872026---------------66338899999999999999999899631
Q 002642 687 VVAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------------RTIDRRKRIIIAMDAAFGIEYLHEKNIVH 751 (897)
Q Consensus 687 IVkL~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~---------------~~lse~~il~Ia~QIl~aL~yLHs~GIIH 751 (897)
|+++++++.++ ..+++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+|
T Consensus 81 Iv~~~~~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEECCCCCCCC--CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 97346522018--8689999736999099999860677643222334574346799999999999999998766379786
Q ss_pred CCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 26899975851379999909998259950233443---358864688645731113588878923469999999999990
Q 002642 752 FDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQKTL---ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT 828 (897)
Q Consensus 752 RDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~~~~---~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt 828 (897)
|||||+|||++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++||||||+++|||++
T Consensus 159 rDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCEEEC----CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC--CCCHHHHHHHHHHHHHHCC
T ss_conf 30221022454----78976762211101135555543146678884663266751798--8825554775888887401
Q ss_pred -CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf -9999999995999999992478999999882999999999300399999789999999999999
Q 002642 829 -GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 829 -Gk~PF~~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~ 892 (897)
|.+||......+....+. ....+..|..+++++.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 233 ~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 7989899999999999997-288889874352999999999766797679399999999988860
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.75 Aligned_cols=262 Identities=31% Similarity=0.582 Sum_probs=219.5
Q ss_pred CCCCCCCCCCCCEEEEEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 333332348891599995226954999856559-4079998547865678724789999999999999617999632683
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWKG-SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFY 691 (897)
Q Consensus 613 ~~~~~~i~~~~Yeiik~LG~G~fG~VYla~~kg-~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~ 691 (897)
....|++..++|++.+.||+|+||+||++++++ +.||||+++..... .+.+.+|+.+++.++||||++++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCEECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 875607477997984699307980999999999999999998804488---------89999999999866667886899
Q ss_pred EEEECCCCCEEEEEEEEEECCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCE
Q ss_conf 221048975079999542236267887202-6663388999999999999999998996312689997585137999990
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLKQVLRRK-DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPV 770 (897)
Q Consensus 692 d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~-~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~ 770 (897)
+++.++ .+++||||+++|+|..++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.
T Consensus 79 g~~~~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~ 151 (285)
T d1fmka3 79 AVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLV 151 (285)
T ss_dssp EEECSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGC
T ss_pred EEEECC---CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEEC----CCCC
T ss_conf 998239---759999944799435420000355305999999999999999987541143353123079998----9992
Q ss_pred EEEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHH
Q ss_conf 999825995023344--335886468864573111358887892346999999999999099-99999995999999992
Q 002642 771 CKIGDLGLSKIKQKT--LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE-EPYADLHSEEIIAGIIK 847 (897)
Q Consensus 771 VKLiDFGLAk~~~~~--~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk-~PF~~~~~~e~l~~ii~ 847 (897)
+||+|||+++..... .......||+.|+|||.+.... ++.++||||||+++|||+++. +|+......+.+..+..
T Consensus 152 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~ 229 (285)
T d1fmka3 152 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229 (285)
T ss_dssp EEECCCCTTC--------------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCC--CCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 998442555425688733524545566545808983799--891774132358999998689999988889999999982
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 4789999998829999999993003999997899999999999997
Q 002642 848 GNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 848 ~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
...++.+..++.++.++|.+||+.||++||+++++++.|++.+..
T Consensus 230 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 230 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -689999832379999999997566975891999999987666238
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.55 Aligned_cols=257 Identities=31% Similarity=0.617 Sum_probs=225.0
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 32348891599995226954999856559407999854786567872478999999999999961799963268322104
Q 002642 617 QTIKTSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTD 696 (897)
Q Consensus 617 ~~i~~~~Yeiik~LG~G~fG~VYla~~kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e 696 (897)
|++..++|++.+.||+|+||.||+++++++.||||+++... ..+.+.+|+.++++++||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH----------HHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 95578994885798207980899999999099999988577----------79999999999986789898549878872
Q ss_pred CCCCEEEEEEEEEECCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 89750799995422362678872026-66338899999999999999999899631268999758513799999099982
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKD-RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~IVmEyl~GGSL~~~L~~~~-~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiD 775 (897)
.. ..+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred CC-CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEEC----CCCCEEECC
T ss_conf 38-9289999636999899998745788889999999999998523211337655366656760146----899776324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 59950233443358864688645731113588878923469999999999990-99999999959999999924789999
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLT-GEEPYADLHSEEIIAGIIKGNLGPKI 854 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLt-Gk~PF~~~~~~e~l~~ii~~~~~~~~ 854 (897)
||+++...... ....+++.|+|||.+.+.. ++.++||||||+++|||++ |++||......+....+.. ...+.+
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCC
T ss_pred CCCCEECCCCC--CCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCC
T ss_conf 56003447877--6556664677817872798--885887775799999999789999999999999999980-899999
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 998829999999993003999997899999999999997
Q 002642 855 PSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAA 893 (897)
Q Consensus 855 p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~a 893 (897)
+..+++++.+||.+||..||.+|||+.+++++|+.+.+.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 765799999999997566976893999999999999867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.16 Aligned_cols=261 Identities=30% Similarity=0.533 Sum_probs=222.9
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC--C--CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEEEEEE
Q ss_conf 2348891599995226954999856559--4--079998547865678724789999999999999617-9996326832
Q 002642 618 TIKTSDLEYIKELGSGTFGTVFYGKWKG--S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNVVAFYG 692 (897)
Q Consensus 618 ~i~~~~Yeiik~LG~G~fG~VYla~~kg--~--~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L-~HPNIVkL~d 692 (897)
.+..++|++.+.||+|+||+||++++++ . .||||.++... .....+.+.+|++++.++ +||||+++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCEEEEEE
T ss_conf 66879968877982078828999999899969999999978233-------85799999999999986228998836788
Q ss_pred EEECCCCCEEEEEEEEEECCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCC
Q ss_conf 21048975079999542236267887202---------------666338899999999999999999899631268999
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRK---------------DRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSH 757 (897)
Q Consensus 693 ~~~e~~~~~l~IVmEyl~GGSL~~~L~~~---------------~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPe 757 (897)
++.+. ..+++||||+++|+|.++++.. ...+++..++.++.|++.||.|||+++|+||||||+
T Consensus 79 ~~~~~--~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEET--TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEECC--CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 88418--7369999802898699998640355555123101234578999999999999999987663089545550520
Q ss_pred CEEECCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 7585137999990999825995023344335886468864573111358887892346999999999999099-999999
Q 002642 758 NFLVNMRDPQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGE-EPYADL 836 (897)
Q Consensus 758 NILLd~~d~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk-~PF~~~ 836 (897)
|||++ ..+.+||+|||+++............||..|+|||.+.... ++.++||||||+++|||++|. +||...
T Consensus 157 NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 157 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEEEC----CCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCC--CCCCCEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf 48986----88763874344322444223455301377555538752699--9962215313889999983689999999
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 9599999999247899999988299999999930039999978999999999999972
Q 002642 837 HSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 837 ~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
+..+....+.. ...+..+..+++++.+||.+||+.||++||++++++++|+++.++.
T Consensus 231 ~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 231 TCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 99999999982-6888887667899999999976789668949999999999998618
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.05 Aligned_cols=264 Identities=29% Similarity=0.503 Sum_probs=226.7
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEEC-------CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCE
Q ss_conf 33234889159999522695499985655-------94079998547865678724789999999999999617-99963
Q 002642 616 LQTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQI-HHPNV 687 (897)
Q Consensus 616 ~~~i~~~~Yeiik~LG~G~fG~VYla~~k-------g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L-~HPNI 687 (897)
.|++..++|++.+.||+|+||.||++++. ++.||||+++... .......+.+|+.+++.+ +||||
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCE
T ss_conf 2637789969854982068829999998066447788699999987424-------877999999999998762699988
Q ss_pred EEEEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCE
Q ss_conf 26832210489750799995422362678872026-----------------6633889999999999999999989963
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD-----------------RTIDRRKRIIIAMDAAFGIEYLHEKNIV 750 (897)
Q Consensus 688 VkL~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~-----------------~~lse~~il~Ia~QIl~aL~yLHs~GII 750 (897)
+++++++.+. ..++++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++++
T Consensus 90 v~~~g~~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv 167 (311)
T d1t46a_ 90 VNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (311)
T ss_dssp CCEEEEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEEEEEC--CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 7899898319--97899997379987999998535665444445332223345889999999999999999988757926
Q ss_pred ECCCCCCCEEECCCCCCCCEEEEEECCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 1268999758513799999099982599502334---4335886468864573111358887892346999999999999
Q 002642 751 HFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIKQK---TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELL 827 (897)
Q Consensus 751 HRDIKPeNILLd~~d~~~g~VKLiDFGLAk~~~~---~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELL 827 (897)
||||||+||+++ ..+.+||+|||+++.... ........||+.|+|||.+.+.. ++.++||||||+++|||+
T Consensus 168 HrDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 168 HRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELF 241 (311)
T ss_dssp CSCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCCC----CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCC--CCCCCCCCCHHHHHHHHH
T ss_conf 662410210000----25752102340102336788615862013596876778861799--997400102589999998
Q ss_pred C-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 0-999999999599999999247899999988299999999930039999978999999999999972
Q 002642 828 T-GEEPYADLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 828 t-Gk~PF~~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
+ |.+||......+.+..++.....+..+..++..+.+||.+||+.||.+||+++++++.|++++++-
T Consensus 242 t~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp TTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 58998877899899999998668988985436599999999975779657929999999998765349
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.97 Aligned_cols=255 Identities=25% Similarity=0.501 Sum_probs=212.8
Q ss_pred EEEEEECCCCCEEEEEEEECC---C--CEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 599995226954999856559---4--07999854786567872478999999999999961799963268322104897
Q 002642 625 EYIKELGSGTFGTVFYGKWKG---S--DVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 625 eiik~LG~G~fG~VYla~~kg---~--~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~ 699 (897)
.+.++||+|+||+||+|++.. + .||||.++.. ......+++.+|++++++++||||+++++++.+.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~- 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE- 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-------CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-
T ss_conf 2666981368809999999779987999999998843-------69789999999999998678999867867898069-
Q ss_pred CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 50799995422362678872026663388999999999999999998996312689997585137999990999825995
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLA 779 (897)
...++||||+++++|.+++......+++..++.++.|++.||.|+|+.+|+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGG
T ss_pred CCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEEC----CCCCEEEECCCCH
T ss_conf 943899987406741442101345404899999999988765200336762577668757677----9998899106523
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCCCCC
Q ss_conf 0233443-----3588646886457311135888789234699999999999909999999995-999999992478999
Q 002642 780 KIKQKTL-----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKGNLGPK 853 (897)
Q Consensus 780 k~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~-~e~l~~ii~~~~~~~ 853 (897)
+...... ......||+.|+|||.+.... ++.++||||||+++|||+++..||..... .+....+.. ...+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-g~~~~ 254 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLL 254 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-TCCCC
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCC
T ss_conf 225566555310025655564556768874379--997457466199999999789999888999999999980-89889
Q ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 99988299999999930039999978999999999999972
Q 002642 854 IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAM 894 (897)
Q Consensus 854 ~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~al 894 (897)
.|..+++.+.+||.+||+.||++||++.+++++|+.+.+..
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 96447599999999976889768939999999999999752
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.89 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=205.8
Q ss_pred EEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
Q ss_conf 59999522695499985655--9407999854786567872478999999999999961799963268322104897507
Q 002642 625 EYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPVTNL 702 (897)
Q Consensus 625 eiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~~~l 702 (897)
|.++.||+|+||+||+++++ ++.||||+++...... ..+.....+.+|+.+++.++||||+++++++..+ ..+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCC
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CCE
T ss_conf 95638512728299999999999699999984202124---5679999999999999867999986898542258--740
Q ss_pred EEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCCCCC
Q ss_conf 99995422362678872026663388999999999999999998996312689997585137999990999825995023
Q 002642 703 ATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKIK 782 (897)
Q Consensus 703 ~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~~ 782 (897)
|+||||+.++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++..
T Consensus 76 ~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTT
T ss_pred EEHHHHHCCHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC----CCCCCCCCCCCCCCCC
T ss_conf 22045534507765541-266778999999999999999886316355035776258853----7784114657610005
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--------
Q ss_conf 344-33588646886457311135888789234699999999999909999999995999999992478999--------
Q 002642 783 QKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK-------- 853 (897)
Q Consensus 783 ~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~-------- 853 (897)
... .......||+.|+|||++.+.. .++.++||||+||++|+|++|.+||......+.+..+......+.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCCCCCCCCEECCHHHCCHHHHCCCC-CCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHH
T ss_conf 78755433020473336399972677-88805643630428999985969999999999999999851899725452100
Q ss_pred ------------------CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ------------------999882999999999300399999789999999
Q 002642 854 ------------------IPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ------------------~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
....+++++.+||.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 021344303478988678565689999999999763894569089999679
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.69 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=208.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|+++++||+|+||+||++++. ++.||+|+++..... +....++.+|+.++++++||||+++++++.+.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~- 73 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCC-
T ss_conf 99977651772376809999999999979999998022257------58999999999999867998388744533224-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
..+|+||||+.++.+..........+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||.
T Consensus 74 -~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 74 -NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGL 148 (298)
T ss_dssp -TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTH
T ss_pred -CCEEEEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEEC----CCCCCEECCCCC
T ss_conf -320378862377445554420256888899999999999999986528899213571140113----467621035786
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC----
Q ss_conf 502334-433588646886457311135888789234699999999999909999999995999999992478999----
Q 002642 779 SKIKQK-TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPK---- 853 (897)
Q Consensus 779 Ak~~~~-~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~---- 853 (897)
|+.... ........||+.|+|||++.... +++.++||||+|+++|+|++|+.||...+..+.+..+......+.
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CEECCCCCCCCEEECCCCEEEEHHHHCCCC-CCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHC
T ss_conf 134368864100103652154112213665-7774221033331342796687998988999999999983289833314
Q ss_pred ------------C-----------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ------------9-----------99882999999999300399999789999999
Q 002642 854 ------------I-----------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 854 ------------~-----------p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
. ...++.++.+||.+||..||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44222421243454322220444166789999999999763995579189999678
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.51 Aligned_cols=262 Identities=32% Similarity=0.530 Sum_probs=222.6
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEEC-------CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 333234889159999522695499985655-------9407999854786567872478999999999999961799963
Q 002642 615 ELQTIKTSDLEYIKELGSGTFGTVFYGKWK-------GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNV 687 (897)
Q Consensus 615 ~~~~i~~~~Yeiik~LG~G~fG~VYla~~k-------g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNI 687 (897)
+.|++..++|++.++||+|+||+||+|.++ ++.||||+++... .......+.+|+.++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 10042689918835982078818999998786447789689999987012-------86899999999999997699988
Q ss_pred EEEEEEEECCCCCEEEEEEEEEECCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 26832210489750799995422362678872026---------663388999999999999999998996312689997
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSLKQVLRRKD---------RTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHN 758 (897)
Q Consensus 688 VkL~d~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~---------~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeN 758 (897)
+++++++... ...++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 86 v~~~~~~~~~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp CCEEEEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred EEEEEEEECC--CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCC
T ss_conf 4125478428--81067776048998899987503321134446887999999999999999998764796543286775
Q ss_pred EEECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 585137999990999825995023344---33588646886457311135888789234699999999999909-99999
Q 002642 759 FLVNMRDPQRPVCKIGDLGLSKIKQKT---LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTG-EEPYA 834 (897)
Q Consensus 759 ILLd~~d~~~g~VKLiDFGLAk~~~~~---~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtG-k~PF~ 834 (897)
||++ .++.+||+|||+++..... .......||+.|+|||.+.+.. ++.++||||||+++|||+++ .+||.
T Consensus 164 iLld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 164 CMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EEEC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEEC----CCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf 4035----99649994245420235776303134023163237888873699--88333444378999999968999999
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9995999999992478999999882999999999300399999789999999999999
Q 002642 835 DLHSEEIIAGIIKGNLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAA 892 (897)
Q Consensus 835 ~~~~~e~l~~ii~~~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~ 892 (897)
.....+.+..+..+. .+..+..++..+.++|.+||+.||.+|||++++++.|++..+
T Consensus 238 ~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 238 GLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 989999999998088-888863353999999999757796589399999999787617
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.30 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=206.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC---CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCEEEEEEEE
Q ss_conf 889159999522695499985655---9407999854786567872478999999999999961---7999632683221
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK---GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQ---IHHPNVVAFYGVV 694 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k---g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~---L~HPNIVkL~d~~ 694 (897)
.++|+++++||+|+||+||++++. ++.||||+++........ ...+.+|+.+++. ++||||+++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHH------HHHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 589798889921558699999998889989999998023245167------99999999999987425898802366322
Q ss_pred ECC---CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEE
Q ss_conf 048---97507999954223626788720266633889999999999999999989963126899975851379999909
Q 002642 695 TDG---PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 695 ~e~---~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~V 771 (897)
... ....++++|||++++.+..........+++..+..++.|++.||+|||+++|+||||||+|||++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEC----CCCCE
T ss_conf 14666667469999974058714444430378999899999999999999999758898357986278985----89975
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 99825995023344335886468864573111358887892346999999999999099999999959999999924789
Q 002642 772 KIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG 851 (897)
Q Consensus 772 KLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~ 851 (897)
||+|||+++............||+.|+|||++.+.. ++.++||||+||++|||++|+.||...+..+.+..+......
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCC--CCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 421000101100234577765485114831001798--881110003289999998787998998989999999984079
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -------------------------99999882999999999300399999789999999
Q 002642 852 -------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 -------------------------~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
..++..+++.+.+||.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 961105321111033302234564544044589999999999874896679189999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.43 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=211.1
Q ss_pred CCCCCCCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 33333234889159999522695499985655--9407999854786567872478999999999999961799963268
Q 002642 613 NTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF 690 (897)
Q Consensus 613 ~~~~~~i~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL 690 (897)
+...|++ .++|+++++||+|+||+||+++++ ++.||||+++... ..+...+.+.+|+.+|+.++||||+++
T Consensus 10 ~~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~hpniv~l 82 (346)
T d1cm8a_ 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGL 82 (346)
T ss_dssp SSSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred CCCEEEC-CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH------CCHHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 6733344-771899889801778199999999999899999985222------596999999999999986689875479
Q ss_pred EEEEECCC----CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCC
Q ss_conf 32210489----75079999542236267887202666338899999999999999999899631268999758513799
Q 002642 691 YGVVTDGP----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 691 ~d~~~e~~----~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~ 766 (897)
++++.... ...+++||||+ +.+|..+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---- 155 (346)
T d1cm8a_ 83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---- 155 (346)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----
T ss_pred EEEECCCCCCCCCCEEEEEEECC-CCCHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCC----
T ss_conf 99863576555541599998405-5218999874--0226999999999999999998737876456685111121----
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 99909998259950233443358864688645731113588878923469999999999990999999999599999999
Q 002642 767 QRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii 846 (897)
.++.+||+|||+++...... ....||+.|+|||++.+.. .++.++||||+||++|+|++|+.||...+....+....
T Consensus 156 ~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 156 EDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp TTCCEEECCCTTCEECCSSC--CSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCCCCCCCCEECCCCCC--CCCCCCCCCCCHHHHCCCC-CCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 00122113431022068763--1024553335889981787-89965010300389999997869988897689999998
Q ss_pred HCCCC-----------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 24789-----------------------------99999882999999999300399999789999999
Q 002642 847 KGNLG-----------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 ~~~~~-----------------------------~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
..... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 503788488886530003443311578666556677556899999999999772995579299999639
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=336.31 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=209.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 889159999522695499985655-9407999854786567872478999999999999961799963268322104897
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGPV 699 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k-g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~~ 699 (897)
.++|+++++||+|+||+||+++++ ++.||||+++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 72 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHTK-- 72 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--
T ss_pred CCCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEECCCC--
T ss_conf 99963431872277818999996899999999981232685------8999999999999867998687660120467--
Q ss_pred CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 50799995422362678872026663388999999999999999998996312689997585137999990999825995
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLS 779 (897)
Q Consensus 700 ~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLA 779 (897)
...++++|++.++.+..+.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||.+
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLA 147 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHH
T ss_pred CCEEEEEEEEHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEEC----CCCCEEECCCCCC
T ss_conf 731589974004567899860-47751445689999999999986057488267877505686----8997873236643
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC------
Q ss_conf 023344-3358864688645731113588878923469999999999990999999999599999999247899------
Q 002642 780 KIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP------ 852 (897)
Q Consensus 780 k~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~------ 852 (897)
...... .......+++.|+|||.+.+.. .++.++||||+|+++|+|++|+.||......+.+.++......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred EECCCCCCCCCEECCCCHHHHHHHHHCCC-CCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCC
T ss_conf 01146765410102431101378871788-88841002111758999977979989889899999999863899711042
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ---------------------9999882999999999300399999789999999
Q 002642 853 ---------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ---------------------~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.....+++.+.+||.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1233322143333356764666512589999999999866896689099998569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.13 Aligned_cols=248 Identities=23% Similarity=0.253 Sum_probs=200.7
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--
Q ss_conf 89159999522695499985655--94079998547865678724789999999999999617999632683221048--
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDG-- 697 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~-- 697 (897)
.+|+.+++||+|+||+||+++++ ++.||||+++.... ...+|+.++++++||||+++++++...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------------HHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 776751698217683999999999997999999881606------------89999999986689898738789974476
Q ss_pred --CCCEEEEEEEEEECCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCC-CEEE
Q ss_conf --9750799995422362678872--0266633889999999999999999989963126899975851379999-9099
Q 002642 698 --PVTNLATVTEYMVNGSLKQVLR--RKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQR-PVCK 772 (897)
Q Consensus 698 --~~~~l~IVmEyl~GGSL~~~L~--~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~-g~VK 772 (897)
...++++||||++++.+..+.. .....+++..+..++.|++.||+|||++||+||||||+|||++ .+ ..+|
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~----~~~~~~k 163 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD----PDTAVLK 163 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTTCCEE
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE----CCCCCEE
T ss_conf 577318999984168860788886310368999999999999999999999866876457886037873----5897116
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-
Q ss_conf 9825995023344335886468864573111358887892346999999999999099999999959999999924789-
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLG- 851 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~- 851 (897)
|+|||+++............|++.|+|||.+.+.. .++.++||||+||++|||++|+.||......+.+..+......
T Consensus 164 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp ECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 73366054404776532002555556827764046-88821000246527785502879989879999999999974898
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf --------------------------99999882999999999300399999789999999
Q 002642 852 --------------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 --------------------------~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.......++++.+||.+||..||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1776543062101103554456744443156899999999999765895579299999669
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=333.14 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=202.6
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 4889159999522695499985655--940799985478656787247899999999999996179-9963268322104
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTD 696 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-HPNIVkL~d~~~e 696 (897)
..++|+++++||+|+||+||+++++ ++.||||+++... .+++.+|+.+|+.+. ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 9867189789831748199999988999799999988899-----------99999999999851579987679999981
Q ss_pred CCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 89750799995422362678872026663388999999999999999998996312689997585137999990999825
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 697 ~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDF 776 (897)
.....+++||||+.+++|..+. +.+++..+..++.||+.||.|||++||+||||||+|||++ .+...+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~---~~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTTEEEECCG
T ss_pred CCCCCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC---CCCCEEEECCC
T ss_conf 6877126888631798589974----6899999999999999999887643344345644123774---89983664156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHH--------
Q ss_conf 9950233443358864688645731113588878923469999999999990999999999599-9999992--------
Q 002642 777 GLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEE-IIAGIIK-------- 847 (897)
Q Consensus 777 GLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e-~l~~ii~-------- 847 (897)
|+|+............+|+.|+|||.+.+.. .++.++||||+|+++|+|++|+.||....... ....+..
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHH
T ss_conf 5426646887444322486424761026888-888452323354555876048899988760189999999987884155
Q ss_pred -----CC----------------------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -----47----------------------8999999882999999999300399999789999999
Q 002642 848 -----GN----------------------LGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 -----~~----------------------~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.. ........+++++.+||.+||..||.+|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 555422544474300000333433112115521124489999999999866995689089999649
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.64 Aligned_cols=261 Identities=30% Similarity=0.441 Sum_probs=207.1
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC--C
Q ss_conf 89159999522695499985655940799985478656787247899999999999996179996326832210489--7
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP--V 699 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~--~ 699 (897)
.+|.+.+.||+|+||.||+++++++.||||+++.. ... ......|+..+..++||||+++++++.+.. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCC-------CHH--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 68999889820788199999999989999998720-------046--799999999996279986832688998379860
Q ss_pred CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEECCCCCCCCEE
Q ss_conf 50799995422362678872026663388999999999999999998--------9963126899975851379999909
Q 002642 700 TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHE--------KNIVHFDLKSHNFLVNMRDPQRPVC 771 (897)
Q Consensus 700 ~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs--------~GIIHRDIKPeNILLd~~d~~~g~V 771 (897)
..+++||||+++|+|.+++++. .+++..++.++.|++.||.|+|+ ++|+||||||+|||++ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred EEEEEEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC----CCCCE
T ss_conf 4899999646698989998658--99989999999999999999887665204689866153173135786----88776
Q ss_pred EEEECCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHCCCCCCCCC------
Q ss_conf 998259950233443-----3588646886457311135888----7892346999999999999099999999------
Q 002642 772 KIGDLGLSKIKQKTL-----ISGGVRGTIPWMAPELFKSKDN----LVTEKVDVYSFGVVMWELLTGEEPYADL------ 836 (897)
Q Consensus 772 KLiDFGLAk~~~~~~-----~~~~~~GT~~Y~APEvl~g~~~----~~s~ksDIWSLGiLLyELLtGk~PF~~~------ 836 (897)
||+|||+++...... ......||+.|+|||++.+... .++.++||||||+++|||++|..||...
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 88763866234677762001355250354767822105654546777675012201599999996289988766311241
Q ss_pred ---------CHHHHHHHHHHCCCCCCCCCC-----CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf ---------959999999924789999998-----8299999999930039999978999999999999972999
Q 002642 837 ---------HSEEIIAGIIKGNLGPKIPSW-----CEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897 (897)
Q Consensus 837 ---------~~~e~l~~ii~~~~~~~~p~~-----is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~algv~ 897 (897)
...+...........+.++.. .+..+.+++.+||+.||.+|||+.++++.|+++.++.++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred HHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCC
T ss_conf 012255643099999987502468887765577689999999999976069858959999999999888865998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.36 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=203.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|+++++||+|+||+||+++++ ++.||||++.+. ......+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH-------CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 89859978994064809999999999949999998031-------09589999999999999768989885888995056
Q ss_pred C--CEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 7--50799995422362678872026663388999999999999999998996312689997585137999990999825
Q 002642 699 V--TNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDL 776 (897)
Q Consensus 699 ~--~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDF 776 (897)
. ...+++++++.+++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred CCCCCEEEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf 4554149999962598656644058--999999999999999999999978986777876437887----9997787545
Q ss_pred CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 9950233443----358864688645731113588878923469999999999990999999999599999999247899
Q 002642 777 GLSKIKQKTL----ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP 852 (897)
Q Consensus 777 GLAk~~~~~~----~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~ 852 (897)
|+++...... ......||+.|+|||++.... .++.++||||+|+++|+|++|+.||......+...........+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCC-CCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 70565047776410101102652000387860478-88741010046701337766979978888899999876520699
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -----------------------------9999882999999999300399999789999999
Q 002642 853 -----------------------------KIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 -----------------------------~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.....++.++.+||.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 756642343322220244677557787778378999999999999764895679089998619
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.55 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=203.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179--9963268322104
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH--HPNVVAFYGVVTD 696 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~--HPNIVkL~d~~~e 696 (897)
.++|++.+.||+|+||+||+++++ +..||||++++........ .....++.+|+.+++.++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHH--HHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 883799679840878399999999999799999985688443345--567999999999999743589881279999830
Q ss_pred CCCCEEEEEEEEEEC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 897507999954223-6267887202666338899999999999999999899631268999758513799999099982
Q 002642 697 GPVTNLATVTEYMVN-GSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~IVmEyl~G-GSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiD 775 (897)
. ...++||||+.+ +++.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++ .+.+.+||+|
T Consensus 81 ~--~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~---~~~~~vkl~D 154 (273)
T d1xwsa_ 81 P--DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRGELKLID 154 (273)
T ss_dssp S--SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEECC
T ss_pred C--CEEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE---CCCCEEEECC
T ss_conf 9--96899998336862289998615-8999999999999999999999877975566761114774---4788489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 59950233443358864688645731113588878923469999999999990999999999599999999247899999
Q 002642 776 LGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGPKIP 855 (897)
Q Consensus 776 FGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~~~p 855 (897)
||+|+...... .....||+.|+|||++.+.. +++.++||||+||++|+|++|+.||.... .+..... .++
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~--~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV--FFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--CCS
T ss_pred CCCCEECCCCC-CCCCCCCCCCCCHHHHCCCC-CCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHCCC--CCC
T ss_conf 46535324445-56656587747999984899-78865332554034536756889988736------7761544--778
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 9882999999999300399999789999999
Q 002642 856 SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 856 ~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
..+|+++.+||.+||+.||.+|||+++++++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7799999999999760897589399998539
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=332.02 Aligned_cols=260 Identities=19% Similarity=0.269 Sum_probs=206.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE-EEEEECC
Q ss_conf 889159999522695499985655--9407999854786567872478999999999999961799963268-3221048
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAF-YGVVTDG 697 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL-~d~~~e~ 697 (897)
.++|++++.||+|+||.||++++. ++.||||++...... .++.+|+++++.++|++++.. .+++.+.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----------HHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 88899968985078809999999889989999997210058----------88999999999703899601799999519
Q ss_pred CCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 97507999954223626788720266633889999999999999999989963126899975851379999909998259
Q 002642 698 PVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLG 777 (897)
Q Consensus 698 ~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFG 777 (897)
...++||||+ ++++...+......+++..+..++.|++.||+|||++||+||||||+|||++..+ ....+||+|||
T Consensus 76 --~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG 151 (299)
T d1ckia_ 76 --DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 151 (299)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCS
T ss_pred --CEEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCC-CCCEEEEECCC
T ss_conf --8778999873-8713332443068876899999999999999999979944266787660643357-77615650467
Q ss_pred CCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H
Q ss_conf 950233443--------35886468864573111358887892346999999999999099999999959999999---9
Q 002642 778 LSKIKQKTL--------ISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGI---I 846 (897)
Q Consensus 778 LAk~~~~~~--------~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~i---i 846 (897)
+|+...... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............ .
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCC--CCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 51342554455410001357767873532999991899--8983218861778999984987665530577999999852
Q ss_pred HC---CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 24---789999998829999999993003999997899999999999997299
Q 002642 847 KG---NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNI 896 (897)
Q Consensus 847 ~~---~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~algv 896 (897)
.. ...+.....+|+++.++|.+||+.+|.+||+++++.+.|+++....+.
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCC
T ss_conf 35678983575347889999999998439955791999999999999997699
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.46 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=210.2
Q ss_pred CCCCCCCCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 533333234889159999522695499985655--940799985478656787247899999999999996179996326
Q 002642 612 ANTELQTIKTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVA 689 (897)
Q Consensus 612 ~~~~~~~i~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVk 689 (897)
.+.+.|++ .++|++++.||+|+||+||+++++ ++.||||+++... ......+++.+|+.+++.++||||++
T Consensus 9 ~~~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~h~~iv~ 81 (348)
T d2gfsa1 9 LNKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIG 81 (348)
T ss_dssp CSSSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT------SSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCCC-CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH------CCHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 37755458-987188889831788399999999999799999988200------28689999999999998668987425
Q ss_pred EEEEEECCC---CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCC
Q ss_conf 832210489---75079999542236267887202666338899999999999999999899631268999758513799
Q 002642 690 FYGVVTDGP---VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDP 766 (897)
Q Consensus 690 L~d~~~e~~---~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~ 766 (897)
+++++.... ....+++++++.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---- 155 (348)
T d2gfsa1 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---- 155 (348)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----
T ss_pred EEEEEEECCCCCCCCEEEEEEEECCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----
T ss_conf 9999963464566864999996258862320022--4530999999999999999999738876516677633455----
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 99909998259950233443358864688645731113588878923469999999999990999999999599999999
Q 002642 767 QRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGII 846 (897)
Q Consensus 767 ~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii 846 (897)
.++.+|++|||++....... ....|++.|+|||.+.+.. .++.++||||+|+++|+|++|+.||...+.......+.
T Consensus 156 ~~~~~kl~dfg~a~~~~~~~--~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~ 232 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232 (348)
T ss_dssp TTCCEEECCC----CCTGGG--SSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCCCCCCCCHHCCCCCCC--CCCCCCCCCCCCHHHCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 43220013210001257544--4434543555835533775-67855124320589999976889978898899999999
Q ss_pred HCCCCCC---------------------C--------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 2478999---------------------9--------99882999999999300399999789999999
Q 002642 847 KGNLGPK---------------------I--------PSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 847 ~~~~~~~---------------------~--------p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.....+. . ...++.++.+||.+||..||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 730799757732001024454443035578755566267899999999999775883459389998559
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.58 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=203.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|+++++||+|+||+||+++++ ++.||||++....... ....++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 279889999722748299999998999799999984222463------78999999999999835999660676540246
Q ss_pred ------CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEE
Q ss_conf ------75079999542236267887202666338899999999999999999899631268999758513799999099
Q 002642 699 ------VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 699 ------~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VK 772 (897)
...++++|||+.++.+.... .....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEE
T ss_pred CCCCCCCCEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEEC----CCCCEE
T ss_conf 54444576389998535787410122-2034433089999999999999885229988567672220366----899687
Q ss_pred EEECCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9825995023344-----33588646886457311135888789234699999999999909999999995999999992
Q 002642 773 IGDLGLSKIKQKT-----LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIK 847 (897)
Q Consensus 773 LiDFGLAk~~~~~-----~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~ 847 (897)
|+|||+++..... .......||+.|+|||++.+.. .++.++||||+|+++|+|++|+.||......+....+..
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCC-CCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 6313500223554443211356602497874289970799-989178700678646617448799899899999999998
Q ss_pred CCCCCCCC--C----------------------------CCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 47899999--9----------------------------882999999999300399999789999999
Q 002642 848 GNLGPKIP--S----------------------------WCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 848 ~~~~~~~p--~----------------------------~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
....+... . ..++.+.+||.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 418998255344320344433201334455503340444599899999999873896589099999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=324.47 Aligned_cols=263 Identities=17% Similarity=0.242 Sum_probs=212.7
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 4889159999522695499985655--940799985478656787247899999999999996179-9963268322104
Q 002642 620 KTSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTD 696 (897)
Q Consensus 620 ~~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-HPNIVkL~d~~~e 696 (897)
..++|++++.||+|+||+||++++. ++.||||++...... ..+.+|++.++.+. |++++.+++++.+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----------HHHHHHHHHHHHHCCCCCCCEEEEEEEC
T ss_conf 898069979984178829999999889979999997502582----------9999999999996489998779999601
Q ss_pred CCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CCCCEEEEEE
Q ss_conf 897507999954223626788720266633889999999999999999989963126899975851379-9999099982
Q 002642 697 GPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRD-PQRPVCKIGD 775 (897)
Q Consensus 697 ~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d-~~~g~VKLiD 775 (897)
. ...++||||+ +++|.+++...+..+++..+..++.|++.||+|||++||+||||||+|||++... ...+.+||+|
T Consensus 73 ~--~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 G--LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp T--TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred C--CCCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf 8--8117999964-888799997520311068999999999999999997796626677131523475434479568723
Q ss_pred CCCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH
Q ss_conf 5995023344--------33588646886457311135888789234699999999999909999999995---999999
Q 002642 776 LGLSKIKQKT--------LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS---EEIIAG 844 (897)
Q Consensus 776 FGLAk~~~~~--------~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~---~e~l~~ 844 (897)
||+|+..... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... .+....
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred CCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 6605771467665411102467627751026798964888--88699989831999999869876788530219999999
Q ss_pred HHHC---CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 9924---7899999988299999999930039999978999999999999972999
Q 002642 845 IIKG---NLGPKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKELRAMAAAMNIK 897 (897)
Q Consensus 845 ii~~---~~~~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~Le~l~~algv~ 897 (897)
+... .........+|+++.+++..|+..+|++||+++.+.+.|+++.++.+++
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
T ss_conf 97056799958965799899999999984399300859999999999999975999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.13 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=209.0
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE-----CCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEEE
Q ss_conf 3488915999952269549998565-----59407999854786567872478999999999999961799-96326832
Q 002642 619 IKTSDLEYIKELGSGTFGTVFYGKW-----KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHH-PNVVAFYG 692 (897)
Q Consensus 619 i~~~~Yeiik~LG~G~fG~VYla~~-----kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~H-PNIVkL~d 692 (897)
+..++|++++.||+|+||+||++++ +++.||||.+++...... ....+.+.+|+.++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCC----HHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 451025999898328783999999876588794899999836772101----6899999999999986467983999620
Q ss_pred EEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEE
Q ss_conf 21048975079999542236267887202666338899999999999999999899631268999758513799999099
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VK 772 (897)
++.+. ..++++|||+.+++|.+++.... .+++..+..++.|++.||.|+|+++|+||||||+|||++ .++.+|
T Consensus 97 ~~~~~--~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vk 169 (322)
T d1vzoa_ 97 AFQTE--TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 169 (322)
T ss_dssp EEEET--TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred EECCC--CCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEEC----CCCCEE
T ss_conf 00248--73001231234117999987304-543788888899999999885149989654773201246----999888
Q ss_pred EEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC--
Q ss_conf 982599502334--4335886468864573111358887892346999999999999099999999959999999924--
Q 002642 773 IGDLGLSKIKQK--TLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKG-- 848 (897)
Q Consensus 773 LiDFGLAk~~~~--~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~-- 848 (897)
|+|||+++.... ........|++.|++||.+.+....++.++||||+||+||+|++|+.||......+....+...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 74132022203444432212223333310687605776887132517777999999768999888877779999998335
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 789999998829999999993003999997-----89999999
Q 002642 849 NLGPKIPSWCEPTWRSLMERCWSSDPKSRP-----AFSEITKE 886 (897)
Q Consensus 849 ~~~~~~p~~is~eL~dLI~kcL~~DP~eRP-----SaeELL~~ 886 (897)
...+.++..++.++.+||.+||..||.+|| +++|++++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf 6899886547999999999974458988199974509999749
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.94 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=205.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
..+|+++++||+|+||+||+++++ +..||||+++.... ......++.+|+.+++.++||||+++++++....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 3775998896217585999999999998999999882336------9799999999999998648987648998970256
Q ss_pred ----CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEE
Q ss_conf ----7507999954223626788720266633889999999999999999989963126899975851379999909998
Q 002642 699 ----VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIG 774 (897)
Q Consensus 699 ----~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLi 774 (897)
...+|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+|++
T Consensus 90 ~~~~~~~~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred CCCCCCEEEEEEECCCHHHH-HHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCEEEE
T ss_conf 43457626999841446778-7650---3899999999999999999886522112456776321136----54431320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--
Q ss_conf 259950233443358864688645731113588878923469999999999990999999999599999999247899--
Q 002642 775 DLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSEEIIAGIIKGNLGP-- 852 (897)
Q Consensus 775 DFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~e~l~~ii~~~~~~-- 852 (897)
|||+++............+|+.|+|||++.+.. ++.++||||+||++|+|++|+.||...+.......++.....+
T Consensus 162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~--~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCCC---------------CCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 102321146665533221465555813314777--787743335662578986598998889778899999972058987
Q ss_pred ------------------CC--------------C------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ------------------99--------------9------9882999999999300399999789999999
Q 002642 853 ------------------KI--------------P------SWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 853 ------------------~~--------------p------~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
.. + ...+.++.+||.+||..||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=318.18 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=204.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 889159999522695499985655--940799985478656787247899999999999996179996326832210489
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIHHPNVVAFYGVVTDGP 698 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d~~~e~~ 698 (897)
.++|+++++||+|+||+||++++. ++.||||+++..... .....++.+|+.+++.++||||+++++++...
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~- 73 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSD- 73 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCC-
T ss_conf 99978626971286819999999999969999998032178------68999999999999856757888213544444-
Q ss_pred CCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 75079999542236267887202666338899999999999999999899631268999758513799999099982599
Q 002642 699 VTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGL 778 (897)
Q Consensus 699 ~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGL 778 (897)
...++++|++.+++|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++ ..+.+||+|||.
T Consensus 74 -~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~ 147 (292)
T d1unla_ 74 -KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGL 147 (292)
T ss_dssp -SEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred -CCEEEEEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCC----CCCCEEEEECCH
T ss_conf -3115886302332221121235-6540367899999999998774339986001467612113----378266520460
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCCC-----
Q ss_conf 5023344-33588646886457311135888789234699999999999909999999995-9999999924789-----
Q 002642 779 SKIKQKT-LISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHS-EEIIAGIIKGNLG----- 851 (897)
Q Consensus 779 Ak~~~~~-~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~-~e~l~~ii~~~~~----- 851 (897)
++..... .......+++.|.|||.+.... .++.++||||+||++|+|++|+.||..... .+....+......
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred HHCCCCCCCCCEEECCCCCHHHHHHHCCCC-CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 110468875100103443101466750698-8880444026541889985189999889999999999986118997355
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ----------------------99999882999999999300399999789999999
Q 002642 852 ----------------------PKIPSWCEPTWRSLMERCWSSDPKSRPAFSEITKE 886 (897)
Q Consensus 852 ----------------------~~~p~~is~eL~dLI~kcL~~DP~eRPSaeELL~~ 886 (897)
......+++.+.+||.+||+.||.+|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 134432221133444544310433065689999999999864996689099999649
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-40 Score=282.74 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=187.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------CCCE
Q ss_conf 88915999952269549998565--5940799985478656787247899999999999996179-----------9963
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKW--KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-----------HPNV 687 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~--kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-----------HPNI 687 (897)
..+|+++++||+|+||+||++++ +++.||||++++.. ...+.+.+|+.+++.+. |+||
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---------CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCE
T ss_conf 785799899750778189999999999799999983431---------33689999999999840145555542276764
Q ss_pred EEEEEEEECCCCCEEEEEEEEEECCCH-HHHH-HHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCC
Q ss_conf 268322104897507999954223626-7887-2026663388999999999999999998-996312689997585137
Q 002642 688 VAFYGVVTDGPVTNLATVTEYMVNGSL-KQVL-RRKDRTIDRRKRIIIAMDAAFGIEYLHE-KNIVHFDLKSHNFLVNMR 764 (897)
Q Consensus 688 VkL~d~~~e~~~~~l~IVmEyl~GGSL-~~~L-~~~~~~lse~~il~Ia~QIl~aL~yLHs-~GIIHRDIKPeNILLd~~ 764 (897)
+++++++........++++++...+.. .... ......+++..+..++.|++.||.|||+ +||+||||||+|||++..
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECC
T ss_conf 78998763125652023432000354200000122346786899999999999998887640586465677057056305
Q ss_pred C--CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH---
Q ss_conf 9--99990999825995023344335886468864573111358887892346999999999999099999999959---
Q 002642 765 D--PQRPVCKIGDLGLSKIKQKTLISGGVRGTIPWMAPELFKSKDNLVTEKVDVYSFGVVMWELLTGEEPYADLHSE--- 839 (897)
Q Consensus 765 d--~~~g~VKLiDFGLAk~~~~~~~~~~~~GT~~Y~APEvl~g~~~~~s~ksDIWSLGiLLyELLtGk~PF~~~~~~--- 839 (897)
+ .....++++|||.+....... ....||+.|+|||++.... ++.++||||+|+++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~--~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCCCCCEEEEEECCCCCCCCCCC--CCCCCCCCCCCHHHCCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 765644305675314421234454--2236652105713214667--776432012378999998788998987554321
Q ss_pred ---HHHHHHHHC--C-----------------------C---------------CCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf ---999999924--7-----------------------8---------------99999988299999999930039999
Q 002642 840 ---EIIAGIIKG--N-----------------------L---------------GPKIPSWCEPTWRSLMERCWSSDPKS 876 (897)
Q Consensus 840 ---e~l~~ii~~--~-----------------------~---------------~~~~p~~is~eL~dLI~kcL~~DP~e 876 (897)
+........ . . ....+...+..+.+||.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred CHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 02689999999837998788624532200013201220243235776444210001567435899999999987799457
Q ss_pred CCCHHHHHHH
Q ss_conf 9789999999
Q 002642 877 RPAFSEITKE 886 (897)
Q Consensus 877 RPSaeELL~~ 886 (897)
|||++|++++
T Consensus 319 Rpta~e~L~H 328 (362)
T d1q8ya_ 319 RADAGGLVNH 328 (362)
T ss_dssp CBCHHHHHTC
T ss_pred CCCHHHHHCC
T ss_conf 9089999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3e-22 Score=163.06 Aligned_cols=171 Identities=18% Similarity=0.025 Sum_probs=119.6
Q ss_pred CEEEEEECCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCC----------HHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 15999952269549998565-5940799985478656787----------247899999999999996179996326832
Q 002642 624 LEYIKELGSGTFGTVFYGKW-KGSDVAIKRIKPSCFAEGS----------LEEDRLIADFWREAHMLGQIHHPNVVAFYG 692 (897)
Q Consensus 624 Yeiik~LG~G~fG~VYla~~-kg~~VAIK~ik~~~~~~~~----------~~~~~~~~~i~rEi~iLk~L~HPNIVkL~d 692 (897)
+.+.++||+|+||+||++++ +++.||||+++........ ...........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCCEEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCEEE
Q ss_conf 21048975079999542236267887202666338899999999999999999899631268999758513799999099
Q 002642 693 VVTDGPVTNLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLHEKNIVHFDLKSHNFLVNMRDPQRPVCK 772 (897)
Q Consensus 693 ~~~e~~~~~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLHs~GIIHRDIKPeNILLd~~d~~~g~VK 772 (897)
... .+++|||+++..+.+ ++......++.|++.+|.|||++||+||||||+|||++ + ..++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEE
T ss_pred ECC------CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEE----C-CCEE
T ss_conf 628------889999504565420--------01578999999999999998268889836890361142----8-9899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9825995023344335886468864573------11135888789234699999999
Q 002642 773 IGDLGLSKIKQKTLISGGVRGTIPWMAP------ELFKSKDNLVTEKVDVYSFGVVM 823 (897)
Q Consensus 773 LiDFGLAk~~~~~~~~~~~~GT~~Y~AP------Evl~g~~~~~s~ksDIWSLGiLL 823 (897)
|+|||+|......... .|... +.+. ..|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-------EILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred EEECCCCCCCCCCCCH-------HHHHHHHHHHHHHHC---CCCCCCCCHHHHHHHH
T ss_conf 9877884308998709-------999877999999975---7899844689999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.83 E-value=3e-22 Score=163.11 Aligned_cols=134 Identities=12% Similarity=0.042 Sum_probs=107.8
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|++++|||+|++.|+|...+..+++.|||++|++...+. ...+.++|...+.+.+|.+.||+|||. ..|||||
T Consensus 79 ~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~-~~~~~l~~~~~~~i~~qia~gl~yLH~----~~iiHrD 153 (299)
T d1jpaa_ 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLAD----MNYVHRD 153 (299)
T ss_dssp HHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH-TTTTCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEEECCCCCCEEEEC-CCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCC
T ss_conf 99985799888618999962887799997227985300210-456799999999999999998898852----7983576
Q ss_pred CCCCCCCCCCCCCEEECC--CCCC--CCCCCCCCCCCCEEECCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778--888775454652120465-------55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNN--MNYRNGTASGCNMKNGTK-------NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~--~~~~~~tt~gt~~v~GT~-------~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||+++.+||+| +|+. ......+..++....||. ...+.++.++| |||||+.-
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD-vwS~Gvvl 223 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD-VWSYGIVM 223 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCC-CCCCHHHH
T ss_conf 15044898899919988844315756777765365025666883003878883699786121-44535789
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.82 E-value=7.9e-22 Score=160.30 Aligned_cols=135 Identities=10% Similarity=0.054 Sum_probs=111.3
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.|+|...+..+++.||+++|++...+.+.....+++...+.+..|.+.||+|||.. .|||||
T Consensus 65 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrD 140 (287)
T d1opja_ 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRD 140 (287)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred HHHHHCCCCCEECCCCCEEECCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 9998679998826775274578547876314676067775303554157999999999999978889878----930576
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCC-CCCC-CC--CCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677888-8775-45--4652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN-YRNG-TA--SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~-~~~~-tt--~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||+++.+||+| +|+... .... .+ .|+....+++ ...+.++.|+| |||||+.-
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~D-iwS~Gv~l 206 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD-VWAFGVLL 206 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCCEEECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHH-HHHHHHHH
T ss_conf 0457689989992898324454653788722103556654666927872799981043-02178999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.5e-21 Score=156.94 Aligned_cols=134 Identities=10% Similarity=0.020 Sum_probs=108.8
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|++++|||+|++.|+|...+..+++.|++..+++.....+. ...++|...+.+..|.++||+|||- +.|||||
T Consensus 61 ~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~----~~iiHrD 135 (283)
T d1mqba_ 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN----MNYVHRD 135 (283)
T ss_dssp HHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSC
T ss_pred HHHHHCCCCCEEEEEEEEECCCCEEEEEEECCCCCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCC----CCCCCCC
T ss_conf 9998568987832367783388038999721357402221023-4542089999999999985412121----2342576
Q ss_pred CCCCCCCCCCCCCEEECC--CCCC--CCCC--CCC--CCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778--8887--754--54652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNN--MNYR--NGT--ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~--~~~~--~~t--t~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||+++.+||+| +|+. .... ... ..||..+.+++ ...+..+.|+| |||||+.-
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sD-I~S~Gvil 203 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD-VWSFGIVM 203 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCEEEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCC-CCCCHHHH
T ss_conf 564427888998499845510300357876526742677773434888870499997355-63448989
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.8e-21 Score=157.89 Aligned_cols=135 Identities=8% Similarity=0.008 Sum_probs=108.5
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 00023356653100012224699603585203699502443123566543100245787776554210289987883105
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-..+.+++|||+|++.|+|...+..+++.||+++|++...+.+. ...++|...+.+.+|.+.||+|||. ..||||
T Consensus 51 ~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~----~~iiHr 125 (263)
T d1sm2a_ 51 AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE----ACVIHR 125 (263)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH----TTCCCT
T ss_pred HHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHC----CCEEEC
T ss_conf 99999668997565352431599337999836999189975201-3478899999999999998776531----643104
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCCC--CCCC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--677888--8775--454652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNMN--YRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~~--~~~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||||+++++||+| +|+... .... ...|+....+++ ...+.++.|+| |||||+.-
T Consensus 126 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~D-VwS~Gvil 192 (263)
T d1sm2a_ 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD-VWSFGVLM 192 (263)
T ss_dssp TCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHH-HHHHHHHH
T ss_pred CCCHHHEEECCCCCEEECCCCHHEECCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHH-HCCHHHHH
T ss_conf 43153266668877686553210023688733504300176667857860799984033-21059999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.9e-21 Score=157.79 Aligned_cols=134 Identities=15% Similarity=0.080 Sum_probs=107.7
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|++++|||+|+++|+|.. +..+++.||+++|++...+.......++|..++.+.+|.+.||.|||. ..|||||
T Consensus 60 ~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~----~~ivHrD 134 (272)
T d1qpca_ 60 NLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE----RNYIHRD 134 (272)
T ss_dssp HHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH----TTEECSC
T ss_pred HHHHHCCCCCEEEEEEEECC-CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCC
T ss_conf 99986799988578731045-976999995789828888751478988788999999999999999974----8954675
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC--CCCCC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788--88775--454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--NYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~--~~~~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||+++.+||+| +|+.. ..... ...|+....+++ ...+..+.|+| |||||+.-
T Consensus 135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sD-vwS~Gvvl 200 (272)
T d1qpca_ 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD-VWSFGILL 200 (272)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHH-HHHHHHHH
T ss_pred CCHHHEEEECCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHH-HHHHHHHH
T ss_conf 6422515620244042341014773588644203567744445828983799982456-45257999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.5e-21 Score=155.29 Aligned_cols=134 Identities=13% Similarity=0.098 Sum_probs=105.4
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 00023356653100012224699603585203699502443123566543100245787776554210289987883105
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-..|.+++|||+|++.|+|.+ +..+++.|||++|++...+... .+.+++...+.+.+|.+.||+|||. ..||||
T Consensus 55 ~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~----~~ivHr 128 (276)
T d1uwha_ 55 VGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA----KSIIHR 128 (276)
T ss_dssp HHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCS
T ss_pred HHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHC----CCEECC
T ss_conf 999984799878645679715-5899999658998889998523-5789999999999999999888750----999516
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCC---CCCCC--CCCCCCEEECCCC----CCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--67788---88775--4546521204655----5587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNM---NYRNG--TASGCNMKNGTKN----LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~---~~~~~--tt~gt~~v~GT~~----~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||||++..+||+| +|+.. ..... +..||..+.+++. ..+.++.|+| ||||||.-
T Consensus 129 DlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sD-iwS~Gv~l 199 (276)
T d1uwha_ 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD-VYAFGIVL 199 (276)
T ss_dssp CCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHH-HHHHHHHH
T ss_pred CCCHHHEEECCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHH-HHHHHHHH
T ss_conf 147899798189978875002213335567763125665574317999995056899995315-16359999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.5e-20 Score=148.64 Aligned_cols=133 Identities=8% Similarity=0.050 Sum_probs=104.3
Q ss_pred HCCCCCCCCCCCEECCCCCCCC-CCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 0023356653100012224699-603585203699502443123566543100245787776554210289987883105
Q 002642 410 YGLSNLVESHLACHSTCNVAGD-QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-.|++++|||+++++|+|.+.+ ..+++.|||+.+++...... .....++..++.+.+|.+.||+|+|.. .||||
T Consensus 80 ~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHr 154 (311)
T d1r0pa_ 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHR 154 (311)
T ss_dssp HHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred HHHHHCCCCCEEEEEEEEEECCCCEEEEEEEEECCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCC----CCCCC
T ss_conf 9998678999867867898069943899987406741442101-345404899999999988765200336----76257
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--67788--88775454652120465-------55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNM--NYRNGTASGCNMKNGTK-------NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-------~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||||+++.+||+| +++.. ....... ......||. ...+..+.|+| |||||+.-
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksD-I~SfGivl 224 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSD-VWSFGVLL 224 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT-CTTCSSCCGGGSCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCCE-ECCCCCCCCCCCCHHHHHCCCCCCHHH-HHHHHHHH
T ss_conf 76687576779998899106523225566555310-025655564556768874379997457-46619999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.5e-20 Score=150.34 Aligned_cols=135 Identities=11% Similarity=0.053 Sum_probs=107.6
Q ss_pred HCCCCC-CCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCC---------------------CCCCCCCHHHHHHH
Q ss_conf 002335-66531000122246996035852036995024431235---------------------66543100245787
Q 002642 410 YGLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK---------------------DDMLTGSKLERHEV 467 (897)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~ 467 (897)
..|.++ +|||+|++.|+|...+..+++.|||++|++...+.+.. .+.+++...+.+..
T Consensus 92 ~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 171 (325)
T d1rjba_ 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171 (325)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHH
T ss_pred HHHHHHCCCCCEEEEEEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 99997158996868778886299589999727999599999862577751022100001222001257789999999999
Q ss_pred HHHHHHHHCCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCCCC--CCCC-C--CCCCCCEEECCC-CCCCCCCCCC
Q ss_conf 7765542102899878831058999972248999825713--67788--8877-5--454652120465-5558743321
Q 002642 468 QCQALYENFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNM--NYRN-G--TASGCNMKNGTK-NLQGGVASSM 539 (897)
Q Consensus 468 ~~~~~~~~~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~--~~~~-~--tt~gt~~v~GT~-~~~g~~t~ks 539 (897)
|.+.||+|||- ..||||||||+|||+|.+..+||+| +|+.. .... . +..||....+++ ...+..+.++
T Consensus 172 qi~~gl~yLH~----~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~ 247 (325)
T d1rjba_ 172 QVAKGMEFLEF----KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247 (325)
T ss_dssp HHHHHHHHHHH----TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHH----CCEEECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCE
T ss_conf 99999999973----99050527032144345982898514222204577861562343578765783887279999633
Q ss_pred CCCCCCCCCC
Q ss_conf 1101135799
Q 002642 540 DLLYNLSLSS 549 (897)
Q Consensus 540 D~Vy~~~~s~ 549 (897)
| ||||||.-
T Consensus 248 D-iwS~Gvil 256 (325)
T d1rjba_ 248 D-VWSYGILL 256 (325)
T ss_dssp H-HHHHHHHH
T ss_pred E-CCCHHHHH
T ss_conf 0-30003999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.2e-20 Score=152.43 Aligned_cols=134 Identities=12% Similarity=0.112 Sum_probs=108.3
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.+.+++|||+|++.|+|. .++.+++.||+..|++...+.+.....++|..++++.+|-+.||+|||.. .|+|||
T Consensus 64 ~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~D 138 (285)
T d1fmka3 64 QVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRD 138 (285)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred HHHHHCCCCCEEEEEEEEE-CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH----HEECCC
T ss_conf 9998666678868999982-39759999944799435420000355305999999999999999987541----143353
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC--CCCCC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788--88775--454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--NYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~--~~~~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||+++.+||+| +|+.. ..... ...|+..+.+++ ...+.++.|+| |||||+.-
T Consensus 139 lKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD-I~S~Giil 204 (285)
T d1fmka3 139 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD-VWSFGILL 204 (285)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred CCCEEEEECCCCCEEECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHH-HHCCHHHH
T ss_conf 1230799989992998442555425688733524545566545808983799891774-13235899
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.5e-20 Score=151.73 Aligned_cols=133 Identities=11% Similarity=0.042 Sum_probs=104.3
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|++++|||+|+++|+|. .+..+++.||+++|++...+... ...+++...+.+..|.+.||+|||. ..|||||
T Consensus 61 ~il~~l~HpnIv~l~g~~~-~~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~----~~iiHrD 134 (285)
T d1u59a_ 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE----KNFVHRD 134 (285)
T ss_dssp HHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH----TTEECCC
T ss_pred HHHHHCCCCCEEEEEEEEC-CCEEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHH----CCEECCC
T ss_conf 9998679988806865603-68079999807899689975212-5699999999999999998789986----8810576
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCC--CC--CC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677888--87--75--454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN--YR--NG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~--~~--~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++..+||+| +|+... .. .. ...|+....+++ ...+..+.|+| |||||+.-
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD-VwS~Gv~l 202 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD-VWSYGVTM 202 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCH-HHCCHHHH
T ss_conf 764660454688542033134211554343211356211374335868872799995412-32201789
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.1e-20 Score=150.78 Aligned_cols=132 Identities=10% Similarity=0.031 Sum_probs=103.9
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.|+| +.+..+++.||+++|++...+.+ ...+++...+.+.+|.+.||+|||. ..|||||
T Consensus 60 ~il~~l~HpnIv~~~g~~-~~~~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~----~~iiHrD 132 (277)
T d1xbba_ 60 NVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE----SNFVHRD 132 (277)
T ss_dssp HHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH----TTEECSC
T ss_pred HHHHHCCCCCCCEEEEEE-CCCCEEEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCC
T ss_conf 999867998985277775-05977999974788968999752--2578999999999999999766874----7955677
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC--CCCCCC----CCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788--887754----54652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--NYRNGT----ASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~--~~~~~t----t~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++..+|++| +|+.. ...... ..|+....+++ ...+..+.|+| |||||+.-
T Consensus 133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD-iwS~Gv~l 200 (277)
T d1xbba_ 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD-VWSFGVLM 200 (277)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHH-HHHHHHHH
T ss_pred CCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHH-HCCCHHHH
T ss_conf 761131023567512341345331343234432244567784203916653799984344-30340313
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=7e-20 Score=147.33 Aligned_cols=137 Identities=13% Similarity=0.127 Sum_probs=104.3
Q ss_pred HHCCCCCCCCCCCEECCCCCCCC----CCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC---
Q ss_conf 00023356653100012224699----60358520369950244312356654310024578777655421028998---
Q 002642 409 QYGLSNLVESHLACHSTCNVAGD----QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPI--- 481 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~--- 481 (897)
-..+++++|||+|.+.|+|...+ +.+++.||++.+++...+-+. .++|..++.+..|.|.||+|+|....
T Consensus 48 i~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~ 124 (303)
T d1vjya_ 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 999962799868326889983798604899999646698989998658---99989999999999999999887665204
Q ss_pred -CCCCEECCCCCCCCCCCCCCCEEECC--CCC---CCCCC-CC---CCCCCCEEECCCCC-------CCCCCCCCCCCCC
Q ss_conf -78831058999972248999825713--677---88887-75---45465212046555-------5874332111011
Q 002642 482 -TCKPIHPELENEKLLIDSEESANISG--LSN---NMNYR-NG---TASGCNMKNGTKNL-------QGGVASSMDLLYN 544 (897)
Q Consensus 482 -~~~iIHrDiK~sNILLD~~~~aKisD--Lar---~~~~~-~~---tt~gt~~v~GT~~~-------~g~~t~ksD~Vy~ 544 (897)
...||||||||+|||||+++.+||+| +++ ..... .. ...||..+.+++.. .+.++.|+| |||
T Consensus 125 ~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~D-i~S 203 (303)
T d1vjya_ 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD-IYA 203 (303)
T ss_dssp CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHH-HHH
T ss_pred CCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHH-HHH
T ss_conf 6898661531731357868877688763866234677762001355250354767822105654546777675012-201
Q ss_pred CCCCC
Q ss_conf 35799
Q 002642 545 LSLSS 549 (897)
Q Consensus 545 ~~~s~ 549 (897)
||+.-
T Consensus 204 ~Gvvl 208 (303)
T d1vjya_ 204 MGLVF 208 (303)
T ss_dssp HHHHH
T ss_pred HHHHH
T ss_conf 59999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=7.6e-20 Score=147.09 Aligned_cols=134 Identities=11% Similarity=0.092 Sum_probs=105.2
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 00023356653100012224699603585203699502443123566543100245787776554210289987883105
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-..|++++|||+|+++|+|... ..+++.+++..+++....... ...+++...+.+..|.+.||+|||. ..||||
T Consensus 62 ~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~----~~iiHr 135 (317)
T d1xkka_ 62 AYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED----RRLVHR 135 (317)
T ss_dssp HHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH----TTCCCS
T ss_pred HHHHHHCCCCCEEEEEEEEECC-CEEEEEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCC
T ss_conf 9999867998881589999619-836999842687401011133-4579999999999999999999987----695047
Q ss_pred CCCCCCCCCCCCCCEEECC--CCC--CCCCCCC-CC--CCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--677--8888775-45--4652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSN--NMNYRNG-TA--SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar--~~~~~~~-tt--~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||||++..+||+| +|+ ....... +. .||....+++ ...+.++.|+| |||||+.-
T Consensus 136 DlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD-vwS~Gvil 203 (317)
T d1xkka_ 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD-VWSYGVTV 203 (317)
T ss_dssp CCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred CCHHHCCEECCCCCEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHH-HHHHHHHH
T ss_conf 621203116799875860255222335444532236510586446708874699983565-44079999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=5e-20 Score=148.29 Aligned_cols=135 Identities=13% Similarity=0.163 Sum_probs=109.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCC-CCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 0023356653100012224699-603585203699502443123566543100245787776554210289987883105
Q 002642 410 YGLSNLVESHLACHSTCNVAGD-QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
..|++++|||+|++.|+|.+.+ ..+++.||++.|++...+.+.....++|...+.+.+|-+.||.|||. ..||||
T Consensus 52 ~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~----~~ivH~ 127 (262)
T d1byga_ 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG----NNFVHR 127 (262)
T ss_dssp HHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH----TTCCCS
T ss_pred HHHHHCCCCCEEEEEEEEEECCCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCC----CCEECC
T ss_conf 9998678989854987887238928999963699989999874578888999999999999852321133----765536
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--6778888775454652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||+|.+..+|++| +++.......+..++....+++ ...+.+|.++| |||||+.-
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sD-IwSfG~il 190 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD-VWSFGILL 190 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred CCCHHHHEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCHHHHHCCCCCHHHH-HHHHHHHH
T ss_conf 6656760146899776324560034478776556664677817872798885887-77579999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.73 E-value=1e-19 Score=146.17 Aligned_cols=136 Identities=10% Similarity=0.020 Sum_probs=105.9
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECC----------------------CCCCCCCCHHHHHH
Q ss_conf 00023356653100012224699603585203699502443123----------------------56654310024578
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT----------------------KDDMLTGSKLERHE 466 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~ 466 (897)
-..|++++|||++.+.|+|...+..+++.+++.++++...+... ....+++...+++.
T Consensus 67 ~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 146 (301)
T d1lufa_ 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146 (301)
T ss_dssp HHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCEEEECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 99999668997655246660598038999815899299999852755421000011100121034678898999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCC--C-CCCCCCC--CCCCCEEECCC-CCCCCCCCC
Q ss_conf 77765542102899878831058999972248999825713--677--8-8887754--54652120465-555874332
Q 002642 467 VQCQALYENFHGMPITCKPIHPELENEKLLIDSEESANISG--LSN--N-MNYRNGT--ASGCNMKNGTK-NLQGGVASS 538 (897)
Q Consensus 467 ~~~~~~~~~~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar--~-~~~~~~t--t~gt~~v~GT~-~~~g~~t~k 538 (897)
+|.++||+|||- ..||||||||+|||||.++.+||+| +|+ . ....... ..|+.....++ .....+|.|
T Consensus 147 ~qi~~gl~ylH~----~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k 222 (301)
T d1lufa_ 147 RQVAAGMAYLSE----RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222 (301)
T ss_dssp HHHHHHHHHHHH----TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHCCC----CCEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHH
T ss_conf 999998554135----7868548840116898999289833144211367764111577776767679899726889805
Q ss_pred CCCCCCCCCCC
Q ss_conf 11101135799
Q 002642 539 MDLLYNLSLSS 549 (897)
Q Consensus 539 sD~Vy~~~~s~ 549 (897)
+| |||||+.-
T Consensus 223 sD-VwS~Gvvl 232 (301)
T d1lufa_ 223 SD-VWAYGVVL 232 (301)
T ss_dssp HH-HHHHHHHH
T ss_pred HH-HCCCHHHH
T ss_conf 63-02523629
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=5.8e-19 Score=141.21 Aligned_cols=135 Identities=13% Similarity=0.066 Sum_probs=106.4
Q ss_pred HCCCCCCCCCCCEECCCCCC----CCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 00233566531000122246----99603585203699502443123566543100245787776554210289987883
Q 002642 410 YGLSNLVESHLACHSTCNVA----GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKP 485 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~i 485 (897)
-.|.+++|||+|++.+++.. ....+++.||++++++...+.+ ...+++.....+.+|.+.||+|||... ++|
T Consensus 60 ~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~--~~I 135 (270)
T d1t4ha_ 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT--PPI 135 (270)
T ss_dssp HHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS--SCC
T ss_pred HHHHHCCCCCEEEEEEEEEECCCCCCEEEEEEECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCE
T ss_conf 9998579998506999984033458889999957898948999751--355469999999999999999999789--979
Q ss_pred EECCCCCCCCCCC-CCCCEEECC--CCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 1058999972248-999825713--67788-8877545465212046555587433211101135799
Q 002642 486 IHPELENEKLLID-SEESANISG--LSNNM-NYRNGTASGCNMKNGTKNLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 486 IHrDiK~sNILLD-~~~~aKisD--Lar~~-~~~~~tt~gt~~v~GT~~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||||||+||||+ ++..+||+| +|+.. .....+..||..+.+++...+.++.++| |||||+.-
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~D-IwSlGvil 202 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVD-VYAFGMCM 202 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHH-HHHHHHHH
T ss_pred EECCCCHHHCEEECCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCC-HHHHHHHH
T ss_conf 96876743511667999889800576542368766775538130089884789998671-10079999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=4.4e-19 Score=142.04 Aligned_cols=135 Identities=11% Similarity=0.081 Sum_probs=107.2
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 00023356653100012224699603585203699502443123566543100245787776554210289987883105
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-..+++++|||+|++.|+|...+..+++.||++.|++....... ...+.+..+.++.+|.+.||+|||. ..||||
T Consensus 50 v~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~----~~iiH~ 124 (258)
T d1k2pa_ 50 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES----KQFLHR 124 (258)
T ss_dssp HHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH----TTBCCS
T ss_pred HHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCC
T ss_conf 99999668986015889985078169999704899388864102-4677689999999999999998754----684346
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCC--CCCCCCC--CCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--67788--8877545--4652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNM--NYRNGTA--SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~--~~~~~tt--~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||+|++..+||+| +|+.. ......+ .++.....++ ...+..+.|+| |||||+.-
T Consensus 125 dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksD-iwS~G~~l 191 (258)
T d1k2pa_ 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD-IWAFGVLM 191 (258)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred CCCCEEEEECCCCCEEECCCHHHEECCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEE-ECCCCHHH
T ss_conf 65413588769984798861442023578722524657887757807863799885210-33643246
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.72 E-value=3e-19 Score=143.14 Aligned_cols=132 Identities=11% Similarity=0.106 Sum_probs=107.6
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.|||.++++.... .....+++.....+..|.+.||+|||.. .|||||
T Consensus 67 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~--~~~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrD 140 (309)
T d1u5ra_ 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRD 140 (309)
T ss_dssp HHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCC
T ss_pred HHHHHCCCCCEEEEEEEEEECCEEEEEEEECCCCCHHHHH--HHCCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCC
T ss_conf 9999778999823899999899889999806999457899--7379999999999999999999999868----976667
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCCC----CCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788887754546521204655----5587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTKN----LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~~----~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++...||+| +|+..... .+..||..+++++. ..+.++.++| ||||||.-
T Consensus 141 iKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~D-iwSlGvil 204 (309)
T d1u5ra_ 141 VKAGNILLSEPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVD-VWSLGITC 204 (309)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCCEEEEECCCCCCCCCC-CCCCCCCCCCCHHHHHCCCCCCCCCHHH-HHHHHHHH
T ss_conf 8842179879997898443653346778-7313476636889983467888672145-45589999
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=9.7e-20 Score=146.40 Aligned_cols=134 Identities=9% Similarity=0.086 Sum_probs=109.0
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...++.+++.||++++++...+.+ .+.+++.....+..|-+.||.|||. .+.|||||
T Consensus 56 ~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRD 130 (322)
T d1s9ja_ 56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRD 130 (322)
T ss_dssp GGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH---HCCEECCC
T ss_conf 999867999999499999989999999976799868998742--4999999999999999999999998---59997144
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC-CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788-88775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~-~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+||||+++...||+| +|+.. .....+..||..+++++ .....++.++| |||+|+.-
T Consensus 131 iKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~D-iWSlGvil 193 (322)
T d1s9ja_ 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD-IWSMGLSL 193 (322)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCHHH-HHHHHHHH
T ss_conf 5779946878998999548776256788621113771411946875899894888-99899999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.1e-19 Score=144.21 Aligned_cols=135 Identities=10% Similarity=0.037 Sum_probs=108.2
Q ss_pred HCCCCC-CCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECC--------------CCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 002335-6653100012224699603585203699502443123--------------5665431002457877765542
Q 002642 410 YGLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNT--------------KDDMLTGSKLERHEVQCQALYE 474 (897)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~ 474 (897)
-.|+++ +|||+|++.|+|...+..+++.||+++|++...+.+. ....++|...++..+|.++|+.
T Consensus 62 ~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 141 (309)
T d1fvra_ 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141 (309)
T ss_dssp HHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCEEEEEEEEECCCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 99986228998836788884187369999802898699998640355555123101234578999999999999999987
Q ss_pred HCCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCCCCCCCCC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 102899878831058999972248999825713--6778888775--454652120465-55587433211101135799
Q 002642 475 NFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNMNYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 475 ~~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~~~~~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|+|-. .||||||||+|||+|.+..+||+| +|+....... ...|+..+..++ ...+.++.++| |||||+.-
T Consensus 142 ~lH~~----~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD-vwSfGvil 216 (309)
T d1fvra_ 142 YLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD-VWSYGVLL 216 (309)
T ss_dssp HHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHH-HHHHHHHH
T ss_pred HHHCC----CCCCCCCCCCEEEECCCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCE-EEHHHHHH
T ss_conf 66308----95455505204898688763874344322444223455301377555538752699996221-53138899
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.2e-19 Score=142.18 Aligned_cols=135 Identities=7% Similarity=0.001 Sum_probs=104.6
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCC--------CCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 00233566531000122246996035852036995024431235--------6654310024578777655421028998
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK--------DDMLTGSKLERHEVQCQALYENFHGMPI 481 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~h~~~~ 481 (897)
-.+.++.|||+|.+.|+|...+..+++.|++++|++...+.... ...+++..++++..|.|.||.|||.
T Consensus 75 ~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--- 151 (308)
T d1p4oa_ 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--- 151 (308)
T ss_dssp HHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHCCCCCEEEEEEEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---
T ss_conf 99997699988412547842881067776048998899987503321134446887999999999999999998764---
Q ss_pred CCCCEECCCCCCCCCCCCCCCEEECC--CCCCCC--CCCC-CC--CCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 78831058999972248999825713--677888--8775-45--4652120465-55587433211101135799
Q 002642 482 TCKPIHPELENEKLLIDSEESANISG--LSNNMN--YRNG-TA--SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 482 ~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~~--~~~~-tt--~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
.+||||||||+|||||+++++||+| +|+... .... .+ .++.....++ ...+..+.++| |||||+.-
T Consensus 152 -~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~D-v~S~G~il 225 (308)
T d1p4oa_ 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD-VWSFGVVL 225 (308)
T ss_dssp -TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHH-HHHHHHHH
T ss_pred -CCEEECEECCCCEEECCCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCC-CCCHHHHH
T ss_conf -796543286775403599649994245420235776303134023163237888873699883334-44378999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.1e-18 Score=139.51 Aligned_cols=134 Identities=10% Similarity=0.078 Sum_probs=104.6
Q ss_pred CCCCC-CCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCC--------------CCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 02335-66531000122246996035852036995024431235--------------6654310024578777655421
Q 002642 411 GLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK--------------DDMLTGSKLERHEVQCQALYEN 475 (897)
Q Consensus 411 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~ 475 (897)
.+.++ +|||+|.+.|+|.+.++.+++.||++.|++...+.... ...+++...+.+..|.+.||+|
T Consensus 71 ~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCEEEECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 99981399969734652201886899997369990999998606776432223345743467999999999999999987
Q ss_pred CCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCCCCCC---CCCC--CCCCCEEECCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 02899878831058999972248999825713--6778888---7754--54652120465-555874332111011357
Q 002642 476 FHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNMNY---RNGT--ASGCNMKNGTK-NLQGGVASSMDLLYNLSL 547 (897)
Q Consensus 476 ~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~~~---~~~t--t~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~ 547 (897)
|| . ..||||||||+|||+|.+...||+| +++.... .... ..++.....++ ...+.++.|+| |||||+
T Consensus 151 lH---~-~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D-iwS~Gv 225 (299)
T d1fgka_ 151 LA---S-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD-VWSFGV 225 (299)
T ss_dssp HH---H-TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH-HHHHHH
T ss_pred HH---H-CCEEEEEECCCCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHH-HHHHHH
T ss_conf 66---3-797863022102245478976762211101135555543146678884663266751798882555-477588
Q ss_pred CC
Q ss_conf 99
Q 002642 548 SS 549 (897)
Q Consensus 548 s~ 549 (897)
.-
T Consensus 226 vl 227 (299)
T d1fgka_ 226 LL 227 (299)
T ss_dssp HH
T ss_pred HH
T ss_conf 88
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.1e-18 Score=139.32 Aligned_cols=133 Identities=14% Similarity=0.077 Sum_probs=108.0
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.|||+++++...+.+ .+.++......+..|-+.||+|||-. .|||||
T Consensus 58 ~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrD 131 (263)
T d2j4za1 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRD 131 (263)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCC
T ss_pred HHHHHCCCCCCCEEEEEEEECCEEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEEE
T ss_conf 999856888888599999989998999850479858988750--48999999999999999999999988----946522
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC-CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788-88775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~-~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++...||+| +|+.. ........||..+++++ .....++.++| |||||+.-
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~D-iwSlGvil 194 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD-LWSLGVLC 194 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHH-HHHHHHHH
T ss_pred ECCCCCEECCCCCEEECCCCEEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHH-HHHHHHHH
T ss_conf 0234414668998711555633544888523557887634999975899893144-04675999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.5e-18 Score=138.40 Aligned_cols=132 Identities=11% Similarity=0.218 Sum_probs=105.5
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|++.+++...+..+++.|||+++++.....+ ..++......+..|.+.||+|||-. .|||||
T Consensus 69 ~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrD 141 (293)
T d1yhwa1 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRD 141 (293)
T ss_dssp HHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCEEEEEEEEEECCEEEEEEEECCCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 999867999880585779889998999970379808988641---5999999999999999999999987----972267
Q ss_pred CCCCCCCCCCCCCEEECC--CCCC--CCC-CCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778--888-775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNN--MNY-RNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~--~~~-~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||++++.++||+| +|+. ... ......||..+.+++ ...+.++.++| ||||||.-
T Consensus 142 iKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D-iwSlGvil 206 (293)
T d1yhwa1 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD-IWSLGIMA 206 (293)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEECCCHHHEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHC-EEHHHHHH
T ss_conf 768886887899686425156413213666444444477736826644799880120-31372999
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2e-18 Score=137.68 Aligned_cols=133 Identities=17% Similarity=0.142 Sum_probs=105.1
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.|||+.++++..+.+ .+.++......+..|-+.||+|||.. .|||||
T Consensus 55 ~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrD 128 (271)
T d1nvra_ 55 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRD 128 (271)
T ss_dssp HHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSC
T ss_pred HHHHHCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 999857998884696540467436798864589808999753--79999999999999999999999975----983575
Q ss_pred CCCCCCCCCCCCCEEECC--CCCC---CCCCC--CCCCCCCEEECCC-CCCCC-CCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778---88877--5454652120465-55587-433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNN---MNYRN--GTASGCNMKNGTK-NLQGG-VASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~---~~~~~--~tt~gt~~v~GT~-~~~g~-~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++..+||+| +|+. ..... .+..||..+++++ ..... .+.++| |||+|+.-
T Consensus 129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~D-iwSlGvil 196 (271)
T d1nvra_ 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD-VWSCGIVL 196 (271)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEECCCHHHEEECCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEE-EEHHHHHH
T ss_conf 468997887899879832314224046886531113255747428728618999997101-61737999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.1e-19 Score=143.07 Aligned_cols=134 Identities=12% Similarity=0.098 Sum_probs=106.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.|||+++++...+.+. ...++......+..|.+.||.|||-. .|||||
T Consensus 61 ~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrD 135 (288)
T d2jfla1 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN----KIIHRD 135 (288)
T ss_dssp HHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCCCEEEEEEEECCEEEEEEECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEEE
T ss_conf 9998679999884988980099589999627998188999862-89999999999999999999999988----988714
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCC---CCCCCCCCCCEEECCCC------CCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677888---87754546521204655------5587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN---YRNGTASGCNMKNGTKN------LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~---~~~~tt~gt~~v~GT~~------~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+|.+.++||+| +|+... ....+..||..+++++. ....++.|+| ||||||.-
T Consensus 136 iKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~D-iwSlGvil 205 (288)
T d2jfla1 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD-VWSLGITL 205 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEECHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHH-HHHHHHHH
T ss_conf 07003148789998997161230357786410010256264799998320257888880665-78789999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=6.1e-19 Score=141.08 Aligned_cols=133 Identities=9% Similarity=0.029 Sum_probs=104.1
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.|++. .+..+++.||++.+.+.....+ ....+++...+.+.+|.+.||+|||- ..|||||
T Consensus 60 ~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrD 133 (273)
T d1mp8a_ 60 LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES----KRFVHRD 133 (273)
T ss_dssp HHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSC
T ss_pred HHHHHCCCCCEEEEEEEEE-CCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHCC----CCEECCC
T ss_conf 9998689999856988995-3747999984069807765422-47899999999999999877523022----6744141
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCC--CCCCCC--CCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677888--877545--4652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN--YRNGTA--SGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~--~~~~tt--~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+|++..+||+| +|+... ....++ .|+....+++ ...+..+.++| |||||+.-
T Consensus 134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~D-iwSlGvil 199 (273)
T d1mp8a_ 134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD-VWMFGVCM 199 (273)
T ss_dssp CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCC-CCCCHHHH
T ss_conf 0265532067896787650342133677623305400583103266751699887452-44424789
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.69 E-value=2.7e-18 Score=136.75 Aligned_cols=134 Identities=13% Similarity=0.113 Sum_probs=105.7
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 00023356653100012224699603585203699502443123566543100245787776554210289987883105
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
...|.+++|||+|++.+++...+..+++.||+.++.+...+... ..++......+..|.+.||+|||-. .||||
T Consensus 55 ~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~iiHr 128 (316)
T d1fota_ 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK----DIIYR 128 (316)
T ss_dssp HHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECC
T ss_pred HHHHHHCCCCCHHHEEEEEEECCEEEEEEEECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCC----CEECC
T ss_conf 99998636967533035685288005676503786322343222--2111007999999998765541247----67705
Q ss_pred CCCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999972248999825713--6778888775454652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||||++..+||+| +|+.......+..||..+++++ .....++.++| |||+|+.-
T Consensus 129 DiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~D-iwSlGvil 191 (316)
T d1fota_ 129 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSID-WWSFGILI 191 (316)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHH-HHHHHHHH
T ss_pred CCCCHHEEECCCCCEEEECCCCCEEECCCCCCCCCCCCCCCHHHHCCCCCCCHHH-CCCCCHHH
T ss_conf 5681050386899889831752167124564345763435999983899980430-46533368
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.2e-18 Score=139.09 Aligned_cols=131 Identities=13% Similarity=0.090 Sum_probs=103.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.|+|.. +...++.||++.+++..+... ..+.+++...+.+..|.+.||.|||. ..|||||
T Consensus 63 ~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrD 136 (273)
T d1u46a_ 63 NAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES----KRFIHRD 136 (273)
T ss_dssp HHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHH----TTEECSC
T ss_pred HHHHHCCCCCEEEEEEEEEE-CCHHEEEEEECCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEEEE
T ss_conf 99986899998789877740-100114654238612544421-26899999999999999999987521----7875205
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788--88775454652120465-------55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--NYRNGTASGCNMKNGTK-------NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-------~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||.+..+||+| +++.. ....... .....||. ......+.++| |||||+.-
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~D-i~S~Gvil 204 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM--QEHRKVPFAWCAPESLKTRTFSHASD-TWMFGVTL 204 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-------CCGGGCCHHHHHHCEEEHHHH-HHHHHHHH
T ss_pred ECHHHHCCCCCCCEEECCCHHHHHCCCCCCCCEE--CCCCCCCCCCCCHHHHHCCCCCCCHH-HHHHHHHH
T ss_conf 6688815655654332561155530358875265--47632573107999983799994215-66148999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.67 E-value=2.5e-18 Score=137.01 Aligned_cols=134 Identities=11% Similarity=0.139 Sum_probs=106.7
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...++.+++.|||+++.+...+.+. .+.++......+..|.+.||.|||.. .|||||
T Consensus 75 ~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrD 149 (350)
T d1koaa2 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLD 149 (350)
T ss_dssp HHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC----CCEEEE
T ss_conf 9998679979992999999899999999857998899999762-37899999999999999999999756----976000
Q ss_pred CCCCCCCCCC--CCCEEECC--CCCCCC--CCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999722489--99825713--677888--8775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDS--EESANISG--LSNNMN--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~--~~~aKisD--Lar~~~--~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+||||+. +...||+| +|+... ....+..||..+++++ .....++.++| |||+|+.-
T Consensus 150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~D-iwSlGvil 215 (350)
T d1koaa2 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD-MWSVGVLS 215 (350)
T ss_dssp CCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHH-HHHHHHHH
T ss_pred ECHHHEEECCCCCCEEEEEECCHHEECCCCCCCCEECCCCCCCCHHHHCCCCCCHHHH-HHHHHHHH
T ss_conf 1546736416889869995452104425654320006862421889975899872676-55465999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.67 E-value=5.7e-18 Score=134.63 Aligned_cols=133 Identities=14% Similarity=0.150 Sum_probs=105.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.++.+.|||+|++.+++...+..+++.||++++++...+.+ ...++......+..|.+.||+|||.. .|||||
T Consensus 59 ~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrD 132 (364)
T d1omwa3 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRD 132 (364)
T ss_dssp HHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHCCCCCCEEEEEEEEEECCEEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCEE
T ss_conf 998508998588999999989988999991489838999873--25532789999999999999999977----962204
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC-CCCCCCCCCCCEEECCC-CCCC-CCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788-88775454652120465-5558-7433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-NYRNGTASGCNMKNGTK-NLQG-GVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~-~~~~~tt~gt~~v~GT~-~~~g-~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++..+||+| +|+.. ........||..+.+++ ...+ .++.++| ||||||.-
T Consensus 133 lKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~D-iwSlGvil 196 (364)
T d1omwa3 133 LKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD-WFSLGCML 196 (364)
T ss_dssp CSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHH-HHHHHHHH
T ss_pred ECCCEEEECCCCCEEEEEECEEEECCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCC-HHHHHHHH
T ss_conf 44221678588967982201023337886433113455421687603899984410-46778999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9.4e-19 Score=139.85 Aligned_cols=139 Identities=9% Similarity=0.069 Sum_probs=105.9
Q ss_pred HCCCCCCCCCCCEECCCCCC--CCCCEEEEECCCCCCEEEEEEC--CCCCCCCCCHHHHHHHHHHHHHHHCCCCCC-CCC
Q ss_conf 00233566531000122246--9960358520369950244312--356654310024578777655421028998-788
Q 002642 410 YGLSNLVESHLACHSTCNVA--GDQFFLSHTAINNPSTFVRVMN--TKDDMLTGSKLERHEVQCQALYENFHGMPI-TCK 484 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~-~~~ 484 (897)
-.|.+++|||+|++.+++.. ....+++.|||++|++...+.+ .....+++.....+..|-+.||.|||.... ..+
T Consensus 55 ~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~ 134 (269)
T d2java1 55 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134 (269)
T ss_dssp HHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC----
T ss_pred HHHHHCCCCCEEEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99997789998248999991789989999956899938999985154578999999999999999999999971677887
Q ss_pred CEECCCCCCCCCCCCCCCEEECC--CCCC-CCCCCC--CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 31058999972248999825713--6778-888775--454652120465-55587433211101135799
Q 002642 485 PIHPELENEKLLIDSEESANISG--LSNN-MNYRNG--TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 485 iIHrDiK~sNILLD~~~~aKisD--Lar~-~~~~~~--tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||||||+|||||++..+||+| +|+. ...... +..||..+.+++ .....++.|+| |||||+.-
T Consensus 135 IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~D-IwSlGvil 204 (269)
T d2java1 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSD-IWSLGCLL 204 (269)
T ss_dssp -----CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHH-HHHHHHHH
T ss_pred EEECCCCHHHCCCCCCCCEEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHH-HHHHCHHH
T ss_conf 88586765425747888579800100032245777556677882327999983999993898-87527899
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2.2e-18 Score=137.44 Aligned_cols=133 Identities=11% Similarity=0.021 Sum_probs=105.5
Q ss_pred HHCCCCC-CCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCC----------------CCCCCCCHHHHHHHHHHH
Q ss_conf 0002335-66531000122246996035852036995024431235----------------665431002457877765
Q 002642 409 QYGLSNL-VESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTK----------------DDMLTGSKLERHEVQCQA 471 (897)
Q Consensus 409 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~ 471 (897)
-..++++ +|||+|++.|+|...+..+++.|||+++++...+.... ...+++...+.+..|.+.
T Consensus 77 ~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 156 (311)
T d1t46a_ 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (311)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCEEEEEEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 99987626999887899898319978999973799879999985356654444453322233458899999999999999
Q ss_pred HHHHCCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCCCC-CC-CCCCCCCCCEEECCC-------CCCCCCCCCCC
Q ss_conf 542102899878831058999972248999825713--67788-88-775454652120465-------55587433211
Q 002642 472 LYENFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNNM-NY-RNGTASGCNMKNGTK-------NLQGGVASSMD 540 (897)
Q Consensus 472 ~~~~~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~-~~-~~~tt~gt~~v~GT~-------~~~g~~t~ksD 540 (897)
|++|||-+. ||||||||+|||+|.+..+|++| +++.. .. ..... ....||. ...+..+.++|
T Consensus 157 gl~~LH~~~----ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~D 229 (311)
T d1t46a_ 157 GMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESD 229 (311)
T ss_dssp HHHHHHHTT----CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEEC---SSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHCC----EEECCCCCCCCCCCCCCCCCCCCCCHHEECCCCCCCEEE---EECCCCHHHCCHHHHCCCCCCCCCC
T ss_conf 999887579----266624102100002575210234010233678861586---2013596876778861799997400
Q ss_pred CCCCCCCCC
Q ss_conf 101135799
Q 002642 541 LLYNLSLSS 549 (897)
Q Consensus 541 ~Vy~~~~s~ 549 (897)
|||||+.-
T Consensus 230 -IwS~G~~l 237 (311)
T d1t46a_ 230 -VWSYGIFL 237 (311)
T ss_dssp -HHHHHHHH
T ss_pred -CCCHHHHH
T ss_conf -10258999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=4.5e-18 Score=135.29 Aligned_cols=134 Identities=12% Similarity=0.036 Sum_probs=101.7
Q ss_pred CCCCC-CCCCCCEECCCCCCCCC-CEEEEECCCCCCEEEEEECCC--------------CCCCCCCHHHHHHHHHHHHHH
Q ss_conf 02335-66531000122246996-035852036995024431235--------------665431002457877765542
Q 002642 411 GLSNL-VESHLACHSTCNVAGDQ-FFLSHTAINNPSTFVRVMNTK--------------DDMLTGSKLERHEVQCQALYE 474 (897)
Q Consensus 411 ~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~ 474 (897)
.+.++ .|+|+|.+.++|.+.+. .+++.|||+.|++...+.... ...+++...+.+..|.+.||+
T Consensus 69 ~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 148 (299)
T d1ywna1 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 148 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCEEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHH
T ss_conf 98861499849974115404797579999845899299999853666665322202332146899999999999999999
Q ss_pred HCCCCCCCCCCEECCCCCCCCCCCCCCCEEECC--CCCC--CCCCC-CC--CCCCCEEECCC-CCCCCCCCCCCCCCCCC
Q ss_conf 102899878831058999972248999825713--6778--88877-54--54652120465-55587433211101135
Q 002642 475 NFHGMPITCKPIHPELENEKLLIDSEESANISG--LSNN--MNYRN-GT--ASGCNMKNGTK-NLQGGVASSMDLLYNLS 546 (897)
Q Consensus 475 ~~h~~~~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~--~~~~~-~t--t~gt~~v~GT~-~~~g~~t~ksD~Vy~~~ 546 (897)
|||- ..||||||||+|||||++.++||+| +|+. ..... .. ..||..+.+++ ...+..+.++| |||||
T Consensus 149 ylH~----~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD-iwS~G 223 (299)
T d1ywna1 149 FLAS----RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD-VWSFG 223 (299)
T ss_dssp HHHH----TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH-HHHHH
T ss_pred HHHH----CCCCCCCCCCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCC-EEEHH
T ss_conf 8873----797178677310657799828984575200113566522247516672102036864688996632-21367
Q ss_pred CCC
Q ss_conf 799
Q 002642 547 LSS 549 (897)
Q Consensus 547 ~s~ 549 (897)
+.-
T Consensus 224 vil 226 (299)
T d1ywna1 224 VLL 226 (299)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 899
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.65 E-value=1.2e-17 Score=132.52 Aligned_cols=134 Identities=11% Similarity=0.111 Sum_probs=104.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.++.|||+|++.++....+..+++.|||+.+++....... ...++...-..+..|.+.||.|||-. .|||||
T Consensus 78 ~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRD 152 (352)
T d1koba_ 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLD 152 (352)
T ss_dssp HHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECC
T ss_conf 9998679979891999999899999999828998088889863-89989999999999999999999977----926513
Q ss_pred CCCCCCCCC--CCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248--999825713--67788--88775454652120465-55587433211101135799
Q 002642 490 LENEKLLID--SEESANISG--LSNNM--NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD--~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+||||+ .+...||+| +|+.. .....+..|+..+.+++ .....++.++| |||+|+.-
T Consensus 153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlGvil 218 (352)
T d1koba_ 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD-MWAIGVLG 218 (352)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCCCEEEEEECCCCEECCCCCCEEECCCCCCCCCHHHHCCCCCCCCCC-HHHHHHHH
T ss_conf 1445531134678848995256303437887201004764534899974799897633-38989999
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.9e-17 Score=131.11 Aligned_cols=133 Identities=14% Similarity=0.141 Sum_probs=103.1
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|.+.++....+..+++.|||+++.++..+.+. +.++-..-.....|.+.||+|+|-+ .|||||
T Consensus 57 ~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~----~iiHRD 130 (337)
T d1o6la_ 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR----DVVYRD 130 (337)
T ss_dssp HHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCC
T ss_pred HHHHHCCCCCEEEEEEEECCCCCCCCCEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 9998679998877876403564211100035798605555325--6775999999999996521134315----962246
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC-C--CCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788-8--8775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM-N--YRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~-~--~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++...||+| +|+.. . ....+..||..+++++ .....++.++| +||+|+.-
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~D-iwSlGvil 195 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD-WWGLGVVM 195 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHH-HHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEECCCCCCCCCCCCCCCCCEECHHHHHHHHCCCCCCCHHHC-CCCHHHHH
T ss_conf 477784765899888820565200356786205510088996666504898883331-02230678
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.64 E-value=1.3e-17 Score=132.14 Aligned_cols=133 Identities=15% Similarity=0.174 Sum_probs=108.1
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|.+.++....+..+++.+++..+.+...+.+. +.++...-..+..|-+.||.|||-. .|||||
T Consensus 93 ~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRD 166 (350)
T d1rdqe_ 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRD 166 (350)
T ss_dssp HHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC----CEECCC
T ss_conf 9999748772740344443222223222233466226667515--8989999999999999989999859----986176
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778888775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||.+...||+| +|+.......+..||..+++++ ......+.++| |||||+.-
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~D-iwSlGvil 228 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVD-WWALGVLI 228 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHH-HHHHHHHH
T ss_pred CCHHHCCCCCCCCEEEEECEEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCC-CCCHHHHH
T ss_conf 799993607789788610103332256664336763567889971799885331-14500789
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=5.8e-18 Score=134.57 Aligned_cols=133 Identities=13% Similarity=0.129 Sum_probs=104.8
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.||+++|++...+.. .+.++......+..|.+.||+|||.. .|||||
T Consensus 60 ~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrD 133 (288)
T d1uu3a_ 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRD 133 (288)
T ss_dssp HHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSC
T ss_pred HHHHHCCCCCEEEEEEEEEECCEEEEEEECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHCCC----CEECCC
T ss_conf 999876888861799999989988999970489877776531--59999999999999999999762165----088476
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCC--C--CCCC-CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--67788--8--8775-454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNM--N--YRNG-TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~--~--~~~~-tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||++...||+| +|+.. . .... +..||..+++++ .....++.++| |||+||.-
T Consensus 134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~D-iwSlGvil 200 (288)
T d1uu3a_ 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD-LWALGCII 200 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-EEHHHHHH
T ss_conf 77412366888538860321024225677643335556775525844002689896662-30456999
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=1.4e-17 Score=132.11 Aligned_cols=133 Identities=18% Similarity=0.229 Sum_probs=106.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++-|||+.+++...+.. .+.++......+..|-+.||+|||-. .|||||
T Consensus 59 ~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrD 132 (307)
T d1a06a_ 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL----GIVHRD 132 (307)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC----EEEEEE
T ss_conf 999867998999198999989988898852689848886530--36788789999999999998752413----055687
Q ss_pred CCCCCCCC---CCCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 99997224---8999825713--67788--88775454652120465-55587433211101135799
Q 002642 490 LENEKLLI---DSEESANISG--LSNNM--NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILL---D~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+ |++...||+| +|+.. .....+..||..+++++ .....++.++| |||||+.-
T Consensus 133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~D-iwSlGvil 199 (307)
T d1a06a_ 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD-CWSIGVIA 199 (307)
T ss_dssp CCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHH-HHHHHHHH
T ss_pred ECCCCEEECCCCCCCEEEEECCCEEEECCCCCEEEEEEECCCCCCCHHHCCCCCCCHHH-HHHHHHHH
T ss_conf 04630011046888249983154358725897044003284225918873799980787-34515999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.3e-17 Score=129.55 Aligned_cols=133 Identities=11% Similarity=0.084 Sum_probs=105.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|++.+++...+..+++.|||+.+++...+.. .+.++......+..|.+.||+|||-. .|||||
T Consensus 65 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrD 138 (293)
T d1jksa_ 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFD 138 (293)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCCCCCHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECC
T ss_conf 999867998999388999979989999986778643100103--56421557899999999998766625----422113
Q ss_pred CCCCCCCCCCCC----CEEECC--CCCC--CCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999----825713--6778--888775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDSEE----SANISG--LSNN--MNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~----~aKisD--Lar~--~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||++.+. ..|++| +|+. ......+..|+..+.+++ ......+.++| |||||+.-
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~D-iwSlGvil 206 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD-MWSIGVIT 206 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHH-HHHHHHHH
T ss_pred CCCCEEEEECCCCCCCCEEECCHHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC-CHHHHHHH
T ss_conf 330127982589866646964334421057776312247777430999981899997665-22140999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=8.8e-17 Score=126.71 Aligned_cols=131 Identities=11% Similarity=0.080 Sum_probs=102.5
Q ss_pred CCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECCCC
Q ss_conf 23356653100012224699603585203699502443123566543100245787776554210289987883105899
Q 002642 412 LSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPELE 491 (897)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrDiK 491 (897)
.-+++|||+|++.+++..++..+++.||+++|.+...+-+ .+.++-..-..+.+|.+.||+|||-. .|||||||
T Consensus 57 ~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDik 130 (320)
T d1xjda_ 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLK 130 (320)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCC
T ss_pred HHHCCCCCEEEEEEEECCCCCEEEEEEECCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCCC
T ss_conf 9847999687898897049831677750379808998640--47899999999999999999999868----93403476
Q ss_pred CCCCCCCCCCCEEECC--CCCCC--CCC-CCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 9972248999825713--67788--887-75454652120465-55587433211101135799
Q 002642 492 NEKLLIDSEESANISG--LSNNM--NYR-NGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 492 ~sNILLD~~~~aKisD--Lar~~--~~~-~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|+|||+|++...|++| +|+.. ... .....||..+.+++ ...+..+.++| |||||+.-
T Consensus 131 p~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlGvil 193 (320)
T d1xjda_ 131 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD-WWSFGVLL 193 (320)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH-HHHHHHHH
T ss_pred CCCEEECCCCCEECCCCCHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHH-HHHHHHHH
T ss_conf 5404444899630155530232356653345457877768999982799883232-01122789
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=9.6e-17 Score=126.46 Aligned_cols=133 Identities=11% Similarity=0.076 Sum_probs=102.3
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|++.+++...+..+++.||+..+...... .....++......+..|.+.||+|||- ..|||||
T Consensus 52 ~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~----~~iiHrD 125 (299)
T d1ua2a_ 52 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQ----HWILHRD 125 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHH----TTCCCCC
T ss_pred HHHHHCCCCCEEEEEEEECCCCCEEEHHHHHCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHC----CCEECCC
T ss_conf 9998679999868985422587402204553450776554--126677899999999999999988631----6355035
Q ss_pred CCCCCCCCCCCCCEEECC--CCCCCC---CCCCCCCCCCEEECCC-CC-CCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677888---8775454652120465-55-587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNNMN---YRNGTASGCNMKNGTK-NL-QGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~~~---~~~~tt~gt~~v~GT~-~~-~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+|++...||+| +|+... ....+..||..+++++ .. ....+.++| |||||+.-
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D-iwSlGvil 191 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD-MWAVGCIL 191 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCEECCHHHCCHHHHCCCCCCCHHHH-HHHCCHHH
T ss_conf 7762588537784114657610005787554330204733363999726778880564-36304289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=6.8e-17 Score=127.48 Aligned_cols=134 Identities=10% Similarity=0.047 Sum_probs=102.6
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-+|.++.|||+|++.+++...++.+++.||+..+..... .......+++.....+.+|-+.||.|||-. .|||||
T Consensus 53 ~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~-~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrD 127 (298)
T d1gz8a_ 53 SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRD 127 (298)
T ss_dssp HHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH-HHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred HHHHHCCCCCEEEECCCCCCCCCEEEEEEECCCCHHHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHCC----CEECCC
T ss_conf 999867998388744533224320378862377445554-420256888899999999999999986528----899213
Q ss_pred CCCCCCCCCCCCCEEECC--CCC--CC-CCCCCCCCCCCEEECCC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677--88-88775454652120465--55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSN--NM-NYRNGTASGCNMKNGTK--NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar--~~-~~~~~tt~gt~~v~GT~--~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+|.+...|++| +|+ .. ........|+...+.++ ......+.++| +||+||.-
T Consensus 128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~D-iwSlGvil 193 (298)
T d1gz8a_ 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD-IWSLGCIF 193 (298)
T ss_dssp CCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHH-HHHHHHHH
T ss_pred CCCHHEEECCCCCCEECCCCCCEECCCCCCCCEEECCCCEEEEHHHHCCCCCCCCCCC-CCCCCHHH
T ss_conf 5711401134676210357861343688641001036521541122136657774221-03333134
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.57 E-value=2.6e-16 Score=123.65 Aligned_cols=134 Identities=12% Similarity=0.185 Sum_probs=105.1
Q ss_pred HHCCCCCC-CCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 00023356-65310001222469960358520369950244312356654310024578777655421028998788310
Q 002642 409 QYGLSNLV-ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIH 487 (897)
Q Consensus 409 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIH 487 (897)
...|.++. |||++++.+++...+..+++.||++++++...+-. .+.+++........|-+.||+|||-. .|||
T Consensus 60 ~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~ivH 133 (277)
T d1phka_ 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVH 133 (277)
T ss_dssp HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEEC
T ss_pred HHHHHHHCCCCCEEEEEEECCCCCCEEEEEECCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCC
T ss_conf 99999850799747997621467605999976898668999986--59999999999999999999999875----9943
Q ss_pred CCCCCCCCCCCCCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 58999972248999825713--67788--88775454652120465-------55587433211101135799
Q 002642 488 PELENEKLLIDSEESANISG--LSNNM--NYRNGTASGCNMKNGTK-------NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 488 rDiK~sNILLD~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-------~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||||+|||+|++...||+| +++.. ........||....+++ ......+.++| |||+|+.-
T Consensus 134 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~D-iwslGvil 205 (277)
T d1phka_ 134 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD-MWSTGVIM 205 (277)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH-HHHHHHHH
T ss_pred CCCCCCEEEECCCCCEEECCCHHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHE-ECCCCHHH
T ss_conf 2346254898689983871240316726887213452467888988860534456788992331-85656023
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.9e-16 Score=123.27 Aligned_cols=131 Identities=11% Similarity=0.119 Sum_probs=100.4
Q ss_pred CCCCCCCCEECCCCCC----CCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 3566531000122246----996035852036995024431235665431002457877765542102899878831058
Q 002642 414 NLVESHLACHSTCNVA----GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 414 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
...|||+|.+.++... ....+++.|||++|++...+.+.....++......+..|-+.||+|||-. .|||||
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRD 136 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRD 136 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HCCCCCCCEEEEEEEECCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 6699997829899950346897899999778998499999862787757999999999999999999976----986444
Q ss_pred CCCCCCCCCC---CCCEEECC--CCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999722489---99825713--677--8888775454652120465-55587433211101135799
Q 002642 490 LENEKLLIDS---EESANISG--LSN--NMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~---~~~aKisD--Lar--~~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||+++ +..+|++| +|+ .......+..||..+.+++ .....++.++| |||+|+.-
T Consensus 137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~D-iwSlGvil 203 (335)
T d2ozaa1 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD-MWSLGVIM 203 (335)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHH-HHHHCHHH
T ss_conf 10022011355556631135455123336888643226775637927774898888888-87645167
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.9e-16 Score=124.55 Aligned_cols=134 Identities=10% Similarity=0.056 Sum_probs=101.5
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
..|.+++|||+|.+.++....+..+++.|||+++.++..+... ...++......+..|.+.||+|||-. .|||||
T Consensus 53 ~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrD 127 (321)
T d1tkia_ 53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFD 127 (321)
T ss_dssp HHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCCCEEEEEEEECCEEEEEEECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCC
T ss_conf 9998579979890989998899889999538998088998753-89999999999999999999999876----997513
Q ss_pred CCCCCCCCCC--CCCEEECC--CCCCCCCCC-C-CCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999722489--99825713--677888877-5-454652120465-55587433211101135799
Q 002642 490 LENEKLLIDS--EESANISG--LSNNMNYRN-G-TASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~--~~~aKisD--Lar~~~~~~-~-tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||++. ....|++| +++...... . +..++..+..++ .....++.++| |||+|+.-
T Consensus 128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~D-iWSlGvil 193 (321)
T d1tkia_ 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD-MWSLGTLV 193 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHH-HHHHHHHH
T ss_pred CCCCCEEECCCCCEEEEECCCCHHHCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHH-CCCHHHHH
T ss_conf 5544434437885189976441110034677532122332223402104877784011-30279999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.54 E-value=3.2e-16 Score=123.00 Aligned_cols=133 Identities=12% Similarity=0.084 Sum_probs=101.0
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||+|++.+++...+..+++.+++..+.+.... ...+.++......+..|.+.||+|||-+ .|||||
T Consensus 52 ~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrD 125 (286)
T d1ob3a_ 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRD 125 (286)
T ss_dssp HGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred HHHHHCCCCCEEEEEEECCCCCCEEEEEEEEHHHHHHHHH--HHCCCCCHHHHHHHHHHHHHHHHHHCCC----CEEECC
T ss_conf 9998679986876601204677315899740045678998--6047751445689999999999986057----488267
Q ss_pred CCCCCCCCCCCCCEEECC--CCC--CC-CCCCCCCCCCCEEECCC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--677--88-88775454652120465--55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSN--NM-NYRNGTASGCNMKNGTK--NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar--~~-~~~~~tt~gt~~v~GT~--~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||||.+...|++| +|. .. ........++.....++ ......+.++| +||+|+.-
T Consensus 126 iKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~D-iwslGv~l 191 (286)
T d1ob3a_ 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID-IWSVGCIF 191 (286)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHH-HHHHHHHH
T ss_pred CCCCEEEECCCCCEEECCCCCCEECCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCEE-EHHCCCHH
T ss_conf 8775056868997873236643011467654101024311013788717888884100-21117589
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.4e-16 Score=122.85 Aligned_cols=133 Identities=11% Similarity=0.103 Sum_probs=97.9
Q ss_pred CCCCCCCCCCCEECCCCCC-----CCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 0233566531000122246-----99603585203699502443123566543100245787776554210289987883
Q 002642 411 GLSNLVESHLACHSTCNVA-----GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKP 485 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~i 485 (897)
.|+..+|||++.+++.+.. ....+++.|+++.+.+...... ....++......+..|.+.||+|||-. .|
T Consensus 63 ~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~----~i 137 (305)
T d1blxa_ 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH----RV 137 (305)
T ss_dssp HHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT----TC
T ss_pred HHHHCCCCCCCEEEEEECCCCCCCCCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CE
T ss_conf 8742589880236632214666667469999974058714444430-378999899999999999999999758----89
Q ss_pred EECCCCCCCCCCCCCCCEEECC--CCCCC--CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 1058999972248999825713--67788--88775454652120465-55587433211101135799
Q 002642 486 IHPELENEKLLIDSEESANISG--LSNNM--NYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 486 IHrDiK~sNILLD~~~~aKisD--Lar~~--~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||||||+|||++++..+||+| +++.. .....+..||..+++++ .....++.++| |||+|+.-
T Consensus 138 vHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~D-iwSlG~il 205 (305)
T d1blxa_ 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVD-LWSVGCIF 205 (305)
T ss_dssp CCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHH-HHHHHHHH
T ss_pred EECCCCCCEEEECCCCCEEECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEH-HHCHHHHH
T ss_conf 835798627898589975421000101100234577765485114831001798881110-00328999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.53 E-value=2.6e-16 Score=123.56 Aligned_cols=133 Identities=11% Similarity=0.097 Sum_probs=101.4
Q ss_pred HCCCCCCCCCCCEECCCCCCCCC----CEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 00233566531000122246996----03585203699502443123566543100245787776554210289987883
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQ----FFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKP 485 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~i 485 (897)
-.|.+++|||+|.+.+++...+. .+++.||++++++...... .+.+++.....+..|-+.||+|||- ..|
T Consensus 59 ~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~----~~i 132 (277)
T d1o6ya_ 59 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ----NGI 132 (277)
T ss_dssp HHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH----TTE
T ss_pred HHHHHCCCCCCCCCCCEEEECCCCCCEEEEEEECCCCCEEHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH----CCC
T ss_conf 9998569998873114354326887669999977889871011203--5899999999999999999999985----795
Q ss_pred EECCCCCCCCCCCCCCCEEECC--CCCC----CCC--CCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 1058999972248999825713--6778----888--775454652120465-55587433211101135799
Q 002642 486 IHPELENEKLLIDSEESANISG--LSNN----MNY--RNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 486 IHrDiK~sNILLD~~~~aKisD--Lar~----~~~--~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||||||+||||+.+...+++| +++. ... ...+..||..+++++ .....++.++| |||||+.-
T Consensus 133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D-iwSlGvil 204 (277)
T d1o6ya_ 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD-VYSLGCVL 204 (277)
T ss_dssp ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEE-CCCCHHHH
T ss_conf 2763467556657543201003444322123544333346425762436999983999996632-02652899
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.1e-16 Score=119.98 Aligned_cols=136 Identities=10% Similarity=0.022 Sum_probs=97.8
Q ss_pred HHCCCCCCCCCCCEECCCCCCCCC------CEEEEECCCCCCEEEEE-ECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 000233566531000122246996------03585203699502443-12356654310024578777655421028998
Q 002642 409 QYGLSNLVESHLACHSTCNVAGDQ------FFLSHTAINNPSTFVRV-MNTKDDMLTGSKLERHEVQCQALYENFHGMPI 481 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~ 481 (897)
...|.+++|||++++.++++.... .+++.||++.+.....+ .......+++.....+..|-+.||+|||-
T Consensus 64 i~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--- 140 (350)
T d1q5ka_ 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140 (350)
T ss_dssp HHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---
T ss_conf 99998668989873878997447657731899998416886078888631036899999999999999999999986---
Q ss_pred CCCCEECCCCCCCCCCCCC-CCEEECC--CCCC--CCCCCCCCCCCCEEECCC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 7883105899997224899-9825713--6778--888775454652120465--55587433211101135799
Q 002642 482 TCKPIHPELENEKLLIDSE-ESANISG--LSNN--MNYRNGTASGCNMKNGTK--NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 482 ~~~iIHrDiK~sNILLD~~-~~aKisD--Lar~--~~~~~~tt~gt~~v~GT~--~~~g~~t~ksD~Vy~~~~s~ 549 (897)
..||||||||+|||||.+ ...||+| +++. ......+..|+.....++ ......+.++| +||+|+..
T Consensus 141 -~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D-IwSlG~il 213 (350)
T d1q5ka_ 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID-VWSAGCVL 213 (350)
T ss_dssp -TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHH-HHHHHHHH
T ss_pred -CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEE-ECCCCEEE
T ss_conf -68764578860378735897116733660544047765320025555568277640468882100-02465277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2e-15 Score=117.68 Aligned_cols=131 Identities=11% Similarity=0.107 Sum_probs=99.7
Q ss_pred HCCCCCCCCCCCEECCCCCCCC------CCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 0023356653100012224699------6035852036995024431235665431002457877765542102899878
Q 002642 410 YGLSNLVESHLACHSTCNVAGD------QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITC 483 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~ 483 (897)
-.|.++.|||+|++.+++...+ +.+++.||+ +.+....++ .+.++......+..|-+.||+|||-.
T Consensus 69 ~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~--~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---- 140 (346)
T d1cm8a_ 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAA---- 140 (346)
T ss_dssp HHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC--SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----
T ss_pred HHHHHCCCCCEEEEEEEECCCCCCCCCCEEEEEEECC--CCCHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHC----
T ss_conf 9998668987547999863576555541599998405--521899987--40226999999999999999998737----
Q ss_pred CCEECCCCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCCC--CCCCCCCCCCCCCCCCCCC
Q ss_conf 831058999972248999825713--67788887754546521204655--5587433211101135799
Q 002642 484 KPIHPELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTKN--LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 484 ~iIHrDiK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~~--~~g~~t~ksD~Vy~~~~s~ 549 (897)
.||||||||+|||+|.+...|++| +|+..+.......|+..+++++. .....+.++| |||+|+.-
T Consensus 141 ~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D-iwSlGvil 209 (346)
T d1cm8a_ 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVD-IWSVGCIM 209 (346)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHH-HHHHHHHH
T ss_pred CCCCCCCCCCHHHCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCH-HHCCHHHH
T ss_conf 8764566851111210012211343102206876310245533358899817878996501-03003899
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.4e-15 Score=118.64 Aligned_cols=134 Identities=13% Similarity=0.085 Sum_probs=99.2
Q ss_pred HCCCCCC--CCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 0023356--65310001222469960358520369950244312356654310024578777655421028998788310
Q 002642 410 YGLSNLV--ESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIH 487 (897)
Q Consensus 410 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIH 487 (897)
..|.++. |||+|.+.++....+..+++.|++..+.+....+.. ...++......+..|-+.||+|||- ..|||
T Consensus 59 ~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~----~~iiH 133 (273)
T d1xwsa_ 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN----CGVLH 133 (273)
T ss_dssp HHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH----TTEEC
T ss_pred HHHHHHCCCCCCCCEEEEEEEECCEEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHH----CCCCC
T ss_conf 999974358988127999983099689999833686228999861-5899999999999999999999987----79755
Q ss_pred CCCCCCCCCCCCC-CCEEECC--CCC-CCCCCCCCCCCCCEEECCC-CCCCC-CCCCCCCCCCCCCCC
Q ss_conf 5899997224899-9825713--677-8888775454652120465-55587-433211101135799
Q 002642 488 PELENEKLLIDSE-ESANISG--LSN-NMNYRNGTASGCNMKNGTK-NLQGG-VASSMDLLYNLSLSS 549 (897)
Q Consensus 488 rDiK~sNILLD~~-~~aKisD--Lar-~~~~~~~tt~gt~~v~GT~-~~~g~-~t~ksD~Vy~~~~s~ 549 (897)
|||||+|||||.+ ...|++| +|+ .......+..||..+++++ ..... .+.++| |||+|+.-
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~D-iwSlGvil 200 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA-VWSLGILL 200 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHH-HHHHHHHH
T ss_pred CCCCCCCEEEECCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC-CCCCEEEE
T ss_conf 66761114774478848977546535324445566565877479999848997886533-25540345
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=6.8e-15 Score=114.14 Aligned_cols=133 Identities=12% Similarity=0.031 Sum_probs=99.5
Q ss_pred HCCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 00233566531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 410 YGLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
-.|.+++|||++.+.+++...+...++.+++..+.++..... .+.+..........|-+.||+|||.. .|||||
T Consensus 53 ~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrD 126 (292)
T d1unla_ 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRD 126 (292)
T ss_dssp HHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCC
T ss_pred HHHHHCCCCCEEEECCCCCCCCCEEEEEEECCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHCC----CEEEEC
T ss_conf 999856757888213544444311588630233222112123--56540367899999999998774339----986001
Q ss_pred CCCCCCCCCCCCCEEECC--CCCC--CCCCCCCC-CCCCEEECCC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 999972248999825713--6778--88877545-4652120465--55587433211101135799
Q 002642 490 LENEKLLIDSEESANISG--LSNN--MNYRNGTA-SGCNMKNGTK--NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~~~~aKisD--Lar~--~~~~~~tt-~gt~~v~GT~--~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||++.+...|++| +|+. ........ .++...+..+ ......+.++| |||+|+.-
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D-iwSlG~il 192 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID-MWSAGCIF 192 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCCEEEEECCHHHCCCCCCCCCEEECCCCCHHHHHHHCCCCCCCCHHH-CCCCCHHH
T ss_conf 4676121133782665204601104688751001034431014667506988880444-02654188
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=1.4e-14 Score=112.11 Aligned_cols=133 Identities=11% Similarity=0.067 Sum_probs=95.2
Q ss_pred HHCCCCCCCCCCCEECCCCCCCC----CCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 00023356653100012224699----60358520369950244312356654310024578777655421028998788
Q 002642 409 QYGLSNLVESHLACHSTCNVAGD----QFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCK 484 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~ 484 (897)
.-+|.++.|||++.+.+++.... +.+..-+++..++++..+.+ ..++......+..|...||+|||-. .
T Consensus 57 i~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~----~ 129 (345)
T d1pmea_ 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----N 129 (345)
T ss_dssp HHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred HHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEECCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC----C
T ss_conf 99999768989885888995056455414999996259865664405---8999999999999999999999978----9
Q ss_pred CEECCCCCCCCCCCCCCCEEECC--CCCC--CC-CC---CCCCCCCCEEECCC-C-CCCCCCCCCCCCCCCCCCC
Q ss_conf 31058999972248999825713--6778--88-87---75454652120465-5-5587433211101135799
Q 002642 485 PIHPELENEKLLIDSEESANISG--LSNN--MN-YR---NGTASGCNMKNGTK-N-LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 485 iIHrDiK~sNILLD~~~~aKisD--Lar~--~~-~~---~~tt~gt~~v~GT~-~-~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||||||+|||||++..+||+| +|+. .. .. .....|+..+++++ . .....+.++| +||+|+..
T Consensus 130 iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~D-iwSlG~il 203 (345)
T d1pmea_ 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID-IWSVGCIL 203 (345)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHH-HHHHHHHH
T ss_pred CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHH-HHCCCCEE
T ss_conf 867778764378879997787545705650477764101011026520003878604788874101-00467013
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2.1e-14 Score=110.97 Aligned_cols=134 Identities=11% Similarity=0.020 Sum_probs=94.0
Q ss_pred HHCCCCCCCCCCCEECCCCCCC--------CCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 0002335665310001222469--------96035852036995024431235665431002457877765542102899
Q 002642 409 QYGLSNLVESHLACHSTCNVAG--------DQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMP 480 (897)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~ 480 (897)
.-.|.+++|||++.+.+.+... +..+++.+++..+.......... ..+-.....+..|.+.|++|||-
T Consensus 60 ~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~-- 135 (318)
T d3blha1 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR-- 135 (318)
T ss_dssp HHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHCCCCCCCEEEEEECCCCCCCCCCCEEEEEEECCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCC--
T ss_conf 99999835999660676540246544445763899985357874101222034--43308999999999999988522--
Q ss_pred CCCCCEECCCCCCCCCCCCCCCEEECC--CCCCCC-------CCCCCCCCCCEEECCCC--CCCCCCCCCCCCCCCCCCC
Q ss_conf 878831058999972248999825713--677888-------87754546521204655--5587433211101135799
Q 002642 481 ITCKPIHPELENEKLLIDSEESANISG--LSNNMN-------YRNGTASGCNMKNGTKN--LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 481 ~~~~iIHrDiK~sNILLD~~~~aKisD--Lar~~~-------~~~~tt~gt~~v~GT~~--~~g~~t~ksD~Vy~~~~s~ 549 (897)
..||||||||+|||++++..+|++| +++... ....+..||..++.++. .....+.|+| +||+|+.-
T Consensus 136 --~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~D-iwSlGvil 212 (318)
T d3blha1 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID-LWGAGCIM 212 (318)
T ss_dssp --TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHH-HHHHHHHH
T ss_pred --CCEEECCCCCHHEEECCCCCEEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHH-CCCCCCEE
T ss_conf --998856767222036689968763135002235544432113566024978742899707999891787-00678646
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=3.9e-14 Score=109.11 Aligned_cols=132 Identities=12% Similarity=0.037 Sum_probs=96.1
Q ss_pred CCCCCCC-CCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECC
Q ss_conf 0233566-531000122246996035852036995024431235665431002457877765542102899878831058
Q 002642 411 GLSNLVE-SHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPE 489 (897)
Q Consensus 411 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrD 489 (897)
.+.++.| +|.+.+..++..+...+++.|++. +++... +......++......+..|.+.||+|||-. .|||||
T Consensus 53 ~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~-~~l~~~-~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrD 126 (293)
T d1csna_ 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG-PSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRD 126 (293)
T ss_dssp HHHHTTTCTTCCCEEEEEEETTEEEEEEECCC-CBHHHH-HHHTTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCC
T ss_pred HHHHHCCCCCCCEEEEEEECCCCCEEEEEECC-CCHHHH-HHHHCCCHHHHHHHHHHHHHHHHHHHHHHC----CCEECC
T ss_conf 99996489998779999601881179999648-887999-975203110689999999999999999977----966266
Q ss_pred CCCCCCCCCC-----CCCEEECC--CCCC---C-CCCCCCCCCCCEEECCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999722489-----99825713--6778---8-88775454652120465-------55587433211101135799
Q 002642 490 LENEKLLIDS-----EESANISG--LSNN---M-NYRNGTASGCNMKNGTK-------NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 490 iK~sNILLD~-----~~~aKisD--Lar~---~-~~~~~tt~gt~~v~GT~-------~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||+|||++. +...|++| +|+. . ............+.||. .....++.++| +||||+.-
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~D-iwSlG~~l 203 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDD-LEALGHVF 203 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHH-HHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHH-HHHHHHHH
T ss_conf 771315234754344795687236605771467665411102467627751026798964888886999-89831999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=1.9e-14 Score=111.17 Aligned_cols=132 Identities=11% Similarity=0.001 Sum_probs=96.7
Q ss_pred HCCCCCCCCCCCEECCCCC-----CCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 0023356653100012224-----69960358520369950244312356654310024578777655421028998788
Q 002642 410 YGLSNLVESHLACHSTCNV-----AGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCK 484 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~ 484 (897)
-.|.+++|||+|++.++.. +...++++-+++..+++...+.. ..++......+..|.+.||+|||-. .
T Consensus 69 ~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~----g 141 (348)
T d2gfsa1 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----D 141 (348)
T ss_dssp HHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred HHHHHCCCCCEEEEEEEEEECCCCCCCCEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----C
T ss_conf 99986689874259999963464566864999996258862320022---4530999999999999999999738----8
Q ss_pred CEECCCCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCEEECCC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 31058999972248999825713--6778888775454652120465--55587433211101135799
Q 002642 485 PIHPELENEKLLIDSEESANISG--LSNNMNYRNGTASGCNMKNGTK--NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 485 iIHrDiK~sNILLD~~~~aKisD--Lar~~~~~~~tt~gt~~v~GT~--~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||||||+|||+|.+...|++| +|........+..|+...+.++ ......+.++| +||+|+.-
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~D-iwSlGv~l 209 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD-IWSVGCIM 209 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHH-HHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCC-HHHHHHHH
T ss_conf 765166776334554322001321000125754444345435558355337756785512-43205899
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.3e-14 Score=112.30 Aligned_cols=134 Identities=15% Similarity=0.157 Sum_probs=96.9
Q ss_pred HHCCCCCCC-CCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 000233566-5310001222469960358520369950244312356654310024578777655421028998788310
Q 002642 409 QYGLSNLVE-SHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIH 487 (897)
Q Consensus 409 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIH 487 (897)
...|.+++| ||++++.++....+..+.+.|++..+.+...+.+... ..-..-..+..|-+.||+|+|-. .|||
T Consensus 79 ~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~----~ivH 152 (322)
T d1vzoa_ 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL----GIIY 152 (322)
T ss_dssp HHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT----TCCC
T ss_pred HHHHHHCCCCCEEEEEEEEECCCCCEEEEEECCCCCHHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHCC----CEEE
T ss_conf 99998646798399962000248730012312341179999873045--43788888899999999885149----9896
Q ss_pred CCCCCCCCCCCCCCCEEECC--CCCCCC--CC--CCCCCCCCEEECCC---CCCCCCCCCCCCCCCCCCCC
Q ss_conf 58999972248999825713--677888--87--75454652120465---55587433211101135799
Q 002642 488 PELENEKLLIDSEESANISG--LSNNMN--YR--NGTASGCNMKNGTK---NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 488 rDiK~sNILLD~~~~aKisD--Lar~~~--~~--~~tt~gt~~v~GT~---~~~g~~t~ksD~Vy~~~~s~ 549 (897)
|||||+|||||.+...||+| +|+... .. ..+..|+.....++ ......+.++| |||+|+.-
T Consensus 153 rDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksD-IWSlG~iL 222 (322)
T d1vzoa_ 153 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD-WWSLGVLM 222 (322)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH-HHHHHHHH
T ss_pred CCCCCCCEEECCCCCEEEEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHH-HHHHHHHH
T ss_conf 54773201246999888741320222034444322122233333106876057768871325-17777999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.9e-14 Score=110.00 Aligned_cols=130 Identities=10% Similarity=0.097 Sum_probs=97.2
Q ss_pred HCCCCCCCCCCCEECCCCCC------CCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 00233566531000122246------996035852036995024431235665431002457877765542102899878
Q 002642 410 YGLSNLVESHLACHSTCNVA------GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITC 483 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~ 483 (897)
..|.+++|||+|++.+++.. ..+.+++.||+..+... .+ ...++......+..|.+.||+|||.+.
T Consensus 68 ~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~----~~~~~~~~i~~~~~qil~gl~~LH~~g--- 139 (355)
T d2b1pa1 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI----QMELDHERMSYLLYQMLCGIKHLHSAG--- 139 (355)
T ss_dssp HHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHCCCCCEEEEEEEEECCCCCCCCCEEEEEEECCCHHHHH-HH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---
T ss_conf 9998648987648998970256434576269998414467787-65----038999999999999999998865221---
Q ss_pred CCEECCCCCCCCCCCCCCCEEECC--CCCC--CCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 831058999972248999825713--6778--888775454652120465-55587433211101135799
Q 002642 484 KPIHPELENEKLLIDSEESANISG--LSNN--MNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 484 ~iIHrDiK~sNILLD~~~~aKisD--Lar~--~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||||||+|||++.+...|++| +++. .........+|..+++++ ......+.++| +||+|+.-
T Consensus 140 -iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~D-iwSlG~~l 208 (355)
T d2b1pa1 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD-IWSVGCIM 208 (355)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHH-HHHHHHHH
T ss_pred -CCCCCCCCCCCCCCCCCCEEEECHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC-CCCCCCHH
T ss_conf -1245677632113654431320102321146665533221465555813314777787743-33566257
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.37 E-value=1.1e-13 Score=106.18 Aligned_cols=130 Identities=15% Similarity=0.102 Sum_probs=94.2
Q ss_pred HCCCCCC-CCCCCEECCCCCC--CCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCE
Q ss_conf 0023356-6531000122246--996035852036995024431235665431002457877765542102899878831
Q 002642 410 YGLSNLV-ESHLACHSTCNVA--GDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPI 486 (897)
Q Consensus 410 ~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iI 486 (897)
..|.++. |||++++.++... .+..+++.||+..+.+... ...++......+..|-+.||.|||-. .||
T Consensus 81 ~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~-----~~~l~e~~i~~i~~qil~aL~~LH~~----gIv 151 (328)
T d3bqca1 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSM----GIM 151 (328)
T ss_dssp HHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT-----TTSCCHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred HHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEECCCCCHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHC----CCC
T ss_conf 999851579987679999981687712688863179858997-----46899999999999999999887643----344
Q ss_pred ECCCCCCCCCCCCCC-CEEECC--CCC--CCCCCCCCCCCCCEEECCCC--CCCCCCCCCCCCCCCCCCC
Q ss_conf 058999972248999-825713--677--88887754546521204655--5587433211101135799
Q 002642 487 HPELENEKLLIDSEE-SANISG--LSN--NMNYRNGTASGCNMKNGTKN--LQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 487 HrDiK~sNILLD~~~-~aKisD--Lar--~~~~~~~tt~gt~~v~GT~~--~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||||+|||+|.+. ..|++| +|+ ..........+|...++++. .....+.++| ++|+|+.-
T Consensus 152 HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D-iwslG~~l 220 (328)
T d3bqca1 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD-MWSLGCML 220 (328)
T ss_dssp CCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHH-HHHHHHHH
T ss_pred CCCCCCCCEEECCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHHHHHHH
T ss_conf 3456441237748998366415654266468874443224864247610268888884523-23354555
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.33 E-value=1.4e-13 Score=105.38 Aligned_cols=133 Identities=12% Similarity=0.025 Sum_probs=92.2
Q ss_pred HCCCCCCCCCCCEECCCC-CCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 002335665310001222-4699603585203699502443123566543100245787776554210289987883105
Q 002642 410 YGLSNLVESHLACHSTCN-VAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
-.+.+++|++.+.++++| ..++..+++-|++....... .......++....+++..|.+.||+|||- ..||||
T Consensus 54 ~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~--~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~iiHr 127 (299)
T d1ckia_ 54 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIHS----KNFIHR 127 (299)
T ss_dssp HHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHH--HHHTTTCCCHHHHHHHHHHHHHHHHHHHH----TTEECS
T ss_pred HHHHHCCCCCCCCEEEEEEECCCEEEEEEEECCCCHHHH--HHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEEC
T ss_conf 999970389960179999951987789998738713332--44306887689999999999999999997----994426
Q ss_pred CCCCCCCCC---CCCCCEEECC--CCCCC--CCCC--------CCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 899997224---8999825713--67788--8877--------5454652120465-55587433211101135799
Q 002642 489 ELENEKLLI---DSEESANISG--LSNNM--NYRN--------GTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILL---D~~~~aKisD--Lar~~--~~~~--------~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+|||+ |.+...|++| +|+.. .... .+..||..+.+++ ......+.++| |||||+.-
T Consensus 128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlG~~l 203 (299)
T d1ckia_ 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD-LESLGYVL 203 (299)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHH-HHHHHHHH
T ss_pred CCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHH-EEECCHHH
T ss_conf 67876606433577761565046751342554455410001357767873532999991899898321-88617789
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.95 E-value=1.9e-11 Score=91.17 Aligned_cols=134 Identities=9% Similarity=0.043 Sum_probs=86.3
Q ss_pred CCCCCCCCCCEECCCCCCCCC--CEEEEECCCCCCEEEEEE-CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEEC
Q ss_conf 233566531000122246996--035852036995024431-23566543100245787776554210289987883105
Q 002642 412 LSNLVESHLACHSTCNVAGDQ--FFLSHTAINNPSTFVRVM-NTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHP 488 (897)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHr 488 (897)
+..+.|+|++.++.++...+. ..++.+++...-...... .......+......+..|-+.||+|||. ...|+||
T Consensus 74 ~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHr 150 (362)
T d1q8ya_ 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHT 150 (362)
T ss_dssp HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECS
T ss_pred HHHCCCCCEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---HCCCCCC
T ss_conf 5422767647899876312565202343200035420000012234678689999999999999888764---0586465
Q ss_pred CCCCCCCCCCCCCC------EEECC--CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 89999722489998------25713--6778888775454652120465-55587433211101135799
Q 002642 489 ELENEKLLIDSEES------ANISG--LSNNMNYRNGTASGCNMKNGTK-NLQGGVASSMDLLYNLSLSS 549 (897)
Q Consensus 489 DiK~sNILLD~~~~------aKisD--Lar~~~~~~~tt~gt~~v~GT~-~~~g~~t~ksD~Vy~~~~s~ 549 (897)
||||+||||+.+-. .|++| .|+..........|+...+.++ ......+.++| ++|+|+.-
T Consensus 151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwSlG~il 219 (362)
T d1q8ya_ 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD-IWSTACLI 219 (362)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHH-HHHHHHHH
T ss_pred CCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCC-CCCHHHHH
T ss_conf 6770570563057656443056753144212344542236652105713214667776432-01237899
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=2.9e-06 Score=56.73 Aligned_cols=140 Identities=16% Similarity=0.046 Sum_probs=85.8
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCCC
Q ss_conf 89159999522695499985655940799985478656787247899999999999996179-99632683221048975
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFYGVVTDGPVT 700 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-HPNIVkL~d~~~e~~~~ 700 (897)
..|+..+..+.++.+.||+....+..+.+|+........ ...+.+|...+..+. +--+.+++.+.... .
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred HCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCC--------HHHHHHHHHHHHHHHCCCCCCCEEEEEECC--C
T ss_conf 352799767899877189999089869999848876532--------556999999999876069987289997508--9
Q ss_pred EEEEEEEEEECCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------
Q ss_conf 079999542236267887202666338899999999999999999-----------------------------------
Q 002642 701 NLATVTEYMVNGSLKQVLRRKDRTIDRRKRIIIAMDAAFGIEYLH----------------------------------- 745 (897)
Q Consensus 701 ~l~IVmEyl~GGSL~~~L~~~~~~lse~~il~Ia~QIl~aL~yLH----------------------------------- 745 (897)
..++||++++|.++........ .. ..++.++...+..||
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~---~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQ---SP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCS---CH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred CEEEEEEECCCCCCCCCCCCCC---CH---HHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 6499998604334354334402---69---99999899999998556842143576446565557789987765555430
Q ss_pred ------------------HC------CCEECCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf ------------------89------9631268999758513799999099982599502
Q 002642 746 ------------------EK------NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 746 ------------------s~------GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~ 781 (897)
+. .++|+|+.|.||+++ +.+...|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC----CCCEEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364----996599960231441
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.22 E-value=2.7e-07 Score=63.56 Aligned_cols=83 Identities=12% Similarity=-0.007 Sum_probs=60.0
Q ss_pred CCCCCCCCCCCEECCCCCCCCCCEEEEECCCCCCEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCEECCC
Q ss_conf 02335665310001222469960358520369950244312356654310024578777655421028998788310589
Q 002642 411 GLSNLVESHLACHSTCNVAGDQFFLSHTAINNPSTFVRVMNTKDDMLTGSKLERHEVQCQALYENFHGMPITCKPIHPEL 490 (897)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~~~~~iIHrDi 490 (897)
.|.++.|++++....+. ...++.+++..... ..++......+..|.+++++|||- +.||||||
T Consensus 67 ~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~----~giiHrDi 129 (191)
T d1zara2 67 ALQKLQGLAVPKVYAWE----GNAVLMELIDAKEL---------YRVRVENPDEVLDMILEEVAKFYH----RGIVHGDL 129 (191)
T ss_dssp HHHHTTTSSSCCEEEEE----TTEEEEECCCCEEG---------GGCCCSCHHHHHHHHHHHHHHHHH----TTEECSCC
T ss_pred HHHHCCCCCCCEEEEEC----CCEEEEEEECCCCC---------CCHHHHHHHHHHHHHHHHHHHHHH----CCEEECCC
T ss_conf 99981699914499862----88899995045654---------200157899999999999999826----88898368
Q ss_pred CCCCCCCCCCCCEEECC--CCCC
Q ss_conf 99972248999825713--6778
Q 002642 491 ENEKLLIDSEESANISG--LSNN 511 (897)
Q Consensus 491 K~sNILLD~~~~aKisD--Lar~ 511 (897)
||+|||++++ .+++.| +|+.
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEE
T ss_pred CHHHEEEECC-CEEEEECCCCCC
T ss_conf 9036114289-899987788430
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.64 E-value=8.5e-05 Score=46.98 Aligned_cols=62 Identities=19% Similarity=0.254 Sum_probs=52.0
Q ss_pred ECCCEEEEEECCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHH
Q ss_conf 459527998158999379999999771689960278514899999989998668621616698989986432
Q 002642 41 IGGETRIISVDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKL 112 (897)
Q Consensus 41 ~gg~tri~~v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~ 112 (897)
.+++++++.|+.+++|.+|..++.+.+.. ..+.|||+-. | +.+|+++||+||..+|++..++
T Consensus 19 ~~~D~~~~~l~~~it~~dL~~kI~~rf~~-~~~~lkY~De--------d-gd~v~i~sD~Dl~~ai~~~~kl 80 (85)
T d1ip9a_ 19 YKDDIFALMLKGDTTYKELRSKIAPRIDT-DNFKLQTKLF--------D-GSGEEIKTDSQVSNIIQAKLKI 80 (85)
T ss_dssp BTTCCEEEEECSCCCHHHHHHHHHHHHTS-SCEEEEECCS--------S-SCCSCCCSHHHHHHHHHTTCCE
T ss_pred ECCCEEEEEECCCCCHHHHHHHHHHHHCC-CCEEEEEECC--------C-CCEEEEECHHHHHHHHHHCCCE
T ss_conf 89929999937998899999999998587-8368999968--------9-9978983789999999722828
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.62 E-value=0.00031 Score=43.22 Aligned_cols=136 Identities=18% Similarity=0.116 Sum_probs=74.5
Q ss_pred EECCCC-CEEEEEEEEC-CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCCCCEEEE
Q ss_conf 952269-5499985655-940799985478656787247899999999999996179--996326832210489750799
Q 002642 629 ELGSGT-FGTVFYGKWK-GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH--HPNVVAFYGVVTDGPVTNLAT 704 (897)
Q Consensus 629 ~LG~G~-fG~VYla~~k-g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~--HPNIVkL~d~~~e~~~~~l~I 704 (897)
.+..|. .+.||+.... +..+.+|....... ..+..|...++.+. .-.+.+++.+..+. ...++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH-----------HHHHHHHHHHHHHHHCCCCCCCEEEECCCC--CCEEE
T ss_conf 76786547758999938987899995896677-----------689999999999986599988613222456--61599
Q ss_pred EEEEEECCCHHHH--------------HHH-C-----CCCCCHHHHHHH----------------------HHHHHHHHH
Q ss_conf 9954223626788--------------720-2-----666338899999----------------------999999999
Q 002642 705 VTEYMVNGSLKQV--------------LRR-K-----DRTIDRRKRIII----------------------AMDAAFGIE 742 (897)
Q Consensus 705 VmEyl~GGSL~~~--------------L~~-~-----~~~lse~~il~I----------------------a~QIl~aL~ 742 (897)
||++++|.++... +.+ + ...+.......+ .......+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CCEECCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 99989-------9631268999758513799999099982599502
Q 002642 743 YLHEK-------NIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 743 yLHs~-------GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~ 781 (897)
.+... .++|+|+.|.|||++ ....+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~----~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEE----CCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773----796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00031 Score=43.23 Aligned_cols=82 Identities=21% Similarity=0.076 Sum_probs=45.2
Q ss_pred EEEECCCCCEEEEEEEEC--CCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC--C-CCEEEEEEEEECCCCCE
Q ss_conf 999522695499985655--940799985478656787247899999999999996179--9-96326832210489750
Q 002642 627 IKELGSGTFGTVFYGKWK--GSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH--H-PNVVAFYGVVTDGPVTN 701 (897)
Q Consensus 627 ik~LG~G~fG~VYla~~k--g~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~--H-PNIVkL~d~~~e~~~~~ 701 (897)
.+.||.|....||++... +..+++|.-.+........ ......+...|...++.+. . ..+++++.+.. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~-~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC-CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TT
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECC----CC
T ss_conf 998079852768999957998489996177130346777-8887789999999999865057988552899859----88
Q ss_pred EEEEEEEEECCC
Q ss_conf 799995422362
Q 002642 702 LATVTEYMVNGS 713 (897)
Q Consensus 702 l~IVmEyl~GGS 713 (897)
.+++||++++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEECCCCCC
T ss_conf 779871357765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.014 Score=32.31 Aligned_cols=77 Identities=16% Similarity=0.287 Sum_probs=44.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEECC---------CCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEE
Q ss_conf 891599995226954999856559---------40799985478656787247899999999999996179-99632683
Q 002642 622 SDLEYIKELGSGTFGTVFYGKWKG---------SDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-HPNVVAFY 691 (897)
Q Consensus 622 ~~Yeiik~LG~G~fG~VYla~~kg---------~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-HPNIVkL~ 691 (897)
++++ ++.|+.|-.-.+|++.... ..+.+++.-.. ... ....+|..+++.+. +.-..+++
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~-----idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETE-----SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCH-----HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CCEE-EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-----CHH-----HHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 0169-999178533434899968877544578981799965996-----116-----58999999999997579998089
Q ss_pred EEEECCCCCEEEEEEEEEECCCHH
Q ss_conf 221048975079999542236267
Q 002642 692 GVVTDGPVTNLATVTEYMVNGSLK 715 (897)
Q Consensus 692 d~~~e~~~~~l~IVmEyl~GGSL~ 715 (897)
+++.. .+|+||++|.++.
T Consensus 112 ~~~~~------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPLS 129 (395)
T ss_dssp EEETT------EEEECCCCEEECC
T ss_pred EECCC------CEEEEEECCCCCC
T ss_conf 98189------5699973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0033 Score=36.40 Aligned_cols=132 Identities=15% Similarity=0.073 Sum_probs=68.2
Q ss_pred CCCEEEEEEEE-CCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCEEEEEE--EEECCCCCEEEE
Q ss_conf 69549998565-5940799985478656787247899999999999996179-----996326832--210489750799
Q 002642 633 GTFGTVFYGKW-KGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-----HPNVVAFYG--VVTDGPVTNLAT 704 (897)
Q Consensus 633 G~fG~VYla~~-kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-----HPNIVkL~d--~~~e~~~~~l~I 704 (897)
+.--.||+++. ++..+++|+.++.... .+++..|...+..|. .+..+..-+ .+... ...+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~--~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ--GFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET--TEEEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEE--EEEEE
T ss_conf 6120269998389997999984787788---------999999999999998559987875206898056653--47999
Q ss_pred EEEEEECCCHH-----HH------H---HH----CC----CCCCH-------------------H---HHHHHHHHHHHH
Q ss_conf 99542236267-----88------7---20----26----66338-------------------8---999999999999
Q 002642 705 VTEYMVNGSLK-----QV------L---RR----KD----RTIDR-------------------R---KRIIIAMDAAFG 740 (897)
Q Consensus 705 VmEyl~GGSL~-----~~------L---~~----~~----~~lse-------------------~---~il~Ia~QIl~a 740 (897)
++++++|..+. ++ + .. .. ...+. . .....+.++...
T Consensus 102 l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 181 (325)
T d1zyla1 102 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 181 (325)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 98652776889999999999899999988630357865567789788766568999874769988989999999999999
Q ss_pred HHHHH----HCCCEECCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 99999----899631268999758513799999099982599502
Q 002642 741 IEYLH----EKNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSKI 781 (897)
Q Consensus 741 L~yLH----s~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk~ 781 (897)
+.-.- ..++||+|+.+.|||++ .. ..++||+.+..
T Consensus 182 l~~~~~~~~p~~liHgDlh~~NvL~~----~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 182 VTAHWREDFTVLRLHGDCHAGNILWR----DG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES----SS--EEECCCTTCCE
T ss_pred HHHHCCCCCCCEEECCCCCCCCEEEE----CC--CEEEECHHCCC
T ss_conf 99845456871202478880428783----89--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.45 E-value=0.023 Score=30.76 Aligned_cols=144 Identities=10% Similarity=0.017 Sum_probs=74.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCEEEEE-EE-
Q ss_conf 889159999522695499985655940799985478656787247899999999999996179-----99632683-22-
Q 002642 621 TSDLEYIKELGSGTFGTVFYGKWKGSDVAIKRIKPSCFAEGSLEEDRLIADFWREAHMLGQIH-----HPNVVAFY-GV- 693 (897)
Q Consensus 621 ~~~Yeiik~LG~G~fG~VYla~~kg~~VAIK~ik~~~~~~~~~~~~~~~~~i~rEi~iLk~L~-----HPNIVkL~-d~- 693 (897)
.....-.+.|..|---+.|+.+.++..+++|++.... . ..++..|+.++..|. .|..+... +.
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~---------~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~ 86 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL 86 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred CCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCC-C---------HHHHHHHHHHHHHHHHCCCCCCCCCEECCCCC
T ss_conf 9985685237888526738999789728999807899-9---------88999999998754302555455641048976
Q ss_pred -EECCCCCEEEEEEEEEECCCHHH-----------H---HHHC----C----------------------CCCCHHHHHH
Q ss_conf -10489750799995422362678-----------8---7202----6----------------------6633889999
Q 002642 694 -VTDGPVTNLATVTEYMVNGSLKQ-----------V---LRRK----D----------------------RTIDRRKRII 732 (897)
Q Consensus 694 -~~e~~~~~l~IVmEyl~GGSL~~-----------~---L~~~----~----------------------~~lse~~il~ 732 (897)
.... .....++.++.+..... . +... . ..........
T Consensus 87 ~~~~~--~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (316)
T d2ppqa1 87 LGELS--GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 164 (316)
T ss_dssp CEEET--TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CEEEE--CCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHH
T ss_conf 21341--2550245311465533320467888889987645444320245310111012002456777765311412799
Q ss_pred HHHHHHHHHHHHHH----CCCEECCCCCCCEEECCCCCCCCEEEEEECCCCC
Q ss_conf 99999999999998----9963126899975851379999909998259950
Q 002642 733 IAMDAAFGIEYLHE----KNIVHFDLKSHNFLVNMRDPQRPVCKIGDLGLSK 780 (897)
Q Consensus 733 Ia~QIl~aL~yLHs----~GIIHRDIKPeNILLd~~d~~~g~VKLiDFGLAk 780 (897)
.+..+...+..... .|+||+|+.+.||+++ .+...-++||+.+.
T Consensus 165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~----~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCC----CCCCEEEECCCCCC
T ss_conf 9999987642048554545033378636564020----45412674222123
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.23 E-value=0.024 Score=30.68 Aligned_cols=70 Identities=23% Similarity=0.452 Sum_probs=57.2
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 59527998158999379999999771689960278514899999989998668621616698989986432017999899
Q 002642 42 GGETRIISVDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKLESCGKGVAD 121 (897)
Q Consensus 42 gg~tri~~v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~~~~~~~~~~ 121 (897)
-||.||+.++|.++|.+|..|....+|. .+.+-|-= +| .+|.+++.+||+.-++-.||.. ..+
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq--~ldl~y~n-------~E---l~IPl~~Q~DLDkAvellDrs~----~~k- 72 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQ--PLDLHYMN-------NE---LSILLKNQDDLDKAIDILDRSS----SMK- 72 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSS--CCEEEEEC-------SS---CEEECCSHHHHHHHHHHHHHCS----SCC-
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCC--EEEEEEEC-------CE---EEEECCCHHHHHHHHHHHCCCC----CCC-
T ss_conf 3706899527884299999999998598--36467756-------71---7885256777899999871696----633-
Q ss_pred CCEEEEEE
Q ss_conf 85489973
Q 002642 122 DSLRKKVM 129 (897)
Q Consensus 122 ~~~r~f~f 129 (897)
++|+.|.
T Consensus 73 -sLrilL~ 79 (80)
T d2c60a1 73 -SLRILLL 79 (80)
T ss_dssp -SEEEEEE
T ss_pred -EEEEEEE
T ss_conf -0699973
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.03 E-value=0.029 Score=30.15 Aligned_cols=70 Identities=24% Similarity=0.358 Sum_probs=57.1
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 59527998158999379999999771689960278514899999989998668621616698989986432017999899
Q 002642 42 GGETRIISVDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKLESCGKGVAD 121 (897)
Q Consensus 42 gg~tri~~v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~~~~~~~~~~ 121 (897)
-||.||+.++|.+.|.+|..|....+|. .+.+-|-= + .-+|.+++.+||+.-++-.||.. ..++
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq--~ldl~y~n-------~---EL~IPl~~Q~DLDkAvellDrs~----~~ks 73 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQ--SMDLHYTN-------N---ELVIPLTTQDDLDKAVELLDRSI----HMKS 73 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTS--CEEEEEEE-------T---TEEEECCCHHHHHHHHHHHHHCS----SCCS
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCC--EEEEEEEC-------C---EEEEECCCHHHHHHHHHHHCCCC----CCCC
T ss_conf 3706899527884389999999998598--46688856-------7---68886256777899999871696----6342
Q ss_pred CCEEEEEE
Q ss_conf 85489973
Q 002642 122 DSLRKKVM 129 (897)
Q Consensus 122 ~~~r~f~f 129 (897)
+|..|.
T Consensus 74 --LrilL~ 79 (82)
T d2nptb1 74 --LKILLV 79 (82)
T ss_dssp --EEEEEE
T ss_pred --EEEEEE
T ss_conf --689999
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.82 E-value=0.038 Score=29.35 Aligned_cols=70 Identities=13% Similarity=0.178 Sum_probs=50.4
Q ss_pred CCCEEE--EEECCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 595279--981589993799999997716899602785148999999899986686216166989899864320179998
Q 002642 42 GGETRI--ISVDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKLESCGKGV 119 (897)
Q Consensus 42 gg~tri--~~v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~~~~~~~~ 119 (897)
||+|+- ++++++.+|.+|.+++...++- ..+.|||.= |-+-.|+++||+||+.-++ +...
T Consensus 12 ~~dt~RF~ls~~~~~~~~~L~~~i~~rf~l-~~~~lkY~D---------dd~e~v~l~~d~dl~E~~~----~a~~---- 73 (85)
T d2bkfa1 12 KNEIQSFLVSDPENTTWADIEAMVKVSFDL-NTIQIKYLD---------EENEEVSINSQGEYEEALK----MAVK---- 73 (85)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTC-SSEEEEEEC---------TTSCEEEECSHHHHHHHHH----HHHH----
T ss_pred CCCEEEEEECCCCCCCHHHHHHHHHHHCCC-CCCEEEEEC---------CCCCEEEEECHHHHHHHHH----HHHC----
T ss_conf 784589996488777699999999986696-641389875---------9999899806888999999----9866----
Q ss_pred CCCCEEEEEE
Q ss_conf 9985489973
Q 002642 120 ADDSLRKKVM 129 (897)
Q Consensus 120 ~~~~~r~f~f 129 (897)
....+|++++
T Consensus 74 ~~~~irl~v~ 83 (85)
T d2bkfa1 74 QGNQLQMQVH 83 (85)
T ss_dssp TTTEEEEEEE
T ss_pred CCCEEEEEEE
T ss_conf 8988999996
|
| >d1oeyj_ d.15.2.2 (J:) Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.71 E-value=0.79 Score=20.61 Aligned_cols=57 Identities=28% Similarity=0.358 Sum_probs=49.4
Q ss_pred CCCEEEEEECCCC----CHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHH
Q ss_conf 5952799815899----937999999977168996027851489999998999866862161669898998
Q 002642 42 GGETRIISVDRTI----SFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEE 108 (897)
Q Consensus 42 gg~tri~~v~r~~----~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~e 108 (897)
|+.+|=|+|.-+. +|.+|...+...+.- .+++|-|+=| .+| ||-+-+|||+.-|+.|
T Consensus 15 ~~~~rDI~veedl~~~P~ykdLl~lmr~~f~~-~dIaLNYrD~------eGD---LIRllddeDv~LMv~~ 75 (105)
T d1oeyj_ 15 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQR-EDIALNYRDA------EGD---LVRLLSDEDVALMVRQ 75 (105)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCC-SSEEEEEECT------TSC---EEECCSHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCC-CEEEEEEECC------CCC---EEEECCHHHHHHHHHH
T ss_conf 64031278720013394599999999977350-0067630468------898---8998361258999987
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.98 E-value=0.85 Score=20.39 Aligned_cols=54 Identities=15% Similarity=0.304 Sum_probs=44.4
Q ss_pred ECCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHH
Q ss_conf 158999379999999771689960278514899999989998668621616698989986432
Q 002642 50 VDRTISFPKLRLKISDICSSIPSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKL 112 (897)
Q Consensus 50 v~r~~~~~~l~~~l~~~~~~~~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~ 112 (897)
-++.++|.++...++....-.....++|. .||-| -|+|.|||+|.-|+.=|-..
T Consensus 32 ~~~~l~F~dvL~~i~q~~p~at~taFEYE--------DEdGD-RITVRSDEEl~AMisyy~~~ 85 (105)
T d2npta1 32 SGPQLLFRDVLDVIGQVLPEATTTAFEYE--------DEDGD-RITVRSDEEMKAMLSYYYST 85 (105)
T ss_dssp C--CCCHHHHHHHHHHHSTTSCCSEEEEE--------CTTSC-EEEECSHHHHHHHHHHHHHH
T ss_pred CCCEEEHHHHHHHHHHHCCCCCCCCEEEC--------CCCCC-EEEECCHHHHHHHHHHHHHH
T ss_conf 88643399999999986634454210302--------56588-76872679999999999999
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.54 E-value=1.1 Score=19.73 Aligned_cols=73 Identities=23% Similarity=0.312 Sum_probs=56.9
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHHCCC--CCCEEEEECCCCCCCCCCCCCCEEEECCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 59527998158999379999999771689--9602785148999999899986686216166989899864320179998
Q 002642 42 GGETRIISVDRTISFPKLRLKISDICSSI--PSFTLKYRLPLNPDRKQGDDTPLVLIASDDDVRCMVEEYDKLESCGKGV 119 (897)
Q Consensus 42 gg~tri~~v~r~~~~~~l~~~l~~~~~~~--~~~~~kyqlp~~~~~~~~dld~lisv~~d~dl~~m~~ey~~~~~~~~~~ 119 (897)
+|+--|..++.+++|.+|...+.++|+.. ..+++|.-= |+-| =++|+|+.+|..-+--|..-
T Consensus 9 ~G~i~it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWiD--------eEGD-PCTISSQmEL~EA~RLye~n------- 72 (83)
T d1wmha_ 9 RGDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWID--------EEGD-PCTVSSQLELEEAFRLYELN------- 72 (83)
T ss_dssp TTEEEEEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEEC--------TTSC-EEECCSHHHHHHHHHHHHHT-------
T ss_pred CCEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEC--------CCCC-CEEEECHHHHHHHHHHHHCC-------
T ss_conf 6759999438875599999999998489867967788774--------7999-50655488799999999705-------
Q ss_pred CCCCEEEEEEE
Q ss_conf 99854899730
Q 002642 120 ADDSLRKKVMK 130 (897)
Q Consensus 120 ~~~~~r~f~f~ 130 (897)
+.+-+-+-+||
T Consensus 73 ~dseL~iHVFP 83 (83)
T d1wmha_ 73 KDSELLIHVFP 83 (83)
T ss_dssp TCSCEEEEEEC
T ss_pred CCCCEEEEECC
T ss_conf 77646998469
|